Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,maintenance of blood-brain barrier (GO:0035633),-0.6606453478388168,-2.2319094563012722,0.0,0.010312136164550645,0.009,15/30,7.62%,TJP1;CDH5;GJB6;OCLN;PECAM1;DMD;CLDN5;LAMA2;ESAM;SLC12A2;F11R;LSR;TJP2;ACTB;GJA1
prerank,superoxide anion generation (GO:0042554),0.8971664584955423,1.941149084251555,0.0,0.04460051650754515,0.04,3/13,0.87%,NOX4;DUOX1;NCF4
prerank,protein localization to cell-cell junction (GO:0150105),-0.6657596021511888,-1.9160878543318813,0.0,0.6886215372105486,0.645,7/15,5.82%,TJP1;CGNL1;CDH5;F11R;LSR;TJP2;ACTB
prerank,dopaminergic neuron differentiation (GO:0071542),0.836347586746925,1.9158520937079966,0.0,0.05526585741152334,0.095,5/19,3.91%,LMX1A;LRP6;WNT2;VEGFA;LMX1B
prerank,collagen fibril organization (GO:0030199),0.6827744851972096,1.8919695686389195,0.0,0.07013269624737173,0.173,35/88,10.86%,COL14A1;PLOD2;COL3A1;P4HA3;COL5A2;COL6A3;COL1A2;DDR2;COL1A1;LOXL2;COL17A1;COL5A1;BMP1;COL8A1;COL11A1;COL5A3;ADAMTS2;COL6A2;TGFB2;COL8A2;P4HA1;ADAMTS3;DPT;DST;COL12A1;COL6A1;P4HA2;TLL1;COL15A1;PLOD3;COL9A3;LOXL1;COL2A1;COLGALT1;SERPINH1
prerank,ethanol metabolic process (GO:0006067),-0.7133074474123037,-1.8813917253697636,0.008064516129032258,0.6771636081388258,0.775,5/12,15.32%,ALDH1A1;ACSS1;ACSS2;ADH1A;SULT1A1
prerank,regulation of cell junction assembly (GO:1901888),-0.5559076314466616,-1.878010479062135,0.005494505494505495,0.5270647372992552,0.786,8/27,3.21%,TJP1;RAPGEF2;PRKCH;OCLN;PDLIM5;CLDN5;MEF2C;F11R
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.6189731457723802,-1.8439823762434961,0.0,0.5948956774038551,0.872,6/19,4.00%,TJP1;PRKCH;OCLN;CLDN5;F11R;NPHP1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.7939242248454087,1.8215009509874267,0.0,0.29765996886557305,0.598,9/19,11.47%,GFPT2;UAP1;UGDH;UGP2;GFPT1;GNPNAT1;NAGK;GMPPB;SLC35D1
prerank,protein homotrimerization (GO:0070207),0.8357491295274805,1.804804069353346,0.0013315579227696406,0.2730973655715627,0.699,5/14,4.28%,SCARA5;SLC1A5;DISP1;MIF;P2RX3
prerank,protein trimerization (GO:0070206),0.8357491295274805,1.804804069353346,0.0013315579227696406,0.2730973655715627,0.699,5/14,4.28%,SCARA5;SLC1A5;DISP1;MIF;P2RX3
prerank,regulation of multicellular organismal development (GO:2000026),-0.5532018650442782,-1.8032550999719887,0.0,0.7239501518483611,0.944,10/25,18.82%,PTN;INSR;TRIP12;MYSM1;SOX17;OAS2;SPAAR;TDG;DUSP6;RACGAP1
prerank,regulation of transmembrane transport (GO:0034762),-0.5124122433679626,-1.792158369744063,0.005714285714285714,0.6925499700351394,0.962,8/31,5.82%,NEDD4L;OCLN;SLC2A1;BCL2;CTTNBP2NL;SNCA;WWP2;ACTB
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.8366287191986532,1.784617738196158,0.0013227513227513227,0.34018282156065494,0.814,5/13,6.59%,GFPT2;UAP1;GFPT1;GNPNAT1;NAGK
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.8689456391167418,1.779709266633897,0.0013850415512465374,0.3275956416301482,0.831,3/11,1.22%,LMX1A;LRP6;WNT2
prerank,positive regulation of protein processing (GO:0010954),0.7738926647363502,1.7787700889338494,0.0,0.29625946955494964,0.839,6/19,7.11%,GSN;CCBE1;HPN;CLEC3B;KLKB1;MELTF
prerank,heart process (GO:0003015),0.8101477666989172,1.7756970166932666,0.00129366106080207,0.28447372920247277,0.855,3/14,3.15%,NOX4;FYN;TNNI3
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.6774242866048663,-1.7698766732839335,0.003257328990228013,0.7364583910849919,0.981,9/12,21.83%,ATP1B3;DMD;WNK4;FXYD1;NOS1;ATP1B1;GLRX;ANK3;ATP1B2
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.4958252535327359,-1.7633409328367171,0.007751937984496124,0.6938412604543336,0.983,12/35,13.24%,TJP1;RAPGEF3;ESAM;F11R;IQGAP2;NRP1;NTRK3;MDK;TEK;CDK5;ABL1;ABI3
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.8505317175157268,1.76192379176951,0.0027210884353741495,0.3330054374812363,0.922,5/11,6.59%,GFPT2;UAP1;GFPT1;GNPNAT1;NAGK
prerank,macrophage activation involved in immune response (GO:0002281),0.8193790457839587,1.7592333310415003,0.0,0.3206874094537078,0.928,2/13,0.28%,SYK;LBP
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.6921576821319454,-1.7534890503585248,0.010676156583629894,0.6756740773595018,0.989,4/11,4.28%,TJP1;RAPGEF2;F11R;TJP2
prerank,amino sugar biosynthetic process (GO:0046349),0.8426906940702259,1.751878109926229,0.0027397260273972603,0.33659219230526966,0.949,5/12,6.59%,GFPT2;UAP1;GFPT1;GNPNAT1;NAGK
prerank,skin development (GO:0043588),0.6517245940316251,1.7490508658556259,0.0,0.32806311598795246,0.961,13/65,4.91%,COL3A1;COL5A2;COL1A2;COL1A1;LORICRIN;COL5A1;ANXA1;COL5A3;SCEL;ADAM9;PKD1;KRT10;DACT2
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.8572923433322068,1.7474769114192088,0.0,0.3138842147255641,0.964,3/10,3.12%,GFPT2;PFKP;GFPT1
prerank,smooth muscle cell differentiation (GO:0051145),-0.6515960692776765,-1.7416324704226458,0.02158273381294964,0.6775802601050701,0.995,9/12,23.49%,MEF2C;TBX18;MRTFB;TMEM204;EDNRB;MYOCD;APLNR;HEY1;HEY2
prerank,C21-steroid hormone metabolic process (GO:0008207),0.7460259675673251,1.735527360504378,0.0012706480304955528,0.35831909525694905,0.98,2/20,0.74%,AKR1B1;DHRS9
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.8002418606974653,1.733154747976747,0.0039946737683089215,0.35070150384257687,0.983,4/14,8.08%,SYK;CD55;TGFBR2;CD81
prerank,positive regulation of vascular permeability (GO:0043117),-0.6623791214283221,-1.7327627528171436,0.011904761904761904,0.6667559892320108,0.997,8/12,12.50%,TJP1;BMP6;OCLN;PDE3A;TJP2;PDE2A;TGFB1;TRPV4
prerank,cGMP-mediated signaling (GO:0019934),-0.6383639985231878,-1.7316893814082297,0.007142857142857143,0.6212841694351924,0.998,5/13,9.63%,IRAG1;PDE3A;APOE;GUCY1B1;PDE2A
prerank,vascular transport (GO:0010232),-0.4059600215465532,-1.7295834555585585,0.0,0.5850909638124807,0.998,22/81,5.75%,ATP1A2;SLC24A3;SLC7A2;SLC6A13;SLC1A3;SLC16A12;ABCC4;SLC13A3;SLC22A8;SLC16A2;INSR;ABCG2;SLCO2B1;SLC2A1;SLCO1C1;SLC12A2;SLC6A1;SLC5A3;SLC7A5;ABCC9;SLC6A9;SLC5A5
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.7656979800407379,1.729315786243572,0.005134788189987163,0.350986673385464,0.987,5/17,7.26%,SFRP4;FSTL1;PCSK6;SLIT2;SULF1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.7843977555998712,1.7281266218941156,0.003952569169960474,0.33838217958985345,0.988,2/15,0.49%,SYK;CD55
prerank,carbohydrate catabolic process (GO:0016052),-0.45709912458177626,-1.7266757304883342,0.008130081300813009,0.5583830767619646,0.999,18/38,20.37%,ENO1;HK2;PGAM1;PGAM4;DERA;MAN2B1;PGK1;PFKM;ALDOC;GAPDH;PFKL;MANBA;TPI1;MAN2B2;GAPDHS;NEU3;ENO3;GPI
prerank,superoxide metabolic process (GO:0006801),0.7080083512103399,1.7227809638957068,0.002352941176470588,0.34890208402695916,0.991,3/29,0.87%,NOX4;DUOX1;NCF4
prerank,embryonic eye morphogenesis (GO:0048048),0.8195604225488327,1.713604884417907,0.005517241379310344,0.3801663073738373,0.999,3/11,0.47%,MFAP5;FBN1;LRP6
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.4948570230886594,-1.7129878489845587,0.014084507042253521,0.5840679344310769,1.0,13/35,7.48%,PDE7B;IRAG1;RAPGEF2;ADCY1;RAPGEF3;PDE3A;ADGRG6;APOE;NUDT4;KSR1;GUCY1B1;AHR;CAP2
prerank,extracellular matrix organization (GO:0030198),0.5905503961447819,1.7116405552238025,0.0,0.3728902867295845,0.999,75/276,10.15%,COL14A1;PLOD2;MFAP5;COMP;COL3A1;P4HA3;DCN;ADAMTS5;COL5A2;COL6A3;COL1A2;TIMP2;DDR2;FBN1;HAS2;GSN;COL1A1;HAS1;LOXL2;COL17A1;COL5A1;BMP1;COL8A1;FLRT2;COL11A1;POSTN;VIT;COL5A3;ITGA11;ADAMTS2;SPARC;COL6A2;CD44;ITGB3;CAPN2;MMP2;FGF2;TGFB2;COL8A2;P4HA1;KLKB1;ELN;SMOC2;ADAMTS3;ACAN;SCUBE3;ITGA2;ADAMTSL1;ADAM19;ITGA5;ITGB5;DPT;DST;VCAN;ADAMTSL4;COL12A1;CREB3L1;JAM3;COL6A1;TGFBI;P4HA2;TLL1;GAS6;MMP11;CAPN1;COL15A1;PLOD3;ADAMTSL5;ADAMTSL3;ADAMTS18;ITGAV;COL9A3;LOXL1;COL2A1;CD47
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.7704523965560623,1.709366720513798,0.006535947712418301,0.3687341378936649,0.999,6/15,8.69%,DCN;CSGALNACT2;VCAN;CHST12;CHST14;B3GAT3
prerank,transport across blood-brain barrier (GO:0150104),-0.40008861902826354,-1.7040096416534403,0.0,0.5903529455248308,1.0,22/83,5.75%,ATP1A2;SLC24A3;SLC7A2;SLC6A13;SLC1A3;SLC16A12;ABCC4;SLC13A3;SLC22A8;SLC16A2;INSR;ABCG2;SLCO2B1;SLC2A1;SLCO1C1;SLC12A2;SLC6A1;SLC5A3;SLC7A5;ABCC9;SLC6A9;SLC5A5
prerank,amino acid import (GO:0043090),-0.5618222922853848,-1.7010146934095558,0.01951219512195122,0.5713687297099173,1.0,6/21,4.70%,SLC6A13;SLC1A3;SLC16A2;SLC6A1;SLC7A5;SLC22A4
prerank,regulation of fatty acid oxidation (GO:0046320),-0.5723001140492827,-1.6997975127597538,0.017167381974248927,0.5456386433734166,1.0,5/16,8.39%,PRKAG2;LONP2;PPARA;ACADL;APPL2
prerank,extracellular matrix disassembly (GO:0022617),0.6443490311259916,1.6985890252417997,0.0,0.41400914236351694,1.0,13/53,8.22%,ADAMTS5;TIMP2;GSN;BMP1;HPN;CD44;CAPN2;MMP2;KLKB1;SCUBE3;TLL1;MMP11;CAPN1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.7661349616084456,1.6961936643475688,0.005194805194805195,0.41102284691040303,1.0,3/17,2.88%,SFRP4;TMEM100;FGF2
prerank,regulation of interleukin-2 production (GO:0032663),0.6637737326771409,1.695414596430836,0.0033632286995515697,0.3995773698815604,1.0,7/43,3.72%,CD34;CD80;IRF4;ANXA1;GLMN;RUNX1;HDAC7
prerank,actin filament bundle assembly (GO:0051017),-0.4899199725882476,-1.693054364049277,0.0072992700729927005,0.544939106651143,1.0,5/33,2.04%,PAWR;MYO1B;SHROOM2;CALD1;EPS8
prerank,response to iron ion (GO:0010039),-0.6438640348640439,-1.6895828147386522,0.036101083032490974,0.5316479089279444,1.0,5/12,6.86%,BMP6;BCL2;SNCA;ACO1;B2M
prerank,actin filament bundle organization (GO:0061572),-0.4836608842426723,-1.687953775557631,0.013605442176870748,0.5134193854047487,1.0,5/33,2.04%,PAWR;MYO1B;SHROOM2;CALD1;EPS8
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.7280259132384136,1.6870665242070948,0.007662835249042145,0.43379568390591416,1.0,6/21,8.56%,DCN;UGDH;CSGALNACT2;VCAN;CHST12;CHSY3
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.6258267292556882,-1.686833952033109,0.02962962962962963,0.4948330846496694,1.0,6/13,8.64%,PLXNA2;NRP2;PLXNA4;PLXND1;NRP1;PLXNB1
prerank,muscle tissue morphogenesis (GO:0060415),-0.5994139782202764,-1.6865708704696412,0.01652892561983471,0.4750743841363124,1.0,5/16,10.58%,MYLK;NOTCH1;TGFBR3;TBX1;BMP2
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.6659322367499563,-1.686166513110611,0.003436426116838488,0.45767551884090113,1.0,3/10,13.42%,ACTN2;SEMA5A;WDR1
prerank,transition metal ion transport (GO:0000041),-0.48020180529324186,-1.6861124181800742,0.0,0.4402048211440018,1.0,15/35,14.72%,CP;IREB2;ATP2C1;SLC30A10;SLC39A8;FTH1;TRPC5;SLC30A1;TRPC6;TRPC4;CUTC;TFRC;TRPC7;TRPC3;COX17
prerank,eye morphogenesis (GO:0048592),0.748462728495442,1.686017477237673,0.006418485237483954,0.4242935782352102,1.0,7/19,5.31%,MFAP5;COL5A2;FBN1;COL5A1;VEGFA;SKI;TENM3
prerank,bicellular tight junction assembly (GO:0070830),-0.4611435070874963,-1.6852409616573987,0.00980392156862745,0.4262349614680933,1.0,10/46,3.97%,CDH5;PARD6G;OCLN;PECAM1;CLDN5;PATJ;ESAM;F11R;DLG1;STRN
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.755626662813351,1.6851674401819443,0.006402048655569782,0.41461094843333385,1.0,6/17,8.76%,SYK;LIF;TGFB2;ADAM9;RET;FOXC2
prerank,cation transmembrane transport (GO:0098655),-0.4648647881466445,-1.6813713823108927,0.009523809523809525,0.42263389804555185,1.0,10/44,9.21%,ATP1A2;TRPM3;SLC7A2;TRPM6;SLC7A5;ABCC9;SLC6A9;SLC3A2;SLC25A20;SLC38A5
prerank,myeloid cell activation involved in immune response (GO:0002275),0.7493055572277851,1.681337725062592,0.0038412291933418692,0.42150720021116217,1.0,2/18,0.28%,SYK;LBP
prerank,B cell homeostasis (GO:0001782),-0.6760383331961162,-1.6783977455573726,0.013793103448275862,0.41655498690749987,1.0,2/10,2.00%,LYN;MEF2C
prerank,myoblast fusion (GO:0007520),0.7879555122655375,1.6705300337303925,0.005509641873278237,0.47293436894150787,1.0,4/12,8.08%,ADAMTS5;CD9;PTGFRN;CD81
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.690448939872208,1.6674907257973526,0.007326007326007326,0.4770316113415699,1.0,8/27,9.11%,DCN;UGDH;CSGALNACT2;VCAN;CHST12;CHSY3;B3GAT3;XYLT1
prerank,peptide cross-linking (GO:0018149),0.681501815296283,1.6672353457985944,0.011097410604192354,0.46413330650177254,1.0,4/25,4.62%,COL3A1;LORICRIN;ANXA1;KRT10
prerank,smooth muscle tissue development (GO:0048745),-0.6706557054361768,-1.6600910497776953,0.032362459546925564,0.45885186622559804,1.0,4/10,8.06%,MYLK;ENG;PTCH1;STRA6
prerank,tight junction assembly (GO:0120192),-0.44734308031245407,-1.6590413905741646,0.01098901098901099,0.44737668865849833,1.0,11/49,3.97%,CDH5;PARD6G;OCLN;PECAM1;CLDN5;PATJ;ESAM;F11R;DLG1;LSR;STRN
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.6758436240189589,-1.6580110181325114,0.02197802197802198,0.4368693518877862,1.0,4/10,6.08%,ENG;ENPP1;ERRFI1;CAV1
prerank,response to glucagon (GO:0033762),-0.5472501547913816,-1.6576528739031444,0.02727272727272727,0.42429058562561917,1.0,9/19,15.92%,ADCY5;ADCY1;PRKAR1B;CRY1;ADCY4;ADCY9;PRKAR2B;CYSLTR2;PRKACB
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.6424280028043391,-1.6470436707416407,0.034482758620689655,0.4433207557015155,1.0,5/11,9.38%,MLLT3;WNT5B;RSPO3;NKD1;SFRP1
prerank,cellular component disassembly (GO:0022411),0.6253740663113921,1.6443712276659541,0.0010940919037199124,0.6045309139664,1.0,12/53,8.22%,ADAMTS5;TIMP2;GSN;BMP1;CD44;CAPN2;MMP2;KLKB1;SCUBE3;TLL1;MMP11;CAPN1
prerank,positive regulation of bone mineralization (GO:0030501),-0.4607897700798042,-1.6439101022618334,0.0,0.44083563679948884,1.0,14/35,12.16%,PTN;BMP6;WNT4;ADGRV1;BMP7;MEF2C;OSR1;KL;NELL1;ATRAID;BMPR2;BMP2;PKDCC;TGFB1
prerank,vasoconstriction (GO:0042310),-0.6367325629186074,-1.6416970786836589,0.04225352112676056,0.43438282214131857,1.0,5/11,15.59%,EDNRA;ACTA2;EDNRB;EDN1;EDN3
prerank,bone morphogenesis (GO:0060349),0.7403971487524422,1.6400197533774148,0.012178619756427604,0.6199194772707114,1.0,3/14,4.06%,SFRP4;LRP6;SKI
prerank,positive regulation of protein depolymerization (GO:1901881),-0.6383363864836482,-1.6399642084697386,0.02877697841726619,0.4277213955098304,1.0,5/11,19.06%,SEMA5A;NES;TRPV4;WDR1;KATNB1
prerank,modified amino acid transport (GO:0072337),-0.5773285856550798,-1.634171371039026,0.04819277108433735,0.43368261536471325,1.0,5/15,10.50%,SLC6A13;SLC16A12;PDPN;CTNS;MGST1
prerank,homocysteine metabolic process (GO:0050667),0.779231457172797,1.6332126986750666,0.02054794520547945,0.6570765707938279,1.0,1/11,0.01%,NOX4
prerank,negative regulation of hormone secretion (GO:0046888),0.7991264778384983,1.6296025469408697,0.011157601115760111,0.6668589565710981,1.0,2/10,1.02%,LIF;RAB11FIP5
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.5459650471959807,-1.6295602498579276,0.018018018018018018,0.4345199255661084,1.0,11/17,12.05%,MAML3;CREBBP;NOTCH3;NOTCH1;PLXND1;WWC1;HEYL;MAML2;NOTCH4;STAT1;EP300
prerank,external encapsulating structure organization (GO:0045229),0.5615645595498356,1.6176503866819734,0.0,0.7457573778504174,1.0,52/205,10.15%,COL14A1;MFAP5;COMP;COL3A1;DCN;ADAMTS5;COL5A2;COL6A3;COL1A2;DDR2;FBN1;COL1A1;COL17A1;COL5A1;COL8A1;COL11A1;POSTN;VIT;COL5A3;ITGA11;ADAMTS2;SPARC;COL6A2;CD44;ITGB3;MMP2;FGF2;COL8A2;ELN;SMOC2;ADAMTS3;ACAN;ITGA2;ADAMTSL1;ADAM19;ITGA5;ITGB5;VCAN;ADAMTSL4;JAM3;COL6A1;TGFBI;MMP11;COL15A1;ADAMTSL5;ADAMTSL3;ADAMTS18;ITGAV;COL9A3;LOXL1;COL2A1;CD47
prerank,positive regulation of interleukin-10 production (GO:0032733),0.6671167977458461,1.6162019007077073,0.007058823529411765,0.7407066827345598,1.0,3/30,1.14%,CD34;SYK;IRF4
prerank,presynaptic endocytosis (GO:0140238),0.6778498086576288,1.61619043577073,0.017921146953405017,0.7222374944884865,1.0,5/24,3.29%,STON2;SNCB;SYT2;CEL;STX1A
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.7646436610760337,1.6155625551875274,0.013850415512465374,0.709422531659516,1.0,4/12,7.68%,DCN;VCAN;CHST12;CHST14
prerank,heart trabecula morphogenesis (GO:0061384),-0.5407713397860421,-1.614808949551866,0.020100502512562814,0.4652778547799893,1.0,8/18,6.54%,BMP5;ENG;ADGRG6;BMP7;RBP4;NOTCH1;TGFBR3;S1PR1
prerank,renal water homeostasis (GO:0003091),-0.5020184884296328,-1.614550602110227,0.017543859649122806,0.45476799947353025,1.0,9/23,15.92%,ADCY5;ADCY1;PRKAR1B;ADCY4;ADCY9;RAB11A;MYO5B;PRKAR2B;PRKACB
prerank,extracellular structure organization (GO:0043062),0.5601541311879001,1.6141349477511602,0.0,0.7050898424896229,1.0,52/204,10.15%,COL14A1;MFAP5;COMP;COL3A1;DCN;ADAMTS5;COL5A2;COL6A3;COL1A2;DDR2;FBN1;COL1A1;COL17A1;COL5A1;COL8A1;COL11A1;POSTN;VIT;COL5A3;ITGA11;ADAMTS2;SPARC;COL6A2;CD44;ITGB3;MMP2;FGF2;COL8A2;ELN;SMOC2;ADAMTS3;ACAN;ITGA2;ADAMTSL1;ADAM19;ITGA5;ITGB5;VCAN;ADAMTSL4;JAM3;COL6A1;TGFBI;MMP11;COL15A1;ADAMTSL5;ADAMTSL3;ADAMTS18;ITGAV;COL9A3;LOXL1;COL2A1;CD47
prerank,establishment of endothelial barrier (GO:0061028),-0.478777588583509,-1.61226687586581,0.012658227848101266,0.4504875780032403,1.0,10/29,10.96%,TJP1;RAPGEF2;RAPGEF3;PECAM1;PPP1R16B;F11R;TJP2;PDE2A;ROBO4;ICAM1
prerank,regulation of interleukin-1 production (GO:0032652),0.7394244348396769,1.6097674644545543,0.015483870967741935,0.7238226392359488,1.0,6/15,10.19%,ANXA1;FOXP1;F2R;GAS6;TLR4;SIRPA
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.43585501428400314,-1.6097547186953767,0.008771929824561403,0.447631977850869,1.0,15/40,12.16%,PTN;BMP6;WNT4;ADGRV1;BMP7;MEF2C;WNT6;OSR1;KL;NELL1;ATRAID;BMPR2;BMP2;PKDCC;TGFB1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.5030542908899236,-1.608709946236901,0.009900990099009901,0.44055737280774704,1.0,5/22,7.78%,LYN;EPHA4;SP1;ABCG1;CASP3
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.6270980469502302,1.6082134338553455,0.008968609865470852,0.7201749409582958,1.0,12/41,17.16%,CD34;LBP;IRAK3;SYT11;GAS6;TLR4;SIRPA;ZC3H12A;IL4;SELENOS;ILRUN;CHRNA7
prerank,response to interleukin-4 (GO:0070670),-0.6629476602649684,-1.6066715043929312,0.02142857142857143,0.4362160907927942,1.0,2/10,4.64%,LEF1;TCF7
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.6199787016265939,1.6044595698849715,0.01327433628318584,0.7353914149367263,1.0,12/43,17.16%,CD34;LBP;IRAK3;SYT11;GAS6;TLR4;SIRPA;ZC3H12A;IL4;SELENOS;ILRUN;CHRNA7
prerank,renal absorption (GO:0070293),0.7899954684928323,1.603800620125993,0.01818181818181818,0.7248216264940749,1.0,2/10,0.45%,HAS2;GSN
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.6706794117848578,1.6037187724334931,0.014405762304921969,0.7099362511982695,1.0,8/25,10.58%,HAS2;HAS1;B3GALNT1;CSGALNACT2;EXT1;HS2ST1;FUT9;B3GNT8
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.7167236212506022,1.6007085000533317,0.02368421052631579,0.7193045257398926,1.0,3/15,2.91%,TGFB3;IRAK3;TGFB2
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.703692572076061,1.5982327529932463,0.017587939698492462,0.7235612631461418,1.0,7/20,7.85%,NPTN;SULF2;FGF2;SMOC2;CREB3L1;SULF1;PRKD2
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.4787235448562597,-1.5974260370881852,0.006493506493506494,0.4519654847965494,1.0,8/29,12.16%,TPM1;ENG;NOTCH1;TGFBR3;S1PR1;FGFR2;BMP2;TGFB1
prerank,regulation of epithelial cell migration (GO:0010632),-0.40495012571827665,-1.5971716987858497,0.021505376344086023,0.44295866219831026,1.0,18/51,14.15%,PTN;PTPRG;SASH1;DOCK5;GLUL;PLCG1;DAB2IP;DUSP10;PRKCE;BMPR2;EMP2;RAB11A;MACF1;EVL;CEACAM1;PPM1F;PTK2;PFN1
prerank,sulfur amino acid metabolic process (GO:0000096),0.6712331880517451,1.594235256464764,0.01756587202007528,0.7418811132807228,1.0,2/24,0.79%,NOX4;GCLC
prerank,synaptic vesicle membrane organization (GO:0048499),0.7193945044641262,1.5942252651259028,0.023316062176165803,0.7274484926021771,1.0,11/17,17.97%,STX2;STX1A;STX11;AP3D1;STX1B;TOR1A;STX4;SNAP23;SNAP25;SNAP47;STX3
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.7167338836743018,1.5907320983277287,0.018421052631578946,0.7407936960053381,1.0,7/16,14.08%,ZFP36L1;TRIM71;TARDBP;RC3H1;ZFP36L2;ZFP36;ZC3H12A
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.7521719786342058,1.5906060031524556,0.023872679045092837,0.7276945634278634,1.0,9/12,17.97%,STX2;STX1A;STX11;STX1B;STX4;SNAP23;SNAP25;SNAP47;STX3
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.7502149922089258,1.5899170738561652,0.017735334242837655,0.7201259724509312,1.0,4/13,8.08%,SYK;CD9;ABCA1;CD81
prerank,regulation of protein neddylation (GO:2000434),-0.6323196292219551,-1.5898290193410807,0.036544850498338874,0.4542114049515502,1.0,7/10,25.13%,EPAS1;DCUN1D4;RPL5;DCUN1D3;DCUN1D5;HIF1A;DCUN1D2
prerank,positive regulation of interleukin-2 production (GO:0032743),0.6708123843375123,1.589360039730635,0.017921146953405017,0.7115457105905316,1.0,7/25,11.84%,CD80;IRF4;ANXA1;GLMN;RUNX1;PRKD2;PDE4D
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.485246126999169,-1.5892685818071084,0.005988023952095809,0.44650848086642764,1.0,8/27,3.53%,TJP1;CGNL1;PHLDB2;ARHGAP28;ARHGAP6;F11R;SHANK3;RHPN2
prerank,diol biosynthetic process (GO:0034312),-0.5744032955721639,-1.5873570224454145,0.029787234042553193,0.4425739683243703,1.0,8/15,22.81%,ACER2;GCH1;QDPR;SPR;SPHK1;SPTLC2;SPHK2;ABCA2
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.7148172723867885,1.5872304269522581,0.02442159383033419,0.7156339863378741,1.0,5/17,4.94%,MID1;STK25;TGFB2;TAOK3;KLHDC10
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.41005536670470066,-1.5869876938212486,0.0,0.4347273088977233,1.0,14/46,17.58%,ATP1A2;MEF2C;GRM3;SHANK3;DGKZ;CACNG4;OPHN1;GRM7;CACNG8;CDK5;UNC13A;GRM8;CDH2;CLN3
prerank,regulation of B cell differentiation (GO:0045577),0.6925794729721354,1.5855022436004853,0.014230271668822769,0.7161257608572276,1.0,5/17,12.21%,SYK;ZFP36L1;INHA;ZFP36L2;CD27
prerank,regulation of coagulation (GO:0050818),0.7612334719037708,1.580589464092586,0.012345679012345678,0.742494955471936,1.0,4/11,11.65%,EPHB2;F2R;PROCR;HS3ST5
prerank,regulation of mast cell activation (GO:0033003),-0.6496832715297522,-1.5797721877499202,0.05172413793103448,0.44602192359579956,1.0,4/10,12.01%,LYN;PLSCR1;NECTIN2;CD84
prerank,positive regulation of cell adhesion (GO:0045785),0.5815573433977829,1.5780823231290877,0.003157894736842105,0.7497290951021461,1.0,19/74,10.15%,SYK;LIF;FBLN2;PRKCA;VIT;VEGFA;TGFB2;ADAM9;PTPRJ;ZFHX3;C1QBP;RET;FLCN;PRKD2;TNFRSF18;FOXC2;STX4;ITGAV;CD47
prerank,response to glucocorticoid (GO:0051384),0.6515460823742532,1.5762534591382384,0.019559902200488997,0.7523428431310796,1.0,10/26,20.58%,ANXA1;SLIT3;SLIT2;ADAM9;ZFP36L1;ZFP36L2;ZFP36;IL6;PDCD7;GOT1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5426192540002136,-1.5754665173314637,0.022123893805309734,0.4487833011318802,1.0,10/18,30.07%,SLC39A8;ITGA4;VCAM1;GCNT1;ROCK1;JAM2;SELPLG;PODXL2;SELP;ITGB7
prerank,positive regulation of dendrite development (GO:1900006),-0.6222906365321287,-1.5731972759626205,0.052434456928838954,0.4469016705715344,1.0,4/10,3.60%,PTN;BMP5;BMP7;DAB2IP
prerank,regulation of protein localization to membrane (GO:1905475),0.6471208504402785,1.572328550225596,0.01090909090909091,0.7717828508696943,1.0,6/28,5.39%,AR;GSN;GPC6;GPC3;FYN;ZDHHC7
prerank,cardiac muscle cell contraction (GO:0086003),0.6784916766295025,1.57158675123368,0.020356234096692113,0.7653554973337192,1.0,5/19,8.49%,GSN;ATP1A1;KCNJ2;CAMK2D;PIK3CA
prerank,regulation of actin nucleation (GO:0051125),0.7403763220555402,1.5714335184320825,0.022222222222222223,0.7543458649473174,1.0,3/12,9.95%,GSN;SCIN;ARF1
prerank,embryonic appendage morphogenesis (GO:0035113),0.7344228043704378,1.5692832651646993,0.03581267217630854,0.7582239302602335,1.0,5/12,9.48%,LRP6;MBNL1;TGFB2;SKI;FBXW4
prerank,positive regulation of immune system process (GO:0002684),0.7079436451545091,1.568318586250535,0.025839793281653745,0.7541365595558395,1.0,5/16,8.13%,ANXA1;VEGFA;TGFB2;MIA3;TNFRSF18
prerank,cell junction maintenance (GO:0034331),0.735942171456521,1.5677114590924819,0.02406417112299465,0.7476315830375454,1.0,5/14,8.24%,DCTN1;CD177;F2R;MYADM;PARD6A
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.6449615215042263,-1.5664124743696886,0.044444444444444446,0.45812966948410755,1.0,5/10,25.35%,LYN;KIT;CD40;BTLA;FGR
prerank,regulation of spindle organization (GO:0090224),0.6854945959797712,1.5653575618513476,0.021546261089987327,0.7542002332328781,1.0,6/18,7.42%,PARP3;GPSM2;DCTN1;PSRC1;FSD1;CLTC
prerank,gliogenesis (GO:0042063),0.7140065823985428,1.563824976300753,0.022546419098143235,0.754458801139302,1.0,4/15,5.94%,CD9;ANXA1;TGFB2;NFIB
prerank,smooth muscle contraction (GO:0006939),-0.5933113417836355,-1.5634206932380923,0.033707865168539325,0.45821485993077715,1.0,5/14,11.49%,MYLK;EDNRA;MYH11;SMTN;ACTA2
prerank,androgen receptor signaling pathway (GO:0030521),0.7338754844600843,1.5619440487222962,0.04033379694019471,0.7581244696329792,1.0,7/11,16.59%,AR;ZMIZ1;PMEPA1;PLPP1;DDX17;RNF14;DDX5
prerank,endothelial cell proliferation (GO:0001935),0.709394529605724,1.5617588842000014,0.019157088122605363,0.748720782551352,1.0,3/17,1.55%,CD34;LOXL2;ANGPT4
prerank,negative regulation of actin filament polymerization (GO:0030837),0.6635261330824022,1.5614473606527228,0.028186274509803922,0.7407564046035761,1.0,8/22,10.99%,GSN;SCIN;SLIT2;MYADM;PFN2;TWF1;KANK1;SSH1
prerank,positive regulation of ossification (GO:0045778),-0.42297671914378565,-1.5614447732825627,0.008333333333333333,0.45604567868452334,1.0,15/39,12.16%,PTN;BMP6;WNT4;ADGRV1;BMP7;MEF2C;OSR1;KL;WNT5A;NELL1;ATRAID;BMPR2;BMP2;PKDCC;TGFB1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.5414644890421717,-1.5605964721957124,0.041666666666666664,0.44992126656636194,1.0,6/15,18.72%,SORT1;ZFYVE27;CASP3;NTRK2;BDNF;GRB2
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.6919374153351411,1.5602090454312127,0.024484536082474227,0.7398002944972849,1.0,7/19,14.82%,SYK;AXL;ZMIZ1;GAS6;ZBTB1;CD27;IL4
prerank,angiogenesis involved in wound healing (GO:0060055),0.7699685918671153,1.5591372093898122,0.026881720430107527,0.7373828098469004,1.0,4/11,6.10%,CD34;ITGB3;VEGFA;PRCP
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.5701858706673263,1.558043206344748,0.0031380753138075313,0.7350830721571109,1.0,20/86,8.08%,GHR;LIF;CD80;FGF7;EGFR;EFNA5;ANGPT4;CD44;FYN;ITGB3;DGKQ;VEGFA;MIF;ACVR1;ITGA5;PTPRJ;THBS4;SRC;BANK1;CD81
prerank,iron ion transmembrane transport (GO:0034755),0.7567699028625366,1.5580323194752868,0.022377622377622378,0.7253853860159032,1.0,4/10,12.18%,SCARA5;SLC39A14;SLC11A2;SLC25A28
prerank,regulation of sensory perception of pain (GO:0051930),0.7672006222071752,1.557820983465968,0.021246458923512748,0.7174865699039873,1.0,4/11,8.27%,MGLL;TMEM100;F2R;SPX
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.5965397619201964,-1.5574904022690528,0.058823529411764705,0.4512676234569931,1.0,4/11,12.05%,CRY1;C1QTNF3;SIK1;EP300
prerank,cellular response to interleukin-4 (GO:0071353),-0.6413512304210196,-1.5562357255712242,0.04878048780487805,0.44693561999100617,1.0,2/10,4.64%,LEF1;TCF7
prerank,regulation of synapse organization (GO:0050807),-0.46080476032498685,-1.552185733937011,0.011363636363636364,0.4501839115770225,1.0,8/26,12.12%,EPHA4;PDLIM5;MEF2C;CDKL5;WNT5A;ABHD17C;CAMK2B;ABL1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.6195267013771666,-1.5515147188846952,0.05338078291814947,0.4446785311674151,1.0,6/11,15.14%,EFNB2;SOX6;MEF2C;BMP2;TGFB1;MYOCD
prerank,regulation of interleukin-12 production (GO:0032655),0.595906571870128,1.5514523998813325,0.013100436681222707,0.7542549234336404,1.0,11/47,11.89%,SYK;IL16;IRAK3;FOXP1;MAPK14;C1QBP;TIRAP;TLR4;MAPK11;CD47;PIBF1
prerank,spinal cord development (GO:0021510),0.7468275494817895,1.550214048619814,0.02997275204359673,0.7538829780238568,1.0,5/12,7.85%,VIT;ZPR1;PKD1;GLI2;PKD2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.7086535467864239,1.5501169877887184,0.0196078431372549,0.7451133620499653,1.0,6/15,7.85%,FGF18;FGFR1;VEGFA;FGF2;SMOC2;PRKD2
prerank,cellular response to glucagon stimulus (GO:0071377),-0.5352596483444803,-1.5484742601587036,0.035555555555555556,0.44569525370101964,1.0,8/17,15.92%,ADCY5;ADCY1;PRKAR1B;ADCY4;ADCY9;PRKAR2B;CYSLTR2;PRKACB
prerank,dermatan sulfate metabolic process (GO:0030205),0.7203019187707129,1.548351651061289,0.031081081081081083,0.7481736644140699,1.0,4/13,7.68%,DCN;VCAN;CHST12;CHST14
prerank,ganglioside metabolic process (GO:0001573),-0.4984437324773114,-1.5474426903573242,0.015789473684210527,0.44130929940307884,1.0,12/20,31.88%,ST8SIA4;ST6GALNAC3;ST6GALNAC5;ST8SIA2;ST8SIA6;NEU3;ST6GALNAC6;ABCA2;ST3GAL5;GM2A;NEU2;B4GALNT1
prerank,phosphate ion homeostasis (GO:0055062),0.7518587305458019,1.5467096279128532,0.037037037037037035,0.7510387029610589,1.0,1/10,0.14%,SFRP4
prerank,gas transport (GO:0015669),0.7706480745365623,1.5459812082489663,0.03064066852367688,0.7468103453384283,1.0,1/10,0.41%,CYGB
prerank,positive regulation of actin nucleation (GO:0051127),0.743363038275753,1.5451751158247569,0.033045977011494254,0.7440389465466404,1.0,3/11,5.88%,GSN;SCIN;WASF1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.6591610058353622,1.5424276475105871,0.02096177558569667,0.7555309028255371,1.0,6/24,11.91%,GFPT2;GFPT1;COQ10B;PID1;ACADVL;NDUFS1
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.47369107999720944,-1.5404054208500064,0.039603960396039604,0.45385738432253925,1.0,7/24,3.53%,TJP1;CGNL1;PHLDB2;ARHGAP28;ARHGAP6;F11R;RHPN2
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.6505421262165344,1.5402731982235456,0.02383939774153074,0.762007238939524,1.0,8/23,11.70%,DPP4;SLIT2;JAM3;THBS4;C1QBP;MCU;TIRAP;MPP1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.549075204820405,1.537850843647836,0.003061224489795918,0.7706667105425338,1.0,25/121,8.88%,NOX4;GHR;LIF;CD80;FGF7;EFNA5;ANGPT4;CTF1;CD44;ITGB3;DGKQ;VEGFA;MIF;DLG4;ACVR1;ITGA5;CLCF1;PTPRJ;THBS4;SRC;BANK1;GAS6;CD81;TNFRSF18;SRCIN1
prerank,amino sugar metabolic process (GO:0006040),0.7625935502036414,1.5375086331764534,0.03524229074889868,0.7645500334750425,1.0,2/10,3.12%,GFPT2;GFPT1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.7024250826242054,1.5371398444831046,0.021248339973439574,0.7586494971945476,1.0,8/16,17.22%,AR;ESR1;TRIP4;EGLN2;RBFOX2;DDX17;DDX5;PADI2
prerank,secretion (GO:0046903),-0.5519779949899923,-1.536224699827263,0.044,0.45840396536188516,1.0,5/14,16.67%,SLC22A6;SLC22A4;FBLN5;NPR1;SLC22A2
prerank,bone development (GO:0060348),0.5987660190116113,1.535905810741586,0.019473081328751432,0.7594942864777766,1.0,9/39,7.35%,SFRP4;MYOC;LRP6;GNAS;AKAP13;SULF2;SKI;SULF1;LRRC17
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.6463596713866502,1.5358191382845943,0.02096177558569667,0.7515725685102367,1.0,6/24,9.77%,CDON;MAPK12;MAPK14;RBM4;BOC;MAPK11
prerank,central nervous system neuron differentiation (GO:0021953),0.6152460186993298,1.5351047916718463,0.028538812785388126,0.7486621817771542,1.0,3/33,1.22%,LMX1A;LRP6;WNT2
prerank,cyclooxygenase pathway (GO:0019371),-0.6074879917083051,-1.5343235942760156,0.07766990291262135,0.4571713699617453,1.0,7/10,23.96%,PTGDS;PTGS2;PTGIS;PTGES3;TBXAS1;CBR1;PTGS1
prerank,cellular defense response (GO:0006968),0.6078105981852192,1.5338843784913474,0.015765765765765764,0.7495142092391549,1.0,4/40,4.69%,LBP;LSP1;KIR3DL2;RAB23
prerank,limb morphogenesis (GO:0035108),0.6558422861370549,1.5337431248680335,0.036036036036036036,0.7424453442188687,1.0,7/20,11.60%,LRP6;MBNL1;PCSK5;TGFB2;SKI;FBXW4;GLI3
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.5421129802852516,-1.532033466372139,0.045454545454545456,0.4565310739253843,1.0,10/16,21.84%,APOE;SCARB1;PIK3CB;NPR3;GCH1;TERT;S100A1;HIF1A;NOS1AP;TERF2
prerank,regulation of immune response (GO:0050776),0.5427363865926288,1.5316739184631432,0.0020222446916076846,0.7488740286765264,1.0,19/135,11.15%,CD34;COL3A1;SYK;COL1A2;COL1A1;COL17A1;IRF4;KIR3DL2;NPDC1;TGFB2;FOXP1;CD160;CSK;CD81;TIRAP;SAMHD1;COL2A1;SPPL2B;BCL6
prerank,apical junction assembly (GO:0043297),-0.4099403605333844,-1.531592674443815,0.011627906976744186,0.4511933200112812,1.0,10/53,3.97%,CDH5;PARD6G;OCLN;PECAM1;CLDN5;PATJ;ESAM;F11R;DLG1;STRN
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.519653545133717,-1.529419700390422,0.046218487394957986,0.45024750710840417,1.0,3/18,1.84%,PRKAG2;OCLN;SLC2A1
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.43973501109314644,-1.527352859173733,0.0072992700729927005,0.44903785411364905,1.0,7/32,3.17%,NEDD4L;RAPGEF2;TNIK;CUX1;PTPRD;CDKL5;YWHAH
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.706463542097545,1.5272844174205928,0.03260869565217391,0.7732933489115975,1.0,3/13,10.05%,GNAI3;RAB23;RHOQ
prerank,response to laminar fluid shear stress (GO:0034616),0.7594807985732371,1.5271854993083853,0.04460431654676259,0.7658845941576459,1.0,6/10,14.32%,MAPK7;NFE2L2;KLF2;ABCA1;SMAD6;KLF4
prerank,B cell proliferation (GO:0042100),-0.514563921167535,-1.5271149198961367,0.042735042735042736,0.4433581999141682,1.0,3/17,2.75%,MEF2C;BCL2;CTPS1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.6001747671637147,1.526445012504344,0.01670378619153675,0.7636164183312217,1.0,8/41,8.88%,NOX4;AREG;BTC;FYN;DLG4;SRC;GAS6;SRCIN1
prerank,response to fatty acid (GO:0070542),0.6737975511719163,1.5252323497764115,0.03816793893129771,0.7642735802332199,1.0,5/17,8.42%,UCP1;IRS1;FOXO1;PID1;PPP5C
prerank,regulation of mitochondrial depolarization (GO:0051900),0.7400167882791527,1.524888541591401,0.05763688760806916,0.7589433082387343,1.0,3/10,6.81%,DCN;MYOC;SRC
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.51188173307564,-1.5247395226491913,0.04329004329004329,0.44381424990690116,1.0,6/16,12.97%,APOE;NOS3;GUCY1B1;NDNF;NOS1;GUCY1A1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.603731430799781,1.5230272680030141,0.017241379310344827,0.7647049428152362,1.0,20/33,24.80%,AR;ESR1;RUNX1;AXIN1;PRMT2;HDAC6;RNF14;TRIM68;DDX5;UFL1;GPAM;UFM1;KCTD6;CARM1;RNF6;NCOA2;KDM4C;LATS1;UFSP2;CALR
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.7055393846719563,1.521531436889229,0.03238341968911917,0.768365333892362,1.0,6/15,7.11%,DDR2;DPP4;LRP1;FAP;FSCN1;MELTF
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.5529586917583955,1.5214197682399289,0.002070393374741201,0.761545264280047,1.0,26/95,12.53%,DCN;HAS2;HAS1;ST3GAL2;GPC6;UGDH;B4GALT3;GPC3;B4GALT1;OGN;CHST1;CSGALNACT2;EXT1;ACAN;VCAN;CHST12;CHST14;CHSY3;B3GAT3;XYLT1;HS2ST1;HS3ST6;HS3ST5;ST3GAL4;HSPG2;GLCE
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.5517071504084383,1.520649000277508,0.00522466039707419,0.7595078247983903,1.0,24/90,17.74%,EBF2;IL4R;SYK;UCP1;GNAS;IRF4;GADD45G;GRB10;VEGFA;PRKAB2;ADCYAP1;ALMS1;HDAC3;CEBPB;TSHR;HCRT;CNOT3;IL4;DYNC1H1;DIO2;OGT;CXCR4;FABP5;IL18
prerank,embryonic digit morphogenesis (GO:0042733),-0.501280231747252,-1.520634640312081,0.04205607476635514,0.44860889053382264,1.0,7/18,9.71%,MAP3K20;CREBBP;OSR1;TBX3;SALL1;TBX2;INTU
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.5795366082636193,-1.519526164611028,0.052830188679245285,0.44589676775516995,1.0,4/12,13.28%,LYN;IL34;MAPK3;PTK2
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.5018343471015042,-1.5188980294951524,0.04225352112676056,0.4415524034902914,1.0,5/20,12.05%,WNT4;CRY1;C1QTNF3;SIK1;EP300
prerank,regulation of hemopoiesis (GO:1903706),-0.5968226223616105,-1.518220741857254,0.06428571428571428,0.4373208798556694,1.0,4/10,5.37%,PTN;CREBBP;PURB;MYSM1
prerank,regulation of epidermal cell differentiation (GO:0045604),0.6517893588487892,1.5175756837002967,0.03262233375156838,0.7733211211923834,1.0,6/21,12.63%,SFRP4;RUNX1;ZFP36L1;MAFF;SFN;ZFP36
prerank,regulation of leukocyte migration (GO:0002685),0.6834827789917282,1.5175458460016498,0.03851261620185923,0.7662147118522927,1.0,6/16,14.42%,ANXA1;VEGFA;MIA3;CD81;TNFRSF18;HOXA7
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.6112923548193486,1.5169136365167641,0.03161592505854801,0.7637335369798994,1.0,5/30,4.05%,SFRP4;FSTL1;PCSK6;SMAD4;SMURF2
prerank,urogenital system development (GO:0001655),0.7311273253290552,1.5167498062605254,0.03137789904502047,0.7577828919090773,1.0,3/11,1.34%,EPHB2;AMH;ANXA1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.6025524825926583,-1.516548053665114,0.06462585034013606,0.43547475298875193,1.0,4/10,4.66%,ATP1A2;NEDD4L;OSR1;PRKCE
prerank,early endosome to Golgi transport (GO:0034498),0.7395495173724842,1.5164281588583595,0.05164992826398852,0.7530466838102646,1.0,5/11,8.78%,RAB6A;STX5;SNX1;SURF4;LMAN1
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.5509680117578953,-1.5156769723794017,0.05327868852459016,0.4320799556654406,1.0,4/15,5.81%,PLTP;APOE;SCARB1;ABCG1
prerank,extracellular matrix assembly (GO:0085029),0.6504189328879093,1.5151761759372215,0.04472049689440994,0.7545706451572691,1.0,5/23,7.57%,HAS2;TNXB;HAS1;NTN4;GAS6
prerank,synaptic vesicle recycling (GO:0036465),0.6177786428037042,1.5150663321979234,0.026900584795321637,0.748416058525524,1.0,5/31,3.29%,STON2;SNCB;SYT2;CEL;STX1A
prerank,glycolytic process (GO:0006096),-0.4386787902479683,-1.5140737569536855,0.024242424242424242,0.4304600728132912,1.0,13/28,20.37%,ENO1;HK2;PGAM1;PGAM4;PGK1;PFKM;ALDOC;GAPDH;PFKL;TPI1;GAPDHS;ENO3;GPI
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.7527983040043913,1.5135620235570815,0.03473227206946455,0.7517536725790948,1.0,3/10,8.08%,CD55;TGFBR2;CD81
prerank,actin filament capping (GO:0051693),0.6609421342374677,1.512412572239898,0.04046997389033943,0.7461105258618884,1.0,7/18,14.36%,GSN;SCIN;SVIL;ADD3;TWF1;AVIL;TRIOBP
prerank,barbed-end actin filament capping (GO:0051016),0.6609421342374677,1.512412572239898,0.04046997389033943,0.7461105258618884,1.0,7/18,14.36%,GSN;SCIN;SVIL;ADD3;TWF1;AVIL;TRIOBP
prerank,synaptic vesicle endocytosis (GO:0048488),0.6055995053898153,1.5113564923281333,0.04322429906542056,0.7466163885611844,1.0,6/33,3.29%,STON2;SNCB;SYT2;DNM1;CEL;STX1A
prerank,chondroitin sulfate metabolic process (GO:0030204),0.6178550033934344,1.510481242906994,0.03214285714285714,0.7458656509180508,1.0,6/30,8.56%,DCN;UGDH;CSGALNACT2;VCAN;CHST12;CHSY3
prerank,limb development (GO:0060173),0.618652798478551,1.506636870370692,0.03361344537815126,0.7649540236607991,1.0,7/28,11.93%,RSPO2;COMP;PCSK5;KREMEN1;KAT2B;GLI3;LNPK
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.6099251169672508,1.5062641510312753,0.020713463751438434,0.7609103355114819,1.0,9/33,8.76%,SYK;LIF;DPP4;TGFB2;ADAM9;JAM3;MUC1;RET;FOXC2
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.749192105677744,1.5061069201845458,0.03840682788051209,0.7556040710238291,1.0,2/10,1.22%,LRP6;WNT2
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5519912030507355,1.5051783914568915,0.016251354279523293,0.7556829932484103,1.0,16/65,13.17%,ASPN;FBN1;HTRA3;LDLRAD4;SKIL;TGFBR2;PMEPA1;SMURF2;SKI;STUB1;SMAD6;PEG10;SLC2A10;VASN;UBA52;PIN1
prerank,regulation of cellular component biogenesis (GO:0044087),-0.4284157629424521,-1.5034181573968146,0.02877697841726619,0.4523194320955713,1.0,10/39,9.90%,TJP1;RAPGEF2;SNCAIP;APOE;NOTCH1;DAB2IP;TIE1;PINK1;GFAP;PARP10
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.5522619188236687,-1.5005144981397256,0.08171206225680934,0.4543767531149836,1.0,6/14,17.75%,OSR1;CAV1;NOTCH4;SPRED3;SPRED2;SPRY1
prerank,embryonic skeletal system development (GO:0048706),0.6071091118995481,1.4994560586441394,0.026106696935300794,0.7880555755519761,1.0,14/35,14.58%,HOXA3;COL1A1;PCSK5;SULF2;WNT9A;HOXA4;UCMA;SULF1;XYLT1;SLC2A10;SIX1;PDGFRA;HOXC4;HOXA9
prerank,Notch signaling pathway (GO:0007219),-0.36980672724440544,-1.4993189718957447,0.015384615384615385,0.45173230483613225,1.0,19/59,12.05%,SORBS2;ADAM10;GMDS;MAML3;CREBBP;NOTCH3;NOTCH1;PLXND1;WWC1;HEYL;DTX3L;JAG2;MAML2;NOTCH4;STAT1;BMP2;MDK;GALNT11;EP300
prerank,regulation of protein processing (GO:0070613),0.6471001804927854,1.4978325327135031,0.036523929471032744,0.7926968551968041,1.0,3/21,3.49%,CCBE1;GAS1;RUNX1
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.6589451935363514,1.4977729992578495,0.03359173126614987,0.7865490232986,1.0,8/18,16.59%,ESR1;EGFR;NCOR2;NCOR1;ZC3H12A;MAP2K2;IL6;DDX5
prerank,toxin transport (GO:1901998),0.7419861178812821,1.4966148170245344,0.04702627939142462,0.7883208295958926,1.0,2/10,1.15%,ANTXR1;ANTXR2
prerank,renal filtration (GO:0097205),0.743113982675806,1.4961155978748693,0.057534246575342465,0.7853178252866931,1.0,4/10,10.06%,CD34;SULF2;SULF1;XPNPEP3
prerank,negative regulation of interleukin-2 production (GO:0032703),0.6702773147432969,1.4957200169362819,0.045103092783505154,0.7818354194599165,1.0,2/18,3.72%,CD34;HDAC7
prerank,peptidyl-proline hydroxylation (GO:0019511),0.7126876059675867,1.494650012770833,0.046153846153846156,0.7824789719783016,1.0,4/11,7.08%,P4HA3;P4HA1;EGLN2;P4HA2
prerank,positive regulation of interleukin-12 production (GO:0032735),0.6065254098305632,1.4935256963728614,0.038238702201622246,0.7837536844684329,1.0,6/31,9.77%,SYK;IL16;MAPK14;TIRAP;TLR4;MAPK11
prerank,endoplasmic reticulum organization (GO:0007029),0.5400801365378757,1.4921515173987778,0.013713080168776372,0.786864309491726,1.0,31/72,24.68%,SEC16B;TLE6;MOSPD3;EIF2AK3;STX1A;STX5;UBE2J2;SEC31A;GET4;REEP3;TOR1AIP2;MIA3;ALDH3A2;WDR83OS;LMAN1;TRAM2;LNPK;SGTA;RTN3;TRAM1;SEC61A1;REEP5;SHTN1;VAMP2;RAB10;TMEM33;BNIP1;EMD;RAB18;RTN4;SEC61B
prerank,skeletal system development (GO:0001501),0.5246117956495802,1.4905795660778844,0.003048780487804878,0.7913848304874358,1.0,30/148,9.27%,COMP;COL1A2;FBN1;MYOC;COL1A1;TRPS1;GNAS;BMP1;AKAP13;FGFR1;PAPSS2;PCSK5;EIF2AK3;CD44;SULF2;TGFB2;EXT1;PKD1;PAX1;ACAN;VCAN;TNFRSF11B;INHA;TLL1;UCMA;SULF1;GLI2;BPNT2;XYLT1;SOX5
prerank,nucleotide-sugar metabolic process (GO:0009225),0.714585326876518,1.489913062675025,0.045081967213114756,0.7898020562011707,1.0,3/12,3.12%,GFPT2;UGP2;GFPT1
prerank,positive regulation of bone resorption (GO:0045780),0.728983008430344,1.4895000113334134,0.04426002766251729,0.7863264975569373,1.0,2/11,1.26%,SYK;PRKCA
prerank,regulation of cell communication (GO:0010646),0.592602597699656,1.4887912239534848,0.028768699654775604,0.7852981589022837,1.0,9/35,6.99%,MGLL;ANXA1;ANK2;SRI;MTCH1;SOCS2;CAMK2D;SCG5;YWHAG
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.5194373381996695,1.4886137022152046,0.001004016064257028,0.7805746493182232,1.0,56/173,18.08%,AREG;CD55;SEC16B;DCTN1;COPA;SEC24D;BET1L;ANK2;CNIH3;DYNC1LI2;TMED1;STX5;SPTAN1;SEC31A;SPTA1;ZW10;PREB;MIA3;KDELR3;SEC24A;KDELR1;SEC22B;ARF4;GAS6;COPB1;TFG;SEC23A;USO1;DYNC1LI1;DYNC1I1;ARFGAP3;ARFGAP1;LMAN1;CUL3;NRBP2;SCFD1;RAB2A;COPB2;NAPA;MPPE1;STX17;GOSR1;CNIH1;TRAPPC2L;KDELR2;COG6;DYNC1H1;NSF;ANK1;SPTBN1;COPZ2;GOPC;SEC24B;RAB1B;BCAP31;ARCN1
prerank,osteoclast differentiation (GO:0030316),0.640646669781282,1.4879089058115689,0.04353083434099154,0.7794888129203977,1.0,6/22,7.43%,ANXA2;FOXP1;MAPK14;FARP2;SRC;OSTM1
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.691357700011064,1.4874829564023426,0.058902275769745646,0.776609186955535,1.0,5/14,8.22%,SEC24D;SEC31A;MIA3;SEC24A;SEC23A
prerank,gastrulation (GO:0007369),0.6674068541374972,1.4868217225421905,0.05511811023622047,0.7752619192929172,1.0,2/15,2.21%,UGDH;GPC3
prerank,ERBB2 signaling pathway (GO:0038128),0.5935281644646404,1.4861043691745257,0.030696576151121605,0.7745217273991167,1.0,10/31,16.30%,MYOC;PRKCA;EGFR;BTC;SRC;STUB1;PIK3CA;EGF;HSP90AA1;SOS1
prerank,mesonephros development (GO:0001823),-0.5693996197090221,-1.4858858658912129,0.07586206896551724,0.48022363202271173,1.0,4/11,13.56%,BMP7;OSR1;FGF1;PAX8
prerank,transition metal ion homeostasis (GO:0055076),-0.43508626281260904,-1.4856320201940687,0.0375,0.4754770966433921,1.0,10/28,19.01%,CP;IREB2;XIAP;SLC40A1;B2M;CUTC;HFE;FTL;MT3;CYBRD1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.446045163431249,-1.4845497987152287,0.05555555555555555,0.4727861291153026,1.0,8/30,12.56%,FLT1;MLLT3;KDR;KIT;SFRP1;INHBA;TGFB1;FLT4
prerank,potassium ion export across plasma membrane (GO:0097623),0.6957616616284832,1.4834420075640846,0.045205479452054796,0.7865653787102543,1.0,2/13,1.19%,KCNK5;KCNT2
prerank,granulocyte chemotaxis (GO:0071621),0.5565147359282974,1.4826676934665313,0.02275189599133261,0.7858033447984034,1.0,8/55,9.02%,SYK;CCL8;ANXA1;TGFB2;S100A8;S100A9;CXCL10;CCL25
prerank,vesicle coating (GO:0006901),0.551862821377135,1.482067004072931,0.0183585313174946,0.7731006554756277,1.0,22/61,17.28%,AREG;SEC16B;SEC24D;CNIH3;STX5;SEC31A;PREB;SEC24A;SEC22B;TFG;SEC23A;USO1;LMAN1;CUL3;SCFD1;SEC23IP;NAPA;CNIH1;TRAPPC2L;NSF;SEC24B;RAB1B
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.551862821377135,1.482067004072931,0.0183585313174946,0.7731006554756277,1.0,22/61,17.28%,AREG;SEC16B;SEC24D;CNIH3;STX5;SEC31A;PREB;SEC24A;SEC22B;TFG;SEC23A;USO1;LMAN1;CUL3;SCFD1;SEC23IP;NAPA;CNIH1;TRAPPC2L;NSF;SEC24B;RAB1B
prerank,COPII vesicle coating (GO:0048208),0.551862821377135,1.482067004072931,0.0183585313174946,0.7731006554756277,1.0,22/61,17.28%,AREG;SEC16B;SEC24D;CNIH3;STX5;SEC31A;PREB;SEC24A;SEC22B;TFG;SEC23A;USO1;LMAN1;CUL3;SCFD1;SEC23IP;NAPA;CNIH1;TRAPPC2L;NSF;SEC24B;RAB1B
prerank,focal adhesion assembly (GO:0048041),-0.4640649537418289,-1.4815413417730385,0.055,0.4755172265099178,1.0,5/21,5.87%,PTPRK;SORBS1;ACTN2;THSD1;PIP5K1A
prerank,hippo signaling (GO:0035329),-0.45818661829254625,-1.480209428020684,0.030303030303030304,0.473459857767115,1.0,14/26,17.83%,TJP1;FAT4;TEAD4;TEAD1;TJP2;AMOT;WWC1;TEAD2;CASP3;YAP1;AMOTL1;TEAD3;SAV1;NPHP4
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.6443306594542919,1.480089733708585,0.04881101376720901,0.7809429751934545,1.0,5/20,11.62%,PLOD2;GCLC;HAGH;CNDP2;GAMT
prerank,negative regulation of cell communication (GO:0010648),0.6426859222774477,1.4786226798438558,0.029925187032418952,0.7852222577158687,1.0,3/21,4.40%,LIF;SRMS;ACVR1
prerank,chondroitin sulfate catabolic process (GO:0030207),0.6927488576548454,1.477045862275284,0.062162162162162166,0.7902048033402022,1.0,2/13,5.07%,DCN;VCAN
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.5000650590246882,-1.4757576479415055,0.05825242718446602,0.47934053160388784,1.0,8/18,12.76%,ACSL1;ELOVL7;ACSL4;HACD1;ACSL3;HACD2;ACSL6;ELOVL1
prerank,hyaluronan metabolic process (GO:0030212),0.6188861801818639,1.4757507925217814,0.04884004884004884,0.7932729151070999,1.0,4/23,2.88%,HAS2;HAS1;CD44;FGF2
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.7272491303211644,1.4756798163039988,0.04985754985754986,0.7830181454951995,1.0,4/10,18.60%,MAPK7;MYADM;KLF4;MBP
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.7272491303211644,1.4756798163039988,0.04985754985754986,0.7830181454951995,1.0,4/10,18.60%,MAPK7;MYADM;KLF4;MBP
prerank,positive regulation of superoxide anion generation (GO:0032930),0.6910689753118001,1.475514280540279,0.04980340760157274,0.778895247213836,1.0,2/13,2.49%,SYK;CD177
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.4838968756479757,-1.4729699371563525,0.07177033492822966,0.4811439037862501,1.0,9/18,10.67%,FLT1;COL4A3;MEF2C;PLCG1;SP1;HMGB1;ITGA4;IGF2;MDK
prerank,regulation of hormone secretion (GO:0046883),0.67267952913389,1.471723172384815,0.052845528455284556,0.7990473405260459,1.0,3/15,6.70%,LIF;ANXA1;SCG5
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.6810336246293089,1.470495092708918,0.06504065040650407,0.8018589837981915,1.0,2/14,1.34%,CD80;ANXA1
prerank,regulation of muscle cell differentiation (GO:0051147),0.6005548440596487,1.4694496413120506,0.030878859857482184,0.8034216612068545,1.0,8/31,9.77%,CDON;MAPK12;HDAC9;MAPK14;RBM4;BOC;CDK9;MAPK11
prerank,regulation of Wnt signaling pathway (GO:0030111),0.5259308564355673,1.4687473905015545,0.007157464212678937,0.8030691182748876,1.0,26/108,10.38%,RSPO2;SFRP4;ESR1;LRP1;GPC3;GRB10;SULF2;DACT3;CDK14;AMER3;RUNX1;SKI;KREMEN1;AXIN1;DACT1;ZRANB1;NFATC1;DAAM2;SULF1;FOXL1;MDFIC;FZD7;PSEN1;GSKIP;TSKU;KANK1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6606067392905371,1.4682627579771352,0.04933333333333333,0.8006686738138808,1.0,7/17,13.39%,EGFR;PKD1;PSRC1;MAPRE3;PKD2;AKT1;CCND1
prerank,skeletal system morphogenesis (GO:0048705),0.5714308196046765,1.468257422354704,0.023972602739726026,0.79552183546242,1.0,14/42,19.25%,SFRP4;LRP6;HOXA3;FGFR1;SKI;HOXA4;SIX1;PDGFRA;HOXC4;HOXA9;RAB33B;DYNC2I1;TGFBR1;RFLNA
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.6841023713375884,1.467593256265622,0.06775067750677506,0.7947294934206777,1.0,2/13,0.36%,FSTL1;FBN1
prerank,DNA dealkylation (GO:0035510),0.7299188203142702,1.4675871082053074,0.06618705035971223,0.7847248554534054,1.0,1/10,0.11%,MPG
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.7299188203142702,1.4675871082053074,0.06618705035971223,0.7847248554534054,1.0,1/10,0.11%,MPG
prerank,glycine transport (GO:0015816),-0.5923800951622225,-1.4672115072520153,0.07973421926910298,0.4911044675972325,1.0,3/10,10.88%,SLC6A9;SLC38A5;SLC6A17
prerank,regulation of blood coagulation (GO:0030193),0.6098461801690271,1.4637838137165022,0.03832335329341317,0.8039923023590098,1.0,4/27,3.19%,CD34;EPHB2;FAP;F2R
prerank,regulation of interleukin-10 production (GO:0032653),0.5721414277422356,1.462854397256518,0.0378619153674833,0.8051544601641306,1.0,3/44,1.14%,CD34;SYK;IRF4
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.45719461995186766,-1.4625200801765965,0.06403940886699508,0.4984946402443287,1.0,7/20,16.43%,IGF1;NIBAN2;FOXC1;LAMTOR5;EP300;TGFB1;GTF2B
prerank,ribosomal small subunit assembly (GO:0000028),0.6576172215190634,1.4611278256889164,0.061598951507208385,0.8120774844035837,1.0,8/16,17.34%,RPSA;MRPS11;ABT1;XRCC5;RPS27L;RPS5;RRP7A;PWP2
prerank,protein heterooligomerization (GO:0051291),0.6506204822380535,1.460728332956174,0.04878048780487805,0.8095304968188473,1.0,8/17,15.10%,PKD1;KRT10;PKD2;CPSF6;MAT2A;TMEM120A;KCNC2;HSD17B8
prerank,COPII-coated vesicle budding (GO:0090114),0.5384557757748106,1.4581538851899867,0.02459893048128342,0.8211777147105392,1.0,23/68,17.28%,AREG;SEC16B;SEC24D;CNIH3;STX5;SEC31A;PREB;MIA3;SEC24A;SEC22B;TFG;SEC23A;USO1;LMAN1;CUL3;SCFD1;SEC23IP;NAPA;CNIH1;TRAPPC2L;NSF;SEC24B;RAB1B
prerank,regulation of tumor necrosis factor production (GO:0032680),0.5233751493128186,1.4577472821584487,0.009137055837563452,0.8189728459337486,1.0,26/112,17.16%,CD34;SYK;LBP;EPHB2;IRAK3;FOXP1;MIF;TMEM106A;SYT11;PTPRJ;IL33;GAS6;PSEN1;TIRAP;TLR4;CD47;SIRPA;ZFP36;TWIST1;ZC3H12A;IL4;CD14;SELENOS;ILRUN;IL6;CHRNA7
prerank,regulation of superoxide anion generation (GO:0032928),0.6704814462543641,1.4576849741626619,0.06580645161290323,0.8144500907064908,1.0,2/14,2.49%,SYK;CD177
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.7131593244739866,1.4565556912518378,0.06862745098039216,0.8170258577931419,1.0,5/10,16.37%,DGKQ;USP7;ZNF692;SELENOS;OGT
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.5042646579697428,-1.4562660365013773,0.0761904761904762,0.509816241922468,1.0,11/17,26.62%,NRP1;NTRK3;TEK;CDK5;ABL1;BAIAP2L1;FES;HRAS;NTF3;HCK;HCLS1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.5888541207939397,1.4557268983003957,0.04046242774566474,0.8175387309264456,1.0,9/35,10.38%,MYOC;EPHB2;ARHGAP44;HEG1;TGFB2;ABL2;FLCN;CUL3;KANK1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.6947450501884934,1.4536613543568149,0.05518169582772544,0.8258829080308911,1.0,3/11,1.94%,GHR;IRS1;EIF2AK3
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.5680992772756244,-1.4531481426714588,0.08712121212121213,0.5127788938183412,1.0,7/12,21.63%,INSR;IGF1R;UVRAG;JMJD4;ADRB2;IRGM;BNIP3
prerank,positive regulation of metabolic process (GO:0009893),0.522299641723965,1.4522978702384162,0.010438413361169102,0.8297279520693606,1.0,25/103,17.74%,EBF2;IL4R;SYK;UCP1;GNAS;IRF4;GADD45G;GRB10;VEGFA;ACLY;PRKAB2;ADCYAP1;ALMS1;HDAC3;CEBPB;TSHR;HCRT;CNOT3;IL4;DYNC1H1;DIO2;OGT;CXCR4;FABP5;IL18
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.7070816081880702,1.4516416782851513,0.07703488372093023,0.8290848188174317,1.0,5/11,21.60%,ANXA1;RC3H1;ZC3H12A;IL4;RC3H2
prerank,positive regulation of interleukin-6 production (GO:0032755),0.5388284290881487,1.4507942530655191,0.01882845188284519,0.8297533162616523,1.0,10/68,9.07%,SYK;LBP;IL16;RAB7B;F2R;TMEM106A;IL33;IL17RA;TIRAP;TLR4
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.6328772112833538,1.450046935754114,0.05452292441140025,0.8299405264015881,1.0,5/19,7.90%,AR;ZC3H8;MTOR;MAF1;BRF2
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.6603790562084827,1.4498669564343687,0.05997392438070404,0.8265499088379943,1.0,3/14,5.38%,DDX18;URB1;ZNHIT6
prerank,positive regulation of T cell proliferation (GO:0042102),0.5484181984278664,1.4493364930030395,0.03389830508474576,0.8250594048837672,1.0,4/55,1.34%,TNFSF9;SYK;CD80;ANXA1
prerank,miRNA metabolic process (GO:0010586),0.6164318490908578,1.4488525213450762,0.061146496815286625,0.8234972882711138,1.0,6/20,13.11%,DIS3L2;TARBP2;TRIM71;DGCR8;AGO2;DDX17
prerank,melanocyte differentiation (GO:0030318),-0.5598063517071105,-1.447700405974235,0.04827586206896552,0.5221317973094293,1.0,6/11,13.99%,LRMDA;ENPP1;MEF2C;KIT;SLC24A5;MREG
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.6995907184349623,1.4471677489288626,0.05962059620596206,0.8297976778633896,1.0,3/12,7.42%,AR;TMEFF2;CLTC
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.722135760444925,1.4463868700722833,0.06545961002785515,0.8302039401048907,1.0,3/10,6.71%,ESR1;PSMC4;PSMC6
prerank,regulation of cholesterol storage (GO:0010885),-0.5008457190922728,-1.4457316168317027,0.04526748971193416,0.5220876993587256,1.0,5/15,5.81%,SCARB1;TTC39B;PPARA;NR1H3;ABCG1
prerank,positive regulation of vasculogenesis (GO:2001214),0.7130940570651633,1.4453956328544713,0.06198347107438017,0.832234308148729,1.0,2/10,0.95%,CD34;TMEM100
prerank,positive regulation of interleukin-4 production (GO:0032753),0.6498693535257503,1.4445117821971785,0.06606217616580311,0.8334944958260292,1.0,2/17,1.14%,SYK;IRF4
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.559116373790763,1.4444342806633181,0.050335570469798654,0.8293756917511766,1.0,15/47,18.12%,MID1;EGFR;STK25;TGFB2;TAOK3;COPS5;KLHDC10;FOXO1;TAOK2;MAP2K2;PER1;NBR1;PPIA;QARS1;EPHB1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.5268728100975579,1.4443294390933799,0.017708333333333333,0.8253238264273346,1.0,37/80,23.55%,COPA;RAB6A;KLC1;PLPP3;RAB6B;ZW10;KDELR3;ATP9A;RINT1;KDELR1;SEC22B;ARF4;COPB1;SURF4;ARFGAP3;ARFGAP1;KIF2A;RER1;ATP9B;SCFD1;COPB2;NAPA;KIF3A;SCYL1;KIF3B;KDELR2;NSF;COPZ2;RAB1B;ARCN1;CENPE;TMED2;COPG1;USE1;GOLPH3L;BNIP1;PICK1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.6252465384409167,1.4433049281324044,0.05860805860805861,0.8274109676126216,1.0,9/21,12.53%,UGDH;SULF2;EXT1;SULF1;B3GAT3;XYLT1;HS2ST1;HS3ST5;GLCE
prerank,positive regulation of embryonic development (GO:0040019),-0.46960388277181053,-1.4429594511586186,0.06074766355140187,0.524678653100814,1.0,5/19,4.85%,WNT4;TENM4;NIBAN2;OSR1;PLCB1
prerank,neurogenesis (GO:0022008),0.556891871411189,1.4426900158786709,0.039727582292849034,0.8269215507145532,1.0,16/43,19.88%,WNT2;ANXA1;SIX4;TGFB2;LPAR1;TRAK2;DAGLA;MAPT;SIX1;THOC2;DAGLB;CDK5RAP2;CXCR4;EPHB1;CIT;WDR62
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.6128852756281056,1.4426568298658318,0.0779537149817296,0.8226013032797563,1.0,5/22,13.19%,ESR1;PSMC4;PSMC6;MED24;MED13
prerank,organelle transport along microtubule (GO:0072384),0.585021118374555,1.442410600961205,0.059371362048894066,0.8197323368306262,1.0,15/31,25.67%,ARHGAP21;RAB6A;NDEL1;TRAK2;BICD1;DYNC1I1;MAPT;UXT;PAFAH1B1;COPG1;TMEM201;FBXW11;MAP1S;RHOT2;RAB1A
prerank,neutrophil activation (GO:0042119),0.6864105902128391,1.4422259414643435,0.07733333333333334,0.8164980484622284,1.0,1/12,0.24%,SYK
prerank,regulation of vasculogenesis (GO:2001212),0.6648839809188165,1.440814229283114,0.05699481865284974,0.8214179060343921,1.0,2/14,0.95%,CD34;TMEM100
prerank,leukocyte tethering or rolling (GO:0050901),-0.5110200476929603,-1.4391762310353324,0.0603448275862069,0.5298590689810325,1.0,9/17,30.07%,ITGA4;VCAM1;GCNT1;ROCK1;JAM2;SELPLG;PODXL2;SELP;ITGB7
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5415965218516319,1.437916980619434,0.04143947655398037,0.8363989321975196,1.0,17/48,11.30%,FGF18;PRKCA;ANXA1;FGFR1;ANGPT4;VEGFA;FGF2;HDAC9;HDAC7;MAPK14;MAP2K3;PRKD2;STAT5A;FOXC2;AKT3;RHOJ;AKT1
prerank,anion transport (GO:0006820),-0.4170818764778805,-1.4369250362215062,0.046511627906976744,0.5305831316808752,1.0,7/33,7.50%,SLC13A4;SLC13A3;ABCG2;SLCO2B1;SLC26A7;SLC22A6;LRRC8B
prerank,regulation of lymphocyte activation (GO:0051249),-0.534512856565236,-1.4364648122809025,0.11290322580645161,0.526457467058454,1.0,8/12,38.31%,PAG1;DCAF15;LAT;IKZF3;THEMIS2;CCL5;CRTAM;LCK
prerank,actin filament-based transport (GO:0099515),-0.47378752278995,-1.4351872090252324,0.06666666666666667,0.5248071849375989,1.0,5/21,5.81%,SYNE2;MYO1B;FNBP1L;SUN2;MYO1D
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.5416023667140278,1.4341685268097213,0.04,0.8567208255436563,1.0,8/51,6.84%,FSTL1;FBN1;HTRA3;SKIL;SMAD4;SMURF2;SKI;SMAD5
prerank,DNA modification (GO:0006304),0.6066040733164696,1.4339460338423402,0.07702020202020202,0.853783503016118,1.0,2/22,0.89%,MPG;PARP3
prerank,PERK-mediated unfolded protein response (GO:0036499),0.7063388012016616,1.4333986419407942,0.08916323731138547,0.8529379222794512,1.0,5/10,13.67%,EIF2AK3;NFE2L2;HERPUD1;QRICH1;EIF2S1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.6315087643965781,1.4327445358371351,0.06985769728331177,0.8526616860581956,1.0,8/19,18.66%,HNRNPA1;CTC1;GNL3L;SRC;ACD;TERF1;TENT4B;TINF2
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.6726717232359694,1.431960295258682,0.07692307692307693,0.8534885053502884,1.0,6/13,17.66%,SEC16B;EDEM1;CD81;EDEM2;TMEM30A;BCAP31
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.6851327736658186,1.4316839862223365,0.07172413793103448,0.8509082853550657,1.0,3/12,5.49%,UMPS;TK1;TK2
prerank,regulation of plasminogen activation (GO:0010755),0.6744182689127556,1.4294696746554678,0.0972972972972973,0.860586108932655,1.0,4/12,7.11%,HPN;CLEC3B;RUNX1;MELTF
prerank,chordate embryonic development (GO:0043009),0.5453993002875931,1.4293903457848653,0.04500548847420417,0.8567691944366448,1.0,18/55,9.11%,COL1A1;TGFB3;FGFR1;MBNL1;PCSK5;SIX4;SULF2;VEGFA;LMX1B;PKD1;DACT1;TRIM71;UCMA;SULF1;FLCN;PKD2;SOX8;XYLT1
prerank,cAMP biosynthetic process (GO:0006171),-0.5756222433426726,-1.429078476080954,0.0798611111111111,0.5361299811824713,1.0,4/10,9.13%,ADCY5;ADCY1;ADCY4;ADCY9
prerank,actin filament polymerization (GO:0030041),0.5826742620530585,1.428865945994147,0.06175771971496437,0.8559145248025986,1.0,7/29,5.88%,GSN;PSTPIP1;ANG;DIAPH3;COBL;MSRB1;WASF1
prerank,cellular response to fatty acid (GO:0071398),0.6811913793161987,1.4286661706321713,0.0743801652892562,0.8528698022144945,1.0,4/12,14.08%,UCP1;IRS1;PID1;ZC3H12A
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.34613564814482767,-1.4280980270479524,0.03076923076923077,0.5336725138707149,1.0,23/66,12.16%,PTPRK;NR2F2;ROBO1;MTSS1;APOE;THBS1;DAB2IP;CDK6;DUSP10;PTPRM;TGFBR3;CAV1;RGCC;FGFR2;B2M;BRCA2;AQP11;SFRP1;CAV2;STAT1;CEACAM1;CDKN1C;TGFB1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.6047414844589312,1.426756762479521,0.05990220048899755,0.8612469850308855,1.0,8/23,13.71%,LIF;SIX4;VEGFA;FGF2;SOX8;EGF;GDNF;SIX1
prerank,nuclear membrane disassembly (GO:0051081),0.6471484547213787,1.4266120706520733,0.09594594594594595,0.8578230646714239,1.0,2/14,1.73%,PRKCA;DCTN1
prerank,cellular response to estradiol stimulus (GO:0071392),0.6294451095342342,1.4266072135953887,0.08015267175572519,0.8535794070473325,1.0,3/18,6.23%,ESR1;EGFR;NCOA3
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.6915287072642964,1.4261952030941512,0.06887052341597796,0.8519073043845944,1.0,2/11,1.26%,SYK;PRKCA
prerank,cellular sodium ion homeostasis (GO:0006883),-0.505833325461249,-1.4248648688628458,0.09243697478991597,0.5373768734638059,1.0,4/15,2.85%,ATP1A2;NEDD4L;ATP1B3;SLC12A2
prerank,GTP metabolic process (GO:0046039),0.645001401998336,1.4241890689449392,0.07436918990703852,0.8601910282689941,1.0,3/15,10.05%,GNAI3;RAB23;RHOQ
prerank,histone H4 deacetylation (GO:0070933),0.7088823177590149,1.424151164164762,0.09251700680272108,0.8562025412157107,1.0,4/10,13.86%,HDAC9;SIRT2;HDAC3;HDAC4
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.5989371200215463,1.4233106068688777,0.080545229244114,0.8574413826266561,1.0,9/24,18.66%,HNRNPA1;CTC1;GNL3L;SRC;ACD;ERCC4;TERF1;TENT4B;TINF2
prerank,regulation of mitotic spindle organization (GO:0060236),0.5731276078036769,1.4232285910411697,0.05190311418685121,0.853740300631818,1.0,10/35,15.34%,PARP3;GPSM2;DCTN1;PSRC1;VPS4B;FSD1;CLTC;CCSAP;CEP97;DYNC1H1
prerank,regulation of translational initiation (GO:0006446),0.5375390514435677,1.422934673931809,0.04397905759162304,0.8515270005799397,1.0,31/63,26.92%,EIF3B;EIF2AK3;DAZL;RBM4;PAIP2B;CTIF;AGO2;EIF1;NPM1;CEBPB;LARP1;POLR2D;POLR2G;CDC123;EIF3E;NCK1;YTHDF1;YTHDF2;PAIP2;MTIF2;ATF4;YTHDF3;TPR;EIF4G3;NCK2;EIF4H;DNAJC3;EIF2B2;EIF4EBP2;EIF4G1;DDX1
prerank,cytoplasmic sequestering of protein (GO:0051220),0.6857473736251247,1.4226952438909766,0.07887323943661972,0.8490226667695713,1.0,9/13,24.04%,DBN1;PKD1;GET4;PKD2;KEAP1;GOPC;FLNA;YWHAB;LATS1
prerank,negative regulation of translational initiation (GO:0045947),0.6773571725410379,1.42247076496134,0.09454061251664447,0.8463520938842857,1.0,8/13,26.07%,RBM4;PAIP2B;AGO2;LARP1;EIF3E;PAIP2;TPR;EIF4EBP2
prerank,glutathione biosynthetic process (GO:0006750),0.6878025731433801,1.4224546293786466,0.09027777777777778,0.8424372715855291,1.0,3/11,9.77%,GCLC;HAGH;CNDP2
prerank,positive regulation of viral life cycle (GO:1903902),0.6094224599252948,1.4209152714152031,0.07290400972053462,0.847818781907233,1.0,7/22,20.74%,AXL;KPNA2;LGALS1;TRIM11;DDB1;VPS37B;TYRO3
prerank,atrioventricular valve morphogenesis (GO:0003181),0.6293678531125908,1.42070696088001,0.06779661016949153,0.8452008257974652,1.0,7/19,10.09%,TGFB2;SLIT3;TGFBR2;SMAD4;ACVR1;MDM4;SMAD6
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.5593178624671015,1.4203381948976481,0.06375838926174497,0.8435360598621862,1.0,12/38,14.60%,CD34;KLF2;ATP2B4;PKD2;TLR4;CD47;SIRPA;AKT1;GLA;ZC3H12A;KLF4;HSP90AA1
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.45673662013963057,-1.420211376809795,0.08717948717948718,0.5445680879954872,1.0,9/21,15.06%,PLTP;PTCH1;APOE;NR1H3;CAV1;SIRT1;ABCA3;NFKBIA;EEPD1
prerank,atrial septum development (GO:0003283),0.6696731079397302,1.4190848137604424,0.07650273224043716,0.8475412048439591,1.0,3/13,6.76%,ANK2;TGFB2;MDM4
prerank,vasculogenesis (GO:0001570),0.5667911320823859,1.4187548750924452,0.06367924528301887,0.8455608539094758,1.0,6/32,3.19%,HAS2;WT1;GLMN;VEGFA;TNNI3;TGFBR2
prerank,cAMP-mediated signaling (GO:0019933),-0.44097726471857046,-1.4186304249221517,0.05434782608695652,0.5435274033145704,1.0,10/24,9.63%,PDE7B;RAPGEF2;ADCY1;RAPGEF3;PDE3A;ADGRG6;KSR1;AHR;CAP2;PDE2A
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.5436082546796398,-1.4184710656814474,0.09126984126984126,0.5389938335477592,1.0,6/13,17.35%,NAMPT;PTGS2;PTGIS;PARP10;NUDT12;PARP9
prerank,protein import into peroxisome membrane (GO:0045046),0.6117744569208143,1.417240432427817,0.07525510204081633,0.8516472218139619,1.0,13/22,24.14%,PXMP2;PEX16;GDAP1;ALDH3A2;PXMP4;PEX12;SLC25A17;PEX3;PEX5;ATAD1;ABCD3;PEX2;FIS1
prerank,response to hydrogen peroxide (GO:0042542),0.5427076700343165,1.4166407271064745,0.040793825799338476,0.8514981198549791,1.0,14/45,16.30%,ANXA1;STK25;FYN;MAPK7;ADAM9;NFE2L2;HDAC6;ANKZF1;SIRPA;GPX1;PLEKHA1;OSER1;STK24;IL6
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.5835713012314574,1.4162635154684537,0.0655940594059406,0.849962735110782,1.0,12/26,23.83%,FYN;MAPK7;PDE8A;NFE2L2;AKT1;GPR37L1;GPR37;HTRA2;PPIA;PYCR1;ATF4;BAG5
prerank,activation of protein kinase A activity (GO:0034199),-0.4864681300463244,-1.4161365518262798,0.08733624454148471,0.5409839992826816,1.0,7/16,15.92%,ADCY5;ADCY1;PRKAR1B;ADCY4;ADCY9;PRKAR2B;PRKACB
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.6689876614108019,1.415538272352781,0.09226594301221167,0.8505443347558594,1.0,8/13,25.23%,DESI1;DESI2;UBA6;UBA2;SENP6;SAE1;ATG10;UBA7
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.6651124669707855,1.4149365922098345,0.08567415730337079,0.8505741585892489,1.0,1/12,0.38%,AKR1B1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.6161309493797031,1.4139786863582002,0.06896551724137931,0.8527227415885318,1.0,3/20,3.89%,SFRP4;GSN;CD160
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.4739772396056502,-1.4122816030038488,0.07407407407407407,0.546311955767443,1.0,8/17,12.16%,PTN;IL34;TENM4;NOTCH1;PTPRZ1;BMP2;MDK;TGFB1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.40135201820587996,-1.4121721151922972,0.03676470588235294,0.5417100539127483,1.0,11/35,10.43%,FLT1;NR2F2;COL4A3;MEF2C;APOE;THBS1;PTPRM;CAV1;RGCC;CAV2;STAT1
prerank,regulation of BMP signaling pathway (GO:0030510),0.5172376045313246,1.4101816340970563,0.03632478632478633,0.8723392837006501,1.0,10/73,7.26%,SFRP4;FSTL1;HTRA3;PCSK6;SKIL;SMAD4;SMURF2;SKI;SMAD5;SULF1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.6163477870520162,1.4101402419109799,0.0825,0.8686796251811733,1.0,8/18,9.72%,ANXA1;VEGFA;FGF2;HDAC9;HDAC7;FOXC2;AKT3;RHOJ
prerank,protein insertion into membrane (GO:0051205),0.5629837500193268,1.4099771458281454,0.062206572769953054,0.8658274376475896,1.0,10/32,14.22%,EGFR;STX1A;STX5;UBE2J2;GET4;ALDH3A2;WDR83OS;TRAM2;SGTA;TRAM1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.556807058887227,-1.4097290087515975,0.09375,0.5431780952100296,1.0,7/11,32.93%,ALG10B;LRRC38;AKAP6;NOS1AP;LRRC55;TREM2;RNF207
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.6702248125753476,1.4097146420805642,0.07621550591327202,0.8636297502747007,1.0,6/12,25.20%,TIPIN;NBN;GMNN;BLM;WDR18;KAT7
prerank,supramolecular fiber organization (GO:0097435),0.4859929489003435,1.409289135544796,0.002,0.8624854403274202,1.0,75/333,13.66%,COL14A1;PLOD2;COL3A1;P4HA3;COL5A2;COL6A3;COL1A2;DDR2;DBN1;TNXB;GSN;KRT20;COL1A1;LOXL2;COL17A1;COL5A1;BMP1;COL8A1;TLE6;DCTN1;COL11A1;COL5A3;ADAMTS2;CCDC88C;COL6A2;FGF13;TGFB2;CDC42EP2;COL8A2;P4HA1;HOOK2;CLIP1;ADAMTS3;SPTA1;DPT;DST;MARCKS;VPS4B;COL12A1;FSD1;MYO1A;NEFL;COL6A1;TGFBI;P4HA2;TLL1;MYO5A;SLK;CLIP2;COL15A1;PLOD3;SIAH1;KIF2A;GGA1;COL9A3;LOXL1;COL2A1;CALCA;COLGALT1;SERPINH1;CLIP4;CAMSAP1;AVIL;MAPT;COL20A1;TPPP3;NAT8;UBA52;HSPG2;PIN1;SLAIN2;P3H1;CRIPT;RHOA;WDR73
prerank,aggrephagy (GO:0035973),0.5796844607002435,1.409239930440749,0.09048178613396005,0.859053273516904,1.0,9/27,15.34%,DYNC1LI2;HDAC6;UBE2N;ARL13B;DYNC1LI1;DYNC1I1;SQSTM1;UBA52;DYNC1H1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.6709460323526675,1.4082515468212176,0.08891928864569083,0.8613878740705415,1.0,3/12,17.74%,CD80;PAEP;IL18
prerank,muscle cell differentiation (GO:0042692),-0.4005044914577475,-1.4079896292584777,0.0457516339869281,0.543269522700692,1.0,9/32,11.66%,NEBL;DMD;WNT5B;MEF2C;SPEG;TBX18;TBX1;MRTFB;TMEM204
prerank,regulation of cholesterol efflux (GO:0010874),-0.4130253555575176,-1.4076746263533924,0.0784313725490196,0.5393946857516579,1.0,11/30,16.89%,PLTP;PTCH1;APOE;TTC39B;NR1H3;CAV1;SIRT1;ABCA3;NFKBIA;EEPD1;ABCA5
prerank,regulation of cell killing (GO:0031341),0.6345474009312083,1.4076743549201944,0.08165997322623829,0.8613691740881438,1.0,4/16,8.19%,CD55;CFH;TGFB2;FZD7
prerank,positive regulation of vasoconstriction (GO:0045907),0.6633629975532899,1.4074844962508786,0.09379128137384413,0.8589772821969216,1.0,2/13,3.19%,AVPR1A;F2R
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.5888841147169332,1.4073061418488695,0.07142857142857142,0.8563122882822157,1.0,11/26,16.59%,EGFR;PDE8A;ZPR1;ZFP36L1;ZFP36L2;SYAP1;IQGAP1;INPP5K;ZFP36;STAT5B;SNAI2
prerank,negative regulation of interleukin-8 production (GO:0032717),0.6304840235763565,1.407257904235547,0.09505208333333333,0.8529347277009828,1.0,7/17,23.23%,ANXA1;OTUD7B;BCL3;KLF4;ANXA4;ARRB1;SSC5D
prerank,negative regulation of macroautophagy (GO:0016242),0.5759258100456826,1.4058560937483695,0.08150851581508516,0.8582291216224227,1.0,19/26,31.63%,USP36;MTOR;SEC22B;PIK3CA;NRBP2;SCFD1;AKT1;SMCR8;NUPR1;QSOX1;UBQLN4;TSC2;MTM1;TMEM39A;TSC1;LZTS1;RUBCN;CHMP4A;CHMP4B
prerank,receptor internalization (GO:0031623),0.5376752783997462,1.4052675827255316,0.06326304106548279,0.8585267948575666,1.0,8/44,8.08%,ACKR3;SYK;CD9;LRP1;DNM1;CLTC;SNX1;CD81
prerank,proteoglycan metabolic process (GO:0006029),0.587053317754933,1.4051488677091304,0.07524271844660194,0.8555666333598626,1.0,9/26,9.11%,SULF2;CSGALNACT2;CHST10;GAL3ST3;SULF1;CHST12;CHST14;FOXL1;XYLT1
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.6034569972830822,1.4050610533507222,0.08739076154806492,0.8523973806146328,1.0,18/23,31.45%,SYVN1;PREB;SURF4;LMAN1;HERPUD1;SELENOS;AUP1;DERL1;SEL1L;TECPR2;SEC61B;HSP90B1;UFD1;NPLOC4;RANGRF;SEC13;TMEM129;DERL2
prerank,negative regulation of T cell activation (GO:0050868),0.5591881861238309,1.4045395866603376,0.07551487414187644,0.8519631410028238,1.0,3/35,1.78%,CD80;LAX1;GLMN
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.6247973436459204,1.4039267521661254,0.08816120906801007,0.8522739912748896,1.0,6/18,10.38%,MYOC;HEG1;ABL2;FLCN;CUL3;KANK1
prerank,cellular response to hormone stimulus (GO:0032870),0.5147592252218983,1.403629886934949,0.0405982905982906,0.8505335536570753,1.0,14/69,7.15%,GHR;AR;UCP1;WT1;SLIT3;SLIT2;SFR1;ATP1A3;ATP1A1;ZFP36L1;SOCS2;NCOA3;SRC;GAS2L1
prerank,negative regulation of signaling (GO:0023057),0.5893312099337644,1.4033886289287725,0.06107784431137724,0.848528866457904,1.0,3/25,4.40%,LIF;SRMS;ACVR1
prerank,neutrophil migration (GO:1990266),0.5228836233131492,1.4022856435498159,0.06170212765957447,0.8514530681165748,1.0,10/58,12.90%,SYK;CCL8;CD177;TGFB2;S100A8;S100A9;CXCL10;CCL25;IRAK4;CCL13
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.652799826794487,1.4022503162209503,0.11185983827493262,0.8481510187775562,1.0,3/13,11.60%,TGFBR2;RUNX1;GLI3
prerank,response to cAMP (GO:0051591),0.5518721615031175,1.402220749389618,0.0759493670886076,0.8448402365606185,1.0,10/37,11.33%,IGFBP5;DUOX1;WT1;DGKQ;ZFP36L1;RAP1B;PKD2;INPP5K;HCN4;SLC26A6
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.657625792957775,1.4014262751044675,0.09004092769440655,0.8461223432808805,1.0,6/13,19.80%,PDE8A;NFE2L2;GPR37L1;GPR37;HGF;PYCR1
prerank,mammary gland development (GO:0030879),0.607009571533458,1.4010369219194296,0.08899876390605686,0.8450076385306622,1.0,5/21,7.49%,WNT2;TGFB3;GPAT4;VEGFA;GLI2
prerank,intracellular lipid transport (GO:0032365),-0.43895392540439604,-1.4004734766643392,0.06735751295336788,0.5542220393622336,1.0,6/21,11.32%,PRKAG2;PLEKHA8;CERT1;PRKAA2;SLC25A20;ACACB
prerank,RNA catabolic process (GO:0006401),0.5497902598897787,1.4004524863845906,0.06404494382022471,0.8451159376617925,1.0,17/46,19.45%,DIS3L2;ZPR1;ZFP36L2;HNRNPD;NUDT16L1;EXOSC7;SIDT2;ERN1;NUDT16;RNASE6;ZFP36;DNA2;CNOT10;AGO4;YTHDF2;SUPV3L1;AGO3
prerank,protein insertion into ER membrane (GO:0045048),0.545851241309046,1.4000594916463007,0.07019562715765247,0.8440889161811695,1.0,18/37,24.68%,STX1A;STX5;UBE2J2;GET4;ALDH3A2;WDR83OS;EMC1;TRAM2;EMC10;EMC8;SGTA;TRAM1;EMC3;VAMP2;EMC2;EMD;EMC6;SEC61B
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.6863902024101791,1.398635691504693,0.08555399719495091,0.8493919719418611,1.0,3/10,14.32%,MAPK7;IRAK3;KLF4
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.528352396448975,1.3983934270892935,0.04861878453038674,0.8473708748302728,1.0,18/52,17.06%,DCTN1;GFPT1;LMNA;CXXC1;SEC31A;SYVN1;PREB;EDEM1;KDELR3;TPP1;ARFGAP1;CTDSP2;ACADVL;ERN1;DDX11;DNAJB11;KLHDC3;PPP2R5B
prerank,cellular response to interleukin-2 (GO:0071352),0.6654056895167069,1.398393373106838,0.09078014184397164,0.8406189156682786,1.0,2/11,8.10%,SYK;STAT5A
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.6654056895167069,1.398393373106838,0.09078014184397164,0.8406189156682786,1.0,2/11,8.10%,SYK;STAT5A
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.6513217318747927,1.398244429364054,0.11590296495956873,0.8382026849336826,1.0,4/14,7.26%,SULF2;FGF2;CREB3L1;SULF1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.5549933843885483,1.3958433610713687,0.06924882629107981,0.849230164677993,1.0,20/35,26.82%,AR;ESR1;ZMIZ1;PMEPA1;TRIP4;SRC;EGLN2;PLPP1;RBFOX2;DDX17;RNF14;DDX5;PADI2;TMF1;UBE3A;NCOA4;NR3C1;KDM3A;SAFB;ARID1A
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.5103803647769757,-1.3957769099376178,0.10116731517509728,0.5621658539250638,1.0,8/14,24.03%,WNT5A;SEMA7A;KIT;MAVS;SIRT1;CD74;NR4A3;GPRC5B
prerank,protein ADP-ribosylation (GO:0006471),0.5654144287709507,1.395046985533957,0.07942238267148015,0.8507727933629013,1.0,8/28,11.05%,PARP3;ART4;PARP11;ARF4;PARP6;SIRT2;ZC3HAV1;PARP14
prerank,regulation of transforming growth factor beta production (GO:0071634),0.6205502939419237,1.394632079629933,0.07364341085271318,0.849843260409328,1.0,3/18,3.68%,CD34;TGFB2;SMAD4
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.5792424072816923,1.3941405529638247,0.07108433734939759,0.8493830532069137,1.0,8/27,14.13%,DDR2;WNT2;MIF;CDK4;GAS6;S100A6;CDKN1A;PDGFRA
prerank,sphingoid biosynthetic process (GO:0046520),-0.5515446778912172,-1.3940325302794507,0.10583941605839416,0.5574723182972892,1.0,5/11,22.81%,ACER2;SPHK1;SPTLC2;SPHK2;ABCA2
prerank,sphingosine biosynthetic process (GO:0046512),-0.5515446778912172,-1.3940325302794507,0.10583941605839416,0.5574723182972892,1.0,5/11,22.81%,ACER2;SPHK1;SPTLC2;SPHK2;ABCA2
prerank,actin polymerization or depolymerization (GO:0008154),0.5202081236974904,1.3922576799046364,0.06090808416389812,0.8571583954954554,1.0,13/50,11.23%,GSN;PSTPIP1;SCIN;ANG;DIAPH3;COBL;SVIL;MSRB1;WASF1;ABI1;TWF1;AVIL;MICAL2
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.6741915374954585,1.3921790610197573,0.08502024291497975,0.8542682516806236,1.0,1/11,0.11%,CD34
prerank,keratinocyte differentiation (GO:0030216),0.5675775753502541,1.3921171759625695,0.07032181168057211,0.8513405289642343,1.0,6/29,8.92%,LORICRIN;ANXA1;SCEL;ADAM9;KRT10;JAG1
prerank,regulation of lymphocyte proliferation (GO:0050670),0.6325433363863486,1.3920367462028882,0.0984251968503937,0.8485583888176323,1.0,1/16,0.18%,TNFSF9
prerank,natural killer cell activation (GO:0030101),0.5944213511397307,1.3918553847596127,0.09068923821039904,0.8464588114589557,1.0,3/23,2.92%,AXL;ELF4;PBX1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.6148555309372038,1.3906165095606788,0.08656330749354005,0.8504813726129282,1.0,7/18,14.97%,NXF1;DDX19B;NUP93;MCM3AP;POLDIP3;THOC2;ZC3H11A
prerank,adipose tissue development (GO:0060612),-0.5428766246008296,-1.3903225189767054,0.12237762237762238,0.5629533015781434,1.0,6/11,17.21%,ARID5B;NAMPT;SH3PXD2B;SPTLC2;DYRK1B;PGRMC2
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.6609819509999536,1.3902901365375882,0.09090909090909091,0.8491904426294006,1.0,6/13,21.13%,SYK;CD177;STX4;IL4;ITGAM;GAB2
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.5362285276546834,-1.3900444645454768,0.12962962962962962,0.558944739951755,1.0,2/11,1.20%,NEDD4L;ACTN2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.6835201255721209,1.38988277497562,0.08835904628330996,0.848346336346703,1.0,4/11,6.33%,TRIAP1;CD44;MIF;MUC1
prerank,circulatory system development (GO:0072359),0.494902295635957,1.3898444448596423,0.019427402862985686,0.8453865088337866,1.0,32/118,13.16%,COL3A1;FBN1;WT1;AKAP13;PCSK5;PLCE1;ZDHHC16;HEG1;TGFB2;TNNI3;TGFBR2;BORCS8;HDAC9;CRIP1;PKD1;ACVR1;TCF25;PDLIM7;GLI2;ZFPM2;FOXL1;PKD2;PIK3CA;FOXC2;ECE1;KAT2B;EEF1AKMT4-ECE2;MICAL2;PDLIM1;FLRT3;HSPG2;CDKN1A
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.6274722197556065,1.389397564297971,0.09825033647375504,0.8450332578438384,1.0,6/15,14.01%,SFRP4;NCOA3;CYP27B1;VDR;SFN;NME2
prerank,neutrophil chemotaxis (GO:0030593),0.5257765087360524,1.3891569058729059,0.05664488017429194,0.8433063627678061,1.0,7/53,9.02%,SYK;CCL8;TGFB2;S100A8;S100A9;CXCL10;CCL25
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.606496111633151,1.3884304605644955,0.10526315789473684,0.8447688031752764,1.0,4/19,4.22%,DCN;CCBE1;SMOC2;ADAMTS3
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.5466171775711184,-1.3875047363252662,0.14381270903010032,0.5611329797391781,1.0,6/11,10.54%,LYN;RAPGEF2;MEF2C;PIK3CB;PIK3CD;SIRT1
prerank,regulation of glucose import (GO:0046324),-0.41428745793648497,-1.3870020666815355,0.062111801242236024,0.5579632683414304,1.0,7/30,3.34%,PRKAG2;SORBS1;OCLN;INSR;IGF1;ENPP1;OSBPL8
prerank,receptor signaling pathway via STAT (GO:0097696),0.5743161684531067,1.3869211255403333,0.0851581508515815,0.8500013581212087,1.0,10/25,19.87%,GHR;PKD1;CLCF1;SOCS2;PKD2;STAT5A;SOCS6;STAT5B;THPO;IL31RA
prerank,central nervous system neuron axonogenesis (GO:0021955),0.6530690578018936,1.3864820542708884,0.09876543209876543,0.8494710613466857,1.0,6/12,22.26%,EPHB2;MYCBP2;HSP90AA1;EPHB1;PTEN;SPTBN4
prerank,positive regulation of multicellular organismal process (GO:0051240),0.47652743449204377,1.385508475874826,0.0,0.8517102966244318,1.0,59/308,14.01%,EBF2;IL4R;GHR;SYK;LBP;AVPR1A;UCP1;COL1A1;LOXL2;GNAS;IRF4;BMP1;LRP1;TGFB3;TLE6;TMEM119;GLMN;GADD45G;SIX4;GRB10;VEGFA;FGF2;TGFB2;F2R;TGFBR2;MIF;SMAD4;WWTR1;SMURF2;ACVR1;MTOR;PRKAB2;IL33;NCOA3;C1QBP;ABCA1;SCAMP5;ADCYAP1;GAS6;HMCES;SOX8;CYP27B1;VDR;AGO2;SOX5;ALMS1;INPP5K;TSKU;HDAC3;CEBPB;FBXO5;TSHR;HCRT;EGF;GDNF;CNOT3;TWIST1;SIX1;NME2
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6044966780030602,1.385504882430401,0.0897597977243995,0.848614654962056,1.0,7/20,13.39%,EGFR;PKD1;PSRC1;MAPRE3;PKD2;AKT1;CCND1
prerank,regulation of cardiac muscle contraction (GO:0055117),0.5526908727397237,1.3843343568994244,0.07450523864959255,0.8525950942693347,1.0,11/34,15.37%,ANK2;TNNI3;SRI;TNNI3K;HCN4;PDE4D;SLC9A1;CALM2;ATP2A2;ZC3H12A;STC1
prerank,positive regulation of translational initiation (GO:0045948),0.6102357729766915,1.3838296245294532,0.09762202753441802,0.852544322485983,1.0,9/18,22.31%,DAZL;MTOR;LARP1;POLR2D;POLR2G;CDC123;YTHDF1;YTHDF2;YTHDF3
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.6316043716678887,1.3836299774300007,0.09007832898172324,0.8506288074434677,1.0,4/15,5.33%,PIEZO2;HPN;COL11A1;PDZD7
prerank,pyroptosis (GO:0070269),-0.4798437989566485,-1.3836221314991013,0.11440677966101695,0.5624152660090628,1.0,7/15,30.72%,CASP4;AIM2;GSDMD;ZBP1;CASP1;TREM2;NLRC4
prerank,regulation of T cell proliferation (GO:0042129),0.5161714297395323,1.3834922697298546,0.0563230605738576,0.8482950790938857,1.0,11/61,18.08%,TNFSF9;CD80;ANXA1;GLMN;CEBPB;GPNMB;TNFRSF1B;IL4;IL6;NCK1;VTCN1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.6912194632503394,1.3830974653638834,0.10014513788098693,0.8475043210947552,1.0,3/10,11.33%,LBP;TIRAP;WDFY1
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.5731279648742269,1.382847255876494,0.08273381294964029,0.8458264046275284,1.0,10/25,12.37%,AR;EGFR;GLMN;ANG;MIF;SRC;FZD7;PSEN1;DSCAM;EGF
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.6291191687260308,1.382398886744391,0.1134020618556701,0.8454845614893,1.0,12/15,31.45%,SYVN1;HERPUD1;SELENOS;AUP1;DERL1;SEL1L;SEC61B;HSP90B1;UFD1;NPLOC4;TMEM129;DERL2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.5900820485843594,1.3820389851167851,0.09068923821039904,0.8446672974109063,1.0,5/24,6.33%,ACKR3;TRIAP1;CD44;MIF;MUC1
prerank,positive regulation of macrophage differentiation (GO:0045651),0.6580140281122459,1.3813579328494314,0.12175102599179206,0.8457501472005193,1.0,2/11,1.26%,LIF;PRKCA
prerank,regulation of cholesterol esterification (GO:0010872),-0.5594457159248684,-1.3812305289314009,0.15087719298245614,0.5645964415512648,1.0,3/10,6.36%,APOE;ABCG1;AGTR1
prerank,heart development (GO:0007507),0.48638902600046047,1.381068397178835,0.011133603238866396,0.8444667021624406,1.0,37/150,13.16%,COL3A1;FBN1;WT1;AKAP13;FLRT2;PCSK5;PLCE1;GPC3;ZDHHC16;HEG1;VEGFA;TGFB2;TNNI3;TGFBR2;BORCS8;HDAC9;CRIP1;MEF2D;PKD1;ACVR1;TCF25;PDLIM7;GLI2;ZFPM2;FOXL1;PKD2;NDRG4;FOXC2;ECE1;KAT2B;EEF1AKMT4-ECE2;ALPK2;MICAL2;PDLIM1;FLRT3;SGCZ;CDKN1A
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.605709092895172,1.3808166033848357,0.10219922380336352,0.8399331502055499,1.0,6/17,16.38%,IRS1;SOCS2;STAT5A;IRS2;SMARCA4;STAT5B
prerank,cellular response to interleukin-7 (GO:0098761),0.605709092895172,1.3808166033848357,0.10219922380336352,0.8399331502055499,1.0,6/17,16.38%,IRS1;SOCS2;STAT5A;IRS2;SMARCA4;STAT5B
prerank,regulation of integrin activation (GO:0033623),0.6171707313965059,1.3807822003070567,0.11140583554376658,0.8371969417474272,1.0,4/15,6.81%,RAP1B;JAM3;FARP2;SRC
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.45825343112595535,-1.3799894213762816,0.09210526315789473,0.5631017722829,1.0,3/18,4.62%,PTN;LYN;IL6R
prerank,telomere maintenance via recombination (GO:0000722),0.6755418283324841,1.378741033746248,0.10274963820549927,0.8461181750914138,1.0,9/11,26.41%,XRCC3;SMC5;ERCC4;SMC6;RAD50;TEP1;ERCC1;NSMCE2;RAD51D
prerank,regulation of T cell activation (GO:0050863),0.5381200842888821,1.3785519086824511,0.06375838926174497,0.8442071708885364,1.0,9/42,20.96%,TNFSF9;LAX1;CD47;SIRPA;GPNMB;TNFRSF1B;VTCN1;PRELID1;PYCARD
prerank,regulation of platelet aggregation (GO:0090330),0.620371632539949,1.3782461453381467,0.10128205128205128,0.8430635525615915,1.0,4/17,1.27%,SYK;C1QTNF1;PRKCA;CD9
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.5320381612370348,-1.3780681714354888,0.11186440677966102,0.563858439134372,1.0,6/11,31.90%,AHR;CEACAM1;HFE;PTPRC;LILRB1;IL4I1
prerank,plasma membrane repair (GO:0001778),0.6447906267952235,1.3776638067991571,0.11404728789986092,0.8436086713834625,1.0,2/13,4.28%,AHNAK2;SYT11
prerank,lipid translocation (GO:0034204),0.5846094055258386,1.3776109382787283,0.11138613861386139,0.8410206392021347,1.0,7/21,12.70%,ATP8B1;ATP9A;ABCA1;ATP11A;ATP9B;TMEM30A;ABCC1
prerank,positive regulation of collagen metabolic process (GO:0010714),0.6174222053485945,1.3773242564729113,0.09218950064020487,0.8397664859227313,1.0,4/17,5.66%,TGFB3;F2R;RUNX1;CREB3L1
prerank,camera-type eye morphogenesis (GO:0048593),0.6805760282790899,1.3772061441094203,0.13121546961325967,0.8375712690921475,1.0,4/10,5.31%,LRP6;VEGFA;SKI;TENM3
prerank,muscle tissue development (GO:0060537),-0.5088777619220286,-1.376956164684002,0.10820895522388059,0.5620387017515143,1.0,4/13,8.06%,PGM5;ENG;PTCH1;STRA6
prerank,"base-excision repair, AP site formation (GO:0006285)",0.6056549426372541,1.3765881573730467,0.10539845758354756,0.8384222039954506,1.0,7/17,22.09%,MPG;ACD;TERF1;ERCC5;TINF2;OGG1;TERF2IP
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.6775815765387785,1.3763931159882374,0.11379800853485064,0.8366719193998968,1.0,6/10,20.09%,PDE8A;NFE2L2;GPR37L1;GPR37;PYCR1;STK26
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.4923139268892544,-1.376325508169326,0.1070110701107011,0.5594987963644867,1.0,6/14,12.02%,KMT5B;SHLD1;KMT5C;NECTIN2;TFRC;RIF1
prerank,regulation of chondrocyte differentiation (GO:0032330),0.5793468461574323,1.3761835444911341,0.09310761789600967,0.8350846893321349,1.0,9/24,18.39%,LOXL2;TRPS1;SCIN;WNT9A;CHADL;SOX5;SNAI2;EFEMP1;TGFBR1
prerank,integrated stress response signaling (GO:0140467),0.6462792210218749,1.3760154029214076,0.10013003901170352,0.8331904509700871,1.0,5/14,13.67%,EIF2AK3;NFE2L2;HERPUD1;QRICH1;EIF2S1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.5636783165483293,1.3759793938614442,0.07710843373493977,0.8306103510501923,1.0,9/29,16.38%,GHR;PKD1;CLCF1;SOCS2;PKD2;STAT5A;FER;SOCS6;STAT5B
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.6248483860049677,1.375708379400037,0.09778357235984354,0.8293652801920268,1.0,4/16,5.66%,TGFB3;F2R;RUNX1;CREB3L1
prerank,negative regulation of neurogenesis (GO:0050768),-0.40046259648151805,-1.3752054735571866,0.07377049180327869,0.5583592060763984,1.0,7/34,10.51%,PTN;RAPGEF2;YWHAH;NOTCH1;B2M;APPL2;SORL1
prerank,response to peptide hormone (GO:0043434),0.5230208186816022,1.3750718599103915,0.06923950056753689,0.8302395551798235,1.0,12/43,16.38%,IGFBP5;ANXA1;IRS1;ZFP36L1;MEAK7;SRC;STAT5A;EPM2AIP1;AKT1;EIF6;OGT;STAT5B
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.632204707460361,1.3749757281757586,0.11875843454790823,0.8279536462973127,1.0,4/15,6.67%,SFRP4;GPC3;DACT1;DAAM2
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.6101584833898616,1.372668463568538,0.10911424903722722,0.8382809776053409,1.0,6/17,17.74%,CD55;JAG1;TLR4;BACH2;BTN3A3;IL18
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.5033581101983892,1.3726488492919988,0.04772234273318872,0.8356143703919382,1.0,16/72,15.09%,FGF18;FGF7;POLR2H;FGFR1;FLRT2;HNRNPA1;FGF2;TRIM71;HNRNPH1;RBFOX2;FLRT3;SHOC2;POLR2D;POLR2G;CBL;GTF2F1
prerank,positive regulation of cell killing (GO:0031343),0.6321012353713586,1.3716165800315425,0.1194225721784777,0.8389076201894514,1.0,2/13,8.19%,SYK;FZD7
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.4914985105777467,1.370785526603361,0.042283298097251586,0.8407407861821682,1.0,20/87,15.09%,FGF18;FGF7;POLR2H;FGFR1;FLRT2;HNRNPA1;CD44;FGF2;ZFP36L1;TRIM71;ZFP36L2;HNRNPH1;RBFOX2;FLRT3;SHOC2;ZFP36;POLR2D;POLR2G;CBL;GTF2F1
prerank,peroxisomal membrane transport (GO:0015919),0.5770748932329621,1.3707288061704315,0.09136420525657071,0.8382799003568526,1.0,13/27,21.43%,PXMP2;PEX16;GDAP1;ALDH3A2;PXMP4;PEX12;PEX1;SLC25A17;PEX3;PEX5;ATAD1;ABCD3;PEX2
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.6193469038684815,1.370567620089379,0.12005277044854881,0.8365100000041169,1.0,5/15,13.71%,SIX4;VEGFA;SOX8;GDNF;SIX1
prerank,regulation of cellular pH (GO:0030641),0.5703357087983755,1.3703625623345808,0.10035419126328217,0.8349000667317032,1.0,12/29,15.88%,SLC4A10;SLC4A8;ATP1A4;SLC4A3;SLC9A9;SLC4A4;SLC26A6;SLC9A1;ATP6AP1;CHP1;SLC9A7;SLC9A6
prerank,response to UV-A (GO:0070141),0.6318189656463253,1.3695824693169782,0.11627906976744186,0.8365870739657082,1.0,4/14,13.39%,EGFR;MMP2;AKT1;CCND1
prerank,skeletal muscle organ development (GO:0060538),0.5604115901203711,1.369517789765735,0.09720534629404617,0.8342248290953977,1.0,7/26,13.71%,WT1;DISP1;SIX4;SVIL;MYH14;LARGE1;SIX1
prerank,peptidyl-amino acid modification (GO:0018193),0.6802282002508435,1.3694472659827461,0.1111111111111111,0.8319372501677038,1.0,5/10,21.79%,FKBP10;METAP2;METAP1;FKBP7;METAP1D
prerank,calcium-ion regulated exocytosis (GO:0017156),0.5616337438282522,1.3679884609032888,0.09963985594237695,0.8372994071681747,1.0,10/27,21.36%,SCIN;SYT2;SYT12;SYT11;SYT13;SYT1;VAMP2;RIMS2;PPP3CB;ARHGAP17
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.5609908340237729,1.367639779845976,0.09307875894988067,0.8366885356367365,1.0,4/29,3.66%,DBN1;EPHB2;SLC4A10;DLG4
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.45012940197290924,-1.3670944929966813,0.09216589861751152,0.5769378161657082,1.0,7/19,14.84%,TJP1;BMP6;NOTCH1;RGCC;NOTCH4;PPM1F;AFDN
prerank,response to ketone (GO:1901654),0.5700829676036475,1.3667134264617216,0.10272277227722772,0.8391606696331069,1.0,5/24,3.64%,TGFB3;TGFB2;SLIT3;SLIT2;CATSPERB
prerank,negative regulation of calcium ion transport (GO:0051926),-0.4829839106509054,-1.366689592440254,0.08960573476702509,0.5733900259153905,1.0,4/15,11.92%,ATP1A2;SLC30A1;ADRA2A;NOS1
prerank,membrane repolarization (GO:0086009),-0.4903481544636389,-1.3660550261961808,0.09523809523809523,0.5705174026643847,1.0,3/15,2.68%,ATP1A2;ATP1B3;KCND3
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.5577282955906719,1.3659535157892944,0.09345794392523364,0.8408234870225746,1.0,12/29,17.05%,COPA;RAB6A;RAB6B;COPB1;COPB2;NAPA;GOSR1;COG6;RAB33B;NSF;COPZ2;NAPG
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.3840104513637975,-1.3652964201873041,0.058394160583941604,0.5680789152264453,1.0,13/35,25.10%,CDH5;ATP2C1;CDH6;CDH7;CDH13;PCDHB14;PCDHGC3;CDH11;CDH19;DCHS1;CDH24;PCDHGB4;CDH20
prerank,cellular glucan metabolic process (GO:0006073),-0.5263146119462603,-1.3650362322589282,0.12542372881355932,0.564384849132867,1.0,4/11,5.32%,PRKAG2;PHKB;PYGM;GBE1
prerank,axonal transport (GO:0098930),0.5481128421734281,1.364513271779651,0.07208237986270023,0.8459446759030134,1.0,15/36,22.51%,DCTN1;DST;DTNBP1;NEFL;AP3D1;SYBU;MAPT;KIF3A;KIF3B;BLOC1S2;DYNC1H1;SNAPIN;PAFAH1B1;AP3B2;FBXW11
prerank,regulation of muscle contraction (GO:0006937),-0.40660614029434095,-1.3640901019193368,0.08426966292134831,0.5628835916883951,1.0,7/26,10.28%,ATP1A2;TPM1;KCNB2;CAV1;ENO1;MYL9;KCNA1
prerank,secretory granule organization (GO:0033363),0.6788369432151113,1.3636481957029338,0.10407876230661041,0.8482781368527439,1.0,6/10,21.09%,F2R;DTNBP1;ABCA1;BLOC1S2;VPS33B;LYST
prerank,aminoglycan metabolic process (GO:0006022),0.6716121416549341,1.3635086000850813,0.11691884456671252,0.8463974167866853,1.0,5/10,21.54%,GAL3ST3;B3GAT3;XYLT1;XYLT2;B3GAT2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.5665309980495643,1.3633828160132708,0.11529126213592233,0.8445163292185793,1.0,13/26,26.46%,CUL3;HECW2;CDC23;ANAPC5;FBXO5;CDC27;CDK5RAP2;ANAPC4;CENPE;RIOK2;ANAPC15;NSMCE2;DUSP1
prerank,regulation of interleukin-6 production (GO:0032675),0.4973201031895882,1.3626576224635005,0.03402061855670103,0.8458688253736751,1.0,20/96,16.30%,SYK;LBP;IL16;RAB7B;IRAK3;F2R;TMEM106A;SYT11;IL33;IL17RA;GAS6;TIRAP;TLR4;CD47;SIRPA;TWIST1;CD200R1;ZC3H12A;SELENOS;IL6
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.6422933069892118,1.362544198156288,0.11838440111420613,0.8438890391744877,1.0,3/11,8.92%,TGFB2;ZFPM2;JAG1
prerank,positive regulation of protein maturation (GO:1903319),0.6760509183663989,1.3623550006367944,0.10591471801925723,0.8423233129120355,1.0,1/11,0.71%,CCBE1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.5499891149460794,1.3622848718987415,0.09382151029748284,0.8400837903741938,1.0,11/33,14.32%,CDK2AP2;FHL1;CDK4;DACT1;PRMT2;PKD2;BRD7;GPNMB;CDKN1A;NACC2;KLF4
prerank,regulation of receptor internalization (GO:0002090),0.5350221074994199,1.3615063441501105,0.08872901678657075,0.8419315566352631,1.0,15/35,24.50%,SFRP4;VEGFA;DLG4;ATXN2;ARF1;MAGI2;EGF;AHI1;ATAD1;MKLN1;ARRB1;SDCBP;FLOT1;PICK1;RSPO1
prerank,positive regulation of natural killer cell activation (GO:0032816),0.6424666391108732,1.3595800941663532,0.12698412698412698,0.8500342535908294,1.0,3/13,8.30%,AXL;GAS6;ZBTB1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.5675963455506329,1.3595758967508336,0.099626400996264,0.8474485967011905,1.0,11/27,17.31%,ANK2;FGF13;SRI;DSC2;CAMK2D;HCN4;PDE4D;JUP;ATP2A2;STC1;AKAP9
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.5026775662384521,1.359554996415372,0.05672268907563025,0.8449769500461872,1.0,10/69,9.07%,SYK;LBP;EPHB2;MIF;TMEM106A;PTPRJ;IL33;PSEN1;TIRAP;TLR4
prerank,integrin-mediated signaling pathway (GO:0007229),0.4974997874038922,1.3594206288021768,0.04501607717041801,0.8431934903835699,1.0,19/73,14.01%,COL3A1;SYK;ITGA11;PRAM1;ITGBL1;ITGB3;ADAM9;PLPP3;ITGA2;ITGA5;ITGB5;DST;SRC;CUL3;ITGAV;CD47;FYB2;ADAM15;NME2
prerank,negative regulation of interleukin-6 production (GO:0032715),0.5630886909886064,1.3593461286227326,0.10369487485101311,0.8410247980245683,1.0,8/27,15.83%,IRAK3;SYT11;GAS6;TLR4;SIRPA;CD200R1;ZC3H12A;SELENOS
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.6246496556855357,1.3592091293370385,0.11345646437994723,0.8392848219682355,1.0,3/15,2.91%,FGFR1;SCEL;TGFB2
prerank,regulation of dendrite development (GO:0050773),-0.3699609385164193,-1.3588161413025106,0.07317073170731707,0.5725824214560331,1.0,8/37,3.60%,PTN;NEDD4L;BMP5;MARK1;TNIK;BMP7;CDKL5;DAB2IP
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.656092613445902,1.3588030684398589,0.10758620689655173,0.8389363031290126,1.0,4/12,6.33%,TRIAP1;CD44;MIF;MUC1
prerank,regulation of Rho protein signal transduction (GO:0035023),0.5027707686842193,1.3586825669613494,0.05425531914893617,0.8369524483516242,1.0,16/72,10.38%,COL3A1;MYOC;ARHGEF28;AKAP13;HEG1;F2R;LPAR1;RIT2;ABCA1;ARHGEF3;ABL2;MYO9B;FLCN;CUL3;GPR20;KANK1
prerank,embryonic organ morphogenesis (GO:0048562),0.5280404155950538,1.3572812402728094,0.08314606741573034,0.8423604230565621,1.0,13/42,18.94%,MFAP5;FBN1;HOXA3;ACVR1;HOXA4;ALDH1A3;SIX1;PDGFRA;HOXC4;HOXA9;EFEMP1;DYNC2I1;NIPBL
prerank,endodermal cell differentiation (GO:0035987),0.547345486720271,1.3570798985990362,0.09920182440136831,0.8408877378516814,1.0,9/31,11.81%,COL8A1;COL11A1;MMP2;ITGA5;ITGB5;COL12A1;COL6A1;ITGAV;SETD2
prerank,positive regulation of phospholipase C activity (GO:0010863),0.5285794457783685,1.3564889274043002,0.0920314253647587,0.8416358988208177,1.0,7/40,3.92%,AVPR1A;ESR1;EGFR;FGFR1;ANG;FGF2;LPAR1
prerank,positive regulation of behavior (GO:0048520),-0.5424277625918743,-1.3560760478576583,0.13333333333333333,0.5759294348110148,1.0,5/10,21.73%,MEF2C;STRA6;SGIP1;CFAP20;NR4A3
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.6679180895329004,1.3555145850361925,0.12554112554112554,0.8443621599196431,1.0,4/10,12.42%,GAP43;F2R;PLPP1;PRKD3
prerank,positive regulation of heart rate (GO:0010460),-0.47397718915884307,-1.3547464469142827,0.14222222222222222,0.575213129756123,1.0,7/17,15.59%,TPM1;ADRA1B;KCNQ1;RYR2;EDN1;ADM;EDN3
prerank,regulation of axonogenesis (GO:0050770),-0.34771139666070805,-1.3544476757847914,0.06578947368421052,0.5718835062334295,1.0,8/51,5.19%,PLXNA2;ROBO1;EPHA4;PLXNA4;CHN1;PLXND1;SIPA1L1;ROBO2
prerank,hematopoietic stem cell proliferation (GO:0071425),0.6683355641328699,1.354399373017136,0.12985274431057564,0.8479292295964737,1.0,3/11,3.49%,CD34;WNT10B;RUNX1
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.6003518448441493,1.354032942203976,0.11183355006501951,0.8473752886660587,1.0,8/18,18.62%,RAB23;FLCN;MDFIC;OTUD7B;CABP1;CHP1;ILRUN;UFM1
prerank,negative regulation of cation channel activity (GO:2001258),0.5553004744577389,1.3539983866772458,0.0984759671746776,0.8450547181936091,1.0,6/26,12.62%,EPHB2;SRI;PKD2;CRHR1;GSTM2;CALM2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.6529710313242025,1.353896194355768,0.11559139784946236,0.8431739944213703,1.0,6/12,13.76%,GPAA1;KDELR3;KDELR1;INSIG2;RER1;KDELR2
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.5221258428115527,1.3536952145366927,0.09578107183580388,0.8416836092221845,1.0,9/39,7.85%,LRP6;WT1;VEGFA;FGF2;SLIT2;TGFBR2;PKD1;GLI2;PKD2
prerank,N-glycan processing (GO:0006491),-0.4420036245851193,-1.3532894353230862,0.11061946902654868,0.5709675648071663,1.0,8/18,21.59%,FUT8;ST8SIA4;MAN2A1;MGAT4A;ST8SIA2;ST8SIA6;MAN2A2;MAN1A2
prerank,acylglycerol catabolic process (GO:0046464),0.5538405228781969,1.3529355553816362,0.11019929660023446,0.8434547378775796,1.0,6/30,18.64%,MGLL;FABP12;DAGLA;FABP5;LIPC;LIPH
prerank,odontogenesis (GO:0042476),0.5267322625456118,1.3528985613295916,0.10404624277456648,0.8411982873486699,1.0,5/35,7.49%,COL1A2;LRP6;TGFB3;TGFB2;GLI2
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.668154317791593,1.35281421735397,0.12517385257301808,0.8392291890538766,1.0,1/10,0.19%,DCN
prerank,renal system development (GO:0072001),0.5130761405413728,1.3527251360185466,0.0918141592920354,0.8372912687582411,1.0,10/52,7.49%,HAS2;WT1;PCSK5;SULF2;VEGFA;TGFB2;C1GALT1;PKD1;SULF1;GLI2
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.430166203937971,-1.3523726667670224,0.0880503144654088,0.5693035743986568,1.0,11/25,19.65%,EPHA4;RPS7;PSMF1;OPHN1;PDCL3;PSME3IP1;RPL5;HIPK2;HFE;CSNK2A1;TAF1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.6384748915906774,1.3523404708612954,0.13877551020408163,0.8370142679243024,1.0,4/12,16.56%,GCLC;HAGH;CNDP2;BDH2
prerank,regulation of wound healing (GO:0061041),0.527038179560266,1.351864139280854,0.08577878103837472,0.8371536003725853,1.0,6/42,3.19%,EPHB2;DUOX1;ANXA1;SRSF6;FGF2;F2R
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.6357591903343496,1.3501282424197318,0.14037433155080214,0.8441769607678266,1.0,5/12,13.71%,SIX4;VEGFA;SOX8;GDNF;SIX1
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.465218481911316,-1.3500783404816674,0.10416666666666667,0.5714093606640723,1.0,5/15,9.08%,GGACT;GGT5;PRODH;ALDH4A1;SARDH
prerank,negative regulation of peptidase activity (GO:0010466),0.5195181796319438,1.3499786071771327,0.08472686733556299,0.8425563591358526,1.0,10/47,12.89%,TIMP2;LRP1;SERPINB8;ECM1;SERPINE3;SERPINF1;CSTB;SERPINH1;AKT1;SERPING1
prerank,aminoglycan biosynthetic process (GO:0006023),0.5190967976198682,1.3497653171967237,0.0861878453038674,0.8413839932680703,1.0,13/49,12.32%,HAS1;GPC6;UGDH;GPC3;B3GALNT1;EXT1;B3GAT3;XYLT1;HS2ST1;B3GNT8;HS3ST6;HS3ST5;HSPG2
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.476151703019734,1.349371384259255,0.016145307769929364,0.8410937156534695,1.0,23/150,8.49%,AREG;MYOC;CD80;ESR1;FGF18;AXL;FGF7;EGFR;IRS1;FGFR1;BTC;FYN;FGF2;MST1R;PIK3R2;TCF7L2;PTPRJ;C1QBP;RET;SRC;GAS6;FLT3LG;PIK3CA
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.492210670831594,1.3488914192003083,0.06863780359028511,0.8413078353846457,1.0,22/79,17.19%,DCTN1;SEC24D;DYNC1LI2;ACTR1B;KLC1;SEC31A;AP1M1;SEC24A;AP2A2;CLTC;SEC23A;DYNC1LI1;DYNC1I1;KIF2A;ARF1;AP1S2;KIF3A;KIF3B;DYNC1H1;MFSD6;SEC24B;CTSD
prerank,ion homeostasis (GO:0050801),0.5536994107105552,1.3487333591301987,0.0995260663507109,0.8397551177827804,1.0,9/30,12.92%,SLC4A10;FHL1;SLC4A8;SLC4A3;CAMK2D;AP3D1;HCN4;SLC4A4;SLC12A5
prerank,carbohydrate transport (GO:0008643),0.6584526647116175,1.3486956487137214,0.11862068965517242,0.8375767154110009,1.0,4/11,13.02%,SLC50A1;SLC26A6;SLC23A1;SLC23A2
prerank,regulation of cartilage development (GO:0061035),0.5922865770025798,1.348595122156558,0.13222079589216945,0.835826935707322,1.0,3/18,1.35%,TRPS1;SCIN;BMP1
prerank,cellular response to fluid shear stress (GO:0071498),0.6429935883958053,1.3484236887092265,0.13186813186813187,0.8343929084581184,1.0,7/12,14.32%,HAS2;MAPK7;NFE2L2;KLF2;PKD2;HDAC3;KLF4
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.5427704530816492,1.3482459075878306,0.11834319526627218,0.8330649845980941,1.0,6/31,7.33%,SYT2;STX1A;SYT12;SYT11;SYT13;SCAMP5
prerank,sulfur compound biosynthetic process (GO:0044272),0.48611382165127587,1.3473273038940077,0.0368474923234391,0.8355087380535355,1.0,28/104,18.15%,DCN;GCLC;ST3GAL2;UGDH;B4GALT3;PAPSS2;B4GALT1;OGN;CHST1;CSGALNACT2;ACAN;VCAN;CHST12;CHST14;CHSY3;HAGH;CNDP2;GSTM2;ST3GAL4;MAT2A;MAT2B;GLCE;GGT7;SLC26A1;MPST;GSTO2;ST3GAL1;ST3GAL3
prerank,eye development (GO:0001654),0.5081199033148329,1.3463807435706752,0.07574094401756312,0.8382340454913318,1.0,9/54,5.70%,COL5A2;FBN1;COL5A1;WT1;ZDHHC16;TGFB2;PBX1;SKI;MEIS2
prerank,cardiac ventricle development (GO:0003231),-0.44520639752632846,-1.3460958531655272,0.07281553398058252,0.578375280233823,1.0,7/20,9.63%,ENG;NOTCH1;SALL1;HEYL;STRA6;HECTD1;PDE2A
prerank,regulation of RNA metabolic process (GO:0051252),0.5037711519084626,1.3454530634056856,0.07234042553191489,0.8407848247252878,1.0,19/59,21.97%,AHNAK2;AHNAK;AFF2;MBNL1;USP36;CLK1;RC3H1;MBNL2;SON;HNRNPH1;MITF;IGF2BP1;TNFRSF1B;YTHDF2;NOVA1;PTBP1;RASA1;RC3H2;PTBP2
prerank,signal peptide processing (GO:0006465),0.64867503704406,1.3449159178359176,0.13314840499306518,0.8414603848411134,1.0,3/11,9.03%,PCSK5;SPCS1;SEC11C
prerank,regulation of lipase activity (GO:0060191),0.6294538895289011,1.3448862004917117,0.12256267409470752,0.839298675509383,1.0,5/13,18.77%,PCSK6;PCSK5;RHOA;LIPC;ANGPTL3
prerank,activation of phospholipase C activity (GO:0007202),0.5453246359505755,1.3445612239092555,0.11538461538461539,0.8387934395378587,1.0,4/29,3.92%,AVPR1A;EGFR;ANG;LPAR1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.5950257128866936,1.343896965705562,0.11764705882352941,0.8401046026810788,1.0,4/18,12.63%,ANXA1;ZFP36L1;ZFP36L2;ZFP36
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.5959581143066437,1.3433218888757965,0.12531328320802004,0.840867836305653,1.0,13/17,31.45%,SYVN1;HERPUD1;SELENOS;AUP1;DERL1;SEL1L;SEC61B;HSP90B1;UFD1;NPLOC4;HM13;TMEM129;DERL2
prerank,wound healing (GO:0042060),0.5009771450550152,1.3427892209881356,0.06324972737186478,0.841358594071935,1.0,13/62,10.18%,COL3A1;AHNAK2;DCBLD2;ITGB3;FGF2;TGFB2;SYT11;DST;MIA3;PPL;PRCP;FZD7;TSKU
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.5523788496310199,1.3426224036385777,0.10035005834305717,0.839891622514324,1.0,10/31,14.32%,CDK2AP2;FHL1;CDK4;DACT1;PRMT2;PKD2;BRD7;GPNMB;CDKN1A;KLF4
prerank,protein auto-ADP-ribosylation (GO:0070213),0.6371721049958895,1.342078525123772,0.13717421124828533,0.8404906836390182,1.0,3/12,7.35%,PARP3;PARP11;PARP6
prerank,female gamete generation (GO:0007292),-0.3954516408060206,-1.3419989187522343,0.09395973154362416,0.5856524137834777,1.0,4/29,3.90%,PTN;MCM9;DIAPH2;TOB2
prerank,response to organophosphorus (GO:0046683),0.5985024273800745,1.3417866304917865,0.13071895424836602,0.839777033851158,1.0,2/16,2.74%,DUOX1;DGKQ
prerank,membrane assembly (GO:0071709),0.532513947892098,1.3413068623101019,0.1173054587688734,0.840002670009873,1.0,8/34,9.18%,CEL;STX2;ANXA2;S100A10;RFTN1;CHMP7;TLCD2;STX4
prerank,long-chain fatty acid transport (GO:0015909),-0.3895143191815097,-1.3412428169590929,0.06716417910447761,0.5836541758812647,1.0,7/30,11.32%,PRKAG2;ACSL1;APOE;PRKAA2;ACSL3;SLC25A20;ACACB
prerank,protein polymerization (GO:0051258),0.5069068260732505,1.3410522242323284,0.08807733619763695,0.839037390009891,1.0,17/55,17.82%,GSN;PSTPIP1;ANG;DIAPH3;FGF13;COBL;MSRB1;WASF1;MAPT;TPPP3;PIN1;CASQ1;DIAPH1;WASHC3;CORO7;MAP7D3;CKAP5
prerank,amino acid import across plasma membrane (GO:0089718),-0.42551758764509445,-1.3409636892647707,0.0851063829787234,0.5804507847534347,1.0,8/24,6.69%,SLC7A2;SLC6A13;SLC1A3;SLC16A2;SLC7A5;SLC22A4;SLC6A9;SLC3A2
prerank,pentose-phosphate shunt (GO:0006098),-0.5191372412146703,-1.3407809473572638,0.1353135313531353,0.57690672876125,1.0,7/11,29.43%,DERA;PGLS;TALDO1;RBKS;RPE;RPIA;H6PD
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.4401781514081756,-1.3405984257184336,0.1099476439790576,0.5735511923902455,1.0,3/21,3.34%,OSBPL10;PLA1A;OSBPL8
prerank,negative regulation of defense response to virus (GO:0050687),0.6569264746269993,1.3405952952933928,0.13100436681222707,0.839216762005531,1.0,5/10,20.73%,TARBP2;ITCH;C1QBP;ILRUN;TSPAN6
prerank,protein targeting to membrane (GO:0006612),0.48902430975759315,1.3402588729324212,0.06197478991596639,0.8387383597852113,1.0,48/83,33.06%,PXMP2;PEX16;GDAP1;ZDHHC7;ALDH3A2;VPS37D;SRP19;PXMP4;TAOK2;ZDHHC2;VPS37C;SGTA;PEX12;TRAM1;SEC63;SLC25A17;SEC61A1;ZDHHC4;PEX3;ZDHHC24;VPS37B;ZDHHC21;ZDHHC20;NACA;PEX5;ATAD1;ABCD3;ZDHHC18;ICMT;PEX2;ATG3;SDCBP;FIS1;MICALL1;SSR1;RAB8B;PRKCI;ZDHHC15;PARD3;MYO1C;GOLGA7B;PIKFYVE;CHMP4A;CHMP4B;ARL6;CHM;PEX19;ZDHHC3
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.5150671533747564,1.3401244207802236,0.09060402684563758,0.8372253618612993,1.0,12/49,17.74%,GHR;LIF;CTF1;VEGFA;CLCF1;TNFRSF18;PARP14;PIBF1;FLT3;IL4;IL6;IL18
prerank,positive regulation of signaling receptor activity (GO:2000273),0.5352608228907558,1.3394717563026397,0.12240184757505773,0.8385073390045,1.0,5/36,7.10%,AREG;EPHB2;BTC;NCOA3;HDAC6
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.4525244004116845,-1.3392172680329757,0.0958904109589041,0.5731441925931032,1.0,4/18,7.78%,EPHA4;SP1;ABCG1;CASP3
prerank,cytoplasmic microtubule organization (GO:0031122),0.5043520312650306,1.3390884577832585,0.07516339869281045,0.8383087227386298,1.0,27/54,26.59%,DCTN1;CCDC88C;HOOK2;CLIP1;DST;VPS4B;FSD1;SLK;CLIP2;CLIP4;CAMSAP1;MAPT;SLAIN2;CRIPT;RHOA;WDR73;CHP1;DYNC1H1;CLIP3;NUMA1;TUBGCP5;PCM1;CCDC88A;KATNA1;CEP126;CCDC88B;KPNB1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5397680662044116,1.3390482253018683,0.11893764434180139,0.8363473589823166,1.0,4/33,4.40%,LIF;PRKCA;RUNX1;ZFP36L1
prerank,positive regulation of glucose import (GO:0046326),-0.4346575898274924,-1.3387171766721315,0.09693877551020408,0.5706279374276516,1.0,5/21,3.34%,SORBS1;OCLN;INSR;IGF1;OSBPL8
prerank,JNK cascade (GO:0007254),-0.3643456278125115,-1.3380423751012938,0.045871559633027525,0.5684431384869374,1.0,21/40,26.54%,MAP4K3;TNFRSF19;CRKL;IRAK2;MAP3K13;IKBKG;MAPK8;MAPK10;NOD1;MAPK9;TAB1;UBE2V1;MAP3K5;MINK1;MAP2K7;MAP3K10;NOD2;TAB3;RIPK2;ARHGEF6;SH2D3C
prerank,atrioventricular valve development (GO:0003171),0.6217352778280121,1.3374804594381193,0.13568521031207598,0.8422944620499138,1.0,5/14,6.76%,TGFB2;SLIT3;TGFBR2;ACVR1;MDM4
prerank,positive regulation of macrophage activation (GO:0043032),0.5926398982525933,1.3372110344860177,0.13537675606641125,0.8415128394398356,1.0,3/17,9.07%,LBP;IL33;TLR4
prerank,oogenesis (GO:0048477),-0.4584109596697514,-1.3371576938936267,0.12109375,0.5671523129852899,1.0,1/15,0.09%,PTN
prerank,RNA transport (GO:0050658),0.49627155705772424,1.3363754848914409,0.07104984093319194,0.8438487307605712,1.0,24/71,19.21%,SRSF2;HNRNPA1;SRSF6;NXF1;TGFBR2;RFTN1;ZFP36L1;RTRAF;U2AF1;SRSF3;ATXN2;SIDT2;SRSF11;THOC7;ZFP36;POLDIP3;THOC2;THOC1;ZC3H11A;DDX39A;CKAP5;SRRM1;SLBP;U2AF2
prerank,negative regulation of T cell proliferation (GO:0042130),0.5501159082890812,1.3358624841489584,0.11179361179361179,0.8442969629488954,1.0,5/28,11.78%,CD80;GLMN;RC3H1;CEBPB;GPNMB
prerank,snRNA metabolic process (GO:0016073),0.5868321696564321,1.3357320321850232,0.13108614232209737,0.8427069861581391,1.0,7/17,18.59%,INTS3;MEPCE;INTS10;INTS6;ZCCHC8;INTS2;INTS12
prerank,cell projection assembly (GO:0030031),0.5593695014550305,1.3355723041693721,0.14232673267326731,0.8413233101955379,1.0,4/22,10.05%,GSN;SCIN;RHOJ;RHOQ
prerank,negative regulation of immune effector process (GO:0002698),0.6257770793456819,1.335259611198522,0.16120218579234974,0.8407139136454889,1.0,4/13,14.21%,CD55;RC3H1;CD47;FER
prerank,protein import (GO:0017038),0.4851603603227037,1.3347761378241674,0.06799163179916318,0.8413019870224481,1.0,39/84,27.68%,SYK;PXMP2;PEX16;SPRN;NUP93;GDAP1;ALDH3A2;NUP107;PXMP4;AKT1;IPO9;TNPO2;PEX12;HSP90AA1;SLC25A17;E2F3;PEX3;IPO5;PEX5;NUP50;NXT2;ATAD1;ABCD3;PEX2;RANBP6;TPR;IPO11;FIS1;IPO13;TSC2;NUP133;NUP85;TNPO1;FAM53C;NUP188;KPNB1;SNX33;NUP88;RAB8B
prerank,regulation of fibroblast migration (GO:0010762),0.5787524264417854,1.3347277365203725,0.1275,0.8393560331921365,1.0,3/20,2.88%,DDR2;HAS1;FGF2
prerank,regulation of vesicle-mediated transport (GO:0060627),0.47990623916314096,1.333982860943047,0.06217616580310881,0.8409417842444545,1.0,34/91,24.55%,SYK;STON2;BET1L;CD177;GAS1;ATP9A;RINT1;SRC;RIT2;ABL2;INPP5F;ARFGAP1;STX4;SCFD1;ITGAV;RAB3D;RUFY1;USP7;MAP2K2;RAB33B;NSF;SYT1;RAB5B;RAB5C;VAMP2;RIMS2;RALA;RAB10;MAPK1;PACSIN2;PACSIN3;STXBP5L;RAB12;TSC2
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.4951380542210535,-1.3337931089168875,0.1285140562248996,0.571908961014834,1.0,10/14,38.75%,WDR48;ARID2;MRNIP;FANCB;TIMELESS;WRAP53;RAD51AP1;ERCC6;WAS;PARP1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.48666095510850277,1.3331684306885705,0.07903055848261328,0.840862673725733,1.0,21/78,17.19%,DCTN1;SEC24D;DYNC1LI2;ACTR1B;KLC1;SEC31A;AP1M1;SEC24A;AP2A2;CLTC;SEC23A;DYNC1LI1;DYNC1I1;KIF2A;ARF1;AP1S2;KIF3A;KIF3B;DYNC1H1;SEC24B;CTSD
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.48666095510850277,1.3331684306885705,0.07903055848261328,0.840862673725733,1.0,21/78,17.19%,DCTN1;SEC24D;DYNC1LI2;ACTR1B;KLC1;SEC31A;AP1M1;SEC24A;AP2A2;CLTC;SEC23A;DYNC1LI1;DYNC1I1;KIF2A;ARF1;AP1S2;KIF3A;KIF3B;DYNC1H1;SEC24B;CTSD
prerank,lipoprotein transport (GO:0042953),0.6570746226031099,1.3330679632925015,0.13333333333333333,0.8392020623938136,1.0,2/10,5.30%,LRP1;MIA3
prerank,chemokine-mediated signaling pathway (GO:0070098),0.5170819769771134,1.332820048642322,0.10555555555555556,0.8383181698937429,1.0,6/42,12.90%,ACKR3;CCL8;CXCL10;CCL25;STK39;CCL13
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5078557851367633,1.3328171840262553,0.09728506787330317,0.8361890120645386,1.0,13/45,16.67%,AREG;EGFR;PLCE1;BTC;SRC;PIK3CA;IQGAP1;AKT1;EGF;AAMP;CBL;SOS1;EFEMP1
prerank,regulation of extracellular matrix organization (GO:1903053),0.6183261233105445,1.332271998309598,0.13404825737265416,0.8369225582090194,1.0,4/15,3.49%,DDR2;LRP1;FAP;RUNX1
prerank,establishment of spindle orientation (GO:0051294),0.5443340585768436,1.3319945153337371,0.1216374269005848,0.8363028590401402,1.0,5/28,4.97%,GPSM2;DCTN1;LLGL1;NDEL1;ZW10
prerank,catecholamine metabolic process (GO:0006584),-0.48577851029518926,-1.3306067237002432,0.12681159420289856,0.5765210533709273,1.0,3/14,11.47%,SNCAIP;DDC;RNF180
prerank,glycosaminoglycan catabolic process (GO:0006027),0.5003709571855333,1.3303202273138814,0.07431693989071038,0.8432239011196693,1.0,14/55,16.73%,DCN;GPC6;GPC3;CD44;OGN;FGF2;ACAN;VCAN;SLC9A1;HSPG2;CHP1;NAGLU;IDUA;SDC2
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.44523075525228756,-1.3303175126682076,0.11555555555555555,0.5734693500397331,1.0,8/18,11.91%,PTN;IL34;TENM4;NOTCH1;PTPRZ1;TNFRSF21;MDK;SLC45A3
prerank,regulation of platelet activation (GO:0010543),0.5642650126426276,1.3299159090765067,0.13586291309669524,0.84320995212743,1.0,3/21,1.26%,SYK;C1QTNF1;PRKCA
prerank,response to interleukin-1 (GO:0070555),0.4904002867767636,1.3299108633793448,0.07368421052631578,0.8410928761933432,1.0,17/73,14.08%,HAS2;CCL8;PRKCA;ANXA1;IRAK3;USP10;NR1D1;SRC;RC3H1;CCL25;MAPK11;CD47;SIRPA;IRAK1;CCL13;HDAC4;ZC3H12A
prerank,vasculature development (GO:0001944),-0.4700286654554664,-1.3297916241973562,0.14222222222222222,0.5710853615715843,1.0,8/16,16.14%,CDH5;ERRFI1;BMPR2;STRA6;PDGFRB;NOTCH4;FLT4;SOX18
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.565250637252739,1.3297257511702123,0.12547051442910917,0.8398852165915702,1.0,4/21,4.00%,IGFBP5;MMP2;FGF2;MEF2D
prerank,engulfment of apoptotic cell (GO:0043652),-0.46594337218395465,-1.3296384218702055,0.12878787878787878,0.5677991441144958,1.0,5/15,16.69%,RHOBTB1;THBS1;XKR6;RHOH;MEGF10
prerank,ncRNA metabolic process (GO:0034660),0.5191916534731339,1.3292308312901016,0.11649365628604383,0.8403474967679277,1.0,10/37,18.36%,TARBP2;TRIM71;DGCR8;MEPCE;AGO2;MAPT;DDX17;DDX4;ZCCHC8;TENT4B
prerank,positive regulation of keratinocyte migration (GO:0051549),0.6385858053069325,1.3288804267424825,0.14744525547445256,0.8401537854047433,1.0,3/10,5.16%,FGF7;ADAM9;MTOR
prerank,cell junction assembly (GO:0034329),-0.305963856806054,-1.3284066173325948,0.0,0.5674375166780904,1.0,25/100,13.24%,TJP1;PKP4;CDH5;ITGA6;CLDN5;SPOCK2;CDH1;SHANK3;PLXND1;DNM3;CDH6;ACTB;TLN2;RYK;CDH7;OPHN1;SDK2;LIMS1;SDK1;CDK5;FBLIM1;BDNF;TRPV4;PCDHB14;SLITRK1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.5464820750365431,1.3282640606563467,0.11393939393939394,0.8410833273344073,1.0,6/30,8.98%,COL3A1;AKAP13;F2R;LPAR1;ARHGEF3;GPR20
prerank,nuclear membrane organization (GO:0071763),0.5720658741353879,1.328070880456473,0.13102595797280595,0.839887738025068,1.0,5/19,9.04%,DCTN1;TMEM43;CHMP7;TARDBP;TOR1A
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.4882327423518035,1.3273025825351406,0.06964656964656965,0.8417997767951775,1.0,10/73,9.07%,SYK;LBP;EPHB2;MIF;TMEM106A;PTPRJ;IL33;PSEN1;TIRAP;TLR4
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.6109159315036798,1.327234855815902,0.13049267643142476,0.840083857619759,1.0,3/16,5.30%,SEC16B;ANK2;MIA3
prerank,epidermal cell differentiation (GO:0009913),0.5152764610587665,1.3270521829725317,0.11698537682789652,0.8388804208502124,1.0,7/41,11.87%,LORICRIN;ANXA1;SCEL;ADAM9;KRT10;JAG1;ERCC3
prerank,nucleosome organization (GO:0034728),0.5039343461745038,1.3269549827163558,0.09611231101511879,0.8372950963999666,1.0,25/55,22.50%,CHAF1B;SMARCD2;MCM3AP;SMARCD1;SPTY2D1;POLE3;NPM1;SMARCC2;SETD2;ANP32B;DMAP1;INO80;SMARCA4;SRCAP;GRWD1;NAP1L2;SET;CTCF;PRDM9;ZNHIT1;PAF1;BRD2;KAT6B;VPS72;NAP1L3
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.6426865260160556,1.3256094843289765,0.13988919667590027,0.8422658046180177,1.0,4/11,16.31%,HPN;MST1R;SIRT2;HGF
prerank,plasma membrane organization (GO:0007009),0.4907333150626478,1.3255460766992975,0.0855614973262032,0.8405465464679366,1.0,12/61,11.28%,AHNAK2;COL5A1;STX2;ANK2;PLSCR4;BIN1;SYT11;TLCD2;OSBPL2;STX4;EHD2;FA2H
prerank,carnitine shuttle (GO:0006853),-0.5063981191438679,-1.325269602700628,0.13818181818181818,0.571946460732732,1.0,4/11,11.32%,PRKAG2;PRKAA2;SLC25A20;ACACB
prerank,visual perception (GO:0007601),0.47971442605480247,1.3246155302797176,0.07395833333333333,0.8434198164557957,1.0,20/84,20.29%,COL1A1;SLC4A10;ROM1;RABGGTA;COL11A1;ABLIM1;MYO9A;CNGB1;COL2A1;CRYBB1;RPGR;CABP1;CRYZ;OPA3;EFEMP1;TYR;RP2;SFRP5;KIFC3;ATF6
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6597287804465026,1.324324862519369,0.13387978142076504,0.842905668785043,1.0,4/10,7.85%,GRB10;ITGB3;ITGA5;PRKD2
prerank,positive regulation of cell cycle (GO:0045787),0.4896075390915926,1.3237993601297084,0.10656620021528525,0.8438010974084419,1.0,17/62,17.07%,LRP6;PRKCA;EGFR;TGFB2;SMOC2;PKD1;CDK4;PSRC1;MEIS2;MAPRE3;PKD2;AKT1;NUDT16;CCND1;NUPR1;USP22;TTL
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.622884751094148,1.3236526486549522,0.14304993252361672,0.8425265454126049,1.0,5/12,16.30%,ESR1;NCOR2;NCOR1;ZC3H12A;IL6
prerank,negative regulation of response to stimulus (GO:0048585),0.49483745509139193,1.3235083251965427,0.09159482758620689,0.8411946403584051,1.0,6/60,4.40%,CD34;COL3A1;SRMS;MAPK7;SLIT2;ACVR1
prerank,stress granule assembly (GO:0034063),0.5855650044429664,1.3232717591574736,0.13,0.840418533605487,1.0,12/20,24.44%,UBAP2L;BICD1;ATXN2;MAPT;EIF2S1;ATXN2L;DYNC1H1;YTHDF1;YTHDF2;YTHDF3;OGFOD1;G3BP1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.656681607506554,1.3231709363592958,0.1564245810055866,0.8349102019152033,1.0,7/10,22.85%,XRCC3;TERF1;DNA2;NBN;BLM;SMARCAL1;ERCC1
prerank,t-circle formation (GO:0090656),0.656681607506554,1.3231709363592958,0.1564245810055866,0.8349102019152033,1.0,7/10,22.85%,XRCC3;TERF1;DNA2;NBN;BLM;SMARCAL1;ERCC1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.656681607506554,1.3231709363592958,0.1564245810055866,0.8349102019152033,1.0,7/10,22.85%,XRCC3;TERF1;DNA2;NBN;BLM;SMARCAL1;ERCC1
prerank,fatty acid transmembrane transport (GO:1902001),-0.4419168582846204,-1.322642817900614,0.1380952380952381,0.5753321642944755,1.0,5/19,11.32%,PRKAG2;SLC2A1;PRKAA2;SLC25A20;ACACB
prerank,import into nucleus (GO:0051170),0.48573476311602204,1.3224173683885376,0.08184679958027283,0.83680027570029,1.0,31/73,27.02%,SYK;GEMIN6;HNRNPA1;SPRN;NUP93;NUP107;AKT1;BACH2;IPO9;TNPO2;DDX20;E2F3;SNRPG;SNRPD3;IPO5;NUP50;NXT2;RANBP6;TPR;HTATIP2;SMN1;IPO11;IPO13;TSC2;NUP133;NUP85;TNPO1;FAM53C;NUP188;KPNB1;NUP88
prerank,response to estradiol (GO:0032355),0.5388922248786349,1.3223975050877848,0.1135005973715651,0.8348911436001281,1.0,5/31,6.23%,ESR1;EGFR;ANXA1;SOCS2;NCOA3
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.6382426909649538,1.322312168434811,0.15782122905027932,0.8333937646402343,1.0,3/11,5.60%,SESTD1;BIN1;CAMK2D
prerank,polyol metabolic process (GO:0019751),-0.3556485713532864,-1.3221154224118965,0.06593406593406594,0.573268836280978,1.0,14/46,11.72%,ITPKB;INPP4B;PLCG1;ISYNA1;SLC5A3;NUDT4;PLCB1;INPPL1;ITPK1;INPP5D;MINPP1;NUDT3;ITPKC;PLCD3
prerank,positive regulation of microtubule polymerization (GO:0031116),0.5390480831871972,1.3217635572021966,0.11799761620977355,0.8340966056361626,1.0,12/28,20.64%,DCTN1;CLIP1;PSRC1;TOGARAM1;MAPRE1;MAPT;SLAIN2;CDK5RAP2;AKAP9;CKAP5;NAV3;NUMA1
prerank,regulation of neurotransmitter transport (GO:0051588),-0.458772219395964,-1.321679314189286,0.12831858407079647,0.5708753033647995,1.0,4/16,14.37%,SNCAIP;MEF2C;MCTP1;KCNMB4
prerank,polyamine metabolic process (GO:0006595),0.619357272029006,1.3213430058836986,0.1574585635359116,0.8342756225020519,1.0,6/13,22.17%,SRM;HDAC6;ODC1;SMS;SAT1;AMD1
prerank,regulation of defense response to virus (GO:0050688),0.5982129798916921,1.3205793645031143,0.14190093708165996,0.8363355044755046,1.0,5/14,16.06%,ITCH;C1QBP;RNF216;ILRUN;TRAF3
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.6082609060120296,1.320386256825937,0.1505235602094241,0.8353898162867145,1.0,4/15,6.33%,TRIAP1;CD44;MIF;MUC1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.48965850002542116,1.3202290956432634,0.07741935483870968,0.8342039080429131,1.0,18/67,14.82%,GHR;SYK;DDR2;EPHB2;SRMS;EGFR;FGFR1;EPHA3;FYN;SRC;ABL2;ABI1;PIBF1;FLT3;PDGFRA;FER;DDR1;IL4
prerank,axonal transport of mitochondrion (GO:0019896),0.6356332871788305,1.3201090103406923,0.15718157181571815,0.8329003873012614,1.0,4/11,11.37%,NEFL;TRAK2;SYBU;MAPT
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.4852417743136965,1.319796101271603,0.08645833333333333,0.8325133867939047,1.0,27/69,22.79%,IRS1;FGFR1;PLCE1;PIK3C2B;PIK3R2;CD160;ZFP36L1;PLCB4;C1QBP;INPP5F;PIK3CA;SIRT2;AKT1;IRS2;PLEKHA1;RHOA;PI4KB;PDGFRA;PI4KA;OGT;PLCD4;TYRO3;PTEN;GAB2;PIK3CG;NF1;HTR2A
prerank,energy reserve metabolic process (GO:0006112),0.5685621385260659,1.3196234840382297,0.14125,0.8314515390269731,1.0,4/19,7.25%,GFPT2;UGP2;GFPT1;PID1
prerank,positive regulation of vacuole organization (GO:0044090),0.6480463103540787,1.3195270261103649,0.14285714285714285,0.8299914181015804,1.0,4/10,20.46%,ANXA2;PIP4K2C;LRSAM1;PIP4K2B
prerank,insulin secretion (GO:0030073),0.5740060071645103,1.3193599187783174,0.1320049813200498,0.8288884174348177,1.0,3/19,7.34%,RAB11FIP5;ANXA1;ADCYAP1
prerank,response to molecule of bacterial origin (GO:0002237),0.4874699662213092,1.3193449081086635,0.07457983193277311,0.8270306696496675,1.0,18/69,16.30%,LBP;IRAK3;FOXP1;F2R;S100A8;S100A9;CYP27B1;TIRAP;SIRT2;TLR4;SMAD6;C4B;SLPI;IRAK1;FER;GGT7;CD14;IL6
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.46935676212418515,1.3190693898436006,0.05197505197505198,0.8265515472730383,1.0,36/104,23.82%,ASPN;HTRA3;LDLRAD4;SKIL;TGFBR2;PMEPA1;SMAD4;SMURF2;SKI;ACVR1;IGSF1;SMAD5;STUB1;SMAD6;PEG10;SLC2A10;MAGI2;VASN;UBA52;PIN1;SNX6;HTRA4;TGFBR1;STRAP;NBL1;UBE2D3;BMPER;PPM1A;ACVR2A;BMPR1A;SMURF1;CILP;CD109;FKBP1A;SKOR2;CCN3
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.654494177338087,1.318940174444454,0.1452513966480447,0.8252576851243628,1.0,4/10,13.72%,DPP4;FAP;CHADL;TNFRSF1B
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.515606722441842,1.318856638966621,0.10888888888888888,0.823766031446191,1.0,16/41,22.29%,MGLL;DAGLA;SCP2;PTGR1;GPX1;GSTM2;PNPLA8;ELOVL5;FADS1;DAGLB;ACOX1;EPHX1;FADS3;SCD5;HSD17B4;CYP1B1
prerank,atrial septum morphogenesis (GO:0060413),0.6567528569844819,1.318853068504166,0.13154172560113153,0.8218813573153816,1.0,2/10,4.40%,TGFB2;ACVR1
prerank,phospholipid translocation (GO:0045332),0.541054289612837,1.3185696096474815,0.12142857142857143,0.82145191183192,1.0,8/28,12.70%,ATP8B1;PLSCR4;ATP9A;ABCA1;ATP11A;ATP9B;TMEM30A;ABCC1
prerank,blood vessel morphogenesis (GO:0048514),0.4944801872143019,1.3182416493138305,0.11732456140350878,0.8213958107462066,1.0,8/54,3.19%,SYK;HAS2;CCBE1;WT1;GLMN;VEGFA;TNNI3;TGFBR2
prerank,membrane raft organization (GO:0031579),0.6143411444985035,1.3181154356237468,0.12048192771084337,0.8201817995860206,1.0,6/15,16.97%,ANXA2;S100A10;RFTN1;MYADM;FA2H;FLOT2
prerank,regulation of hydrolase activity (GO:0051336),-0.31801018602376296,-1.3180524103042102,0.041666666666666664,0.5772886597303074,1.0,14/71,6.08%,PLXNA2;PRKG1;EPHA4;CHN2;SCARB2;PLXNA4;FGD4;CHN1;FGD5;DAB2IP;PLXND1;SIPA1L1;RASIP1;CAV1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.5721419370680345,1.3179277894470025,0.15,0.8192854557801277,1.0,4/19,5.35%,MYOC;VEGFA;S100A10;PTPRJ
prerank,long-term synaptic potentiation (GO:0060291),0.5720513464229258,1.3174354454638,0.15024630541871922,0.8198685419364604,1.0,8/21,18.55%,NPTN;NFATC4;MPP2;GRIN2D;STX4;SLC8A2;GRIN2A;VAMP2
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.6491902077423699,1.3173200186978775,0.1486111111111111,0.8185847466258085,1.0,2/11,4.28%,NEUROD2;P2RX3
prerank,sulfur compound transport (GO:0072348),-0.39809631987954375,-1.3170294863069585,0.1111111111111111,0.5762705676686176,1.0,9/27,12.51%,SLC6A13;SLC13A4;ABCG2;SLC26A7;SLC25A26;SLC35F3;SLC25A11;MGST1;SLC6A6
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.5083377036167969,1.3167537790456203,0.12443946188340807,0.8196064945191136,1.0,15/49,18.03%,LDLRAD4;PMEPA1;DACT1;AIDA;JAM3;SRC;HDAC6;TFIP11;SMAD6;ULK1;NOP53;NLRP2B;ANKRD27;PEX5;IAPP
prerank,miRNA mediated inhibition of translation (GO:0035278),0.6421439017206952,1.3167200573771882,0.15767634854771784,0.8160725776361427,1.0,9/11,27.66%,RBM4;TRIM71;AGO2;EIF6;ZFP36;AGO4;AGO3;TNRC6A;AGO1
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.6421439017206952,1.3167200573771882,0.15767634854771784,0.8160725776361427,1.0,9/11,27.66%,RBM4;TRIM71;AGO2;EIF6;ZFP36;AGO4;AGO3;TNRC6A;AGO1
prerank,positive regulation of DNA recombination (GO:0045911),-0.40526773371153846,-1.3158553105373707,0.12087912087912088,0.5756351780959734,1.0,11/27,19.44%,WDR48;KMT5B;SHLD1;KMT5C;ARID2;MRNIP;TFRC;RIF1;FANCB;TIMELESS;MAD2L2
prerank,membrane depolarization during action potential (GO:0086010),-0.40559074559620506,-1.315115213467756,0.10606060606060606,0.5741602978837552,1.0,4/26,4.94%,ATP1A2;YWHAH;CACNA1D;SCN3A
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5863305487744849,1.3147230097892415,0.13824289405684753,0.82405481344515,1.0,3/17,3.71%,PCSK6;PCSK5;HDAC9
prerank,positive regulation of receptor internalization (GO:0002092),0.5531718892986849,1.3139685646401127,0.15111695137976347,0.825981084779083,1.0,8/22,23.55%,SFRP4;VEGFA;MAGI2;EGF;AHI1;ATAD1;ARRB1;PICK1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.6447382426084052,1.3131350121709173,0.14365411436541142,0.8282595918693783,1.0,4/11,5.77%,SMAD4;LMNA;ATP2B4;FOXO1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.5225817929202042,-1.3131240843891128,0.20074349442379183,0.576223394437093,1.0,6/10,13.64%,EPHA4;DAB2IP;NELL1;ATRAID;RGP1;RIC1
prerank,ribosome assembly (GO:0042255),0.5017644979024596,1.3130641400640901,0.11148648648648649,0.8268057719010578,1.0,20/47,26.66%,RPSA;MRPS11;C1QBP;NPM1;EIF6;SBDS;RPS27L;RPS5;RRP7A;RPL6;NOP53;PWP2;RPF2;MPV17L2;EIF2A;NOP2;RSL24D1;BRIX1;ERAL1;DHX29
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.6123600035647063,1.3130240134955253,0.15683646112600536,0.8251658254511728,1.0,3/14,17.74%,CD80;PAEP;IL18
prerank,macrophage activation (GO:0042116),0.5250885956283271,1.3119019709873336,0.1258741258741259,0.8289122817171628,1.0,6/34,11.37%,SYK;LBP;FOXP1;TMEM106A;TLR4;MAPT
prerank,receptor metabolic process (GO:0043112),0.4957243442192649,1.3112149430918278,0.1031390134529148,0.8304336073842782,1.0,9/53,8.08%,ACKR3;SYK;CD9;LRP1;DNM1;MVB12A;CLTC;SNX1;CD81
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.47340456508260337,-1.3101847111283969,0.1615720524017467,0.5767362238643494,1.0,4/16,3.43%,PHLDB2;ARHGAP6;THBS1;APOD
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.47340456508260337,-1.3101847111283969,0.1615720524017467,0.5767362238643494,1.0,4/16,3.43%,PHLDB2;ARHGAP6;THBS1;APOD
prerank,reticulophagy (GO:0061709),0.6258415184908102,1.3100809253707804,0.1694915254237288,0.8340485772558907,1.0,7/12,18.62%,ATG2B;ULK2;ATG2A;ULK1;UFC1;UFL1;UFM1
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.6066929262997047,1.3099679987712611,0.13547486033519554,0.8327610580051303,1.0,4/15,12.63%,ANXA1;ZFP36L1;ZFP36L2;ZFP36
prerank,negative chemotaxis (GO:0050919),0.5288591320113213,1.3095704632421823,0.12571428571428572,0.8330159911309651,1.0,10/33,13.49%,SEMA3C;ITGB3;SLIT3;SLIT2;SLIT1;NTN1;SEMA3A;ITGAV;SEMA3D;RHOA
prerank,lipoprotein localization (GO:0044872),0.6344834614313651,1.3093048393537932,0.16453900709219857,0.8325970774579369,1.0,2/11,5.30%,LRP1;MIA3
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.6257632704703956,1.3091661097815654,0.15272244355909695,0.8297341798844323,1.0,7/12,24.32%,EFNA5;MELTF;KANK1;RCC2;CORO1C;FBLN1;DMTN
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.6257632704703956,1.3091661097815654,0.15272244355909695,0.8297341798844323,1.0,7/12,24.32%,EFNA5;MELTF;KANK1;RCC2;CORO1C;FBLN1;DMTN
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.45243669052544616,-1.3085994007552406,0.14601769911504425,0.5774796252148362,1.0,13/16,45.25%,TRIB2;TNFRSF21;JAK3;FCGR2B;DLL1;AGER;LILRB1;TYROBP;PDCD1LG2;IL23A;FOXP3;IL23R;IL12B
prerank,calcium-mediated signaling (GO:0019722),0.47448826135674005,1.3084744405272966,0.07284079084287201,0.8312410125633465,1.0,21/93,17.66%,ACKR3;EGFR;EIF2AK3;PLCE1;ANK2;TNNI3;PTPRJ;RCAN3;STIMATE;MCU;ACKR4;RCAN1;PPP3CC;CAMKK2;SLC9A1;ATP2A2;PPP3CA;CXCR4;PPP1R9B;CXCR2;BCAP31
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.47919745058497687,1.3083424152671885,0.07660020986358866,0.8301013922001411,1.0,46/80,32.02%,SGSM2;DCTN1;RAB7B;BET1L;RAB6A;STX5;HEATR5A;RAB6B;VPS52;CLTC;SNX1;SURF4;MAGEL2;LMAN1;TBC1D17;GGA1;TBC1D10A;TBC1D23;GOSR1;ARFRP1;TMEM87A;EVI5;PHETA2;PREPL;SNX6;DENND2A;STX16;ANKFY1;VTI1A;BAIAP3;RAB29;RNF126;GOSR2;GBF1;RBSN;VAMP3;YKT6;RHOBTB3;TBC1D5;SPAG9;RAB9B;PIKFYVE;TRAPPC10;TMEM87B;SNX5;ARL1
prerank,myotube differentiation (GO:0014902),0.5802681987940874,1.3082288211075306,0.15243101182654403,0.8288674562547423,1.0,3/17,4.06%,ADAMTS5;SIX4;SKI
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.42186772104745623,-1.3080802150416178,0.09895833333333333,0.5753632783157061,1.0,9/23,16.37%,EFNB2;IGF1;MEF2C;NIBAN2;TGFB1;AKAP6;EDN1;MYOCD;MAML1
prerank,epithelial cell morphogenesis (GO:0003382),0.5818913795985214,1.3075059998030225,0.16890080428954424,0.8304274714173988,1.0,4/17,8.29%,TNMD;CCDC88C;DACT2;COL15A1
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.3774194449983232,-1.3067693282598987,0.1437908496732026,0.5756838796059346,1.0,9/33,4.18%,NR2F2;PTPRG;SP100;ADAMTS9;APOE;THBS1;DAB2IP;DUSP10;PTPRM
prerank,water transport (GO:0006833),-0.4921562160708227,-1.3057421199341936,0.1471698113207547,0.5750281613204211,1.0,2/12,8.86%,PDPN;AQP11
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.6108586055827244,1.30543044881874,0.16886543535620052,0.838694141644524,1.0,3/13,7.04%,AR;ESR1;PLPP1
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.38183242203835477,-1.3048872941255645,0.09554140127388536,0.574009131091378,1.0,6/28,3.46%,PTN;EPHA4;ADCY1;APP;APOE;SHANK3
prerank,muscle cell migration (GO:0014812),0.6384510490423236,1.3045956092210669,0.1732394366197183,0.8410467058863996,1.0,5/10,14.52%,ITGB3;THBS4;SIX1;AAMP;DDR1
prerank,regulation of vasculature development (GO:1901342),-0.3964150423786347,-1.3045462775518741,0.14204545454545456,0.5715136000774907,1.0,11/26,15.58%,ETS1;SP100;PLXND1;EMP2;ERBB2;TSPAN12;SFRP1;EGLN1;CTNNB1;ADGRA2;EPHA2
prerank,positive regulation of leukocyte activation (GO:0002696),0.5678803675006063,1.3045124012734595,0.15938303341902313,0.8396406373712669,1.0,3/18,9.07%,LBP;IL33;TLR4
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.5522979564869368,1.304203895726474,0.1375598086124402,0.8393481198331016,1.0,15/24,29.96%,MAPK7;VEGFA;NFE2L2;KLF2;CREB3L1;MUC1;CEBPB;ATF6;SESN2;ATF4;CHD6;DDIT3;RBPJ;TP53;HSF1
prerank,endoderm formation (GO:0001706),0.5225048449529341,1.3041782388164187,0.11943793911007025,0.8376660916405642,1.0,9/35,11.81%,COL8A1;COL11A1;MMP2;ITGA5;ITGB5;COL12A1;COL6A1;ITGAV;SETD2
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.47524609647044075,1.303995130228516,0.08755274261603375,0.836831859457672,1.0,13/79,7.26%,HTRA3;TNMD;SULF2;SKIL;FGF2;SLIT2;SMAD4;SMURF2;SKI;ATP2B4;CREB3L1;SMAD5;SULF1
prerank,positive regulation of B cell activation (GO:0050871),0.4906600041799877,1.3036497841010608,0.12053571428571429,0.8367673107284674,1.0,12/50,16.30%,SYK;EPHB2;MIF;CLCF1;HMCES;CD81;TIRAP;TNFSF13B;IRS2;CD27;IL4;IL6
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.4858632354811087,1.3035922538818256,0.09272918861959958,0.8352673188806896,1.0,27/69,25.50%,UBE2J2;SYVN1;EDEM1;RNF121;PSMC6;STUB1;ANKZF1;FBXO2;EDEM2;FBXO17;ECPAS;UBE2G2;HERPUD1;DNAJB2;TMUB2;SGTA;AMFR;SELENOS;AUP1;JKAMP;DERL1;SEL1L;USP19;RHBDD2;SEC61B;HSP90B1;UFD1
prerank,regulation of establishment of cell polarity (GO:2000114),0.5828045931003677,1.3034471922773527,0.14921465968586387,0.8342037276393622,1.0,7/16,19.86%,GSN;RAP1B;KANK1;KIF20B;BCAS3;SHTN1;ARFGEF1
prerank,regulation of dopamine secretion (GO:0014059),0.5443534093917124,1.3031414245628652,0.14250614250614252,0.8338708131882692,1.0,8/25,17.26%,SYT2;SYT12;SYT11;SYT13;DTNBP1;KCNA2;GDNF;SYT1
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.4449910892751563,-1.3031125496879117,0.12719298245614036,0.5714429334410485,1.0,3/16,3.59%,PTN;SOX6;FOXC1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.6335634414555291,1.30300781652818,0.17119565217391305,0.8310153441220463,1.0,3/10,8.76%,AP2A2;CLTC;MYLIP
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.6335634414555291,1.30300781652818,0.17119565217391305,0.8310153441220463,1.0,3/10,8.76%,AP2A2;CLTC;MYLIP
prerank,negative regulation of proteolysis (GO:0045861),0.5180924027405471,1.3027378930935225,0.12398609501738123,0.8305477928330322,1.0,7/34,11.30%,TIMP2;GAS1;ECM1;CAMK2N1;HDAC6;CSTB;AKT1
prerank,monosaccharide transmembrane transport (GO:0015749),0.599681516587141,1.3024240838930385,0.17724867724867724,0.8302601745679928,1.0,5/16,13.02%,SLC5A9;SLC50A1;SLC2A10;SLC23A1;SLC23A2
prerank,regulation of catecholamine secretion (GO:0050433),0.5390164835427339,1.3020147715781363,0.13237063778580024,0.8304636585840608,1.0,7/29,10.51%,SYT2;STX1A;SYT12;SYT11;SYT13;DTNBP1;KCNA2
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.5265305530026577,-1.301787736520683,0.1649122807017544,0.5715162939479621,1.0,5/10,12.23%,BMP6;NOTCH1;RGCC;NOTCH4;PPM1F
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.47318733127271967,1.3016465449201977,0.07905544147843943,0.8304748166464757,1.0,21/95,16.30%,LBP;CD80;AXL;ADAM9;MAPK14;NR1D1;CXCL10;CARD16;TIRAP;SIRT2;TLR4;SIRPA;IRAK1;ZFP36;RHOA;TNFRSF1B;ZC3H12A;CD14;SELENOS;PDCD4;IL6
prerank,cell proliferation in forebrain (GO:0021846),0.6542707736289559,1.3015377415191844,0.16455696202531644,0.829264302255934,1.0,3/10,5.71%,NUMBL;AKNA;DOCK7
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.5547007336811666,1.3007773295481408,0.16729088639200998,0.8313773194430832,1.0,8/21,17.29%,CDK4;RAD51B;VPS4B;DTL;NPM1;FBXO5;CCND1;RCC2
prerank,intracellular protein transport (GO:0006886),0.4480031618205048,1.3004757202547021,0.01,0.8310403674694213,1.0,123/304,25.81%,SYK;SGSM2;COPA;DESI1;STX2;RAB32;RABGAP1L;RAB6A;AP4B1;STX1A;TMED1;SPRN;STX5;STX11;PKD1;SEC31A;RAB23;RAB19;RAB6B;NUP93;PREB;SCFD2;ARF4;TRAK2;SCG5;TBCK;AP3D1;HDAC6;NUP107;STX1B;CLTC;SNX1;STRADA;ACD;SURF4;USO1;HPS4;TBC1D2B;ARFGAP3;LMAN1;STX4;TBC1D17;GGA1;SCFD1;ARF1;STX12;AP4E1;NPM1;SEC23IP;COPB2;VPS33A;AKT1;TBC1D10A;NAPA;STX17;RAB43;RPGR;IPO9;TNPO2;ARFRP1;SYNDIG1;ARF6;GGA2;GIPC1;CHP1;E2F3;NSF;EVI5;SGSM1;COPZ2;EVI5L;AP4M1;NAPG;TBC1D13;RAB1B;RAB5B;RAB5C;IPO5;BCS1L;STX3;SNX6;ARCN1;ADPRH;NUP50;NXT2;TBC1D22B;TBC1D15;CLIP3;RAB24;TMED2;VPS33B;VPS36;AP1S3;COX18;RUNDC1;CTTN;SMURF1;RANBP6;NAPB;STX16;BAG3;TPR;TBC1D8B;IPO11;TBC1D12;FUT10;TECPR2;XPO7;PICK1;RABL3;STAM;IPO13;RAB18;TSC2;NUP133;CALR;NUP85;STX7;TNPO1;RAB29;KIF13B;RAB1A;FAM53C
prerank,cellular response to pH (GO:0071467),0.5888356459736233,1.299952912460529,0.16050955414012738,0.831920829921444,1.0,6/17,20.32%,RAB11FIP5;SLC9A1;GPR68;CHP1;GPLD1;ASIC1
prerank,protein hydroxylation (GO:0018126),0.5950721502070279,1.2998508173661971,0.15803108808290156,0.8306569033706376,1.0,7/15,22.69%,PLOD2;PLOD3;P3H1;VPS33B;PLOD1;OGFOD1;JMJD7
prerank,basement membrane organization (GO:0071711),0.5892273164858515,1.2996253072345365,0.17032967032967034,0.8300177847003561,1.0,3/14,3.04%,HPN;FLRT2;NTN4
prerank,regulation of osteoblast proliferation (GO:0033688),0.5814556704060019,1.2990069006902325,0.1645077720207254,0.8312361543805397,1.0,4/17,8.12%,MN1;TMEM119;TNN;SOX8
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.6215413037670015,1.2984926743196137,0.16059379217273953,0.8319606947381213,1.0,7/12,21.33%,DCTN1;BICD1;KIF3A;BBS4;NIN;CCDC120;PCM1
prerank,ESCRT complex disassembly (GO:1904896),0.6414502381065674,1.2983409188912771,0.16986301369863013,0.8291793824460976,1.0,2/10,5.32%,CHMP7;VPS4B
prerank,ESCRT III complex disassembly (GO:1904903),0.6414502381065674,1.2983409188912771,0.16986301369863013,0.8291793824460976,1.0,2/10,5.32%,CHMP7;VPS4B
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.4622328632442812,1.2982972729534668,0.07150153217568948,0.8277156653846025,1.0,30/113,17.52%,SYK;ESR1;PSMC4;GTF2H3;VEGFA;CDC42EP2;MPP7;RAP1B;GNL3L;PSMC6;SRC;FSCN1;ABCA1;STUB1;DHX33;TIRAP;TLR4;BMF;USP50;TPPP3;ERCC3;BAK1;ERCC4;DDB1;IL5;TERF1;HSP90AA1;HRK;SPIDR;ERCC5
prerank,protein localization to nucleus (GO:0034504),0.46698913224108796,1.2980768968511895,0.08057851239669421,0.8271003660426751,1.0,42/102,27.02%,SYK;COL1A1;SIX4;SPRN;LMNA;TOR1AIP2;TAF8;NUP93;NUP107;YWHAE;TOR1A;TAF3;AKT1;BCL3;IPO9;SIX1;TNPO2;BBS4;NOP53;E2F3;PML;IPO5;RPF2;TBRG1;NUP50;NXT2;PAF1;RANBP6;TPR;IPO11;IPO13;DVL1;TSC2;NUP133;MDM2;CALR;NUP85;TNPO1;FAM53C;NUP188;KPNB1;NUP88
prerank,alpha-amino acid metabolic process (GO:1901605),0.5032187470526943,1.2980279793442773,0.11902113459399333,0.8256508526691514,1.0,2/45,2.65%,NOX4;ALDH18A1
prerank,cellular response to virus (GO:0098586),0.534543952894098,1.297484670214324,0.13493975903614458,0.8266786862498552,1.0,15/30,30.22%,MAPK14;CXCL10;CHUK;MAPK11;ARF1;ZC3H12A;HSP90AA1;VWCE;IL6;RRP1B;LGALS8;RIOK3;GBF1;BAX;LGALS9
prerank,T cell activation involved in immune response (GO:0002286),-0.494870310496923,-1.2974644698386408,0.22556390977443608,0.5797064769666286,1.0,6/12,31.71%,MDK;ICAM1;CD74;LCP1;SLC11A1;LILRB1
prerank,neuron differentiation (GO:0030182),0.45576537522248795,1.2972742574968212,0.041289023162134945,0.8260119921222492,1.0,16/165,5.31%,LMX1A;LRP6;LHX8;WNT10B;WNT2;UGDH;CTF1;NEUROD2;VEGFA;WNT9A;TGFB2;PBX1;RUNX1;LMX1B;IRX5;TENM3
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.610256728107273,1.296433937122778,0.15775034293552812,0.8283257114049756,1.0,8/12,22.26%,EPHB2;NFIB;GLI2;MYCBP2;TSKU;EPHB1;PAFAH1B1;SPTBN4
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.4783941569117498,1.2963654043980213,0.09735449735449736,0.8269798742536242,1.0,29/71,27.80%,FAP;CAPN2;ZRANB1;VPS4B;NR1D1;HDAC6;STUB1;UBE2W;CLPX;OTUD7B;UBA52;RSPRY1;DDB1;CLPP;NGLY1;SOCS6;ZER1;IDE;NEDD8;RNF41;PDCD6IP;RNF123;ZYG11B;CTSK;MDM2;PRPF19;CTSB;CTSL;CASP8
prerank,lysosome organization (GO:0007040),0.5181352771554629,1.2961422012539014,0.11811926605504587,0.82643438150482,1.0,13/36,20.10%,HOOK2;ACP2;MTOR;ABCA1;TPP1;CLVS2;HPS4;VPS33A;GAA;SNAPIN;TMEM165;CLVS1;ACP3
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.6422308023320447,1.2952947803728363,0.16901408450704225,0.8286901326480742,1.0,3/10,13.75%,CNGB1;SAG;GNB1
prerank,protein targeting to peroxisome (GO:0006625),0.538327769052001,1.2950984653804545,0.13675213675213677,0.8279400930781776,1.0,13/29,21.43%,PXMP2;PEX16;GDAP1;ALDH3A2;PXMP4;PEX12;PEX1;SLC25A17;PEX3;PEX5;ATAD1;ABCD3;PEX2
prerank,ribosomal subunit export from nucleus (GO:0000054),0.603716601825586,1.2944403956431545,0.17181208053691274,0.8294541162443794,1.0,5/13,12.34%,SDAD1;ABCE1;NOP9;NPM1;EIF6
prerank,B cell activation involved in immune response (GO:0002312),-0.4804247757752509,-1.2938406699235605,0.14942528735632185,0.5856224793023247,1.0,7/13,25.78%,MSH2;BATF;RNF8;CD180;GPR183;LIG4;FCGR2B
prerank,establishment of mitotic spindle orientation (GO:0000132),0.546854844576597,1.2936196599834233,0.1539408866995074,0.8316376474032835,1.0,4/23,4.97%,GPSM2;DCTN1;NDEL1;ZW10
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.6021482159500329,1.29354580844015,0.15394736842105264,0.8303343871787632,1.0,3/15,3.63%,FANCD2;EME1;TIPIN
prerank,dendritic spine morphogenesis (GO:0060997),0.5970286447237939,1.2935097959617907,0.16600265604249667,0.8288230331770612,1.0,7/15,21.11%,EPHB2;DLG4;EPHB3;CTNND2;DIP2A;EPHB1;PTEN
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.5476927747821901,1.2923105117816325,0.16766467065868262,0.8328313318742293,1.0,4/24,7.26%,CCBE1;EIF2AK3;SULF2;SULF1
prerank,regulation of macrophage differentiation (GO:0045649),0.5878033800254667,1.2922655944084738,0.18691588785046728,0.8314002137242931,1.0,3/15,6.74%,LIF;PRKCA;INHA
prerank,regulation of collagen biosynthetic process (GO:0032965),0.5712334575947112,1.29090005057659,0.14559386973180077,0.8361045137333935,1.0,4/19,5.66%,TGFB3;F2R;RUNX1;CREB3L1
prerank,coenzyme A metabolic process (GO:0015936),0.6040655989838918,1.2900242855658455,0.16621983914209115,0.838616293933386,1.0,9/14,26.30%,ACLY;NUDT7;SLC25A16;PANK1;PANK3;DCAKD;ACAT1;CROT;ACOT7
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.6245345949482699,1.2900008108955878,0.17565698478561548,0.8370651049501743,1.0,3/11,4.40%,TGFB2;TGFBR2;ACVR1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.5172240361897948,1.2894800127949517,0.145475372279496,0.8379880599198829,1.0,10/37,13.14%,PHLDB1;CDK2AP2;EFNA5;EPHA3;MAPRE3;BICD1;GAS2L1;MAPRE1;MAPT;MAP6
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.6379180590854886,1.2894602514661173,0.1704225352112676,0.8364231929703518,1.0,7/10,29.58%,CSGALNACT2;B3GAT3;XYLT1;XYLT2;B3GAT2;DSEL;CSGALNACT1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.6177304891199431,1.2891915243442016,0.17783857729138167,0.8360497368608814,1.0,4/12,12.62%,SRI;CAMK2D;PDE4D;CALM2
prerank,regulation of cilium movement (GO:0003352),-0.5207896133306136,-1.2890753587343557,0.1892744479495268,0.5951914071933039,1.0,8/10,35.94%,DNAH11;CFAP43;CFAP298;ODAD2;DRC1;CCDC65;CFAP206;CCDC40
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.47289947396039694,1.288825460609107,0.09735449735449736,0.8361977763937034,1.0,12/74,5.16%,COL1A1;PHLDB1;LOXL2;TGFB3;HPN;LDLRAD4;EPHA3;TGFB2;TGFBR2;SMAD4;WWTR1;MTOR
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.39079646944782254,-1.288355169074873,0.11956521739130435,0.5939408499812114,1.0,10/25,17.11%,ATP1B3;ACTN2;DMD;WNK4;SLC6A9;TRPC6;NDUFA4;COX17;ATP1B1;GLRX
prerank,mRNA metabolic process (GO:0016071),0.46806483060960963,1.2868411699370452,0.09533678756476684,0.8440562198190052,1.0,32/90,21.68%,SRSF2;DIS3L2;RNASE4;U2AF1;ZFP36L2;PRPF3;AURKAIP1;CPSF6;USP39;NUDT16L1;ERN1;SON;TCERG1;NUDT16;SRSF11;ZFP36;CNOT10;SF3B4;SF3A1;DDX5;SNRPG;SNRPD3;AGO4;YTHDF2;SLBP;U2AF2;AGO3;PTBP1;HIPK3;SF3B2;AKAP8L;KIN
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.49767306844168624,1.286666942081272,0.128680479825518,0.843214640411069,1.0,10/47,14.08%,SYK;CD177;TGFBR2;MAPK14;PID1;DHRS4;TLR4;MAPT;CDKN1A;ZC3H12A
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.5966451874139098,1.2864585438020122,0.1875,0.84258276215823,1.0,6/14,22.15%,EHHADH;CRAT;SCP2;ACOX1;HSD17B4;CROT
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.5408474213766429,1.2864270918325902,0.15867158671586715,0.8410839415884908,1.0,6/23,14.76%,CCDC88C;HOOK2;MYO10;DYNC1I1;MAP6;CCDC186
prerank,import into cell (GO:0098657),-0.3650035488424562,-1.2863253546723763,0.13513513513513514,0.5962491057107802,1.0,9/41,4.70%,ATP1A2;SLC6A13;SLC1A3;SLC16A2;SLC12A7;GLUL;SLC5A3;SLC7A5;SLC22A4
prerank,sensory perception of light stimulus (GO:0050953),0.4664521541782824,1.2860206302624682,0.0954356846473029,0.8413848580637139,1.0,20/87,20.29%,COL1A1;SLC4A10;ROM1;RABGGTA;COL11A1;ABLIM1;MYO9A;CNGB1;COL2A1;CRYBB1;RPGR;CABP1;CRYZ;OPA3;EFEMP1;TYR;RP2;SFRP5;KIFC3;ATF6
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.6330372771516197,1.285444574073612,0.173974540311174,0.8425506353780149,1.0,2/10,2.27%,AREG;BTC
prerank,regulation of trophoblast cell migration (GO:1901163),0.5983540384428937,1.2850809964001093,0.1781767955801105,0.842654003596147,1.0,4/14,8.89%,VEGFA;SMURF2;C1QBP;AGO2
prerank,regulation of immune effector process (GO:0002697),0.49925266503283566,1.2849728416284698,0.14768883878241262,0.8415717256823794,1.0,9/41,13.58%,CD55;IRF4;CFH;C7;C1QBP;CD81;C4B;SERPING1;CR2
prerank,arachidonate transport (GO:1903963),0.6258994994702356,1.2846254957882945,0.1630901287553648,0.8399502399475118,1.0,2/10,11.43%,ANXA1;PNPLA8
prerank,arachidonic acid secretion (GO:0050482),0.6258994994702356,1.2846254957882945,0.1630901287553648,0.8399502399475118,1.0,2/10,11.43%,ANXA1;PNPLA8
prerank,intestinal lipid absorption (GO:0098856),0.6262504388293967,1.2843838749226073,0.17467248908296942,0.839477932488546,1.0,1/11,1.78%,CEL
prerank,keratan sulfate biosynthetic process (GO:0018146),0.5407571233268329,1.2843499590236749,0.16924910607866508,0.8380266957166682,1.0,6/26,4.27%,ST3GAL2;B4GALT3;B4GALT1;OGN;CHST1;ACAN
prerank,regulation of interleukin-4 production (GO:0032673),0.5551060904048805,1.283963707637883,0.1745049504950495,0.8382192690956594,1.0,2/21,1.14%,SYK;IRF4
prerank,acylglycerol biosynthetic process (GO:0046463),0.54240192104887,1.283774705224559,0.15770609318996415,0.8375323694687715,1.0,8/23,20.27%,PLCE1;GPAT4;ANG;MOGAT1;MOGAT2;GPAT3;GPAM;LPIN3
prerank,icosanoid metabolic process (GO:0006690),0.504234558706224,1.2836930683267116,0.16121495327102803,0.8363299973121605,1.0,12/40,17.77%,MGLL;CYP2S1;DPEP1;DAGLA;PON3;PTGR1;GPX1;PNPLA8;ABCC1;FADS1;DAGLB;EPHX1
prerank,iron ion transport (GO:0006826),0.491176804505329,1.283647480399925,0.14983351831298558,0.8349401371440226,1.0,13/47,16.13%,SCARA5;STEAP3;ATP6V0A2;SLC39A14;MELTF;SLC11A2;CLTC;ATP6V1E1;ATP6AP1;REP15;ATP6V0A1;ATP6V1D;ATP6V1B2
prerank,lymphocyte mediated immunity (GO:0002449),0.6196861827708624,1.2835634267872602,0.18157181571815717,0.8338449599080701,1.0,3/12,15.15%,CD55;JAG1;BTN3A3
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.5633832695960563,1.2834726954547504,0.17857142857142858,0.8327778563879951,1.0,5/18,17.44%,FBN1;LRRC17;TLR4;IL4;GPR137B
prerank,intestinal absorption (GO:0050892),-0.48481774051295623,-1.2833860821602943,0.1673469387755102,0.6009935620735642,1.0,4/13,10.39%,F11R;TJP2;ADRA2A;KCNQ1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.5956108202142623,1.2833810847823135,0.18641810918774968,0.8316523600798184,1.0,8/15,24.70%,SKI;ACVR1;DACT1;IGSF1;MAGI2;ACVR2A;FKBP1A;ACVR1B
prerank,cartilage development (GO:0051216),0.493757320014876,1.2832156801009982,0.1362126245847176,0.8308756943282201,1.0,11/49,10.13%,WNT10B;CD44;SULF2;FGF2;RUNX1;PKD1;SLC39A14;NFIB;SULF1;SOX5;COL2A1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.4764477325007874,-1.2829076404934094,0.1532567049808429,0.5990055050774501,1.0,7/14,17.70%,RAPGEF2;PKIG;PRKAR1B;SIRT1;HTT;PRKAR2B;ADRB2
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.5052087643550776,-1.282828104071947,0.18726591760299627,0.5959181730307991,1.0,3/11,12.88%,ENPP3;CTPS2;SLC19A3
prerank,regulation of intracellular pH (GO:0051453),0.5235468942072891,1.282693141236012,0.16121495327102803,0.831799632865717,1.0,12/34,16.48%,SLC4A10;SLC4A8;SLC4A3;SLC9A9;VPS33A;SLC4A4;SLC26A6;SLC9A1;CHP1;SLC9A7;SLC9A6;TMEM165
prerank,ERBB signaling pathway (GO:0038127),0.47034810306100594,1.2826893339887795,0.12137486573576799,0.8302422849360811,1.0,16/64,16.67%,AREG;PRKCA;EGFR;PLCE1;BTC;SRC;STUB1;PIK3CA;IQGAP1;AKT1;EGF;AAMP;CBL;HSP90AA1;SOS1;EFEMP1
prerank,response to peptide (GO:1901652),0.5049337023757248,1.2818956448740033,0.16350710900473933,0.8323066557364427,1.0,5/33,8.10%,ANXA1;IRS1;FYN;MMP2;STAT5A
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.4509726148802107,1.2815760332159412,0.05348133198789102,0.832256770878538,1.0,28/152,12.37%,RSPO2;SFRP4;COL1A1;DKK2;EGFR;SCEL;GPC3;PSMC4;SULF2;UBE2B;SMURF2;SKI;AXIN1;DACT1;ZRANB1;DAAM2;PSMC6;SULF1;PSMD8;GSKIP;PLEKHA4;KANK1;TMEM9;CSNK1G1;CSNK1G3;PRDM15;JUP;EGF
prerank,protein mono-ADP-ribosylation (GO:0140289),0.6258372671006617,1.2815061518134458,0.164804469273743,0.8310359552381696,1.0,4/11,11.05%,PARP3;PARP11;PARP6;PARP14
prerank,positive regulation of T cell migration (GO:2000406),-0.4116871479353522,-1.2814740583405744,0.16129032258064516,0.5961839202400271,1.0,5/20,4.18%,ADAM10;APP;WNT5A;DOCK8;CXCL12
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.5668827982040575,1.281191371273668,0.1981382978723404,0.8308835190463524,1.0,8/17,24.12%,GET4;EMC1;EMC10;EMC8;SGTA;EMC3;EMC2;EMC6
prerank,proteolysis (GO:0006508),0.44169830157087203,1.2803035925093946,0.03206412825651302,0.833596967113036,1.0,60/252,19.06%,CAPN5;HTRA3;PCSK6;PRSS48;DPP4;BMP1;HPN;FAP;PCSK5;DESI1;DESI2;PSMC4;ANPEP;CAPN2;MMP2;KLKB1;ADAMTS3;ACAN;ADAM19;ADAM33;PCSK4;SPCS1;PRCP;RET;LNPEP;TPP1;FBXO2;CAPN1;CLPX;PSEN1;ECE1;FBXL2;CNDP2;XPNPEP3;EEF1AKMT4-ECE2;ECE2;CAPN11;SPPL2B;NAPSA;THOP1;RSPRY1;NPEPPS;TASP1;FAM111A;CLPP;HGF;OGT;HTRA2;SENP6;IDE;SPG7;LAP3;CTSD;PGPEP1;HTRA4;MMP16;METAP2;CAPN10;NEDD8;PCSK7
prerank,phosphatidylserine metabolic process (GO:0006658),-0.3742999688204328,-1.2802589991665196,0.08888888888888889,0.5961326409294475,1.0,6/32,13.11%,OSBPL10;PLA1A;OSBPL8;PLSCR1;PLAAT3;PLA2G15
prerank,proteoglycan biosynthetic process (GO:0030166),0.5119136896493629,1.2798296681794614,0.16113744075829384,0.8343196288534744,1.0,10/31,12.53%,UGDH;CSGALNACT2;CHST10;EXT1;GAL3ST3;CHST12;FOXL1;B3GAT3;XYLT1;GLCE
prerank,response to chemokine (GO:1990868),-0.46933648081002627,-1.2797135157010269,0.17424242424242425,0.5942621213257715,1.0,5/13,5.61%,SLC12A2;FOXC1;DOCK8;CXCL12;LRCH1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5248209959827621,1.2784080716588762,0.15783274440518258,0.8394261265523434,1.0,6/32,12.90%,ANG;S100A9;CXCL14;CXCL10;RNASE6;CCL13
prerank,establishment of protein localization to extracellular region (GO:0035592),0.5082911523235873,1.2777793500550512,0.15332581736189402,0.8409465702856258,1.0,19/39,30.69%,NECAB3;STEAP3;PREB;MIA3;RCN3;ABCA1;ARFGAP3;RAB3D;MON1A;RAB10;COPG1;SEL1L;RAB12;AFM;RAB3C;RAB8B;PDIA4;COPG2;TMEM167A
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5615051987454024,1.2776306524368253,0.19490445859872613,0.8401128531326226,1.0,4/18,11.78%,LAX1;MIA3;AKT1;GPNMB
prerank,selective autophagy (GO:0061912),0.48506672102243253,1.2773657760744024,0.1299126637554585,0.839812707259227,1.0,20/56,18.77%,DYNC1LI2;HDAC6;UBE2N;ATG2B;ARL13B;DYNC1LI1;DYNC1I1;SQSTM1;UBA52;ULK2;ATG2A;ULK1;UFC1;DYNC1H1;NBR1;UFL1;PEX5;AUP1;UFM1;ATG13
prerank,negative regulation of T cell differentiation (GO:0045581),0.6192667174249827,1.2772705276047993,0.19197707736389685,0.8387265589053655,1.0,2/10,11.60%,ZC3H8;GLI3
prerank,peripheral nervous system development (GO:0007422),0.541010254959237,1.2771499787323553,0.18392204628501826,0.8377961864163332,1.0,7/23,14.31%,PMP22;SOX10;ALDH3A2;SOX8;GDNF;ASIC2;ARTN
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.4832996243131881,1.2770122415692353,0.1341330425299891,0.8369048806072537,1.0,13/57,17.74%,GHR;LIF;CTF1;VEGFA;CLCF1;TNFRSF18;INPP5F;PARP14;PIBF1;FLT3;IL4;IL6;IL18
prerank,cellular response to oxygen levels (GO:0071453),0.6312919084876919,1.2767390125504807,0.19285714285714287,0.8366128238274706,1.0,5/10,23.55%,ATP6V0A2;ATP6AP1;CCDC115;TMEM199;PICK1
prerank,negative regulation of immune system process (GO:0002683),0.5732361916545499,1.2765153156689777,0.17852522639068563,0.8361566892163667,1.0,1/16,0.16%,COL3A1
prerank,regulation of osteoblast differentiation (GO:0045667),-0.313963722590661,-1.2761849568563612,0.0,0.6001273190608587,1.0,24/82,10.58%,BMP6;RANBP3L;SMOC1;WNT4;TMEM64;PTCH1;IGF1;BMP7;MEF2C;PRKD1;NOTCH1;CDK6;ZHX3;IL6R;NELL1;ATRAID;FGFR2;NOCT;BMPR2;YAP1;NPNT;RUNX2;LRP3;BMP2
prerank,detection of mechanical stimulus (GO:0050982),0.557967484724287,1.2744875612163629,0.1815856777493606,0.8443575090004045,1.0,4/19,12.08%,PIEZO2;PKD1;PKD2;JUP
prerank,positive regulation of cell projection organization (GO:0031346),-0.30248350227067755,-1.2743834127104559,0.0625,0.601607962625131,1.0,32/115,12.46%,PLXNA2;PTN;ROBO1;LYN;RAPGEF2;PTK7;CUX1;ITGA6;SCARB2;APOE;PLXNA4;PTPRD;CDKL5;PRKD1;WNT5A;DAB2IP;PLXND1;SNX3;ROBO2;NDNF;PLPPR5;DVL3;NTRK3;MAP3K13;PLXNB1;CX3CL1;CAMK2B;MDK;EP300;SS18L1;NTRK2;BDNF
prerank,cellular response to estrogen stimulus (GO:0071391),0.5874546624548362,1.2743035218050291,0.18037135278514588,0.8436854369673668,1.0,2/14,3.41%,AR;SFR1
prerank,cellular response to reactive oxygen species (GO:0034614),0.47342050127612983,1.2742617442172213,0.11517761033369214,0.8423658968323359,1.0,17/59,14.21%,UCP1;EGFR;ANXA1;MAPK7;NFE2L2;HDAC6;PKD2;ANKZF1;CHUK;SIRPA;CAMKK2;AKT1;MAPT;PLEKHA1;OSER1;PDGFRA;FER
prerank,organic acid transport (GO:0015849),-0.2922204226600481,-1.2741670784079622,0.0,0.5990325928476455,1.0,12/94,2.99%,SLC7A11;SLC7A2;SLC6A13;ABCC4;SLC13A3;ACSL1;ABCG2;SLCO2B1;SLC26A7;SLCO1C1;SLC6A12;PDPN
prerank,regulation of actomyosin structure organization (GO:0110020),0.594294251086444,1.2734545715183818,0.19389110225763612,0.8446703194673607,1.0,5/13,15.98%,AKAP13;ASAP3;ALMS1;SLC9A1;ACTG1
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.47635655587095727,-1.273353590330998,0.2037735849056604,0.5977979528409753,1.0,3/13,4.21%,DDO;GLUL;MTHFS
prerank,regulation of RNA splicing (GO:0043484),0.4734857637210605,1.2732313816073602,0.13818565400843882,0.8442054602716133,1.0,12/69,10.62%,AHNAK2;AHNAK;AFF2;MBNL1;ZPR1;CLK1;SRSF3;RBM22;ERN1;MBNL2;SON;HNRNPH1
prerank,regulation of keratinocyte migration (GO:0051547),0.59835684483757,1.2730383922048012,0.1747159090909091,0.8436105494181759,1.0,8/12,28.74%,FGF7;ADAM9;MTOR;ARF6;PTEN;IQSEC1;FGF10;MAPRE2
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.61023524294435,1.2730214107766535,0.19605077574047955,0.8421849713132814,1.0,5/11,17.51%,TIMM10B;TIMM9;AGK;TIMM22;TIMM8B
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.6080467425250199,1.272807869392913,0.18588873812754408,0.8416851122818692,1.0,2/12,5.24%,DCN;ATP2B4
prerank,response to estrogen (GO:0043627),0.5151317678951985,1.2726782535525,0.15058823529411763,0.8408062119042854,1.0,4/31,8.43%,AR;ESR1;SFR1;CYP27B1
prerank,positive regulation of organelle organization (GO:0010638),0.5234896400777139,1.272595154651163,0.17339667458432304,0.8396549459193566,1.0,8/32,16.64%,ANXA1;ANXA2;SORBS3;SURF4;LMAN1;LNPK;SMCR8;HTRA2
prerank,ERAD pathway (GO:0036503),0.46606976015245233,1.2721078388928253,0.09791666666666667,0.8403634124716093,1.0,32/83,25.50%,UBE2J2;GET4;SYVN1;EDEM1;RNF121;RCN3;PSMC6;STUB1;ANKZF1;FBXO2;FBXO17;TOR1A;ECPAS;UBE2G2;HERPUD1;DNAJB2;TMUB2;SGTA;AMFR;SELENOS;AUP1;UGGT1;JKAMP;USP13;DERL1;SEL1L;USP19;UBXN6;RHBDD2;SEC61B;HSP90B1;UFD1
prerank,antibacterial humoral response (GO:0019731),0.566300122769087,1.2720234419063952,0.175,0.8392535558715635,1.0,4/16,12.31%,ANG;DMBT1;SLPI;RNASE6
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.441044838353018,-1.271996497841451,0.16981132075471697,0.598247121657334,1.0,8/16,25.96%,ST8SIA4;ST6GALNAC3;ST6GALNAC5;ST8SIA2;ST8SIA6;ST6GALNAC6;ST3GAL5;A4GALT
prerank,keratan sulfate metabolic process (GO:0042339),0.5201253563645125,1.2711585097441556,0.16937354988399073,0.84177794473537,1.0,6/31,4.27%,ST3GAL2;B4GALT3;B4GALT1;OGN;CHST1;ACAN
prerank,regulation of microtubule-based process (GO:0032886),0.5059471057470494,1.2711394784550205,0.15507411630558723,0.8403665333191074,1.0,10/36,15.00%,PHLDB1;CDK2AP2;EFNA5;EPHA3;ATF5;BICD1;HDAC6;MAPT;MAP6;DIAPH1
prerank,positive regulation of DNA replication (GO:0045740),0.5830459245765253,1.2707711312884795,0.19894598155467721,0.8406417898255036,1.0,5/16,13.51%,EGFR;CTC1;GLI2;EGF;DNA2
prerank,positive regulation of lipid transport (GO:0032370),0.6012108474436586,1.2704338854913722,0.17768595041322313,0.8407004136473093,1.0,2/12,1.66%,LRP1;TRIAP1
prerank,cardiocyte differentiation (GO:0035051),0.6158362745848296,1.270340461452698,0.1887052341597796,0.8396445912735795,1.0,3/10,10.65%,AKAP13;TGFB2;EEF1AKMT4-ECE2
prerank,cardiac muscle cell differentiation (GO:0055007),0.5531825594464741,1.2699816015290974,0.1760299625468165,0.8398818433308949,1.0,4/21,4.40%,WT1;AKAP13;VEGFA;ACVR1
prerank,regulation of biosynthetic process (GO:0009889),0.6081710015881114,1.2699099857362723,0.18282548476454294,0.838711082663106,1.0,1/11,0.56%,UCP1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.5260173588550393,1.269561898535582,0.15846338535414164,0.8388891895417858,1.0,11/26,20.64%,DCTN1;CLIP1;PSRC1;TOGARAM1;MAPRE1;MAPT;SLAIN2;CDK5RAP2;AKAP9;NAV3;NUMA1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.5186263188290354,1.269229897956355,0.1567251461988304,0.8389555174385689,1.0,12/31,18.39%,HOXA3;TGFBR2;IRX5;HOXA4;COL2A1;TWIST1;SIX1;PDGFRA;HOXC4;HOXA9;DYNC2I1;TGFBR1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.5253150904058658,1.2685669227339047,0.16346153846153846,0.8405527914904641,1.0,12/28,22.56%,MAP1B;MAPRE3;GAS2L1;MAPRE1;CAMSAP1;MAPT;GBA2;FKBP4;STMN4;CLASP2;MAP1A;MAP1S
prerank,peptidyl-tyrosine modification (GO:0018212),0.4785797952547425,1.2682272126356868,0.13123644251626898,0.8406602665398816,1.0,11/56,8.00%,SYK;DDR2;EPHB2;SRMS;EGFR;FGFR1;EPHA3;FYN;SRC;ABL2;ABI1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.3474629457161632,-1.2682036422256004,0.13157894736842105,0.6047055644495105,1.0,8/37,6.12%,ALCAM;TENM4;PTPRD;FAT4;CADM1;HMCN1;CXADR;VCAM1
prerank,positive regulation of response to external stimulus (GO:0032103),-0.2806636312270493,-1.2681206915494303,0.0,0.6018306775667505,1.0,38/128,17.80%,PTN;BMP6;ETS1;SASH1;APP;THBS1;SNCA;WNT5A;GPR4;PLSCR1;POLR3C;OPTN;NAPEPLD;AGTR1;POLR3B;DDX60;PUM2;PDGFRB;TLR3;FEM1A;CX3CL1;PDE2A;GBP5;MDK;RIPK1;TGFB1;PPM1F;USF1;NFKBIA;LY86;NMI;SERPINE1;USP15;LY96;LPL;DHX58;CYBA;RARRES2
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.5348017513361893,1.268068230571208,0.18026796589524968,0.8398777355695436,1.0,10/24,17.66%,SEC24D;SEC31A;SEC24A;SEC23A;PDIA3;MFSD6;IDE;SEC24B;ABCB9;BCAP31
prerank,peptidyl-proline modification (GO:0018208),0.5348045850413106,1.2679854815994807,0.17914110429447852,0.8387685272462324,1.0,14/25,25.76%,FKBP10;PPIL6;NTMT1;NKTR;PPIC;PIN1;PPIA;FKBP4;FKBP7;OGFOD1;FKBP1A;PPIG;CWC27;PPIH
prerank,recombinational repair (GO:0000725),0.46616320655360577,1.2674532252541575,0.12054507337526206,0.8397210046254868,1.0,25/77,18.42%,REV3L;XRCC3;SFR1;RAD51B;RFWD3;UBE2N;RHNO1;HELQ;AP5S1;SAMHD1;SMC5;RMI1;ERCC4;FAN1;SEM1;SMC6;NBN;INO80;RECQL;SPIDR;RNF138;RAD50;ERCC5;BLM;MORF4L1
prerank,regulation of smooth muscle cell migration (GO:0014910),0.5433292588937584,1.2674158307839567,0.17826617826617827,0.8384365782294603,1.0,4/20,8.17%,IGFBP5;LRP1;SLIT2;NDRG4
prerank,lytic vacuole organization (GO:0080171),0.5162899605926733,1.267176053770086,0.14827995255041518,0.8380130300752822,1.0,11/32,20.10%,HOOK2;ACP2;MTOR;ABCA1;TPP1;CLVS2;HPS4;GAA;SNAPIN;CLVS1;ACP3
prerank,negative regulation of lymphocyte activation (GO:0051250),0.5531992597681427,1.2669959331103793,0.18867924528301888,0.8373751189841366,1.0,4/21,11.89%,LAX1;BANK1;GPNMB;PIBF1
prerank,"wound healing, spreading of cells (GO:0044319)",0.5408318417015661,1.2665357152777483,0.15942028985507245,0.8379951590227848,1.0,7/24,14.52%,COL5A1;TMEFF2;CD44;ITGA5;TOR1A;RHOA;DDR1
prerank,cellular response to chemokine (GO:1990869),0.48425781957569713,1.2664147287520244,0.14332965821389196,0.8371023926405216,1.0,8/46,14.08%,ACKR3;CCL8;CXCL10;CCL25;STK39;CCL13;RHOA;ZC3H12A
prerank,regulation of tissue remodeling (GO:0034103),0.5762343797528201,1.2659835045524548,0.16709183673469388,0.8375681094779536,1.0,4/18,11.78%,DDR2;RUNX1;THBS4;GPNMB
prerank,positive regulation of B cell proliferation (GO:0030890),0.5204422151451971,1.2658667741081364,0.1773220747889023,0.8366607442034715,1.0,8/29,14.82%,EPHB2;MIF;CLCF1;CD81;TIRAP;TNFSF13B;IRS2;IL4
prerank,regulation of protein kinase activity (GO:0045859),0.45050341969750085,1.2658552220876769,0.08281573498964803,0.8352516593495282,1.0,25/106,13.16%,DDR2;LRP6;PLCE1;TARBP2;CAMKK1;CAMK2N1;WWTR1;MAP2K3;DTNBP1;RTRAF;MAPRE3;RASSF2;YWHAG;ADCYAP1;GAS6;IQGAP1;GSKIP;INPP5K;CAMKK2;AKT1;XRCC5;SFN;DEPTOR;SMCR8;CDKN1A
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.3390453144930732,-1.264808295922302,0.1015625,0.6075405304101873,1.0,14/39,12.92%,ROBO1;TSPAN14;EPN2;MAML3;CREBBP;NOS3;NOTCH1;ROBO2;JAG2;YAP1;MAML2;NOTCH4;EP300;PDCD10
prerank,positive regulation of chemotaxis (GO:0050921),-0.33222897531798107,-1.2646450126187463,0.12844036697247707,0.6048968126364589,1.0,14/43,12.23%,PTN;F3;THBS1;PRKD1;SEMA5A;KDR;IL6R;NRP1;NTRK3;PDGFRB;CDH13;MDK;TGFB1;PPM1F
prerank,negative regulation of ATP metabolic process (GO:1903579),0.5693005109178157,1.2644535262798975,0.19788918205804748,0.8401054485773725,1.0,7/17,15.11%,MLXIPL;PID1;FLCN;TIGAR;NCOR1;HDAC4;NUPR1
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.6201922344369569,1.263639179282072,0.20630372492836677,0.841040211949574,1.0,1/10,1.06%,SMPD3
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.6201922344369569,1.263639179282072,0.20630372492836677,0.841040211949574,1.0,1/10,1.06%,SMPD3
prerank,microtubule bundle formation (GO:0001578),0.4978286611890059,1.2635066068164806,0.15753424657534246,0.8401911177762195,1.0,14/42,22.56%,NAV1;CLIP1;PSRC1;GAS2L1;TOGARAM1;RSPH1;TPPP3;TTLL3;CHP1;CDK5RAP2;SPAG16;NUMA1;DCX;MAP1S
prerank,eosinophil chemotaxis (GO:0048245),0.5869781992388848,1.2633718612771248,0.18995929443690637,0.8379523068783656,1.0,2/14,12.90%,CCL8;CCL13
prerank,eosinophil migration (GO:0072677),0.5869781992388848,1.2633718612771248,0.18995929443690637,0.8379523068783656,1.0,2/14,12.90%,CCL8;CCL13
prerank,cellular response to hydrogen peroxide (GO:0070301),0.5066208380066827,1.263367037327556,0.15217391304347827,0.8365347006633682,1.0,9/33,16.30%,ANXA1;MAPK7;NFE2L2;HDAC6;ANKZF1;SIRPA;PLEKHA1;OSER1;IL6
prerank,regulation of urine volume (GO:0035809),0.627240517470959,1.2631664844692039,0.20857142857142857,0.836009045707349,1.0,2/10,9.96%,HAS2;INPP5K
prerank,negative regulation of hemostasis (GO:1900047),0.6123935838617068,1.2630456266762822,0.20027624309392264,0.835136193982907,1.0,1/12,0.11%,CD34
prerank,response to cholesterol (GO:0070723),0.5516108629928962,1.2627422359423115,0.19129287598944592,0.8350863326820431,1.0,3/17,3.19%,LRP6;GRAMD1A;TGFBR2
prerank,positive regulation of histone acetylation (GO:0035066),0.5393430929424526,1.2619020874342208,0.19636363636363635,0.837558195103381,1.0,4/23,10.14%,LIF;SMAD4;MUC1;BRD7
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.5708980440082111,1.261610898067491,0.18925831202046037,0.83746346608349,1.0,4/16,12.39%,PRKCA;SLC39A14;GRP;KLK6
prerank,organelle fission (GO:0048285),0.5287453157601083,1.2609077924734227,0.1977886977886978,0.8392297277101057,1.0,3/24,5.15%,SEC16B;DNM1;GDAP1
prerank,positive regulation of immune effector process (GO:0002699),0.5236577908813204,1.2608776692503136,0.16998827667057445,0.8379654208563334,1.0,3/27,8.08%,LBP;PTPRJ;CD81
prerank,Golgi localization (GO:0051645),0.6057000310214022,1.260852218074044,0.20110957004160887,0.8366906979112924,1.0,2/11,1.49%,ARHGAP21;STK25
prerank,cell-matrix adhesion (GO:0007160),0.4538652728052315,1.260667780641348,0.12045690550363447,0.8361230328026317,1.0,24/95,14.67%,CD34;COL3A1;THBS3;COL17A1;ITGA11;CD44;ITGBL1;ITGB3;ADAM9;TNN;PPFIA2;PKD1;ITGA2;ITGB5;TIMM10B;SRC;TESK2;ITGAV;L1CAM;TAOK2;ADAM15;SGCE;DDR1;PPFIA1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.5012087219749014,1.2606432121234836,0.1605351170568562,0.8348378014707227,1.0,4/38,8.88%,NOX4;DLG4;GAS6;SRCIN1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.474774230466423,-1.260517824364068,0.18181818181818182,0.6126153356322364,1.0,1/12,0.65%,IL1R1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.590539005284185,1.2604584261175185,0.19828815977175462,0.834302696606605,1.0,3/13,12.18%,SEC16B;CD81;TMEM30A
prerank,regulation of interleukin-8 production (GO:0032677),0.4694539268490769,1.2603526130631852,0.12166488794023479,0.8334084175560288,1.0,14/69,16.43%,SYK;LBP;ANXA1;F2R;TLR5;PRKD2;TIRAP;TLR4;OTUD7B;BCL3;KLF4;CD14;IL6;ANXA4
prerank,establishment of protein localization to membrane (GO:0090150),0.4666969093809218,1.2601012854191782,0.13347457627118645,0.8331004812638538,1.0,35/66,33.06%,EGFR;RFTN1;NECTIN3;ZDHHC7;VPS37D;TAOK2;ZDHHC2;VPS37C;SEC63;FRMPD1;ZDHHC4;ZDHHC24;VPS37B;ZDHHC21;ZDHHC20;NACA;RAB10;COX18;ZDHHC18;ICMT;ATG3;SDCBP;SYNE3;MICALL1;GORASP1;PRKCI;ZDHHC15;PARD3;MYO1C;GOLGA7B;PIKFYVE;ARL6;CHM;RAB3GAP1;ZDHHC3
prerank,intracellular cholesterol transport (GO:0032367),0.5770163173926256,1.2597115314440155,0.20107238605898123,0.8335227686423831,1.0,3/15,7.00%,LRP6;OSBPL2;ABCA1
prerank,ribonucleoprotein complex assembly (GO:0022618),0.4430678578729703,1.259448498941916,0.09576612903225806,0.8332414349160404,1.0,53/132,27.22%,RPSA;GEMIN6;TARBP2;MRPS11;SRSF6;ABT1;LSM4;WDR77;CPSF6;USP39;KHDC4;CELF2;EIF6;EIF3A;XRCC5;TGS1;POLR2D;RPS27L;RPS5;RRP7A;HSP90AA1;DDX20;RPL6;NOP53;SNRPG;SNRPD3;PWP2;LUC7L3;RPF2;EIF2S2;PUF60;GCFC2;STRAP;LUC7L2;SF3B1;SRPK1;NOP2;RSL24D1;RBM5;SMN1;COIL;BRIX1;EIF4H;CPSF7;CELF3;RAMAC;ERAL1;PRPF19;CRNKL1;PRPF6;DHX29;DDX1;PRKDC
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.4461344439038211,1.2587839328221022,0.10450819672131148,0.8348583812452796,1.0,38/122,17.46%,AR;NIBAN1;EGFR;IRS1;CTC1;FGF2;TGFB2;SMOC2;TMEM106A;MTOR;IL33;GLI2;PRKD2;LARP4;EPM2AIP1;TLR4;HNRNPD;DYRK2;NPM1;AKT1;PASK;IRS2;EIF6;EGF;RPS27L;BCL3;ZCCHC4;DNA2;POLDIP3;RBM3;KLF4;EIF3E;IL4;IL6;HGF;EIF3D;FXR2;YTHDF1
prerank,sulfur compound catabolic process (GO:0044273),0.4966512253568122,1.258621910456596,0.1611804767309875,0.8342675580773027,1.0,6/38,7.87%,DCN;OGN;ACAN;VCAN;NUDT7;DPEP1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.577179268126151,1.2582828790401617,0.19947848761408082,0.834423899692203,1.0,7/15,26.92%,TSEN54;RTRAF;ERN1;CPSF4;TRPT1;CPSF1;DDX1
prerank,Golgi inheritance (GO:0048313),0.600096249498306,1.2578700077188207,0.20916905444126074,0.8349173171269669,1.0,2/11,3.58%,STK25;STX5
prerank,positive regulation of interleukin-8 production (GO:0032757),0.4818325094213807,1.2573600457979581,0.14065934065934066,0.835870735810448,1.0,7/49,9.07%,SYK;LBP;F2R;TLR5;PRKD2;TIRAP;TLR4
prerank,myelination in peripheral nervous system (GO:0022011),0.6007166939705549,1.2572732849748445,0.18281036834924966,0.8349265169034743,1.0,4/13,9.54%,MYOC;SKI;SIRT2;ARHGEF10
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.49484032622848756,1.2571668768663442,0.14123006833712984,0.8339965434364589,1.0,9/40,5.16%,COL1A1;LOXL2;TGFB3;TGFB2;TGFBR2;SMAD4;WWTR1;TCF7L2;MTOR
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.4737906179188283,1.2566935175881475,0.15608180839612487,0.8348688986310795,1.0,20/51,24.31%,DBN1;DCLK1;TAOK3;TRIO;DTNBP1;WASF1;SNX1;KIF20B;TAOK2;SLC9A6;ANKRD27;SRGAP2;SHTN1;GPM6A;NBL1;GAS7;CTTN;MAP1S;CNTNAP1;ALS2
prerank,long-chain fatty acid import into cell (GO:0044539),-0.5096684250685541,-1.256233893554925,0.2,0.6212222948376411,1.0,3/10,5.97%,ACSL1;SLC2A1;ACSL3
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5315974581379509,1.2561256018358036,0.21177944862155387,0.8360906830574218,1.0,6/21,16.35%,EIF2AK3;SYVN1;CREB3L1;HERPUD1;SELENOS;NCK1
prerank,regulation of regulated secretory pathway (GO:1903305),0.5069894062024357,1.2560236722103086,0.15632458233890215,0.8351744559782622,1.0,10/34,18.84%,SYT2;SYT12;SYT11;SYT13;DTNBP1;RAB3D;SNAPIN;SYT1;PREPL;RIMS2
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.526671593646763,1.2554242442398094,0.18941176470588236,0.8365926304248635,1.0,4/26,7.26%,CCBE1;EIF2AK3;SULF2;SULF1
prerank,neuron apoptotic process (GO:0051402),-0.4188318400660563,-1.2553701466110136,0.16740088105726872,0.6205476199165888,1.0,8/19,13.10%,APP;BCL2;TRPC5;FAM162A;TNFRSF21;FAS;CDK5;GAPDH
prerank,protein heterotetramerization (GO:0051290),0.5920025614288548,1.255355285166609,0.19143239625167335,0.8355364499689408,1.0,5/13,15.10%,PKD1;KRT10;PKD2;CPSF6;HSD17B8
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.5459144056449181,1.2545391684801879,0.19053549190535493,0.8378039123679788,1.0,2/21,4.35%,LRP6;AXIN1
prerank,mitochondrion distribution (GO:0048311),0.6050869516931181,1.2541473706411048,0.20385674931129477,0.8382586489420991,1.0,4/12,14.51%,CLUH;TRAK2;MAPT;ATCAY
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.589950251558455,1.2540869383512205,0.20883534136546184,0.837151474845484,1.0,4/13,12.62%,SRI;CAMK2D;PDE4D;CALM2
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.4203273244838679,-1.2538171699914047,0.18951612903225806,0.6215640073182902,1.0,4/17,6.08%,PRKAG2;PRKAA2;PPARA;CAV1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.5303232616843427,1.2535896564675313,0.19225967540574282,0.8379870367281925,1.0,6/23,16.30%,GHR;F2R;IL10RA;PIBF1;IL4;IL6
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.47265069471508886,1.2534789406038236,0.1504907306434024,0.837104735392914,1.0,15/54,12.08%,FGF18;PRKCA;FGFR1;ANGPT4;VEGFA;FGF2;MAPK14;MAP2K3;ATP2B4;PRCP;PRKD2;STAT5A;AKT3;AKT1;JUP
prerank,protein glycosylation (GO:0006486),0.44535929939653685,1.2532080315232237,0.09193054136874361,0.8369696646880853,1.0,26/125,16.48%,GFPT2;PLOD2;ST3GAL2;B4GALT1;B3GALNT1;GFPT1;FUT2;MGAT1;POMGNT2;GALNT10;GALNT18;OGA;PLOD3;ALG1;LARGE1;FUT9;B3GNT8;GALNT1;ST3GAL4;MGAT5;MGAT2;MGAT4B;TUSC3;B3GALNT2;OGT;TMEM165
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.5907270271583374,1.253127051274278,0.20488466757123475,0.8359841124670568,1.0,4/12,14.08%,ESR1;NCOR2;NCOR1;ZC3H12A
prerank,regulation of macrophage cytokine production (GO:0010935),0.5847689109483076,1.2528407823308,0.19654714475431606,0.8359853349112246,1.0,3/13,2.91%,TGFB3;IRAK3;TGFB2
prerank,establishment of spindle localization (GO:0051293),0.5888660084567402,1.2515457781264077,0.22116689280868385,0.84044224743482,1.0,7/14,26.59%,TLE6;LLGL1;DYNC1H1;MAP4;CLASP2;NLRP5;KPNB1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.5406935855828328,1.251307483656561,0.1973365617433414,0.8401954812107864,1.0,5/22,11.33%,LBP;RAB7B;NR1D1;TIRAP;WDFY1
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5293591342156281,1.251184381541738,0.19230769230769232,0.8393879259612529,1.0,8/22,17.41%,VEGFA;RASSF2;GPNMB;CALM2;TAOK2;NBN;TNKS1BP1;RAD50
prerank,mRNA transport (GO:0051028),0.45004646158456935,1.2505295412355621,0.10301768990634755,0.8410657479531611,1.0,44/101,28.06%,SRSF2;SRSF6;NXF1;DDX19B;ZFP36L1;NUP93;MCM3AP;NUP107;U2AF1;SRSF3;NUP98;CPSF4;SRSF11;THOC7;ZFP36;POLDIP3;SMG7;THOC2;THOC1;ZC3H11A;SMG6;FYTTD1;NUP37;CPSF2;DDX39A;SRRM1;NUP50;SLBP;U2AF2;TPR;CPSF1;AGFG1;WDR33;NUP133;NUP85;ALYREF;UPF3B;NUP188;UPF1;NUP88;SMG5;CDC40;THOC5;CPSF3
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.35789938764978924,-1.2501398495764047,0.16363636363636364,0.6282479417883509,1.0,5/32,4.40%,PRKAG2;SORBS1;APOE;PRKAA2;PPARA
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.5430636321066445,1.2500814601333885,0.19518377693282637,0.8416913228991341,1.0,5/19,14.87%,LBP;TIRAP;TLR4;IRAK1;CD14
prerank,regulation of bone mineralization (GO:0030500),-0.31779779339734887,-1.2496292980829367,0.09090909090909091,0.6266919978020977,1.0,15/55,7.95%,PTN;BMP6;WNT4;ADGRV1;ENPP1;BMP7;MEF2C;OSR1;ANKH;KL;NELL1;ATRAID;S1PR1;NOTUM;BMPR2
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.3860915022757651,-1.2495791823698528,0.1534090909090909,0.6237346640043778,1.0,5/26,3.34%,SORBS1;OCLN;INSR;IGF1;OSBPL8
prerank,production of siRNA involved in RNA interference (GO:0030422),0.6053234949943456,1.2493023780361825,0.21511627906976744,0.8438603610176708,1.0,2/10,8.89%,TARBP2;AGO2
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.4058933705309866,-1.2491610588516424,0.13942307692307693,0.6218791003677625,1.0,5/20,8.53%,GRK3;MGRN1;SNCA;CRY1;APLP1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.4292890807535291,1.248881367383015,0.01001001001001001,0.8443623531769371,1.0,91/390,16.35%,ANGPTL1;GHR;SYK;DDR2;EPHB2;FGF18;COL1A1;AXL;ARHGEF28;NCF4;FGF7;SRMS;EGFR;TNK1;POLR2H;IRS1;HPN;FGFR1;EFNA5;DNM1;FLRT2;EIF2AK3;HNRNPA1;GRB10;EPHA3;SULF2;FYN;ITGB3;VEGFA;MMP2;FGF2;MST1R;PIK3R2;MAPK14;ATP6V0A2;SLC39A14;ANKS1B;NFATC4;TRIM71;PTPRJ;SOCS2;FOXO1;AP2A2;RET;SRC;ACTR3;SULF1;POLR1G;PRKD2;ABI1;PIK3CA;PSEN1;FOXC2;SIRT2;MAPK11;ITGAV;RHOQ;EFS;EPHB3;MUSK;HNRNPH1;AKT1;ATP6V1E1;RBFOX2;EPHA10;IRS2;FLRT3;NGEF;SHOC2;ATP6AP1;POLR2D;POLR2G;FLT3;RHOA;AAMP;CBL;PDGFRA;FER;DDR1;HSP90AA1;RAPGEF1;GTF2F1;ATP6V0A1;ATP6V1D;AHI1;ACTG1;ATP6V1B2;ARPC1A;SOS1;HGF;NCK1
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.5566611694665116,1.2488745338780658,0.1859557867360208,0.8430482586474164,1.0,4/17,11.41%,SLC4A8;STX1A;SCAMP5;RAB3D
prerank,regulation of neuroinflammatory response (GO:0150077),0.5412037295821903,1.248654529647722,0.20405576679340937,0.8425926628388669,1.0,9/19,17.74%,IL33;NR1D1;DAGLA;CD200R1;TNFRSF1B;IL4;NUPR1;IL6;IL18
prerank,regulation of protein kinase B signaling (GO:0051896),0.43562590801494755,1.2485966708288136,0.04919678714859438,0.8415110455513273,1.0,35/193,13.14%,AREG;MYOC;CD80;ESR1;FGF18;AXL;FGF7;EGFR;IRS1;FGFR1;BTC;FYN;FGF2;MST1R;PIK3R2;OTUD3;TCF7L2;PTPRJ;RCN3;C1QBP;RET;SRC;BANK1;GAS6;FLCN;FLT3LG;PIK3CA;PHLPP2;INPP5K;AKT1;MAGI2;IRS2;EGF;FLT3;PLEKHA1
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.399916743953734,-1.2478874208367015,0.18181818181818182,0.6222270301651844,1.0,9/23,20.41%,SASH1;DAB2IP;DVL3;TNFRSF11A;EDN1;MAP3K5;ARHGEF5;DUSP19;MAP3K10
prerank,regulation of protein-containing complex assembly (GO:0043254),0.44613521332111233,1.247417623089645,0.11134020618556702,0.8454139872469937,1.0,26/110,18.03%,SYK;GSN;VEGFA;CDC42EP2;MPP7;AIDA;GNL3L;PREB;FARP2;SRC;ABCA1;HDAC6;STX1B;TFIP11;HJURP;TIRAP;BMF;NAPA;BAK1;ULK1;HSP90AA1;NOP53;HRK;SPIDR;PEX5;IAPP
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.5266542175587086,1.246625075863986,0.20074349442379183,0.8477630820329218,1.0,9/23,21.11%,MTMR11;OCRL;INPP5F;INPP5K;MTMR6;MTMR1;PIP4P1;INPP5B;PTEN
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.5003245046608757,1.2463164781622054,0.1813953488372093,0.8477869559773997,1.0,15/33,22.79%,IRS1;PIK3C2B;PIK3R2;CD160;ZFP36L1;C1QBP;PIK3CA;SIRT2;AKT1;PLEKHA1;TYRO3;PTEN;PIK3CG;NF1;HTR2A
prerank,negative regulation of biomineral tissue development (GO:0070168),0.5379619008369018,1.2460930209116394,0.19371069182389938,0.8474113381346249,1.0,3/21,7.57%,ASPN;ECM1;GAS6
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.5416072379608414,1.2460769721119562,0.21456436931079323,0.8461449501795066,1.0,7/18,17.29%,CDK4;RAD51B;VPS4B;DTL;FBXO5;CCND1;RCC2
prerank,ribosomal small subunit biogenesis (GO:0042274),0.4912639056809056,1.2455259837379262,0.19080459770114944,0.8473596631375399,1.0,14/39,20.91%,RPSA;MRPS11;RIOK1;RRP36;NPM1;RPS27L;RPS5;SNU13;RRP7A;DDX52;PWP2;SRFBP1;RIOK2;RPS25
prerank,cGMP metabolic process (GO:0046068),-0.4724396574613387,-1.2453665829435712,0.20599250936329588,0.6259644639129959,1.0,4/12,12.97%,GUCY1B1;NPR1;PDE2A;GUCY1A1
prerank,canonical Wnt signaling pathway (GO:0060070),0.4620922894040328,1.2447631517691682,0.13752665245202558,0.8494885612658433,1.0,8/68,5.14%,SFRP4;LRP6;WNT10B;WNT2;WNT9A;PLPP3;AXIN1;TCF7L2
prerank,epithelial cell differentiation (GO:0030855),0.44677429342913694,1.2445389367397104,0.12344398340248963,0.8491565662090235,1.0,17/88,16.56%,FSTL1;DHRS9;ANXA1;WT1;VEGFA;ZDHHC7;TPP1;FZD7;JAG1;TDRD7;ACADVL;AKT1;DMBT1;SIX1;VDAC1;ANXA4;BDH2
prerank,dopamine metabolic process (GO:0042417),-0.41962960200727184,-1.2441698585522785,0.16326530612244897,0.6262173380054258,1.0,4/18,8.05%,SNCAIP;MOXD1;SNCA;GCH1
prerank,artery development (GO:0060840),-0.4036418883033662,-1.244138800128436,0.1656441717791411,0.6232562553042678,1.0,9/23,9.63%,ROBO1;ENG;ROBO2;NRP1;TBX1;BMPR2;STRA6;HECTD1;PDE2A
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.5637991345431699,1.243763736841813,0.20915032679738563,0.8513062706237362,1.0,8/15,21.76%,TGFBR2;IRX5;TWIST1;SIX1;PDGFRA;TGFBR1;NIPBL;LHX1
prerank,regulation of phospholipase activity (GO:0010517),0.6090630789986641,1.2436592843423158,0.19970845481049562,0.8504212395513914,1.0,2/10,1.44%,LRP1;FGFR1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.5097099977385703,1.2435480935729606,0.18369829683698297,0.8496294349936556,1.0,8/27,15.06%,AHNAK;JSRP1;ANK2;CAMK2D;YWHAE;PDE4D;CALM2;CACNB1
prerank,cell differentiation in spinal cord (GO:0021515),-0.5045160647971794,-1.2432213188913186,0.2077922077922078,0.6226096118743689,1.0,2/10,2.51%,SOX6;SOX13
prerank,catecholamine biosynthetic process (GO:0042423),-0.48860043021153854,-1.2428195211571051,0.17421602787456447,0.6207687724791455,1.0,4/11,10.24%,MOXD1;SNCA;GCH1;DDC
prerank,sensory perception of chemical stimulus (GO:0007606),0.560391910318396,1.242263688668195,0.21578947368421053,0.8538264826061974,1.0,2/15,14.11%,GNAS;BBS4
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.5412670971682183,1.2421918789433337,0.20584498094027953,0.8528664996872536,1.0,7/19,17.16%,HPN;MAPK7;TMEM106A;KLF2;EGF;KLF4;CHRNA7
prerank,positive regulation of heart contraction (GO:0045823),-0.42064277330770794,-1.2418276855480328,0.18357487922705315,0.6205038773642488,1.0,6/19,15.59%,ATP1A2;KCNQ1;RYR2;EDN1;ADM;EDN3
prerank,neurotransmitter uptake (GO:0001504),-0.48814389390342977,-1.24167836051836,0.23381294964028776,0.6179336813949522,1.0,3/12,1.65%,ATP1A2;SLC1A3;GLUL
prerank,regulation of exosomal secretion (GO:1903541),0.5477019143302699,1.2414105442122207,0.21161290322580645,0.8550538582850635,1.0,3/19,5.87%,SMPD3;VPS4B;ATP9A
prerank,respiratory tube development (GO:0030323),0.5097779273125573,1.2412172219402071,0.20334928229665072,0.8545729904764359,1.0,5/28,7.49%,FGF7;PCSK5;VEGFA;FGF2;GLI2
prerank,cardiac muscle tissue development (GO:0048738),-0.3188247880440221,-1.2404248019472424,0.07954545454545454,0.6185398940432216,1.0,12/50,10.58%,GJB6;BMP5;ADAMTS9;BMP7;RBP4;NOTCH1;TBX18;GJA1;BMPR2;TBX2;SIK1;BMP2
prerank,body fluid secretion (GO:0007589),0.5640319751257952,1.2404189232072516,0.2077922077922078,0.8567823859529144,1.0,2/15,2.76%,GPAT4;VEGFA
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.5287538556718564,1.240169868813216,0.22600243013365734,0.8565662605407499,1.0,6/22,9.53%,ABT1;URB1;KRI1;ERI3;NOP9;EXOSC7
prerank,phospholipid dephosphorylation (GO:0046839),0.4921523440203766,1.2399364192306335,0.1772885283893395,0.8563329002570078,1.0,16/37,24.98%,MTMR11;PLPP3;PLPP5;PLPP1;OCRL;INPP5F;INPP5K;PLPPR3;MTMR6;MTMR1;PIP4P1;PLPP2;INPP5B;PTEN;SGPP1;MTM1
prerank,regulation of intracellular transport (GO:0032386),0.48962032074108586,1.2395303117257603,0.18129988597491448,0.856841960542519,1.0,14/38,23.18%,GAS1;NDEL1;RBM4;ATP9A;RINT1;INPP5F;SCFD1;ANTKMT;DYNC1H1;REEP5;CAPN10;NUMA1;GRIPAP1;CRYAB
prerank,embryonic limb morphogenesis (GO:0030326),0.4967523869555611,1.2385087007500224,0.1776470588235294,0.8600232299215987,1.0,9/34,13.56%,LRP6;AFF3;MBNL1;TGFB2;SKI;ECE1;FBXW4;GLI3;TWIST1
prerank,aorta development (GO:0035904),-0.44375461917649295,-1.238421534565736,0.2066115702479339,0.6211107766192615,1.0,8/14,9.63%,ROBO1;ADAMTS9;ROBO2;TBX1;PDGFRB;HECTD1;TBX2;PDE2A
prerank,negative regulation of interferon-gamma production (GO:0032689),0.529751484853476,1.2383105457792971,0.2114914425427873,0.859613410593072,1.0,6/23,14.08%,AXL;C1QBP;INHA;GAS6;TLR4;ZC3H12A
prerank,synaptic vesicle exocytosis (GO:0016079),0.4873038195595279,1.2379532980597963,0.16970387243735763,0.8598645716269999,1.0,15/40,18.84%,SYT2;STX2;STX1A;STX11;STX1B;STX4;SNAP23;SNAP25;SNAP47;SNAPIN;SNPH;SYT1;STX3;VAMP2;RIMS2
prerank,regulation of osteoclast differentiation (GO:0045670),0.493440683024909,1.2375401938427975,0.19632606199770378,0.8603784537071681,1.0,7/33,17.44%,FBN1;MTOR;LRRC17;TLR4;CEBPB;IL4;GPR137B
prerank,positive regulation of protein secretion (GO:0050714),-0.300321374025552,-1.2375393161056238,0.06557377049180328,0.6204921580231505,1.0,10/69,3.64%,BMP6;WLS;UNC13B;FRMD4A;MYRIP;IGF1;RBP4;CD2AP;MYO18A;ACSL4
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.48890229903513505,-1.2374412234948278,0.21428571428571427,0.6178369976119047,1.0,5/11,6.26%,ADAMTS9;EPN2;THBS1;PIK3CB;SEMA6A
prerank,glycosaminoglycan metabolic process (GO:0030203),0.4680109117633669,1.237206260589026,0.18494623655913978,0.8604724914301316,1.0,15/54,17.63%,HAS1;GPC6;UGDH;GPC3;EXT1;B3GAT3;XYLT1;HS2ST1;HS3ST6;HS3ST5;HSPG2;NAGLU;IDUA;SDC2;NDST2
prerank,cellular response to cytokine stimulus (GO:0071345),0.4253173619085015,1.2367924909655017,0.02,0.8610429144142102,1.0,92/416,17.97%,IL4R;GHR;SYK;LBP;LIF;COL1A2;HAS2;CD80;DUOX1;AXL;CCL8;IRF4;ANXA1;NUMBL;IL16;CTF1;GRB10;FYN;VEGFA;IRAK3;MMP2;FGF2;STX1A;NFE2L2;ZFP36L1;CLCF1;PTPRJ;SOCS2;USP10;FOXO1;NR1D1;CSK;CXCL10;MUC1;FSCN1;RC3H1;PID1;ABL2;GAS6;IL10RA;FLT3LG;ZFP36L2;STAT5A;CHUK;PIK3CA;CDK9;CCL25;TLR4;STX4;UBE2G2;MAPK11;INPP5K;CD47;SIRPA;IRAK4;BCL6;AKT1;SLC26A6;CSF2RA;IRAK1;STK39;UBA52;CDC34;ZFP36;CCL13;FLT3;CDKN1A;CCND1;IL5;RHOA;TWIST1;TNFRSF1B;CBL;ZC3H12A;FER;CNTFR;HSP90AA1;IL4;RAPGEF1;BAG4;SOCS6;IL6;SOS1;HGF;STAT5B;HTRA2;ZEB1;CXCR4;PTPN5;IL18;EPRS1;STX3
prerank,camera-type eye development (GO:0043010),0.5181037595809552,1.2364761933216453,0.2111506524317912,0.8610796627130187,1.0,7/25,12.56%,FBN1;WT1;VEGFA;SKI;TENM3;TSKU;ALDH1A3
prerank,RNA export from nucleus (GO:0006405),0.44385056510440024,1.2364488997879717,0.13174273858921162,0.8598833631238278,1.0,43/100,28.06%,SRSF2;HNRNPA1;SRSF6;NXF1;DDX19B;NUP93;MCM3AP;NUP107;U2AF1;SRSF3;NUP98;CPSF4;SRSF11;THOC7;POLDIP3;SMG7;THOC2;THOC1;ZC3H11A;SMG6;FYTTD1;NUP37;CPSF2;DDX39A;SRRM1;NUP50;SLBP;U2AF2;TPR;CPSF1;AGFG1;WDR33;NUP133;NUP85;ALYREF;UPF3B;NUP188;UPF1;NUP88;SMG5;CDC40;THOC5;CPSF3
prerank,protein targeting (GO:0006605),0.4407893869867343,1.2360919672507993,0.11734693877551021,0.8601494605192942,1.0,60/118,33.06%,AP4B1;PEX16;GDAP1;EDEM1;ZDHHC7;SPCS1;VPS37D;TIMM10B;TRAK2;TIMM9;HPS4;AP4E1;TAOK2;ZDHHC2;VPS37C;PEX12;PEX1;SEC63;GIPC1;TIMM22;SEC61A1;ZDHHC4;AP4M1;ZDHHC24;VPS37B;ZDHHC21;TIMM8B;ZDHHC20;NACA;BCAP31;TOMM5;AP1S3;ZDHHC18;ICMT;TIMM17A;ATG3;SDCBP;FUT10;SRPRB;FIS1;TOMM40;KIF13B;MICALL1;PITRM1;NLGN1;PRKCI;SPCS3;ZDHHC15;PARD3;MYO1C;GOLGA7B;PIKFYVE;MFN2;CDC37;TOMM34;ARL6;CHM;AP4S1;PEX19;ZDHHC3
prerank,monocarboxylic acid transport (GO:0015718),-0.3245527099282875,-1.2358711354863092,0.11827956989247312,0.6191030606399015,1.0,9/51,2.26%,SLC6A13;SLC16A12;ABCC4;SLC16A2;ABCG2;SLCO2B1;SLCO1C1;SLC16A6;SLC6A12
prerank,tube closure (GO:0060606),0.5018640575862772,1.235617084099344,0.2032520325203252,0.8609384120696253,1.0,4/31,4.06%,LRP6;TGFB2;COBL;SKI
prerank,regulation of protein import into nucleus (GO:0042306),0.4871757219592011,1.23533232915698,0.18213457076566125,0.8609150468863657,1.0,17/36,22.68%,ZPR1;PIK3R2;RAB23;MDFIC;PSEN1;RBM22;HDAC3;JUP;CABP1;ZC3H12A;DMAP1;CHP1;IPO5;UFM1;FLNA;BAG3;TPR
prerank,negative regulation of axonogenesis (GO:0050771),0.5102618527308083,1.2349856474460807,0.20727272727272728,0.8611418239393067,1.0,8/27,14.33%,FGF13;PTPRS;TRIM46;GDI1;ULK2;RHOA;ULK1;DCC
prerank,primary neural tube formation (GO:0014020),0.5049440764470703,1.2348263652345288,0.2044392523364486,0.8605502028540506,1.0,4/30,4.06%,LRP6;TGFB2;COBL;SKI
prerank,regulation of cell differentiation (GO:0045595),0.43510690762955495,1.2348246388061643,0.10404040404040404,0.8592648904567887,1.0,36/148,16.97%,LIF;AR;PHLDB1;TRPS1;SCIN;FGFR1;EPHA3;RUNX1;BIN1;ZFP36L1;HOPX;HEMGN;TAF8;NR1D2;NR1D1;ZFHX3;TRIP4;YWHAG;CDK9;PDCD2;PLEKHB2;BCL6;CEBPB;ANP32B;KLK6;ST7;GDNF;DDX17;SIX1;FADS1;KLF4;KLHL41;CDK5RAP2;DDX5;SNAI2;FLOT2
prerank,myoblast differentiation (GO:0045445),0.5644508963648673,1.234686637693618,0.2077922077922078,0.8585948824619853,1.0,6/14,16.59%,MAPK12;MBNL1;TCF7L2;JAG1;DDX17;DDX5
prerank,protein import into nucleus (GO:0006606),0.45733905423394106,1.2343106243075128,0.15458422174840086,0.8589066353974213,1.0,28/66,27.02%,SYK;SPRN;NUP93;KPNA2;NUP107;AKT1;IPO9;TNPO2;E2F3;IPO5;NUP50;NXT2;KPNA1;RPL23;RANBP6;TPR;IPO11;CBLB;IPO13;TSC2;NUP133;NUP85;TNPO1;KPNA6;FAM53C;NUP188;KPNB1;NUP88
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.43316713968691267,1.2342021802736431,0.10953346855983773,0.8581288586319097,1.0,24/128,10.84%,COL3A1;COL1A2;AMH;TMEM100;TGFB3;ZMIZ1;TGFB2;TGFBR2;ADAM9;SMAD4;SMURF2;SKI;ACVR1;BMP15;ITGB5;FAM83G;RNF111;SRC;SMAD5;STUB1;PARD6A;BMP8A;SMAD6;AMHR2
prerank,regulation of fibrinolysis (GO:0051917),0.5854991678084389,1.2341142679401063,0.22837837837837838,0.857250507316141,1.0,2/13,3.63%,FAP;KLKB1
prerank,modulation by symbiont of entry into host (GO:0052372),-0.420130845821658,-1.2340431824067506,0.18218623481781376,0.6210512912719843,1.0,8/16,22.96%,TRIM25;CAV1;NECTIN2;TRIM62;TRIM21;EXOC2;TRIM5;TRIM6
prerank,secondary palate development (GO:0062009),0.5709654366783525,1.233952984363973,0.22580645161290322,0.8566685451363907,1.0,4/14,3.68%,TGFB3;TGFB2;TGFBR2;SMAD4
prerank,regulation of signal transduction (GO:0009966),0.4309750323344008,1.2336024143254338,0.08132530120481928,0.8568729375534179,1.0,35/190,10.07%,IGFBP5;CD80;CD55;ESR1;MGLL;SRMS;PLCE1;FYN;CD177;GAS1;DGKQ;IGFBP6;CDKN2AIP;RUNX1;LLGL1;WWTR1;AXIN1;ACVR1;GNG4;IGFBP4;ZDHHC7;MTCH1;SOCS2;TSPEAR;DTNBP1;CSK;SRC;YWHAG;SULF1;ADCYAP1;FOXL1;MDFIC;RFNG;GSKIP;USP33
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.49002934338516074,1.233517762449431,0.2127906976744186,0.8560047048453328,1.0,11/32,14.32%,ANXA1;MEOX2;VEGFA;FGF2;HDAC9;HDAC7;FOXC2;AKT3;RHOJ;RHOA;KLF4
prerank,positive regulation of GTPase activity (GO:0043547),-0.23406236764261373,-1.2330534593881928,0.0,0.6207529272021514,1.0,46/188,11.95%,ARHGAP29;PKP4;TBC1D4;RAPGEF2;RAPGEF3;TBC1D1;ITGA6;RAP1GDS1;NET1;CDKL5;F11R;ARHGAP24;RALGAPA1;DOCK8;TGM2;RASGRP2;SIPA1L1;ARHGEF26;MAP4K4;PIP5K1A;RGS6;DVL3;NTRK3;RANGAP1;TBC1D25;DOCK9;GRTP1;CCDC125;TBC1D16;BCAR3;PLXNB1;ERBB2;CX3CL1;SFRP1;CAV2;MTSS2;ZC3H15;USP6NL;LIMS1;AGRN;TBC1D30;RGP1;RALGAPA2;TBC1D10B;TBC1D8;SCRIB
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.33950498551008695,-1.2329494476383263,0.10084033613445378,0.6181656897186086,1.0,14/38,17.73%,BMP6;SASH1;PLSCR1;POLR3C;POLR3B;DDX60;PUM2;GBP5;LY86;NMI;USP15;LY96;DHX58;CYBA
prerank,response to alcohol (GO:0097305),0.5116643549254302,1.2327844655674352,0.2179640718562874,0.8579282053683267,1.0,7/27,18.39%,SLIT3;SLIT2;TGFBR2;GRIN3A;PMVK;GRIN2A;TGFBR1
prerank,negative regulation of viral entry into host cell (GO:0046597),0.5887113262624688,1.2327468452563672,0.22988505747126436,0.8568149928759191,1.0,3/12,10.83%,GSN;MID2;TRIM11
prerank,regulation of cellular protein localization (GO:1903827),0.47148284262072865,1.2326695925695448,0.18632855567805953,0.8558760115272699,1.0,12/45,16.65%,RAB11FIP5;GPC6;GPC3;NDEL1;TRIM46;TOR1A;MAPT;SETD2;EGF;PIN1;HSP90AA1;SPIDR
prerank,chromatin assembly (GO:0031497),0.4905956915187161,1.2323905452666895,0.19328703703703703,0.8557530476452999,1.0,21/38,29.86%,CHAF1B;NOC2L;SPTY2D1;POLE3;NPM1;ANP32B;EZH1;BAHD1;GRWD1;NAP1L2;CTCF;PRDM9;PAF1;BRD2;KAT6B;NAP1L3;H1-0;LIN54;ATRX;TP53;SOX9
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.46121824426647945,1.231451472724652,0.17419354838709677,0.858580709178611,1.0,13/63,17.74%,EPHB2;CD80;ANXA1;MIF;CLCF1;CD81;TIRAP;TNFSF13B;IRS2;IL4;IL6;NCK1;IL18
prerank,response to purine-containing compound (GO:0014074),0.5427187810868015,1.2312717967073523,0.2266839378238342,0.8581366468587963,1.0,2/17,2.74%,DUOX1;DGKQ
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.6049937398233072,1.2311877235347657,0.2327823691460055,0.8572440890223507,1.0,5/11,16.99%,MTOR;DDX11;SMARCA4;NOP53;IPPK
prerank,regulation of peptidase activity (GO:0052547),0.5408565665454659,1.2309567799457595,0.22467532467532467,0.8570029170660806,1.0,4/19,10.48%,MAPK12;ECM1;RCN3;CSTB
prerank,regulation of biomineral tissue development (GO:0070167),0.5128642296879824,1.2308953069203246,0.21983273596176822,0.8560007450296353,1.0,10/26,16.45%,DDR2;ECM1;GAS6;CYP27B1;BMP2K;SGMS2;CEBPB;FBXO5;TWIST1;NBR1
prerank,glucan biosynthetic process (GO:0009250),0.5796643996921266,1.230806616665319,0.2313937753721245,0.8539399039080058,1.0,4/12,12.79%,UGP2;NR1D1;PGM2L1;PPP1R3C
prerank,glycogen biosynthetic process (GO:0005978),0.5796643996921266,1.230806616665319,0.2313937753721245,0.8539399039080058,1.0,4/12,12.79%,UGP2;NR1D1;PGM2L1;PPP1R3C
prerank,transepithelial transport (GO:0070633),-0.4207713772141995,-1.230490124468619,0.19246861924686193,0.6219892727626829,1.0,4/15,6.09%,SLC1A3;ABCG2;SLC12A2;CXADR
prerank,protein localization to cell junction (GO:1902414),-0.3941966588114358,-1.2299092443300381,0.1619047619047619,0.6208442738907893,1.0,4/22,4.53%,TJP1;CGNL1;TJP2;PCLO
prerank,regulation of protein sumoylation (GO:0033233),0.5470269212739971,1.2298152595896454,0.2212041884816754,0.8570573827811138,1.0,5/17,13.86%,ZMIZ1;GNL3L;PIAS3;UBA2;HDAC4
prerank,RNA metabolic process (GO:0016070),0.43080076727540706,1.2278306215327541,0.13069908814589665,0.8643653702045727,1.0,40/127,19.98%,POLR2H;ADARB1;HNRNPA1;RNASE4;RBM4;BICD1;PRPF4;ATXN2;TFIP11;AGO2;DUSP11;HNRNPD;EXOSC7;SIDT2;HNRNPH1;DHX8;CELF2;RBFOX2;RNASE6;POLR2D;POLR2G;MPHOSPH10;DDX17;HNRNPA3;ZC3H12A;RBM3;THOC1;GTF2F1;DDX20;AGO4;NUFIP1;TENT2;RBM6;RBM39;SUPV3L1;DDX24;HNRNPUL1;AGO3;NOVA1;PTBP1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.4409161681735355,1.2277236633951503,0.14477766287487073,0.8635392690364402,1.0,42/96,28.06%,SRSF2;SRSF6;NXF1;DDX19B;NUP93;MCM3AP;NUP107;U2AF1;SRSF3;NUP98;CPSF4;SRSF11;THOC7;POLDIP3;SMG7;THOC2;THOC1;ZC3H11A;SMG6;FYTTD1;NUP37;CPSF2;DDX39A;SRRM1;NUP50;SLBP;U2AF2;TPR;CPSF1;AGFG1;WDR33;NUP133;NUP85;ALYREF;UPF3B;NUP188;UPF1;NUP88;SMG5;CDC40;THOC5;CPSF3
prerank,cytokine-mediated signaling pathway (GO:0019221),0.42118801393090743,1.2276330931341661,0.012,0.8627099275430571,1.0,104/532,17.97%,MID1;IL4R;TNFSF9;GHR;ACKR3;SYK;LBP;LIF;COL1A2;CD80;DUOX1;CCL8;IL1RL1;IRF4;ANXA1;IRS1;NUMBL;IL16;CTF1;PSMC4;CD44;GRB10;FYN;ANXA2;VEGFA;IRAK3;MMP2;FGF2;STX1A;MIF;SMAD4;RAP1B;CLCF1;PTPRJ;SOCS2;CAMK2D;FOXO1;IL33;CSK;CXCL10;MUC1;TNFRSF11B;PSMC6;SRC;FSCN1;PELI3;IL17RA;ABL2;IL10RA;UBE2N;FLT3LG;STAT5A;TNFRSF18;CHUK;PIK3CA;PSMD8;TNFSF13B;CCL25;STX4;SAMHD1;ARF1;SQSTM1;IRAK4;BCL6;AKT1;CSF2RA;IRAK1;UBA52;PLVAP;IRS2;CD27;CCL13;FLT3;CDKN1A;TRAF3IP2;CCND1;IL5;TWIST1;TNFRSF1B;CBL;FER;CNTFR;HSP90AA1;IL4;RAPGEF1;SMARCA4;EDA;BAG4;TRIM68;TRAF3;SOCS6;PDCD4;IL6;SOS1;HGF;STAT5B;ZEB1;PML;MAP3K14;PPIA;CXCR2;IL18;ILK;STX3
prerank,regulation of histone modification (GO:0031056),0.5733503773408551,1.2274731031802328,0.22058823529411764,0.8621620320078984,1.0,6/13,14.66%,FLCN;UBE2N;CDK9;PARG;AKAP8;SETD5
prerank,cellular response to drug (GO:0035690),-0.37844891233360967,-1.2267428193425007,0.16483516483516483,0.6261475643033382,1.0,8/25,12.23%,PPM1E;MEF2C;ACER2;AIM2;TFRC;KCNQ1;CERS1;PPM1F
prerank,regulation of stress fiber assembly (GO:0051492),-0.3003061043027084,-1.2266837631154288,0.11320754716981132,0.6235108322311017,1.0,15/74,6.56%,TJP1;CGNL1;PHLDB2;ARHGAP28;TPM1;ARHGAP6;PPM1E;RAPGEF3;CCN2;F11R;RHPN2;LIMCH1;FHOD1;NRP1;RGCC
prerank,regulation of keratinocyte proliferation (GO:0010837),0.5238491981162503,1.2262935257044065,0.2030264817150063,0.8663074073891717,1.0,5/22,8.44%,AREG;FGF7;SRSF6;ZFP36L1;VDR
prerank,regulation of centrosome cycle (GO:0046605),0.5290162587909678,1.226046807932267,0.2376237623762376,0.8660917250160047,1.0,4/21,10.70%,XRCC3;ATF5;VPS4B;NPM1
prerank,glycolipid metabolic process (GO:0006664),0.473466877691181,1.2260019578138615,0.1986754966887417,0.8650417928302266,1.0,11/47,13.74%,SMPD3;ST3GAL2;ARSA;B3GALNT1;FUT2;GBA2;ST3GAL4;GLA;CERK;GLTP;PIGW
prerank,protein secretion (GO:0009306),0.46785280468566104,1.2257146563398176,0.19042437431991294,0.8650359287999587,1.0,11/56,11.41%,ANXA1;NECAB3;PCSK5;STEAP3;PREB;MIA3;RCN3;ABCA1;ADCYAP1;ARFGAP3;RAB3D
prerank,cellular response to cAMP (GO:0071320),0.5011484789494233,1.2255200403156152,0.220763723150358,0.8646761093400644,1.0,8/30,11.33%,IGFBP5;WT1;ZFP36L1;RAP1B;PKD2;INPP5K;HCN4;SLC26A6
prerank,amino acid transport (GO:0006865),-0.32051585273954863,-1.2253722890801646,0.11214953271028037,0.6241261275690504,1.0,13/49,13.35%,SLC7A11;SLC7A2;SLC6A12;PDPN;SLC38A11;SLC7A5;SLC3A2;SLC38A5;SLC25A44;SLC6A17;SLC6A6;SLC43A1;SLC7A14
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.45257610100870777,1.2253373923337283,0.1664899257688229,0.8642572522025763,1.0,13/75,8.12%,DCN;TNMD;ANGPT4;ISM1;SPARC;TGFB2;CD160;ATP2B4;HOXA5;CXCL10;THBS4;SULF1;SERPINF1
prerank,mRNA destabilization (GO:0061157),0.4798761150620354,1.225140891555629,0.19953596287703015,0.8638744772599374,1.0,12/38,17.49%,DIS3L2;ZFP36L1;TRIM71;TARDBP;RC3H1;ZFP36L2;PUM1;ZFP36;POLR2D;ZC3H12A;YTHDF1;YTHDF2
prerank,ureteric bud morphogenesis (GO:0060675),0.5522519413631828,1.2250968182643598,0.22024623803009577,0.8628561694353263,1.0,5/16,13.71%,WT1;FGF2;PKD2;GDNF;SIX1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5995798228096644,1.224761111518534,0.23401360544217686,0.8630746635089765,1.0,3/10,9.83%,C1QTNF1;CD9;ADAMTS18
prerank,positive regulation of interleukin-13 production (GO:0032736),0.6053570455298499,1.2245446097079014,0.21944444444444444,0.8628132996142115,1.0,5/10,24.85%,IRF4;IL4;IL18;PRKCZ;RARA
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.4407992460668192,1.2244216386968052,0.15126050420168066,0.862108814496454,1.0,19/87,14.03%,COL3A1;COL1A2;TGFB3;ZMIZ1;TGFB2;TGFBR2;ADAM9;SMAD4;SKI;ACVR1;ITGB5;SRC;SMAD5;PARD6A;SMAD6;AMHR2;UBA52;RHOA;CBL
prerank,epithelium development (GO:0060429),0.4362256667584719,1.224395945626493,0.14329896907216494,0.860989424321618,1.0,23/107,16.59%,CD34;DHRS9;WNT2;WT1;MEOX2;VEGFA;PKD1;SOX10;DACT1;TRIM71;RCN3;PKD2;TPP1;SOX8;NDRG4;ACADVL;DMBT1;SIX1;VDAC1;AHI1;ANXA4;BDH2;SNAI2
prerank,regulation of spindle assembly (GO:0090169),0.515781219698234,1.2239469130527865,0.22341696535244923,0.8615454360060419,1.0,9/25,22.68%,GPSM2;VPS4B;CCSAP;CEP97;DYNC1H1;SENP6;NUMA1;PDCD6IP;TPR
prerank,alpha-amino acid catabolic process (GO:1901606),-0.3660023498123124,-1.223647956161842,0.13194444444444445,0.6259476791642483,1.0,14/29,33.11%,DDO;PRODH;ALDH4A1;SARDH;BLMH;CBS;THNSL2;KYNU;HSD17B10;HOGA1;FAH;HGD;IL4I1;HAAO
prerank,autophagy of nucleus (GO:0044804),0.5464614319301956,1.2231920544297452,0.23371647509578544,0.8637254924958175,1.0,8/16,21.77%,ATG2B;WIPI2;WDR45B;ULK2;ATG2A;ULK1;ATG13;ATG3
prerank,respiratory system development (GO:0060541),0.4946390523568788,1.222936322509942,0.20848056537102475,0.8636084983604436,1.0,6/32,7.49%,FGF7;WT1;DISP1;VEGFA;FGF2;GLI2
prerank,regulation of cell morphogenesis (GO:0022604),0.49732199977581276,1.2228261690417435,0.21805392731535755,0.8628762106412498,1.0,7/30,11.10%,EFNA5;SPARC;CD44;ZRANB1;MYO9A;LARP4;CAMSAP1
prerank,positive regulation of axon extension (GO:0045773),0.5265800056876258,1.2224994753523795,0.2222222222222222,0.863057814778814,1.0,9/22,17.86%,DBN1;VEGFA;NTN1;ISLR2;DSCAM;L1CAM;MAPT;GOLGA4;SHTN1
prerank,cellular response to lipid (GO:0071396),0.42977085677396676,1.2222426038673442,0.08542713567839195,0.8630246637693213,1.0,40/191,16.64%,LBP;AR;CD80;UCP1;ESR1;AXL;WNT10B;WNT2;EGFR;IRS1;EPHA3;WNT9A;ADAM9;ATP1A3;ATP1A1;MAPK14;NR1D1;CXCL10;NCOA3;CARD16;RET;PID1;ABL2;FZD7;TLR4;SIRPA;URI1;IRAK1;ADCY8;ZFP36;ADAM15;RHOA;TNFRSF1B;ZC3H12A;CD14;FZD4;SELENOS;PDCD4;IL6;HTRA2
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.5153322383443609,1.2219439082067811,0.2246376811594203,0.8630766330450611,1.0,4/24,5.35%,MYOC;VEGFA;S100A10;PTPRJ
prerank,actomyosin structure organization (GO:0031032),-0.2995743500582602,-1.2219326177222882,0.10714285714285714,0.6277834671217924,1.0,10/75,3.56%,TJP1;SORBS1;TPM1;ACTN2;PGM5;FRMD5;PHACTR1;EPB41;F11R;MYO18A
prerank,intermediate filament organization (GO:0045109),0.5458738213495038,1.2214485201308138,0.22125,0.8639035688882877,1.0,2/17,6.68%,KRT20;NEFL
prerank,response to thyroid hormone (GO:0097066),0.5655459084637746,1.2209425761860333,0.24859550561797752,0.8649141556834811,1.0,2/13,7.15%,HPN;GAS2L1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.5474527144207101,1.2208726441980198,0.21038961038961038,0.8640250764831405,1.0,6/18,18.84%,SLC4A8;RAP1B;DTNBP1;SNAPIN;PREPL;RIMS2
prerank,cellular biogenic amine metabolic process (GO:0006576),0.5828944635298089,1.2208387800639933,0.24287652645861602,0.8629707655747343,1.0,4/12,13.66%,SRM;ODC1;TRH;SMS
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.47390120554316295,1.22076639486456,0.2006651884700665,0.8620515073869193,1.0,14/44,16.31%,TRIAP1;CD44;VEGFA;CARD16;SRC;GAS6;CAST;DPEP1;YWHAE;GPX1;AKT1;SFN;KLF4;HGF
prerank,peptide catabolic process (GO:0043171),0.5141015587102237,1.22040333679356,0.22399020807833536,0.8624008525475343,1.0,8/23,16.88%,ANPEP;LNPEP;DPEP1;TPP1;ECE1;NPEPPS;GGT7;IDE
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.5467181625240981,1.220265169006499,0.2340966921119593,0.8617321144473123,1.0,5/17,12.62%,DGKQ;SIRT2;INPP5K;PPEF2;CALM2
prerank,acute-phase response (GO:0006953),0.5836005265119552,1.2202646323602941,0.2445945945945946,0.860530962859746,1.0,4/12,18.60%,LBP;CEBPB;IL6;MBL2
prerank,placenta development (GO:0001890),0.5777765322534352,1.2193622308261232,0.25407608695652173,0.8630679315804705,1.0,2/12,4.55%,ANG;ADAM19
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.604930741439948,1.219356975115622,0.24778761061946902,0.8618899037156031,1.0,6/10,24.12%,EMC1;EMC10;EMC8;EMC3;EMC2;EMC6
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.3824628350348654,-1.2179365873681371,0.18556701030927836,0.6354828784366898,1.0,10/26,22.94%,ACER2;NOS3;GCH1;NOS1;SPR;SPHK1;SPTLC2;SPHK2;ABCA2;NQO1
prerank,positive regulation of translation (GO:0045727),0.4370804376675258,1.2176852097383495,0.15946502057613168,0.8678897528874364,1.0,33/94,22.31%,NIBAN1;DAZL;MTOR;C1QBP;LARP4;AGO2;HNRNPD;MRPS27;NPM1;PASK;EIF6;LARP1;POLR2D;RPS27L;POLR2G;BCL3;ZCCHC4;POLDIP3;CDC123;RBM3;EIF3E;PKM;IL6;EIF3D;FXR2;YTHDF1;YTHDF2;RCC1L;RMND1;PCIF1;EIF5A2;MPV17L2;YTHDF3
prerank,positive regulation of mitochondrial fission (GO:0090141),0.5321801293589492,1.2176186063204704,0.23415265200517466,0.8669618148782522,1.0,3/18,8.59%,DCN;MIEF2;MCU
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.4332164244782702,1.2175000207973015,0.1408016443987667,0.8662061303526669,1.0,22/112,10.84%,COL3A1;COL1A2;WNT2;TGFB3;CLEC3B;MAPK7;ZMIZ1;TGFB2;TGFBR2;ADAM9;SMAD4;SKI;ACVR1;ZFP36L1;ITGB5;SRC;SMAD5;ZFP36L2;PARD6A;SOX5;SMAD6;AMHR2
prerank,negative regulation of cellular component organization (GO:0051129),0.4503374240347518,1.217302585078727,0.17073170731707318,0.8658317661138657,1.0,12/74,7.93%,AR;TMEFF2;FAP;EPHA3;VEGFA;IRAK3;SYT11;AIDA;SRC;HDAC6;SCAMP5;TFIP11
prerank,global genome nucleotide-excision repair (GO:0070911),0.5047284702763243,1.2169226110579279,0.21561338289962825,0.8662614952865265,1.0,7/26,13.25%,GTF2H3;RAD23B;RNF111;ERCC3;UBA52;ERCC4;DDB1
prerank,negative regulation of angiogenesis (GO:0016525),0.44254383336231085,1.2168771853788796,0.16371220020855057,0.8652296363432274,1.0,15/84,8.12%,DCN;TNMD;ANGPT4;ISM1;SPARC;TGFB2;CD160;KLF2;ATP2B4;HOXA5;CREB3L1;CXCL10;THBS4;SULF1;SERPINF1
prerank,response to lipopolysaccharide (GO:0032496),0.43228830254383066,1.2163214026592113,0.11883182275931521,0.8664451169594234,1.0,30/138,16.30%,LBP;CD80;AXL;IRAK3;FOXP1;F2R;S100A8;S100A9;ADAM9;MAPK14;NR1D1;CXCL10;CARD16;CYP27B1;TIRAP;TLR4;SMAD6;SIRPA;SLPI;IRAK1;ZFP36;RHOA;TNFRSF1B;ZC3H12A;FER;GGT7;CD14;SELENOS;PDCD4;IL6
prerank,replicative senescence (GO:0090399),-0.45994013987748394,-1.2163133501883965,0.2226148409893993,0.6370858737001791,1.0,7/12,31.67%,ATM;TERT;SERPINE1;PLA2R1;CHEK1;ATR;WNT16
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.45150064181358546,1.2162442618414668,0.1824973319103522,0.8656057545009789,1.0,16/66,14.55%,CDK2AP2;EGFR;ANXA1;FHL1;PKD1;CDK4;DACT1;PRMT2;PKD2;BRD7;AKT1;GPNMB;CDKN1A;CCND1;KLF4;INO80
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.5151271444754172,1.2159033968113413,0.23039215686274508,0.8658664892372695,1.0,5/22,16.30%,GHR;F2R;IL10RA;MGAT5;IL6
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.4747441568021311,1.2156320152429558,0.19640852974186307,0.8658037590913592,1.0,22/42,31.04%,MARS2;TARS1;SARS2;VARS1;HARS1;GARS1;VARS2;EEF1E1;EPRS1;QARS1;AIMP1;EARS2;AIMP2;NARS1;PPA1;YARS1;SARS1;PPA2;DARS1;WARS2;AARS1;LARS2
prerank,positive regulation of T cell differentiation (GO:0045582),0.4830678440434216,1.2155846194954851,0.21191294387170675,0.8648209027589556,1.0,7/36,14.82%,TNFSF9;ZMIZ1;GLI2;ZBTB1;BCL6;GLI3;IL4
prerank,regulation of macrophage activation (GO:0043030),0.49255575030212356,1.2151146506455917,0.23625730994152047,0.8655298541067322,1.0,10/30,19.87%,LBP;MIF;IL33;TLR4;ZC3H12A;IL4;LRFN5;IL6;GPR137B;IL31RA
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.46618255439915457,1.2147362451522796,0.19700214132762311,0.8659420056275681,1.0,16/57,15.54%,CDC14B;FANCD2;EME1;TIPIN;TAOK3;RFWD3;RINT1;DTL;FBXO31;TAOK2;RPS27L;CDKN1A;ABRAXAS1;CCND1;NBN;NOP53
prerank,negative regulation of cell junction assembly (GO:1901889),-0.3773561382081144,-1.2147054740182672,0.2023121387283237,0.6386002042500399,1.0,5/25,5.19%,PHLDB2;ARHGAP6;THBS1;APOD;ROBO2
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.4481047631966677,-1.2146799731199809,0.2188679245283019,0.6359001830532574,1.0,3/12,3.36%,CDH5;SNCA;DYRK1A
prerank,kidney development (GO:0001822),0.4470952963245648,1.21375821920095,0.1853035143769968,0.8689566937559218,1.0,10/65,7.49%,HAS2;WT1;PCSK5;SULF2;VEGFA;TGFB2;C1GALT1;PKD1;SULF1;GLI2
prerank,regulation of leukocyte activation (GO:0002694),-0.4305073148533147,-1.2136263211297151,0.22406639004149378,0.635924941005685,1.0,6/14,15.79%,LYN;MYO18A;PLSCR1;CD200;GPER1;CD74
prerank,muscle cell development (GO:0055001),-0.35575188807786673,-1.2134303037645933,0.1746987951807229,0.6336775708936558,1.0,8/30,8.78%,NEBL;ENG;DMD;IGF1;DYSF;CXADR;MYOF;MYH11
prerank,regulation of supramolecular fiber organization (GO:1902903),0.5192105168053239,1.2132986203592568,0.22413793103448276,0.8697325893828939,1.0,8/22,11.50%,MAP1B;AKAP13;MAPRE3;PIK3CA;GPX1;CAMSAP1;MAPT;GBA2
prerank,regulation of telomere maintenance (GO:0032204),0.5024621193765038,1.2129582000767731,0.22727272727272727,0.8699865268455282,1.0,15/26,29.29%,HNRNPD;ERCC4;XRCC5;NBN;USP7;SMG6;PML;RAD50;TINF2;TERF2IP;ERCC1;UPF1;SMG5;HDAC8;ATRX
prerank,growth hormone receptor signaling pathway (GO:0060396),0.5641276313251467,1.2126509510357797,0.22888283378746593,0.8701935391712023,1.0,3/14,8.10%,GHR;SOCS2;STAT5A
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.5521002128278717,1.2119823099617844,0.24005305039787797,0.8719367998434403,1.0,4/14,15.94%,CARD16;PELI3;GAS6;NLRP2B
prerank,regulation of immunoglobulin production (GO:0002637),0.5116036648197386,1.2118424457694987,0.2289890377588307,0.8713528189459521,1.0,5/23,16.30%,EPHB2;CLCF1;STX4;IL4;IL6
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.5947873832964277,1.2113026361246095,0.2531824611032532,0.8724872440506147,1.0,4/11,16.59%,EGFR;MAP2K2;IL6;DDX5
prerank,L-amino acid transport (GO:0015807),-0.3728653074747428,-1.2112131064624017,0.16149068322981366,0.6369972012262859,1.0,6/28,9.21%,SLC7A2;SLC1A3;SLC7A5;SLC3A2;CTNS;SLC38A5
prerank,myelin assembly (GO:0032288),0.5878489085333816,1.2109150613846151,0.2559774964838256,0.8729682691676239,1.0,2/10,1.65%,CD9;PMP22
prerank,cellular response to oxygen-containing compound (GO:1901701),0.4192939995242385,1.2108684723643763,0.084,0.8720231480459449,1.0,66/291,17.31%,IGFBP5;LBP;CD80;UCP1;ESR1;AXL;WNT10B;WNT2;EGFR;WT1;IRS1;EPHA3;CAPN2;WNT9A;SLIT2;ADAM9;MAPK14;P2RX3;ZFP36L1;RAP1B;MTOR;ATP2B4;FOXO1;NR1D1;CXCL10;NCOA3;CARD16;RET;PID1;ABL2;PKD2;DPEP1;CHUK;FZD7;TIRAP;TLR4;INPP5K;HCN4;SIRPA;CAMKK2;SSH1;AKT1;SLC26A6;MAPT;IRAK1;TSHR;MTR;ZFP36;RHOA;NSMF;RRAGD;TNFRSF1B;GNB1;ZC3H12A;PDGFRA;FER;KCNC2;CD14;RAPGEF1;FZD4;SELENOS;PDCD4;IL6;HTRA2;CPEB1;AKAP9
prerank,heart contraction (GO:0060047),-0.32951742676376305,-1.2107614141223757,0.12612612612612611,0.6354860006047459,1.0,3/41,1.52%,ATP1A2;TPM1;DMD
prerank,endothelial cell migration (GO:0043542),0.4732735540260083,1.210513481897359,0.2152046783625731,0.8724248859454158,1.0,5/37,2.76%,FSTL1;LOXL2;DPP4;FAP;VEGFA
prerank,retinoid metabolic process (GO:0001523),0.44738000570634956,1.210335248023076,0.1880252100840336,0.8720352235087572,1.0,6/71,2.21%,AKR1B1;DHRS9;LRP1;CYP2S1;GPC6;GPC3
prerank,mRNA export from nucleus (GO:0006406),0.4346482460802743,1.2102529811818281,0.1590909090909091,0.8711866505814597,1.0,44/102,28.06%,SRSF2;SRSF6;NXF1;DDX19B;NUP93;MCM3AP;NUP107;U2AF1;SRSF3;NUP98;CPSF4;SRSF11;THOC7;POLR2D;POLDIP3;SMG7;THOC2;THOC1;ZC3H11A;SMG6;FYTTD1;NUP37;CPSF2;DDX39A;SRRM1;NUP50;SLBP;U2AF2;TPR;CPSF1;AGFG1;WDR33;PABPN1;NUP133;NUP85;ALYREF;UPF3B;NUP188;UPF1;NUP88;SMG5;CDC40;THOC5;CPSF3
prerank,negative regulation of coagulation (GO:0050819),0.568976847989784,1.2097123247578443,0.2567204301075269,0.8722873444146096,1.0,2/14,4.72%,CD34;PROCR
prerank,telomere capping (GO:0016233),0.5467205928966457,1.2096860403115939,0.2503192848020434,0.87123220266153,1.0,11/16,27.64%,CTC1;ACD;TFIP11;TERF1;NBN;RAD50;TINF2;DCLRE1A;TERF2IP;PRKDC;STN1
prerank,regulation of viral transcription (GO:0046782),0.4655374816822441,1.2094353808935858,0.22613636363636364,0.8711741974025575,1.0,12/39,16.11%,POLR2H;TARBP2;MID2;MDFIC;CDK9;TRIM11;ZFP36;POLR2D;POLR2G;CTDP1;GTF2F1;UBP1
prerank,peptidyl-lysine modification (GO:0018205),0.43752381606912544,1.2093853008909428,0.16476683937823836,0.8702065574230041,1.0,17/99,10.03%,PLOD2;LOXL2;LIPT2;STX1A;HDAC9;RNF212B;NUP93;PIAS3;HDAC6;NUP107;UBA2;PLOD3;NUP98;SIRT2;KAT2B;LOXL1;NDUFAB1
prerank,positive regulation of double-strand break repair (GO:2000781),-0.3368497434016313,-1.2090765724715125,0.16129032258064516,0.6374881012006394,1.0,18/39,19.44%,WDR48;SPIRE1;KMT5B;SHLD1;DTX3L;SLF2;KMT5C;ARID2;MGMT;MRNIP;PNKP;RIF1;SMCHD1;SETMAR;PARP9;FANCB;TIMELESS;MAD2L2
prerank,homologous chromosome segregation (GO:0045143),0.5228850891216443,1.2089398074691642,0.23767383059418457,0.8709197710236374,1.0,6/20,21.28%,FANCD2;RNF212B;TERB1;CENPC;PRDM9;FMN2
prerank,regulation of DNA metabolic process (GO:0051052),0.47134168832347706,1.2084607060340382,0.2006726457399103,0.8717879208846215,1.0,20/44,27.95%,KPNA2;UBE2N;CDK9;HNRNPD;PARG;MPHOSPH8;XRCC5;NBN;THOC1;SMG6;KPNA1;KDM1B;TERF2IP;WDR18;POLH;KAT7;ALYREF;UPF1;SMG5;HDAC8
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.499169063625838,1.2078198881787308,0.2278177458033573,0.8733243007846054,1.0,13/27,28.67%,RNASE4;NYNRIN;ERN1;NUDT16;RNASE6;ZC3H12A;RPP30;KHNYN;RNASE1;TRIR;NHP2;CPSF3;PDE12
prerank,protein O-linked glycosylation via serine (GO:0018242),0.5976316624045278,1.2075255119052806,0.2273381294964029,0.8733789491680988,1.0,5/10,23.97%,GALNT16;GALNT1;MGAT5B;POGLUT2;GALNT4
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.4280676132579995,1.207439904006188,0.1305668016194332,0.8725736145826435,1.0,22/138,10.43%,ANGPTL1;SYK;LIF;DDR2;EPHB2;AXL;SRMS;EGFR;TNK1;FGFR1;EPHA3;FYN;MST1R;TRIO;RET;PTPRF;SRC;POLR1G;ABI1;EFS;EPHB3;MUSK
prerank,regulation of keratinocyte differentiation (GO:0045616),0.5027468171693134,1.2073465502416156,0.2466091245376079,0.8718310203723534,1.0,9/24,14.42%,SRSF6;RUNX1;ZFP36L1;NCOA3;CYP27B1;VDR;ZFP36;NME2;HOXA7
prerank,response to progesterone (GO:0032570),0.5310117430573857,1.207200338359263,0.23722149410222804,0.8713273202582794,1.0,4/18,6.81%,TGFB3;TGFB2;CATSPERB;SRC
prerank,protein localization to organelle (GO:0033365),0.4259127045460889,1.2067816254483412,0.1345565749235474,0.8719012632282588,1.0,48/133,29.02%,COL1A1;TSPAN17;SIX4;RAB6A;ANK2;STX1A;STX5;LMNA;UBE2J2;GET4;ALDH3A2;BICD1;BBS9;WDR83OS;YWHAE;TOR1A;TRAM2;TMEM30A;SGTA;SIX1;ARFRP1;BBS4;TRAM1;MTCH2;ARF6;ATP6V1D;RAB33B;RAB35;AUP1;VAMP2;TOLLIP;PAF1;CROCC;PACSIN2;EMD;DVL1;SEC61B;MDM2;CALR;DCP1A;GBF1;DDX1;MICALL1;DNAJA1;TOPORS;CNTLN;ZBTB7A;PRNP
prerank,thyroid hormone generation (GO:0006590),0.5917092674170525,1.2067246219537129,0.23925501432664756,0.8709878580740671,1.0,1/10,0.50%,DUOX1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.465005812438009,1.2066447278632835,0.19799777530589543,0.8701756224921453,1.0,16/46,20.74%,ANTXR1;TMEFF2;ITGB3;NTN4;RADIL;MEGF9;SRCIN1;ITGAV;EPHB3;ATRN;RHOA;FER;SRGAP2;ILK;LAMC1;TYRO3
prerank,protein localization to chromosome (GO:0034502),0.48249896242955437,1.2065409558661577,0.2304093567251462,0.8694590322889666,1.0,9/34,18.67%,ESR1;PARP3;CHMP7;ACD;TPP1;XRCC5;IFFO1;TINF2;CTCF
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.5754093489492726,1.2061318467943078,0.255524861878453,0.8700707850339643,1.0,4/12,17.74%,IL33;NUPR1;IL6;IL18
prerank,in utero embryonic development (GO:0001701),0.5080521290686729,1.206057691809329,0.22518159806295399,0.869250193741012,1.0,7/25,8.12%,TGFB3;MBNL1;VEGFA;LMX1B;PKD1;FLCN;SOX8
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.5937784516284684,1.2058094445260161,0.26778242677824265,0.8679658535603074,1.0,4/11,12.62%,SRI;PKD2;GSTM2;CALM2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.5937784516284684,1.2058094445260161,0.26778242677824265,0.8679658535603074,1.0,4/11,12.62%,SRI;PKD2;GSTM2;CALM2
prerank,regulation of lymphocyte migration (GO:2000401),0.5995822326046907,1.2057492650991661,0.25102880658436216,0.867073638306932,1.0,5/10,27.25%,MIA3;AKT1;SLC8B1;STK10;WASL
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.34677111733233107,-1.2055509550144854,0.2222222222222222,0.6443417176460295,1.0,10/35,8.64%,PLXNA2;NRP2;PLXNA4;SEMA5A;SEMA7A;PLXND1;SEMA6A;NRP1;SEMA3B;PLXNB1
prerank,relaxation of cardiac muscle (GO:0055119),0.5694963194364813,1.2046399735101236,0.2527932960893855,0.8706326308744077,1.0,6/13,11.17%,GSN;ATP1A1;KCNJ2;CAMK2D;PIK3CA;GSTM2
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.43887336089902507,-1.20457254558886,0.21052631578947367,0.6442437262092285,1.0,5/13,11.92%,GLUL;NOS3;PRODH;ALDH4A1;NOS1
prerank,RNA processing (GO:0006396),0.41896241248240434,1.2045123445003243,0.10976837865055387,0.8700121127271098,1.0,57/176,21.68%,SRSF2;WT1;MBNL1;ADARB1;TSEN54;DHX16;RBM4;ZCRB1;TENT4A;TARDBP;BICD1;LSM4;PRPF4;U2AF1;TFIP11;PRPF3;AURKAIP1;CPSF6;USP39;DUSP11;HNRNPD;SON;HNRNPH1;TCERG1;DHX8;CELF2;SRSF11;MPHOSPH10;DDX17;RBM3;THOC1;SF3B4;DDX20;ZCCHC8;BCAS2;SF3A1;SNRPG;SNRPD3;NUFIP1;TENT2;PPP1R9B;LUC7L3;PDCD7;SRRM1;RBM6;RBM39;TENT4B;HNRNPUL1;U2AF2;ZMAT5;NOVA1;PTBP1;SF3B2;SF3B1;SRPK1;AKAP8L;KIN
prerank,tRNA aminoacylation (GO:0043039),0.47731363276744404,1.2044638098286473,0.2153325817361894,0.8690738269614444,1.0,21/37,31.04%,MARS2;TARS1;SARS2;VARS1;HARS1;GARS1;EEF1E1;EPRS1;QARS1;AIMP1;QRSL1;AIMP2;NARS1;PPA1;YARS1;SARS1;PPA2;DARS1;WARS2;AARS1;LARS2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.5561198367746024,1.204083401517434,0.25559947299077734,0.8695202070578715,1.0,6/14,26.92%,TSEN54;RTRAF;CPSF4;TRPT1;CPSF1;DDX1
prerank,regulation of actin filament-based movement (GO:1903115),0.5944518406879329,1.2040583662692628,0.24277456647398843,0.868483880042578,1.0,4/10,15.37%,ANK2;SRI;PDE4D;STC1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5108152398780718,1.2039906947611527,0.21712907117008443,0.8676269975018223,1.0,5/24,7.85%,TNMD;GRB10;ITGB3;ITGA5;PRKD2
prerank,cytoplasmic translational initiation (GO:0002183),0.535476119294614,1.2034621825871006,0.25,0.8687127572435015,1.0,9/17,27.14%,RBM4;EIF4A1;EIF3A;EIF3D;EIF2S2;EIF4H;EIF4G1;DHX29;EIF3M
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.492832227055502,1.2033746955752933,0.22800925925925927,0.8679434280614419,1.0,4/33,2.55%,IGFBP5;TGFB3;ANG;OGN
prerank,response to steroid hormone (GO:0048545),0.48092910533502353,1.2033619910769993,0.23826291079812206,0.8668780535365881,1.0,6/31,3.99%,AR;TGFB3;TGFB2;CATSPERB;ATP1A3;ATP1A1
prerank,protein localization to phagophore assembly site (GO:0034497),0.5873003561771594,1.2030769974531945,0.25068870523415976,0.8669118642270807,1.0,5/11,18.77%,PACS2;WIPI2;WDR45B;STX17;ATG13
prerank,chondrocyte differentiation (GO:0002062),0.490475922970663,1.2029157403978368,0.23892773892773891,0.8664263058749483,1.0,8/32,9.27%,WNT10B;EIF2AK3;SULF2;RUNX1;SLC39A14;NFIB;SULF1;SOX5
prerank,androgen metabolic process (GO:0008209),0.5287365833985356,1.2027932944599684,0.25153374233128833,0.8657866695349904,1.0,5/18,23.86%,DHRS9;SRD5A1;HSD17B4;HSD17B11;SRD5A3
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5710186064981698,1.20199368172072,0.27977839335180055,0.8658479881136026,1.0,6/12,23.87%,CUL3;CDC23;ANAPC5;CDC27;ANAPC4;NSMCE2
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.5710186064981698,1.20199368172072,0.27977839335180055,0.8658479881136026,1.0,6/12,23.87%,CUL3;CDC23;ANAPC5;CDC27;ANAPC4;NSMCE2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5710186064981698,1.20199368172072,0.27977839335180055,0.8658479881136026,1.0,6/12,23.87%,CUL3;CDC23;ANAPC5;CDC27;ANAPC4;NSMCE2
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.4991250925126913,1.2014607014001386,0.23591549295774647,0.8669533841103112,1.0,9/27,14.87%,IRAK3;TLR5;TIRAP;TLR4;IRAK4;IRAK1;TNIP1;UBA52;CD14
prerank,spliceosomal snRNP assembly (GO:0000387),0.47303228844477885,1.2014014812667175,0.22722159730033745,0.8661068320888661,1.0,11/38,18.71%,GEMIN6;CD2BP2;USP4;LSM4;WDR77;PRPF3;TGS1;DDX20;SNRPG;SNRPD3;STRAP
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.47154625533332734,1.200388867754295,0.2296037296037296,0.8692016657864396,1.0,12/38,18.73%,ANK2;BIN1;DSC2;KCNJ2;CAMK2D;YWHAE;HCN4;JUP;KCNJ3;SCN4B;AKAP9;KCNH2
prerank,establishment of mitotic spindle localization (GO:0040001),0.4915866769522082,1.2003275836441925,0.23353293413173654,0.868317159256662,1.0,9/28,22.51%,GPSM2;DCTN1;NDEL1;ZW10;CDK5RAP2;PAFAH1B1;CLASP2;NUMA1;FBXW11
prerank,regulation of ossification (GO:0030278),0.47472357996172976,1.2002154634463784,0.23711340206185566,0.8676308139692098,1.0,9/36,10.09%,DDR2;LRP6;TGFB2;ECM1;ACVR1;CYP27B1;BMP2K;SGMS2;SMAD6
prerank,phospholipid homeostasis (GO:0055091),0.5891140639109955,1.2001683730020711,0.26564673157162727,0.8667270455140255,1.0,3/11,7.00%,TLCD2;RCN3;ABCA1
prerank,ovarian follicle development (GO:0001541),0.5594396333754584,1.2000762614000626,0.2540322580645161,0.8659913010137512,1.0,5/13,14.19%,ANG;VEGFA;INHA;CEBPB;LHCGR
prerank,response to nutrient levels (GO:0031667),0.5359507575006315,1.1998710979589116,0.24296675191815856,0.8657416016800509,1.0,3/17,6.04%,UCP1;MTOR;MEAK7
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.42577710450731426,1.1996901777150604,0.13765182186234817,0.8653556127956912,1.0,16/140,10.16%,ACKR3;CD55;ESR1;C1QTNF1;LPAR3;NPTN;PLCE1;F2R;DLG4;LPAR1;P2RX3;ADCYAP1;ABL2;GPR20;ACKR4;CALCA
prerank,RNA splicing (GO:0008380),0.43068710946719363,1.1994879303852861,0.17653167185877466,0.8650371323050327,1.0,29/95,21.08%,SRSF2;WT1;MBNL1;DHX16;ZCRB1;TARDBP;LSM4;PRPF4;U2AF1;PRPF3;USP39;TCERG1;DHX8;SRSF11;MPHOSPH10;SF3B4;BCAS2;SNRPG;SNRPD3;PPP1R9B;LUC7L3;PDCD7;SRRM1;ZMAT5;NOVA1;PTBP1;SF3B2;SF3B1;SRPK1
prerank,negative regulation of phosphorylation (GO:0042326),0.4370088158393183,1.1987264217021676,0.19622245540398742,0.867059732221638,1.0,33/85,24.13%,EPHB2;LRP6;NIBAN1;SLIT2;WWTR1;PLPP3;TARDBP;MYADM;INHA;PID1;PIP5KL1;TIGAR;INPP5K;SIRPA;MAPT;IRS2;CDKN1A;NCOR1;HDAC4;ZC3H12A;NUPR1;CHP1;PPIA;IBTK;FKBP8;CORO1C;PTEN;CDKN2C;TERF2IP;FBLN1;ANKLE2;ATG14;DYNLL1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.530593836253386,1.198532384930673,0.2540880503144654,0.8667583321977002,1.0,5/18,10.78%,DDR2;RUNX1;FSCN1;MELTF;COLGALT1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.5503990681736838,1.198472821755556,0.25823451910408435,0.8647959986085373,1.0,4/15,12.63%,ZFP36L1;ZFP36L2;AGO2;ZFP36
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.5503990681736838,1.198472821755556,0.25823451910408435,0.8647959986085373,1.0,4/15,12.63%,ZFP36L1;ZFP36L2;AGO2;ZFP36
prerank,regulation of filopodium assembly (GO:0051489),0.47914405311199676,1.1983095744604377,0.2306805074971165,0.8643455719153544,1.0,16/38,24.32%,ARHGAP44;TGFB3;GAP43;MYO10;FSCN1;PALM;RHOQ;BCAS3;ARF6;FXR2;ARAP1;GPM6A;RALA;ABITRAM;DOCK11;DMTN
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.5266398485426912,1.1982631470723464,0.24494949494949494,0.8634414483943564,1.0,9/19,20.19%,UGDH;EXT1;B3GAT3;XYLT1;HS2ST1;HS3ST5;GLCE;NDST2;XYLT2
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.42721361654471335,1.198223881134802,0.17580144777662876,0.8625212853272062,1.0,33/95,24.11%,ASPN;HTRA3;LDLRAD4;SKIL;TGFBR2;PMEPA1;SMAD4;SMURF2;SKI;RNF111;STUB1;FLCN;SMAD6;PEG10;SLC2A10;VASN;UBA52;PIN1;BCL9;GIPC1;DKK3;SNX6;HTRA4;TGFBR1;STRAP;PPM1A;SMURF1;CD109;SDCBP;FKBP1A;SKOR2;LATS1;ZEB2
prerank,establishment of protein localization to organelle (GO:0072594),0.43941003287277536,1.1980564240547162,0.19153439153439153,0.862135179689628,1.0,27/72,27.02%,SYK;TSPAN17;SPRN;NUP93;NUP107;IL10RA;AKT1;IPO9;TNPO2;E2F3;IPO5;NUP50;NXT2;LRSAM1;RALA;RANBP6;TPR;IPO11;IPO13;TSC2;NUP133;NUP85;TNPO1;FAM53C;NUP188;KPNB1;NUP88
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.40189312698698554,-1.1975250350232889,0.20851063829787234,0.6607437725444111,1.0,3/17,2.00%,PRKG1;TPM1;MEF2C
prerank,microtubule anchoring at centrosome (GO:0034454),0.5940202390607003,1.1974033634133672,0.26704545454545453,0.8637537542840134,1.0,6/10,21.33%,DCTN1;KIF3A;BBS4;NIN;CCDC120;PCM1
prerank,regulation of T cell migration (GO:2000404),-0.40374347111512965,-1.1973354341887341,0.21363636363636362,0.6585062803003703,1.0,5/18,5.61%,APP;APOD;DOCK8;CXCL12;LRCH1
prerank,endosome organization (GO:0007032),0.4686138696070617,1.1970306429571262,0.2225950782997763,0.8642587895210923,1.0,17/41,27.52%,DNM1;HOOK2;PLEKHF1;PI4K2B;TMEM9;SQSTM1;USP50;PHETA2;VPS11;ANXA8;ANXA8L1;VPS33B;CORO1C;PI4K2A;ALS2;SNX33;ARFGEF2
prerank,negative regulation of blood coagulation (GO:0030195),0.4781101707995188,1.196842272709217,0.2233560090702948,0.8639691587311135,1.0,3/38,3.63%,CD34;C1QTNF1;KLKB1
prerank,relaxation of muscle (GO:0090075),0.5646793251800972,1.1966533469423497,0.2569060773480663,0.8636693315375896,1.0,6/13,11.17%,GSN;ATP1A1;KCNJ2;CAMK2D;PIK3CA;GSTM2
prerank,positive regulation of protein kinase activity (GO:0045860),0.42178243896988044,1.1965864782640714,0.14747474747474748,0.8628503185429809,1.0,30/148,14.60%,NOX4;DDR2;CAMKK1;ITGB3;VEGFA;TGFB2;TGFBR2;DLG4;TAOK3;AXIN1;MAP2K3;MAPRE3;ETAA1;RASSF2;SRC;ADCYAP1;GAS6;STRADA;SYAP1;SRCIN1;IQGAP1;CALCA;XRCC5;CALM2;TAOK2;CDKN1A;RHOA;SLC8A2;STK3;HSP90AA1
prerank,prostanoid metabolic process (GO:0006692),0.559613160162349,1.1959373291350412,0.26713286713286716,0.8644457922930673,1.0,4/13,23.15%,CYP2S1;PTGR1;ACOX1;GSTM1
prerank,leukotriene biosynthetic process (GO:0019370),-0.4259470345265083,-1.1957191985507716,0.2140077821011673,0.659872119328097,1.0,9/14,33.14%,GGT5;GGTA1;MGST3;GGT1;PLA2G4A;PLA2G5;ALOX5AP;MGST2;ALOX5
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.4628837746328369,1.1956554299354514,0.23307436182019978,0.8644741173000856,1.0,9/46,12.46%,IGFBP5;ANG;OGN;FOXP1;ELN;TCF7L2;NDRG4;AKT1;XRCC5
prerank,positive regulation of synaptic transmission (GO:0050806),0.44564734219331287,1.1952632152679934,0.1980728051391863,0.8649696520636628,1.0,26/72,24.63%,EPHB2;NPTN;DLG4;NFATC4;DTNBP1;MPP2;GRIN2D;STX1B;STX4;SQSTM1;CACNG2;LGI1;ADCY8;ZDHHC2;SLC8A2;GRIN2A;CHRNA7;SYT1;VAMP2;RIMS2;CLSTN3;NMU;FLOT1;GRIK2;PRKCZ;BAIAP3
prerank,cell projection organization (GO:0030030),0.48412360553013384,1.195222914190511,0.24224343675417662,0.8640505914739768,1.0,4/30,10.05%,GSN;SCIN;RHOJ;RHOQ
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.38313163985395216,-1.1950774329276643,0.21390374331550802,0.6590865944215373,1.0,8/23,12.76%,ACSL1;ELOVL7;ACSL4;HACD1;ACSL3;HACD2;ACSL6;ELOVL1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.5934721563343155,1.1949894641888692,0.25383542538354253,0.8638697288092265,1.0,6/10,25.88%,DLGAP4;DLGAP3;DLGAP1;AKAP9;NPTX1;BEGAIN
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.5462330344492772,1.1947938347927485,0.24528301886792453,0.8635870643174723,1.0,4/14,8.17%,IGFBP5;LRP1;SLIT2;NDRG4
prerank,regulation of trans-synaptic signaling (GO:0099177),0.4817874760381296,1.1946408884552806,0.2330654420206659,0.8631453064696958,1.0,20/33,32.57%,CEL;SLC4A8;NRG3;PXK;BTBD9;GRID1;FABP5;GRIK5;GRIK2;BCR;GRIK4;EIF4EBP2;GRID2;NLGN1;NLGN3;IQSEC2;PSMC5;NLGN2;NGF;LRRC4C
prerank,ventricular septum morphogenesis (GO:0060412),0.4915983761294799,1.1945395883615872,0.24879227053140096,0.862498247095948,1.0,7/27,7.56%,TGFB2;SLIT3;SLIT2;TGFBR2;SMAD4;ACVR1;ZFPM2
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.5366796110537889,1.194509762555058,0.24360699865410498,0.8615615548945291,1.0,5/16,13.71%,WT1;FGF2;PKD2;GDNF;SIX1
prerank,regulation of amyloid-beta formation (GO:1902003),-0.34780066594855447,-1.1942148417957037,0.18243243243243243,0.6588309216240691,1.0,9/34,12.26%,EPHA4;IGF1;SP1;APOE;GGA3;ABCG1;CASP3;SORL1;NTRK2
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.4727341327908373,1.194160217225333,0.24464487034949267,0.8618421385905255,1.0,18/38,26.43%,UBE2J2;USP36;HPS4;LMAN1;NPEPPS;BAG4;HTRA2;VPS11;ARIH2;ATG13;SREBF1;UBE2D3;SAE1;CSNK2A2;PARL;LEPROT;FBXW7;RNF31
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.41333965863561445,-1.1936700192949017,0.20920502092050208,0.6574597268335186,1.0,4/16,4.85%,RANBP3L;MEF2C;IGFBP3;PLCB1
prerank,modulation by host of viral genome replication (GO:0044827),0.5569927342677128,1.1934679830022967,0.25202156334231807,0.8635961212881242,1.0,3/13,14.08%,CCL8;FBXL2;ZC3H12A
prerank,positive regulation of signaling (GO:0023056),0.4708524972050071,1.1934598453938583,0.24627720504009165,0.8625600426390672,1.0,15/37,23.03%,CD80;ANXA2;CDKN2AIP;DLG4;INPP5F;ECE1;HCRT;LGI1;NSF;SYT1;ILK;RIMS2;CLSTN3;NMU;GRIK2
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.48452620947253494,1.1933699364627024,0.24912689173457508,0.8618747493276194,1.0,4/29,11.82%,FANCD2;RNF212B;SYCP2;TERB1
prerank,nucleus organization (GO:0006997),0.45437895745717305,1.1932101814159108,0.2287292817679558,0.8615032147574821,1.0,9/47,9.04%,BIN1;USP36;REEP3;NUP93;CHMP7;VPS4B;SYNE1;NUP98;TOR1A
prerank,epithelial cell-cell adhesion (GO:0090136),0.577556874342651,1.19309617743605,0.26273458445040215,0.8608946590584824,1.0,6/11,23.82%,SERPINB8;ITGB5;THBS4;JUP;KIFC3;CCN3
prerank,positive regulation of wound healing (GO:0090303),0.469181299123658,1.1921010804993426,0.23672055427251731,0.8639472707179533,1.0,9/36,11.72%,DUOX1;ANXA1;F2R;SMOC2;PLPP3;MTOR;FOXC2;KANK1;ST3GAL4
prerank,male gonad development (GO:0008584),0.47553209007330016,1.1919999667723287,0.24204545454545454,0.8633111047051587,1.0,6/34,9.98%,AR;WT1;SIX4;TGFB2;SOX8;COL9A3
prerank,neurotrophin signaling pathway (GO:0038179),-0.3865907287146326,-1.1914525579421185,0.22727272727272727,0.6605987163951349,1.0,6/21,12.46%,RAPGEF2;SORT1;ZFYVE27;CASP3;NTRK2;BDNF
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.32018167162013644,-1.1914316966658745,0.1865671641791045,0.657964590401573,1.0,8/41,6.77%,TPM1;ENG;CPE;MEF2C;NOTCH1;TGFBR3;FGFR2;HEYL
prerank,outflow tract septum morphogenesis (GO:0003148),0.49020336845791324,1.19141502041765,0.24369747899159663,0.8646666149570963,1.0,7/24,10.09%,SEMA3C;TGFB2;TGFBR2;SMAD4;ACVR1;ZFPM2;SMAD6
prerank,negative regulation by host of viral process (GO:0044793),0.5933903332304724,1.191396729884826,0.26770538243626063,0.8636818872059264,1.0,2/10,14.08%,CCL8;ZC3H12A
prerank,C4-dicarboxylate transport (GO:0015740),0.5475719969600519,1.1911709169996816,0.2483130904183536,0.863566267979495,1.0,2/14,4.54%,LRRC8D;SLC1A6
prerank,regulation of programmed necrotic cell death (GO:0062098),0.5100328480318997,1.1911253601520164,0.25972396486825594,0.862691566638317,1.0,10/20,22.92%,SPATA2;STUB1;HSP90AA1;NUPR1;OGT;FLOT2;PDCD6IP;SDCBP;CYLD;FLOT1
prerank,protein transport (GO:0015031),0.4112314288766232,1.1911042296365775,0.06906906906906907,0.8617258103865102,1.0,112/332,23.64%,SGSM2;LRP1;COPA;NECAB3;STX2;RAB32;RABGAP1L;RAB6A;STEAP3;STX1A;TMED1;STX5;STX11;ATP6V0A2;SEC31A;RAB23;ARRDC2;RAB19;RAB6B;PREB;MIA3;TOM1;SCFD2;SCAMP3;RCN3;ARF4;SCG5;TBCK;AP3D1;ABCA1;HDAC6;STX1B;SCAMP5;CLTC;SNX1;IL10RA;ACD;USO1;TBC1D2B;ARFGAP3;STX4;TBC1D17;GGA1;SCFD1;ARF1;STX12;NPM1;SEC23IP;COPB2;VPS33A;RAB3D;ATP6V1E1;TBC1D10A;NAPA;LRP1B;STX17;ATP6AP1;RUFY1;KIF3A;RAB43;RPGR;KIF3B;CMTM6;ARFRP1;SYNDIG1;ARF6;GGA2;REP15;ATP6V0A1;ATP6V1D;GOLGA4;NSF;EVI5;SGSM1;ATP6V1B2;SPTBN1;COPZ2;BLZF1;EVI5L;AP4M1;NAPG;TBC1D13;RAB1B;RAB5B;RAB5C;PREPL;STX3;SNX6;ARCN1;ADPRH;VAMP2;TBC1D22B;TBC1D15;RAB24;LRSAM1;MON1A;TMED2;VPS33B;RAB10;COPG1;RUNDC1;CTTN;VAMP4;NAPB;STX16;SEL1L;GOLPH3L;TBC1D8B;ATP6V0B;TBC1D12;PICK1;RABL3
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5048859834251482,1.1910455705097136,0.2395709177592372,0.8609084854734453,1.0,14/25,27.31%,HDAC6;STUB1;UBE2W;CUL3;TOR1A;CLPP;NGLY1;ZER1;AUP1;UGGT1;DERL1;ZYG11B;UFD1;UGGT2
prerank,blood circulation (GO:0008015),0.45409672360993397,1.1907925769981418,0.23119469026548672,0.8609097536468158,1.0,10/49,12.89%,AVPR1A;GCLC;MEOX2;TNNI3;ELN;CXCL10;HCN4;GPX1;SGCZ;SERPING1
prerank,purine nucleotide biosynthetic process (GO:0006164),0.5569521676553884,1.1905891065343364,0.27823691460055094,0.8607335568751375,1.0,5/12,16.62%,AMPD2;GART;PRPSAP1;PRPS1;PRPS1L1
prerank,negative regulation of viral life cycle (GO:1903901),0.5394418725685665,1.1905768684253681,0.26506024096385544,0.8597361117759437,1.0,3/15,10.83%,GSN;MID2;TRIM11
prerank,inflammatory response (GO:0006954),0.4171229273230164,1.190490701389532,0.11222444889779559,0.8590400413851917,1.0,34/195,17.74%,NOX4;MGLL;CCL8;ANXA1;CD44;F2R;S100A8;S100A9;HDAC9;NFATC4;ITCH;CXCL10;TLR5;CHUK;CCL25;TLR4;LTB4R2;CEBPB;GPR68;HSPG2;PXK;ADCY8;ACKR1;CCL13;TRAF3IP2;HDAC4;TUSC2;IL4;CD14;IL6;CXCR4;ABCF1;CXCR2;IL18
prerank,mitochondrial genome maintenance (GO:0000002),0.5765499081020582,1.1900974582301913,0.29045643153526973,0.8596618406392214,1.0,5/11,22.34%,SLC25A4;AKT3;SLC25A36;SLC25A33;MGME1
prerank,cellular response to increased oxygen levels (GO:0036295),0.5739223329696638,1.1900602655452486,0.2629370629370629,0.8587885943928704,1.0,5/11,19.69%,ATP6V0A2;FOXO1;ATP6AP1;CCDC115;TMEM199
prerank,T cell homeostasis (GO:0043029),0.5844937154599794,1.1892730575196897,0.2593703148425787,0.8610271059673089,1.0,2/10,11.30%,ZC3H8;AKT1
prerank,regulation of rRNA processing (GO:2000232),0.5366761700292785,1.1887570545290427,0.264669163545568,0.8621121395082555,1.0,7/16,19.78%,DIMT1;USP36;RIOK1;KAT2B;NUDT16;YTHDF2;RIOK2
prerank,mitochondrial transport (GO:0006839),0.4528573232908083,1.1887369985954668,0.23196448390677027,0.8611493644801042,1.0,21/53,25.08%,SLC25A31;GDAP1;TIMM10B;TIMM9;SLC25A4;SLC25A16;BAK1;HSP90AA1;TIMM22;SPG7;FLVCR1;TIMM8B;BCAP31;BCS1L;TOMM5;ABCB10;COX18;TIMM17A;FIS1;TMEM14A;TOMM40
prerank,metal ion export (GO:0070839),0.48282354512277625,1.1883613775395605,0.25589622641509435,0.8616729466169855,1.0,8/31,12.04%,KCNK5;KCNT2;ATP1A3;ATP1A4;ATP1A1;ATP2B4;SLC4A4;SLC9A1
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.4775175012596368,1.1881802614951111,0.2465437788018433,0.8614570464908364,1.0,15/37,26.91%,ENTPD2;NUDT1;HNRNPD;EXOSC7;SIDT2;NUDT16;RNASE6;DNASE1L2;NUDT5;ENTPD6;SUPV3L1;DFFB;RNASEH2C;DNASE1L1;ADPRM
prerank,epithelial cell migration (GO:0010631),0.4664466691058968,1.1881231826682308,0.23208191126279865,0.8606564341150599,1.0,4/37,1.79%,FSTL1;LOXL2;DPP4;FAP
prerank,regulation of GTPase activity (GO:0043087),-0.2657346225713573,-1.1877057144632637,0.25,0.6651768515714849,1.0,43/177,10.64%,PLXNA2;PKP4;PRKG1;EPHA4;RAPGEF2;RAPGEF3;CHN2;ITGA6;RAP1GDS1;NET1;PLXNA4;FGD4;CHN1;CDKL5;F11R;FGD5;DAB2IP;DOCK8;TGM2;PLXND1;RASGRP2;SIPA1L1;RASIP1;LRCH1;MAP4K4;RGS6;DVL3;DOCK9;CPEB2;BCAR3;PLXNB1;ERBB2;CX3CL1;SFRP1;CAV2;STMN3;ZC3H15;USP6NL;LIMS1;AGRN;TBC1D30;ARL2;RGP1
prerank,protein K63-linked deubiquitination (GO:0070536),0.4742694494567736,1.1876886572259748,0.2514827995255042,0.8613376169182463,1.0,9/31,14.79%,ZRANB1;SPATA2;OTUD1;USP33;OTUD7B;USP50;ABRAXAS1;STAMBPL1;USP7
prerank,nucleoside salvage (GO:0043174),0.5940155749817999,1.1875124762510865,0.28156748911465895,0.86102442770271,1.0,2/10,5.49%,TK1;TK2
prerank,cardiac myofibril assembly (GO:0055003),-0.4138536157436009,-1.1874116020144283,0.2345132743362832,0.6633032100681931,1.0,1/15,0.08%,NEBL
prerank,response to muscle stretch (GO:0035994),0.5424860912037478,1.187222320394653,0.2496607869742198,0.8612106583279588,1.0,3/15,12.04%,GSN;PIK3CA;SLC9A1
prerank,positive regulation of developmental process (GO:0051094),0.4107809931425898,1.1868027862747674,0.1401015228426396,0.8618413638881167,1.0,26/164,9.27%,DCN;AR;PHLDB1;BMP1;WT1;FGFR1;TLE6;TMEM119;NEUROD2;VEGFA;COBL;DLG4;LMNA;SMURF2;ACVR1;KRT10;NCOA3;C1QBP;SRC;MIEF2;HMCES;SOX8;MCU;PSEN1;AGO2;SOX5
prerank,neuron cell-cell adhesion (GO:0007158),0.5530729161685792,1.1867772658079396,0.26322751322751325,0.8609077028783277,1.0,10/14,32.87%,CEL;RET;NRXN3;CNTN4;NLGN1;NLGN3;NRXN1;NLGN2;NCAM2;NRXN2
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4660074675158802,1.1867050198458298,0.23825887743413515,0.8601722527101656,1.0,8/34,9.05%,WNT10B;WWTR1;TRIO;FOXO1;ZFPM2;FLCN;ZFP36L2;SIRT2
prerank,tRNA 5'-leader removal (GO:0001682),0.5660488129256809,1.1866223260930433,0.27534246575342464,0.8594788525134286,1.0,5/13,15.93%,RPP25;RPP21;PRORP;RPP25L;POP4
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.36006507856315295,-1.1864375903282867,0.22988505747126436,0.6633496711615919,1.0,6/28,8.54%,SORT1;BCL2;DAB2IP;CASP8AP2;DELE1;GABARAP
prerank,positive regulation of actin filament polymerization (GO:0030838),0.45888613220256635,1.1862128508119254,0.2577777777777778,0.8601178209385217,1.0,9/44,16.35%,GSN;SCIN;CDC42EP2;BIN1;PFN2;FCHSD1;FER;ARF6;NCK1
prerank,cellular response to chemical stress (GO:0062197),0.426954588091251,1.1856444679665552,0.18871794871794872,0.861321627338659,1.0,19/96,17.21%,NOX4;NCF4;LRRC8D;STX2;NFE2L2;FOXO1;PKD2;BRF2;PIK3CA;SIRT2;STX4;GPX1;EIF2S1;ZC3H12A;SOD3;SELENOS;HTRA2;KEAP1;PPIA
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.43481590184959096,1.1855092015694408,0.21789473684210525,0.8608702885378784,1.0,12/73,7.85%,LIF;EGFR;CD44;VEGFA;MIF;AXIN1;ATP2B4;DOCK7;PFN2;HDAC6;GAS6;PRKD2
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.3891124641661421,-1.1853748068759795,0.21153846153846154,0.6609033916633369,1.0,4/20,4.23%,INSR;IGF1;APP;PRKAA2
prerank,positive regulation of glycolytic process (GO:0045821),-0.3891124641661421,-1.1853748068759795,0.21153846153846154,0.6609033916633369,1.0,4/20,4.23%,INSR;IGF1;APP;PRKAA2
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.4277382780316648,-1.185213668668022,0.252,0.6586717837202952,1.0,7/14,17.24%,PLCG1;THBS1;ITGA4;RGCC;ECSCR;GPER1;CD40
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.32563719143889797,-1.1850599904263845,0.14285714285714285,0.6564442304696034,1.0,9/36,12.46%,SGMS1;BCL2;DAB2IP;TPD52L1;DAPK2;ING5;CX3CL1;FAS;BDNF
prerank,heterotypic cell-cell adhesion (GO:0034113),0.4996882898517664,1.1848423422779242,0.27764127764127766,0.8624073046243872,1.0,7/25,13.61%,ITGB3;ITGA5;DSC2;JAM3;ITGAV;JUP;CD200R1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.3063150378981984,-1.184737393462688,0.11627906976744186,0.6546447176167625,1.0,7/51,4.62%,PTN;IL34;VEGFC;HMGB1;THBS1;CXCL12;IL6R
prerank,protein import into peroxisome matrix (GO:0016558),0.5651263150010972,1.1845465597320628,0.28240109140518416,0.8625441350012515,1.0,6/12,21.43%,PEX16;PEX12;PEX1;PEX5L;PEX5;PEX2
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.33307301727347755,-1.1842318999232346,0.19791666666666666,0.6534434483076001,1.0,16/43,10.58%,BMP6;WNT4;IGF1;BMP7;MEF2C;PRKD1;ZHX3;IL6R;NELL1;ATRAID;BMPR2;YAP1;NPNT;RUNX2;LRP3;BMP2
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.5516988949383771,1.1840377855307787,0.27823691460055094,0.8635233052128009,1.0,4/13,15.36%,CD2BP2;USP4;PRPF3;DDX20
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.4699642053468995,-1.1839391496275837,0.254416961130742,0.6516607644471548,1.0,4/10,29.57%,APPL2;CD300A;C3;TREM2
prerank,regulation of exit from mitosis (GO:0007096),0.4693212116511135,1.1837742322376945,0.24026696329254726,0.8634837694441387,1.0,14/38,26.29%,CDC14B;ZW10;SIRT2;CDC23;ANAPC5;UBA52;CDC27;CDC26;PPP1R9B;ANAPC4;ANAPC10;ANAPC15;CDC14A;ANAPC2
prerank,regulation of fat cell differentiation (GO:0045598),0.43051455919260184,1.1835673907550939,0.21689259645464026,0.8632686622623963,1.0,17/74,14.39%,MEDAG;WNT10B;WWTR1;TRIO;ZFP36L1;TAF8;FOXO1;NR1D1;ZFPM2;ZFP36L2;SYAP1;SIRT2;CEBPB;AKT1;ZFP36;ZC3H12A;WDFY2
prerank,7-methylguanosine mRNA capping (GO:0006370),0.4765847529323771,1.1832405156773262,0.24733727810650888,0.8625110805869974,1.0,8/31,15.40%,POLR2H;GTF2H3;ERCC3;POLR2D;POLR2G;CCNH;GTF2F1;CMTR2
prerank,7-methylguanosine RNA capping (GO:0009452),0.4765847529323771,1.1832405156773262,0.24733727810650888,0.8625110805869974,1.0,8/31,15.40%,POLR2H;GTF2H3;ERCC3;POLR2D;POLR2G;CCNH;GTF2F1;CMTR2
prerank,negative regulation of B cell proliferation (GO:0030889),-0.47010426394110294,-1.182677976054208,0.256140350877193,0.6525134564510606,1.0,4/11,13.51%,LYN;TNFRSF21;ATM;CD300A
prerank,negative regulation of kinase activity (GO:0033673),0.4365113019115524,1.1822333305785337,0.21581196581196582,0.8655146361861016,1.0,19/62,17.85%,LRP6;TARBP2;CAMK2N1;WWTR1;DTNBP1;RTRAF;YWHAG;GSKIP;INPP5K;AKT1;MAPT;IRS2;SFN;DEPTOR;SMCR8;CHP1;CEP85;PPIA;QARS1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.4109401645482157,1.181784723084094,0.13039117352056168,0.8663290430263568,1.0,35/199,11.91%,ADAMTS5;LOXL2;PARP3;WNT10B;RAB11FIP5;EGFR;HPN;NPTN;LDLRAD4;SRSF6;F2R;HDAC9;SYT11;PROCR;TRPV3;ATP2B4;DOCK7;NR1D1;NFIB;PFN2;LNPEP;GAS6;FLCN;SPX;WDR77;FOXC2;TLR4;PAEP;SMAD6;ALPK2;HS3ST5;SLC6A4;GPNMB;VASN;PGAM5
prerank,epidermis development (GO:0008544),0.44620300830709125,1.1817022107006763,0.2092274678111588,0.8656389848322412,1.0,10/56,17.18%,COL17A1;FGF7;SCEL;EMP1;ALDH3A2;SVEP1;ATP2A2;EVPL;FLOT2;FABP5
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.5788866448578069,1.1811751814350226,0.29027576197387517,0.8667843523182248,1.0,3/10,8.17%,LRP1;PTPRJ;NDRG4
prerank,anion transmembrane transport (GO:0098656),-0.30104403525842577,-1.1808525782082062,0.1,0.6545852703866399,1.0,14/67,9.55%,SLC7A2;SLC6A13;SLC1A3;SLC16A12;SLC13A4;SLC13A3;SLC39A8;SLC7A5;SLC6A9;SLC25A42;SLC3A2;LRRC8B;SLC38A5;SLC25A11
prerank,cellular response to sterol (GO:0036315),0.5465356221248145,1.1807632172256024,0.2907801418439716,0.8674213284316857,1.0,3/13,8.51%,LRP6;GRAMD1A;INSIG2
prerank,negative regulation of catabolic process (GO:0009895),0.4531001077019834,1.180548954637364,0.22822491730981256,0.8672737003153359,1.0,14/47,21.70%,EGFR;IRAK3;ZDHHC7;MDM4;TIGAR;SIRT2;PIN1;NCOR1;PDE3B;HDAC4;NUPR1;FLNA;FMN2;AZIN2
prerank,regulation of phosphate metabolic process (GO:0019220),0.5258986462541915,1.1804850144695802,0.2712082262210797,0.8665067448270182,1.0,6/16,15.16%,TIGAR;PSEN1;SIRT2;SMG7;IL4;SMG6
prerank,cell-substrate junction assembly (GO:0007044),-0.3343255560908198,-1.180299264561926,0.21739130434782608,0.6535045329745113,1.0,7/33,5.87%,PTPRK;SORBS1;ACTN2;ITGA6;THSD1;ITGB4;PIP5K1A
prerank,dendritic cell differentiation (GO:0097028),0.5069737002615617,1.1802034288214456,0.2599758162031439,0.8666525238493937,1.0,5/22,14.82%,AXL;TGFBR2;GAS6;FLT3;IL4
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.5843503918896074,1.1801888820201438,0.26895565092989987,0.8657045162435089,1.0,4/10,21.60%,RC3H1;ZC3H12A;IL4;RC3H2
prerank,protein N-linked glycosylation (GO:0006487),0.44050644355952645,1.1801027685137961,0.22863247863247863,0.8650804006082912,1.0,19/66,24.67%,GFPT2;B4GALT1;GFPT1;MGAT1;LMAN1;ALG1;MGAT5;MGAT2;MGAT4B;TUSC3;TMEM165;ST3GAL1;DDOST;UGGT1;MGAT5B;KRTCAP2;SRD5A3;DPM2;PGM3
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.5513542214494336,1.1793588019387873,0.27989487516425754,0.8669642493785038,1.0,5/14,12.63%,MAPK14;DAZL;TARDBP;TIRAP;ZFP36
prerank,muscle contraction (GO:0006936),-0.27177937086505793,-1.1789645381081366,0.125,0.6543182603281289,1.0,29/126,18.87%,SORBS1;TPM1;MYLK;CALD1;ACTN2;ITGA1;DMD;DTNA;DYSF;TMOD3;MYOF;EDNRA;MYL9;MYH11;SMTN;FXYD1;KCNJ12;ACTA2;NOS1;DES;MYOM1;MYL12A;CLCN1;MYBPC1;GJC1;UTRN;MYL6;ROCK1;TNNT3
prerank,amino acid transmembrane transport (GO:0003333),-0.31379468045570447,-1.1788693596141544,0.18095238095238095,0.6521317646265788,1.0,7/45,6.69%,SLC7A11;SLC6A13;SLC16A2;SLC38A11;SLC7A5;SLC22A4;SLC3A2
prerank,carboxylic acid transport (GO:0046942),-0.2963050653150463,-1.1786891844409597,0.17567567567567569,0.6500406783285869,1.0,18/55,15.87%,SLC6A13;SLC16A12;SLC13A3;SLC16A2;SLC16A6;SLC6A12;SLC7A5;SLC16A11;SLC6A9;SLC3A2;SLC16A4;SLC38A5;SLC6A17;SLC6A6;SLC6A7;SLC16A13;LLGL2;SLC38A6
prerank,epithelial structure maintenance (GO:0010669),-0.4669954673351965,-1.1784590193212012,0.2852112676056338,0.6481746119246643,1.0,2/11,6.09%,RBP4;CXADR
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.43010473315490416,1.178205870584869,0.1934156378600823,0.8704888751996726,1.0,18/93,14.08%,MID1;SH3RF3;STK25;GADD45G;VEGFA;TGFB2;TAOK3;AXIN1;KLHDC10;RASSF2;FZD7;SEMA3A;TIRAP;EMC10;ANKRD6;CD27;TAOK2;ZC3H12A
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.4963342425362248,1.177289884668656,0.2568922305764411,0.8731893381258164,1.0,7/20,19.45%,TARBP2;TRIM71;AGO2;PUM1;AGO4;SNIP1;AGO3
prerank,cellular response to oxidative stress (GO:0034599),0.4157650985824614,1.1772670729358448,0.18839103869653767,0.8722560497698625,1.0,25/118,17.21%,NOX4;UCP1;NCF4;EGFR;STX2;NFE2L2;FOXO1;PKD2;BRF2;CHUK;SIRT2;STX4;GPX1;CAMKK2;AKT1;MAPT;EIF2S1;ZC3H12A;PDGFRA;FER;SOD3;SELENOS;HTRA2;KEAP1;PPIA
prerank,anterior/posterior pattern specification (GO:0009952),0.43942893846342046,1.1770982668417684,0.2298474945533769,0.8719232112123211,1.0,10/53,14.58%,HOXA3;WT1;PCSK5;BHLHE40;SKI;HOXA5;HOXA4;HOXA7;HOXC4;HOXA9
prerank,response to insulin (GO:0032868),0.4241962341252665,1.177065770910129,0.2159090909090909,0.8710460320690153,1.0,31/80,21.65%,IRS1;HDAC9;PIK3R2;ZFP36L1;SLC39A14;FOXO1;MEAK7;MYO5A;INSIG2;SYAP1;EPM2AIP1;KAT2B;INPP5K;RHOQ;AKT1;IRS2;EIF6;PDE3B;FER;PKM;SELENOS;OGT;CPEB1;EPRS1;VAMP2;CAPN10;GPLD1;LPIN3;GOT1;RAB10;SLC25A33
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.5532830014132509,1.176752376937571,0.2896551724137931,0.8712174341276225,1.0,1/12,1.26%,PRKCA
prerank,positive regulation of cellular component organization (GO:0051130),0.42034275504912616,1.1766101012020624,0.2038735983690112,0.870806696291019,1.0,20/107,12.18%,SYK;AR;LRP1;TGFB3;DCTN1;GPC3;NEUROD2;VEGFA;TGFB2;CDC42EP2;RUNX1;MPP7;GNL3L;SURF4;LMAN1;TIRAP;GPX1;BMF;BAK1;TMEM30A
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.54650623297932,1.1760043181153705,0.2812920592193809,0.8721479277138209,1.0,6/13,26.46%,XRCC3;DYNC1LI1;CDK5RAP2;ANAPC15;TPR;DUSP1
prerank,positive regulation of protein polymerization (GO:0032273),0.43815560426545097,1.1754734776168512,0.22376873661670235,0.8732514721034659,1.0,22/65,21.98%,DCTN1;CDC42EP2;BIN1;CLIP1;PSRC1;PFN2;TOGARAM1;MAPRE1;MAPT;FCHSD1;TPPP3;SLAIN2;FER;HSP90AA1;ARF6;CDK5RAP2;NCK1;AKAP9;NAV3;NUMA1;PYCARD;CTTN
prerank,regulation of mitochondrial fission (GO:0090140),0.48014975458183934,1.1751322439709155,0.26634382566585957,0.8736616789924502,1.0,10/24,26.56%,DCN;MIEF2;MCU;MAPT;DDHD1;RALA;STAT2;FIS1;MUL1;INF2
prerank,protein palmitoylation (GO:0018345),0.47484531137752745,1.1750766511216932,0.2491186839012926,0.8729149990732895,1.0,13/30,23.21%,ZDHHC16;ZDHHC7;HHAT;SELENOK;ZDHHC2;ZDHHC4;ZDHHC24;ZDHHC21;ZDHHC20;CLIP3;ZDHHC18;ZDHHC8;ZDHHC5
prerank,vesicle organization (GO:0016050),0.4522342772663174,1.174756793519672,0.24344978165938866,0.8731673044810694,1.0,11/46,18.18%,CD34;DNM1;HOOK2;PLEKHF1;PI4K2B;SQSTM1;USP50;PHETA2;VPS11;ANXA8;ANXA8L1
prerank,cellular protein localization (GO:0034613),0.4033329447705198,1.174710605140997,0.103,0.87234762974003,1.0,100/285,23.64%,FGF7;SGSM2;EGFR;COPA;STX2;RAB32;RABGAP1L;CD177;RAB6A;ANK2;STX1A;TMED1;STX5;STX11;SEC31A;RAB23;RAB19;RAB6B;SCFD2;JAM3;USP4;ARF4;SCG5;TBCK;BICD1;AP3D1;HDAC6;STX1B;CLTC;SNX1;ACD;PACS2;USO1;TBC1D2B;ARFGAP3;STX4;TBC1D17;GGA1;SCFD1;WIPI2;ARF1;STX12;WDR45B;NPM1;SEC23IP;COPB2;VPS33A;TBC1D10A;NAPA;DUOXA1;STX17;RAB43;RPGR;HPS6;RRAGD;ARFRP1;BBS4;SYNDIG1;PIGK;ARF6;GGA2;AHI1;NSF;EVI5;SGSM1;COPZ2;EVI5L;AP4M1;NAPG;TBC1D13;RAB1B;RAB5B;RAB5C;STX3;SNX6;ARCN1;ADPRH;TBC1D22B;ATG13;TBC1D15;NIPBL;RAB24;TMED2;VPS33B;FLNA;COX18;CNTN2;ABHD17A;RUNDC1;CTTN;SMURF1;CROCC;SEPTIN9;NAPB;STX16;CNTNAP1;TBC1D8B;TBC1D12;PICK1;RABL3
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.49149751968800276,1.1745408158877468,0.2710163111668758,0.8720560710054793,1.0,8/23,20.50%,SCNN1B;SLC12A8;SLC12A4;SLC9A1;SLC12A5;SLC9A7;KCNH2;SLC12A6
prerank,skeletal muscle contraction (GO:0003009),0.5222520607315266,1.1744809991208087,0.2681704260651629,0.8712848053956884,1.0,3/19,9.10%,JSRP1;TNNI3;MYH14
prerank,regulation of myotube differentiation (GO:0010830),0.5014954160309019,1.1741214483478044,0.2819548872180451,0.871756220141714,1.0,6/24,13.86%,TMEM119;HDAC9;MAPK14;ATP11A;HDAC3;HDAC4
prerank,muscle organ development (GO:0007517),0.4371432328970509,1.1741148464067253,0.24676724137931033,0.8707865221102695,1.0,10/54,10.54%,COL6A3;MAPK12;CTF1;FHL1;ITGA11;SRI;MEF2D;CXCL10;LARGE1;CHD2
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.3501399293860512,-1.173881368235874,0.20987654320987653,0.6581712226775153,1.0,10/29,12.76%,ACSL1;ELOVL7;ACSL4;HACD1;ACSL3;CBR4;HACD2;ACSL6;SCD;ELOVL1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.5716445060956227,1.1737702572402637,0.2827298050139276,0.8712035057642957,1.0,6/11,20.60%,TIPIN;FBXO5;GMNN;BLM;SMARCAL1;DONSON
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.5656512712383236,1.173661754773534,0.2914923291492329,0.8706136907615986,1.0,1/11,0.45%,GSN
prerank,regulation of response to stress (GO:0080134),0.5769226577079509,1.1730243154640487,0.31232876712328766,0.8721718956700861,1.0,2/10,12.54%,CORO2B;ADCY8
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.49044785880384895,1.1728572134844686,0.2723926380368098,0.8718598115281256,1.0,7/24,12.62%,JSRP1;SRI;CAMK2D;PKD2;GSTM2;PDE4D;CALM2
prerank,regulation of peptide hormone secretion (GO:0090276),-0.2877045449875319,-1.1725574734190731,0.16666666666666666,0.6590773751927815,1.0,11/67,5.33%,ITPR1;RAPGEF4;CHD7;RAPGEF3;SLC2A1;CACNA1E;KCNB1;CACNA1D;HADH;ITPR3;KCNS3
prerank,regulation of neuron migration (GO:2001222),0.48141316309317855,1.1725061030534616,0.2807646356033453,0.8722276839564362,1.0,9/26,18.94%,COL3A1;IGSF10;TNN;SEMA3A;KIF20B;NSMF;SRGAP2;SHTN1;NIPBL
prerank,inositol lipid-mediated signaling (GO:0048017),0.44518253902284666,1.1724450376436624,0.23168103448275862,0.8714905469279915,1.0,15/50,17.17%,IRS1;FGFR1;PLCE1;PIK3C2B;PIK3R2;PLCB4;INPP5F;PIK3CA;IRS2;RHOA;PI4KB;PDGFRA;PI4KA;OGT;PLCD4
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.48186674104536026,1.1724044286578457,0.2745803357314149,0.8706851138246029,1.0,10/30,18.66%,HNRNPA1;CTC1;GNL3L;SRC;ACD;ERCC4;CDKN1A;TERF1;TENT4B;TINF2
prerank,high-density lipoprotein particle assembly (GO:0034380),0.576672502811905,1.172133632490897,0.2838616714697406,0.8707779162259686,1.0,2/10,7.00%,BMP1;ABCA1
prerank,regulation of T cell cytokine production (GO:0002724),0.5342048907253449,1.171422121139793,0.29133858267716534,0.8726318888806418,1.0,1/15,0.49%,CD55
prerank,calcineurin-mediated signaling (GO:0097720),0.5758753639487302,1.1713401131168575,0.28330995792426367,0.8709865176557638,1.0,5/10,19.14%,NFATC4;NFATC1;PPP3CC;PPP3CA;PPP3CB
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.5758753639487302,1.1713401131168575,0.28330995792426367,0.8709865176557638,1.0,5/10,19.14%,NFATC4;NFATC1;PPP3CC;PPP3CA;PPP3CB
prerank,striated muscle contraction (GO:0006941),-0.2973556559098159,-1.1705670629022908,0.12658227848101267,0.6619323159592722,1.0,5/53,2.81%,ATP1A2;TPM1;DMD;RCSD1;DTNA
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5270105773284259,1.1703642578475983,0.2983425414364641,0.8738329457300685,1.0,4/14,15.83%,SYVN1;CREB3L1;HERPUD1;SELENOS
prerank,mitochondrion transport along microtubule (GO:0047497),0.5375378327504963,1.1700981044713397,0.27248322147651005,0.8739086744906033,1.0,6/13,25.60%,NEFL;SYBU;MAPT;UXT;MAP1S;RHOT2
prerank,maturation of LSU-rRNA (GO:0000470),0.4815169629427259,1.1699387483186403,0.2725060827250608,0.8735374044220582,1.0,10/26,22.24%,DDX18;URB1;ZNHIT6;RPL10A;EIF6;SNU13;RSL1D1;RPF2;MAK16;NOP2
prerank,positive regulation of cytokine production (GO:0001819),0.40687010867400175,1.1695842973900061,0.104,0.8739512917690528,1.0,38/292,11.89%,CD34;SYK;LBP;CD80;CCBE1;IRF4;POLR2H;ANXA1;IL16;GLMN;EIF2AK3;RAB7B;SULF2;FOXP1;F2R;RFTN1;RUNX1;MIF;TMEM106A;MAPK14;IL33;CGAS;TLR5;SULF1;SCAMP5;IL17RA;DHX33;POLR3E;PRKD2;TIRAP;TLR4;PAEP;MAPK11;POLR3D;CEBPB;IRAK1;PDE4D;PIBF1
prerank,positive regulation of viral process (GO:0048524),0.4332783873861039,1.1695280212780301,0.23440860215053763,0.8732118011143863,1.0,14/60,15.31%,AXL;POLR2H;TARBP2;ADARB1;KPNA2;MDFIC;CDK9;LARP1;POLR2D;POLR2G;DDB1;CTDP1;GTF2F1;HACD3
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.5366092095489813,1.1692143846287575,0.2699724517906336,0.8734597493670706,1.0,6/14,19.25%,WNT9A;CHADL;SNAI2;EFEMP1;TGFBR1;RFLNA
prerank,gonad development (GO:0008406),0.45621527598641315,1.1690648374307664,0.2570145903479237,0.8730765967947417,1.0,8/41,9.98%,AR;WT1;SIX4;TGFB2;IRX5;NUP107;SOX8;COL9A3
prerank,oligodendrocyte development (GO:0014003),0.5303630305517467,1.1686938605174002,0.304,0.8735527869988469,1.0,8/15,28.07%,PRDM8;SOX10;PLP1;EIF2B1;CNTNAP1;EIF2B2;B4GALT5;MYRF
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.47120131342849925,1.1680812002084182,0.2494033412887828,0.8749414754758899,1.0,10/30,16.59%,AR;FOXP1;PRMT2;HDAC6;NCOR2;NCOR1;SMARCA4;RNF14;TRIM68;DDX5
prerank,defense response to fungus (GO:0050832),0.533236487619126,1.1680504393676188,0.2857142857142857,0.8740790845164577,1.0,2/17,3.54%,S100A8;S100A9
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.40871428964992196,1.1679635546315832,0.17558022199798184,0.8734153158092463,1.0,24/152,14.19%,ADGRD1;GNAS;VIPR2;LPAR3;GPR12;GNAI3;LPAR1;GLP2R;CXCL10;S1PR2;ABCA1;HTR1F;ADCYAP1;ADGRG2;CRHR1;GNAZ;CALCA;AKAP12;GPR161;GPR37L1;TSHR;ADCY8;GPR37;LHCGR
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.49077722753868586,1.1670536764359598,0.2824519230769231,0.8749097473499147,1.0,9/22,22.78%,ZDHHC7;ZDHHC2;ZDHHC4;ZDHHC24;ZDHHC21;ZDHHC20;CLIP3;ZDHHC18;ZDHHC8
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.49077722753868586,1.1670536764359598,0.2824519230769231,0.8749097473499147,1.0,9/22,22.78%,ZDHHC7;ZDHHC2;ZDHHC4;ZDHHC24;ZDHHC21;ZDHHC20;CLIP3;ZDHHC18;ZDHHC8
prerank,cAMP metabolic process (GO:0046058),-0.44128289041667124,-1.1665904432330558,0.2629310344827586,0.66988546293072,1.0,4/13,9.13%,ADCY5;ADCY1;ADCY4;ADCY9
prerank,response to acidic pH (GO:0010447),0.5506939396508305,1.1665182472027853,0.3048128342245989,0.8759882133031889,1.0,3/13,15.24%,RAB11FIP5;SLC9A1;CHP1
prerank,hepaticobiliary system development (GO:0061008),-0.3875747712833278,-1.1663697097045578,0.21524663677130046,0.6679887141881102,1.0,6/20,9.21%,ARID5B;WNT4;LSR;TGFBR3;PHF2;CITED2
prerank,amide transport (GO:0042886),-0.3636625379951253,-1.1661589756696609,0.2147239263803681,0.6660123596965318,1.0,7/26,9.21%,PLTP;ABCG2;PDPN;PLEKHA8;CERT1;AQP11;SLC38A5
prerank,positive regulation of cellular protein localization (GO:1903829),0.4329581906968193,1.1661002563643326,0.22115384615384615,0.8766533522287591,1.0,21/69,23.06%,LIF;EIF2AK3;FYN;WWTR1;SYT11;GNL3L;MEAK7;BICD1;PARD6A;STX4;AKT1;MAPT;GPR137B;STX3;ENTR1;NUMA1;MAP1A;SESN2;CROCC;CCDC88A;TRAPPC12
prerank,positive regulation of DNA metabolic process (GO:0051054),0.43004533919178184,1.1657972498482148,0.2374331550802139,0.876943945997283,1.0,16/61,17.41%,PARP3;EGFR;WT1;FGF2;SMOC2;STPG4;EYA2;UBE2N;PRKD2;TIGAR;ABRAXAS1;NBN;USP7;HGF;PML;RAD50
prerank,response to reactive oxygen species (GO:0000302),0.4330078597951897,1.1653174697496318,0.2565789473684211,0.8778051809673205,1.0,14/54,14.37%,UCP1;EGFR;STK25;FYN;ADAM9;PKD2;CHUK;GPX1;CAMKK2;AKT1;MAPT;PDGFRA;FER;STK24
prerank,glutamate metabolic process (GO:0006536),0.5121784851530912,1.1649785787114348,0.29757343550446996,0.878228264962354,1.0,6/19,15.42%,GCLC;ALDH18A1;GLS2;GLS;ALDH5A1;GLUD1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.4579357493393808,-1.1645653827996365,0.27986348122866894,0.6677426442354091,1.0,5/11,15.14%,EFNB2;MEF2C;TGFB1;GPER1;MYOCD
prerank,T cell differentiation in thymus (GO:0033077),0.5406669701044869,1.1645485525400905,0.29365079365079366,0.8788571200150778,1.0,3/14,11.60%,ZFP36L1;ZFP36L2;GLI3
prerank,toll-like receptor signaling pathway (GO:0002224),0.4223924942915146,1.1642786287933515,0.21897810218978103,0.8789364804687886,1.0,36/84,30.45%,LBP;IRAK3;RFTN1;S100A8;S100A9;TLR5;SCARA3;CHUK;TIRAP;TLR4;IRAK4;IRAK1;TNIP1;UBA52;EPG5;CD14;TRAF3;ITGAM;UBE2D3;TAB2;MAP3K7;TNIP2;CTSK;TICAM1;HSP90B1;CTSB;CTSL;BCL10;CASP8;MAPKAPK3;SFTPA1;SFTPA2;MYD88;TRIL;LGALS9;TRAF6
prerank,regulation of postsynapse organization (GO:0099175),-0.34306952968426907,-1.1641391085223778,0.22527472527472528,0.6664244421454028,1.0,7/28,5.39%,EPHA4;PDLIM5;CDKL5;WNT5A;SHANK3;SIPA1L1;ABHD17C
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.5548789238273983,1.1639058668821396,0.2962962962962963,0.8794387934493937,1.0,6/11,26.46%,SLIT2;MIF;PADI2;NBL1;CCN3;DUSP1
prerank,negative regulation of RNA metabolic process (GO:0051253),0.5173435352630822,1.1637581655392601,0.27261146496815286,0.8791201670629326,1.0,8/18,21.97%,ESR1;KAT2B;NUDT16;NCOR2;NCOR1;ZC3H12A;PTBP1;PTBP2
prerank,regulation of fibroblast proliferation (GO:0048145),0.45092817180191946,1.1633710903642276,0.27624309392265195,0.8796816458475376,1.0,7/45,7.92%,DDR2;WNT2;MIF;SKI;CDK4;GAS6;S100A6
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.3968451421418156,-1.163218772801332,0.251063829787234,0.6663923123166215,1.0,6/17,17.82%,ATP1A2;GJA1;RYR2;ATP1B1;GJC1;GJD3
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.5286960742563719,1.1632042351256322,0.30569948186528495,0.8793676890852932,1.0,3/16,4.58%,IGFBP5;IGFBP6;IGFBP4
prerank,nucleoside catabolic process (GO:0009164),-0.4525104311806456,-1.1632036585858287,0.2936802973977695,0.6639723000536883,1.0,4/11,8.10%,DPYD;UPB1;NT5E;DERA
prerank,mesenchymal to epithelial transition (GO:0060231),0.5640489767685213,1.1631854243125672,0.30491329479768786,0.8784807164714021,1.0,2/10,8.19%,WT1;FZD7
prerank,regulation of endocytosis (GO:0030100),0.4341586807505095,1.1628602820893426,0.2616216216216216,0.8788116139315753,1.0,18/61,19.46%,STON2;LRP1;GPC3;EPHA3;CD177;SYT11;SRC;RIT2;SCAMP5;ABL2;ARFGAP1;RUFY1;CALY;RAB5B;RAB5C;SMPD1;CLIP3;LRSAM1
prerank,protein homooligomerization (GO:0051260),0.4164997707625706,1.1627747415386438,0.19815195071868583,0.878192281522784,1.0,20/114,14.86%,SCARA5;SLC1A5;DISP1;MIF;P2RX3;TK1;KCNJ2;MPP2;OSBPL2;PKD2;ZBTB1;SAMHD1;VSTM5;ADCY8;ALDH1A3;TMEM120A;GLS;NACC2;KCNC2;CRYZ
prerank,transport along microtubule (GO:0010970),0.549763113992351,1.1622864992189157,0.2742155525238745,0.8791473529720226,1.0,6/13,22.58%,ARHGAP21;APBA1;DYNC1I1;CLIP3;COPG1;BAG3
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.50595030092443,1.161965473458165,0.29292929292929293,0.879340495333944,1.0,10/20,25.76%,PPIL6;NKTR;PPIC;PIN1;PPIA;FKBP4;FKBP1A;PPIG;CWC27;PPIH
prerank,positive regulation of endothelial cell migration (GO:0010595),0.42326588878433796,1.1613155579996841,0.22164412070759626,0.8808944151765564,1.0,23/84,14.55%,FGF18;PRKCA;FGFR1;ANGPT4;SPARC;ITGB3;VEGFA;FGF2;FOXP1;SMOC2;MAPK14;PLPP3;MAP2K3;PRKD2;STAT5A;FOXC2;AKT3;EMC10;AKT1;EGF;AAMP;ZC3H12A;BCAS3
prerank,leukocyte cell-cell adhesion (GO:0007159),0.4864416700069054,1.1611471954713612,0.2735961768219833,0.8805909910781067,1.0,2/24,2.49%,SYK;CD177
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.5450563210935246,1.160658053942788,0.29395973154362415,0.8815876459738843,1.0,5/14,18.58%,ENTPD2;NUDT1;NUDT16;NUDT5;ENTPD6
prerank,regulation of complement activation (GO:0030449),0.45475103748848433,1.1605589313685432,0.2981859410430839,0.8810270437241084,1.0,8/40,13.58%,CD55;CFH;C7;C1QBP;CD81;C4B;SERPING1;CR2
prerank,monoacylglycerol metabolic process (GO:0046462),0.5556036304278791,1.1604548742023162,0.2961992136304063,0.8804791836855799,1.0,1/13,0.62%,MGLL
prerank,negative regulation of secretion by cell (GO:1903531),0.45491353980570737,1.1598278601536336,0.2761795166858458,0.8820203421708465,1.0,4/38,5.42%,LIF;ANXA1;SYT11;RHBDF1
prerank,TOR signaling (GO:0031929),0.4842550837577776,1.1597599693013931,0.2812121212121212,0.8813115195098524,1.0,14/26,29.14%,MTOR;MEAK7;FLCN;SYAP1;AKT1;LARP1;CARD11;CCDC88A;TIPRL;MAPKAP1;EIF4EBP2;PRR5;RHEBL1;FNIP1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.5725963569022927,1.1596773743972888,0.29957805907172996,0.8797252016862072,1.0,5/11,27.86%,OCRL;INPP5K;INPP5B;PTEN;SYNJ2
prerank,inositol phosphate dephosphorylation (GO:0046855),0.5725963569022927,1.1596773743972888,0.29957805907172996,0.8797252016862072,1.0,5/11,27.86%,OCRL;INPP5K;INPP5B;PTEN;SYNJ2
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.33048234774813523,-1.1595107889095622,0.16783216783216784,0.6711711948688334,1.0,7/32,7.51%,INSR;IGF1;APP;PRKAA2;PPARA;PINK1;ENO1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.4283835278715609,1.1594452665311914,0.24944812362030905,0.8796591772975862,1.0,16/62,19.35%,ACKR3;MAPK7;NFE2L2;SYVN1;CREB3L1;SRC;NOC2L;HERPUD1;URI1;AKT1;SELENOS;SNAI2;HTRA2;PPIA;PLAUR;MCL1
prerank,non-motile cilium assembly (GO:1905515),0.4695036828760303,1.1592384046163882,0.30465116279069765,0.8795297671791937,1.0,11/30,21.35%,DCTN1;ARL13B;TOGARAM1;PIBF1;VANGL2;BBS4;TTC8;RPGRIP1;CEP89;PCM1;IFT57
prerank,positive chemotaxis (GO:0050918),0.5071300805534096,1.1591730179388082,0.3005249343832021,0.8788367823683166,1.0,4/17,11.78%,FGF7;VEGFA;PTPRJ;GPNMB
prerank,fatty acid beta-oxidation (GO:0006635),0.4356388365227448,1.1590803952752073,0.2610132158590308,0.87822530169029,1.0,18/51,22.15%,EHHADH;ETFA;CRAT;AUH;SCP2;ACADVL;SLC25A17;ACOX1;ETFDH;ETFB;BDH2;ABCD3;MCAT;HSD17B4;ACAT1;CPT2;PEX2;CROT
prerank,tRNA 5'-end processing (GO:0099116),0.5323130210498555,1.1587207856818693,0.31175693527080584,0.8786283066358961,1.0,5/15,15.93%,RPP25;RPP21;PRORP;RPP25L;POP4
prerank,interstrand cross-link repair (GO:0036297),0.4412012885558443,1.1586043842893594,0.25081788440567065,0.8781624971483046,1.0,12/53,14.21%,FANCD2;XRCC3;EME1;RFWD3;FANCL;FAAP100;FANCE;EXO5;UBA52;ERCC4;FAN1;FANCG
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.4958924913939747,1.1580534353642156,0.3100120627261761,0.8793716525703437,1.0,7/22,16.99%,EIF2AK3;MTOR;DHX33;UBTF;DDX11;SMARCA4;IPPK
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.4495522873730526,1.15738577273751,0.26477272727272727,0.8810604283903619,1.0,4/45,5.60%,MID1;IRF4;CD44;CAMK2D
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.4097143457133713,1.1572931543700644,0.2032520325203252,0.8804839474778791,1.0,24/129,13.17%,SFRP4;COL1A1;DKK2;EGFR;SCEL;GPC3;PSMC4;UBE2B;SMURF2;AXIN1;DACT1;DAAM2;PSMC6;PSMD8;GSKIP;PLEKHA4;KANK1;TMEM9;CSNK1G1;CSNK1G3;PRDM15;JUP;EGF;PIN1
prerank,regulation of protein catabolic process (GO:0042176),0.4170669831045157,1.1571199590405463,0.22440537745604963,0.8801730304971894,1.0,24/99,16.88%,EGFR;GPC3;IRAK3;STX5;SMURF2;AXIN1;DACT1;ITCH;FOXO1;SEC22B;MDM4;EGLN2;WDR91;DTL;SIRT2;ODC1;HECW2;TMEM9;PIN1;ZDHHC2;DDB1;NSF;HACE1;IDE
prerank,regulation of multicellular organism growth (GO:0040014),0.5315263823027209,1.1570719175691515,0.3062583222370173,0.8794109936768129,1.0,2/15,8.10%,GHR;STAT5A
prerank,protein-DNA complex disassembly (GO:0032986),0.5229382165834177,1.1569377472460571,0.30361757105943155,0.8790173875560654,1.0,7/16,19.50%,SMARCD2;SMARCD1;SMARCC2;SMARCA4;GRWD1;SET;RPL23
prerank,glucose transmembrane transport (GO:1904659),-0.3979927444561533,-1.1566830306515659,0.2317596566523605,0.6764219676389106,1.0,3/18,3.66%,SORT1;SLC2A1;SLC5A3
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.3784576961620693,-1.1566193615923126,0.25133689839572193,0.6741123118099429,1.0,13/20,29.46%,WNT4;BMP5;ACADL;SIK1;BMP2;CEACAM1;GPER1;ABCA2;BRCA1;ERLIN2;TRIB3;ASXL3;APOC1
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.37212560899362757,-1.156542348017113,0.24083769633507854,0.6719020609261068,1.0,3/22,4.40%,SORBS1;APOE;PPARA
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5597907811819842,1.1562331591826345,0.3103448275862069,0.8807850639958378,1.0,7/11,28.37%,ZMIZ1;SMARCD1;PADI2;ELOF1;SERTAD2;ARID1A;ARID1B
prerank,positive regulation of developmental growth (GO:0048639),0.43860945094176473,1.1562040927682362,0.26717557251908397,0.8799785342135317,1.0,11/49,18.84%,GHR;DBN1;SYT2;NTN1;ISLR2;L1CAM;MAPT;GOLGA4;SYT1;SHTN1;RIMS2
prerank,Golgi organization (GO:0007030),0.40795000835620926,1.1561525176346454,0.22176591375770022,0.8792332846149351,1.0,46/112,28.30%,SEC16B;ATP8B1;ARHGAP21;STK25;TMED1;STX5;FBXW8;FHDC1;ZW10;LYSMD3;RAB30;PI4K2B;SEC22B;SYNE1;SURF4;LMAN1;RAB2A;SEC23IP;STX17;RAB43;BCAS3;BLZF1;HACE1;DYNC2H1;ARFGEF1;TMED2;CLASP2;ATP8B2;VAMP4;TJAP1;PI4K2A;STX16;GOLPH3L;TRAPPC12;VTI1A;BAG5;RAB29;RAB1A;GOSR2;GBF1;ARHGEF7;GORASP1;CUL7;VCPIP1;NPLOC4;TMED3
prerank,neuron remodeling (GO:0016322),-0.4721457621069435,-1.1558668907883751,0.31715210355987056,0.6711543777120013,1.0,7/10,22.67%,APP;EPHA8;ANKS1A;CX3CL1;C1QA;C3;SCARF1
prerank,peptidyl-methionine modification (GO:0018206),0.5456369034923223,1.155795112182168,0.3231622746185853,0.8796623380605348,1.0,6/12,23.22%,NAA15;METAP2;NAA20;METAP1;METAP1D;NAA30
prerank,negative regulation of endopeptidase activity (GO:0010951),0.4477002042930943,1.155740736607493,0.2741398446170921,0.8789405216550805,1.0,9/47,12.89%,TIMP2;SERPINB8;BIN1;SERPINE3;SERPINF1;SERPINH1;AKT1;RECK;SERPING1
prerank,acetyl-CoA metabolic process (GO:0006084),0.5180572548547225,1.1557227581920337,0.31723237597911225,0.8780830351219296,1.0,7/15,25.37%,ACLY;MVK;NUDT7;PMVK;DIP2A;ACAT1;MVD
prerank,chromatin disassembly (GO:0031498),0.5362586088741601,1.1556573950331088,0.29673202614379085,0.8764807601020028,1.0,6/14,17.70%,SMARCD2;SMARCD1;SMARCC2;SMARCA4;GRWD1;SET
prerank,nucleosome disassembly (GO:0006337),0.5362586088741601,1.1556573950331088,0.29673202614379085,0.8764807601020028,1.0,6/14,17.70%,SMARCD2;SMARCD1;SMARCC2;SMARCA4;GRWD1;SET
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.4507800790813455,1.1555978669754183,0.2671156004489338,0.8757959501565009,1.0,14/39,20.71%,MYOC;CORO2B;EFNA5;MELTF;FZD7;JAG1;KANK1;ADAM15;RHOA;HOXA7;FZD4;RCC2;RASA1;CORO1C
prerank,regulation of endothelial cell proliferation (GO:0001936),0.419908545364963,1.1555407545529264,0.2302839116719243,0.8750819943924044,1.0,19/88,12.37%,TNMD;FGF18;PRKCA;SPARC;ANG;ITGB3;VEGFA;FGF2;ECM1;FUT2;THBS4;SULF1;PRKD2;STAT5A;AKT3;EMC10;NRAS;AKT1;EGF
prerank,negative regulation of interleukin-12 production (GO:0032695),0.531830185205709,1.1553178458132605,0.31763122476446837,0.8750060776936055,1.0,3/14,11.89%,IRAK3;C1QBP;PIBF1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.49231408462213744,1.154974535695229,0.2816377171215881,0.8753688171139506,1.0,8/22,22.45%,EDEM3;SYVN1;EDEM1;EDEM2;UBA52;AMFR;UGGT1;SEL1L
prerank,regulation of monooxygenase activity (GO:0032768),0.49422213235665846,1.154865679492525,0.2976629766297663,0.8748618360521014,1.0,8/23,17.32%,CYGB;EGFR;VDR;AKT1;POR;GDNF;HSP90AA1;ZDHHC21
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.479248191840952,1.1547294924464775,0.2857142857142857,0.8744706414829232,1.0,5/26,9.05%,IRAK3;ITCH;CARD16;C1QBP;SIRT2
prerank,positive regulation of secretion (GO:0051047),0.548327908015627,1.1546495124154097,0.3047619047619048,0.8738409138048807,1.0,3/11,19.54%,SCIN;TRH;GPLD1
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.49257429799331787,1.1537069317542366,0.3108108108108108,0.8765518166605544,1.0,2/22,8.30%,CD55;ZBTB1
prerank,positive regulation of integrin activation (GO:0033625),0.5528803126855366,1.1536545088275543,0.3203342618384401,0.8758159745042381,1.0,2/11,6.81%,RAP1B;SRC
prerank,ventricular septum development (GO:0003281),0.45261239123251684,1.1532571121137953,0.28751431844215347,0.8763353424387712,1.0,8/37,7.56%,TGFB2;SLIT3;SLIT2;TGFBR2;SMAD4;ACVR1;MDM4;ZFPM2
prerank,protein deubiquitination (GO:0016579),0.3985103854036383,1.1529387766510237,0.15963855421686746,0.8767233415218676,1.0,87/242,27.59%,AR;ESR1;UCHL1;DESI2;PSMC4;JOSD2;SMAD4;SMURF2;USP36;COPS5;OTUD3;ZRANB1;SPATA2;FOXK2;USP32;USP10;RAD23B;IL33;USP29;USP4;PSMC6;MDM4;OTUD1;UCHL5;ADRM1;PSMD8;SENP8;ATXN7L3;KAT2B;POLB;USP26;USP33;OTUD7B;ACTR5;USP48;USP50;TNIP1;UBA52;USP5;ABRAXAS1;RHOA;NFRKB;ZC3H12A;RCE1;INO80;STAMBPL1;RNF128;USP7;TRAF3;USP22;OGT;KEAP1;CCP110;WDR20;TGFBR1;NEDD8;SKP2;SUDS3;KDM1B;FOXO4;USP35;TRRAP;PTEN;USP13;CLSPN;USP19;CYLD;MAP3K7;RNF123;TNIP2;TFPT;PSMD3;STAM;PSMD4;MDM2;ASXL1;UFD1;OTUD4;USP49;PSMB3;INO80C;CFTR;OTULIN;USP38;VCPIP1;USP9Y;PSMB2
prerank,positive regulation of lipid catabolic process (GO:0050996),0.5053778467329836,1.1527252152006646,0.2784163473818646,0.8766161601090053,1.0,5/19,18.77%,IRS1;IRS2;TWIST1;DAGLB;ANGPTL3
prerank,regulation of humoral immune response (GO:0002920),0.44340978219479266,1.152157537981588,0.28876404494382024,0.8779041015275729,1.0,8/44,13.58%,CD55;CFH;C7;C1QBP;CD81;C4B;SERPING1;CR2
prerank,positive regulation of histone deacetylation (GO:0031065),0.5384605740084969,1.1521548134795416,0.3177570093457944,0.876999514750411,1.0,6/12,21.50%,VEGFA;PRKD2;AKAP8;NIPBL;CTBP1;AKAP8L
prerank,N-terminal protein amino acid modification (GO:0031365),0.5358517591133515,1.1516974476757809,0.308411214953271,0.8778478758630006,1.0,6/14,21.79%,NTMT1;NAA15;METAP2;NAA50;METAP1;METAP1D
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.3866138589263505,-1.1515709359415613,0.24789915966386555,0.6801451337682418,1.0,2/18,0.55%,ATP1A2;NEDD4L
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.5669077046952412,1.1513102227827978,0.3063583815028902,0.8783377951512482,1.0,2/10,8.10%,GHR;STAT5A
prerank,generation of neurons (GO:0048699),0.4023052090038631,1.1512487410393768,0.18693467336683417,0.8776844868681549,1.0,33/190,15.34%,LMX1A;LHX8;NAV1;WNT10B;WNT2;MAP1B;FGFR1;CTF1;SIX4;NEUROD2;WNT9A;FGF13;TGFB2;BHLHE40;RUNX1;LMX1B;IRX5;POMGNT2;DOCK7;LRP12;FZD7;SEMA3A;NRBP2;FUT9;MAPT;PIN1;SIX1;TAFA1;ARTN;THOC2;POU3F2;MDGA1;FZD4
prerank,steroid hormone biosynthetic process (GO:0120178),0.47023045665105623,1.1508032406065178,0.30011723329425555,0.878394148005935,1.0,6/29,23.86%,AKR1B1;SRD5A1;HSD17B8;FDX1;HSD17B11;SRD5A3
prerank,regulation of neuron death (GO:1901214),0.4170005170093374,1.1503676915737502,0.2529100529100529,0.8791514227011216,1.0,21/82,19.92%,CD34;SNCB;FYN;KIR3DL2;EGLN2;AKT1;MAPT;GPNMB;NSMF;CD200R1;EIF2S1;TNFRSF1B;DCC;CHP1;HTRA2;SARM1;CHRNA7;FAIM2;EPHB1;RRAS2;ITGAM
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.3687450348977671,-1.150289886523956,0.25906735751295334,0.6812434493118642,1.0,7/21,12.97%,ADCY5;ADCY1;GUCY1B1;ADCY4;ADCY9;NPR1;GUCY1A1
prerank,regulation of mononuclear cell migration (GO:0071675),-0.3653612472377292,-1.15005975406121,0.23369565217391305,0.6794715041724895,1.0,4/23,2.72%,LYN;IL34;BMP5;THBS1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.43084157013896895,-1.1499347591979967,0.234375,0.677374889100432,1.0,5/13,11.92%,NOS3;PPARA;PINK1;ENO1;NOS1
prerank,regulation of glucose metabolic process (GO:0010906),0.45754504341461616,1.14981850844643,0.2828638497652582,0.8803493973340383,1.0,10/34,19.54%,IRS1;DGKQ;FOXK2;AKT1;IRS2;USP7;ZNF692;SELENOS;OGT;GPLD1
prerank,BMP signaling pathway (GO:0030509),0.4286798841336158,1.1496924375282298,0.2722400857449089,0.879917612788548,1.0,12/62,10.84%,AMH;TMEM100;TGFB3;TGFB2;SMAD4;ACVR1;BMP15;FAM83G;SMAD5;BMP8A;SMAD6;AMHR2
prerank,spindle assembly (GO:0051225),0.42832216308046167,1.1493623655077245,0.2631578947368421,0.8802525931277456,1.0,22/67,21.06%,KIFC2;MAPRE3;STARD9;TOGARAM1;KIF2A;ARHGEF10;SMC1A;HDAC3;MAPRE1;HAUS3;PIBF1;NCOR1;ABRAXAS1;RHOA;KIF3B;INO80;NEK7;STAG2;FLNA;CLASP2;NUMA1;TUBGCP5
prerank,regulation of cytoskeleton organization (GO:0051493),0.40927059885149747,1.1491218498079518,0.25102880658436216,0.8803235424562706,1.0,23/108,16.20%,PHLDB1;CDK2AP2;CORO2B;ARHGAP44;LRP1;EFNA5;EPHA3;CAPN2;S100A8;S100A9;SORBS3;MTOR;FSCN1;BICD1;IQGAP1;RHOQ;MAPT;TAOK2;MAP6;RHOA;DIAPH1;RND3;RAC3
prerank,defense response to Gram-positive bacterium (GO:0050830),0.4480115593494621,1.1489604267484306,0.300794551645857,0.8799927639262953,1.0,7/40,18.60%,LBP;ANG;TIRAP;DMBT1;RNASE6;IL6;MBL2
prerank,regulation of cytoplasmic transport (GO:1903649),0.5560212523723905,1.1484886308878814,0.30983847283406757,0.8808173963143966,1.0,5/11,21.04%,ATP9A;SRC;USP7;MAP2K2;MAPK1
prerank,development of primary male sexual characteristics (GO:0046546),0.45846326249978236,1.1483079867362873,0.28815489749430523,0.8805265672829179,1.0,6/34,9.98%,AR;WT1;SIX4;TGFB2;SOX8;COL9A3
prerank,lung development (GO:0030324),0.4628415092917183,1.1481738400162362,0.28554778554778554,0.8801320252711651,1.0,6/33,7.49%,FGF7;VEGFA;FGF2;PKD1;RCN3;GLI2
prerank,vasodilation (GO:0042311),0.5357706439032218,1.1480985476840075,0.3125,0.8795398105827081,1.0,2/13,4.86%,KCNMA1;KLF2
prerank,negative regulation of cell migration (GO:0030336),0.40721794971078284,1.1478913278905727,0.20101522842639594,0.8794504487684435,1.0,31/137,15.37%,COL3A1;IGFBP5;HAS1;LRP1;TMEFF2;ADARB1;LDLRAD4;FGF2;SLIT2;MIF;TNN;GTPBP4;MIA3;PTPRJ;SRGAP1;PFN2;SULF1;PIP5KL1;FLCN;DPEP1;NDRG4;JAG1;KANK1;MITF;MAGI2;RECK;ADAM15;STK24;HOXA7;IL4;STC1
prerank,ceramide biosynthetic process (GO:0046513),-0.31244695579682996,-1.147701255223224,0.21739130434782608,0.6810503967991981,1.0,13/40,14.59%,SGMS1;ST8SIA4;ST6GALNAC3;SPTSSA;SAMD8;ST6GALNAC5;DEGS2;ST8SIA2;CERS1;CERS5;ST8SIA6;SPTLC2;SPTSSB
prerank,regulation of lysosomal lumen pH (GO:0035751),0.5545683241725056,1.1474252087105343,0.3108665749656121,0.8802951924823027,1.0,5/12,19.69%,TMEM9;VPS33A;CCDC115;TMEM165;TMEM199
prerank,triglyceride biosynthetic process (GO:0019432),0.5050083012090354,1.1471326269379223,0.30583756345177665,0.8804347746243218,1.0,6/18,20.27%,GPAT4;MOGAT1;MOGAT2;GPAT3;GPAM;LPIN3
prerank,response to tumor necrosis factor (GO:0034612),0.41164272935232427,1.146123163060084,0.2634297520661157,0.883264375034667,1.0,18/91,15.58%,HAS2;CCL8;AFF3;ADAM9;NFE2L2;ZFP36L1;NR1D1;PID1;ZFP36L2;CHUK;CCL25;INPP5K;AKT1;ZFP36;CCL13;ZC3H12A;GGT7;BAG4
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.5191658283365748,1.1460984158198586,0.3094289508632138,0.8824666173960564,1.0,5/16,18.22%,SRSF6;RBM17;DDX17;DDX5;PUF60
prerank,protein modification by small protein removal (GO:0070646),0.39651501253252774,1.1456529585790938,0.1706827309236948,0.8832062209389442,1.0,85/252,25.98%,AR;ESR1;UCHL1;DESI1;DESI2;PSMC4;JOSD2;SMAD4;SMURF2;USP36;COPS5;OTUD3;ZRANB1;FOXK2;USP32;USP10;RAD23B;IL33;USP29;USP4;PSMC6;MDM4;OTUD1;UCHL5;ADRM1;PSMD8;SENP8;TOR1A;KAT2B;POLB;USP26;USP33;OTUD7B;ACTR5;USP48;USP50;TNIP1;UBA52;USP5;ABRAXAS1;RHOA;NFRKB;ZC3H12A;RCE1;INO80;STAMBPL1;RNF128;USP7;TRAF3;USP22;OGT;KEAP1;SENP6;CCP110;WDR20;TGFBR1;COPS4;NEDD8;SKP2;SUDS3;KDM1B;FOXO4;USP35;TRRAP;PTEN;USP13;CLSPN;USP19;CYLD;MAP3K7;RNF123;TNIP2;TFPT;PSMD3;STAM;GPS1;SENP5;PSMD4;MDM2;ASXL1;UFD1;OTUD4;USP49;PSMB3;INO80C
prerank,inner ear morphogenesis (GO:0042472),0.4843861219223881,1.1456300835791031,0.3195121951219512,0.8824062024909736,1.0,5/22,13.71%,EPHB2;HPN;MYO3B;TTC39C;SIX1
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.2943966879235892,-1.1455119413719859,0.19402985074626866,0.6843772620755302,1.0,27/61,24.30%,PRKAG2;PPARA;PSMC1;CAV1;PSMA5;PSMD12;SIRT5;PSMF1;PSMA2;SIRT1;PSME2;PSMA3;FGFR4;PSME1;PSMB10;PSMA1;PSMB8;PSMB9;NR1H4;PSMB4;PSMA8;PDK4;PSMD6;NQO1;PSMD11;PSMD10;PSMD9
prerank,dendrite self-avoidance (GO:0070593),0.5229153744857958,1.1452856808433844,0.3016905071521456,0.8828096895021273,1.0,7/16,21.46%,NPTN;TNN;DSCAM;IGSF9;PALLD;CNTN4;CNTN2
prerank,ephrin receptor signaling pathway (GO:0048013),0.41718572990931047,1.145272815441371,0.2576235541535226,0.8819644954952658,1.0,31/82,25.16%,EPHB2;ARHGEF28;EFNA5;DNM1;EPHA3;FYN;MMP2;ANKS1B;AP2A2;SRC;ACTR3;PSEN1;EPHB3;EPHA10;NGEF;RHOA;ACTG1;ARPC1A;SDC2;ARPC2;EPHB1;RASA1;TIAM1;YES1;SDCBP;AP2M1;VAV2;NCK2;EPHA5;ITSN1;RAC1
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.44433940418294615,-1.1450260639959848,0.2691029900332226,0.6833026459256752,1.0,5/11,12.14%,WNT4;BMP5;SIRT1;BMP2;FGFR4
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.3498908509752545,-1.145004838081948,0.25925925925925924,0.6810016137509624,1.0,4/23,6.76%,TPM1;ADAMTS9;TGFBR3;FGFR2
prerank,negative regulation of metabolic process (GO:0009892),0.4350044844238859,1.1448177920141183,0.2903575297941495,0.8828371742734646,1.0,9/54,9.07%,ADAMTS5;WNT10B;ZDHHC7;DOCK7;NR1D1;LNPEP;FLCN;FOXC2;TLR4
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.4164195812121646,1.1443532604582582,0.26479750778816197,0.883755191423974,1.0,19/78,16.15%,AR;EPHB2;EGFR;LRP1;EPHA3;TMBIM1;ATP2B4;ZDHHC7;PID1;CLTC;STX4;RHOQ;SQSTM1;AKT1;ZDHHC2;PPFIA1;ARF6;PLS1;SPTBN1
prerank,regulation of epithelial cell proliferation (GO:0050678),0.412352765045875,1.1439056322040329,0.27348643006263046,0.8845439052658309,1.0,13/85,5.88%,FGF18;FGF7;EGFR;HPN;SIX4;SRSF6;VEGFA;FGF2;TGFB2;FUT2;ZFP36L1;TCF7L2;NR1D1
prerank,vesicle transport along microtubule (GO:0047496),0.48826957102273405,1.143882160407906,0.28997613365155134,0.8837346524063102,1.0,10/23,26.53%,NDEL1;TRAK2;DYNC1I1;KIF3A;KIF3B;DYNC1H1;PAFAH1B1;FBXW11;RAB1A;KIFAP3
prerank,striated muscle tissue development (GO:0014706),-0.34402078399562624,-1.1437891470935677,0.25609756097560976,0.6817787182457637,1.0,9/29,11.33%,BMP5;PGM5;BMP7;MEF2C;RBP4;CAV1;BMPR2;TBX2;CFLAR
prerank,anterograde axonal transport (GO:0008089),0.4606809668235919,1.1433096847791973,0.28815489749430523,0.8850931702397824,1.0,12/37,21.22%,DTNBP1;DLG2;NEFL;TRAK2;AP3D1;KIF3A;KIF3B;BLOC1S2;RAB27B;SNAPIN;MAP1A;AP3B2
prerank,response to organic cyclic compound (GO:0014070),0.4340123450114557,1.1432780126084134,0.265642151481888,0.8843182266946797,1.0,5/52,8.43%,IGFBP5;ESR1;ANXA1;SOCS2;CYP27B1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.4228881104240296,1.143244358837017,0.2566560170394036,0.8835311742038053,1.0,14/66,14.30%,LIF;EIF2AK3;ZPR1;PIK3R2;WWTR1;MEPCE;PSEN1;RBM22;HDAC3;AKT1;CCT7;JUP;ZC3H12A;DMAP1
prerank,actin filament depolymerization (GO:0030042),0.5403880357670956,1.143218051207929,0.3081395348837209,0.8827525333226921,1.0,3/11,11.23%,GSN;TWF1;MICAL2
prerank,positive regulation of cellular metabolic process (GO:0031325),0.40586037701794075,1.1423246830985,0.24205128205128204,0.8851823681852405,1.0,22/98,15.86%,SFRP4;HPN;ANXA2;VEGFA;LIPT2;TGFBR2;MAPK14;ACLY;PID1;DHRS4;INPP5F;ECE1;AKT1;MAGI2;EGF;CDKN1A;ZC3H12A;KLF4;IL4;GHITM;AHI1;NSF
prerank,endochondral bone morphogenesis (GO:0060350),-0.4491059195434024,-1.1421873958984308,0.30689655172413793,0.6834575122330847,1.0,7/11,16.52%,MEF2C;FOXC1;COL13A1;INPPL1;BMPR2;TRPV4;FGFR3
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.49649387303262993,1.1419896322664993,0.28292046936114734,0.8855202034799626,1.0,10/20,17.66%,CAMK2D;PACS2;PSEN1;HERPUD1;SELENOK;BAK1;THADA;ATP2A2;PML;BCAP31
prerank,glycoprotein biosynthetic process (GO:0009101),0.4163426253452889,1.1419852178902472,0.28197064989517817,0.8846485511189787,1.0,17/79,11.99%,ST3GAL2;B3GALNT1;CSGALNACT2;FUT2;CHST10;TMEM106A;MGAT1;GAL3ST3;CHST12;FOXL1;XYLT1;ALG1;LARGE1;FUT9;B3GNT8;ST3GAL4;TNIP1
prerank,negative regulation of translation (GO:0017148),0.41319471604598257,1.1419072192911712,0.2779519331243469,0.8840603862069011,1.0,21/87,19.65%,IGFBP5;EIF2AK3;RBM4;PAIP2B;TRIM71;SAMD4B;MRPL13;AGO2;PUM1;IGF2BP1;UNK;LARP1;CNOT10;EIF3E;FXR2;CPEB1;YTHDF1;YTHDF2;EPRS1;PAIP2;PCIF1
prerank,autophagosome assembly (GO:0000045),0.43194310578939954,1.1417430952064198,0.2841648590021692,0.8837975614977532,1.0,21/52,24.12%,RAB23;RAB19;ATG2B;PACS2;WIPI2;STX12;WDR45B;ULK2;STX17;RAB43;ATG2A;ATP2A2;ULK1;RAB1B;ATG16L2;ATG13;ATG16L1;ATG3;SMURF1;ATG14;EMC6
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.4744981099814588,1.1414991108749575,0.30456226880394577,0.883797048078394,1.0,11/27,24.62%,IRS1;GRB10;TNS2;PID1;INPP5K;KANK1;NCK1;PIP4K2C;PIP4K2B;TSC2;PRKCZ
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.5170723434402007,1.141473107529835,0.2989949748743719,0.8830206808066272,1.0,1/16,0.24%,ACKR3
prerank,mRNA processing (GO:0006397),0.3928687580897706,1.1414582081401357,0.15915915915915915,0.8821936105473049,1.0,111/287,28.89%,GEMIN6;POLR2H;SRSF2;CD2BP2;HNRNPA1;GTF2H3;SRSF6;DHX16;RBM4;ZCRB1;DDX42;LSM4;PRPF4;U2AF1;SRSF3;TFIP11;PRPF3;GPATCH1;AURKAIP1;CPSF6;USP39;HNRNPD;RBM22;DNAJC8;ERN1;SNRPB2;SON;CPSF4;HNRNPH1;TCERG1;DHX8;RBM17;ERCC3;PRPF40A;SRSF11;THOC7;POLR2D;POLR2G;SNU13;HNRNPA3;AQR;POLDIP3;CCNH;THOC2;THOC1;SF3B4;ZC3H11A;GTF2F1;ZCCHC8;CMTR2;BCAS2;SF3A1;CPSF2;PHF5A;DDX5;SNRPA;SNRPG;SNRPD3;PNN;SNIP1;PDCD7;DDX39A;SRRM1;RBM6;PUF60;GCFC2;PRCC;HNRNPUL1;U2AF2;ELAVL2;ZMAT5;NOVA1;LSM7;PTBP1;SF3B2;SF3B1;AKAP8L;KIN;PRPF38A;GPKOW;RBM5;RNMT;SNRPA1;CSTF2T;CPSF1;RALY;CPSF7;WDR33;PABPN1;POLR2C;CWC27;RAMAC;ALYREF;UPF3B;PPIH;USP49;RBMX;PRPF19;CRNKL1;PRPF6;LSM5;CDC40;THOC5;WDR83;CELF1;CPSF3;RBM15;HNRNPC;SNRPC;WBP11;SRSF5
prerank,negative regulation of cell growth (GO:0030308),0.4087712694822034,1.1413783838785077,0.22154471544715448,0.8816050252029812,1.0,25/121,15.05%,WT1;DCBLD2;FHL1;DACT3;FGF13;TGFB2;SLIT3;SLIT2;PTPRS;CDKN2AIP;SMAD4;GNG4;PSRC1;PTPRJ;TRIM46;FLCN;CYP27B1;BCL6;DNAJB2;ULK2;ADAM15;CDKN1A;ULK1;DCC;SMARCA4
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.4353815277122923,1.1413362972634098,0.2825361512791991,0.8808814467230286,1.0,18/47,25.16%,MYOC;EFNA5;S100A10;MYADM;C1QBP;MELTF;KANK1;TRIOBP;LIMS2;RAC3;RCC2;ILK;FLNA;CORO1C;FBLN1;DMTN;CALR;RAC1
prerank,negative regulation of complement activation (GO:0045916),0.5684436335255638,1.141175763150896,0.31754874651810583,0.880607918197568,1.0,3/10,13.58%,CD55;SERPING1;CR2
prerank,endomembrane system organization (GO:0010256),0.395669373368665,1.1409474904102386,0.21464393179538616,0.8806019043167813,1.0,43/178,18.18%,SEC16B;ATP8B1;ARHGAP21;DNM1;EIF2AK3;TMED1;HOOK2;SEC31A;FBXW8;REEP3;TOR1AIP2;ZW10;NUP93;MIA3;TLCD2;PLEKHF1;LYSMD3;RAB30;PI4K2B;SYNE1;OSBPL2;AP3D1;SURF4;LMAN1;TOR1A;SQSTM1;RAB2A;SEC23IP;USP50;LNPK;STX17;RAB43;BCAS3;SEC61A1;SPTBN1;PHETA2;BLZF1;HACE1;REEP5;DYNC2H1;VPS11;ANXA8;ANXA8L1
prerank,positive regulation of cartilage development (GO:0061036),0.5085454725359924,1.1405674100327412,0.33725490196078434,0.8811678273144222,1.0,3/17,9.27%,LOXL2;BMP1;SOX5
prerank,heart morphogenesis (GO:0003007),-0.3040375271582956,-1.140558016242731,0.22105263157894736,0.68546961554549,1.0,14/50,11.15%,CHD7;INSR;ENG;EPHB4;NOS3;NOTCH1;TBX3;TGFBR3;HEYL;TBX1;SOX17;TBX2;BMP2;RYR2
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.5568442911888096,1.140380686943995,0.3258741258741259,0.8810035213518209,1.0,6/11,27.54%,MOSPD3;BNIP1;RTN4;ATL1;LPCAT3;VCPIP1
prerank,response to copper ion (GO:0046688),0.5004902882389951,1.1400863838907485,0.3122629582806574,0.8812191076667445,1.0,1/20,0.82%,LOXL2
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.4678924689600596,1.1394065239655453,0.2978723404255319,0.8829116711870951,1.0,7/30,16.59%,ACKR3;CD44;MIF;FBXO5;TWIST1;THOC1;SNAI2
prerank,double-strand break repair via homologous recombination (GO:0000724),0.4149164730956024,1.1393086651443065,0.26212590299277605,0.8823673121858369,1.0,26/95,18.94%,REV3L;XRCC3;SFR1;RAD51B;RFWD3;UBE2N;HELQ;AP5S1;SAMHD1;MCM3;SMC5;RMI1;ERCC4;FAN1;SEM1;SMC6;NBN;INO80;RECQL;SPIDR;RNF138;RAD50;ERCC5;BLM;MORF4L1;NIPBL
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.5754701795058181,1.1389698390240455,0.33903133903133903,0.8826843843766194,1.0,3/10,11.30%,MIA3;TLR4;AKT1
prerank,positive regulation of ERAD pathway (GO:1904294),0.5258653316256049,1.138936038620118,0.31039136302294196,0.8819403264130626,1.0,6/13,21.67%,NFE2L2;TMEM259;HERPUD1;SGTA;BCAP31;USP13
prerank,regulation of phospholipase C activity (GO:1900274),0.5199356961416272,1.1388809043118493,0.31776913099870296,0.8812713626331892,1.0,5/15,7.45%,ESR1;FGFR1;FGF2;BICD1;ABL2
prerank,protein localization to cell surface (GO:0034394),0.4804566387430579,1.1387171660475033,0.30036188178528345,0.8810135182846606,1.0,9/26,14.77%,FGF7;CD177;ANK2;JAM3;USP4;GGA1;PIGK;ARF6;GGA2
prerank,organelle assembly (GO:0070925),0.39212008490124156,1.138600564014641,0.112,0.880618761220088,1.0,121/384,24.53%,CD34;GSN;NME8;CDC14B;RAB32;ABLIM1;PKD1;RAB23;RAB19;FHDC1;CHMP7;VPS4B;CENPT;MAPRE3;MVB12A;UBAP2L;VPS37D;FARP2;STARD9;ARF4;BICD1;RC3H1;ACTR3;HDAC6;LSM4;BBS9;ATAT1;ATXN2;ATG2B;PACS2;ARL13B;TMEM138;OCRL;CPLANE1;HPS4;CNGB1;EHD2;WIPI2;NUDCD3;STX12;WDR45B;DZIP1;HDAC3;NPM1;MAPRE1;TTC39C;HAUS3;AVIL;TEKT5;MAPT;PIBF1;ULK2;DYNC2I2;KIF3A;RAB43;ATG2A;NCOR1;RPGR;ATP2A2;VPS37C;KIF3B;IFT46;EIF2S1;ATXN2L;TTLL3;ULK1;BBS4;INO80;TMOD2;TTC8;DYNC1H1;KLHL41;ATP6V1D;AHI1;CENPC;RAB1B;VPS37B;CEP164;YTHDF1;YTHDF2;DYNC2H1;ATG16L2;CEP89;AUP1;DYNC2I1;CEP83;CCDC28B;RP2;ATG13;CENPE;BBS5;NEK7;BBIP1;IFT52;EXOC4;CC2D2A;SPAG16;FLNA;VPS36;TUBGCP5;ATG16L1;PCM1;DNAH5;ATG3;FBF1;EIF2A;PDCD6IP;TMEM231;YTHDF3;OGFOD1;TCTN2;ATG14;IST1;EDC3;RAB11FIP3;PDE6D;STAM;EMC6;DYNLL1;G3BP1;TCTN1
prerank,histone ubiquitination (GO:0016574),0.49395151880062765,1.1385844677539068,0.30527638190954776,0.8798100648833417,1.0,9/21,25.69%,UBE2B;UBE2N;ATXN7L3;PHC1;UBE2A;USP22;PAF1;UBR2;RNF20
prerank,positive regulation of protein export from nucleus (GO:0046827),0.5307045930213538,1.1382670011017166,0.32769830949284784,0.8801011121956126,1.0,8/15,23.96%,TCF7L2;GAS6;YWHAE;RBM22;ANP32B;BAG3;TPR;EMD
prerank,mRNA stabilization (GO:0048255),0.44766553171009843,1.137405845436787,0.2987736900780379,0.882451581402454,1.0,9/40,13.07%,TENT5B;MAPK14;DAZL;TARDBP;TIRAP;IGF2BP1;LARP1;ZFP36;GDNF
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.44753065104023615,1.1366383601212546,0.30689655172413793,0.88443907878725,1.0,15/39,23.57%,TTC7A;PIK3C2B;PIK3R2;SOCS2;PI4K2B;PIK3CA;PI4KB;PI4KA;SOCS6;PIP4K2C;IP6K1;PIP4K2B;PIK3CG;PI4K2A;TTC7B
prerank,actin nucleation (GO:0045010),0.48912599208849067,1.1363446238443469,0.3233082706766917,0.8847237874782804,1.0,6/21,17.42%,SCIN;ACTR3;MAGEL2;ARPC5L;ARPC1A;ARPC2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.44343022677350324,1.1357680787185689,0.2992036405005688,0.886044873505803,1.0,5/37,4.00%,IGFBP5;TGFB3;MMP2;FGF2;MEF2D
prerank,retinol metabolic process (GO:0042572),0.521480943675926,1.1357488083366707,0.33067729083665337,0.8852469894692369,1.0,1/14,0.74%,DHRS9
prerank,mitotic recombination (GO:0006312),0.5220266735603966,1.1356224225447706,0.336986301369863,0.8848369794150598,1.0,8/15,26.41%,XRCC3;SMC5;SMC6;RAD50;TEP1;ERCC1;NSMCE2;RAD51D
prerank,neural tube closure (GO:0001843),0.45815197525075985,1.1356205181029493,0.31981460023174973,0.8839831831077847,1.0,4/34,4.06%,LRP6;TGFB2;COBL;SKI
prerank,proton transmembrane transport (GO:1902600),0.4525397972846545,1.135360512887925,0.29965556831228474,0.8841393728241943,1.0,7/36,12.04%,UCP1;ATP1A3;ATP1A4;ATP1A1;SLC25A27;ATP5PO;SLC9A1
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.5002387302327724,1.1353298176346258,0.3192019950124688,0.883411593764833,1.0,1/18,0.18%,TNFSF9
prerank,macromolecule catabolic process (GO:0009057),0.4694565313382465,1.1351634961931427,0.29506172839506173,0.8831690756731977,1.0,10/26,23.82%,MTOR;MVB12A;TPP1;CLPX;SIAH1;IDE;LRSAM1;SMURF1;USE1;TRIM24
prerank,cellular response to lipopolysaccharide (GO:0071222),0.41043461138003434,1.1351322183719483,0.261758691206544,0.8824351738414917,1.0,19/101,16.30%,LBP;CD80;AXL;ADAM9;MAPK14;NR1D1;CXCL10;CARD16;TLR4;SIRPA;IRAK1;ZFP36;RHOA;TNFRSF1B;ZC3H12A;CD14;SELENOS;PDCD4;IL6
prerank,DNA geometric change (GO:0032392),0.4838036566636219,1.1349564267948498,0.3193069306930693,0.8821790132575978,1.0,10/24,18.62%,ANXA1;ASCC3;DNA2;DDX11;NBN;HMGB3;RECQL;RAD50;BLM;SUPV3L1
prerank,regulation of microtubule polymerization (GO:0031113),0.44383878617621797,1.1349492939592067,0.3142857142857143,0.8813496913635389,1.0,16/40,20.64%,DCTN1;CLIP1;PSRC1;MAPRE3;TOGARAM1;MAPRE1;CAMSAP1;MAPT;GBA2;SLAIN2;TUBB4A;CDK5RAP2;AKAP9;NAV3;CLIP3;NUMA1
prerank,negative regulation of protein phosphorylation (GO:0001933),0.39991717072423116,1.1349205493422072,0.23255813953488372,0.8806102908160833,1.0,38/150,16.35%,EPHB2;LRP6;NIBAN1;TARBP2;LDLRAD4;DGKQ;SLIT2;CAMK2N1;PMEPA1;WWTR1;PLPP3;DTNBP1;RTRAF;RASSF2;TARDBP;MYADM;MLXIPL;YWHAG;PID1;PIP5KL1;SIRT2;GSKIP;INPP5K;SMAD6;SIRPA;AKT1;PPEF2;PDE4D;SFN;CALM2;DEPTOR;SMCR8;TWIST1;ZC3H12A;CHP1;NLRP2B;CEP85;NCK1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3906859964194026,1.1341707164753378,0.12712712712712712,0.8825914534483226,1.0,51/348,12.37%,CD34;SFRP4;AR;GSN;EPHB2;AMH;FGF18;SEC16B;FGF7;C1QTNF1;WT1;HPN;TMEM119;PKP3;EIF2AK3;ANXA2;MAPK7;ANK2;DGKQ;VEGFA;FGF2;CAMK2N1;ZPR1;NFE2L2;RBMS3;MAPK14;ADAM19;KLF2;MTOR;ITCH;HOXA5;DTNBP1;IL33;PID1;GAS6;INPP5F;VDR;PSEN1;AGO2;ECE1;TLR4;MAPK11;MUSK;MPHOSPH8;MITF;KRAS;AKT1;SLC2A10;MAGI2;NAT8;EGF
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.5331384659635172,1.1339848606217053,0.33649932157394846,0.8824645968642406,1.0,3/13,10.58%,B3GALNT1;GAL3ST3;B3GNT8
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.4701992346799823,1.1338855295562964,0.31942789034564956,0.8819791952892606,1.0,7/26,17.44%,FBN1;INHA;LRRC17;TLR4;HOXA7;IL4;GPR137B
prerank,regulation of exocytosis (GO:0017157),0.4355057991467013,1.1337803680913632,0.2976324689966178,0.8815265508593654,1.0,19/46,27.68%,ANXA1;STX4;RAB3D;ATP6AP1;RAB27B;NSF;SYT1;VAMP2;RIMS2;RAB2B;RALA;CLASP2;RAB10;STXBP5L;RAB12;RAB3C;CFTR;IL1RAPL1;RAB8B
prerank,inositol phosphate-mediated signaling (GO:0048016),0.4960838447963396,1.1333887829491622,0.3137755102040816,0.8820939099152939,1.0,6/19,19.14%,PLCE1;NFATC4;NFATC1;PPP3CC;PPP3CA;PPP3CB
prerank,histone H3 deacetylation (GO:0070932),0.5154199402394323,1.1332765492426946,0.327319587628866,0.8816691154768845,1.0,5/15,16.19%,HDAC9;SIRT2;HDAC3;HDAC4;PER1
prerank,negative regulation of cytokine production (GO:0001818),0.3995463852009582,1.1331699374939437,0.21830985915492956,0.8811984796203673,1.0,31/163,16.85%,CD34;AXL;ANXA1;NPTN;IRAK3;HDAC9;HDAC7;SYT11;ITCH;C1QBP;INHA;GAS6;TLR4;SIRPA;OTUD7B;SLC2A10;GPNMB;PIBF1;ZFP36;PIN1;BCL3;CD200R1;ZC3H12A;KLF4;RNF216;SELENOS;ILRUN;PDCD4;IL6;ANXA4;TAX1BP1
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.4885568550340062,1.133029456834887,0.3211125158027813,0.8800354556419129,1.0,8/19,24.65%,POLR2H;ACD;POLR2D;POLR2G;TERF1;TINF2;TERF2IP;POLR2C
prerank,regulation of DNA recombination at telomere (GO:0072695),0.4885568550340062,1.133029456834887,0.3211125158027813,0.8800354556419129,1.0,8/19,24.65%,POLR2H;ACD;POLR2D;POLR2G;TERF1;TINF2;TERF2IP;POLR2C
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.39813474681063243,1.132932594152839,0.25101214574898784,0.8795314532652591,1.0,31/136,16.85%,SFRP4;ESR1;IRAK3;BHLHE40;GLIS2;PKD1;TCF7L2;ITCH;PRMT2;TBX6;GAS6;RNF2;PKD2;CHUK;TAF3;IRAK1;NWD1;COMMD6;HDAC4;ZC3H12A;KLF4;USP7;NUPR1;CHP1;NLRP2B;TRAF3;RBCK1;ANXA4;KEAP1;UFL1;TAX1BP1
prerank,histone H3-K36 demethylation (GO:0070544),-0.4629043168952949,-1.1325832893606727,0.32525951557093424,0.704939208612692,1.0,2/10,2.52%,KDM7A;KDM4A
prerank,glycerol metabolic process (GO:0006071),0.5525816443419301,1.1325172792105458,0.3261494252873563,0.8801485895482043,1.0,6/10,28.42%,GK5;COQ3;ANGPTL3;GOT1;COQ2;PGP
prerank,response to lipid (GO:0033993),0.40741973330998826,1.1323222169427156,0.2599795291709314,0.8800837968969072,1.0,17/105,11.73%,LBP;ESR1;ANXA1;IRAK3;FOXP1;F2R;S100A8;S100A9;VPS4B;SOCS2;FOXO1;CYP27B1;TIRAP;TLR4;SMAD6;SLPI;IRAK1
prerank,cellular response to growth factor stimulus (GO:0071363),0.3990310191121763,1.1322474999312533,0.24316109422492402,0.8795403708860515,1.0,41/151,16.74%,HAS2;HAS1;TMEM100;WNT2;EGFR;ANXA1;CLEC3B;CD44;MAPK7;GAS1;VEGFA;PDE8A;TGFBR2;ZPR1;SMAD4;MAPK14;ACVR1;ZFP36L1;MAP2K3;PRKD2;ZFP36L2;SYAP1;SIRT2;IQGAP1;SOX5;INPP5K;ERN1;URI1;AMHR2;AKT1;MAPT;MAGI2;KIDINS220;ZFP36;KLF4;RAPGEF1;HGF;STAT5B;SNAI2;HTRA2;RAB35
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5113899985916186,1.1322412879903256,0.32114882506527415,0.8787199027320572,1.0,5/15,14.21%,EGFR;RHBDF1;MVB12A;EGF;FER
prerank,carboxylic acid metabolic process (GO:0019752),0.4558903562325417,1.132198886378268,0.30806257521058966,0.8780334272887216,1.0,11/33,18.67%,CYP2S1;LIPT2;MIF;PON3;SLC23A1;SLC23A2;SLC2A3;GLUD1;GSTO2;ST3GAL1;GNE
prerank,positive regulation of lyase activity (GO:0051349),-0.41765244635877197,-1.1317998912550613,0.27800829875518673,0.7048555721118249,1.0,4/14,13.06%,NOS3;CACNA1D;NOS1;ISCU
prerank,positive regulation of response to stimulus (GO:0048584),0.4391579613029977,1.1310982055807581,0.3028571428571429,0.8811951119719037,1.0,9/40,19.01%,CD80;TGFB2;CDKN2AIP;CGAS;YPEL3;FXR2;EEF1E1;ILK;SELENON
prerank,regulation of mitochondrion organization (GO:0010821),0.4411280927089503,1.13098918250436,0.28634850166481685,0.880765461666823,1.0,20/47,26.67%,USP36;MIEF2;HDAC6;PID1;FLCN;SQSTM1;MAPT;VDAC1;HTRA2;IAPP;SREBF1;STAT2;CSNK2A2;PARL;FIS1;RHOT2;FBXW7;MUL1;INF2;PLSCR3
prerank,negative regulation of ossification (GO:0030279),-0.3583535929007439,-1.1309368525150347,0.2903225806451613,0.70478428030864,1.0,7/23,14.48%,ENPP1;MEF2C;NOTCH1;SFRP1;MDK;SRGN;BCOR
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.3520959536512817,-1.1308330998567557,0.23383084577114427,0.7026291487924298,1.0,4/23,2.10%,PRKAG2;CEMIP;BMP7;APP
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.3644146865973746,-1.1306907622185118,0.27419354838709675,0.7005939039140633,1.0,8/21,10.06%,CNOT2;SAMD4A;CNOT9;PAN3;CNOT7;TUT4;CNOT11;TUT7
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.3112655602889716,-1.1304674852299395,0.2268041237113402,0.698801615887493,1.0,4/41,1.98%,TJP1;GCNT2;PODXL;BMP7
prerank,membrane organization (GO:0061024),0.392047341062922,1.1301755982168624,0.19238476953907815,0.8827947368849547,1.0,66/227,24.21%,STON2;AREG;TRIP10;EGFR;TIMM50;SYT2;DNM1;MOSPD3;BTC;ANK2;BIN1;TMEM43;STX11;REEP3;TOR1AIP2;NUP93;CHMP7;VPS4B;TLCD2;MTCH1;AP2A2;MYADM;OSBPL2;SLC18A3;AP3D1;ACTR3;CLTC;USO1;OCRL;TOR1A;SNAP23;NAPA;UBA52;EGF;SGCZ;GLTP;CBL;CHP1;FZD4;ACTG1;ARPC1A;SPTBN1;IGF2R;HACE1;NAPG;SYT1;ARPC2;VAMP2;VPS33B;CORO1C;COX18;CNTN2;ARRB1;AZIN2;CTTN;VAMP4;PDCD6IP;LDLR;CCDC88A;PACSIN2;TMEM33;AP2M1;PICK1;STAM;EMD;AGFG1
prerank,actin-myosin filament sliding (GO:0033275),-0.31696431656536395,-1.130163333972185,0.24390243902439024,0.6949484744757425,1.0,3/38,1.52%,TPM1;ACTN2;DMD
prerank,muscle filament sliding (GO:0030049),-0.31696431656536395,-1.130163333972185,0.24390243902439024,0.6949484744757425,1.0,3/38,1.52%,TPM1;ACTN2;DMD
prerank,positive regulation of macrophage migration (GO:1905523),-0.37410870777987515,-1.1300699403276082,0.2946859903381642,0.6928740437720674,1.0,6/19,13.28%,IL34;THBS1;CX3CL1;MDK;MAPK3;PTK2
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.34736891211859533,-1.129890355718773,0.21978021978021978,0.6910779026068612,1.0,6/26,4.69%,NEDD4L;ATP1B3;ACTN2;DLG1;WWP2;CACNA1D
prerank,cellular response to organic substance (GO:0071310),0.40034869771864645,1.1298672298452372,0.2635897435897436,0.8830691932214543,1.0,26/116,18.39%,GHR;IGFBP5;UCP1;CLEC3B;MAPK7;SLIT3;SLIT2;TGFBR2;ACVR1;SOCS2;NCOA3;HDAC6;PID1;CDK9;INPP5K;URI1;AMHR2;FLT3;RHOA;KLF4;STAT5B;HTRA2;CXCR4;PTPN5;IL18;TGFBR1
prerank,regulation of necroptotic process (GO:0060544),0.473072439673314,1.1297780371806256,0.33454987834549876,0.8825293102857782,1.0,10/23,22.92%,SPATA2;STUB1;SLC25A4;HSP90AA1;OGT;FLOT2;PDCD6IP;SDCBP;CYLD;FLOT1
prerank,mRNA catabolic process (GO:0006402),0.4424677363398482,1.1295238370471758,0.29204545454545455,0.8826064514793732,1.0,19/44,28.67%,DIS3L2;RC3H1;ZFP36L2;NUDT16L1;ERN1;NUDT16;ZFP36;CNOT10;DDX5;AGO4;YTHDF2;SUPV3L1;AGO3;THRAP3;EXOSC10;UPF1;LSM5;AGO1;PDE12
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.4842894864615389,1.128784050153123,0.3193588162762022,0.8844533372643945,1.0,5/24,12.28%,SEMA3C;VEGFA;SEMA3A;DSCAM;SEMA3D
prerank,xenobiotic transport (GO:0042908),-0.3813702395448046,-1.1284994956713155,0.2857142857142857,0.6926127158371989,1.0,7/17,18.36%,ABCG2;SLC7A5;SLC22A4;GJA1;ABCA3;SLC22A2;SLC22A18
prerank,base conversion or substitution editing (GO:0016553),0.5488949242202628,1.1284741105032212,0.33518005540166207,0.8847398853519912,1.0,2/11,11.59%,ADARB1;NUDT16
prerank,regulation of dendritic spine development (GO:0060998),0.4960280340643266,1.1282873087926246,0.3245382585751979,0.8845888468066488,1.0,7/19,14.69%,PTPRS;PPFIA2;GRIN3A;PSEN1;TANC2;LLPH;ARF6
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.5355637003864578,1.1282615178882796,0.3240611961057024,0.8838528624757435,1.0,5/11,18.73%,ATP1A1;KCNJ2;YWHAE;KCNJ3;KCNH2
prerank,negative regulation of protein secretion (GO:0050709),0.44066332400158764,1.1279656076600137,0.3114382785956965,0.8840979265278623,1.0,6/38,9.59%,RAB11FIP5;IRS1;F2R;MIDN;RHBDF1;BMP8A
prerank,negative regulation of locomotion (GO:0040013),-0.43213140976106523,-1.1271213443267005,0.33090909090909093,0.6941411375939368,1.0,4/12,16.73%,FRMD5;CCDC125;PTPN2;SPINT2
prerank,axon development (GO:0061564),0.4114529380901224,1.1267586772319955,0.2860125260960334,0.8878189033624738,1.0,29/78,26.08%,EPHB2;MAP1B;GAP43;ZPR1;LLGL1;DOCK7;S100A6;EPHB3;PLP1;L1CAM;MAPT;MTR;TAOK2;RTN4RL1;DCC;SHTN1;CNTN4;SLITRK4;RAB10;MAP1A;SPTBN4;MAP1S;NTNG2;RTN4;MARK2;PAX2;ATL1;NRCAM;SLITRK5
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.4998745791675197,1.1263807182566052,0.33029908972691807,0.8883625274472096,1.0,5/17,17.21%,MAPK7;NFE2L2;AKT1;HTRA2;PPIA
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.46990198063792776,1.1262462441720298,0.3271375464684015,0.8879940356368952,1.0,8/25,18.49%,ARHGAP44;SLIT2;PFN2;KANK1;CEP97;EVI5L;CCP110;ODF2L
prerank,manganese ion transport (GO:0006828),-0.402238767634777,-1.125701753704507,0.3029045643153527,0.6956784074335305,1.0,8/14,14.13%,ATP2C1;SLC30A10;SLC39A8;TRPC5;TRPC6;TRPC4;TRPC7;TRPC3
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.3910295138628937,-1.125538393911249,0.2849740932642487,0.6939005038719762,1.0,15/16,46.95%,CEACAM1;CYRIB;PTPRC;AGER;LILRB1;FADD;IL12A;IL12RB1;IL23A;KLRD1;IL23R;IL12B;RIPK3;XCL1;KLRC1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.5248710291658769,1.1253070193692636,0.32486631016042783,0.8906636961983804,1.0,4/14,13.56%,IRS1;AKT1;IRS2;TWIST1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.41646019376482313,1.1252520158174382,0.30761099365750527,0.8900328685003579,1.0,16/68,22.48%,GNAI3;GPAT4;AMPD2;RAB23;ACLY;ACOT6;BPNT2;RHOQ;ACOT9;ACOT1;SULT4A1;ABHD14B;ACAT1;TPST2;CROT;ADSS2
prerank,cellular response to nitrogen compound (GO:1901699),0.4934420534443233,1.125195264218073,0.34285714285714286,0.8894250967140792,1.0,10/20,29.96%,ATP2B4;EPG5;DDX11;SPIDR;BLM;NSMCE3;RIOK3;PDE12;ATRX;HSF1
prerank,positive regulation of nuclear division (GO:0051785),-0.34294174989748394,-1.1251824484933002,0.2732919254658385,0.6925715074958004,1.0,6/25,8.68%,INSR;TGFA;IGF1;RGCC;IGF2;PDGFRB
prerank,anterior/posterior axis specification (GO:0009948),-0.40052708893691435,-1.124476624736486,0.30578512396694213,0.6922242106465428,1.0,2/15,3.49%,WLS;TBX3
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.31361590575861253,-1.1240391488325523,0.26229508196721313,0.691036688926647,1.0,11/38,12.45%,SP100;BMP5;BCL2L1;NOS3;THBS1;SFRP1;FAS;ICAM1;CFLAR;RIPK1;TNFSF10
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.4253169519267239,1.1240243161724977,0.3085339168490153,0.8927850809071374,1.0,19/52,23.21%,EPHB2;GPSM2;EGFR;LRP1;EPHA3;ATP2B4;STX4;SQSTM1;AKT1;ARF6;PLS1;SPTBN1;STX3;CLIP3;NUMA1;STAC3;ZDHHC8;EPB41L2;ZDHHC5
prerank,protein depolymerization (GO:0051261),0.46720743532329134,1.123984476591803,0.311495673671199,0.8921003752429628,1.0,8/27,20.38%,GSN;VPS4B;KIF2A;TWF1;MICAL2;CKAP5;MICAL1;STMN4
prerank,positive regulation of growth (GO:0045927),0.41315273975462985,1.123929020870836,0.2956989247311828,0.8914578442286385,1.0,9/64,4.22%,EGFR;HPN;TGFB2;RFTN1;CDKN2AIP;S100A8;S100A9;ZPR1;DDX49
prerank,positive regulation of signal transduction (GO:0009967),0.3913264788942875,1.1239259424206827,0.199,0.8906367635193301,1.0,44/238,12.88%,RSPO2;MN1;CD80;CCBE1;AXL;PRKCA;IRS1;NPTN;GRB10;SULF2;ITGB3;ZMIZ1;TGFB2;CDKN2AIP;DLG4;TEDC1;SMOC2;SKI;ADAMTS3;SLC39A14;DACT1;ITGA5;ZRANB1;KLF2;SRC;UCHL5;STX1B;SULF1;ESM1;GAS6;PRKD2;PKD2;CYP27B1;JAG1;KAT2B;BMP2K;ITGAV;ERN1;KANK1;ENHO;BAK1;KLK6;TUBD1;MGAT5
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.46758287573094554,1.123207680551253,0.3248792270531401,0.8924211983734986,1.0,5/26,11.99%,ST3GAL2;GK5;LARGE1;ST3GAL4;TNIP1
prerank,cell part morphogenesis (GO:0032990),0.5229322957308471,1.122964237539014,0.3483606557377049,0.8924162836534503,1.0,7/13,24.98%,WASF1;PID1;MYH14;SUPV3L1;PACSIN2;FIS1;MTM1
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.46524741722801066,1.1222606635590182,0.3345280764635603,0.8933082239939499,1.0,7/29,22.15%,GPAT4;ACLY;ACOT6;ACOT9;ACOT1;ACAT1;CROT
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.46524741722801066,1.1222606635590182,0.3345280764635603,0.8933082239939499,1.0,7/29,22.15%,GPAT4;ACLY;ACOT6;ACOT9;ACOT1;ACAT1;CROT
prerank,regulation of gastrulation (GO:0010470),-0.42331547354896515,-1.1222586539817758,0.28294573643410853,0.6934398389797976,1.0,3/14,2.28%,PHLDB2;TENM4;OSR1
prerank,glycosphingolipid metabolic process (GO:0006687),0.4388534286520704,1.1221441592104717,0.3092324805339266,0.8929076175793238,1.0,8/42,13.63%,SMPD3;ARSA;B3GALNT1;LARGE1;GBA2;GLA;CERK;GLTP
prerank,histone H4-K16 acetylation (GO:0043984),0.49035421825372805,1.1220560599195248,0.3246268656716418,0.892395813523681,1.0,8/19,20.13%,MSL2;MSL3;ING4;MSL1;WDR5;KANSL3;OGT;KMT2A
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.4250191265400007,1.1219674786547107,0.31515812431842966,0.891893980977405,1.0,20/54,28.10%,SYK;SPATA2;CARD16;PELI3;GAS6;CHUK;SPPL2B;MADD;NLRP2B;RBCK1;TAX1BP1;CLIP3;PYCARD;CPNE1;CYLD;UBE2K;RNF31;OTULIN;CASP8;LAPTM5
prerank,cellular response to acid chemical (GO:0071229),0.4665373748759937,1.1218015350621593,0.3254437869822485,0.8916751234242826,1.0,10/27,22.91%,CAPN2;VEGFA;KLF2;MTOR;NSMF;RRAGD;CPEB1;IPO5;SESN2;SLC38A9
prerank,dendritic spine organization (GO:0097061),0.4662784996976725,1.1217774949840023,0.3358024691358025,0.8909408252134566,1.0,9/26,18.12%,EPHB2;FYN;DLG4;ARF1;EPHB3;CTNND2;DIP2A;CHRNA7;EPHB1
prerank,positive regulation of exosomal secretion (GO:1903543),0.5166447119497733,1.1216148942493964,0.33509234828496043,0.890697174667701,1.0,6/15,26.13%,SMPD3;VPS4B;PDCD6IP;SDCBP;STAM;SDC4
prerank,positive regulation of cell communication (GO:0010647),0.46229808028061004,1.121465856066355,0.32091346153846156,0.8904081477571214,1.0,11/28,23.03%,CD80;CDKN2AIP;DLG4;HCRT;LGI1;SYT1;ILK;RIMS2;CLSTN3;NMU;GRIK2
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.5032614716468126,1.121429142206687,0.3469656992084433,0.8897093816040264,1.0,4/17,8.91%,THBS4;C1QBP;MCU;TIRAP
prerank,positive regulation of MAPK cascade (GO:0043410),0.3890745915957743,1.120623104360037,0.2002002002002002,0.8918632343718893,1.0,40/245,13.10%,MID1;ACKR3;LIF;FGF18;CCL8;PRKCA;EGFR;FGFR1;STK25;CD44;VEGFA;PDE8A;FGF2;TGFB2;MST1R;F2R;MIF;LPAR1;TAOK3;TMEM106A;KLHDC10;PTPRJ;RET;RIT2;ADCYAP1;GAS6;DHX33;PRKD2;NDRG4;TIRAP;CCL25;IQGAP1;GPR37L1;IRAK1;GPNMB;EGF;ATP6AP1;TAOK2;CCL13;FLT3
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.41793048733300825,1.120611149979207,0.3040614709110867,0.8910873507246638,1.0,13/56,13.53%,EGFR;ANXA1;CDK4;RAD51B;VPS4B;CUL3;DTL;CDC23;AKT1;ANAPC5;FBXO5;CCND1;CDC27
prerank,modification-dependent protein catabolic process (GO:0019941),0.3920475057792765,1.1203454212472161,0.23517587939698492,0.8912135406432609,1.0,74/193,26.29%,UBE2B;SPSB1;SPSB4;UBA6;SMURF2;SYVN1;ITCH;RBBP6;RNF111;SPSB2;RC3H1;STUB1;WDR91;ADRM1;SIAH1;MYLIP;CUL3;DTL;UBE2G2;FBXW4;USP33;HERPUD1;SQSTM1;CDC23;ANAPC5;RNF7;UBE2A;UBA52;CDC34;NDFIP1;DDB1;CDC27;CBL;UBR4;AMFR;RNF128;TRPC4AP;RNF14;HACE1;KEAP1;CDC26;UBE2G1;FBXO11;ANAPC4;NTAN1;ARIH2;UBE2R2;NEDD8;RNF19A;UBE3C;TOLLIP;KCTD6;ARIH1;KCTD10;ANAPC10;KCTD21;ARRB1;RC3H2;SMURF1;ANAPC15;RNF6;RNF114;RNF13;PSMD3;UBQLN4;MDM2;RNF166;UFD1;FBXO22;RNF20;RNF126;UBE2K;RNF167;ANAPC2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.4021909228368282,1.1193913525602603,0.2947916666666667,0.8937473388757876,1.0,30/88,21.51%,AP1G2;AP4B1;LLGL1;ACBD3;AP1M1;DTNBP1;SCAMP3;CLTC;MYO5A;CLVS2;STX4;SCFD1;SNAP23;ARF1;AP4E1;AP1S2;PUM1;NAPA;CORO7;AP4M1;GOPC;SORCS1;VAMP2;RP2;SH3D19;CLVS1;EXOC4;RAB10;AP1S3;ARRB1
prerank,neuron projection organization (GO:0106027),0.5075107521489431,1.118965816142898,0.3383152173913043,0.8944945905374182,1.0,8/15,23.55%,DCTN1;ATP1A3;PSEN1;ARF1;PLS1;CHRNA7;MAP1A;PICK1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.40230709864544373,1.1188877068696172,0.2845360824742268,0.8939182351828636,1.0,23/93,17.31%,LIF;EGFR;CD44;VEGFA;MIF;AXIN1;ATP2B4;DOCK7;RASSF2;MLXIPL;PFN2;HDAC6;GAS6;PRKD2;INPP5K;AKT1;PDE4D;HSP90AA1;TNKS1BP1;NLRP2B;IL6;NCK1;AKAP9
prerank,glycogen metabolic process (GO:0005977),-0.33816481472302284,-1.1186656502087264,0.25149700598802394,0.701098775556834,1.0,6/27,5.34%,PRKAG2;PHKB;PYGM;GYS1;GBE1;AGL
prerank,establishment of melanosome localization (GO:0032401),-0.36048404378153764,-1.118438427361244,0.31351351351351353,0.6994045979680147,1.0,8/19,17.84%,SHROOM2;BLOC1S5;RAB11A;BBS7;MREG;RAB27A;BLOC1S6;MLPH
prerank,T cell proliferation (GO:0042098),-0.41842612022103065,-1.1180748761478199,0.3250883392226148,0.6981722755077525,1.0,3/13,4.78%,CTPS1;DOCK8;CADM1
prerank,protein O-linked glycosylation (GO:0006493),0.40404231689849435,1.118020706388336,0.2897196261682243,0.8962436418453315,1.0,29/96,24.67%,PLOD2;ST3GAL2;GALNT16;C1GALT1;POFUT2;POMGNT2;GALNT10;MUC1;GALNT18;OGA;PLOD3;LARGE1;B3GNT8;GALNT1;ST3GAL4;B3GALNT2;OGT;ST3GAL1;ST3GAL3;GALNTL6;PLOD1;MGAT5B;CRPPA;TMTC3;GXYLT1;POGLUT2;GALNT4;DPM2;PGM3
prerank,positive regulation of neurogenesis (GO:0050769),-0.2758208902645004,-1.1179990599713001,0.21818181818181817,0.696096822768917,1.0,22/68,15.57%,PLXNA2;ROBO1;CUX1;PLXNA4;PTPRD;CDKL5;SHANK3;TGM2;PLXND1;ROBO2;NUMB;PLXNB1;CX3CL1;SS18L1;SMARCD3;NTRK2;SLITRK1;CTNNB1;TRIM32;CUX2;GPER1;SOX11
prerank,synaptic membrane adhesion (GO:0099560),0.5090371895863686,1.11778558668141,0.34308510638297873,0.8962450978627767,1.0,3/14,6.77%,GPC6;PTPRS;PTPRF
prerank,regulation of catabolic process (GO:0009894),0.494900051120504,1.1172026248285007,0.32954545454545453,0.8975152807151652,1.0,5/18,13.23%,FAP;ZDHHC7;ODC1;TMEM9;ZDHHC2
prerank,negative regulation of developmental process (GO:0051093),0.4127495930178212,1.116810869763319,0.32123799359658484,0.898160469184273,1.0,15/69,12.33%,LOXL2;PARP3;NEUROD2;PTPRS;MIF;HOPX;GRIN3A;NFIB;RC3H1;GAS6;WDR77;KANK1;ALPK2;MAPT;ANP32B
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5587153478326459,1.1162840922357802,0.35,0.8992923735945493,1.0,2/10,3.49%,IRF4;RUNX1
prerank,fat cell differentiation (GO:0045444),0.41785242756169266,1.1157975034041876,0.3065217391304348,0.9001984565092519,1.0,12/57,14.32%,UCP1;ATF5;METRNL;TCF7L2;FOXO1;PID1;BBS9;SOX8;SMAD6;TMEM120A;BBS4;KLF4
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.4672209676416144,1.1155703431612984,0.3373934226552984,0.900174110599985,1.0,8/25,17.31%,ANK2;FGF13;DSC2;CAMK2D;HCN4;JUP;ATP2A2;AKAP9
prerank,diterpenoid metabolic process (GO:0016101),0.4232275511110057,1.1153836803059536,0.31189710610932475,0.9000647275362573,1.0,5/55,5.79%,AKR1B1;LRP1;GPC6;GPC3;ALDH3A2
prerank,T cell mediated immunity (GO:0002456),0.5259641120988222,1.1152721968090442,0.3770491803278688,0.8996757395494699,1.0,3/13,15.15%,CD55;JAG1;BTN3A3
prerank,nuclear pore complex assembly (GO:0051292),0.5558241065563463,1.1147053282429926,0.3484626647144949,0.9009718350743683,1.0,4/10,8.69%,NUP93;AHCTF1;NUP107;NUP98
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.40485198170096715,1.114484966662128,0.3086548488008342,0.9009398021947327,1.0,30/84,24.93%,MBNL1;HNRNPA1;SRSF6;RBM4;C1QBP;SRSF3;NSRP1;NUP98;MBNL2;SON;CELF2;RBFOX2;DDX17;RBM3;SF3B4;DDX5;FXR2;SAP18;RBM39;PUF60;U2AF2;NOVA1;PTBP1;SRPK1;THRAP3;LARP7;RBM5;DAZAP1;RBM24;CELF3
prerank,NAD biosynthetic process (GO:0009435),-0.36486402957387865,-1.1144752641354128,0.2995391705069124,0.7032377416033235,1.0,7/20,17.35%,NAMPT;PTGS2;PTGIS;PARP10;NUDT12;NMNAT3;PARP9
prerank,translesion synthesis (GO:0019985),0.4385556081762117,1.1144113316114028,0.3377777777777778,0.9003974313188103,1.0,17/42,28.17%,REV3L;POLDIP2;USP10;ZBTB1;DTL;POLI;UBA52;PCLAF;RFC4;POLD1;FAAP20;REV1;POLH;UFD1;POLE2;NPLOC4;RFC3
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.4086706433546212,1.1136255597860716,0.3063157894736842,0.9022742540550209,1.0,29/82,26.73%,DCTN1;ODF2;ATF5;YWHAG;SSNA1;YWHAE;ALMS1;NPM1;MAPRE1;HAUS3;SFI1;HSP90AA1;TUBB4A;TUBA4A;DYNC1H1;CDK5RAP2;CCP110;AKAP9;CEP164;CKAP5;PAFAH1B1;PCM1;DCTN2;NEDD1;DYNLL1;CEP78;CSNK1E;ACTR1A;CETN2
prerank,cellular potassium ion homeostasis (GO:0030007),0.5210045058299227,1.1135414758414977,0.3541383989145183,0.9017545734313558,1.0,5/13,5.51%,KCNMA1;ATP1A3;ATP1A4;ATP1A1;KCNJ2
prerank,microtubule polymerization (GO:0046785),0.4594581533901429,1.113061601089754,0.3242603550295858,0.9027249864781016,1.0,12/28,23.10%,FGF13;NDEL1;MAPT;TPPP3;PIN1;SLAIN2;MAP7D3;AKAP9;CKAP5;CLASP2;TUBGCP5;TUBG2
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.5526814799849145,1.1129154157800507,0.36585365853658536,0.9024099613573889,1.0,3/10,18.92%,DIS3L2;UBA52;NEDD8
prerank,ceramide transport (GO:0035627),-0.4372110356835379,-1.1126946454262243,0.32116788321167883,0.7057791453764162,1.0,3/12,3.81%,PLTP;PLEKHA8;CERT1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.4734225325913638,1.112512784269934,0.33079847908745247,0.9030290434313256,1.0,5/22,13.25%,GTF2H3;RAD23B;ERCC3;UBA52;DDB1
prerank,connective tissue development (GO:0061448),0.4442246723280978,1.112463985287115,0.3418903150525088,0.9023946344039199,1.0,8/35,10.13%,CD44;SULF2;SLC39A13;PKD1;SULF1;SOX8;SOX5;COL2A1
prerank,inositol phosphate metabolic process (GO:0043647),-0.2994787678980687,-1.1119297938167623,0.20224719101123595,0.7056186816742701,1.0,13/46,11.72%,ITPKB;INPP4B;PLCG1;ISYNA1;NUDT4;PLCB1;INPPL1;ITPK1;INPP5D;MINPP1;NUDT3;ITPKC;PLCD3
prerank,myelination (GO:0042552),0.42752160139052875,1.111402068552635,0.3470982142857143,0.9054387445642704,1.0,12/46,18.60%,MYOC;PMP22;SKI;SOX10;MAL2;SIRT2;ARHGEF10;PLP1;KLK6;MARVELD1;CXCR4;MBP
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.5315129751750063,1.1113813197038764,0.36792452830188677,0.9046858327097244,1.0,3/12,13.56%,IRS1;IRS2;TWIST1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.426806354471355,1.1113370925202788,0.3460207612456747,0.9040323773914388,1.0,9/40,15.86%,SFRP4;ANXA2;VEGFA;BICD1;MAGI2;EGF;CBL;IL4;AHI1
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.4702341655771968,1.1111526089930805,0.3320754716981132,0.9039497715107552,1.0,8/23,21.15%,TIMM10B;TIMM9;AGK;BMF;HSP90AA1;TIMM22;TIMM8B;COX18
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.4081113452728259,-1.1106105413784901,0.2897959183673469,0.7071251833019311,1.0,11/13,42.47%,OAS2;STAT1;CRLF1;IL27;OASL;CANX;IL27RA;STAT3;JAK1;TYK2;EBI3
prerank,GPI anchor biosynthetic process (GO:0006506),0.4570781589840387,1.1102451979627337,0.34152046783625734,0.9063467724939996,1.0,9/30,14.92%,PIGT;GPAA1;PIGZ;PIGC;MPPE1;PIGS;PIGW;PIGK;PIGM
prerank,defense response to bacterium (GO:0042742),0.39623434528025275,1.1101165620221927,0.2930327868852459,0.9059661165246016,1.0,11/105,12.31%,SYK;LBP;ANG;S100A8;S100A9;TIRAP;TLR4;CEBPB;DMBT1;SLPI;RNASE6
prerank,negative regulation of transferase activity (GO:0051348),0.4559112746915386,1.109817600352825,0.3253012048192771,0.9061691134604637,1.0,8/28,13.43%,SRC;INPP5K;MAPT;FBXO5;IRS2;ERCC4;ZFP36;TERF1
prerank,negative regulation of bone remodeling (GO:0046851),0.5462637264815753,1.109661533028819,0.3728813559322034,0.9059192181577914,1.0,4/11,17.44%,TMEM119;CALCA;IL6;GPR137B
prerank,regulation of protein phosphorylation (GO:0001932),0.38369108467044466,1.1096541071563815,0.2337011033099298,0.9051357643908964,1.0,76/256,22.92%,EPHB2;LRP6;FGF18;NIBAN1;FGF7;EGFR;EFNA5;TMEM119;NPTN;EIF2AK3;PLCE1;CCDC88C;FYN;ITGB3;VEGFA;PDE8A;FGF2;SLIT2;WWTR1;PLPP3;AXIN1;TARDBP;MYADM;PID1;PIP5KL1;GAS6;FLCN;INPP5K;SIRPA;TWF1;MUSK;HDAC3;NPM1;CAMKK2;CEBPB;KRAS;AKT1;GPNMB;PIN1;CCND1;AKAP8;ZC3H12A;FER;WDFY2;HSP90AA1;CHP1;NOP53;PPIL4;HGF;FXR2;PML;PPP2R5B;CHRNA7;PPIA;PLAUR;ILK;IBTK;THPO;CLIP3;BMPER;FKBP8;CORO1C;ACVR2A;PTEN;MOB1B;AKAP8L;ARRB1;NSD1;SESN2;TERF2IP;ATF4;SPTBN4;CCDC88A;STAT2;FBLN1;FLOT1
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.47744791330366604,1.109550736736122,0.35459183673469385,0.9046679156549471,1.0,3/18,9.59%,IRS1;MIDN;BMP8A
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.496442494378429,1.1094597091845657,0.34776902887139105,0.9041887320555271,1.0,5/15,18.73%,ATP1A1;KCNJ2;YWHAE;KCNJ3;KCNH2
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.5174623248211774,1.1093020198803445,0.352,0.9039380317858587,1.0,7/13,28.37%,ZMIZ1;SMARCD1;PADI2;ELOF1;SERTAD2;ARID1A;ARID1B
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.4304467595457249,1.1092565345451697,0.33111111111111113,0.9032876239593578,1.0,8/46,9.07%,ADAMTS5;WNT10B;DOCK7;NR1D1;LNPEP;FLCN;FOXC2;TLR4
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.3490680106217725,-1.1091457767206065,0.3277777777777778,0.7089049724090355,1.0,10/25,23.81%,TMTC2;SNCA;CAV1;CNNM2;KCNA1;JPH2;MT3;ANK3;GRIN1;CIB2
prerank,positive regulation of viral transcription (GO:0050434),0.46080866905987633,1.1089560326508743,0.35074626865671643,0.9035984164380193,1.0,7/25,15.09%,POLR2H;MDFIC;CDK9;POLR2D;POLR2G;CTDP1;GTF2F1
prerank,cellular glucose homeostasis (GO:0001678),0.4328795924508367,1.1087562969792772,0.3263736263736264,0.9034944822624741,1.0,9/41,12.54%,LRRC8D;PIK3R2;SLC39A14;FOXK2;FOXO1;NR1D1;GAS6;ERN1;ADCY8
prerank,aorta morphogenesis (GO:0035909),-0.38336434071171216,-1.1086936414544677,0.3246753246753247,0.7079084487331713,1.0,6/17,9.45%,MYLK;ADAMTS9;ENG;TBX1;PDGFRB;TBX2
prerank,regulation of hippo signaling (GO:0035330),-0.3707976806632766,-1.1085419423740788,0.26570048309178745,0.7060282212814586,1.0,9/17,19.05%,MOB3B;VGLL4;WTIP;WWC1;MARK3;AJUBA;SOX11;NF2;WWC2
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.47873354735723356,1.1083165567273086,0.35361216730038025,0.9042330532209735,1.0,3/21,2.97%,EPHB2;TGFB2;SLIT2
prerank,regulation of acute inflammatory response (GO:0002673),0.48363529274837064,1.108236290972704,0.3433962264150943,0.9037196307070668,1.0,3/18,16.30%,KLKB1;IL4;IL6
prerank,negative regulation of wound healing (GO:0061045),0.45891827601627316,1.1080265803366414,0.33807829181494664,0.9036815418061557,1.0,2/28,2.88%,CD34;FGF2
prerank,UV protection (GO:0009650),0.5435612246231386,1.1079718690024691,0.36746143057503505,0.903068509240853,1.0,3/10,17.52%,SCARA3;GPX1;ERCC5
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.5340677678395511,1.1073916108114674,0.3697841726618705,0.9043336122727269,1.0,3/11,10.38%,CD44;SRC;KANK1
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.507701836729548,1.1073604402137598,0.3579920739762219,0.9036193921288089,1.0,3/15,12.04%,PRKCA;CAMK2D;SLC9A1
prerank,regulation of axon regeneration (GO:0048679),-0.42640345300413734,-1.1072719021905681,0.3125,0.7072918554910552,1.0,2/12,0.51%,PTN;EPHA4
prerank,negative regulation of cartilage development (GO:0061037),0.511958050380732,1.1065573295622624,0.3469945355191257,0.9057144235213869,1.0,5/13,18.39%,WNT9A;CHADL;SNAI2;EFEMP1;TGFBR1
prerank,regulation of actin filament-based process (GO:0032970),0.404811995166387,1.1064325499559742,0.32192513368983955,0.9053736229041088,1.0,13/70,16.20%,CORO2B;ARHGAP44;LRP1;EFNA5;EPHA3;MTOR;FSCN1;IQGAP1;RHOQ;TAOK2;RHOA;RND3;RAC3
prerank,nucleic acid metabolic process (GO:0090304),0.4019686098591052,1.106175366911523,0.3244962884411453,0.9054597651222558,1.0,26/69,28.67%,POLR2H;HNRNPA1;KPNA2;ATXN2;DNASE2;DUSP11;HNRNPD;HNRNPH1;RBFOX2;POLR2D;POLR2G;DNA2;HNRNPA3;DNASE1L2;GTF2F1;RAD50;DDX24;PTBP1;POLR2C;DNASE1L1;RBMX;DDX1;MMS19;LSM1;HNRNPC;PDE12
prerank,cell-cell junction assembly (GO:0007043),-0.27118367473133104,-1.1060216331690216,0.22666666666666666,0.7085332695755022,1.0,12/63,7.75%,TJP1;PKP4;CDH5;GJB6;CLDN5;PATJ;GJB2;CDH6;ACTB;TLN2;GJA1;CDH7
prerank,regulation of protein localization to nucleus (GO:1900180),0.4285262773610018,1.105792615549303,0.33408071748878926,0.9059854563712457,1.0,8/43,15.96%,LIF;EIF2AK3;WWTR1;FLCN;OTUD7B;AKT1;PIN1;ILRUN
prerank,positive regulation of epithelial cell migration (GO:0010634),0.39657620431348173,1.1057207583001665,0.3088082901554404,0.905450547360872,1.0,23/92,14.69%,FGF7;PRKCA;ANGPT4;SPARC;ITGB3;VEGFA;FGF2;TGFB2;FOXP1;ADAM9;SMOC2;MTOR;SRC;HDAC6;PRKD2;FOXC2;EMC10;AKT1;EGF;AAMP;ZC3H12A;BCAS3;ARF6
prerank,neural crest cell migration (GO:0001755),0.4393469371343085,1.1057014036835096,0.3616279069767442,0.9047254122413946,1.0,7/36,13.07%,SEMA3C;RADIL;SOX10;SOX8;SEMA3A;SEMA3D;GDNF
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.45130288942249325,1.1055063548232977,0.3329369797859691,0.9045600069036406,1.0,5/31,11.78%,CD80;GLMN;RC3H1;CEBPB;GPNMB
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.40868940181530605,1.1049941274406765,0.32116004296455425,0.9055792658303926,1.0,18/70,17.93%,ANTXR1;TMEFF2;ITGB3;NTN4;RADIL;DACT2;MEGF9;ARL13B;SRCIN1;ITGAV;EPHB3;ATRN;UNK;RHOA;FER;SRGAP2;YTHDF2;ILK
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.38209359028319995,1.1045401331197793,0.23795180722891565,0.9063616005592141,1.0,91/241,28.89%,GEMIN6;POLR2H;SRSF2;CD2BP2;HNRNPA1;SRSF6;DHX16;RBM4;ZCRB1;DDX42;LSM4;PRPF4;U2AF1;SRSF3;TFIP11;PRPF3;GPATCH1;USP39;HNRNPD;RBM22;DNAJC8;SNRPB2;CPSF4;HNRNPH1;DHX8;RBM17;PRPF40A;SRSF11;POLR2D;POLR2G;SNU13;HNRNPA3;AQR;SF3B4;GTF2F1;ZCCHC8;BCAS2;SF3A1;CPSF2;PHF5A;DDX5;SNRPA;SNRPG;SNRPD3;PNN;SNIP1;PDCD7;DDX39A;SRRM1;RBM6;PUF60;GCFC2;PRCC;HNRNPUL1;U2AF2;ELAVL2;ZMAT5;NOVA1;LSM7;PTBP1;SF3B2;SF3B1;PRPF38A;GPKOW;RBM5;SNRPA1;CSTF2T;CPSF1;RALY;CPSF7;WDR33;PABPN1;POLR2C;CWC27;ALYREF;UPF3B;PPIH;USP49;RBMX;PRPF19;CRNKL1;PRPF6;LSM5;CDC40;WDR83;CPSF3;RBM15;HNRNPC;SNRPC;WBP11;SRSF5
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.45388345329578456,1.1044691627528145,0.3468208092485549,0.9058167570383756,1.0,12/32,21.72%,CDC14B;TAOK3;RINT1;DTL;TAOK2;CDKN1A;ABRAXAS1;NBN;NOP53;BLM;DONSON;CLSPN
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.3247519907738218,-1.104213710609674,0.25766871165644173,0.7110448114873597,1.0,5/31,3.70%,RANBP3L;TMEM64;PTCH1;NOTCH1;CDK6
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.4281662865124235,1.104081976698139,0.3404494382022472,0.906379009257695,1.0,18/46,23.96%,ZPR1;PIK3R2;TCF7L2;GAS6;YWHAE;PSEN1;CPSF6;RBM22;HDAC3;JUP;ANP32B;ZC3H12A;DMAP1;IPO5;FLNA;BAG3;TPR;EMD
prerank,mononuclear cell differentiation (GO:1903131),0.4641891303941064,1.104074455659929,0.353584447144593,0.9056057191356416,1.0,5/24,14.82%,AXL;VEGFA;GAS6;FLT3;IL4
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.46045411505073464,1.1040206205510392,0.3541666666666667,0.9049888521184937,1.0,5/26,14.58%,LBP;TLR5;TIRAP;WDFY1;SLC15A4
prerank,RNA 3'-end processing (GO:0031123),0.4096372885050274,1.1037362982067003,0.326984126984127,0.9051783530133531,1.0,30/69,28.89%,SRSF2;SRSF6;TENT4A;U2AF1;SRSF3;CPSF4;SRSF11;THOC7;POLDIP3;THOC2;THOC1;ZC3H11A;CPSF2;TENT2;DDX39A;SRRM1;TENT4B;SUPV3L1;U2AF2;CSTF2T;CPSF1;CPSF7;WDR33;PABPN1;ALYREF;UPF3B;CDC40;THOC5;CPSF3;SRSF5
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.4692023413794366,1.1034855856086139,0.3449564134495641,0.9052416466136771,1.0,10/22,28.35%,VPS4B;MVB12A;VPS37D;VPS37C;VPS37B;UBAP1;VPS36;STAM;RNF126;PTPN23
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.4530168461353111,1.103458540315075,0.3539518900343643,0.9045502421674757,1.0,3/33,5.24%,MN1;PKD1;ATP2B4
prerank,positive regulation of protein import into nucleus (GO:0042307),0.44686005425006387,1.1032455970852375,0.3632075471698113,0.9044942636529006,1.0,12/28,22.68%,ZPR1;PIK3R2;PSEN1;RBM22;HDAC3;JUP;ZC3H12A;DMAP1;IPO5;FLNA;BAG3;TPR
prerank,multivesicular body assembly (GO:0036258),0.4533784032791433,1.1028587861683197,0.36140350877192984,0.9049982435033893,1.0,10/30,23.94%,CHMP7;VPS4B;MVB12A;VPS37D;VPS37C;VPS37B;VPS36;PDCD6IP;IST1;STAM
prerank,autophagosome organization (GO:1905037),0.4160483353076222,1.1028226198103939,0.34164859002169196,0.9043427662200214,1.0,20/50,25.67%,RAB23;RAB19;ATG2B;PACS2;WIPI2;STX12;WDR45B;ULK2;RAB43;ATG2A;ATP2A2;ULK1;RAB1B;ATG16L2;ATG13;ATG16L1;ATG3;ATG14;EMC6;RAB1A
prerank,cellular response to retinoic acid (GO:0071300),0.4263036482673916,1.1027191563723384,0.34961154273029965,0.9039043657473521,1.0,7/42,8.19%,WNT10B;WNT2;EPHA3;WNT9A;RET;ABL2;FZD7
prerank,negative regulation of viral release from host cell (GO:1902187),0.5044375694515499,1.1027187067463275,0.35733695652173914,0.9031164645350471,1.0,5/13,23.61%,MID2;TRIM11;PML;TRIM35;TRIM8
prerank,endothelial cell differentiation (GO:0045446),0.5323526975470447,1.102646033912901,0.37746478873239436,0.9026063552148142,1.0,2/12,8.92%,FSTL1;JAG1
prerank,cellular response to misfolded protein (GO:0071218),0.4880007653284491,1.1024046408207187,0.36625,0.9026917180518067,1.0,10/20,27.31%,STUB1;UBE2W;CUL3;TOR1A;AUP1;UGGT1;DERL1;UFD1;RNF126;UGGT2
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.47464897550520796,1.101465583345617,0.3682219419924338,0.90516838543342,1.0,8/21,22.52%,EFNA5;EPHA3;SLK;SLC9A1;RHOA;ACTG1;CORO1C;LDB1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.37821853898668495,1.1011479822459596,0.193,0.9055034618368529,1.0,62/348,13.42%,GHR;LIF;DDR2;CD80;FGF18;NIBAN1;FGF7;EGFR;TGFB3;EFNA5;ANGPT4;TMEM119;NPTN;CAMKK1;CD44;ITGB3;DGKQ;VEGFA;PDE8A;FGF2;TGFB2;MIF;SMAD4;AXIN1;ACVR1;BMP15;ITGA5;MAP2K3;ATP2B4;PTPRJ;DOCK7;MAPRE3;RASSF2;THBS4;INHA;SRC;PFN2;S1PR2;BANK1;HDAC6;ADCYAP1;GAS6;FLCN;PRKD2;CD81;CDK9;IQGAP1;BMP8A;MUSK;HDAC3;CAMKK2;KRAS;AKT1;GPNMB;EGF;XRCC5;CALM2;TAOK2;CDKN1A;PIN1;CCND1;IL5
prerank,gene expression (GO:0010467),0.37802359892107307,1.1008692074857915,0.21421421421421422,0.9057225502942531,1.0,79/348,19.51%,NOX4;RPSA;TSPAN17;POLR2H;SRSF2;ADARB1;MRPS11;SRSF6;NXF1;RRBP1;DDX19B;COPS5;RBM4;MRPS18B;NUP93;IGHMBP2;MCM3AP;BICD1;NUP107;PRPF4;STUB1;U2AF1;SRSF3;TFIP11;PPP5C;MRPL13;MRPS17;NUP98;AGO2;DUSP11;HNRNPD;CPSF4;GSPT2;HNRNPH1;RPL10A;DHX8;MRPL10;CELF2;MRPL55;TNIP1;SRSF11;THOC7;POLR2D;POLR2G;MPHOSPH10;DDX17;RPS5;BCL3;MRPL36;POLDIP3;RBM3;DNAJB11;SMG7;TASP1;THOC2;MRPL3;THOC1;GSPT1;ZC3H11A;SMG6;FYTTD1;DDX20;RPL6;NUP37;MRPL51;HARS1;CPSF2;ABCF1;NUFIP1;DDX39A;SRRM1;RBM6;RBM39;NUP50;SLBP;HNRNPUL1;U2AF2;RPL23;RPL17
prerank,negative regulation by host of viral transcription (GO:0043922),0.5262616574348048,1.1007039266430196,0.37907608695652173,0.9054850861383311,1.0,4/12,21.89%,TARDBP;INPP5K;TFAP4;JUN
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.452280659863721,1.1006572671180732,0.35308056872037913,0.9048603714939363,1.0,7/27,16.30%,HAS2;CD44;CD47;SIRPA;IRAK1;RHOA;IL6
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.4580676043346479,1.1006337760160199,0.36678614097968937,0.9041661637887443,1.0,6/25,14.69%,ITGB3;DLG4;ATXN2;PSEN1;ITGAV;ARF6
prerank,error-free translesion synthesis (GO:0070987),0.4758769435653406,1.1002797118613143,0.34835566382460414,0.9046643520939621,1.0,12/22,33.17%,POLDIP2;UBA52;RFC4;POLD1;REV1;POLH;UFD1;NPLOC4;RFC3;SPRTN;RPA3;RCHY1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.5331218238631562,1.1002773545158502,0.34946236559139787,0.903888480346101,1.0,5/12,18.60%,FOXP1;TIRAP;TLR4;KLF4;MBP
prerank,histone H2A ubiquitination (GO:0033522),0.48631410350620646,1.0999090496817183,0.3735408560311284,0.9043424710122956,1.0,8/17,22.64%,UBE2B;RNF2;RYBP;UBE2A;DDB1;RING1;KDM2B;UBR2
prerank,negative regulation of B cell activation (GO:0050869),0.47645667056863705,1.0992412367145554,0.3561643835616438,0.9058154911514361,1.0,4/21,7.01%,PARP3;INHA;BANK1;RC3H1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.42066366437885266,1.0988417965910453,0.3416757344940152,0.9064293289602973,1.0,12/48,17.49%,IRAK3;SLIT3;SLIT2;CARD16;PELI3;GAS6;SAMHD1;PARP14;NLRP2B;IL6;PADI2;YTHDF2
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.5151096231880664,1.098139146468406,0.37177747625508817,0.9080300733927249,1.0,2/13,7.49%,ZC3H8;GLI2
prerank,cochlea morphogenesis (GO:0090103),0.5369950600451053,1.0980523381907288,0.36027397260273974,0.907517707431145,1.0,2/10,7.53%,HPN;MYO3B
prerank,response to prostaglandin E (GO:0034695),-0.43141196157997297,-1.098017843519429,0.34055727554179566,0.7256178380051771,1.0,5/10,25.18%,TGFBR3;SFRP1;GNG2;CCL19;ADCY6
prerank,regulation of cell growth (GO:0001558),0.3823675639784673,1.0978006360932244,0.26452905811623245,0.9076186752416412,1.0,37/204,13.16%,EGFR;WT1;HPN;DCBLD2;FHL1;PLCE1;DACT3;SGK3;SGK2;TGFB2;SLIT3;SLIT2;CDKN2AIP;S100A8;S100A9;SMAD4;DDX49;GNG4;PSRC1;MTOR;ITCH;PTPRJ;SOCS2;CAMK2D;EGLN2;MELTF;FLCN;CYP27B1;NRG3;URI1;BCL6;AKT1;DNAJB2;LGI1;TAOK2;ADAM15;CDKN1A
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4528560525801662,1.0976547483192267,0.35322777101096225,0.9073343066346068,1.0,11/28,24.62%,IRS1;GRB10;TNS2;PID1;INPP5K;KANK1;NCK1;PIP4K2C;PIP4K2B;TSC2;PRKCZ
prerank,positive regulation of T cell activation (GO:0050870),0.41030732416534854,1.0976390594789935,0.33016877637130804,0.9065997901581804,1.0,11/62,16.97%,CD80;ANXA1;ZMIZ1;CD81;ZBTB1;CD47;SIRPA;IL4;IL6;NCK1;FLOT2
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.32882985784847957,-1.0976369085813724,0.29577464788732394,0.7244249050498365,1.0,5/29,5.24%,SORBS1;APOE;SCARB1;PPARA;NR1H3
prerank,negative regulation of signal transduction (GO:0009968),0.381767575451077,1.0975809492174864,0.26426426426426425,0.9060246630016316,1.0,37/249,11.64%,SFRP4;DCN;IGFBP5;TNMD;SRMS;EGFR;LRP1;IRS1;GPC3;GRB10;SULF2;DACT3;IRAK3;FGF2;TNS2;TMBIM1;GLIS2;ACVR1;DACT1;PTPRJ;NFATC1;CREB3L1;BEND6;CARD16;NTN1;PID1;SULF1;NDRG4;PALM;SIAH1;INPP5K;CD47;TSKU;KANK1;AKT1;GLI3;SLC2A10
prerank,cellular response to BMP stimulus (GO:0071773),0.40531593282438877,1.0974888182328484,0.3347412882787751,0.9055735903633455,1.0,12/66,10.84%,AMH;TMEM100;TGFB3;TGFB2;SMAD4;ACVR1;BMP15;FAM83G;SMAD5;BMP8A;SMAD6;AMHR2
prerank,regulation of microtubule depolymerization (GO:0031114),0.45732462557703757,1.097423246721803,0.37149817295980514,0.9050260838785436,1.0,7/25,22.56%,MAP1B;FGF13;CAMSAP1;NAV3;CLASP2;MAP1A;MAP1S
prerank,regulation of protein localization to Cajal body (GO:1904869),0.5340227299430335,1.0972635332225027,0.38677918424753865,0.9040392156886894,1.0,5/11,27.81%,MEPCE;CCT7;LARP7;CCT4;CCT6A
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.5340227299430335,1.0972635332225027,0.38677918424753865,0.9040392156886894,1.0,5/11,27.81%,MEPCE;CCT7;LARP7;CCT4;CCT6A
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.4457472199500969,-1.0970109361118177,0.3543859649122807,0.7239183242676064,1.0,5/10,16.30%,ATP5F1C;ATP5F1D;ATP5PD;ATP5MG;ATP5MC2
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.5425067579062933,1.0966574042377761,0.37604456824512533,0.9053639667730246,1.0,2/10,9.27%,LOXL2;SOX5
prerank,epiboly involved in wound healing (GO:0090505),0.495481873734127,1.0966187656814954,0.3646907216494845,0.9047249466342109,1.0,5/16,14.52%,TMEFF2;CD44;TOR1A;RHOA;DDR1
prerank,response to growth factor (GO:0070848),0.42788593736069375,1.0965644872944946,0.3579676674364896,0.9041358267092033,1.0,16/41,25.15%,MAPK7;TGFBR2;ACVR1;HDAC6;URI1;AMHR2;AKT1;KLF4;STAT5B;HTRA2;TGFBR1;ACVR2A;BMPR1A;EMD;ACVR1B;LRP2
prerank,"base-excision repair, gap-filling (GO:0006287)",0.43868706066963536,1.0964396364923268,0.352046783625731,0.9037593153178523,1.0,3/35,9.94%,MPG;POLB;PARG
prerank,protein oxidation (GO:0018158),0.5282853150360762,1.096359783410099,0.38142857142857145,0.90327773343052,1.0,3/11,18.50%,LOXL2;LOXL1;LOX
prerank,ameboidal-type cell migration (GO:0001667),0.414096850728438,1.0962935951052655,0.3344298245614035,0.9027383840845681,1.0,11/51,13.07%,SEMA3C;GPC3;RADIL;SOX10;SOX8;SEMA3A;PDXDC1;AKT1;PDLIM1;SEMA3D;GDNF
prerank,response to metal ion (GO:0010038),0.40471099553361706,1.0961003433201646,0.3501611170784103,0.902632798627005,1.0,11/67,12.62%,LOXL2;KCNMA1;SNCB;ADAM9;CRIP1;SEC31A;MTF1;SLC11A2;PPP5C;MAPT;CALM2
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.2810764428965377,-1.0960917708563716,0.24242424242424243,0.7243596993644118,1.0,13/62,8.80%,LYN;H3-3A;MEF2C;CREBBP;KMT2E;THBS1;CDK6;PURB;HSPA9;MEIS1;MYL9;PRKCQ;CTR9
prerank,protein K11-linked ubiquitination (GO:0070979),0.45496230845106944,1.0960386778630258,0.3548780487804878,0.9020734957091788,1.0,10/27,20.90%,UBE2B;UBE2W;CDC23;ANAPC5;UBE2A;CDC27;CDC26;ANAPC4;UBE2D3;ANAPC10
prerank,triglyceride catabolic process (GO:0019433),0.48463051477815794,1.0956953728811056,0.3585147247119078,0.9025151724072291,1.0,4/19,18.64%,FABP12;FABP5;LIPC;LIPH
prerank,regulation of secretion by cell (GO:1903530),0.41848132300391694,1.095545212147078,0.3478735005452563,0.9022628403714208,1.0,20/54,27.68%,ANXA1;DISP1;LLGL1;RHBDF1;SCG5;STX4;RAB3D;HCRT;P3H1;NSF;SYT1;VAMP2;RIMS2;RALA;RAB10;STXBP5L;RAB12;RAB3C;VAMP3;RAB8B
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.47897424506284547,1.0955405685398425,0.3607188703465982,0.9015130009948558,1.0,5/19,14.82%,THBS4;C1QBP;MCU;TIRAP;IL4
prerank,protein dephosphorylation (GO:0006470),-0.24165046202608867,-1.0954396622449796,0.23076923076923078,0.7239899851396124,1.0,34/135,14.45%,PTPRK;PTPN14;EYA1;PTPRG;PTPRB;PPM1E;PPM1H;CTTNBP2NL;PTPRD;PPM1D;DUSP10;PTPN9;PTPRM;PTPRN2;PTPRZ1;SSU72;RPRD1B;PTPRO;PTPN1;UBLCP1;PPP2R2C;PPP1R15B;PPP2R5A;PPM1L;PTPRT;PTPN2;PPM1F;PTPN4;PTPN21;UBASH3B;DUSP7;PPP1CB;PPP4R1;CTDNEP1
prerank,positive regulation of stress fiber assembly (GO:0051496),0.4253381048147832,1.094722766399727,0.358683314415437,0.9035721803510973,1.0,9/44,10.15%,MYOC;TGFB3;S100A10;SORBS3;LPAR1;PFN2;ARHGEF10L;ARHGEF10;CD47
prerank,spliceosomal complex assembly (GO:0000245),0.4149165988111207,1.0947165100288427,0.3603504928806134,0.902824962859567,1.0,25/46,32.89%,SRSF6;USP39;KHDC4;CELF2;SF3A1;SNRPG;LUC7L3;PUF60;GCFC2;LUC7L2;SF3B1;SRPK1;RBM5;SMN1;CELF3;PRPF19;CRNKL1;PRPF6;DDX1;CELF1;SRSF5;CELF4;SF1;SF3A2;DDX39B
prerank,negative regulation of macrophage activation (GO:0043031),0.49130156794258606,1.0942757043562812,0.36578947368421055,0.9035903348871136,1.0,7/16,22.53%,SYT11;NR1D1;ZC3H12A;IL4;LRFN5;IL31RA;LDLR
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.3769230982868485,1.0934731653528424,0.27127127127127126,0.9055762114020779,1.0,100/264,28.89%,GEMIN6;POLR2H;SRSF2;CD2BP2;HNRNPA1;SRSF6;DHX16;RBM4;ZCRB1;DDX42;LSM4;PRPF4;U2AF1;SRSF3;TFIP11;WDR77;PRPF3;GPATCH1;USP39;HNRNPD;RBM22;DNAJC8;SNRPB2;CPSF4;HNRNPH1;DHX8;RBM17;PRPF40A;SRSF11;TGS1;POLR2D;POLR2G;DDX17;SNU13;HNRNPA3;AQR;SF3B4;GTF2F1;DDX20;ZCCHC8;BCAS2;SF3A1;CPSF2;PHF5A;DDX5;SNRPA;SNRPG;SNRPD3;PNN;SNIP1;PDCD7;DDX39A;SRRM1;RBM6;PUF60;GCFC2;PRCC;STRAP;HNRNPUL1;U2AF2;ELAVL2;ZMAT5;NOVA1;LSM7;PTBP1;SF3B2;SF3B1;SRPK1;PRPF38A;GPKOW;RBM5;SMN1;SNRPA1;COIL;CSTF2T;CPSF1;RALY;CPSF7;WDR33;PABPN1;POLR2C;CWC27;ALYREF;UPF3B;PPIH;USP49;RBMX;PRPF19;CRNKL1;PRPF6;DDX1;LSM5;CDC40;WDR83;CPSF3;RBM15;HNRNPC;SNRPC;WBP11;SRSF5
prerank,acute inflammatory response (GO:0002526),0.4647326126929226,1.0933533985157822,0.37160493827160496,0.9052039336857436,1.0,1/23,0.28%,LBP
prerank,regulation of nuclear division (GO:0051783),0.4707397011595822,1.0932975919776884,0.3751568381430364,0.9046450721155651,1.0,5/20,13.94%,CCDC8;KIF20B;FBXO5;PIN1;CUL9
prerank,glucose homeostasis (GO:0042593),0.39943925725510865,1.0932285170622456,0.3417190775681342,0.9041181916979406,1.0,12/83,9.96%,MTNR1B;IRS1;LRRC8D;CRTC2;PIK3R2;FOXK2;TCF7L2;FOXO1;NR1D1;MLXIPL;MCU;INPP5K
prerank,regulation of translation (GO:0006417),0.38363550270100916,1.0932065809009588,0.29346733668341707,0.9034346829190302,1.0,59/173,27.22%,IGFBP5;NIBAN1;PKP3;EIF3B;EIF2AK3;RBM4;PAIP2B;CTIF;MTOR;TRIM71;SAMD4B;ATXN2;LARP4;MRPL13;HNRNPD;EIF1;NPM1;IGF2BP1;PASK;EIF6;LARP1;LTN1;RPS27L;BCL3;ZCCHC4;CNOT10;NOLC1;POLDIP3;RBM3;EIF3E;GSPT1;IL6;EIF3D;FXR2;YTHDF1;EPRS1;PAIP2;PCIF1;MTIF2;METAP1;NEMF;EIF2A;YTHDF3;OGFOD1;TRAP1;EIF4G3;EIF4H;CALR;LARP6;GRM5;CYFIP1;UPF3B;EIF2B2;EIF4G1;EIF4E2;UPF1;DDX1;TSC1;PRKDC
prerank,regulation of axon extension (GO:0030516),0.43410485542296184,1.0931557781783547,0.3665893271461717,0.9028534403275372,1.0,8/37,11.37%,DBN1;PTPRS;NTN1;TRIM46;ISLR2;SEMA3A;L1CAM;MAPT
prerank,neutrophil activation involved in immune response (GO:0002283),0.3761306617835573,1.0930809320767796,0.203,0.9023302085229264,1.0,104/428,21.60%,SYK;TIMP2;GSN;CD55;ARSA;B4GALT1;CD44;CD177;ANXA2;RAB6A;ANPEP;ACTR1B;TMBIM1;MIF;S100A8;S100A9;SPTAN1;MAPK14;AP1M1;ACLY;RAP1B;TMEM63A;PTPRJ;TOM1;PLEKHO2;AP2A2;PRCP;RAB37;IDH1;DOK3;TCN1;ATP11A;COPB1;SURF4;CAPN1;ARHGAP9;DYNC1LI1;PSEN1;IQGAP1;ABCA13;SNAP23;ITGAV;CD47;LPCAT1;SIRPA;CSTB;NRAS;RAB3D;SLPI;GLA;JUP;TMEM30A;XRCC5;NIT2;SNAP25;RHOA;CMTM6;TNFRSF1B;NME2;SLC2A3;UBR4;SLC15A4;HSP90AA1;CD14;DIAPH1;ATP6V0A1;DYNC1H1;GAA;ATP6V1D;PKM;CAP1;IGF2R;CANT1;FABP5;CTSD;PPIA;PADI2;ILF2;RAB5B;RAB5C;SLC44A2;CXCR2;COTL1;TMEM179B;PLAUR;VAMP2;PYGB;PRG2;ALDOA;APAF1;RAB24;DDOST;TOLLIP;ITGAM;ACP3;QSOX1;RAB10;PYCARD;COMMD9;MAPK1;ANXA3;ERP44;CAB39;CPNE1
prerank,hemopoiesis (GO:0030097),0.3999599002430639,1.0929715140068217,0.33402922755741127,0.9019462499839732,1.0,11/87,8.92%,CD34;MFAP5;WNT10B;TGFB2;TGFBR2;RUNX1;FLCN;FLT3LG;ZFP36L2;TIRAP;JAG1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.3895025887311837,-1.0927315293824786,0.33613445378151263,0.7289835815460767,1.0,2/14,3.31%,ADAM10;WNT5A
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.3813229702796807,-1.0927274546079166,0.32489451476793246,0.7267715504399043,1.0,3/17,4.69%,ATP1A2;CACNB2;CACNA1D
prerank,mRNA 3'-end processing (GO:0031124),0.3991200256976245,1.0922164419534675,0.3459516298633018,0.9038355838164029,1.0,33/78,28.06%,SRSF2;SRSF6;SCAF8;U2AF1;SRSF3;CPSF6;CPSF4;SRSF11;THOC7;POLR2D;POLDIP3;THOC2;THOC1;ZC3H11A;CPSF2;PAPOLB;TENT2;DDX39A;SRRM1;TENT4B;SLBP;U2AF2;PAF1;CSTF2T;CPSF1;CPSF7;WDR33;PABPN1;ALYREF;UPF3B;CDC40;THOC5;CPSF3
prerank,regulation of lamellipodium assembly (GO:0010591),0.4360185397202342,1.0919608614250542,0.36428571428571427,0.9039345762640759,1.0,9/34,14.21%,PLCE1;SLIT2;AKIRIN1;FSCN1;ACTR3;PIK3CA;TWF1;AVIL;FER
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.4066475019360319,1.0918506037585363,0.3487881981032666,0.9035745999707259,1.0,17/67,14.60%,AXL;NCF4;FYN;ITGB3;VEGFA;PIK3R2;MAPK14;SRC;SULF1;PRKD2;ABI1;PIK3CA;MAPK11;ITGAV;RHOA;AAMP;HSP90AA1
prerank,positive regulation of cation channel activity (GO:2001259),0.4243108686945619,1.090726145785058,0.3712374581939799,0.9065937335292297,1.0,7/40,14.04%,EPHB2;ANK2;PKD2;GSTM2;CALM2;ANTKMT;CASQ1
prerank,blood vessel endothelial cell migration (GO:0043534),-0.36160412355615923,-1.090410713877083,0.3465346534653465,0.7308452247684724,1.0,8/22,8.36%,ROBO1;CDH5;EFNB2;EPHB4;KDR;NRP1;ID1;EMP2
prerank,inhibitory synapse assembly (GO:1904862),0.5171441391844623,1.0903181394329462,0.3855755894590846,0.9071976588598667,1.0,2/11,2.87%,LGI2;FGF13
prerank,organic hydroxy compound transport (GO:0015850),-0.314640557130766,-1.090095530635418,0.29850746268656714,0.7294534299025067,1.0,9/36,12.72%,ABCC4;SLCO2B1;SLCO1C1;RBP4;SLC5A3;STRA6;NCOA1;CEACAM1;OSBP
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.5004195054978378,1.090047339920516,0.37566844919786097,0.9073672222446618,1.0,6/15,23.77%,TENT4A;AGO2;ZFP36;POLR2G;TENT4B;TNRC6A
prerank,regulation of protein transport (GO:0051223),0.44967869308593134,1.0896297258267753,0.36885245901639346,0.9080245280919423,1.0,8/27,15.24%,DISP1;LLGL1;NDEL1;RHBDF1;SCFD1;NDFIP1;P3H1;CHP1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.387943365053713,1.0895914744193487,0.3154158215010142,0.9074248974654555,1.0,25/142,18.07%,ACKR3;CD55;ESR1;C1QTNF1;LPAR3;NPTN;PLCE1;F2R;DLG4;LPAR1;ATP2B4;ADCYAP1;ABL2;YWHAE;ACKR4;CALCA;SLC35G1;ADCY8;SLC8A2;PDGFRA;CXCR4;CXCR2;BCAP31;IAPP;ATP2B1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.4988639028715937,1.0894184357604453,0.383289124668435,0.9072528798595052,1.0,5/14,19.98%,SRSF6;C1QBP;SAP18;U2AF2;PTBP1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.4163494008474419,1.0892458277875223,0.36433260393873085,0.9071166702459177,1.0,14/50,17.83%,TRIAP1;CD44;VEGFA;CARD16;SRC;GAS6;DPEP1;YWHAE;GPX1;AKT1;SFN;KLF4;HGF;PLAUR
prerank,translational elongation (GO:0006414),0.3889818699720743,1.089236817146488,0.3219461697722567,0.906394262914459,1.0,24/101,16.83%,MRPS11;MRPL38;EEF2K;MRPS18B;GTPBP2;CHCHD1;MRPL13;MRPS17;AURKAIP1;MRPS27;MRPL30;MRPL10;GFM1;DAP3;MRPL55;MRPS10;LTN1;MRPL36;MRPL3;MRPL21;MRPS34;MRPL51;EEF1B2;EEF1G
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.38385016020650153,-1.0889432848098304,0.3130434782608696,0.7304758636172562,1.0,8/16,14.18%,IGF1;MEF2C;NOTCH1;TGFBR3;FGFR2;TBX2;AKAP6;EDN1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.40705117760496934,-1.088850247235397,0.3436293436293436,0.7285413762384461,1.0,4/13,6.40%,BMP7;SOX13;NAPEPLD;PTGS2
prerank,positive regulation of proteolysis (GO:0045862),0.4097062321588319,1.0885893143576781,0.3566810344827586,0.9078064471596742,1.0,17/55,23.59%,CCBE1;MAPK12;ADAM9;RCN3;STUB1;AURKAIP1;TBC1D10A;TNIP1;BAK1;TNFRSF1B;ZC3H12A;OGT;GPLD1;SH3D19;FBXW11;PACSIN3;IST1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.4243515614048311,1.0883239245848824,0.3601321585903084,0.9079737137766626,1.0,8/47,14.08%,CD34;FYN;ATP2B4;WDTC1;ACADVL;SIRPA;GLA;ZC3H12A
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.30082492077068906,-1.0880943994111623,0.3333333333333333,0.7283664437293089,1.0,11/39,11.50%,CDH5;PLCG1;THBS1;SEMA5A;KDR;ITGA4;NDNF;RGCC;ICAM1;ECSCR;TEK
prerank,negative regulation of protein localization to membrane (GO:1905476),0.46107931593429285,1.08741638079718,0.3614163614163614,0.9102496321208295,1.0,10/24,24.39%,TMBIM1;PID1;CLTC;INPP5K;RHOQ;GDI1;PPFIA1;AP2M1;DMTN;MRAP2
prerank,error-prone translesion synthesis (GO:0042276),0.46925207115371476,1.0873316074940542,0.37668711656441717,0.9097818785213566,1.0,8/21,28.17%,REV3L;POLI;UBA52;RFC4;REV1;POLH;POLE2;RFC3
prerank,potassium ion homeostasis (GO:0055075),0.4528321741443974,1.0872500807723442,0.37982565379825656,0.9093237362293425,1.0,7/23,7.78%,KCNMA1;ATP1A3;ATP1A4;ATP1A1;SLC12A8;KCNJ2;SLC12A4
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.41929953637311884,1.0872221878608894,0.3720136518771331,0.9086648924445173,1.0,5/43,4.00%,IGFBP5;MMP2;FGF2;FOXP1;MEF2D
prerank,cilium organization (GO:0044782),0.37595571096388825,1.0871487711864471,0.27955911823647295,0.9081442746810356,1.0,74/209,27.68%,GSN;NME8;CDC14B;ODF2;ABLIM1;PKD1;RAB23;FHDC1;ARF4;ACTR3;HDAC6;BBS9;PKD2;ATAT1;ARL13B;TMEM138;OCRL;CPLANE1;CNGB1;EHD2;NUDCD3;DZIP1;TTC39C;AVIL;TEKT5;PIBF1;DYNC2I2;KIF3A;RPGR;KIF3B;IFT46;TTLL3;BBS4;TTC8;ATP6V1D;FAM161B;AHI1;CCP110;CEP164;DYNC2H1;CEP89;DYNC2I1;CEP83;CCDC28B;RP2;BBS5;BBIP1;IFT52;EXOC4;CC2D2A;SPAG16;FLNA;PCM1;DNAH5;FBF1;TMEM231;TCTN2;RAB11FIP3;PDE6D;CFAP126;DYNLL1;CEP78;TCTN1;CDC14A;NEK1;CEP126;RAB1A;CFAP70;KIFAP3;GBF1;FUZ;IFT81;PTPDC1;RAB8B
prerank,positive regulation of lipid localization (GO:1905954),0.5346728469135842,1.0871036449372533,0.38028169014084506,0.9075475923693956,1.0,2/11,14.08%,LRP1;ZC3H12A
prerank,negative regulation of protein modification process (GO:0031400),0.39787750647618686,1.0870785439227613,0.3361522198731501,0.9068774358671383,1.0,28/79,23.52%,EPHB2;LRP6;NIBAN1;SLIT2;WWTR1;PLPP3;ATP2B4;TARDBP;MYADM;PID1;PIP5KL1;INPP5K;SIRPA;MAPT;P3H1;ZC3H12A;CDYL;CHP1;PPIA;TINF2;IBTK;FKBP8;CORO1C;PTEN;TERF2IP;YWHAB;FBLN1;ATG14
prerank,ubiquinone metabolic process (GO:0006743),0.48660349735032826,1.086940974079613,0.3915900131406045,0.9066195752445461,1.0,4/15,10.63%,COQ10B;COQ7;AIFM2;COQ3
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.4551464147710859,1.0868216933555446,0.3742550655542312,0.9062997927410564,1.0,14/27,26.42%,MRGBP;ATAT1;MSL3;KAT2B;NAT8;MORF4L1;NAA50;TAF6L;TRRAP;SGF29;KAT6B;KAT5;KAT7;BRD8
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.43402505696646543,1.0865234338269598,0.36681715575620766,0.9065827286932113,1.0,11/36,17.85%,TAOK3;DACT1;AIDA;ITCH;FOXO1;SIRPA;HDAC3;NCOR1;PER1;PPIA;QARS1
prerank,positive regulation of phospholipase activity (GO:0010518),0.46242490757877747,1.0864530834198955,0.36744759556103573,0.9060584155436177,1.0,5/22,7.45%,ESR1;FGFR1;FGF2;ARF4;ABL2
prerank,positive regulation of neutrophil migration (GO:1902624),0.48416360439046136,1.0863033015461183,0.3769633507853403,0.9058188210132756,1.0,4/18,8.91%,THBS4;C1QBP;MCU;TIRAP
prerank,digestive tract development (GO:0048565),0.4368065856838528,1.086128947695007,0.3727598566308244,0.9057174482694467,1.0,8/32,15.10%,PCSK5;TGFB2;COBL;PKD1;GLI2;EPHB3;GLI3;CHD8
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.480422203597837,1.085883083967604,0.38974358974358975,0.905800127171325,1.0,1/18,0.61%,LAX1
prerank,positive regulation of phosphorylation (GO:0042327),0.3765575864320245,1.0858546898077779,0.27627627627627627,0.9051509146146679,1.0,56/240,18.12%,DDR2;AR;EPHB2;FGF18;AXL;NIBAN1;FGF7;EGFR;FGFR1;EFNA5;TMEM119;GLMN;NPTN;EPHA3;ANG;ITGB3;VEGFA;PDE8A;FGF2;MST1R;MIF;AXIN1;RET;MLXIPL;GAS6;FLCN;FZD7;PSEN1;EPHB3;MUSK;DSCAM;HDAC3;CAMKK2;SLC4A4;KRAS;AKT1;EPHA10;GPNMB;EGF;FLT3;PIN1;CCND1;PDGFRA;NBN;WDFY2;DDR1;HSP90AA1;KCTD20;HGF;FXR2;CHRNA7;PPIA;RAD50;PLAUR;ILK;EPHB1
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.41115931366169495,1.0858188245567884,0.3675027262813522,0.9045425030804732,1.0,23/52,28.97%,MBNL1;HNRNPA1;SRSF6;RBM4;NSRP1;MBNL2;CELF2;RBFOX2;DDX17;DDX5;FXR2;SAP18;PUF60;NOVA1;PTBP1;THRAP3;RBM5;RBM24;CELF3;RBMX;CELF1;RBM15;ZBTB7A
prerank,regulation of ion transport (GO:0043269),0.3969157709888315,1.0853714973921176,0.34044823906083244,0.9053287053754971,1.0,19/76,18.55%,SYT2;ITGB3;ATP1A1;SYT12;SYT11;SYT13;KCNJ2;DTNBP1;TOR1A;CLDN10;KCNA2;PXK;GDNF;KCNJ3;STC1;PER1;SYT1;SNX6;VAMP2
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.4258270794557495,1.0850174398976027,0.3681765389082462,0.905796247291702,1.0,16/38,26.47%,OTUD3;PTPRJ;BANK1;FLCN;PHLPP2;INPP5K;AKT1;MAGI2;PLEKHA1;NOP53;PPP2R5B;SFRP5;PTEN;TSC2;DDIT3;MUL1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.4835779752059991,1.0849988851569974,0.390625,0.9051087292005966,1.0,6/16,23.47%,AMPD2;PAICS;GART;ATIC;ADSS2;LHPP
prerank,regulation of autophagosome assembly (GO:2000785),0.4235282262486802,1.0849742485238452,0.3570581257413998,0.9044468907712578,1.0,18/33,33.91%,SEC22B;SCFD1;SMCR8;NUPR1;RAB1B;PIP4K2C;ADPRH;LRSAM1;PIP4K2B;TBC1D12;MTM1;TMEM39A;PIKFYVE;IFT20;CHMP4A;CHMP4B;RAB3GAP1;FEZ1
prerank,regulation of axon guidance (GO:1902667),0.5381863782842166,1.084550172799045,0.3919308357348703,0.9050936759871003,1.0,5/10,17.46%,VEGFA;ZSWIM4;MYCBP2;ZSWIM8;YTHDF1
prerank,neural tube development (GO:0021915),0.49744179978998443,1.0841568121543281,0.38961038961038963,0.9056982821282169,1.0,5/15,8.01%,PKD1;DACT1;TRIM71;PKD2;ARL13B
prerank,axonal fasciculation (GO:0007413),0.5181192706368059,1.08404152454719,0.38461538461538464,0.9053560323460047,1.0,3/12,10.29%,EPHB2;EPHA3;EPHB3
prerank,receptor-mediated endocytosis (GO:0006898),0.38076364485219044,1.0836616079445842,0.3231083844580777,0.9058875904209889,1.0,16/132,8.35%,ACKR3;SYK;LRP6;CD9;LRP1;DNM1;AP1G2;SPARC;COLEC11;WASF1;AP2A2;PDLIM7;CLTC;SNX1;CD81;INPP5F
prerank,regulation of cellular metabolic process (GO:0031323),0.4188741806351312,1.083656366389444,0.3642458100558659,0.9051749535449916,1.0,16/45,24.50%,ACLY;COQ7;ARF4;PID1;STUB1;ARF1;SSH1;EIF6;MBOAT7;NCOR2;MKLN1;RNF41;CYP1B1;FLOT1;PARL;RSPO1
prerank,inorganic ion transmembrane transport (GO:0098660),0.5191256182403707,1.0835623305176565,0.38503401360544215,0.9047567131824866,1.0,6/12,28.26%,P2RX3;PKD2;ASIC2;ABCC8;KCNJ11;CACNA1H
prerank,glutamine family amino acid metabolic process (GO:0009064),0.4357209495967075,1.0831539957409895,0.3719582850521437,0.9053851291975358,1.0,11/33,20.58%,GCLC;ALDH18A1;ART4;GLS2;GLS;NIT2;ALDH5A1;GLUD1;PYCR1;DDAH2;GOT1
prerank,negative regulation of telomere maintenance (GO:0032205),0.49397266632056225,1.082978376076272,0.3730366492146597,0.9051822465255992,1.0,7/15,22.85%,ERCC4;TERF1;NBN;SMG6;RAD50;TERF2IP;ERCC1
prerank,lysosome localization (GO:0032418),0.42899753190626777,1.0827535910398058,0.3576388888888889,0.9051707773505623,1.0,12/37,21.27%,NDEL1;HDAC6;FLCN;VPS33A;MAP6;HPS6;BLOC1S2;SNAPIN;PIP4P1;KXD1;VPS33B;PIK3CG
prerank,hydrogen peroxide metabolic process (GO:0042743),0.4747354173601091,1.0827223963201584,0.3969270166453265,0.9045409664214675,1.0,4/19,17.98%,DUOX1;GPX1;ACOX1;PXDN
prerank,nucleocytoplasmic transport (GO:0006913),0.42187169686729364,1.0825740507053496,0.37656427758816835,0.9043369048681177,1.0,12/40,22.98%,GEMIN6;HNRNPA1;NUP98;NPM1;BACH2;DDX20;SNRPG;SNRPD3;NXT2;NEMF;HTATIP2;SMN1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.3937856375180415,-1.082029923918795,0.35443037974683544,0.7429266321822176,1.0,2/16,1.52%,ATP1A2;DMD
prerank,lipoprotein catabolic process (GO:0042159),-0.42388112282515383,-1.0818019470318019,0.34962406015037595,0.7412938081671258,1.0,3/11,7.56%,APOE;ABHD17C;NOTUM
prerank,carbohydrate derivative transport (GO:1901264),0.4800434843469648,1.0817099160917882,0.37515842839036756,0.9064425853694518,1.0,1/18,0.28%,LBP
prerank,chromatin organization (GO:0006325),0.38520544412630864,1.0815307452243597,0.3495440729483283,0.9063180491823735,1.0,53/132,30.39%,ESR1;LOXL2;SMARCD2;MCM3AP;SMARCD1;PHF1;ZBTB1;SETD7;KAT2B;KDM5C;SATB2;HDAC3;NPM1;SMARCC2;SETD2;KDM5B;DR1;DDX11;HDAC4;EZH1;GATAD1;INO80;SETD5;SMARCA4;NUDT5;BAZ2B;CHD1;PADI2;SUPV3L1;TAF6L;EZH2;BAZ2A;SETDB1;KDM4C;SETDB2;BAZ1A;INO80C;TCF7L1;HP1BP3;SAFB;ARID1A;JARID2;HDAC8;SUV39H1;CHRAC1;KDM4B;TADA2A;PBRM1;ZBTB7A;ATRX;SOX9;HCFC2;HCFC1
prerank,stabilization of membrane potential (GO:0030322),0.48585768384682004,1.0806281454070883,0.3896276595744681,0.908616088939789,1.0,3/16,9.44%,KCNK5;KCNK13;KCNK9
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.391755401303302,1.0803718920768353,0.33124346917450365,0.908762326095687,1.0,17/87,14.32%,CDK2AP2;FHL1;PSMC4;ZFP36L1;CDK4;DACT1;PRMT2;PSMC6;PKD2;ZFP36L2;PSMD8;AVEN;BRD7;GPNMB;FBXO5;CDKN1A;KLF4
prerank,protein modification process (GO:0036211),0.3959276016447312,1.0801417734069363,0.35744234800838576,0.9087574175029122,1.0,28/76,26.45%,PLOD2;LOXL2;RABGGTA;GGCX;PHKA2;ABL2;FBXO2;FBXL2;CSNK1G3;UBA52;CDC34;FBXO11;ST3GAL1;ADPRH;LOX;STK38;NEDD8;UBE2D3;FBXW2;ICMT;YES1;ATG3;MMP15;RABGGTB;UBA7;FBXO22;PIGH;DUSP12
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.4572150985180734,1.0798493317366156,0.3894993894993895,0.9090337799316356,1.0,7/22,22.98%,TIMP2;ADAM9;TNFRSF1B;GPLD1;SH3D19;PTPN3;PACSIN3
prerank,ganglion development (GO:0061548),-0.4175447533213951,-1.0796285743347944,0.34050179211469533,0.7448301815228134,1.0,2/11,6.34%,NRP2;NRP1
prerank,regulation of macrophage migration (GO:1905521),0.5309844852916918,1.0794418197932936,0.3918918918918919,0.90966411577545,1.0,3/10,21.90%,CD81;CD200R1;CSF1
prerank,female gonad development (GO:0008585),0.47449980196104674,1.0789627647361424,0.3838383838383838,0.9105469469315757,1.0,7/19,14.19%,ANG;VEGFA;INHA;NUP107;COL9A3;CEBPB;LHCGR
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.40559345582854744,1.0787938794435177,0.3584699453551913,0.9103481071743463,1.0,6/53,14.19%,LPAR3;MTNR1B;ANXA1;HTR1F;TSHR;LHCGR
prerank,lymphocyte migration (GO:0072676),0.4395496082012409,1.0787065321888256,0.38908659549228947,0.9099151751836422,1.0,4/32,12.90%,CCL8;RET;CCL25;CCL13
prerank,protein processing (GO:0016485),0.3847482901630492,1.0786061008746455,0.37048503611971106,0.9095374086946942,1.0,25/102,19.06%,PCSK6;PCSK5;KLKB1;PRSS12;ADAMTS3;TMEM208;ADAM19;PCSK4;SPCS1;PSEN1;ECE1;SEC11C;XPNPEP3;EEF1AKMT4-ECE2;ECE2;KLK1;KLK6;RCE1;FAM111A;OGT;HTRA2;SPG7;MMP16;METAP2;PCSK7
prerank,cellular response to hexose stimulus (GO:0071331),-0.3392340025554627,-1.0784259109982455,0.34523809523809523,0.7456969838951223,1.0,5/23,4.62%,UNC13B;IGF1R;PRKAA2;KCNB1;TRA2B
prerank,nuclear envelope organization (GO:0006998),0.4621230539284091,1.0784105009970324,0.3666245259165613,0.9094759241383682,1.0,4/20,9.04%,TMEM43;REEP3;NUP93;TOR1A
prerank,microtubule anchoring (GO:0034453),0.5125698372976282,1.0783058763134807,0.384297520661157,0.9090890152537697,1.0,4/12,21.33%,SAXO1;BICD1;CLASP2;PCM1
prerank,regulation of B cell activation (GO:0050864),0.44804894289878766,1.0781906239066392,0.3860294117647059,0.9087399874637813,1.0,5/25,16.30%,ZFP36L1;BANK1;ZFP36L2;IL4;IL6
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.5284724834593171,1.0781707685572663,0.38450899031811897,0.9080727213828724,1.0,1/10,1.21%,DPP4
prerank,peptidyl-threonine modification (GO:0018210),0.3990138483240122,1.0781490185707103,0.37259100642398285,0.9074088471976466,1.0,23/66,24.76%,PRKCA;DYRK4;TGFBR2;GALNT16;ACVR1;CAMK2D;PRKD2;DYRK2;GALNT1;AKT1;STK39;ULK1;HIPK4;TGFBR1;GALNTL6;CIT;OXSR1;HIPK3;MAPK1;CSNK2A2;GALNT4;ACVR1B;MARK2
prerank,glutathione metabolic process (GO:0006749),0.4320945709989594,1.0780527160259923,0.36990950226244346,0.9070015928011506,1.0,8/38,14.50%,GCLC;DPEP1;HAGH;CNDP2;GPX1;GSTM2;NAT8;GGT7
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.40793858753362866,-1.0779971613024644,0.3475177304964539,0.7447348803833977,1.0,5/13,10.54%,SORBS1;IGF2;ECHDC3;SORL1;SIRT1
prerank,bicarbonate transport (GO:0015701),0.46344206907623403,1.0773519407382681,0.38882282996432815,0.9085681887203962,1.0,5/25,11.33%,SLC4A10;SLC4A8;SLC4A3;SLC4A4;SLC26A6
prerank,mRNA splice site selection (GO:0006376),0.4381795673000871,1.0770869100005935,0.3784722222222222,0.9087328176868781,1.0,15/30,31.97%,SRSF6;KHDC4;CELF2;SF3A1;PSIP1;LUC7L3;PUF60;LUC7L2;CELF3;CELF1;SNRPC;SRSF5;CELF4;SF1;SF3A2
prerank,positive regulation of chemokine production (GO:0032722),0.41747635134545746,1.0770663360246275,0.38215859030837,0.9080844397378767,1.0,10/44,18.60%,SYK;IL33;ADCYAP1;IL17RA;TIRAP;TLR4;TWIST1;IL6;IL18;MBP
prerank,regulation of metal ion transport (GO:0010959),0.49399569160626994,1.0769528854669181,0.38903061224489793,0.9077165422262027,1.0,3/16,3.40%,IL16;ANK2;SRI
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.2628483991410896,-1.076904893651819,0.32727272727272727,0.7456779680836327,1.0,18/70,12.99%,SORT1;BCL2L1;SMAD3;BCL2;DAB2IP;IL6R;CASP8AP2;TNFSF12;DELE1;CASP3;GABARAP;TLR3;INHBA;FAS;RIPK1;TGFB1;CASP9;BCL2L2
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3860982827407875,1.0767360525435135,0.3719262295081967,0.9076770502710086,1.0,38/107,23.42%,NIBAN1;EIF2AK3;PIK3R2;RASGRF1;SYVN1;TMEM259;CREB3L1;RCN3;THBS4;SCAMP5;ERN1;HERPUD1;SELENOK;CEBPB;BAK1;BBC3;QRICH1;ATP2A2;EIF2S1;UFC1;PDIA3;SELENOS;NCK1;UFL1;BCAP31;UFM1;ATF6;ERP44;TMTC3;JUN;ATF4;DERL1;SEL1L;USP19;TMEM33;FLOT1;ATG10;UBXN6
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.40065843814928914,-1.0765816868404263,0.3345724907063197,0.7444620915395043,1.0,2/12,1.98%,GCNT2;BMP7
prerank,peroxisome organization (GO:0007031),0.4499122185971799,1.0761883681750144,0.3763702801461632,0.9087829236436312,1.0,8/25,24.14%,SEC16B;PEX16;PEX12;PEX1;PEX3;ABCD3;PEX2;FIS1
prerank,protein O-linked mannosylation (GO:0035269),-0.361530780335594,-1.076180557725441,0.32894736842105265,0.7433911101926848,1.0,3/18,3.02%,TMTC1;TMTC4;TMTC2
prerank,cell-cell junction maintenance (GO:0045217),0.531052556631029,1.0761413827185844,0.42461964038727523,0.9082359108791807,1.0,4/11,8.24%,CD177;F2R;MYADM;PARD6A
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.3859488213880079,1.0760725509803466,0.3732912723449001,0.9077243941191669,1.0,19/84,19.65%,IGFBP5;EIF2AK3;BIN1;RBM4;PAIP2B;TRIM71;SAMD4B;MRPL13;ORMDL2;IGF2BP1;LARP1;PIN1;CNOT10;RTN3;FXR2;CHRNA7;EPRS1;PAIP2;PCIF1
prerank,negative regulation of JNK cascade (GO:0046329),0.4401805423988789,1.0759896620085951,0.38100686498855835,0.9072682801832397,1.0,9/31,16.19%,TAOK3;DACT1;AIDA;ITCH;SIRPA;HDAC3;NCOR1;PDCD4;PER1
prerank,nucleosome assembly (GO:0006334),0.4433115638674732,1.0759466339612689,0.3727598566308244,0.9066838171070389,1.0,16/31,32.82%,CHAF1B;SPTY2D1;NPM1;ANP32B;UBN1;GRWD1;NAP1L2;BRD2;KAT6B;NAP1L3;ATRX;HIRA;SOX9;IPO4;RSF1;NASP
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.39725333624133785,1.075652082499378,0.36869747899159666,0.9069316740759461,1.0,13/72,16.85%,SYK;AXL;IRAK3;RUNX1;SPATA2;ABCE1;GAS6;CHUK;SPPL2B;IRAK1;MADD;RBCK1;TAX1BP1
prerank,protein localization to kinetochore (GO:0034501),0.5011903082732888,1.0747456554027468,0.40027322404371585,0.90919423168506,1.0,3/14,5.95%,CHAMP1;ZW10;CENPT
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.45283995772836927,1.0738352694513813,0.3654080389768575,0.9116271993637249,1.0,6/22,18.60%,CD44;MAPK7;MYADM;KLF4;FLOT2;MBP
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.4127053390716221,1.0736017040619363,0.3955056179775281,0.9116928851726063,1.0,14/46,25.08%,TIMM50;GDAP1;TIMM10B;TIMM9;AKT1;GRPEL2;TIMM22;TIMM8B;BCAP31;TOMM5;RALA;TIMM17A;FIS1;TOMM40
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.43868485510270344,1.0734049305936735,0.3988235294117647,0.9115816936881953,1.0,10/29,19.53%,MRPS11;ABT1;KRI1;NOP9;RRP36;WDR46;DCAF13;PWP2;TBL3;NOL10
prerank,myeloid cell development (GO:0061515),0.4733148837309955,1.073351280369487,0.3833543505674653,0.9110440027764999,1.0,3/18,6.81%,ANXA2;FOXP1;SRC
prerank,regulation of protein localization to centrosome (GO:1904779),0.5179864933538202,1.0729830491138288,0.40106241699867196,0.9115218145455509,1.0,2/10,8.24%,BICD1;PARD6A
prerank,regulation of DNA replication (GO:0006275),0.4159684420843101,1.0727118642035423,0.3901345291479821,0.9117057105833173,1.0,11/49,14.84%,EGFR;CTC1;GTPBP4;RBBP6;GLI2;FBXO5;EGF;TERF1;DNA2;EHMT2;GMNN
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.43437230104717406,1.0722668535909354,0.3953216374269006,0.9124850994708926,1.0,6/31,12.23%,DBN1;ARHGAP44;PPFIA2;SRCIN1;TANC2;NGEF
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.4854854118222042,1.0721904265674405,0.3828947368421053,0.9120284249779668,1.0,4/15,15.94%,DHX33;TLR4;USP50;NLRP2B
prerank,negative regulation of immune response (GO:0050777),0.3743730453737517,1.072082897739268,0.3532388663967611,0.9116631039383307,1.0,23/154,14.21%,COL3A1;SYK;VIPR2;FYN;IRAK3;MAPK14;ITCH;GLP2R;C1QBP;SRC;RC3H1;ADCYAP1;DPEP1;CRHR1;GPR20;SIRT2;CALCA;GPR45;TSHR;ADCY8;GNB1;LHCGR;FER
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.4072824769863647,1.0719656117555252,0.36069114470842334,0.9113828328418382,1.0,11/55,14.08%,UCP1;TGFBR2;MAPK14;COQ7;ARF4;PID1;DHRS4;SIRT2;EIF6;CDKN1A;ZC3H12A
prerank,positive regulation of response to wounding (GO:1903036),-0.33241310077059294,-1.0718164943892508,0.32386363636363635,0.7532214753277889,1.0,9/24,13.28%,PTN;MYLK;VTN;OCLN;PRKCE;ADRA2A;MDK;CLDN1;PTK2
prerank,regulation of Ras protein signal transduction (GO:0046578),0.38834250815132554,1.0715175560605263,0.3572916666666667,0.9121828433886804,1.0,21/86,16.37%,EPHB2;ARHGEF28;ARHGAP44;AKAP13;PLCE1;TGFB2;RASGRF1;RASGEF1A;MYO9B;FLCN;ARFGAP1;KANK1;SQSTM1;IRS2;SHOC2;DENND1A;ARF6;RAPGEF1;MADD;EPS8L2;OGT
prerank,positive regulation of lamellipodium organization (GO:1902745),0.42690527828788,1.0714768120250338,0.38405797101449274,0.9115956223851605,1.0,7/32,11.21%,PLCE1;AKIRIN1;SRC;FSCN1;ACTR3;PIK3CA;AVIL
prerank,DNA packaging (GO:0006323),0.48885720080683825,1.0709911297967503,0.40053404539385845,0.9125392322197976,1.0,2/16,7.60%,CHAF1B;NOC2L
prerank,electron transport chain (GO:0022900),0.48951207220635196,1.0709463941282658,0.4132985658409387,0.9119814806670733,1.0,6/15,17.75%,ETFA;ENOX2;POR;ETFDH;ETFB;CYB561
prerank,regulation of Golgi organization (GO:1903358),0.47461920527902435,1.0701427842287887,0.37142857142857144,0.9138625667631763,1.0,9/17,27.62%,STX5;MYO5A;MAP2K2;RAB33B;AKAP9;ARMH3;MAPK1;RBSN;PDE4DIP
prerank,regulation of viral life cycle (GO:1903900),0.4593802366027701,1.0699582070181377,0.4074534161490683,0.9137697465434936,1.0,6/21,20.74%,AXL;KPNA2;HS3ST5;TRIM68;PPIA;TYRO3
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.43852043109872435,1.0697592328693046,0.38569753810082064,0.9137194570977416,1.0,10/33,20.86%,SCIN;RAB7B;MAPK14;HOXA5;MAPK11;STAT5B;PITHD1;THPO;ABCB10;ACVR2A
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5221842148032584,1.0696494467796556,0.413391557496361,0.9133205918621066,1.0,4/10,15.90%,ETFA;ACADVL;ETFDH;ETFB
prerank,microtubule polymerization or depolymerization (GO:0031109),0.460575543955162,1.0691651113847436,0.4056372549019608,0.9141964761339677,1.0,8/24,20.38%,FGF13;KIF2A;MAPT;TPPP3;PIN1;MAP7D3;CKAP5;STMN4
prerank,positive regulation of cell aging (GO:0090343),0.5113662193727614,1.069087565373678,0.3940256045519203,0.9137480226319863,1.0,4/11,17.25%,LMNA;CGAS;YPEL3;EEF1E1
prerank,regulation of actin filament depolymerization (GO:0030834),-0.4066351459714478,-1.068620936134834,0.38686131386861317,0.7597575720742047,1.0,2/12,3.28%,PLEKHH2;SEMA5A
prerank,response to axon injury (GO:0048678),0.47601344917925653,1.0685424345215058,0.4018087855297158,0.9149028977509523,1.0,9/18,29.94%,GAP43;FLRT3;MTR;RTN4RL1;SARM1;MORN4;P2RX4;DHFR;MAPK8IP3
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.38387672068644235,-1.068429052264425,0.37065637065637064,0.7580752398278647,1.0,6/14,17.80%,IL34;THBS1;MDK;MAPK3;PTK2;RARRES2
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.39121148185072374,1.0681311265154483,0.3845360824742268,0.915559125414218,1.0,12/88,12.13%,SYK;SMPD3;PRKCA;VEGFA;CDC42EP2;MPP7;GNL3L;VPS4B;PFN2;TIRAP;BMF;BAK1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.43259347271967946,1.067809167810568,0.3924050632911392,0.9159175088078815,1.0,14/30,26.43%,UBE2J2;USP36;HPS4;NPEPPS;HTRA2;VPS11;ARIH2;ATG13;UBE2D3;SAE1;CSNK2A2;LEPROT;FBXW7;RNF31
prerank,diacylglycerol metabolic process (GO:0046339),0.4543038302333065,1.0678010104516775,0.40415140415140416,0.9152410204598223,1.0,6/23,12.97%,PLCE1;ANG;DGKQ;MOGAT1;DAGLA;MOGAT2
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.4048961715704562,1.067742256887573,0.37949836423118866,0.9147145159077038,1.0,19/51,28.61%,HNRNPA1;CTC1;GNL3L;SRC;ACD;CCT7;XRCC5;TERF1;SMG6;TENT4B;TINF2;NEK7;MAPK1;CCT4;EXOSC10;SMG5;STN1;CCT6A;HNRNPC
prerank,aminoglycan catabolic process (GO:0006026),0.44228010616346497,1.0677282487628441,0.3888888888888889,0.914064060440158,1.0,7/28,17.87%,GPC6;GPC3;HSPG2;NAGLU;IDUA;SDC2;OVGP1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.44039258519929597,1.0676150408652032,0.38895558223289317,0.9137157746594499,1.0,13/25,28.94%,SCAF8;EAF2;SETD5;THOC1;EAF1;TCEA2;LDB1;ELL;KAT7;ALYREF;HTATSF1;THOC5;WDR43
prerank,regulation of macroautophagy (GO:0016241),0.3794782210477521,1.067445738644651,0.3831967213114754,0.9135421315312113,1.0,24/105,16.13%,DCN;UCHL1;GNAI3;USP36;ATP6V0A2;MTOR;PRKAB2;HDAC6;CAPN1;GPSM1;PIK3CA;NRBP2;ERN1;AKT1;ATP6V1E1;SESN3;LARP1;SMCR8;RRAGD;ULK1;IL4;ATP6V0A1;ATP6V1D;ATP6V1B2
prerank,positive regulation of cholesterol transport (GO:0032376),-0.3249521862379895,-1.067211531500105,0.36666666666666664,0.7593219412913713,1.0,10/27,16.89%,PLTP;PTCH1;APOE;NR1H3;CAV1;SIRT1;ABCA3;NFKBIA;EEPD1;ABCA5
prerank,heme catabolic process (GO:0042167),-0.38503571452976626,-1.0671892968926777,0.36823104693140796,0.7550114858895289,1.0,2/14,1.57%,ABCG2;SLCO2B1
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.38503571452976626,-1.0671892968926777,0.36823104693140796,0.7550114858895289,1.0,2/14,1.57%,ABCG2;SLCO2B1
prerank,protein targeting to lysosome (GO:0006622),-0.34853367215564923,-1.0671734393237908,0.37073170731707317,0.7528715452293997,1.0,5/20,11.22%,SCARB2;GGA3;RAB7A;SORL1;GCC2
prerank,negative regulation of axon extension (GO:0030517),0.4373184349162127,1.067004203616136,0.3836104513064133,0.9143473318276029,1.0,5/30,12.28%,SEMA3C;PTPRS;TRIM46;SEMA3A;SEMA3D
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.2867385348652263,-1.0669021040403606,0.3140495867768595,0.7515383718038147,1.0,18/42,24.94%,WDR48;SHLD1;ARID2;HELB;MRNIP;KLHL15;RIF1;SMCHD1;PPP4C;FANCB;TIMELESS;MAD2L2;RPA2;RMI2;RAD51;PARPBP;CHEK1;WRAP53
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.4197639598272177,1.066801899160312,0.39491150442477874,0.91428286481233,1.0,13/43,21.72%,CDC14B;INTS3;TAOK3;RINT1;DTL;TAOK2;CDKN1A;ABRAXAS1;NBN;NOP53;BLM;DONSON;CLSPN
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.45372842102975275,1.0666105643902595,0.3872549019607843,0.9141833080990471,1.0,6/22,14.04%,ANK2;PKD2;GSTM2;SLC9A1;CALM2;CASQ1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.384191485689735,1.0664384562453588,0.3832460732984293,0.9140158251950679,1.0,17/87,16.20%,CORO2B;ARHGAP44;LRP1;EFNA5;EPHA3;MTOR;FSCN1;ABL2;PIK3CA;IQGAP1;RHOQ;TWF1;TAOK2;RHOA;PDGFRA;RND3;RAC3
prerank,regulation of cell-cell adhesion (GO:0022407),0.4211427592375358,1.066110969738639,0.39380022962112515,0.9144309444630999,1.0,12/39,16.97%,DPP4;EFNA5;GTPBP4;TENM3;SRC;JAG1;CD47;EPHB3;FUT9;ZDHHC2;MDGA1;FLOT2
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.49656963662288156,1.066085401399147,0.42231075697211157,0.9138153425005336,1.0,7/14,24.22%,CPSF6;ERN1;CPSF4;CPSF2;CSTF2T;CPSF1;CPSF7
prerank,positive regulation of protein binding (GO:0032092),-0.2782333535166253,-1.0657771026375578,0.3253012048192771,0.7526779081095208,1.0,18/56,13.99%,RAPGEF2;VTN;CLDN5;APP;APOE;EPB41;CAV1;B2M;DTX3L;MARK3;NMD3;HIP1R;BMP2;TERT;ABL1;BDNF;TRIM21;HIPK2
prerank,negative regulation of nervous system development (GO:0051961),-0.3531221288988957,-1.0654502655241291,0.31797235023041476,0.751405112662528,1.0,5/17,10.51%,NOTCH1;ROBO2;B2M;APPL2;SORL1
prerank,positive regulation of gene expression (GO:0010628),0.36743075983131684,1.0653210959362711,0.264,0.9155630512807954,1.0,71/442,14.82%,CD34;SFRP4;AR;GSN;EPHB2;AMH;FGF18;SEC16B;NIBAN1;FGF7;C1QTNF1;EGFR;POLR2H;WT1;HPN;TMEM119;PKP3;GLMN;EIF2AK3;ANK2;DGKQ;VEGFA;FGF2;CAMK2N1;MIF;ZPR1;NFE2L2;RBMS3;MAPK14;ADAM19;MTOR;HOXA5;DTNBP1;IL33;TENT4A;PID1;SCAMP5;GAS6;POLR1G;LARP4;VDR;PSEN1;AGO2;TLR4;HNRNPD;RBM22;KAT2B;MAPK11;ERN1;MUSK;NPM1;MITF;DDX21;KRAS;AKT1;SLC2A10;PASK;NAT8;EIF6;EGF;NWD1;RPS27L;BCL3;ZCCHC4;TWIST1;POLDIP3;ZC3H12A;RBM3;KLF4;EIF3E;IL4
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.3379284124019864,-1.0652588677189827,0.3155080213903743,0.7497782336308698,1.0,4/23,4.23%,INSR;IGF1;APP;PRKAA2
prerank,regulation of B cell apoptotic process (GO:0002902),0.5156913219035498,1.0651193432574315,0.40476190476190477,0.9154867592162542,1.0,4/12,12.14%,FOXP1;NOC2L;BCL6;IRS2
prerank,negative regulation of insulin secretion (GO:0046676),0.4637859669812134,1.0650780920733005,0.4033290653008963,0.9149276593479007,1.0,3/17,9.59%,IRS1;MIDN;BMP8A
prerank,secondary alcohol metabolic process (GO:1902652),0.4174866442820416,1.0649584266392669,0.39592760180995473,0.9146375039651312,1.0,12/42,20.99%,IDH1;ABCA1;LCAT;TSKU;GBA2;IL4;PIP4P1;FDX1;ANGPTL3;IDH3G;IDH3B;SOAT1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.40277998337399884,1.0648498489580398,0.3952702702702703,0.9143016590743994,1.0,11/48,15.00%,JSRP1;ANK2;F2R;SRI;CAMK2D;CXCL10;GSTM2;PDE4D;CALM2;CASQ1;DIAPH1
prerank,response to ionizing radiation (GO:0010212),0.3947495418249275,1.0648353721110138,0.4032085561497326,0.9136466069889442,1.0,17/70,18.57%,ANXA1;FANCD2;INTS3;MAPK14;RFWD3;COP1;IKBIP;INIP;RHNO1;RAD1;CDKN1A;ABRAXAS1;INO80;TNKS1BP1;SPIDR;BLM;SMPD1
prerank,immunoglobulin mediated immune response (GO:0016064),0.5337099439391259,1.0646279446249094,0.4190751445086705,0.9136151680573316,1.0,2/10,12.21%,CD81;CD27
prerank,cellular response to amino acid stimulus (GO:0071230),0.4255674997050454,1.0645684377568467,0.39637599093997733,0.9130982466466222,1.0,13/33,22.91%,FYN;CAPN2;MTOR;SESN3;NSMF;RRAGD;CPEB1;IPO5;CASTOR2;SESN2;UBR2;KLHL22;SLC38A9
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.47354462487249116,1.0642758124026488,0.39768339768339767,0.9133335936233902,1.0,5/17,10.71%,AR;ATP1A3;ATP1A1;SRC;URI1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.4038319834189642,1.0640323253812685,0.39514348785871967,0.9127684507727509,1.0,24/51,32.29%,LMNA;REEP3;NUP93;CHMP7;AHCTF1;NUP107;NUP98;SIRT2;NUP37;PPP2R2A;CC2D1B;ANKLE2;IST1;EMD;NUP133;NUP85;NUP188;KPNB1;SUMO1;CHMP4C;SEC13;CHMP4A;CHMP4B;NUP160
prerank,mitotic nuclear membrane organization (GO:0101024),0.4038319834189642,1.0640323253812685,0.39514348785871967,0.9127684507727509,1.0,24/51,32.29%,LMNA;REEP3;NUP93;CHMP7;AHCTF1;NUP107;NUP98;SIRT2;NUP37;PPP2R2A;CC2D1B;ANKLE2;IST1;EMD;NUP133;NUP85;NUP188;KPNB1;SUMO1;CHMP4C;SEC13;CHMP4A;CHMP4B;NUP160
prerank,regulation of cytokine production (GO:0001817),0.38045635338156003,1.0639936240494385,0.35598377281947263,0.912196763725858,1.0,26/126,18.08%,ANXA1;GLMN;NPTN;FOXP1;MIF;HDAC9;MAPK14;SYT11;IL33;SCAMP5;CD47;SIRPA;BCL6;GPNMB;LRRC19;IGF2BP1;ACKR1;TNFRSF1B;MOG;BTN3A3;TRAF3;PER1;IL6;SNAI2;ATP2B1;VTCN1
prerank,protein localization to lysosome (GO:0061462),-0.30820079191263733,-1.063932266402446,0.36363636363636365,0.7512052002224155,1.0,7/28,11.22%,SCARB2;GGA3;RAB7A;MFSD1;LAMTOR5;SORL1;GCC2
prerank,negative regulation of intracellular protein transport (GO:0090317),0.45026972019362144,1.0638649513573168,0.3969465648854962,0.9119055063285548,1.0,9/22,18.62%,RAB23;MDFIC;LMAN1;INPP5K;GDI1;CABP1;CHP1;BAG4;UFM1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3711157487642042,1.06377085206025,0.3420260782347041,0.9115378362517012,1.0,48/248,15.34%,SFRP4;LRP6;COL1A1;DKK2;EGFR;TLE6;CCDC88C;SCEL;GPC3;PSMC4;UBE2B;DACT3;CDK14;AMER3;IGFBP6;WWTR1;SMURF2;RBMS3;KREMEN1;AXIN1;IGFBP4;DACT1;TCF7L2;DAAM2;PSMC6;FZD7;PSMD8;PSEN1;CUL3;GSKIP;TLE2;PLEKHA4;KANK1;TMEM9;CSNK1G1;CSNK1G3;PRDM15;ANKRD6;TPBG;GLI3;JUP;EGF;PIN1;STK3;AMFR;CTNND2;CHD8;FZD4
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.460272419929454,1.0637229827683552,0.40803108808290156,0.9109920228696429,1.0,7/18,23.83%,MAPK7;NFE2L2;AKT1;HTRA2;PPIA;TRAP1;BAG5
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.3945279037062983,1.0635593150422615,0.3876889848812095,0.9108019613119388,1.0,28/72,28.67%,RNASE4;GTF2H3;EDC4;PNRC2;ERCC3;UBA52;RNASE6;ERCC4;FAN1;DDB1;DNA2;ZC3H12A;DNASE1L2;RFC4;RAD50;ERCC5;POLD1;OGG1;ERCC1;EDC3;DNASE1L1;RNASE1;DCP1A;DCP1B;MEI4;DDX1;RFC3;PDE12
prerank,multivesicular body organization (GO:0036257),0.4337157098762666,1.0635587641477628,0.3953488372093023,0.9101108108872846,1.0,10/31,23.94%,CHMP7;VPS4B;MVB12A;VPS37D;VPS37C;VPS37B;VPS36;PDCD6IP;IST1;STAM
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.3305171494277034,-1.063375348877556,0.34782608695652173,0.7506917930886364,1.0,6/27,9.21%,SLC7A2;SLC1A3;SLC7A5;SLC6A9;SLC3A2;SLC38A5
prerank,RNA interference (GO:0016246),0.46690365444314746,1.0628673354104827,0.40711462450592883,0.9116516207808529,1.0,6/17,27.88%,TARBP2;AGO2;AGO4;AGO3;AGO1;CELF1
prerank,cytosolic transport (GO:0016482),0.3809805893641649,1.0625648911134729,0.38809034907597534,0.9118678741698858,1.0,52/108,32.02%,DCTN1;BET1L;RAB6A;STX5;HOOK2;HEATR5A;RAB6B;VPS52;CLTC;SNX1;WDR91;MAGEL2;TBC1D17;GGA1;TBC1D10A;TBC1D23;GOSR1;ARFRP1;TMEM87A;EVI5;PHETA2;CORO7;ANKRD27;AP4M1;PREPL;SNX6;DENND2A;STX16;ANKFY1;VTI1A;BAIAP3;SNX16;RAB29;RNF126;GOSR2;GBF1;RBSN;VAMP3;YKT6;LAPTM5;STX8;PTPN23;RHOBTB3;TBC1D5;SPAG9;RAB9B;PIKFYVE;RAB14;AP2A1;TMEM87B;SNX5;ARL1
prerank,dicarboxylic acid transport (GO:0006835),-0.3212759549885846,-1.0625122174835215,0.35,0.7509558989463755,1.0,6/28,7.62%,SLC1A3;SLC13A3;SLC26A7;PDPN;SLC22A6;GJA1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.4423373782465979,1.0624321721484582,0.4164588528678304,0.9115813557688803,1.0,6/24,11.21%,PLCE1;AKIRIN1;FSCN1;ACTR3;PIK3CA;AVIL
prerank,regulation of protein localization to cell periphery (GO:1904375),0.4740729581306895,1.0623402526591732,0.40516129032258064,0.9111813337194294,1.0,4/18,16.15%,AR;ZDHHC7;ZDHHC2;SPTBN1
prerank,cilium assembly (GO:0060271),0.36522461041060367,1.0622437252525294,0.308,0.9108032190646965,1.0,104/296,27.73%,GSN;NME8;DCTN1;CDC14B;ODF2;ABLIM1;PKD1;RAB23;FHDC1;ARF4;YWHAG;ACTR3;HDAC6;BBS9;SSNA1;ATAT1;ARL13B;TOGARAM1;YWHAE;TMEM138;OCRL;CPLANE1;RSPH1;CNGB1;EHD2;ALMS1;NUDCD3;DZIP1;MAPRE1;TTC39C;HAUS3;AVIL;TEKT5;PIBF1;VANGL2;DYNC2I2;KIF3A;SFI1;RPGR;KIF3B;IFT46;CEP97;TTLL3;BBS4;DNAAF3;HSP90AA1;TUBB4A;TUBA4A;TTC8;DYNC1H1;ATP6V1D;CDK5RAP2;AHI1;DYNC2LI1;CCP110;AKAP9;CEP164;RPGRIP1;DYNC2H1;CEP89;CKAP5;DYNC2I1;CEP83;CCDC28B;RP2;BBS5;PAFAH1B1;BBIP1;IFT52;EXOC4;CC2D2A;SPAG16;FLNA;PCM1;IFT57;DYNLRB1;DNAH5;FBF1;DCTN2;TMEM231;DCX;TCTN2;NEDD1;RAB11FIP3;PDE6D;DYNLL1;CEP78;TCTN1;CDC14A;NEK1;TNPO1;CEP126;RAB1A;CSNK1E;CFAP70;ACTR1A;KIFAP3;CETN2;GBF1;FUZ;IFT81;PTPDC1;RAB8B;E2F4
prerank,actin cytoskeleton reorganization (GO:0031532),0.3918206828816006,1.0620073186453547,0.38835978835978835,0.9108623899622498,1.0,9/63,10.06%,ANTXR1;GSN;FGF7;ANXA1;DTNBP1;FARP2;S1PR2;MCU;EFS
prerank,positive regulation of glucose metabolic process (GO:0010907),0.48805970269188326,1.061924640729727,0.41733333333333333,0.9104403502015197,1.0,5/14,19.54%,IRS1;AKT1;IRS2;DDB1;GPLD1
prerank,mitochondrion morphogenesis (GO:0070584),0.5118193558702681,1.0615469862574483,0.40756302521008403,0.9109709362024199,1.0,6/11,24.98%,WASF1;PID1;MYH14;SUPV3L1;FIS1;MTM1
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.4274810611628434,-1.061254466998506,0.36259541984732824,0.7523289102570891,1.0,2/10,3.31%,ADAM10;WNT5A
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.4563493663787672,1.0610365601414988,0.4116915422885572,0.9119327827252456,1.0,5/20,17.74%,LBP;TLR4;IRAK1;CD14;IL18
prerank,positive regulation of protein transport (GO:0051222),-0.261916832158674,-1.0601578210523346,0.3333333333333333,0.7532866226270959,1.0,11/67,6.02%,BMP6;UNC13B;FRMD4A;IGF1;CD2AP;ATP2C1;MYO18A;CEP290;ABCG1;ACSL3;PRR5L
prerank,regulation of protein export from nucleus (GO:0046825),-0.3276589429745981,-1.0597154037304652,0.36312849162011174,0.7524018753505751,1.0,3/23,1.29%,PTPN14;SP100;RAPGEF3
prerank,fatty acid oxidation (GO:0019395),0.3923303497492969,1.0596269877761122,0.40919037199124725,0.915711900777308,1.0,15/57,22.15%,EHHADH;ALDH3A2;AUH;SCP2;ACADVL;SLC25A17;ACOX1;BDH2;ABCD3;MCAT;HSD17B4;ACAT1;CPT2;PEX2;CROT
prerank,cellular response to tumor necrosis factor (GO:0071356),0.36831065646073047,1.0589082031884238,0.36180904522613067,0.9173246111118055,1.0,27/175,16.06%,TNFSF9;HAS2;CCL8;PSMC4;NFE2L2;ZFP36L1;NR1D1;TNFRSF11B;PSMC6;PID1;ZFP36L2;TNFRSF18;CHUK;PSMD8;TNFSF13B;CCL25;INPP5K;AKT1;PLVAP;CD27;ZFP36;CCL13;TNFRSF1B;ZC3H12A;EDA;BAG4;TRAF3
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.4179737471845331,-1.0587143443605669,0.373134328358209,0.7530253117894615,1.0,1/11,0.50%,LYN
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.38521058577844847,-1.0586178843894223,0.38132295719844356,0.7512232057971371,1.0,9/14,25.88%,TFB1M;MTERF2;FASTKD1;TEFM;PNPT1;POLRMT;TWNK;FASTKD5;TFB2M
prerank,neutrophil degranulation (GO:0043312),0.36424066840569436,1.0583761642886564,0.3,0.9183489071808821,1.0,103/425,21.60%,TIMP2;GSN;CD55;ARSA;B4GALT1;CD44;CD177;ANXA2;RAB6A;ANPEP;ACTR1B;TMBIM1;MIF;S100A8;S100A9;SPTAN1;MAPK14;AP1M1;ACLY;RAP1B;TMEM63A;PTPRJ;TOM1;PLEKHO2;AP2A2;PRCP;RAB37;IDH1;DOK3;TCN1;ATP11A;COPB1;SURF4;CAPN1;ARHGAP9;DYNC1LI1;PSEN1;IQGAP1;ABCA13;SNAP23;ITGAV;CD47;LPCAT1;SIRPA;CSTB;NRAS;RAB3D;SLPI;GLA;JUP;TMEM30A;XRCC5;NIT2;SNAP25;RHOA;CMTM6;TNFRSF1B;NME2;SLC2A3;UBR4;SLC15A4;HSP90AA1;CD14;DIAPH1;ATP6V0A1;DYNC1H1;GAA;ATP6V1D;PKM;CAP1;IGF2R;CANT1;FABP5;CTSD;PPIA;PADI2;ILF2;RAB5B;RAB5C;SLC44A2;CXCR2;COTL1;TMEM179B;PLAUR;VAMP2;PYGB;PRG2;ALDOA;APAF1;RAB24;DDOST;TOLLIP;ITGAM;ACP3;QSOX1;RAB10;PYCARD;COMMD9;MAPK1;ANXA3;ERP44;CAB39;CPNE1
prerank,erythrocyte differentiation (GO:0030218),-0.29013059535278757,-1.0582742823119449,0.3482142857142857,0.7500880896767499,1.0,11/44,13.99%,LYN;KMT2E;KIT;TGFBR3;HSPA9;CASP3;RPS14;INHBA;PTPN2;TAL1;HIPK2
prerank,cellular response to superoxide (GO:0071451),-0.43621092604646505,-1.0581011486512446,0.4185185185185185,0.7484844688496359,1.0,5/10,18.61%,NOS3;PRDX1;SOD1;PRDX2;MT3
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5149202337980089,1.0576717023561077,0.4195323246217332,0.9199301892355847,1.0,6/11,29.44%,CREB3L1;CEBPB;ATF6;ATF4;DDIT3;TP53
prerank,negative regulation of establishment of protein localization (GO:1904950),0.5132635640228469,1.0571982776018176,0.4019746121297602,0.9208255001135836,1.0,4/10,13.43%,CORO2B;MAPT;NDFIP1;TERF1
prerank,positive regulation of biosynthetic process (GO:0009891),0.41735039031616517,1.0570958802630253,0.3988505747126437,0.9204568282653345,1.0,8/40,11.30%,TGFB3;F2R;RUNX1;MTOR;CREB3L1;MLXIPL;TLR4;AKT1
prerank,protein methylation (GO:0006479),0.40885700189077184,1.0570379288105638,0.40540540540540543,0.9199415620531798,1.0,14/40,26.53%,RAB6A;PRMT2;NTMT1;EHMT2;GSPT1;SNRPD3;EEF2KMT;N6AMT1;ICMT;NSD1;CARM1;EZH2;CAMKMT;EEF1AKMT3
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5179614952031502,1.0569945856486183,0.4050632911392405,0.9180297208433873,1.0,7/11,30.74%,SLC25A16;PANK1;PANK3;DCAKD;ACAT1;ACOT7;PANK2
prerank,coenzyme A biosynthetic process (GO:0015937),0.5179614952031502,1.0569945856486183,0.4050632911392405,0.9180297208433873,1.0,7/11,30.74%,SLC25A16;PANK1;PANK3;DCAKD;ACAT1;ACOT7;PANK2
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5179614952031502,1.0569945856486183,0.4050632911392405,0.9180297208433873,1.0,7/11,30.74%,SLC25A16;PANK1;PANK3;DCAKD;ACAT1;ACOT7;PANK2
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.47803051033959953,1.056836405684948,0.40960809102402024,0.917848271451545,1.0,4/16,18.92%,EME1;RMI1;ERCC4;TOP2B
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.4713521013257371,1.0567822153220154,0.43224932249322495,0.9173368861434882,1.0,6/15,20.35%,TRIAP1;GPX1;AKT1;GHITM;HGF;PRELID1
prerank,regulation of viral entry into host cell (GO:0046596),0.42471786421288527,1.056678345031226,0.40617577197149646,0.9169974101935677,1.0,6/30,15.77%,GSN;MID2;LGALS1;TRIM11;HS3ST5;TRIM68
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.48784811744318696,1.0566161862113954,0.4177545691906005,0.91648814985436,1.0,9/15,32.61%,ACTR3;MAGEL2;ARPC5L;ARPC1A;ARPC2;ARPC4;ARPC5;WHAMM;TRIM27
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.41913313009116204,-1.0563439600705313,0.3741721854304636,0.7512203386844907,1.0,3/10,4.66%,NEDD4L;OSR1;PRKCE
prerank,regulation of cardiac conduction (GO:1903779),-0.2773918518506543,-1.0563062041361106,0.3523809523809524,0.7492226499821998,1.0,12/54,12.11%,ATP1A2;ITPR1;ATP1B3;AHCYL1;SLC8A3;ABCC9;ITPR3;NPR1;FXYD1;RYR2;NOS1;ATP2A3
prerank,regulation of organelle assembly (GO:1902115),0.3812305827033036,1.0559214983578011,0.40064102564102566,0.9180064197560168,1.0,26/72,24.97%,GSN;CEP295NL;ATXN2;TBC1D2B;TBC1D17;ALMS1;NPM1;TBC1D10A;ATXN2L;EVI5;DYNC2LI1;SENP6;TBC1D13;RAB1B;VPS11;ADPRH;TBC1D22B;TBC1D15;TBC1D19;ATG3;PDCD6IP;CYLD;TRAPPC12;TBC1D12;STAM;CDKL1
prerank,dorsal/ventral pattern formation (GO:0009953),0.4617581277341942,1.0557638767751794,0.4085750315258512,0.9178292826255742,1.0,4/20,7.49%,LMX1B;ACVR1;AIDA;GLI2
prerank,negative regulation of cell death (GO:0060548),0.3811307587146367,1.055695875265321,0.38189386056191466,0.9173538003811412,1.0,16/88,17.33%,CD34;FYN;KIR3DL2;SRSF6;CCN5;PDE8A;FGF2;VPS4B;TIGAR;AKT1;GPNMB;CD200R1;TNFRSF1B;NCK1;HTRA2;SRGAP2
prerank,positive regulation of catabolic process (GO:0009896),0.3912929765548084,1.055671248793867,0.38835978835978835,0.9167417543809583,1.0,15/65,16.88%,GPC3;STX5;SMURF2;AXIN1;DACT1;ITCH;FOXO1;SEC22B;EGLN2;DTL;HECW2;DDB1;NSF;HACE1;IDE
prerank,neutrophil mediated immunity (GO:0002446),0.3631229579184305,1.0556033517595091,0.308,0.9162815070175409,1.0,105/432,21.60%,TIMP2;GSN;CD55;ARSA;B4GALT1;CD44;CD177;ANXA2;RAB6A;ANPEP;ACTR1B;TMBIM1;MIF;S100A8;S100A9;SPTAN1;MAPK14;AP1M1;ACLY;RAP1B;TMEM63A;PTPRJ;TOM1;PLEKHO2;AP2A2;PRCP;RAB37;IDH1;DOK3;TCN1;ATP11A;COPB1;SURF4;CAPN1;ARHGAP9;DYNC1LI1;PSEN1;IQGAP1;ABCA13;SNAP23;ITGAV;CD47;LPCAT1;SIRPA;CSTB;IRAK4;NRAS;RAB3D;SLPI;GLA;JUP;TMEM30A;XRCC5;NIT2;SNAP25;RHOA;CMTM6;TNFRSF1B;NME2;SLC2A3;UBR4;SLC15A4;HSP90AA1;CD14;DIAPH1;ATP6V0A1;DYNC1H1;GAA;ATP6V1D;PKM;CAP1;IL6;IGF2R;CANT1;FABP5;CTSD;PPIA;PADI2;ILF2;RAB5B;RAB5C;SLC44A2;CXCR2;COTL1;TMEM179B;PLAUR;VAMP2;PYGB;PRG2;ALDOA;APAF1;RAB24;DDOST;TOLLIP;ITGAM;ACP3;QSOX1;RAB10;PYCARD;COMMD9;MAPK1;ANXA3;ERP44;CAB39;CPNE1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5267580969882304,1.0551666357421805,0.4422535211267606,0.9170252581707518,1.0,4/10,15.83%,GRB10;PID1;INPP5K;SELENOS
prerank,mitochondrial fission (GO:0000266),0.47315409406740105,1.0547636538137484,0.4028497409326425,0.9176294954355587,1.0,4/16,16.42%,DNM1;GDAP1;SLC25A46;MTFR1L
prerank,negative regulation of vascular permeability (GO:0043116),0.5067532378731836,1.0545793283081941,0.4171195652173913,0.9175621991598125,1.0,3/12,5.35%,VEGFA;SLIT2;PTPRJ
prerank,mitochondrial protein processing (GO:0034982),-0.41314447367069596,-1.0545347570927797,0.3956043956043956,0.7521016034265435,1.0,4/11,17.55%,IMMP2L;ATP23;YME1L1;STOML2
prerank,nervous system development (GO:0007399),0.3618429928998611,1.0544972171563414,0.331,0.9171279025909596,1.0,99/429,19.88%,GSN;EPHB2;NAV2;AXL;NAV1;DCLK1;WNT2;SCIN;EFNA5;NUMBL;MBNL1;PMP22;DCTN1;NEUROD2;VEGFA;FGF13;FGF2;MST1R;GLIS2;APBA1;DLG4;WWTR1;DPF2;LPAR1;PKD1;ACAN;SOX10;DACT1;NAB1;VCAN;TRIM71;MARCKS;ALDH3A2;JRKL;DPF1;TRAK2;MTF1;FARP1;ADAM22;TBX6;SCRG1;PKD2;TPP1;SOX8;SH3GL1;DAGLA;SIAH1;MYLIP;JAG1;GDA;PCDHA1;LSAMP;DSCAM;L1CAM;IRF2BPL;AVIL;GBA2;RBFOX2;IGF2BP1;FLRT3;LGI1;KLK6;MTR;MOBP;GDNF;GJB1;ASIC2;HDAC4;NDUFV2;ARTN;MOG;CNTFR;TMOD2;POU3F2;SH3GL3;DAGLB;ALDH5A1;NR2C2;CDK5RAP2;AHI1;NAGLU;PRPS1;SPG7;CXCR4;BTD;CNTN4;EPHB1;GPM6A;TGFBR1;GMFB;SMPD1;MBP;NAV3;SNTG2;APAF1;COX7B;NBL1;SCD5;WDR62
prerank,Rap protein signal transduction (GO:0032486),-0.41307127627886264,-1.0531973666189254,0.3758169934640523,0.7539066882656607,1.0,2/10,1.29%,RAPGEF2;RAPGEF3
prerank,telomere maintenance (GO:0000723),0.39907748959901723,1.053068092329386,0.4057017543859649,0.9210746068738561,1.0,23/50,28.52%,PARP3;XRCC3;CTC1;ACD;SMC5;ERCC4;XRCC5;TERF1;DNA2;SMC6;NBN;RAD50;BLM;POLD1;TINF2;TEP1;TERF2IP;NSMCE2;LTO1;RAD51D;PRKDC;STN1;XRCC6
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.3760067844078388,-1.0530562400387566,0.3722943722943723,0.7522801676662518,1.0,9/16,23.57%,SHLD1;HELB;KLHL15;RIF1;SMCHD1;FANCB;MAD2L2;RMI2;PARPBP
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.503373956558512,1.052826771149895,0.43691899070385126,0.9211443414416071,1.0,4/13,10.36%,CHST1;NAGK;OGA;LARGE1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.5241162388971052,1.0523942829564377,0.4250720461095101,0.9218833395488875,1.0,6/10,28.16%,C1QBP;SEC14L1;TSPAN6;UFD1;RIOK3;NPLOC4
prerank,positive regulation of protein sumoylation (GO:0033235),0.5184000614948241,1.0522328459857344,0.41452991452991456,0.9217399410079985,1.0,5/10,26.47%,PIAS3;UBA2;HDAC4;SAE1;MUL1
prerank,positive regulation of kinase activity (GO:0033674),0.37765884923846377,1.052213769517816,0.4051020408163265,0.921111249229879,1.0,26/107,14.52%,DDR2;EPHB2;AXL;EGFR;FGFR1;CAMKK1;EPHA3;MST1R;MAP2K3;MAPRE3;RASSF2;RET;ADCYAP1;GAS6;TIGAR;IQGAP1;EPHB3;MUSK;MAPT;EPHA10;XRCC5;FLT3;CDKN1A;PDGFRA;NBN;DDR1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.42516380118146974,1.05212198254572,0.4141656662665066,0.9207214020663693,1.0,17/31,32.25%,DIS3L2;LSM4;EDC4;EXOSC7;POLR2G;EXOSC1;LSM7;EDC3;DCP1A;DCP1B;LSM5;HBS1L;LSM1;PATL1;EXOSC3;CNOT8;LSM6
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.49150774023326005,1.052090375425293,0.4348958333333333,0.9201330596609025,1.0,6/15,22.68%,HECW2;CDC23;CDC27;CENPE;RIOK2;TPR
prerank,positive regulation of protein metabolic process (GO:0051247),0.37683763246896074,1.0520596786601282,0.40454076367389064,0.9195613278581068,1.0,25/110,17.74%,CD80;GPC3;MAPK7;STX5;SMURF2;AXIN1;DACT1;KLF2;ITCH;FOXO1;SEC22B;EGLN2;PSEN1;DTL;PAEP;HECW2;AKT1;DDB1;KLF4;NSF;HACE1;IDE;CHRNA7;RAB1B;IL18
prerank,calcium ion import (GO:0070509),-0.3074824824031575,-1.051334709714479,0.3691275167785235,0.7550899800972718,1.0,6/28,12.50%,CACNA1E;CACNB2;CACNA1D;MICU2;TRPC4;TRPV4
prerank,glycoprotein catabolic process (GO:0006516),0.4707625022406081,1.0508747726235963,0.4247448979591837,0.922575584081069,1.0,5/17,8.70%,EDEM1;OGA;FBXO2;EDEM2;FBXO17
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.41723654504593155,1.0507980818498435,0.4186046511627907,0.9221386499672123,1.0,8/33,17.83%,AREG;BTC;DOK1;AKT1;EGF;CBL;ARAP1;PLAUR
prerank,negative regulation of biosynthetic process (GO:0009890),-0.36162599740003554,-1.0504341649212927,0.37037037037037035,0.755496718353556,1.0,8/16,28.21%,SLC30A10;PPARA;CEACAM1;GPER1;CIITA;SLC18A2;PARK7;ASXL3
prerank,oligosaccharide biosynthetic process (GO:0009312),0.45303149071842574,1.0503810189288183,0.42663378545006164,0.9227447611251666,1.0,5/20,11.72%,ST3GAL2;B4GALT1;FUT2;FUT9;ST3GAL4
prerank,modulation by symbiont of host process (GO:0044003),-0.42852214527868426,-1.0502970993897358,0.36330935251798563,0.7539224427066086,1.0,4/10,18.90%,B2M;ENO1;PGK1;MRC1
prerank,phospholipid metabolic process (GO:0006644),0.3839937820273468,1.0502924242052545,0.4088514225500527,0.9223532928003239,1.0,16/71,20.46%,SMPD3;PLPP3;PLPP1;LCAT;AGPAT3;LPCAT1;PLPPR3;AGPAT5;FADS1;PLA2G4E;PIP4P1;PLPP2;GPAM;SMPD1;ANGPTL3;PIP4K2B
prerank,neuromuscular process (GO:0050905),0.47780595130080444,1.0501072650410763,0.43444730077120824,0.9223103070065165,1.0,3/16,7.88%,DCTN1;MYCBP2;TPP1
prerank,response to organonitrogen compound (GO:0010243),0.41301378303548675,1.0496465066534884,0.4106334841628959,0.9230845072192768,1.0,5/38,6.12%,IRAK3;SYVN1;MTOR;MEAK7;RCN3
prerank,regulation of cellular response to heat (GO:1900034),0.3825733323330105,1.0496094754802632,0.4143763213530655,0.922523513114941,1.0,26/77,26.14%,CD34;NUP93;MTOR;CAMK2D;DNAJC2;NUP107;YWHAE;NUP98;MAPT;HSP90AA1;HSBP1;CHORDC1;NUP37;BAG4;FKBP4;NUP50;MAPK1;DNAJB1;BAG3;TPR;CRYAB;BAG5;NUP133;NUP85;HSPH1;NUP188
prerank,negative regulation of organelle assembly (GO:1902116),0.41677132654815263,1.0491795453362858,0.3971631205673759,0.9232039447697482,1.0,12/35,19.74%,SMAD4;SEC22B;KAT2B;SCFD1;SMCR8;CEP97;NUPR1;CDK5RAP2;EVI5L;CCP110;ODF2L;MDM1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.4036061188602901,1.0490658312852472,0.4197952218430034,0.9228924772832232,1.0,16/44,27.88%,ZFP36L1;RC3H1;ZFP36L2;AGO2;ZC3HAV1;PUM1;ZFP36;POLR2G;ZC3H12A;YTHDF1;YTHDF2;YTHDF3;TNRC6A;RBM24;UPF1;CELF1
prerank,Wnt signaling pathway (GO:0016055),0.38163638464753924,1.0488810381133247,0.40644490644490644,0.922822262067837,1.0,10/92,5.14%,SFRP4;LRP6;WNT10B;WNT2;CCDC88C;WNT9A;PLPP3;AXIN1;ZRANB1;TCF7L2
prerank,positive regulation of secretion by cell (GO:1903532),-0.2551280198938346,-1.0488203375015734,0.3,0.7560688992044455,1.0,12/70,6.56%,BMP6;UNC13B;FRMD4A;IGF1;CD2AP;SLC12A2;SNCA;MYO18A;KCNB1;STXBP5;ABCG1;RGCC
prerank,positive regulation of macroautophagy (GO:0016239),0.3980765424653638,1.0484290915709051,0.41318681318681316,0.9236663622936239,1.0,16/48,22.99%,DCN;GNAI3;GPSM1;SLC25A4;SESN3;LARP1;SMCR8;IL4;VDAC1;PIP4K2C;LRSAM1;VPS13D;PIP4K2B;SESN2;BAG3;MAP3K7
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.31073519481884176,-1.0483927746999253,0.35195530726256985,0.7553146926379726,1.0,11/26,16.04%,CNOT2;STRN3;PIAS2;CNOT9;HEYL;CRY1;SFRP1;SIRT1;KANK2;VPS18;DAB2
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.41592318320948646,1.048119899418031,0.43309859154929575,0.9238574054936924,1.0,12/34,25.16%,MYOC;S100A10;MYADM;C1QBP;TRIOBP;LIMS2;RAC3;ILK;FLNA;DMTN;CALR;RAC1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.4105518276037344,-1.0479506565585974,0.3693379790940767,0.7545092371192311,1.0,9/11,46.84%,PRKCQ;MALT1;NFKBID;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.3209073943352134,-1.0479252688970073,0.3817204301075269,0.7525745504116761,1.0,11/25,28.95%,IGF1;NIBAN2;TGFB1;SOX11;MAD2L2;HEY1;TRIM6;HEY2;RB1;PARK7;SIN3A
prerank,positive regulation of mRNA processing (GO:0050685),0.45200659358198425,1.04787849263575,0.41333333333333333,0.9239999740704309,1.0,12/21,34.07%,NUP98;RBM3;SF3B4;PAF1;THRAP3;DAZAP1;CELF3;RBMX;CELF4;CIRBP;NCBP2;NCL
prerank,peptidyl-serine modification (GO:0018209),0.3702554204310525,1.0475573071407187,0.4056508577194753,0.924337099539387,1.0,29/166,14.06%,PRKCA;MAPK12;EIF2AK3;RPS6KA2;DYRK4;DGKQ;SGK3;SGK2;TGFBR2;GALNT16;MAPK14;PKD1;MTOR;CAMK2D;NTMT1;MAST4;GAS6;PRKD2;CHUK;AKT3;DYRK2;CSNK1G1;CSNK1G3;GALNT1;AKT1;STK39;ULK2;ULK1;HIPK4
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3733742400807071,1.0472572468373533,0.3977389516957862,0.9245590822089561,1.0,17/110,14.19%,ADGRD1;GNAS;LPAR3;GPR12;LPAR1;CXCL10;S1PR2;ABCA1;ADCYAP1;ADGRG2;CRHR1;CALCA;GPR161;TSHR;ADCY8;GNB1;LHCGR
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.41762059005403734,1.0472123614310909,0.41839080459770117,0.9240063528628375,1.0,4/39,5.35%,AREG;EGFR;BTC;PTPRJ
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.3703852210653752,1.0471158756724597,0.4107327141382869,0.9236523019886729,1.0,21/113,12.37%,AREG;FGF7;PRKCA;EGFR;HPN;ANG;ITGB3;SRSF6;VEGFA;FGF2;ECM1;TCF7L2;THBS4;PRKD2;STAT5A;FZD7;AKT3;EMC10;NRAS;AKT1;EGF
prerank,cellular response to interferon-gamma (GO:0071346),0.37946260875512894,1.0469593333108163,0.41993637327677624,0.9234661300070113,1.0,11/88,12.90%,MID1;CCL8;IRF4;CD44;CAMK2D;CCL25;TLR4;CD47;SIRPA;SLC26A6;CCL13
prerank,calcium ion transport (GO:0006816),-0.24736804363433693,-1.0469510506023072,0.4444444444444444,0.7532809225480955,1.0,25/113,14.13%,ITPR1;TRPM3;SLC24A3;TRPM6;CALCRL;NALCN;CACNA1E;ATP2C1;SLC8A3;RAMP1;CACNB2;CACNA1D;TRPC5;CAV1;SLC3A2;TRPC6;TRPC4;ORAI2;CACNG8;RYR2;ATP2A3;TRPV4;SLC24A5;TRPC7;TRPC3
prerank,maturation of SSU-rRNA (GO:0030490),0.41795121409126806,1.0469163749920343,0.4135514018691589,0.9229259878420628,1.0,18/34,32.25%,MRPS11;RIOK1;RRP36;WDR46;SNU13;DCAF13;DDX52;PWP2;SRFBP1;NOL10;RIOK2;TSR3;RIOK3;TSR1;NAT10;RPS28;NOL11;LSM6
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.49198654955521615,1.0468010420513745,0.4340878828229028,0.9226221502714651,1.0,5/13,17.16%,EPHB2;SQSTM1;ADCY8;ZDHHC2;CHRNA7
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.4702165498159737,1.046513194483288,0.4246575342465753,0.9228232723014091,1.0,3/17,10.94%,CD160;PTPRJ;UBASH3A
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.39089778564405603,1.0463731994418364,0.41675503711558853,0.9225847298823707,1.0,18/70,21.35%,SYK;FYN;WIPF1;PIK3R2;MYO10;SRC;ACTR3;ABI1;PIK3CA;MYH2;HSP90AA1;ACTG1;ARPC1A;NCK1;ARPC2;PLD2;MAPK1;YES1
prerank,regulation of response to cytokine stimulus (GO:0060759),0.4586610239154416,1.0461347629492768,0.4183417085427136,0.9226511973950278,1.0,4/19,14.32%,MAPK7;RUNX1;IRAK1;KLF4
prerank,regulation of cell aging (GO:0090342),0.5135467840601214,1.045233039811648,0.4465753424657534,0.9248845261629278,1.0,4/11,17.49%,MIF;LMNA;RSL1D1;NEK4
prerank,neural crest cell differentiation (GO:0014033),0.4779742027577703,1.045160668279536,0.44562334217506633,0.9244250974727698,1.0,4/18,16.59%,LRP6;SOX8;NOLC1;SNAI2
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.5171833486954075,1.0451018079473209,0.42178770949720673,0.9239572070618186,1.0,2/10,3.66%,NPTN;DLG4
prerank,cellular response to alkaloid (GO:0071312),-0.35213318148735206,-1.0450866158197563,0.35864978902953587,0.7562598865924536,1.0,8/17,22.37%,TGM2;CASP3;CASP7;RYR2;CASP6;HTR1B;CASQ2;RAD51
prerank,chromatin assembly or disassembly (GO:0006333),0.5106813797474355,1.045024986020999,0.45152722443559096,0.9235152504662592,1.0,2/11,7.60%,CHAF1B;NOC2L
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.5238560385799846,1.0448248396775552,0.45147679324894513,0.923460922295343,1.0,7/10,27.95%,SIRT2;NCK1;DNAJB1;JUN;BAG3;VHL;IMPACT
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.39021652877566604,1.0446997311383268,0.42127659574468085,0.9231894987184577,1.0,18/71,21.35%,SYK;FYN;WIPF1;PIK3R2;MYO10;SRC;ACTR3;ABI1;PIK3CA;MYH2;HSP90AA1;ACTG1;ARPC1A;NCK1;ARPC2;PLD2;MAPK1;YES1
prerank,cellular response to inorganic substance (GO:0071241),0.4488316674145278,1.044607453321395,0.4278668310727497,0.9227889568778019,1.0,8/21,22.08%,FOXO1;DPEP1;MTR;DDX11;KCNC2;SPIDR;BLM;NSMCE3
prerank,response to X-ray (GO:0010165),0.48888046511836797,1.0443436060253213,0.4458161865569273,0.9229584268052382,1.0,5/14,18.94%,ANXA1;IKBIP;XRCC5;BLM;NIPBL
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.4081621610145837,-1.0442109023794308,0.3939393939393939,0.7565667526820177,1.0,2/10,9.38%,MLLT3;SFRP1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.42353961167466403,1.0430550526433147,0.4148936170212766,0.926418060676872,1.0,7/27,16.59%,EGFR;AGO2;PUM1;ZFP36;MAP2K2;IL6;DDX5
prerank,gene silencing by miRNA (GO:0035195),0.4147493828453195,1.042421239065541,0.42707117852975496,0.9277987379668262,1.0,10/32,19.45%,TARBP2;RBM4;TRIM71;AGO2;PUM1;EIF6;ZFP36;AGO4;SNIP1;AGO3
prerank,positive regulation of cell differentiation (GO:0045597),0.3631255329240935,1.0422739285255012,0.396,0.9276166115941273,1.0,25/237,6.02%,CD34;MEDAG;DDR2;CDON;AR;COL1A1;LOXL2;TMEM100;TGFB3;FGFR1;MAPK12;TMEM119;NEUROD2;TGFB2;TGFBR2;SMAD4;WWTR1;MAPK14;ACVR1;ZFP36L1;RBM4;MTOR;HOXA5;AKIRIN1;BEND6
prerank,fatty acid catabolic process (GO:0009062),0.38024640537663673,1.0420895559670635,0.4128342245989305,0.9275344950663903,1.0,19/67,22.15%,EHHADH;CEL;NUDT7;ALDH3A2;AUH;SCP2;ACADVL;SLC25A17;ACOX1;BDH2;NUDT19;ABCD3;MCAT;LPIN3;HSD17B4;ACAT1;CPT2;PEX2;CROT
prerank,regulation of B cell proliferation (GO:0030888),0.4052661035825401,1.041726468163402,0.42482915717539865,0.9279550592363449,1.0,9/44,14.82%,EPHB2;MIF;CLCF1;RC3H1;CD81;TIRAP;TNFSF13B;IRS2;IL4
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.36472708335877496,1.0416558243745173,0.4124748490945674,0.9275029575740424,1.0,59/184,26.73%,DCTN1;CDC14B;PSMC4;ODF2;PKD1;ZFP36L1;ZW10;PSMC6;YWHAG;SSNA1;ZFP36L2;YWHAE;PSMD8;CUL3;SIRT2;ALMS1;HECW2;CDC23;MAPRE1;HAUS3;ANAPC5;FBXO5;ERCC3;UBA52;SFI1;DDB1;CDC27;INO80;HSP90AA1;TUBB4A;TUBA4A;DYNC1H1;CDK5RAP2;TFAP4;CCP110;CDC26;AKAP9;CEP164;PPP1R9B;ANAPC4;CKAP5;CENPE;PAFAH1B1;RIOK2;ANAPC10;PCM1;DCTN2;ANAPC15;NEDD1;PSMD3;DYNLL1;CEP78;PSMD4;CDC14A;CSNK1E;PSMB3;ANAPC2;ACTR1A;CETN2
prerank,cellular response to organonitrogen compound (GO:0071417),0.3754246459826603,1.0406758276532992,0.43550051599587203,0.9298328599898492,1.0,25/99,19.26%,IGFBP5;WT1;CAPN2;SLIT2;P2RX3;ZFP36L1;RAP1B;MTOR;PKD2;INPP5K;HCN4;SSH1;SLC26A6;TSHR;JUP;LARP1;NSMF;RRAGD;RAPGEF1;DIAPH1;CPEB1;AKAP9;IPO5;HCN1;GABRG2
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.45862271020340845,1.0406150173224258,0.42661691542288555,0.9293508474178245,1.0,4/18,11.36%,EIF2AK3;MAF1;DHX33;UBTF
prerank,serine family amino acid metabolic process (GO:0009069),0.4717156285815162,1.0405078594348776,0.43733333333333335,0.9290057531314798,1.0,1/16,0.79%,GCLC
prerank,signal transduction by p53 class mediator (GO:0072331),0.41915499743822493,1.0404858517510331,0.4369158878504673,0.9284062574360794,1.0,9/30,21.94%,TRIAP1;USP10;MDM4;BCL3;FHIT;NBN;DDX5;PYCARD;SESN2
prerank,protein stabilization (GO:0050821),0.361522120062184,1.0403843727246775,0.4064711830131446,0.9280366538083311,1.0,55/168,26.47%,WNT10B;SAXO1;UBE2B;ANK2;PLPP3;USP36;OTUD3;GTPBP4;SYVN1;RASSF2;MDM4;PFN2;HPS4;USP33;STX12;CCT7;CDKN1A;PIN1;P3H1;IFT46;CCNH;STK3;HSP90AA1;USP7;CHP1;NOP53;BAG4;FLOT2;NAPG;NAA15;TBRG1;RPL23;FLNA;PTEN;USP13;SEL1L;BAG3;USP19;FLOT1;CRYAB;TNIP2;RABL3;PER3;CCT4;BAG5;DVL1;RTN4;TRIM44;CRTAP;CALR;VHL;AFM;FBXW7;STXBP4;MUL1
prerank,negative regulation of neuron death (GO:1901215),0.3723561669080425,1.0397802704069434,0.4281282316442606,0.9292127980550708,1.0,22/93,22.18%,CD34;TGFB3;SIX4;KIR3DL2;F2R;CLCF1;NFATC4;NRBP2;AKT1;GPNMB;GDNF;CD200R1;SIX1;TNFRSF1B;HTRA2;SET;SNX6;RASA1;TYRO3;KDM2B;CSF1;ATF4
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.4604566132738219,1.0396694650953349,0.441591784338896,0.9288812640278633,1.0,7/18,19.86%,LLGL1;RAP1B;KANK1;KIF20B;BCAS3;SHTN1;ARFGEF1
prerank,chromatin remodeling (GO:0006338),0.3750514402224314,1.0396288588523717,0.43634496919917864,0.9283452074578651,1.0,44/100,30.39%,ESR1;SMARCD2;SMARCD1;ZBTB1;KAT2B;KDM5C;POLE3;SATB2;NPM1;ACTR5;SMARCC2;KDM5B;DR1;HDAC4;EZH1;GATAD1;INO80;SMARCA4;CHD8;SRCAP;BAHD1;NUDT5;BAZ2B;CHD3;TAF6L;BAZ2A;KDM4C;BAZ1A;MBD2;INO80C;ARID1A;JARID2;CHRAC1;KDM4B;ARID1B;HNRNPC;TADA2A;PBRM1;ZBTB7A;ATRX;SOX9;MBD3;HCFC2;HCFC1
prerank,cGMP biosynthetic process (GO:0006182),-0.4164649006497368,-1.0395716679361326,0.36824324324324326,0.7672841608455439,1.0,4/10,21.82%,GUCY1B1;NPR1;GUCY1A1;GUCY2C
prerank,negative regulation of protein transport (GO:0051224),-0.33323042839422645,-1.0391543656151725,0.37209302325581395,0.7662845292747943,1.0,8/25,12.23%,APOE;WWP2;SNX3;HMGCR;RHBDF2;NDFIP2;PKDCC;PPM1F
prerank,positive regulation of organelle assembly (GO:1902117),0.39714304449425564,1.0390986132214928,0.4279379157427938,0.9293449058271674,1.0,19/44,27.27%,GPSM2;SAXO1;FSCN1;IL5;BBS4;DYNC1H1;CCP110;PIP4K2C;LRSAM1;ENTR1;PIP4K2B;NUMA1;CROCC;PDCD6IP;CCDC88A;SDCBP;G3BP1;SDC4;FUZ
prerank,membrane depolarization (GO:0051899),-0.30725035482035257,-1.038912328034253,0.4,0.7649403905617012,1.0,13/32,27.15%,CACNA1E;YWHAH;SCN3A;CAV1;CACNG4;ABL1;CACNB3;SCN7A;SCN3B;CHRNA4;CACNA1B;CACNB4;SCN5A
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.49299388799338023,1.0388882121272367,0.4483695652173913,0.929297529315719,1.0,2/13,7.57%,AXL;GAS6
prerank,calcium ion import across plasma membrane (GO:0098703),0.4832469655562367,1.0388630414776068,0.4332892998678996,0.9287208578616674,1.0,6/14,26.25%,TRPV3;ATP2B4;SLC8A2;CACNA2D1;TRPV2;SLC24A2
prerank,regulation of cell motility (GO:2000145),0.3640904037299127,1.0387253620404215,0.41109969167523125,0.9285151595684884,1.0,22/121,13.56%,DUOX1;FGF18;FGF7;EGFR;BTC;FGF2;SGK3;LMNA;MEAK7;NTN1;ABL2;SLK;INPP5F;SRCIN1;KIF2A;PLXNA3;AKT1;CCDC25;EGF;PIN1;RHOA;TWIST1
prerank,cellular response to cadmium ion (GO:0071276),0.43553877676426583,1.0384919111834845,0.449438202247191,0.9286002819730144,1.0,8/24,29.96%,EGFR;CHUK;AKT1;MAPK1;JUN;SUMO1;FOS;HSF1
prerank,membrane repolarization during action potential (GO:0086011),0.4833221201909643,1.0381113543081044,0.4377564979480164,0.9291259371684845,1.0,3/13,8.26%,ATP1A1;KCNJ2;YWHAE
prerank,positive regulation of transport (GO:0051050),0.377486998855275,1.037681068989491,0.4195223260643821,0.9297907343029095,1.0,21/85,20.96%,SCIN;ANXA1;LRP1;GPC3;ANXA2;SGK2;GAS6;INPP5K;CD47;SIRPA;BAK1;CALY;CHP1;DYNC1H1;SMPD1;CAPN10;CLIP3;GPLD1;KMT2A;NUMA1;PYCARD
prerank,regulation of histone deacetylation (GO:0031063),0.48169368013316105,1.0375985451087382,0.44951590594744123,0.9293824063518199,1.0,5/13,21.50%,CAMK2D;AKAP8;NIPBL;CTBP1;AKAP8L
prerank,tRNA processing (GO:0008033),0.38561318675974837,1.0374601025311936,0.4182015167930661,0.9291632058684774,1.0,20/61,24.60%,ANKRD16;TSEN54;TRMT6;RPP21;RTRAF;TRMT61A;FTSJ1;CPSF4;TRMT10B;TRMT1;DTWD1;TRPT1;QTRT1;TYW5;PTCD1;TRUB1;METTL1;RPP30;CPSF1;WDR4
prerank,negative regulation of protein metabolic process (GO:0051248),0.40190323549741963,1.0368756284414902,0.4469026548672566,0.9302769681886517,1.0,20/48,29.02%,EGFR;ITGB3;IRAK3;MDM4;SIRT2;ITGAV;PIN1;FLOT2;PFDN6;IAPP;FLNA;FMN2;AZIN2;LDLR;CRYAB;VBP1;PFDN2;PRKCG;NFKB1;PRNP
prerank,response to interferon-alpha (GO:0035455),0.47132305304919697,1.0365612773112687,0.4318471337579618,0.93053364319509,1.0,2/16,7.57%,AXL;GAS6
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.461581068147763,1.0365071990301327,0.42820838627700125,0.9300401122320918,1.0,9/19,28.82%,USP36;HDAC6;CAMKK2;VDAC1;HTRA2;SREBF1;CSNK2A2;FBXW7;SREBF2
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.33843540185280496,-1.0364204855610017,0.3967391304347826,0.7697472838349051,1.0,10/22,31.71%,WNT5A;SLC7A5;LACC1;SPHK2;NOD2;TRIM6;BTK;CCR2;TNFRSF14;LILRB1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.49532147004565824,1.0362158866832578,0.44382801664355065,0.9303144323153416,1.0,4/13,16.59%,CD44;MIF;TWIST1;SNAI2
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.4200260398208308,1.0358154828954609,0.43080625752105894,0.9308948712324765,1.0,7/29,17.52%,GTF2H3;RAD23B;ERCC3;UBA52;DDB1;CCNH;ERCC5
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.45302543238477944,1.0355230213908382,0.43781725888324874,0.9311366797145431,1.0,4/20,6.84%,VEGFA;SMAD4;NFE2L2;SMAD5
prerank,negative regulation of cell population proliferation (GO:0008285),0.3615009084350515,1.0352586792037843,0.407,0.9312774914773307,1.0,42/351,10.14%,NOX4;SFRP4;MN1;IGFBP5;AR;SCIN;TGFB3;WT1;HPN;DIS3L2;GLMN;FAP;RPS6KA2;ADARB1;ANG;OGN;WNT9A;TNS2;TGFB2;CAMK2N1;F2R;IGFBP6;LMNA;TNN;ATF5;SKI;GTPBP4;PTPRJ;ZBTB7C;MDM4;PLPP1;FLCN;PKD2;ABI1;NDRG4;CYP27B1;VDR;SIRT2;KAT2B;ING4;SMAD6;BRD7
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.4189479488979951,-1.035106043064676,0.4204946996466431,0.7711906135158861,1.0,5/10,31.71%,CEACAM1;ARRB2;PTPRC;FCGR2B;LILRB1
prerank,embryonic digestive tract development (GO:0048566),0.4548857202643283,1.0350247509503636,0.43302990897269183,0.9313715757723404,1.0,6/18,18.94%,PCSK5;TGFB2;GLI2;GLI3;PDGFRA;NIPBL
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.41242651366133665,1.0348392530483146,0.4535840188014101,0.93131509942795,1.0,6/35,16.30%,GHR;F2R;IL10RA;EGF;BCL3;IL6
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.486343360293844,1.0347138537293146,0.4406548431105048,0.9310339030708852,1.0,4/13,23.03%,SLC4A10;SLC8A2;SHISA6;GRIK2
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.44432178836337227,1.034690326853528,0.44402985074626866,0.9304437942228059,1.0,5/21,6.28%,TGFB3;SMAD4;WWTR1;NUP93;SH2B1
prerank,regulation of mast cell degranulation (GO:0043304),0.4803974338822271,1.0346360365736147,0.4572192513368984,0.9299589108595303,1.0,1/14,0.24%,SYK
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.4472764308774866,1.0346313613041702,0.4552238805970149,0.9293233409953796,1.0,3/22,7.92%,AHNAK;SRI;CRHR1
prerank,regulation of cell cycle (GO:0051726),0.3595422204903303,1.0339609834602246,0.4248496993987976,0.9306979974688537,1.0,65/271,19.03%,LRP6;MAPK12;FAP;GADD45G;CDC14B;RPS6KA2;ADARB1;CKS1B;TGFB2;CAMK2N1;TRNP1;MIF;BIN1;PKD1;CDK4;JUND;TCF7L2;TTC28;RASSF1;TARDBP;INHA;MLXIPL;GAS2L1;PKD2;MYBL2;DTL;CDK9;SIRT2;IQGAP1;BEX2;KAT2B;ING4;ERN1;SON;KIF20B;PUM1;MAGI2;FBXO5;LIN9;PCLAF;CDKN1A;FBXL3;CCND1;PLAGL1;CDC123;NBN;UHRF2;GMNN;NUPR1;NOP53;NUDT6;MADD;NLRP2B;PDCD4;HTRA2;E4F1;TFAP4;PML;CDC26;PPP1R9B;TBRG1;TGFBR1;PRCC;SKP2;NEK7
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.3238630599299709,-1.033936277561103,0.3723404255319149,0.770280168696445,1.0,4/23,3.17%,TFDP2;BCL2;PPP1R13B;YWHAH
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.3238630599299709,-1.033936277561103,0.3723404255319149,0.770280168696445,1.0,4/23,3.17%,TFDP2;BCL2;PPP1R13B;YWHAH
prerank,neuron projection morphogenesis (GO:0048812),0.3658081662245737,1.0337996502677833,0.43016194331983804,0.9305428232840703,1.0,50/137,26.08%,DBN1;EPHB2;DCLK1;MAP1B;LLGL1;DLG4;TNN;TAOK3;TRIO;DOCK7;DTNBP1;FARP1;S100A6;IQGAP1;EPHB3;KIF20B;FLRT3;TAOK2;MAP6;DCC;CTNND2;SLC9A6;DIP2A;ANKRD27;SDC2;SRGAP2;SHTN1;CNTN4;EPHB1;GPM6A;NBL1;GAS7;SLITRK4;RAB10;PTEN;MAP1A;ABITRAM;CPNE1;CTTN;SPTBN4;MAP1S;CNTNAP1;NTNG2;ALS2;DVL1;LRP2;PAX2;ATL1;NRCAM;SLITRK5
prerank,double-strand break repair (GO:0006302),0.36181453677325287,1.0336377269912267,0.4186746987951807,0.9304116810459349,1.0,40/158,19.59%,PARP3;REV3L;XRCC3;EME1;SFR1;RAD51B;RFWD3;KPNA2;TENT4A;CYREN;UBE2N;PPP5C;HELQ;AP5S1;SAMHD1;POLB;SMC5;ACTR5;RMI1;ERCC4;FAN1;XRCC5;ABRAXAS1;SEM1;DNA2;BRIP1;SMC6;NBN;INO80;TNKS1BP1;IFFO1;RECQL;SPIDR;RNF138;RAD50;ERCC5;BLM;MORF4L1;DCLRE1A;SMARCAL1
prerank,neuron projection development (GO:0031175),0.3616335048838086,1.0335693343134738,0.4148296593186373,0.9299856342544979,1.0,46/168,18.29%,DBN1;MYOC;EPHB2;DCLK1;ZPR1;DLG4;TAOK3;RASGRF1;UNC5A;TRIO;DOCK7;DTNBP1;LRP12;ADCYAP1;TOR1A;TSKU;EPHB3;PLP1;L1CAM;CAMSAP1;MAPT;KIF20B;TBC1D23;FLRT3;LGI1;TAOK2;GDNF;ULK1;ATCAY;BLOC1S2;CTNND2;MANF;MAP4;SLC9A6;SNAPIN;IL6;DIP2A;ANKRD27;RAB35;SRGAP2;PPP1R9B;SHTN1;STX3;CNTN4;EPHB1;GPM6A
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.47204927730613044,1.0332308881861247,0.4507978723404255,0.9297049908948651,1.0,5/15,21.22%,DTNBP1;AP3D1;BLOC1S2;SNAPIN;AP3B2
prerank,anterograde synaptic vesicle transport (GO:0048490),0.47204927730613044,1.0332308881861247,0.4507978723404255,0.9297049908948651,1.0,5/15,21.22%,DTNBP1;AP3D1;BLOC1S2;SNAPIN;AP3B2
prerank,protein localization to chromatin (GO:0071168),0.4559836060311015,1.0332115506616644,0.4543147208121827,0.9291168145772446,1.0,2/18,5.04%,ESR1;CHMP7
prerank,midbody abscission (GO:0061952),0.4651689535385101,1.0327253439542672,0.45490716180371354,0.9299655188644309,1.0,2/17,5.32%,CHMP7;VPS4B
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3839881138664089,1.0325790684300218,0.43193997856377275,0.9297628318870544,1.0,10/56,10.09%,TGFB3;LDLRAD4;TGFB2;PMEPA1;SMAD4;ACVR1;BMP15;INHA;BMP8A;SMAD6
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.3144314873263936,-1.0325544071495398,0.3764705882352941,0.7721721607844577,1.0,4/28,3.74%,ITPR1;BCL2;DAB2IP;CASP4
prerank,P-body assembly (GO:0033962),0.4895028216979769,1.0324915584220662,0.43956043956043955,0.9293891271255741,1.0,4/12,15.34%,RC3H1;LSM4;ATXN2;DYNC1H1
prerank,mitochondrial translational elongation (GO:0070125),0.3703009523444889,1.032204308916017,0.4318181818181818,0.9296093274251571,1.0,19/88,15.58%,MRPS11;MRPL38;MRPS18B;CHCHD1;MRPL13;MRPS17;AURKAIP1;MRPS27;MRPL30;MRPL10;GFM1;DAP3;MRPL55;MRPS10;MRPL36;MRPL3;MRPL21;MRPS34;MRPL51
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.4736533240408937,1.03211103578988,0.452,0.9292213759636606,1.0,3/13,17.26%,STX1A;SCAMP5;SYT1
prerank,regulation of cation channel activity (GO:2001257),0.373345930039379,1.0320417117756078,0.43536711478800416,0.9287745068545623,1.0,20/89,19.71%,AHNAK;JSRP1;ANK2;CNIH3;FGF13;DLG4;CAMK2D;DLG2;NEFL;CAPN1;GRIA2;CACNG2;PDE4D;CALM2;CACNB1;FGF14;GRIN2A;VAMP2;SELENON;GRIA3
prerank,metanephric mesenchyme development (GO:0072075),0.5054254056905871,1.031863437800793,0.4508990318118949,0.9286638308038125,1.0,4/10,13.71%,WT1;SIX4;PKD2;SIX1
prerank,metal ion transport (GO:0030001),-0.24774701493941792,-1.0312411270504829,0.36585365853658536,0.7738020378950465,1.0,20/86,12.56%,ITPR1;CALCRL;SLC41A1;CACNA1E;ATP2C1;SLC8A3;RAMP1;SLC39A8;CACNA1D;TRPC5;CAV1;SLC3A2;SLC30A1;TRPC4;CACNG8;RYR2;NDFIP2;ATP2A3;TRPV4;NIPA2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.37720186092244473,1.0312275105771072,0.4492146596858639,0.9298960068611184,1.0,13/72,14.13%,DCN;MYOC;FGFR1;FGF2;TGFB2;F2R;SRC;PIK3CA;IRS2;EGF;FLT3;CBL;PDGFRA
prerank,regulation of centrosome duplication (GO:0010824),0.4196964494496781,1.0310612575481757,0.4408352668213457,0.9297004231583297,1.0,5/29,10.70%,XRCC3;CEP295NL;VPS4B;ALMS1;NPM1
prerank,negative regulation of MAPK cascade (GO:0043409),0.37574033084918107,1.030874639312718,0.44479166666666664,0.9296493012531855,1.0,21/87,18.57%,EPHB2;UCHL1;IRAK3;CAMK2N1;SMAD4;PIK3R2;PTPRJ;FOXO1;FLCN;TLR4;INPP5K;SIRPA;PRDM15;PPEF2;TNIP1;PIN1;PPIA;QARS1;SYNJ2BP;STK38;SMPD1
prerank,peptidyl-serine phosphorylation (GO:0018105),0.36522676539651555,1.0306226669410479,0.4647887323943662,0.9297753327154439,1.0,27/153,14.06%,PRKCA;MAPK12;EIF2AK3;RPS6KA2;DYRK4;DGKQ;SGK3;SGK2;TGFBR2;MAPK14;PKD1;MTOR;CAMK2D;MAST4;GAS6;PRKD2;CHUK;AKT3;ERN1;DYRK2;CSNK1G1;CSNK1G3;AKT1;STK39;ULK2;ULK1;HIPK4
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.4801026444375608,1.030419464633716,0.4516971279373368,0.9297605636641006,1.0,4/15,10.36%,CHST1;NAGK;OGA;LARGE1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.3840976385668509,1.0303689723604945,0.44195953141640043,0.9292556478090838,1.0,18/73,21.35%,SYK;FYN;WIPF1;PIK3R2;MYO10;SRC;ACTR3;ABI1;PIK3CA;MYH2;HSP90AA1;ACTG1;ARPC1A;NCK1;ARPC2;PLD2;MAPK1;YES1
prerank,positive regulation of cell growth (GO:0030307),0.3690667446686359,1.0300392389910384,0.44190871369294604,0.9295678111040161,1.0,27/96,22.86%,DBN1;EGFR;HPN;SYT2;TGFB2;CDKN2AIP;S100A8;S100A9;DDX49;NTN1;ISLR2;L1CAM;AKT1;MAPT;LGI1;INO80;GOLGA4;SYT1;SHTN1;TGFBR1;SUPV3L1;RIMS2;N6AMT1;SLC25A33;SMURF1;SDCBP;KLHL22
prerank,cardiac atrium morphogenesis (GO:0003209),-0.355922766979126,-1.0300156218025398,0.3709677419354839,0.7750415608990554,1.0,4/16,10.58%,ENG;NOTCH1;BMPR2;BMP2
prerank,B cell receptor signaling pathway (GO:0050853),0.4141517936736542,1.0295605091235038,0.44188722669735325,0.9303509012260767,1.0,2/32,3.34%,SYK;RFTN1
prerank,regulation of cellular localization (GO:0060341),0.3918539942475321,1.0295541317069776,0.4444444444444444,0.929724505438094,1.0,14/46,20.64%,GSN;EFNA5;CAMK2D;NR1D1;TRIM46;PARD6A;GOSR1;FER;HSP90AA1;DYNC1H1;REEP5;TTL;TRIM67;NUMA1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.38463915565067064,-1.0293423464152238,0.39245283018867927,0.7747952042832156,1.0,3/13,10.58%,BMP5;APOE;BMP2
prerank,axon guidance (GO:0007411),0.35659316301619326,1.0292014007946806,0.4288577154308617,0.93014767420947,1.0,44/201,14.33%,SEMA3C;EPHB2;PRKCA;EFNA5;NPTN;GRB10;EPHA3;FYN;MAPK7;GAP43;VEGFA;SLIT3;SLIT2;NTN4;SLIT1;SPTAN1;DOK1;UNC5A;SPTA1;NFIB;PDLIM7;RET;SRC;NTN1;GLI2;SEMA3A;PIK3CA;SIAH1;PLXNA3;DOK4;USP33;EPHB3;DSCAM;UNC5D;L1CAM;EPHA10;IRS2;SEMA3D;LGI1;IGSF9;GDNF;PALLD;ARTN;DCC
prerank,negative regulation of cell differentiation (GO:0045596),0.35934926721840543,1.0292003197976614,0.4274193548387097,0.9295095535190148,1.0,39/181,18.56%,COL5A2;COL5A1;WNT10B;EGFR;HPN;LDLRAD4;ITGB3;WNT9A;HDAC7;TNN;WWTR1;SKI;TRIO;HOPX;MEIS2;FOXO1;ABCA1;ZFPM2;ZFP36L2;CHADL;SOX8;JAG1;SIRT2;ITGAV;SMAD6;TSKU;VASN;ANP32B;TWIST1;HOXA9;PDCD4;IL6;NBR1;SNAI2;EFEMP1;YTHDF2;CNTN4;TGFBR1;SDHAF2
prerank,transferrin transport (GO:0033572),0.4114554501376335,1.028627715306905,0.4494252873563218,0.9306139359894358,1.0,9/33,16.13%,STEAP3;ATP6V0A2;CLTC;ATP6V1E1;ATP6AP1;REP15;ATP6V0A1;ATP6V1D;ATP6V1B2
prerank,neural crest cell development (GO:0014032),0.402045532306583,1.0281502925989374,0.4377104377104377,0.9313220045413113,1.0,8/44,13.74%,SEMA3C;RADIL;SOX10;SOX8;SEMA3A;SEMA3D;GDNF;NOLC1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.35030641802994755,1.0279218058279551,0.374,0.9313844952787934,1.0,158/834,16.38%,LMX1A;DCN;LIF;AR;LRP6;ESR1;NFIX;IRF4;WNT2;EGFR;TGFB3;WT1;MEOX2;TRIAP1;HSF2;ELF4;MAPK7;ZMIZ1;VEGFA;FGF2;TGFB2;PBX1;GLIS2;RUNX1;CRTC2;SMAD4;NFE2L2;PIK3R2;ATF5;WWTR1;DPF2;LMX1B;AKNA;MEF2D;SKI;PKD1;COPS5;ACVR1;FOXK2;KLF2;JUND;MAFF;TCF7L2;NR1D2;NFATC1;HOXA5;SMARCD2;MEIS2;FOXO1;IL33;AKIRIN1;NR1D1;NFIB;RTRAF;CXCL10;NCOA3;MUC1;SSBP3;NFIA;RNF111;ZFHX3;DPF1;MEPCE;ARF4;MLXIPL;SMAD5;ACTR3;MTF1;PID1;SMARCD1;ADCYAP1;GLI2;ZFPM2;FLCN;PRKD2;PKD2;CD81;SOX8;CHUK;VDR;MYBL2;FOXC2;AGO2;JAG1;CDK9;SIRT2;TLR4;BEX1;ONECUT1;KAT2B;MED24;ATAD2B;RHOQ;RNF10;SATB2;HELZ2;SQSTM1;HDAC3;NPM1;MZF1;TCERG1;MITF;PRDM15;IRF2BPL;CSRNP3;TOX2;SLC30A9;MICAL2;CEBPB;GLI3;DCAF6;ZNF462;TNIP1;SLC9A1;AKIRIN2;UBA52;KANSL3;JUP;CCNC;DR1;GDNF;ATF1;DDX17;PEG3;PIN1;MED13;TWIST1;SIX1;HDAC4;RFX5;PLAGL1;NME2;ZC3H12A;EAF2;KLF4;HOXA7;BCL9;PTOV1;HOXC4;INO80;BCAS3;PPP3CA;POU3F2;IL4;SMARCA4;GTF2F1;CHD8;MLXIP;NR2C2;E2F3;AHI1;UBP1;PER1;IL6;HGF;NCK1;OGT;STAT5B
prerank,somite development (GO:0061053),0.4979914762023081,1.0274316726075858,0.47748976807639837,0.9321545369981117,1.0,1/11,1.62%,MEOX2
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.3910890394568368,1.0268044103973564,0.44493392070484583,0.933408974029186,1.0,9/51,10.15%,MYOC;TGFB3;S100A10;SORBS3;LPAR1;PFN2;ARHGEF10L;ARHGEF10;CD47
prerank,membrane fusion (GO:0061025),0.418950246441861,1.0268019452922186,0.45047169811320753,0.9327759149075151,1.0,11/33,20.24%,DNM1;STX11;USO1;SNAP23;NAPA;CHP1;NSF;HACE1;NAPG;VAMP2;VPS33B
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.4635829721277076,1.0266642536935122,0.44692005242463956,0.9325478278934151,1.0,4/15,14.82%,ADAM9;MAPK14;EHD2;IL4
prerank,spermatid development (GO:0007286),0.41352916576128324,1.0264224503947568,0.4508670520231214,0.932657240436436,1.0,5/32,14.65%,TOPAZ1;DPY19L2;RSPH1;BBS4;CDYL
prerank,positive regulation of programmed cell death (GO:0043068),0.3523738890272441,1.0261415523763953,0.43029087261785354,0.9328397536552495,1.0,75/272,24.04%,SFRP4;SYK;WNT10B;KCNMA1;SCIN;TGFB3;AKAP13;GADD45G;RPS6KA2;SLIT2;BIN1;TRIO;ADAMTSL4;MTCH1;HOXA5;FOXO1;PRMT2;RASSF2;C1QBP;ARHGEF3;HDAC6;PIP5KL1;AIFM2;FLCN;SIAH1;PSEN1;PDCD2;RYBP;ING4;TIAM2;SQSTM1;CSRNP3;BCL6;BMF;ERCC3;UBA52;BAK1;NGEF;QRICH1;DIABLO;STK3;MLLT11;MTCH2;CALHM2;DDX20;HRK;NLRP2B;IL6;SOS1;HTRA2;TFAP4;SAP18;CTSD;EEF1E1;IAPP;SMPD1;SUDS3;APAF1;CLIP3;GPLD1;TRIM35;ATF6;TIAM1;PYCARD;JUN;NF1;ATF4;CYP1B1;UBE2Z;RBM5;HTATIP2;VAV2;RRP1B;TFPT;LATS1
prerank,negative regulation of cellular process (GO:0048523),0.35316741228954973,1.025978150069354,0.4,0.9326859586162903,1.0,98/521,17.33%,NOX4;CD34;SFRP4;AR;EPHB2;CD9;SCIN;TGFB3;WT1;DIS3L2;GLMN;DCBLD2;FHL1;EIF2AK3;RPS6KA2;TMEM98;ADARB1;DACT3;SRSF6;CCN5;PDE8A;WNT9A;FGF2;TNS2;TGFB2;SLIT3;SLIT2;CAMK2N1;F2R;IGFBP6;CDKN2AIP;MIF;SMAD4;LMNA;ATF5;SKI;SYT11;GNG4;HOPX;GTPBP4;DACT2;PSRC1;MIA3;VPS4B;PTPRJ;ZBTB7C;INHA;MDM4;PLPP1;TGFBI;ADAM22;FLCN;PKD2;ABI1;CYP27B1;VDR;SIRT2;PLXNA3;KAT2B;ING4;SMAD6;BRD7;SIRPA;DSCAM;NPM1;BCL6;MAGI2;GPNMB;FBXO5;DNAJB2;ANP32B;ADAM15;SPOCD1;CDKN1A;P3H1;TMEM127;PDE3B;TNFRSF1B;DNAJA3;NACC2;DDX4;ORC6;KLF4;GMNN;SMARCA4;NUPR1;NUDT6;NLRP2B;PDCD4;IL6;NCK1;HTRA2;CD164;TFAP4;PML;NME1;EEF1E1;SRGAP2
prerank,carbohydrate biosynthetic process (GO:0016051),0.43815390464734366,1.0258740116962106,0.4663402692778458,0.9323694484613181,1.0,5/21,11.72%,ST3GAL2;B4GALT1;FUT2;FUT9;ST3GAL4
prerank,positive regulation of intracellular protein transport (GO:0090316),0.3618313283978463,1.0257624838083967,0.450050454086781,0.9320580240194578,1.0,54/144,26.43%,SEC16B;FYN;ZPR1;PIK3R2;UBE2J2;USP36;TCF7L2;MIEF2;YWHAG;GAS6;CD81;YWHAE;HPS4;B3GAT3;PSEN1;RBM22;HDAC3;PPP3CC;KIF20B;JUP;TMEM30A;ANP32B;SFN;NPEPPS;BBC3;ZDHHC2;ZC3H12A;DMAP1;BCAS3;CHP1;HTRA2;IPO5;VPS11;ARIH2;VAMP2;ATG13;ITGAM;UBE2D3;FLNA;SAE1;PCM1;ICE1;YWHAB;BAG3;TPR;CSNK2A2;LEPROT;EMD;FIS1;MTCL1;RAB29;FBXW7;OAZ1;RNF31
prerank,B cell activation (GO:0042113),0.3779887973062384,1.0254776738271865,0.4523305084745763,0.9323188106520713,1.0,10/68,14.82%,EPHB2;LAX1;HDAC9;CLCF1;PTPRJ;BANK1;FLT3;CR2;HDAC4;IL4
prerank,negative regulation of interleukin-17 production (GO:0032700),0.501151249737972,1.0254210791758052,0.45582047685834504,0.9318353010704309,1.0,5/10,36.35%,TLR4;DDIT3;PRNP;NCKAP1L;VSIR
prerank,polarized epithelial cell differentiation (GO:0030859),0.47550513667618344,1.0253786653061603,0.45698924731182794,0.9313173041204831,1.0,4/13,20.69%,ZDHHC7;MYO9A;RHOA;RAB10
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.46455590920500467,1.025250537457602,0.4332892998678996,0.9310684216301768,1.0,8/15,25.55%,REEP3;LNPK;RTN3;RAB10;TMEM33;RAB18;RTN4;ATL1
prerank,mesoderm formation (GO:0001707),0.46581813349108636,1.0249088407591682,0.4470284237726098,0.9314444082337131,1.0,2/17,4.49%,ITGB3;ITGA2
prerank,hexose transmembrane transport (GO:0008645),0.444928385077199,1.024895018546741,0.4636251541307028,0.9308668507722783,1.0,5/21,18.05%,SLC5A9;SLC50A1;SLC2A10;SLC2A3;SLC45A1
prerank,skeletal muscle tissue development (GO:0007519),0.4096093098086769,1.0246930647003376,0.46217494089834515,0.9308502662743696,1.0,7/32,19.01%,SIX4;SKI;SVIL;MYH14;SIX1;KLHL41;SELENON
prerank,protein maturation (GO:0051604),0.3657557361435848,1.0244903963682386,0.4556701030927835,0.9308337043865467,1.0,26/95,21.66%,PCSK6;TSPAN17;PCSK5;LIPT2;ADAMTS3;ADAM19;PCSK4;STUB1;PSEN1;ECE1;NDUFAB1;XPNPEP3;EEF1AKMT4-ECE2;ECE2;DNAJB11;TASP1;CIAO2B;OGT;NAA15;MMP16;METAP2;NAA50;PCSK7;BACE1;CCS;CPZ
prerank,regulation of kinase activity (GO:0043549),0.3718854096843285,1.0244323469510506,0.45265348595213317,0.9303634191373478,1.0,19/89,14.52%,DDR2;EPHB2;AXL;EGFR;FGFR1;PLCE1;EPHA3;MST1R;RET;EPHB3;MUSK;CAMKK2;MAPT;EPHA10;IRS2;FLT3;PDGFRA;NBN;DDR1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.3794637030003559,1.0242619176713714,0.46203208556149733,0.930240287192813,1.0,14/57,20.96%,DCN;MIEF2;MCU;CAMKK2;BMF;BAK1;BBC3;MLLT11;HRK;HTRA2;PLAUR;DDHD1;RALA;PYCARD
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.36827817159216175,1.0241055683520113,0.4584199584199584,0.9300579609515203,1.0,14/88,13.60%,IGFBP5;EIF2AK3;CAMK2N1;RBM4;PAIP2B;TRIM71;SAMD4B;HDAC6;MRPL13;CSTB;AKT1;IGF2BP1;LARP1;CNOT10
prerank,translational termination (GO:0006415),0.36753451144392,1.0239214236722611,0.4436401240951396,0.9299846386300387,1.0,21/95,15.58%,MRPS11;MRPL38;MRPS18B;ABCE1;CHCHD1;MRPL13;MRPS17;AURKAIP1;MRPS27;GSPT2;MRPL30;MRPL10;DAP3;MRPL55;MRPS10;MRPL36;MRPL3;GSPT1;MRPL21;MRPS34;MRPL51
prerank,neuron projection extension (GO:1990138),-0.2967570267239581,-1.0231965174503697,0.3945578231292517,0.7897340794146889,1.0,4/32,3.28%,ALCAM;AUTS2;NRP2;SEMA5A
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.41836278032933766,1.0231347346947748,0.45195729537366547,0.931724761009627,1.0,11/29,24.56%,ESR1;RUNX1;AXIN1;UFL1;VPS11;GPAM;UFM1;KCTD6;CARM1;LATS1;UFSP2
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.49708072708734763,1.0229775458667136,0.4740532959326788,0.9315569376625372,1.0,2/11,7.57%,AXL;GAS6
prerank,organelle disassembly (GO:1903008),0.41284514629226343,1.0229262833950221,0.45066991473812423,0.931076235929074,1.0,10/33,21.05%,STX5;KLC1;ATG2B;ULK2;ATG2A;ULK1;UFC1;UFL1;UFM1;MTIF2
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.39830414211579107,-1.0225396155985176,0.4349315068493151,0.7895335750965845,1.0,3/11,6.08%,NEDD4L;ACTN2;CAV1
prerank,negative regulation of mRNA processing (GO:0050686),0.46363290755644443,1.0224850237143193,0.4717741935483871,0.9317471882702488,1.0,5/15,19.98%,SRSF6;C1QBP;SAP18;U2AF2;PTBP1
prerank,negative regulation of cellular component movement (GO:0051271),-0.36181137915576084,-1.0224463008757412,0.4044943820224719,0.7877282280559886,1.0,5/15,10.93%,SP100;FRMD5;TGFBR3;CCDC125;ACTN1
prerank,regulation of pH (GO:0006885),0.4910686282075114,1.0223012445554873,0.45179063360881544,0.9316821663922157,1.0,4/11,15.88%,ATP1A4;SLC9A1;ATP6AP1;SLC9A7
prerank,protein prenylation (GO:0018342),0.511331091229756,1.0221820742396068,0.4802342606149341,0.93138681865858,1.0,6/10,33.60%,RABGGTA;RCE1;RABGGTB;CHML;CHM;FNTB
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.491730414706117,1.0220464002323832,0.45403111739745405,0.9311587831664466,1.0,4/12,11.75%,WT1;JAG1;IQGAP1;MAGI2
prerank,inorganic anion transport (GO:0015698),-0.2655918590146987,-1.0218623634608768,0.41025641025641024,0.7872591072244166,1.0,13/53,17.09%,SLC13A4;SLC26A7;ENPP1;ANO1;ENPP3;CLIC5;SLC5A5;SLC25A11;FXYD1;CLCN2;PACC1;ANO8;CLCN1
prerank,regulation of cell population proliferation (GO:0042127),0.35015621991640056,1.0217444988024114,0.397,0.9313873273073572,1.0,115/691,14.32%,NOX4;SFRP4;LIF;AREG;AR;HAS2;AVPR1A;FGF18;FGF7;DPP4;WNT2;EGFR;SCIN;TGFB3;WT1;IRS1;FGFR1;DIS3L2;GLMN;CTF1;RPS6KA2;ADARB1;BTC;SIX4;VEGFA;WNT9A;FGF2;TNS2;SGK3;SGK2;TGFB2;MST1R;CAMK2N1;F2R;TGFBR2;TRNP1;IGFBP6;RUNX1;TIPIN;LMNA;ELN;ATF5;WWTR1;SKI;ZFP36L1;CDK4;GTPBP4;JUND;CLCF1;TCF7L2;TRIM71;PTPRJ;MEIS2;GLP2R;MEAK7;ZBTB7C;CXCL10;INHA;MDM4;MLXIPL;S1PR2;PLPP1;MELTF;ESM1;TBX6;PKD2;FLT3LG;DNAJA2;ABI1;CD81;STAT5A;CAPN1;WDR77;CYP27B1;VDR;CUL3;JAG1;SIRT2;STX4;KAT2B;ING4;ITGAV;SMAD6;BRD7;CD47;NPM1;BCL6;KRAS;AKT1;RBFOX2;KIF20B;MAGI2;GPNMB;FBXO5;TSHR;UBE2A;DNAJB2;JUP;IRS2;EGF;XRCC5;GDNF;FLT3;CDKN1A;P3H1;RHOA;TMEM127;SIX1;DNAJA3;NACC2;HDAC4;CDC123;PDGFRA;FER;KLF4
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.4431057734766044,1.0216076274711985,0.47029702970297027,0.9311720468927954,1.0,2/19,4.64%,DBN1;FBXW8
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.35904814445752903,1.0214569467275498,0.4674022066198596,0.9309721147693091,1.0,49/166,20.68%,NIBAN1;EGFR;IRS1;CTC1;FGF2;SMOC2;KLF2;MTOR;NR1D1;MLXIPL;GLI2;PRKD2;PKD2;LARP4;EPM2AIP1;TLR4;HNRNPD;DYRK2;NPM1;AKT1;ELOVL5;PASK;IRS2;DUOXA1;EIF6;EGF;RPS27L;BCL3;DDB1;ZCCHC4;DNA2;POLDIP3;RBM3;KLF4;HSP90AA1;EIF3E;GIPC1;CHP1;IL6;HGF;EIF3D;FXR2;YTHDF1;SREBF1;GPLD1;PCIF1;DDAH2;ABCB10;OPN3
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.4543249348092766,1.0213355308308611,0.45466666666666666,0.9306854391889763,1.0,3/17,6.37%,CD55;PRKCA;CARD16
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.42556648530388336,1.0209827375840719,0.46562123039806996,0.9311000173517827,1.0,10/26,19.35%,FGFR1;MAPK7;RET;EYA2;AKT1;GDNF;PPP2R1B;SNAI2;HTRA2;MCL1
prerank,negative regulation of growth (GO:0045926),0.365792438405221,1.0208782780640275,0.46754563894523327,0.9307888145097499,1.0,19/121,13.16%,WT1;DCBLD2;FHL1;DACT3;TGFB2;SLIT3;SLIT2;CDKN2AIP;SMAD4;GNG4;PSRC1;PTPRJ;FLCN;CYP27B1;ING4;BCL6;DNAJB2;ADAM15;CDKN1A
prerank,regulation of striated muscle contraction (GO:0006942),-0.31583493407830565,-1.0207093648229695,0.43902439024390244,0.788378407724053,1.0,3/27,3.48%,ATP1A2;DMD;SLC8A3
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.3794850267388319,-1.020311283258654,0.3726937269372694,0.7874592619213729,1.0,3/13,5.36%,ENPP1;ENTPD1;ENPP3
prerank,regulation of myoblast fusion (GO:1901739),0.48111274159745954,1.0203065618693803,0.4489247311827957,0.9318432727814449,1.0,4/11,22.92%,MAPK14;EHD2;IL4;FLOT1
prerank,cellular response to insulin stimulus (GO:0032869),0.3595329960758606,1.019848469314104,0.45491388044579534,0.932571379783584,1.0,38/124,20.86%,IRS1;GRB10;HDAC9;PIK3R2;ATP6V0A2;ZFP36L1;SLC39A14;ZDHHC7;FOXO1;MYO5A;INSIG2;FOXC2;SYAP1;KAT2B;INPP5K;RHOQ;AKT1;ATP6V1E1;IRS2;ATP6AP1;PDE3B;FER;ATP6V0A1;ATP6V1D;PKM;SELENOS;ATP6V1B2;SOS1;IDE;CPEB1;EPRS1;VAMP2;CAPN10;GPLD1;LPIN3;GOT1;RAB10;FOXO4
prerank,phospholipid transport (GO:0015914),0.3894381256114618,1.019714310651187,0.46349557522123896,0.9322982853856652,1.0,11/52,12.70%,ATP8B1;TRIAP1;ATP9A;OSBPL2;ABCA1;PRELID3A;ATP11A;SCP2;ATP9B;TMEM30A;ABCC1
prerank,response to cadmium ion (GO:0046686),0.4216805076914388,1.0196763362966117,0.48625,0.9317740415796217,1.0,8/26,29.96%,EGFR;CHUK;AKT1;MAPK1;JUN;SUMO1;FOS;HSF1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.38481289544076946,1.0193382888259894,0.44601962922573607,0.9321412880794809,1.0,18/52,23.21%,EPHB2;EGFR;LRP1;EPHA3;ATP2B4;STX4;SQSTM1;AKT1;ZDHHC2;ARF6;PLS1;CNST;SPTBN1;STX3;CLIP3;STAC3;ZDHHC8;ZDHHC5
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.44504291506666616,1.0192779689399167,0.48055207026348806,0.9316985429071284,1.0,6/20,14.67%,TMBIM1;CSK;PID1;CLTC;RHOQ;PPFIA1
prerank,response to interleukin-6 (GO:0070741),-0.41654027004312266,-1.0190186980694587,0.44,0.7891351322141618,1.0,3/10,11.04%,ST3GAL6;PTGIS;PTPRT
prerank,calcium ion import into cytosol (GO:1902656),0.46636117139526345,1.0187419998407792,0.44743589743589746,0.9326434516913625,1.0,6/15,26.25%,TRPV3;ATP2B4;SLC8A2;CACNA2D1;TRPV2;SLC24A2
prerank,DNA duplex unwinding (GO:0032508),0.3902762344026882,1.0184245574360875,0.46547884187082406,0.9329372436770815,1.0,13/50,18.62%,ANXA1;GTF2H3;RAD23B;ASCC3;ERCC3;UBA52;DDB1;DDX11;NBN;RECQL;RAD50;BLM;SUPV3L1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.3999101046550022,1.01782196986335,0.44329896907216493,0.9340612437607426,1.0,15/40,25.74%,GLMN;DESI1;AXIN1;RAD23B;SGTA;UFL1;PML;RPL23;PTEN;SMURF1;UBE3A;CSNK2A2;LATS1;UBQLN4;FBXW7
prerank,nuclear export (GO:0051168),0.37331458373427406,1.017419988453636,0.449531737773153,0.9345620161099597,1.0,29/80,27.44%,SRSF2;DESI1;HNRNPA1;SRSF6;NXF1;PKD1;U2AF1;STRADA;SRSF3;SRSF11;THOC7;POLDIP3;THOC2;THOC1;ZC3H11A;CHP1;DDX39A;SRRM1;U2AF2;NEMF;SMURF1;TPR;XPO7;CALR;ALYREF;UPF3B;NUP188;CDC40;THOC5
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.41481934533243936,1.0173437673698522,0.4653014789533561,0.9341541539649687,1.0,9/34,17.06%,RAB7B;IRAK3;PTPRS;NR1D1;TLR4;CD14;GRAMD4;NLRP2B;SARM1
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.4874343551592628,1.0172917510944324,0.45308310991957107,0.9330524946255061,1.0,4/12,15.24%,ATP2B4;DYRK2;RCAN1;CHP1
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.4874343551592628,1.0172917510944324,0.45308310991957107,0.9330524946255061,1.0,4/12,15.24%,ATP2B4;DYRK2;RCAN1;CHP1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.3549524089606221,-1.017284125479082,0.4365079365079365,0.7920235602499837,1.0,7/17,20.36%,NEDD4L;GPD1L;KCNQ1;RYR2;KCNE4;SNTA1;SCN3B
prerank,cellular zinc ion homeostasis (GO:0006882),0.426856806478239,1.017220860907489,0.4645858343337335,0.9326445152432534,1.0,5/26,16.58%,SLC39A13;SLC39A14;SLC39A7;SLC30A9;SLC30A5
prerank,intraciliary retrograde transport (GO:0035721),0.4883860689959467,1.017218258686155,0.4673913043478261,0.9320294524184773,1.0,4/12,18.23%,DYNC2I2;DYNC2LI1;DYNC2H1;DYNC2I1
prerank,organonitrogen compound catabolic process (GO:1901565),0.3846009356576521,1.01710051426786,0.460352422907489,0.9317539150492061,1.0,20/57,27.12%,ANPEP;MTOR;NAGK;LNPEP;TPP1;CLPX;SIAH1;PDXDC1;PNPLA8;NPEPPS;IDE;MPST;LIPC;LRSAM1;TXN2;USE1;TRIM24;CTH;PLA2G7;PPT1
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.3899769693481599,1.0170371105821052,0.4588364434687157,0.931337926920142,1.0,21/56,29.06%,LBP;S100A8;S100A9;TLR5;TLR4;IRAK4;IRAK1;UBA52;CD14;TRAF3;TAB2;MAP3K7;CTSK;HSP90B1;CTSB;CTSL;BCL10;MAPKAPK3;SFTPA1;SFTPA2;MYD88
prerank,positive regulation of rRNA processing (GO:2000234),0.5017735194946852,1.0168497458151808,0.4628099173553719,0.9312684933524729,1.0,2/10,4.77%,DIMT1;RIOK1
prerank,triglyceride metabolic process (GO:0006641),0.39089453078161135,1.016430616942147,0.46986607142857145,0.9318694049573509,1.0,12/48,22.45%,GPAT4;FABP12;MOGAT1;GK5;MOGAT2;GPAT3;FABP5;GPAM;LIPC;LIPH;LPIN3;SEL1L
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.35964188546096904,1.0163755753819375,0.4676767676767677,0.9314064645792764,1.0,23/161,11.60%,SFRP4;LRP6;DKK2;TLE6;CCDC88C;PSMC4;DACT3;IGFBP6;TNN;WWTR1;RBMS3;KREMEN1;AXIN1;IGFBP4;DACT1;TCF7L2;PSMC6;PSMD8;CUL3;TLE2;ANKRD6;TPBG;GLI3
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.5067686756889601,1.0162239871160101,0.4724517906336088,0.9312114976934079,1.0,5/10,31.13%,CRHR1;GNB5;GPR35;DRD2;CALM1
prerank,sodium ion homeostasis (GO:0055078),0.4353573056141592,1.0159756195046226,0.4610552763819096,0.9313045723779587,1.0,4/21,3.99%,SCNN1B;ATP1A3;ATP1A4;ATP1A1
prerank,cellular response to gamma radiation (GO:0071480),-0.3458645107087079,-1.0157780098555493,0.4247787610619469,0.7939248117976729,1.0,8/17,20.33%,MAP3K20;YAP1;ATM;TMEM109;RPL26;WRN;HRAS;TSPYL5
prerank,positive regulation of mitochondrial translation (GO:0070131),0.46207214088181214,1.0157506022576426,0.4706649282920469,0.9313389757911503,1.0,5/14,21.41%,C1QBP;MRPS27;RCC1L;RMND1;MPV17L2
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.39876895786623656,1.0157028289202492,0.4751693002257336,0.9308686137422781,1.0,10/38,22.60%,ESR1;USP10;NR1D1;OTUD7B;TNIP1;ZC3H12A;PER1;PPM1A;PYCARD;RORA
prerank,positive regulation of cilium assembly (GO:0045724),0.4564568099619714,1.0156052472800206,0.46657929226736566,0.9305363763345607,1.0,9/18,29.21%,SAXO1;BBS4;CCP110;ENTR1;CROCC;SEPTIN9;CCDC88A;FUZ;KCTD17
prerank,activation of protein kinase B activity (GO:0032148),-0.302082455119548,-1.0153914440688616,0.4503311258278146,0.7930412722257404,1.0,8/29,8.98%,INSR;IGF1;WNT5A;OSBPL8;PINK1;NTRK3;FGF1;ADRA2A
prerank,regulation of centriole replication (GO:0046599),0.4527028712353831,1.0149399408430053,0.46571798188874514,0.9318689115244398,1.0,6/17,19.74%,CEP295NL;KAT2B;ALMS1;NPM1;CDK5RAP2;MDM1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.3601157708049865,-1.0149395506733194,0.4085603112840467,0.7923258461246165,1.0,6/14,12.56%,VEGFC;FOXC1;KDR;NRP1;PIK3CD;FLT4
prerank,regulation of cellular component movement (GO:0051270),0.3854092114084725,1.0147961827372372,0.4732739420935412,0.9316731294178422,1.0,16/49,18.39%,CD9;EGFR;BTC;VEGFA;ZSWIM4;HDAC6;ABL2;MYCBP2;INPP5F;EGF;RHOA;DIAPH1;ZSWIM8;ARAP1;YTHDF1;TGFBR1
prerank,regulation of actin filament polymerization (GO:0030833),0.37758159069408664,1.0147644346966853,0.4708377518557794,0.9311627504391,1.0,23/69,24.09%,DBN1;SLIT2;CDC42EP2;BIN1;MYADM;PFN2;TWF1;KANK1;SSH1;GBA2;FCHSD1;FER;ARF6;NCK1;COTL1;ARFGEF1;RASA1;PYCARD;ABITRAM;SSH3;CTTN;LATS1;NCK2
prerank,regulation of activated T cell proliferation (GO:0046006),0.4121721879370129,1.0147054531149622,0.4703791469194313,0.9307209741445706,1.0,2/30,7.01%,TNFSF9;RC3H1
prerank,regulation of NMDA receptor activity (GO:2000310),0.41504250210156574,1.0142535160768318,0.4589774078478002,0.9314939934206202,1.0,6/32,9.38%,EPHB2;DLG4;DLG2;NEFL;CAPN1;GRIA2
prerank,anterograde trans-synaptic signaling (GO:0098916),0.3498452267549879,1.0138494741901756,0.4724724724724725,0.9320976762981209,1.0,46/224,19.89%,LRP6;LPAR3;SNCB;MTNR1B;APBA3;PMP22;CEL;RPS6KA2;CAMKK1;APBA1;DLG4;SLC1A6;GABRR3;DLG2;SLC18A3;RIT2;HTR1F;SLC12A4;GRIA2;PLP1;CAMKK2;HCRT;SLC12A5;SNAP25;ASIC2;DLGAP1;GABRG3;GAD2;CACNB1;GIPC1;GRIN2A;GRM1;CHRNA7;CHRFAM7A;SYT1;AKAP9;CHRNA5;SYNJ2BP;HTR2C;MBP;PAFAH1B1;PRKAR2A;GABRG2;GRIA3;NOVA1;EXOC4
prerank,inorganic cation transmembrane transport (GO:0098662),0.35045084188688674,1.013674724298093,0.473,0.9319752991127517,1.0,48/268,16.58%,SCARA5;KCNK5;SCNN1B;UCP1;HPN;KCNV1;SLC4A8;SLC39A13;ATP1A3;ATP1A4;ATP1A1;PKD1;P2RX3;SLC39A14;TRPV3;ATP2B4;KCNJ2;SLC9A9;KCND1;SLC6A8;SLC11A2;ABCB8;GAS6;SLC25A27;PKD2;ATP5PO;KCNK13;KCNK9;ITGAV;HCN4;SLC39A7;KCNA2;SLC4A4;KCNA6;KCNAB3;SLC6A11;SLC6A4;SLC9A1;ATP2A2;ASIC2;SLC8A2;KCNC2;TRPC4AP;SLC9A7;SLC9A6;SCN4B;TMEM165;SLC30A5
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.4841091283150001,1.0135928246612282,0.46853146853146854,0.9316095706607476,1.0,3/12,11.30%,MIA3;FUT9;AKT1
prerank,keratan sulfate catabolic process (GO:0042340),0.48800730108826407,1.0133524073472617,0.467966573816156,0.9316844019110302,1.0,2/11,4.27%,OGN;ACAN
prerank,positive regulation of protein catabolic process (GO:0045732),0.3682862508258211,1.0133438735759186,0.4619395203336809,0.9310933885954887,1.0,22/84,20.46%,GPC3;STX5;ADAM9;SMURF2;AXIN1;DACT1;ITCH;FOXO1;SEC22B;EGLN2;DTL;HECW2;DDB1;TNFRSF1B;HSP90AA1;NSF;HACE1;IDE;VPS11;GPLD1;SH3D19;RNF41
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.4140439540311129,1.0131421901334605,0.47735191637630664,0.9310753306079266,1.0,11/30,23.83%,UCHL5;RYBP;FHIT;SGTA;USP7;GIPC1;NOP53;OGT;MAP1A;SDCBP;BAG5
prerank,positive regulation of inflammatory response (GO:0050729),0.3645872347756843,1.0128649308243174,0.4794238683127572,0.9312651082793459,1.0,16/86,19.13%,LBP;IL16;S100A8;S100A9;IL33;IL17RA;CD81;TLR4;CD47;TNIP1;ABCC1;NUPR1;PDCD4;IL6;IL18;IFI35
prerank,negative regulation of myotube differentiation (GO:0010832),0.4895149862772168,1.0125913101418498,0.4692737430167598,0.931423421561023,1.0,3/12,13.86%,TMEM119;HDAC3;HDAC4
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.46846487932780967,1.0125118370400505,0.4709851551956815,0.9310181158137368,1.0,5/14,14.82%,SYT11;NR1D1;CD200R1;TNFRSF1B;IL4
prerank,protein lipidation (GO:0006497),0.37694521191861147,1.0123704015806474,0.4747039827771798,0.9308086569039575,1.0,21/59,24.18%,ZDHHC16;ZDHHC7;PIGZ;WIPI2;HHAT;PIGC;WDR45B;SELENOK;MPPE1;ZDHHC2;PIGW;PIGM;ZDHHC21;ZDHHC20;GPLD1;ZDHHC18;ZDHHC8;ZDHHC5;ATG10;PIGL;DPM2
prerank,negative regulation of signaling receptor activity (GO:2000272),0.4221015183236032,1.0118357281382704,0.47961630695443647,0.9318373516058659,1.0,2/25,3.88%,EPHB2;CNRIP1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.37820125664170834,1.0116303799345194,0.4682454251883746,0.9318150648674779,1.0,27/59,29.86%,CDK4;TCF7L2;MED24;MITF;CEBPB;CCNC;CDKN1A;MED13;CCND1;TWIST1;MED15;IL6;AGO4;MED23;MED6;AGO3;PTEN;JUN;MED7;TNRC6A;RELA;MED26;AGO1;NFKB1;BAX;TP53;SOX9
prerank,negative regulation of potassium ion transport (GO:0043267),-0.36777095398600457,-1.0116010378044442,0.42962962962962964,0.7996717857736875,1.0,3/13,6.08%,NEDD4L;ACTN2;CAV1
prerank,microvillus organization (GO:0032528),-0.3716229582486994,-1.0115647402362675,0.42907801418439717,0.7977976000288685,1.0,3/13,5.73%,RAPGEF2;TNIK;MAP4K4
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.35104447641227576,1.0114891464646538,0.4774774774774775,0.9316181946653552,1.0,103/314,26.29%,UCHL1;PSMC4;UBE2B;SPSB1;SPSB4;NFE2L2;UBE2J2;SMURF2;SYVN1;TRIM71;ITCH;EDEM1;RAD23B;RMND5B;RNF121;COP1;PSMC6;SPSB2;STUB1;UBE2W;ANKZF1;FBXO2;PSMD8;SIAH1;FBXO17;CUL3;SIRT2;FBXL2;ECPAS;UBE2G2;FBXW4;HECW2;FBXL20;HERPUD1;CDC23;ANAPC5;FBXO5;FBXO31;UBE2A;DNAJB2;UBA52;CDC34;LTN1;TMUB2;DDB1;FBXL3;SGTA;CDC27;AMFR;RNF216;SELENOS;RNF187;RBCK1;ZSWIM8;HACE1;PML;CDC26;DMAC2;KCTD2;UBE2G1;FBXL5;ANAPC4;AUP1;SKP2;PCNP;UBE2D3;FBXL19;CUL5;KCTD10;ANAPC10;JKAMP;NEMF;ARRB1;UBXN11;SMURF1;ANAPC15;DERL1;SEL1L;FBXW11;UBR2;USP19;KLHL22;ECRG4;SPSB3;IFI27;FBXO38;PSMD3;DCAF12;RHBDD2;FBXL12;PSMD4;SEC61B;MDM2;AGAP3;KAT5;HSP90B1;UFD1;DDIT3;FBXW7;RNF126;PSMB3;UBE2K;ANAPC2
prerank,embryonic axis specification (GO:0000578),-0.36063628815837667,-1.0112268628621295,0.4732510288065844,0.7966966005293523,1.0,3/15,3.49%,PTCH1;CXXC4;TBX3
prerank,regulation of microtubule nucleation (GO:0010968),0.499673737576997,1.0111496531631354,0.4757142857142857,0.932011703936409,1.0,4/10,28.23%,DCTN1;CKAP5;ARHGEF7;RANGRF
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.36570950125998425,1.0110560906870045,0.4793388429752066,0.9316532608812139,1.0,35/94,26.73%,DCTN1;ODF2;YWHAG;SSNA1;YWHAE;ALMS1;MAPRE1;HAUS3;SFI1;CEP97;HSP90AA1;TUBB4A;TUBA4A;DYNC1H1;CDK5RAP2;AHI1;CCP110;AKAP9;CEP164;CEP89;CKAP5;CEP83;PAFAH1B1;CC2D2A;PCM1;FBF1;DCTN2;TCTN2;NEDD1;DYNLL1;CEP78;TCTN1;CSNK1E;ACTR1A;CETN2
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.49821948131012067,1.0106210161067888,0.4579710144927536,0.9322959146195183,1.0,5/10,13.61%,UBE2B;PDE11A;PDE4D;CDC34;PDE3B
prerank,regulation of cell development (GO:0060284),0.3986819938793064,1.0102337348203114,0.47113163972286376,0.9328123361933891,1.0,5/36,11.30%,BHLHE40;HDAC9;DOCK7;FOXO1;AKT1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.406513505325413,1.010044640044162,0.48568019093078757,0.9327711467258327,1.0,8/31,21.63%,TIMM50;PEX16;GRPEL2;PEX12;PEX1;PEX5;PEX2;TIMM17A
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.45763502678380974,1.0098275668804517,0.47424042272126815,0.9327553097936762,1.0,4/16,12.38%,PRCP;SPX;GPR37L1;KLK1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.39419373897191234,1.009363426793445,0.45707915273132665,0.9334777368527697,1.0,4/43,5.35%,AREG;EGFR;BTC;PTPRJ
prerank,protein K48-linked ubiquitination (GO:0070936),0.3809948402859294,1.008735130849641,0.48091603053435117,0.9346003177809022,1.0,23/54,26.06%,UBE2B;SYVN1;ITCH;CUL3;UBE2G2;UBE2A;CDC34;AMFR;RNF216;RNF187;HACE1;UBE2G1;ARIH2;UBE2R2;SKP2;UBE2D3;UBE2Q2;UBE3A;RNF6;IFI27;FBXO38;RNF126;UBE2K
prerank,protein deacetylation (GO:0006476),0.39320269294160176,1.0087344305009542,0.4665911664779162,0.933994378971008,1.0,13/41,20.33%,HDAC9;HDAC7;HDAC6;SIN3B;MSL3;SIRT2;RCOR3;HDAC3;HDAC4;MORF4L1;SUDS3;MIER1;FLNA
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.3771089709068658,1.0085024058344538,0.47413793103448276,0.9340509629778221,1.0,19/59,24.76%,PRKCA;DYRK4;TGFBR2;ACVR1;CAMK2D;PRKD2;DYRK2;AKT1;STK39;ULK1;HIPK4;TGFBR1;CIT;OXSR1;HIPK3;MAPK1;CSNK2A2;ACVR1B;MARK2
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.4704527429639418,1.0073534496213787,0.4821192052980132,0.9366530843839811,1.0,4/13,6.28%,TGFB3;SMAD4;NUP93;SH2B1
prerank,negative regulation of response to external stimulus (GO:0032102),0.35703345605043035,1.007041890177718,0.4902962206332993,0.9369145086772157,1.0,20/105,15.96%,MAPK7;IRAK3;FGF2;PTPRS;METRNL;ITCH;MVK;NR1D1;CARD16;C1QBP;INPP5F;SIRT2;FNDC4;SIRPA;RTN4RL1;KLF4;IL4;LRFN5;SELENOS;ILRUN
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.4781955021586207,1.0069008925057377,0.4686192468619247,0.9367285809411543,1.0,6/12,26.38%,STX4;ADCY8;PPP3CB;GPLD1;BAIAP3;CFTR
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.31026612955418476,-1.0061169018730634,0.43478260869565216,0.8086028292271016,1.0,8/27,13.28%,FLT1;PRKD1;KIT;EPHA8;PDGFRB;TEK;TGFB1;PTK2
prerank,myeloid cell differentiation (GO:0030099),-0.2681888818902695,-1.0059646917128675,0.42857142857142855,0.806955852207719,1.0,21/47,26.62%,LYN;KMT2E;KIT;HSPA9;CASP3;PRDX3;RPS14;INHBA;PTPN2;TAL1;HIPK2;SNRK;ACIN1;UBA5;SPI1;JAK3;RASGRP4;KAT8;ALAS2;CEBPA;HCLS1
prerank,positive regulation of protein import (GO:1904591),0.4078023216880153,1.0058580386512226,0.4934445768772348,0.9390917291541349,1.0,12/30,22.68%,ZPR1;PIK3R2;PSEN1;RBM22;HDAC3;JUP;ZC3H12A;DMAP1;IPO5;FLNA;BAG3;TPR
prerank,positive regulation of tissue remodeling (GO:0034105),0.508262379884013,1.0057945054220048,0.4843304843304843,0.938662550901443,1.0,2/10,17.74%,TMBIM1;IL18
prerank,positive regulation of immunoglobulin production (GO:0002639),0.40293308512863074,1.0054874303038228,0.4852420306965762,0.9389402179381894,1.0,4/31,9.18%,EPHB2;CLCF1;HMCES;STX4
prerank,hemidesmosome assembly (GO:0031581),0.4824483227660956,1.0051480229409775,0.48214285714285715,0.9393657248111656,1.0,2/11,5.04%,COL17A1;DST
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.36192395174199643,-1.005002252540334,0.46122448979591835,0.8077330754272597,1.0,5/15,21.63%,PRKCH;AGTR1;MAPK9;LPL;MSR1
prerank,zinc ion homeostasis (GO:0055069),0.4157754187577557,1.004894963089391,0.48881036513545345,0.9394612131418768,1.0,5/28,16.58%,SLC39A13;SLC39A14;SLC39A7;SLC30A9;SLC30A5
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.3985304393036325,-1.0047718603406126,0.4305555555555556,0.8063080150972282,1.0,3/10,7.94%,DPYD;UPB1;NT5E
prerank,positive regulation of hormone secretion (GO:0046887),-0.35210602603479935,-1.0043203977697985,0.4322033898305085,0.8054642615822414,1.0,6/17,15.75%,C1QTNF3;SPP1;EDN1;SOX11;EDN3;HFE
prerank,cholesterol transport (GO:0030301),0.3850840185047066,1.0043175880852722,0.4722222222222222,0.9404402346132694,1.0,7/45,10.41%,CEL;ABCG4;OSBPL2;ABCA1;LCAT;TSKU;STX12
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.3700773332270763,1.0043038933670738,0.47793326157158234,0.9398718073873309,1.0,11/67,16.20%,FBLN2;MYOC;VIT;S100A10;MYADM;C1QBP;CCL25;JUP;TRIOBP;LIMS2;RAC3
prerank,positive regulation of fat cell differentiation (GO:0045600),0.3809376440646061,1.0040772038629127,0.4829482948294829,0.9399304559367595,1.0,10/47,14.39%,MEDAG;ZFP36L1;METRNL;SYAP1;CEBPB;AKT1;ZFP36;SIX1;ZC3H12A;WDFY2
prerank,MAPK cascade (GO:0000165),0.3451408503883636,1.0037082199502712,0.495,0.9403733540927937,1.0,54/295,14.35%,AREG;FGF18;FGF7;EGFR;IRS1;FGFR1;MAPK12;PSMC4;BTC;FYN;FGF13;FGF2;DLG4;PIK3R2;TAOK3;SPTAN1;RASGRF1;ZFP36L1;SPTA1;DLG2;RET;NEFL;PSMC6;RASGEF1A;RIT2;FLT3LG;ZFP36L2;CHUK;YWHAE;RGL1;PPP5C;PIK3CA;PSMD8;CUL3;MAPK11;RGL2;ITGAV;CAMKK2;NRAS;KRAS;CSF2RA;UBA52;PLVAP;IRS2;EGF;SHOC2;ZFP36;TAOK2;GDNF;FLT3;IL5;PDGFRA;ARTN;RCE1
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.37800678698982226,-1.0033818545608486,0.4122137404580153,0.8060793517754536,1.0,3/12,4.18%,APP;DOCK8;CXCL12
prerank,base-excision repair (GO:0006284),0.3817478171313565,1.0031234586586215,0.4768211920529801,0.941425575628414,1.0,8/48,20.44%,MPG;POLB;PARG;DNA2;RFC4;ERCC5;POLD1;OGG1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.41639948891384776,1.0030881614625782,0.4652014652014652,0.9409298690079929,1.0,7/26,14.60%,TMEM106A;KLF2;PKD2;TLR4;AKT1;KLF4;HSP90AA1
prerank,negative regulation of gene expression (GO:0010629),0.3464930921147442,1.0030065948429985,0.483,0.9405528746050333,1.0,51/302,14.32%,CD34;IGFBP5;ESR1;DIS3L2;NPTN;EIF2AK3;DGKQ;VEGFA;FGF2;TGFB2;FOXP1;RUNX1;MIF;HDAC9;RBMS3;SYT11;RBM4;PAIP2B;ATP2B4;TRIM71;SAMD4B;CREB3L1;CREBZF;TARDBP;MYADM;FLCN;ZFP36L2;PHF1;VDR;MRPL13;PSEN1;AGO2;NUDT16L1;KAT2B;ERN1;MPHOSPH8;PARP14;MAPT;NUDT16;SLC2A10;GPNMB;IGF2BP1;NDFIP1;LARP1;ZFP36;SMCR8;NCOR2;NCOR1;CNOT10;ZC3H12A;KLF4
prerank,regulation of interferon-alpha production (GO:0032647),0.4181251382135454,1.0028040511017475,0.47496947496947495,0.9405066335366793,1.0,4/23,11.81%,PTPRS;CHUK;TLR4;SETD2
prerank,nuclear pore organization (GO:0006999),0.4608323948231581,1.0026743621406053,0.489851150202977,0.9403075908292726,1.0,4/14,8.69%,NUP93;AHCTF1;NUP107;NUP98
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.40097964962010774,-1.002559194053463,0.43223443223443225,0.8064168921268827,1.0,2/11,6.36%,ABCG1;AGTR1
prerank,retrograde axonal transport (GO:0008090),0.4607522681442161,1.0022317991352037,0.49224806201550386,0.9409898404712889,1.0,7/16,22.51%,DST;DLG2;NEFL;DYNC1H1;PAFAH1B1;MAP1A;FBXW11
prerank,negative regulation of cell motility (GO:2000146),0.358378682266753,1.0019394009047808,0.49847405900305186,0.9411845555995092,1.0,21/108,13.17%,IGFBP5;TMEFF2;ADARB1;LDLRAD4;SLIT2;MIF;GTPBP4;MIA3;PTPRJ;SRGAP1;SULF1;PIP5KL1;FLCN;DPEP1;JAG1;KANK1;MITF;MAGI2;RECK;ADAM15;PIN1
prerank,microvillus assembly (GO:0030033),-0.36053788036988466,-1.0018996812712364,0.44528301886792454,0.80619386257066,1.0,3/14,5.73%,RAPGEF2;TNIK;MAP4K4
prerank,postsynaptic membrane organization (GO:0001941),0.45554387931442575,1.0013337013458805,0.48731642189586116,0.9423299154306871,1.0,4/17,13.81%,CEL;DLG4;MUSK;DNAJA3
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.3021126968082985,-1.0011231086155772,0.44970414201183434,0.8063259711125473,1.0,6/26,13.86%,LYN;EPHA4;AIM2;TTBK1;PSME2;PSME1
prerank,negative regulation of glycolytic process (GO:0045820),0.4960595057793985,1.0009907059015788,0.4910344827586207,0.9420781632300774,1.0,4/10,15.11%,TIGAR;NCOR1;HDAC4;NUPR1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.4960595057793985,1.0009907059015788,0.4910344827586207,0.9420781632300774,1.0,4/10,15.11%,TIGAR;NCOR1;HDAC4;NUPR1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.3309123946160135,-1.0009521502539844,0.4444444444444444,0.8048249615631874,1.0,7/19,9.45%,MEF2C;RBP4;VGLL4;NOTCH1;TGFBR3;FGFR2;TBX2
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.3461767347434514,1.0006259604595038,0.517,0.9425302351648286,1.0,114/341,26.29%,UCHL1;PSMC4;UBE2B;SPSB1;SPSB4;NFE2L2;UBA6;SMURF2;ZRANB1;SYVN1;TRIM71;ITCH;VPS4B;RAD23B;RMND5B;RBBP6;MVB12A;VPS37D;COP1;RNF111;PSMC6;SPSB2;RC3H1;STUB1;UBE2W;WDR91;ADRM1;PSMD8;SIAH1;MYLIP;CUL3;DTL;SIRT2;UBE2G2;FBXW4;HECW2;USP33;OTUD7B;HERPUD1;SQSTM1;CDC23;ANAPC5;RNF7;UBE2A;CDC34;NDFIP1;DDB1;VPS37C;CDC27;CBL;UBR4;AMFR;RNF128;RNF216;TRPC4AP;RNF14;RNF187;RBCK1;ZSWIM8;HACE1;KEAP1;PML;CDC26;KCTD2;VPS37B;UBE2G1;FBXO11;ANAPC4;NTAN1;ARIH2;UBAP1;UBE2R2;NEDD8;SKP2;PCNP;RNF19A;UBE3C;TOLLIP;UBE2D3;KCTD6;FBXL19;ARIH1;KCTD10;ANAPC10;KCTD21;ARRB1;RC3H2;UBXN11;SMURF1;ANAPC15;RNF6;FBXW11;KLHL22;RNF114;SPSB3;IFI27;RNF13;PSMD3;UBQLN4;PSMD4;MDM2;AGAP3;KAT5;RNF166;UFD1;FBXO22;RNF20;DDIT3;FBXW7;RNF126;PSMB3;UBE2K;RNF167;ANAPC2
prerank,positive regulation of cellular process (GO:0048522),0.3419724423882111,1.0005812806325063,0.505,0.9420487978327727,1.0,93/565,14.82%,LBP;LIF;AREG;AR;HAS2;LRP6;AVPR1A;FGF18;FGF7;DPP4;WNT2;PRKCA;EGFR;LRP1;TGFB3;IRS1;HPN;FGFR1;CTF1;BTC;VEGFA;FGF2;TGFB2;MST1R;F2R;TGFBR2;CDKN2AIP;S100A8;S100A9;TIPIN;LMNA;WWTR1;DDX49;P2RX3;ZFP36L1;CDK4;ACLY;CLCF1;PTPRJ;POFUT2;MEIS2;GLP2R;ZFHX3;C1QBP;MLXIPL;S1PR2;ESM1;TBX6;GAS6;FLCN;PRKD2;FLT3LG;DNAJA2;CD81;TNFRSF18;FZD7;CAPN1;WDR77;CUL3;SIRT2;TLR4;STX4;ITGAV;RNF10;CD47;SIRPA;SMC5;NPM1;KRAS;AKT1;MAPT;KIF20B;FBXO5;TSHR;UBE2A;IRS2;LGI1;EGF;ZFP36;GDNF;FLT3;CCND1;SMC6;TNFRSF1B;HDAC4;CDC123;ZC3H12A;PDGFRA;FER;INO80;PPP3CA;POU3F2;IL4
prerank,morphogenesis of an epithelium (GO:0002009),0.4192201121497965,1.0005181618534407,0.4920245398773006,0.9416089449565992,1.0,7/25,21.76%,LRP6;SOX10;SOX8;AHI1;ACTG1;KDM2B;LHX1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.3545133827615535,-1.0003817230843963,0.41841004184100417,0.804446496245745,1.0,5/16,17.98%,PDK1;SCARB2;SIRT1;PDK3;ADIPOR1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.3263423242740051,-1.0000005677535526,0.4868421052631579,0.8036159702854493,1.0,4/20,4.66%,NEDD4L;ACTN2;OSR1;PRKCE
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.3618340601177935,0.9999185849843673,0.5041152263374485,0.9427198606305516,1.0,33/101,23.59%,NIBAN1;DACT1;MTOR;STUB1;LARP4;AURKAIP1;HNRNPD;NPM1;AKT1;TBC1D10A;PASK;BAK1;EIF6;RPS27L;BCL3;ZCCHC4;POLDIP3;RBM3;KLF4;HSP90AA1;EIF3E;IL6;OGT;EIF3D;FXR2;YTHDF1;VPS11;PCIF1;CSF1;YTHDF3;FBXW11;ATG10;IST1
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.3572929085043125,-0.9999028203526006,0.452,0.8020136208191418,1.0,4/13,15.50%,RNF152;ATM;SPAAR;SESN1
prerank,calcium import into the mitochondrion (GO:0036444),0.4860090438067352,0.9997339154653979,0.4930167597765363,0.9426626403055438,1.0,2/10,11.49%,MCU;MCUB
prerank,protein K48-linked deubiquitination (GO:0071108),0.4243550427997641,0.9996495261449739,0.4749082007343941,0.9423006805743435,1.0,5/23,12.26%,OTUD3;USP33;OTUD7B;USP50;USP5
prerank,copper ion transport (GO:0006825),0.4931229955843015,0.9996135901794878,0.4826629680998613,0.9417967804452658,1.0,2/11,7.16%,STEAP3;SLC11A2
prerank,endocardial cushion morphogenesis (GO:0003203),0.44429390373766,0.9995834873478108,0.4915032679738562,0.9412712485664811,1.0,4/18,6.76%,TGFB2;TGFBR2;ACVR1;MDM4
prerank,response to ATP (GO:0033198),0.4391403013223433,0.9994150390386674,0.4701492537313433,0.941153262838911,1.0,3/18,10.99%,DGKQ;P2RX3;SSH1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.4092614559165819,0.9990525701283314,0.49186046511627907,0.9415847923642319,1.0,6/33,10.94%,CD160;PTPRJ;RC3H1;PRKD2;CD81;UBASH3A
prerank,response to UV (GO:0009411),0.3630232699849896,0.9989058265884836,0.5005181347150259,0.9413907967798605,1.0,31/95,24.07%,EGFR;TRIAP1;UBE2B;NOC2L;SCARA3;ZBTB1;RHNO1;DTL;NPM1;GPX1;AKT1;BMF;ERCC3;UBE2A;BAK1;ERCC4;PCLAF;BCL3;CCND1;EIF2S1;INO80;UVSSA;ERCC5;POLD1;SMPD1;NSMCE3;ATF4;SDE2;RELA;REV1;POLH
prerank,negative regulation of autophagosome assembly (GO:1902902),0.4654555309595243,0.9985398572568355,0.4884353741496599,0.9418586560274966,1.0,9/13,33.91%,SEC22B;SCFD1;SMCR8;NUPR1;MTM1;TMEM39A;CHMP4A;CHMP4B;FEZ1
prerank,regulation of glycogen metabolic process (GO:0070873),0.48076616109794157,0.9984967102364803,0.48241912798874825,0.9413742301769203,1.0,5/12,24.09%,INPP5K;AKT1;PPP1R3C;PPP1R3D;PPP1R3E
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.4770994819476273,0.9976983899327325,0.49361702127659574,0.9430779770268546,1.0,6/11,27.89%,MPHOSPH8;TPR;SETDB1;SETDB2;TASOR;ATF7IP
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.3521193920076023,-0.9975130886985336,0.44398340248962653,0.8065170170148825,1.0,6/15,21.16%,OSBPL8;PPARA;PNPLA2;LPL;ABHD5;FITM2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.419623121263895,0.9973860793232125,0.4933171324422843,0.9433479861679092,1.0,2/25,3.89%,CD55;CD160
prerank,regulation of apoptotic process (GO:0042981),0.34047992974459595,0.9972486269859684,0.528,0.9431411748725549,1.0,153/676,20.47%,SFRP4;COMP;TNFSF9;FSTL1;AXL;GCLC;WNT10B;ARHGAP10;KCNMA1;EGFR;SCIN;ANXA1;TGFB3;WT1;AKAP13;HPN;RABGGTA;ANGPT4;TRIAP1;GADD45G;RPS6KA2;SIX4;CD44;GAS1;VEGFA;SLIT2;STEAP3;MIF;BIN1;ATF5;USP36;COPS5;TRIO;ITCH;ADAMTSL4;MTCH1;SOCS2;CBX4;HOXA5;DDX42;FOXO1;PRMT2;CXCL10;RASSF2;TARDBP;C1QBP;ARF4;SRC;EGLN2;ARHGEF3;PIP5KL1;AIFM2;HS1BP3;GAS6;FLCN;DPEP1;SLK;SOX8;SIAH1;PSEN1;PDCD2;BEX2;RYBP;AVEN;LGALS1;ING4;TIAM2;SMAD6;SON;SQSTM1;HDAC3;NPM1;ALPK2;CSRNP3;BCL6;AKT1;BMF;IRAK1;ERCC3;NAT8;UBA52;BAK1;CD27;NGEF;ANP32B;QRICH1;DIABLO;GLS2;GDNF;FLT3;BCL3;NSMF;WDR73;DNAJA3;NME2;CBL;STK3;MLLT11;MTCH2;CALHM2;HSP90AA1;IL4;NUPR1;VDAC1;DDX20;RSL1D1;NOP53;BAG4;HRK;AHI1;MADD;NLRP2B;IL6;SOS1;HGF;ANXA4;HTRA2;TFAP4;TAX1BP1;SAP18;NME1;CTSD;PPIA;EEF1E1;ERCC5;FAIM2;FBXO11;TMBIM4;PLAUR;NAA15;IAPP;VTCN1;SMPD1;UFM1;SUPV3L1;PRDM9;SKP2;DSTYK;SUDS3;APAF1;CLIP3;MCL1;GPLD1;IL31RA;HIPK3;STK26;RASA1;TRIM35;ATF6;FLNA;PRELID1;DDAH2;TIAM1
prerank,regulation of defense response to virus by host (GO:0050691),0.40439726183844205,0.9972376472421524,0.4816132858837485,0.9425765717822298,1.0,7/30,15.17%,TARBP2;CGAS;TRAF3IP2;ZC3H12A;HSP90AA1;IL4;RNF216
prerank,response to hydroxyurea (GO:0072710),0.48401960137077543,0.9971963607715784,0.5159944367176634,0.9420938414230574,1.0,6/11,29.29%,DDX11;SPIDR;BLM;NSMCE3;KAT7;ATRX
prerank,replication fork processing (GO:0031297),0.3870054916707563,0.9971202925361199,0.49265536723163844,0.9417137188907064,1.0,11/38,19.59%,EME1;RFWD3;ETAA1;CDK9;SAMHD1;DNA2;DDX11;THOC1;FAM111A;BLM;SMARCAL1
prerank,phagosome-lysosome fusion (GO:0090385),0.49284405795558084,0.9970457113225765,0.49442896935933145,0.9413119722247363,1.0,1/10,2.11%,RAB7B
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3394474111399184,0.9970176698473566,0.533,0.9407861619352414,1.0,210/1082,16.87%,LMX1A;DCN;LIF;AR;LRP6;CD80;ESR1;COL1A1;NFIX;FGF7;IRF4;WNT2;EGFR;CREB5;TGFB3;WT1;ZC3H8;MEOX2;TRIAP1;EIF2AK3;HSF2;SIX4;ELF4;MAPK7;ZMIZ1;VEGFA;FGF2;PBX1;F2R;GLIS2;SFR1;RUNX1;ZPR1;CRTC2;SMAD4;NFE2L2;PIK3R2;ATF5;WWTR1;DPF2;LMX1B;AKNA;MEF2D;SKI;PKD1;CXXC1;COPS5;AXIN1;SOX10;ACVR1;FOXK2;KLF2;MAP2K3;JUND;MAFF;PSRC1;TCF7L2;MTOR;NR1D2;NFATC1;HOXA5;SCAF8;SMARCD2;MEIS2;FOXO1;IL33;AKIRIN1;NR1D1;NFIB;RTRAF;MAPRE3;EBF3;PRMT2;CXCL10;NCOA3;SSBP3;NFIA;RNF111;ZFHX3;DPF1;RET;ARF4;TRIP4;MLXIPL;SMAD5;DNAJC2;ACTR3;MTF1;PID1;SMARCD1;ADCYAP1;GLI2;ZFPM2;DHX33;FLCN;MDFIC;PRKD2;PKD2;CD81;SOX8;CHUK;FZD7;VDR;MYBL2;PSEN1;FOXC2;AGO2;JAG1;CDK9;SIRT2;TLR4;HNRNPD;ATXN7L3;BEX1;RYBP;ONECUT1;KAT2B;MED24;ATAD2B;INPP5K;RHOQ;RNF10;SATB2;BRD7;HELZ2;SQSTM1;HDAC3;NPM1;MZF1;TCERG1;MITF;PRDM15;CAMKK2;SMARCC2;IRF2BPL;CSRNP3;TOX2;SLC30A9;CEBPB;AKT1;UBTF;GLI3;DCAF6;ZNF462;TNIP1;SLC9A1;AKIRIN2;UBA52;KANSL3;JUP;EGF;CCNC;QRICH1;DR1;GDNF;ATF1;DDX17;PEG3;PIN1;MED13;BCL3;TWIST1;RAI1;SIX1;HDAC4;RFX5;PLAGL1;NME2;ZC3H12A;EAF2;KLF4;TASP1;HOXA7;MLLT11;BCL9;PTOV1;HOXC4;INO80;BCAS3;THOC1;PPP3CA;POU3F2;IL4;SMARCA4;GTF2F1;CHD8;MLXIP;FZD4;NR2C2;MAP2K2;E2F3;RNF14;CDK5RAP2;AHI1;RNF187;UBP1;USP22;PER1;HIVEP3;IL6;HGF;NCK1;OGT;STAT5B;PHF5A;E4F1;BCLAF3;PITHD1;TFAP4;PML
prerank,regulation of secretion (GO:0051046),0.47165068598058646,0.9969058068666736,0.514324693042292,0.9405210423690896,1.0,3/13,12.37%,SCIN;POFUT2;EGF
prerank,cell-cell junction organization (GO:0045216),0.3633524854843481,0.996549504910736,0.5057471264367817,0.9409249102501677,1.0,13/79,8.24%,CADM3;TGFB3;PKP3;ANG;CD177;TGFB2;F2R;NECTIN3;CSK;MYADM;FSCN1;FLCN;PARD6A
prerank,regulation of establishment of protein localization (GO:0070201),0.46666076414616486,0.9962486482054029,0.4898236092265943,0.9411714696625842,1.0,4/13,17.19%,CORO2B;SCFD1;SPIDR;CTSD
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3580700195139567,0.9961963270896856,0.5277486910994764,0.9407517460624547,1.0,22/101,13.99%,FGF18;EGFR;FGFR1;VEGFA;FGF2;MST1R;PKD1;PSRC1;ATP2B4;MAPRE3;ETAA1;SRC;PKD2;SYAP1;AKT1;IRAK1;EGF;CALM2;FLT3;CCND1;RHOA;SLC8A2
prerank,negative regulation of protein catabolic process (GO:0042177),0.39293983126954873,0.9961771163361965,0.4886104783599089,0.9402065377300618,1.0,5/40,9.05%,TIMP2;EGFR;IRAK3;MDM4;SIRT2
prerank,positive regulation of dendritic spine development (GO:0060999),0.4343442905454581,0.9960969746973094,0.48249027237354086,0.9398313565680065,1.0,3/20,13.86%,DBN1;PSEN1;LLPH
prerank,negative regulation of platelet activation (GO:0010544),0.4518191839180642,0.9960224443447062,0.48129032258064514,0.9394432073407442,1.0,4/16,14.13%,C1QTNF1;CD9;ADAMTS18;PDGFRA
prerank,positive regulation of RNA metabolic process (GO:0051254),0.38571354825888077,0.9958258487611537,0.4989059080962801,0.9394029581740133,1.0,12/45,19.78%,EGFR;DIMT1;ZPR1;RIOK1;RBM22;ERN1;MAP2K2;IL6;DDX5;SUPV3L1;U2AF2;RIOK2
prerank,V(D)J recombination (GO:0033151),-0.38615863794558186,-0.9958090872968185,0.42435424354243545,0.809091907047628,1.0,1/11,2.72%,HMGB1
prerank,snRNA processing (GO:0016180),0.4429974079036339,0.9957567340993433,0.4987146529562982,0.9390161772748155,1.0,5/16,18.59%,INTS3;INTS10;INTS6;INTS2;INTS12
prerank,ncRNA catabolic process (GO:0034661),0.4117726339649458,0.995446546212364,0.48984468339307047,0.9392939512883798,1.0,6/28,18.36%,DIS3L2;NUDT16L1;EXOSC7;NUDT16;ZCCHC8;TENT4B
prerank,pre-miRNA processing (GO:0031054),0.4579987546089159,0.9954434208547158,0.49732620320855614,0.9387102752290558,1.0,4/14,19.45%,TARBP2;AGO2;AGO4;AGO3
prerank,positive regulation of potassium ion transport (GO:0043268),0.3913133623020617,0.9953560281125784,0.4853801169590643,0.9383849523033366,1.0,4/38,5.51%,KCNMA1;FHL1;ANK2;KCNJ2
prerank,purine nucleotide metabolic process (GO:0006163),0.41851037849649375,0.9953342682966098,0.4906832298136646,0.9378622271811086,1.0,7/24,16.62%,GDA;GPX1;FHIT;GART;PRPSAP1;PRPS1;PRPS1L1
prerank,protein targeting to mitochondrion (GO:0006626),0.3789517305121189,0.9951838151564038,0.5160575858250277,0.9376716630458405,1.0,17/52,28.04%,TIMM50;GDAP1;TIMM10B;TIMM9;AGK;GRPEL2;HSP90AA1;IMMP1L;TIMM22;TIMM8B;BCAP31;TOMM5;TIMM17A;FIS1;TOMM40;NDUFA13;PITRM1
prerank,rRNA pseudouridine synthesis (GO:0031118),0.48950602086547546,0.9951266094894485,0.48450704225352115,0.9372497337083244,1.0,2/10,9.45%,RPUSD1;GAR1
prerank,positive regulation of T cell cytokine production (GO:0002726),0.4343769642993768,0.9947154689270503,0.4883148831488315,0.937848332385345,1.0,7/20,24.62%,CD55;CD81;IL4;IL6;IL18;MAP3K7;PRKCZ
prerank,positive regulation of cell junction assembly (GO:1901890),0.37831014134145585,0.9946658458813739,0.487292817679558,0.9374122498572441,1.0,5/56,5.35%,MYOC;EPHB2;VEGFA;S100A10;PTPRJ
prerank,regulation of isotype switching (GO:0045191),0.45616621793191453,0.9945970181498829,0.5027027027027027,0.9370222188926555,1.0,4/14,14.82%,PARP3;HMCES;SLC15A4;IL4
prerank,platelet aggregation (GO:0070527),0.39910262182177164,0.9945578002621007,0.49883720930232556,0.9365338383978987,1.0,10/33,21.27%,GNAS;ITGB3;PDGFRA;ACTG1;PPIA;ILK;FLNA;TYRO3;METAP1;PIK3CG
prerank,mitotic metaphase plate congression (GO:0007080),0.377220962976172,0.9941437870594593,0.5188781014023732,0.9371126024691581,1.0,13/51,22.87%,CHAMP1;ZW10;CHMP7;PSRC1;VPS4B;CUL3;CDC23;PIBF1;CENPC;CENPE;PDCD6IP;DCTN2;RMDN1
prerank,insulin receptor signaling pathway (GO:0008286),0.36360803852970414,0.9937322821673321,0.498936170212766,0.9376579407713876,1.0,19/69,16.88%,IRS1;GRB10;PIK3R2;ATP6V0A2;SLC39A14;FOXO1;PIK3CA;FOXC2;RHOQ;AKT1;ATP6V1E1;IRS2;ATP6AP1;FER;ATP6V0A1;ATP6V1D;ATP6V1B2;SOS1;IDE
prerank,purine-containing compound biosynthetic process (GO:0072522),0.4127004415671433,0.9936830346749049,0.4783683559950556,0.937203365597558,1.0,6/25,16.62%,AMPD2;PAICS;GART;PRPSAP1;PRPS1;PRPS1L1
prerank,negative regulation of DNA binding (GO:0043392),-0.30162664061971184,-0.9935895998897535,0.4935064935064935,0.8132278864312142,1.0,2/28,0.77%,LEF1;SP100
prerank,negative regulation of phosphatase activity (GO:0010923),0.4198780424626525,0.9935278623999843,0.4970344009489917,0.9370542025753434,1.0,13/25,30.20%,TGFB2;PPP1R1B;URI1;CHP1;SH2D4A;FKBP1A;TIPRL;PPP1R26;CRY2;PTPA;GPATCH2;FKBP1B;BOD1
prerank,release of cytochrome c from mitochondria (GO:0001836),0.4409811797490737,0.9934838716428346,0.5006305170239597,0.9365757871610308,1.0,4/17,12.73%,TIMM50;BAK1;SFN;BBC3
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.46050846657916783,0.9932561376134358,0.49445983379501385,0.9366029933912857,1.0,5/15,18.58%,ENTPD2;NME2;CMPK2;AK8;ENTPD6
prerank,tRNA wobble base modification (GO:0002097),-0.36262370490219265,-0.9931961421431009,0.4728682170542636,0.8124054554350381,1.0,2/14,3.45%,ELP3;TRMT9B
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3791474229645685,0.9931527382506723,0.49173098125689085,0.9363331348495593,1.0,17/49,24.14%,EIF2AK3;S100A8;S100A9;SRC;NOC2L;SIAH1;HERPUD1;URI1;BMF;BBC3;NUPR1;BCAP31;PLAUR;MCL1;PYCARD;CYLD;FIS1
prerank,cellular response to UV (GO:0034644),0.3650972113164278,0.9931440906285315,0.508994708994709,0.9357740062537517,1.0,23/76,22.85%,TRIAP1;MMP2;CRIP1;CARD16;NOC2L;ZBTB1;RHNO1;NPM1;ACTR5;BMF;BAK1;ERCC4;CDKN1A;DDB1;EIF2S1;INO80;POLD1;SMPD1;OPN3;NSMCE3;ATF4;SDE2;ERCC1
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.29911723216164915,-0.992855022182411,0.43209876543209874,0.8114423526243673,1.0,9/29,13.28%,FLT1;PRKD1;KIT;DGKZ;EPHA8;PDGFRB;TEK;TGFB1;PTK2
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.38886151017094833,0.9927932128427948,0.48667439165701043,0.9361338970510845,1.0,9/39,11.30%,MAPK7;VEGFA;AKNA;GTPBP4;MIA3;MYADM;FXYD5;JAG1;AKT1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.35128097015127757,-0.9927677242815938,0.5020576131687243,0.8097517151666467,1.0,8/15,26.63%,TNK2;PIK3CB;HIP1R;DAB2;NEU3;SCYL2;AAK1;SMAP1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.47424873793255545,0.9926607375341789,0.5038860103626943,0.9359275031596566,1.0,8/12,31.70%,RFWD3;FBXO31;RPS27L;CCND1;SDE2;PRKDC;TP53;WAC
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.3575167371727992,-0.9922796826574876,0.44802867383512546,0.8090601196189576,1.0,7/15,21.58%,RPS7;DTX3L;ABL1;RPL5;MAD2L2;BAG2;MAD2L1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.30722182774858914,-0.9922534672158836,0.48295454545454547,0.8072287098496815,1.0,7/23,12.16%,ENG;SMAD3;LTBP4;ITGA3;TGFBR3;TRIM33;TGFB1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.3447724503105203,-0.9922424452712221,0.4863636363636364,0.805349189628726,1.0,7/17,23.62%,APOE;ABCG1;FGF1;SOD1;MBTPS2;ABCA2;ERLIN2
prerank,inositol phosphate catabolic process (GO:0071545),0.48131036186063475,0.991747729017789,0.4937413073713491,0.9379092359858889,1.0,5/12,27.86%,OCRL;INPP5K;INPP5B;PTEN;SYNJ2
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.38257677264230766,0.9917313789199542,0.4880817253121453,0.9373619524339781,1.0,12/40,20.60%,EME1;TIPIN;RFWD3;ETAA1;CDK9;DDX11;THOC1;FAM111A;BLM;POLD1;SMARCAL1;DONSON
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3631979704080849,0.9916125083402502,0.5005268703898841,0.937080598025807,1.0,17/72,18.45%,POLR2H;GTF2H3;COPS5;ERCC3;UBA52;ERCC4;POLR2D;POLR2G;DDB1;AQR;CCNH;USP7;UVSSA;RFC4;ERCC5;POLD1;COPS4
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.45351489302115033,0.9915220703185829,0.492772667542707,0.9367521054710748,1.0,9/16,31.28%,NUP98;RBM3;SF3B4;THRAP3;DAZAP1;CELF3;RBMX;CELF4;CIRBP
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.4866816714642514,0.9914508450561408,0.5040871934604905,0.9363789653027574,1.0,5/10,22.29%,JAM3;MUC1;PDE3B;SNAI2;CYP1B1
prerank,negative regulation of cyclase activity (GO:0031280),0.46184787587049014,0.9914121141388906,0.4899328859060403,0.9358928197673051,1.0,3/14,9.25%,GNAI3;PALM;LTB4R2
prerank,histone mRNA catabolic process (GO:0071044),-0.3579210290563559,-0.9910216594343193,0.4734848484848485,0.8068350134309974,1.0,6/15,16.74%,SSB;TUT1;TUT4;TUT7;ATM;MTPAP
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3357061646838735,0.9909904289067056,0.589,0.9365010493257845,1.0,302/1668,16.94%,LMX1A;EBF2;DCN;PRRX1;LIF;AR;LRP6;LHX8;ESR1;HOXA3;PAX9;EBF1;LOXL2;TRPS1;SP9;FOXP2;NFIX;IRF4;WNT2;EGFR;CREB5;TGFB3;WT1;ZFHX4;MEOX2;TRIAP1;TLE6;TBX15;SCRT2;ZNF367;HSF2;TADA1;CCNL2;SIX4;HOXA2;ELF4;HIVEP2;NEUROD2;MAPK7;SKIL;GTF2H3;ZMIZ1;DGKQ;VEGFA;KLF3;TSHZ2;FGF2;PBX1;KLF12;FOXP1;BHLHE40;TLX3;GLIS2;RUNX1;TEF;CRTC2;SMAD4;NFE2L2;HDAC9;ZNF25;PIK3R2;ATF5;WWTR1;DPF2;LMX1B;AKNA;MEF2D;SMURF2;SKI;MAPK14;PKD1;PAX1;COPS5;SOX10;ACVR1;CDK4;IRX5;HOPX;DACT1;RFX1;FOXK2;KLF2;TCF25;JUND;ZBTB12;NFATC4;MED13L;MAFF;TCF7L2;MRGBP;NR1D2;ATP2B4;NFATC1;CBX4;RBAK;HOXA5;CAMK2D;CREB3L1;SMARCD2;MEIS2;FOXO1;IL33;AKIRIN1;NR1D1;PIAS3;NFIB;RTRAF;EBF3;ZBTB7C;CXCL10;NCOA3;CREBZF;MUC1;SSBP3;NFIA;RNF111;ZFHX3;DPF1;C1QBP;ARF4;MDM4;MLXIPL;SMAD5;ACTR3;MYT1;MTF1;HOXA4;SIN3B;PID1;SMARCD1;ADCYAP1;GLI2;ZFPM2;TBX6;NOC2L;BRD9;RNF2;MAMSTR;FLCN;FOXL1;PRKD2;PKD2;ETV3;CD81;STAT5A;SOX8;CHUK;ZBTB1;WDR77;VDR;NR6A1;MYBL2;ZNF260;KDM3B;PSEN1;FOXC2;AGO2;JAG1;CDK9;SIRT2;TLR4;ATXN7L3;SOX5;BEX1;RCOR3;ELP4;ONECUT1;KAT2B;MED24;ATAD2B;RHOQ;SMAD6;RNF10;SATB2;BRD7;HELZ2;ZMYM5;MYPOP;OTUD7B;SQSTM1;ZNF3;CHD2;HDAC3;NPM1;URI1;MZF1;TAF3;TCERG1;MITF;PRDM15;ATF7;SMARCC2;IRF2BPL;CSRNP3;BCL6;ZHX2;TOX2;SLC30A9;CEBPB;GLI3;DCAF6;ZNF462;TNIP1;SLC9A1;AKIRIN2;UBA52;KANSL3;JUP;ZFP36;BACH2;LIN9;CCNC;KDM5B;ZNF691;DR1;ZNF112;NCOR2;GDNF;ATF1;DDX17;PEG3;CDKN1A;PIN1;MED13;NCOR1;IKZF5;PROX2;CCND1;CRYM;TWIST1;BRIP1;RAI1;SIX1;DNAJA3;NACC2;HDAC4;RFX5;PLAGL1;EZH1;NME2;ZC3H12A;CCNH;EHMT2;ZNF569;PLAGL2;DMAP1;EAF2;KLF4;HOXA7;BCL9;CTDP1;PTOV1;HOXC4;INO80;BCAS3;HOXA9;HSBP1;PPP3CA;POU3F2;IL4;ZNF692;SMARCA4;GTF2F1;CHD8;CCNQ;MLXIP;DDX20;NFE2L3;NR2C2;YEATS2;NOP53;SRCAP;E2F3;PPIL4;HMGB3;RNF14;AHI1;ZFP28;ZBTB25;MED15;ZBTB5;PSIP1;UBP1;PER1;HIVEP3;IL6;HGF;BAZ2B;NCK1;OGT;STAT5B;ANXA4;CHD1;DDX5;SNAI2;CHD3;E4F1;BCLAF3;TFAP4;ZEB1;SAP18;AGO4
prerank,lipid biosynthetic process (GO:0008610),0.3657362681639955,0.9907824538469349,0.5121436114044351,0.9364957206982769,1.0,19/77,19.72%,GPAT4;ACLY;MVK;SCP2;SRD5A1;GGPS1;NDUFAB1;AGPAT3;LPCAT1;AGPAT5;FADS1;HSD17B8;GPAM;LIPC;LIPH;SREBF1;ABCD3;MCAT;SCD5
prerank,arachidonic acid metabolic process (GO:0019369),0.39448381326787946,0.9907672604822134,0.504093567251462,0.9359450868121552,1.0,7/35,17.77%,MGLL;CYP2S1;DAGLA;GPX1;PNPLA8;DAGLB;EPHX1
prerank,regulation of glycolytic process (GO:0006110),-0.2459343302193755,-0.9904070993901982,0.4393939393939394,0.8066462756134299,1.0,11/68,7.79%,PRKAG2;INSR;IGF1;APP;PRKAA2;CBFA2T3;PPARA;NUP35;NDC1;RAE1;PGAM1
prerank,protein catabolic process (GO:0030163),0.37360092820736646,0.9895295283922385,0.5048439181916039,0.938690734858769,1.0,22/59,24.38%,MTOR;NR1D1;OGA;TPP1;FBXO2;CLPX;SIAH1;FBXO17;UBE2G2;DDB1;HSP90AA1;NGLY1;SOCS6;HTRA2;IDE;CTSD;UBE2G1;LRSAM1;RNF41;USE1;TRIM24;RAB12
prerank,protein localization to condensed chromosome (GO:1903083),0.47340502466816503,0.9894483852589828,0.5020746887966805,0.9383195755182043,1.0,2/12,4.97%,CHAMP1;ZW10
prerank,protein modification by small protein conjugation (GO:0032446),0.3418340657434312,0.9893800851388642,0.537,0.9379040140093764,1.0,133/361,27.84%,TSPAN17;MIB2;UBE2B;NEUROD2;SPSB1;SPSB4;STX1A;NFE2L2;UBA6;UBE2J2;SMURF2;RNF212B;FBXW8;SYVN1;NUP93;ITCH;RFWD3;PIAS3;MSL2;GAN;RNF111;SPSB2;NUP107;STUB1;UBA2;MYCBP2;UBE2N;UBE2W;FBXO2;NUP98;MYLIP;CUL3;FBXL2;UBE2G2;ASB12;HECW2;CDC23;TRIM11;RNF7;UBE2A;UBA52;CDC34;USP5;BSPRY;DDB1;FBXL3;CDC27;PEX12;CUL9;CBL;AMFR;USP7;UHRF2;UFC1;TRPC4AP;KLHL41;NUP37;UVSSA;RNF14;TRIM68;SELENOS;RNF187;ZSWIM8;HACE1;RNF138;KEAP1;UFL1;UBE2G1;FBXL5;FBXO11;PEX5;VPS11;ARIH2;NUP50;UBE2R2;UFM1;NEDD8;PCNP;BRAP;UBE2D3;TRIM35;ARIH1;RNF41;CUL5;KCTD10;SAE1;PEX2;PAF1;ARRB1;ATG3;UBE2Q2;KLHL9;SMURF1;FBXO24;DERL1;RNF6;UBE2Z;FBXW11;SDE2;UBR2;TPR;LZTR1;DTX2;ATG10;TRIM24;RTF1;NSMCE2;RNF157;MKRN2;TRIM44;NUP133;MDM2;BCL11A;NUP85;UBA7;VHL;RNF20;FBXW7;UBE2K;NUP188;MUL1;OTULIN;UBE2F;NUP88;DCUN1D1;CUL7;PRKDC;URM1;BCL10;VCPIP1;DTX3;EIPR1;WWP1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.4487064996134934,0.9893508676415632,0.5098814229249012,0.9373975067094311,1.0,3/16,12.04%,PRKCA;CAMK2D;SLC9A1
prerank,serine family amino acid catabolic process (GO:0009071),-0.4047782870398219,-0.9891892576843004,0.468013468013468,0.8079289007672104,1.0,8/10,37.13%,DLD;CBS;GCSH;THNSL2;SHMT2;SHMT1;AMT;DAO
prerank,negative regulation of autophagy (GO:0010507),0.37531665891512705,0.9890506339054865,0.5108225108225108,0.9376437472590743,1.0,26/54,30.72%,USP36;FOXK2;MTOR;IL10RA;PIK3CA;SIRT2;NRBP2;AKT1;BMF;SMCR8;NUPR1;HGF;DAP;MCL1;QSOX1;TAB2;KLHL22;EIF4G3;LEPR;EIF4G1;CTSA;TSC1;ZKSCAN3;LZTS1;TLK2;RUBCN
prerank,post-translational protein modification (GO:0043687),0.3394080006995317,0.9890440470526217,0.539,0.9370819031952393,1.0,101/332,27.77%,IGFBP5;FSTL1;FBN1;WSB1;RABGGTA;GPC3;PSMC4;PRSS23;SPSB1;SPSB4;COPS5;BMP15;IGFBP4;FBXW8;CALU;VCAN;MIA3;SOCS2;CCDC8;WDTC1;COP1;TULP4;GAN;PSMC6;SPSB2;MELTF;GAS6;FBXO2;PSMD8;FBXO17;CUL3;DTL;SENP8;ASB12;FBXW4;LGALS1;FBXL20;WDR5;RAB2A;RNF7;DCAF6;FBXO31;DDB1;FBXL3;DCAF13;ASB8;CUL9;KLHL41;MXRA8;SOCS6;DCAF10;IL6;SDC2;KEAP1;CHRDL1;RAB1B;FBXL5;FBXO11;COPS4;NEDD8;SKP2;LAMC1;KCTD6;FBXL19;FBXW9;FBXW2;QSOX1;CUL5;PRKCSH;ICMT;CSF1;KLHL9;SUMF2;FBXW11;KLHL22;SPSB3;DCAF5;KLHL11;PSMD3;GPS1;FBXL12;PSMD4;DNAJC3;RABGGTB;SERPINC1;HSP90B1;VHL;FBXO22;RAB1A;FBXW7;FBXO30;PSMB3;UBE2F;MBTPS1;DCUN1D1;CUL7;MEN1;FBXO41;PSMB2;COPS6;CHML
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.4116443856757454,0.9889847760368372,0.4951807228915663,0.9366579829902755,1.0,6/26,17.07%,PRKCA;SMOC2;MEIS2;CUL3;USP22;TTL
prerank,negative regulation of DNA replication (GO:0008156),0.45923328074626085,0.9888814553742631,0.4888304862023653,0.9363520544213728,1.0,3/13,14.84%,GTPBP4;TERF1;GMNN
prerank,regulation of membrane depolarization (GO:0003254),0.4287114319511845,0.988731990087211,0.4967989756722151,0.9361698592153601,1.0,3/18,10.04%,FHL1;CAMK2D;HCN4
prerank,DNA replication (GO:0006260),0.3585201190828595,0.9886053358697762,0.5122448979591837,0.9359521540607377,1.0,34/105,25.20%,REV3L;TIPIN;IGHMBP2;NT5M;RHNO1;POLG2;POLB;POLE3;ING4;MCM3;RMI1;RAD1;PCLAF;DNA2;BRIP1;ORC6;DBF4;NBN;FAM111A;RFC4;GRWD1;RAD50;SET;BLM;TBRG1;POLD1;DONSON;KIN;CLSPN;REV1;ORC2;BAZ1A;KAT5;KAT7
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.36037437145644435,0.9883058096340792,0.5,0.9362209924092095,1.0,24/80,23.56%,TGFB3;SAXO1;PLCE1;CDC42EP2;NDEL1;AKIRIN1;FSCN1;ACTR3;PALM;PIK3CA;RHOQ;AVIL;BBS4;BCAS3;EPS8L2;CCP110;ARAP1;ARPC2;GPM6A;ENTR1;RALA;CROCC;CCDC88A;DOCK11
prerank,ureteric bud development (GO:0001657),0.4363460591387697,0.9882886981868795,0.5032679738562091,0.9357001585979912,1.0,4/17,7.85%,WT1;GPC3;SLIT2;PKD2
prerank,positive regulation of apoptotic process (GO:0043065),0.3388766289990254,0.9881875366798293,0.552,0.9354094278987948,1.0,77/293,22.57%,SFRP4;WNT10B;KCNMA1;SCIN;TGFB3;AKAP13;FAP;GADD45G;RPS6KA2;TGFB2;SLIT2;BIN1;TRIO;ADAMTSL4;MTCH1;HOXA5;FOXO1;PRMT2;RASSF2;C1QBP;ARHGEF3;PIP5KL1;AIFM2;FLCN;SIAH1;PSEN1;SIRT2;PDCD2;RYBP;ING4;TIAM2;SQSTM1;CSRNP3;BCL6;BMF;ERCC3;UBA52;BAK1;NGEF;QRICH1;DIABLO;ZC3H12A;STK3;MLLT11;MTCH2;CALHM2;NUPR1;DDX20;HRK;NLRP2B;IL6;SOS1;HTRA2;TFAP4;PTRH2;SAP18;CTSD;EEF1E1;IAPP;TGFBR1;SMPD1;SUDS3;APAF1;CLIP3;GPLD1;TRIM35;BACE1;ATF6;TIAM1;PYCARD;BTG1;JUN;NF1;ATF4;CYP1B1;UBE2Z;RBM5
prerank,cellular response to organic cyclic compound (GO:0071407),0.3478058501665366,0.987916631580465,0.5248730964467005,0.9355515606272655,1.0,32/141,19.26%,IGFBP5;AR;ESR1;EGFR;WT1;ATP1A3;ATP1A1;P2RX3;ZFP36L1;RAP1B;NCOA3;PKD2;INPP5K;HCN4;URI1;SSH1;SLC26A6;JUP;LARP1;ADCY8;EPG5;GNB1;ZC3H12A;RAPGEF1;DIAPH1;SPIDR;AKAP9;IL18;BLM;NRIP1;HCN1;GABRG2
prerank,embryonic organ development (GO:0048568),0.3691177851441456,0.9875752750204152,0.5178378378378379,0.9359084529441797,1.0,14/61,13.07%,PCSK5;TGFB2;PBX1;TGFBR2;COBL;GLI2;FLT3LG;NDRG4;COL2A1;GLI3;ERCC3;TBC1D23;ALDH1A3;GDNF
prerank,axonogenesis (GO:0007409),0.3426533879441279,0.9872141603680348,0.5495495495495496,0.9362838964616033,1.0,55/237,18.12%,SEMA3C;EPHB2;PRKCA;MAP1B;EFNA5;NPTN;GRB10;EPHA3;FYN;MAPK7;SLIT3;SLIT2;NTN4;LLGL1;SLIT1;SPTAN1;DOK1;UNC5A;SPTA1;DOCK7;PDLIM7;RET;SRC;GLI2;S100A6;SEMA3A;PIK3CA;SIAH1;DOK4;USP33;EPHB3;DSCAM;UNC5D;L1CAM;EPHA10;IRS2;ULK2;SEMA3D;LGI1;TAOK2;IGSF9;GDNF;PALLD;ULK1;ARTN;DCC;HSP90AA1;SLC9A6;SPTBN1;SOS1;NRXN3;CXCR4;SHTN1;CNTN4;EPHB1
prerank,cellular response to arsenic-containing substance (GO:0071243),0.4516965262563905,0.9870071025578792,0.4946236559139785,0.9362757942475086,1.0,3/15,17.76%,HNRNPA1;ZC3H12A;GSTO2
prerank,regulation of neuroblast proliferation (GO:1902692),-0.3481027595200248,-0.9864723798647647,0.47104247104247104,0.8133496618321943,1.0,5/15,16.62%,PTN;CX3CL1;SMARCD3;CTNNB1;DISC1
prerank,ketone body metabolic process (GO:1902224),-0.3974296241137307,-0.9863167552674428,0.47491638795986624,0.8119264816054748,1.0,3/10,9.59%,ACSS3;HMGCS2;AACS
prerank,negative regulation of developmental growth (GO:0048640),0.40313493653275334,0.9858158809715696,0.48263473053892214,0.9389002560778785,1.0,8/30,14.33%,FGF13;PTPRS;TRIM46;SLC6A4;ULK2;CDKN1A;ULK1;DCC
prerank,positive regulation of nervous system process (GO:0031646),-0.33298620063830126,-0.985702747633603,0.465,0.8115411344381253,1.0,2/18,0.93%,UNC13B;TENM4
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.3514572091606292,0.9851831624642299,0.5133196721311475,0.9400751427070609,1.0,32/102,20.69%,IRS1;HDAC9;PIK3R2;ZFP36L1;SLC39A14;FOXO1;SRC;MYO5A;CRHR1;INSIG2;SYAP1;KAT2B;INPP5K;RHOQ;AKT1;TSHR;IRS2;ADCY8;PDE3B;LHCGR;FER;PKM;SELENOS;CPEB1;EPRS1;VAMP2;CAPN10;PRKAR2A;GPLD1;LPIN3;GOT1;RAB10
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.4331785521517141,0.9849307300512218,0.5056890012642224,0.9401665522201196,1.0,3/20,12.28%,SEMA3C;SEMA3A;SEMA3D
prerank,positive regulation of interferon-beta production (GO:0032728),-0.27954304724921003,-0.9848325234915805,0.45454545454545453,0.8119178927598382,1.0,7/33,10.03%,TRIM56;POLR3C;MAVS;POLR3B;TLR3;OAS2;RNF135
prerank,homotypic cell-cell adhesion (GO:0034109),0.3867123178360562,0.9846810027328435,0.5117845117845118,0.9402903863124913,1.0,12/39,21.27%,GNAS;ITGB3;PLPP3;DSC2;PDGFRA;ACTG1;PPIA;ILK;FLNA;TYRO3;METAP1;PIK3CG
prerank,cardiac cell development (GO:0055006),0.4845239882137852,0.9845440123626851,0.5098870056497176,0.9401001394530866,1.0,3/11,10.89%,VEGFA;JAG1;ALPK2
prerank,negative regulation of defense response (GO:0031348),0.3544469661238491,0.9844905530465671,0.5207900207900208,0.9397003745287545,1.0,15/77,15.96%,MAPK7;IRAK3;METRNL;ITCH;MVK;NR1D1;C1QBP;SIRT2;FNDC4;SIRPA;KLF4;IL4;LRFN5;SELENOS;ILRUN
prerank,negative regulation of endothelial cell migration (GO:0010596),0.39084498371264803,0.9844178297260727,0.518213866039953,0.9393241254456135,1.0,5/36,5.24%,DCN;ANGPT4;FGF2;SLIT2;ATP2B4
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.3572163713729107,0.9840045033988609,0.5270988310308182,0.9398323425913212,1.0,15/75,12.37%,PRKCA;FGFR1;ANG;ITGB3;VEGFA;FGF2;ECM1;THBS4;PRKD2;STAT5A;AKT3;EMC10;NRAS;AKT1;EGF
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.48607851228393856,0.98390992254186,0.5127478753541076,0.9395396280635111,1.0,3/10,11.89%,INPP5F;PARP14;PIBF1
prerank,positive regulation of peptidase activity (GO:0010952),0.4271572751677859,0.9837451479855746,0.5269761606022585,0.939406409626537,1.0,2/20,6.12%,MAPK12;RCN3
prerank,entry into host (GO:0044409),0.45712773140248797,0.9837138992855091,0.4924965893587995,0.938909909154208,1.0,5/13,17.21%,SRC;ITGAV;CBL;CXCR4;PPIA
prerank,mitochondrial transcription (GO:0006390),-0.3902679401473794,-0.9835932958256371,0.5083612040133779,0.8134678750195927,1.0,6/10,25.88%,TFB1M;MTERF2;TEFM;POLRMT;TWNK;TFB2M
prerank,DNA metabolic process (GO:0006259),0.34221881819836525,0.9833981724671517,0.5665665665665666,0.9392322940860254,1.0,59/270,19.01%,MPG;PARP3;INTS3;UBE2B;GTF2H3;XRCC3;CTC1;NUDT1;RAD51B;TCF7L2;KPNA2;IGHMBP2;UBE2N;ACD;INIP;ZBTB1;FANCL;DNASE2;SAMHD1;POLB;POLE3;PARG;MCM3;SMC1A;NPM1;DDX21;POLI;ERCC3;UBE2A;UBA52;CDC34;RAD1;ERCC4;FAN1;XRCC5;DDB1;TERF1;DNA2;ORC6;DBF4;FANCG;NBN;INO80;USP7;UHRF2;GMNN;DNASE1L2;NOP53;RFC4;HMGB3;RECQL;RAD50;ERCC5;BLM;POLD1;SUPV3L1;TINF2;TOP2B;NOC3L
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.46504547288391135,0.9831461009118722,0.5048143053645117,0.9393595488155193,1.0,4/12,22.87%,CHAMP1;CENPC;CENPE;RMDN1
prerank,cellular protein metabolic process (GO:0044267),0.3358213591501873,0.9830818510907195,0.552,0.938975695939875,1.0,85/396,21.35%,PLOD2;IGFBP5;FSTL1;RPSA;FBN1;LOXL2;RABGGTA;PCSK5;GPC3;PRSS23;MRPS11;MMP2;IGFBP6;RRBP1;TMEM208;COPS5;BMP15;IGFBP4;MRPS18B;GGCX;CALU;MSRB1;VCAN;MIA3;PHKA2;SPCS1;IGHMBP2;MELTF;ABL2;GAS6;FBXO2;MRPL13;MRPS17;PSEN1;AGO2;SEC11C;FBXL2;UBE2G2;LGALS1;GSPT2;RPL10A;CSNK1G3;MRPL10;CSF2RA;DMBT1;MRPL55;NAPSA;TNIP1;UBA52;CDC34;RPS5;ZDHHC2;MRPL36;MRPL3;GSPT1;MXRA8;RPL6;MRPL51;HARS1;IL6;HTRA2;SDC2;IDE;SPG7;ABCF1;CHRDL1;UBE2G1;FBXO11;ST3GAL1;ADPRH;FDX1;LOX;STK38;NEDD8;RPL23;RPL17;UBE2D3;LAMC1;FBXW2;QSOX1;D2HGDH;PRKCSH;RPS25;ICMT;YES1
prerank,methylguanosine-cap decapping (GO:0110156),0.4832974834718927,0.9829939862919501,0.5014450867052023,0.9386428438400435,1.0,7/10,29.68%,EDC4;PNRC2;EDC3;DCP1A;DCP1B;LSM1;PATL1
prerank,response to exogenous dsRNA (GO:0043330),0.4310368070844118,0.9829391158033144,0.5037783375314862,0.9382223050275091,1.0,3/18,6.69%,IRAK3;RFTN1;CGAS
prerank,neuron development (GO:0048666),0.34688218925261505,0.9828774371295457,0.5307150050352467,0.9378128397341332,1.0,38/141,18.29%,MYOC;UGDH;TGFB2;PBX1;RUNX1;RASGRF1;UNC5A;TENM3;DOCK7;DTNBP1;LRP12;ADCYAP1;GLI2;TOR1A;PLP1;L1CAM;CAMSAP1;MAPT;GBA2;TBC1D23;UNK;FLRT3;LGI1;GDNF;ULK1;THOC2;ATCAY;BLOC1S2;POU3F2;MANF;MAP4;SNAPIN;IL6;RAB35;PPP1R9B;STX3;CNTN4;GPM6A
prerank,cellular response to DNA damage stimulus (GO:0006974),0.338657912246838,0.9827996255543785,0.549,0.9374484480889536,1.0,73/336,17.49%,PARP3;MAPK12;INTS3;ZDHHC16;UBE2B;GTF2H3;XRCC3;FOXP1;CDKN2AIP;CRIP1;UBA6;TAOK3;MAPK14;NUDT1;RAD51B;RFWD3;USP10;FOXO1;RBBP6;ETAA1;ALKBH7;IGHMBP2;CGAS;PHF1;HMCES;INIP;ZBTB1;TIGAR;FANCL;PSEN1;SETD7;DTL;SAMHD1;POLB;POLE3;SMC5;DYRK2;SMC1A;NPM1;BCL6;POLI;FBXO31;ERCC3;UBE2A;BAK1;RAD1;ERCC4;FAN1;XRCC5;SFN;PCLAF;TAOK2;CDKN1A;BCL3;DDB1;CCND1;SMC6;TNFRSF1B;DDX11;ZC3H12A;FANCG;NBN;INO80;FAM111A;NOP53;RFC4;RECQL;HTRA2;SPIDR;UFL1;PML;RAD50;NEK4
prerank,myeloid leukocyte differentiation (GO:0002573),0.36660049575864073,0.9827872265628496,0.511578947368421,0.9369139125728899,1.0,8/65,7.43%,VEGFA;FOXP1;TGFBR2;RUNX1;MAPK14;CDK4;FARP2;OSTM1
prerank,activation of protein kinase activity (GO:0032147),0.35008275074950534,0.9825775679594875,0.5254065040650406,0.936916658685467,1.0,20/106,14.82%,GHR;ANG;ITGB3;VEGFA;TGFB2;TGFBR2;TAOK3;AXIN1;MTOR;GAS6;STRADA;TIRAP;CALCA;AKT1;IRAK1;PIBF1;ADCY8;TAOK2;STK3;IL4
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.4596796634203686,0.9825187793140365,0.5190735694822888,0.9365124838306119,1.0,5/13,19.47%,ABT1;KRI1;NOP9;RCL1;TBL3
prerank,regulation of sodium ion transport (GO:0002028),-0.2753812638927361,-0.9823865011139797,0.4482758620689655,0.8147196189784038,1.0,10/34,12.41%,WNK4;YWHAH;AHCYL1;DLG1;GPD1L;SIK1;NKAIN4;NKAIN3;NOS1;NKAIN1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.4659470627197258,0.9823212183129493,0.5040214477211796,0.9364727536945299,1.0,3/12,9.97%,ITGB3;ABCA1;ITGAV
prerank,regulation of phosphorylation (GO:0042325),0.3491382770652318,0.9822520059879313,0.5483214649033571,0.9361032517519533,1.0,43/120,25.39%,AR;EGFR;GLMN;CCDC88C;ANG;MIF;NUP93;INHA;NUP107;FLCN;FZD7;NUP98;PSEN1;SIRT2;DSCAM;EIF6;EGF;CDKN1A;PIN1;FER;IL4;NOP53;NUP37;KCTD20;OGT;PML;ILK;NUP50;CORO1C;CDKN2C;SESN2;LDB2;LDB1;CCDC88A;STAT2;TPR;SDCBP;ANKLE2;ATG14;DYNLL1;NUP133;NUP85;GRM5
prerank,regulation of lipid storage (GO:0010883),0.4233481590560516,0.9819279458536648,0.5111386138613861,0.9364127234425761,1.0,5/22,16.30%,ITGB3;ALKBH7;ITGAV;ZC3H12A;IL6
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.4658953702470845,0.9817065879921486,0.5178571428571429,0.9364309493419956,1.0,3/13,9.25%,GNAI3;PALM;LTB4R2
prerank,maintenance of protein localization in organelle (GO:0072595),0.4288083060095476,0.9813253697155925,0.49496221662468515,0.9368706067538053,1.0,6/19,16.87%,TAF8;TAF3;AKT1;BCL3;BBS4;PML
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.3599725882393836,-0.9811998891567147,0.47101449275362317,0.8160210361241574,1.0,6/14,21.08%,DMD;WNK4;ATP1B1;GLRX;ACTN4;ANK3
prerank,histone modification (GO:0016570),0.35223489669850483,0.9809257235177037,0.5547594677584442,0.9374176602713025,1.0,33/109,22.80%,UBE2B;HDAC9;USP36;MRGBP;PRMT2;NTMT1;HDAC6;SIN3B;EYA2;UBE2N;MSL3;SIRT2;ATXN7L3;RCOR3;PHC1;UBE2A;HDAC4;EHMT2;USP22;UFL1;PADI2;MORF4L1;NAA50;SUDS3;TAF6L;MIER1;TRRAP;NSD1;SGF29;CARM1;EZH2;KAT6B;BAZ2A
prerank,digestive tract morphogenesis (GO:0048546),-0.3570892490084968,-0.9808611843079634,0.45864661654135336,0.8150406879685584,1.0,6/14,15.57%,RBPMS2;FGFR2;SOX17;STRA6;BBS7;SOX11
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.3951259138729074,0.9803929225413506,0.5088547815820543,0.9382724779696786,1.0,8/29,19.45%,TARBP2;TRIM71;DGCR8;AGO2;PUM1;AGO4;SNIP1;AGO3
prerank,motor neuron axon guidance (GO:0008045),0.4477545310510576,0.9803707793706342,0.49673202614379086,0.9377645494004649,1.0,4/15,8.24%,SLIT2;SLIT1;NTN1;SEMA3A
prerank,positive regulation of filopodium assembly (GO:0051491),0.4184322915620585,0.9803534006665166,0.5024213075060533,0.9372351024842227,1.0,11/24,28.16%,TGFB3;FSCN1;PALM;RHOQ;BCAS3;ARAP1;GPM6A;RALA;DOCK11;WASL;NLGN1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.34543103914079465,0.9803473061465066,0.5390070921985816,0.9366917416920428,1.0,27/138,15.63%,AR;ESR1;POLR2H;GTF2H3;HDAC9;HDAC7;WWTR1;TAF8;NR1D2;NR1D1;VDR;NR6A1;CDK9;KAT2B;HDAC3;TAF3;ERCC3;POLR2D;DR1;POLR2G;NCOR2;NCOR1;GTF2A2;CCNH;GTF2F1;NR2C2;E2F3
prerank,regulation of cell adhesion (GO:0030155),0.346894264427679,0.9802913934285487,0.5428571428571428,0.9362781545606635,1.0,24/129,10.55%,EPHB2;PRKCA;EFNA5;VEGFA;FUT2;DACT2;MIA3;PTPRJ;ZFHX3;MYADM;C1QBP;RET;SRC;TGFBI;ADAM22;ABL2;FLCN;PRKD2;TNFRSF18;STX4;PLXNA3;ITGAV;EPHB3;DSCAM
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.3436111748450714,-0.9801436720001684,0.459915611814346,0.8150871153569988,1.0,4/17,9.13%,RAPGEF2;ADRA1B;ADRA2A;ADCY9
prerank,negative regulation of receptor binding (GO:1900121),0.48351110499288263,0.9801052038137533,0.5098591549295775,0.9361940682941495,1.0,3/10,13.33%,PTPRF;ADAM15;ATP2A2
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.41832604735816176,0.9799934260756361,0.4863861386138614,0.9359665924472977,1.0,7/20,22.52%,ZFP36L1;HOXA5;MEIS2;ZFP36;HOXA9;PAF1;LDB1
prerank,regulation of response to biotic stimulus (GO:0002831),0.4027245164990237,0.9798299188375781,0.5017835909631391,0.9358380884252857,1.0,4/28,9.65%,CD55;FOXP1;TIRAP;SAMHD1
prerank,protein polyubiquitination (GO:0000209),0.3366889003099821,0.9793618620570725,0.5635635635635635,0.936500601580827,1.0,103/297,26.47%,WSB1;MIB2;PSMC4;UBE2B;SPSB1;HECTD2;UBE2J2;SMURF2;FBXW8;SYVN1;TRIM71;ITCH;RBBP6;PSMC6;RC3H1;PELI3;LNPEP;STUB1;ANKRD39;UBE2N;UBE2W;FBXO2;PSMD8;MAGEL2;SIAH1;FBXO17;MYLIP;CUL3;DTL;UBE2G2;FBXW4;HECW2;FBXL20;CDC23;ANAPC5;FBXO31;UBE2A;UBA52;CDC34;THOP1;UNKL;NPEPPS;FBXO28;FBXL3;TRAF3IP2;CDC27;AMFR;RNF216;RNF14;TRIM68;RNF187;TRAF3;RBCK1;HACE1;CDC26;UBE2G1;FBXL5;FBXO11;ANAPC4;ARIH2;UBE2R2;SKP2;RNF19A;UBE3C;LRSAM1;UBE2D3;FBXL19;TPP2;FBXW9;FBXW2;ARIH1;RNF41;ANAPC10;RC3H2;UBE2Q2;SMURF1;UBE3A;RNF6;FBXW11;UBR2;RNF114;TRIM36;IFI27;TRAF5;FBXO38;PSMD3;FBXL12;PSMD4;MDM2;RNF166;FBXO22;RNF20;FBXW7;FBXO30;ZNRF2;RNF126;PSMB3;UBE2K;RNF167;ANAPC2;PRPF19;RNF31;MUL1
prerank,negative regulation of TOR signaling (GO:0032007),-0.2760494216870806,-0.9790750389260919,0.425531914893617,0.8161113182593944,1.0,9/36,16.50%,RNF152;UBR1;EPM2A;PRKAA2;SIRT1;ATM;SPAAR;SESN1;TNFAIP8L1
prerank,central nervous system development (GO:0007417),0.33972032033808663,0.9790133376446895,0.564128256513026,0.936875856488435,1.0,65/250,23.09%,GSN;DCLK1;SCIN;AFF2;VIT;UGP2;PBX1;TGFBR2;GLIS2;ZPR1;PKD1;ACAN;SOX10;VCAN;MARCKS;MEIS2;ALDH3A2;JRKL;NFIB;GRIN2D;ZFHX3;MTF1;ADAM22;TBX6;PKD2;TPP1;SOX8;NDRG4;SH3GL1;EEF1AKMT4-ECE2;GBA2;TBC1D23;HSPG2;KLK6;SLC23A1;ASIC2;MOG;SH3GL3;MDGA1;UFC1;CHD8;ALDH5A1;CDK5RAP2;AHI1;GRIN2A;CXCR4;QARS1;BTD;CNTN4;MBP;UFM1;EML1;NIPBL;SNTG2;COX7B;ITGAM;PITPNM1;PTEN;NF1;DCX;UBE3A;MAP1S;ECRG4;ANKLE2;NPTX1
prerank,regulation of phagocytosis (GO:0050764),0.3761657551537103,0.9788631510799428,0.514689880304679,0.9367348689892339,1.0,6/53,10.19%,SYK;SYT11;GAS6;ITGAV;CD47;SIRPA
prerank,positive regulation of cell population proliferation (GO:0008284),0.33679762476170577,0.9788219848319275,0.59,0.9362893921020394,1.0,67/423,14.21%,LIF;DDR2;AREG;AR;HAS2;AVPR1A;FGF18;FGF7;DPP4;WNT2;EGFR;TGFB3;IRS1;FGFR1;TMEM119;CTF1;BTC;VEGFA;FGF2;TGFB2;MST1R;FOXP1;F2R;TGFBR2;MIF;TIPIN;WWTR1;CDK4;CLCF1;TCF7L2;MEIS2;GLP2R;MLXIPL;S1PR2;PID1;ESM1;ZFPM2;TBX6;GAS6;FLT3LG;S100A6;DNAJA2;CD81;SOX8;CAPN1;WDR77;CUL3;STX4;ITGAV;CD47;NPM1;KRAS;AKT1;KIF20B;FBXO5;TSHR;UBE2A;IRS2;EGF;GDNF;FLT3;CDKN1A;HDAC4;NME2;CDC123;PDGFRA;FER
prerank,cellular response to UV-A (GO:0071492),0.47017571364887495,0.978483842959651,0.5076708507670851,0.936622423690637,1.0,1/11,2.85%,MMP2
prerank,postreplication repair (GO:0006301),0.3830015567038861,0.9780750943346871,0.5189309576837416,0.9371239816867528,1.0,15/45,24.47%,UBE2B;USP10;UBE2N;ZBTB1;DTL;POLI;UBE2A;UBA52;PCLAF;RFC4;POLD1;FAAP20;REV1;POLH;WDR33
prerank,mitotic spindle organization (GO:0007052),0.3443605555454771,0.9780585680207163,0.5561172901921132,0.9366073776908425,1.0,37/153,20.62%,GPSM2;DYNC1LI2;CLIP1;NDEL1;ZW10;KIFC2;AHCTF1;CENPT;NUP107;TOGARAM1;ZWINT;DYNC1LI1;NUP98;DYNC1I1;KIF2A;ARHGEF10;SMC1A;MAPRE1;PIBF1;SBDS;ABRAXAS1;RHOA;KIF3B;DYNC1H1;NUP37;MAP4;CENPC;PPP1CC;RCC2;CKAP5;CENPE;EML1;PAFAH1B1;WDR62;STAG2;FLNA;CLASP2
prerank,negative regulation of cell cycle (GO:0045786),-0.23385492668087574,-0.9775877437162407,0.5094339622641509,0.8182478617224243,1.0,14/73,12.16%,PTPRK;NR2F2;BMP7;SMAD3;PPP1R13B;FOXC1;CDK6;TAF6;BRINP3;INHBA;BMP2;CDKN1C;SCRIB;TGFB1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.34377325971319495,0.9775159853029148,0.5579053373615307,0.9374873946133369,1.0,27/186,11.60%,SFRP4;LRP6;DKK2;LRP1;TLE6;CCDC88C;PSMC4;GRB10;DACT3;IGFBP6;WWTR1;RBMS3;KREMEN1;AXIN1;IGFBP4;DACT1;TCF7L2;NFATC1;PSMC6;PSMD8;CUL3;TLE2;TSKU;ALPK2;ANKRD6;TPBG;GLI3
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.35105830993150694,0.9774361649169754,0.5379098360655737,0.9371126703221851,1.0,27/100,21.27%,DCN;MYOC;EGFR;FGFR1;FGF2;TGFB2;F2R;SRC;PIK3CA;FBXL2;PIK3IP1;IRS2;EGF;FLT3;TWIST1;CBL;PDGFRA;NOP53;HGF;PPP2R5B;PIP4K2C;IL18;DIPK2A;PIP4K2B;MAPK1;PTEN;PIK3CG
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.3592448976470345,0.9774223275421047,0.5450777202072539,0.9365912242779971,1.0,19/80,17.66%,SYK;TRIAP1;CD44;VEGFA;F2R;CARD16;SRC;GAS6;DPEP1;YWHAE;GPX1;AKT1;SFN;KLF4;GRAMD4;HGF;HTRA2;CTSD;BCAP31
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.4633510869676341,0.9773897664816795,0.5161725067385444,0.936112503976006,1.0,4/13,17.66%,EDEM1;EDEM2;UBE2G2;BCAP31
prerank,fluid transport (GO:0042044),-0.3704214984424108,-0.9773155461133133,0.4804270462633452,0.817104333204559,1.0,2/12,8.86%,PDPN;AQP11
prerank,sodium-independent organic anion transport (GO:0043252),0.48121405403684736,0.9771853820671583,0.5077574047954866,0.9360937776501858,1.0,1/10,0.43%,SLCO2A1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3409735186137274,0.9769365444075002,0.5819095477386935,0.9362098809981463,1.0,40/234,17.21%,DDR2;AR;LRP6;ESR1;WNT2;RAB7B;NEUROD2;VEGFA;IRAK3;S100A8;S100A9;CRTC2;MID2;PLPP3;COPS5;CARD16;DHX33;UBE2N;PRKD2;CHUK;TIRAP;TLR4;BEX1;NPM1;AKT1;IRAK1;UBA52;JUP;ADCY8;HDAC4;FER;STK3;SMARCA4;EDA;FZD4;TRIM68;RBCK1;IL6;FLOT2;PPIA
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.3180243799746589,-0.9766757212612472,0.4731182795698925,0.8168644083458076,1.0,6/22,14.71%,SLC16A2;NES;PTPRZ1;APPL2;MDK;TOX
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.37794234708957997,-0.9761461783914849,0.5085910652920962,0.8164774758997745,1.0,4/12,10.54%,SORBS1;IGF2;SORL1;SIRT1
prerank,cell cycle checkpoint signaling (GO:0000075),0.4641578740178677,0.9758741184277241,0.5225352112676056,0.9384267873414078,1.0,3/12,18.48%,ZW10;ZWINT;PRCC
prerank,regulation of dephosphorylation (GO:0035303),0.44867621447733136,0.9755941472108367,0.5431266846361186,0.9385966082694344,1.0,5/15,15.53%,SRC;INPP5K;SMG7;SMG6;MTMR1
prerank,chemical synaptic transmission (GO:0007268),0.3353806116789889,0.9755494012394298,0.5605605605605606,0.9381411212268448,1.0,67/284,23.09%,LRP6;LPAR3;SNCB;MTNR1B;APBA3;PMP22;CEL;RPS6KA2;CAMKK1;STX1A;APBA1;DLG4;SLC1A6;GABRR3;DLG2;GRIN2D;SLC18A3;RIT2;HTR1F;ERC2;SLC12A4;GRIA2;PLP1;CAMKK2;NAPA;FCHSD1;HCRT;SLC12A5;SNAP25;NSG1;ASIC2;DLGAP1;GABRG3;GAD2;CACNB1;GIPC1;GRID1;SNAPIN;GRIN2A;GRM1;CHRNA7;CHRFAM7A;SNPH;SYT1;AKAP9;CHRNA5;SYNJ2BP;HTR2C;VAMP2;MBP;PAFAH1B1;PRKAR2A;GABRG2;GRIA3;NOVA1;EXOC4;SLC12A6;STAC3;MAPK1;PTEN;SHISA6;NAPB;SDCBP;HTR2A;GRIK5;GRIK2;NPTX1
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.3070151535512109,-0.9752159377413437,0.46808510638297873,0.817149949270525,1.0,5/22,14.89%,APOD;ADRA2A;PPP2R5A;CEACAM1;GPER1
prerank,regulation of gene expression (GO:0010468),0.333146040806661,0.9751972076825032,0.64,0.9384862040637227,1.0,156/903,16.97%,CD34;SFRP4;AHNAK2;AR;GSN;EPHB2;AMH;ESR1;AHNAK;FGF18;SEC16B;AFF3;FGF7;C1QTNF1;BNC2;C1D;WT1;HPN;AFF2;MBNL1;TMEM119;PKP3;GLMN;SCRT2;EIF2AK3;PRDM8;ANK2;DGKQ;VEGFA;FGF2;TGFB2;MLF2;FOXP1;CAMK2N1;BHLHE40;RUNX1;MIF;ZPR1;NFE2L2;ATF5;WWTR1;CRIP1;LMX1B;RBMS3;MAPK14;USP36;CXXC1;ZFP36L1;CDK4;ADAM19;FOXK2;NAB1;MTOR;CLK1;COQ7;NR1D2;ATP2B4;TRIM71;SPIN4;RBAK;HOXA5;CREB3L1;DTNBP1;IL33;IGSF1;NFIA;TARDBP;ZFHX3;MYADM;TRIP4;MLXIPL;RC3H1;HDAC6;MYT1;NUP107;STX1B;PID1;GAS6;FLCN;PHF1;MSL3;SPTY2D1;FZD7;LARP4;VDR;MYBL2;PSEN1;AGO2;TLR4;HNRNPD;TDRD7;RYBP;ONECUT1;MAPK11;TSKU;SIRPA;MBNL2;SON;MUSK;CPSF4;HNRNPH1;MZF1;TRIM11;MITF;ALPK2;ACTR5;ATF7;GPX1;PARP14;BCL6;CEBPB;KRAS;AKT1;MAPT;SLC2A10;PUM1;LRRC19;ZNF462;IGF2BP1;NAT8;EGF;NDFIP1;LARP1;SMCR8;NWD1;GDNF;PEG3;PIN1;TWIST1;SIX1;HDAC4;SLC8A2;ZC3H12A;FADS1;KLF4;MOG;IL4;BTN3A3;NR2C2;RPL6;MAP2K2;RNF14;TRIM68;ACTG1;RNF187;TRAF3;PER1;IL6;DIP2A;SNAI2;CHD3;EFEMP1;PML;PTRH2;AGO4;FLOT2
prerank,protein deneddylation (GO:0000338),0.4718351105917616,0.9751919644204895,0.5235378031383737,0.9379463118459616,1.0,7/10,31.26%,COPS5;TOR1A;COPS4;GPS1;COPS6;COPS3;COPS7B
prerank,defense response to Gram-negative bacterium (GO:0050829),0.38079894269093506,0.9749801815792525,0.5178970917225951,0.9379415027871646,1.0,5/42,16.30%,LBP;TLR4;DMBT1;RNASE6;IL6
prerank,defense response to tumor cell (GO:0002357),0.48371435746359587,0.9749303251012683,0.5230547550432276,0.9375241991446845,1.0,3/10,14.32%,RBMS3;DLEC1;KLF4
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3565198617982963,0.9748137400961058,0.5450733752620545,0.9372570398307928,1.0,18/75,15.88%,ATP1A3;ATP1A4;ATP1A1;SLC12A8;SLC39A14;TRPV3;ATP2B4;KCNJ2;SLC9A9;SLC12A4;KCNK9;HCN4;SLC9A1;SLC12A5;KCNJ3;SLC8A2;SLC9A7;SLC9A6
prerank,nuclear membrane reassembly (GO:0031468),0.36950637071611336,0.9748046456633828,0.5281767955801105,0.9367271729105172,1.0,24/54,32.29%,LMNA;REEP3;NUP93;CHMP7;AHCTF1;NUP107;NUP98;SIRT2;NUP37;PPP2R2A;CC2D1B;ANKLE2;IST1;EMD;NUP133;NUP85;NUP188;KPNB1;SUMO1;CHMP4C;SEC13;CHMP4A;CHMP4B;NUP160
prerank,metanephros development (GO:0001656),0.40094545842254825,0.9745764133701476,0.5145278450363197,0.9367775015584673,1.0,6/26,13.71%,WT1;SIX4;PKD1;PKD2;GDNF;SIX1
prerank,regulation of chromatin organization (GO:1902275),-0.3469029491363574,-0.9740963233767455,0.47619047619047616,0.8183651254780064,1.0,3/14,8.12%,MLLT3;SSRP1;IGF2
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.42088581298610084,0.9739878154842341,0.5127226463104325,0.9377996366690504,1.0,2/20,2.91%,HAS2;TGFB2
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.4225501815860314,0.9739243672452719,0.5310945273631841,0.9374076726106734,1.0,4/22,14.08%,GADD45G;VEGFA;EMC10;ZC3H12A
prerank,monocyte chemotaxis (GO:0002548),0.3900483939660779,0.9739085066775319,0.52954808806489,0.9368989755079122,1.0,6/32,16.30%,CCL8;ANXA1;CCL25;CALCA;CCL13;IL6
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.3753851253824206,-0.9738483957110914,0.48659003831417624,0.8171464695276859,1.0,4/12,14.87%,PTPN14;KHDRBS1;TGFB1;NUP214
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.4549399975204342,0.9733119296967576,0.5363881401617251,0.9378712389032746,1.0,1/13,0.51%,TNMD
prerank,macrophage differentiation (GO:0030225),0.4432894992428299,0.973175781650293,0.5108695652173914,0.9376814920270613,1.0,4/13,27.80%,VEGFA;IL31RA;CSF1;CASP8
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.30356207788532297,-0.9729275973092854,0.4634146341463415,0.8177047637617141,1.0,6/23,12.05%,CBFA2T3;PPARA;CRY1;C1QTNF3;SIK1;EP300
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.4345412250469823,0.9726523207794521,0.5050761421319797,0.9384923613976216,1.0,10/18,31.31%,DLG4;STX1B;CHRNA7;RIMS2;PTEN;PRKCZ;NLGN1;NLGN3;NRXN1;NLGN2
prerank,protein acylation (GO:0043543),0.38001186695072653,0.9723416136841624,0.5218855218855218,0.9387467665346727,1.0,13/38,23.21%,ZDHHC16;ZDHHC7;FOXO1;KAT2B;ING4;HHAT;SELENOK;ZDHHC2;ZDHHC21;ZDHHC20;ZDHHC18;ZDHHC8;ZDHHC5
prerank,positive regulation of cellular respiration (GO:1901857),-0.38408341380987693,-0.9721034464428977,0.48727272727272725,0.8180396167883771,1.0,4/11,13.06%,IFNAR1;IL10RB;PINK1;ISCU
prerank,cellular iron ion homeostasis (GO:0006879),0.3631319488861673,0.9720922558753983,0.5223555070883316,0.9388407014826886,1.0,5/55,7.16%,SCARA5;SMAD4;ATP6V0A2;SLC39A14;SLC11A2
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.42345975981762984,0.97186850074714,0.5331632653061225,0.9388553420735574,1.0,5/18,16.91%,SLC25A31;ALKBH7;SLC25A4;BAK1;SPG7
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.3738117514938273,-0.9716988349902591,0.49333333333333335,0.8172451217496952,1.0,4/11,10.97%,WTIP;PUM2;XPO5;AJUBA
prerank,regulation of cell size (GO:0008361),0.4149973687050823,0.971631463889177,0.5220048899755502,0.938932592252129,1.0,8/23,25.84%,RAP1GAP2;MTOR;DEPTOR;RHOA;PTEN;VAV2;RAC1;RARG
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3627291538446446,0.9716120665454707,0.5483528161530287,0.9384248194925222,1.0,17/64,22.29%,MGLL;DAGLA;SCP2;SLC27A3;GPX1;GSTM2;PNPLA8;ELOVL5;ACOT1;FADS1;DAGLB;ACAD9;ACOX1;EPHX1;HSD17B4;CPT2;CYP1B1
prerank,nucleotide-excision repair (GO:0006289),0.34539873888329964,0.9713475792836685,0.5411167512690356,0.9385505682166178,1.0,23/101,18.45%,POLR2H;GTF2H3;COPS5;RAD23B;RNF111;POLB;SLC30A9;ERCC3;UBA52;ERCC4;FAN1;POLR2D;POLR2G;DDB1;BRIP1;AQR;CCNH;USP7;UVSSA;RFC4;ERCC5;POLD1;COPS4
prerank,melanosome organization (GO:0032438),0.40618990834768753,0.9711215081775576,0.5300480769230769,0.9385772795438666,1.0,7/26,16.18%,RAB32;AP1M1;DTNBP1;AP3D1;HPS4;BLOC1S2;SNAPIN
prerank,regulation of response to external stimulus (GO:0032101),0.3472415192768779,0.9709340220682148,0.5430597771023303,0.9385073995304928,1.0,21/121,17.00%,EPHB2;CD55;MGLL;ANXA1;FOXP1;F2R;AKNA;SPATA2;NR1D2;TIRAP;CNGB1;SAMHD1;BCL6;SAG;LRRC19;PDGFRA;STK24;DAGLB;TRAF3;UFL1;CXCR4
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.33866219784705964,-0.9708399115153985,0.47619047619047616,0.8176511179401071,1.0,3/17,3.21%,CDH5;CLDN5;F11R
prerank,T cell migration (GO:0072678),-0.3803717847070999,-0.9705968043305975,0.46558704453441296,0.8165522499552289,1.0,4/13,10.48%,SLC12A2;S1PR1;PIK3CD;CXCL16
prerank,isotype switching (GO:0045190),-0.39315644953916284,-0.9705266471596014,0.4831081081081081,0.8149286548843016,1.0,4/10,23.08%,MSH2;BATF;RNF8;LIG4
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.3502510417008804,0.9703986978258028,0.5649948822927329,0.9393731177271494,1.0,32/100,25.84%,GLMN;DESI1;RAD23B;COP1;UCHL5;STUB1;SIRT2;RYBP;HERPUD1;DNAJB2;USP5;FHIT;USP7;GIPC1;NOP53;RNF14;ZER1;OGT;KEAP1;UFL1;ARIH2;RNF19A;ARIH1;MAP1A;SDCBP;ZYG11B;BAG5;UBQLN4;DVL1;MDM2;FBXO22;CSNK1E
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.4536223040692009,0.9702988389826,0.531628532974428,0.9390651402246276,1.0,2/13,5.94%,NFATC4;NFIB
prerank,mesonephric tubule development (GO:0072164),0.4391440557055719,0.9701832011807074,0.5275908479138627,0.938819326340585,1.0,4/15,7.85%,WT1;SLIT2;PKD1;PKD2
prerank,mitochondrial translational termination (GO:0070126),0.34924846690057065,0.9700448378314093,0.5495867768595041,0.938633300390253,1.0,18/88,15.58%,MRPS11;MRPL38;MRPS18B;CHCHD1;MRPL13;MRPS17;AURKAIP1;MRPS27;MRPL30;MRPL10;DAP3;MRPL55;MRPS10;MRPL36;MRPL3;MRPL21;MRPS34;MRPL51
prerank,negative regulation of response to wounding (GO:1903035),0.4223973684714276,0.9699949965929433,0.5278121137206427,0.9382203888658136,1.0,4/19,13.45%,FGF2;PTPRS;INPP5F;RTN4RL1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.38532671146486214,0.9698090922890251,0.5339366515837104,0.9381707723354297,1.0,14/37,23.83%,UCHL5;RYBP;FHIT;SGTA;USP7;GIPC1;NOP53;OGT;PML;RPL23;MAP1A;SDCBP;CSNK2A2;BAG5
prerank,tricarboxylic acid metabolic process (GO:0072350),0.4615159872708002,0.9696317081178122,0.5265306122448979,0.9380833131044573,1.0,6/12,20.84%,ACLY;IDH1;ACO2;GLUD1;IDH3G;IDH3B
prerank,lipid transport (GO:0006869),0.35138527935051483,0.9695487352575015,0.5568181818181818,0.9377387212994996,1.0,12/97,9.70%,LBP;SLCO2A1;ATP8B1;TRIAP1;SLC51A;ABCG4;OSBPL2;ABCA1;PRELID3A;SCP2;SLC27A3;ABCA13
prerank,quinone biosynthetic process (GO:1901663),0.4415058558884868,0.9685197702660178,0.5309139784946236,0.939864803972816,1.0,6/14,25.82%,COQ10B;COQ7;COQ3;COQ5;COQ2;COQ10A
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.4503785708564736,0.968428721066885,0.5235531628532974,0.9395579750630577,1.0,2/14,8.91%,AVPR1A;ECE1
prerank,central nervous system neuron development (GO:0021954),0.44881157533254623,0.9683991087663251,0.5205298013245033,0.9390884023028795,1.0,4/15,14.60%,LHX8;MAPT;GBA2;HSP90AA1
prerank,endodermal cell fate commitment (GO:0001711),-0.3880142763206572,-0.968140864571104,0.4876325088339223,0.8193460916197514,1.0,2/10,8.80%,SOX17;CTR9
prerank,positive regulation of vasculature development (GO:1904018),0.34791950059997917,0.9681313986494319,0.5423553719008265,0.9392341742032365,1.0,9/94,3.87%,CD34;FGF18;PRKCA;ANGPT4;VEGFA;FGF2;ECM1;RUNX1;SMOC2
prerank,regulation of cell division (GO:0051302),0.35484526537896616,0.9681067757300329,0.5458377239199157,0.9387405325958281,1.0,15/72,14.16%,CDK2AP2;TLE6;AHCTF1;NCOA3;FSD1;FLCN;SIRT2;PRDM15;SETD2;PRPF40A;SFN;CALM2;PIN1;BBS4;ORC6
prerank,protein complex oligomerization (GO:0051259),0.3519919778160121,0.9680369702725042,0.5529045643153527,0.9383697180494058,1.0,27/85,26.22%,UGDH;LRRC8D;ZNHIT6;MPP2;PKD2;ZBTB1;MCU;CPSF6;VSTM5;MAT2A;SLC9A1;ADCY8;TMEM120A;NACC2;ZC3H12A;KCNC2;BLM;CARD11;PYCARD;PDCD6IP;KCNC1;CPSF7;ALS2;ATL1;GLRA3;RBMX;HGSNAT
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.4160280656651566,0.9678011983939085,0.5259822560202788,0.9384424565180535,1.0,7/20,12.57%,KCNMA1;ATP1A3;ATP1A4;ATP1A1;KCNJ2;SLC9A1;ATP6AP1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.4085061163839775,0.967634699922356,0.540272614622057,0.9383130920145678,1.0,3/23,8.28%,INTS3;ZW10;ZWINT
prerank,organophosphate biosynthetic process (GO:0090407),0.3844650152677253,0.9673532211781896,0.5420454545454545,0.9384892604223843,1.0,10/37,20.19%,FGF2;GK5;AGPAT3;LPCAT1;AGPAT5;NFS1;FADS1;IPPK;GPAM;IP6K1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.36036551332520234,0.9673346919119459,0.5579399141630901,0.9379901745413659,1.0,11/65,14.21%,AREG;EGFR;BTC;DOK1;PTPRJ;RHBDF1;MVB12A;AKT1;EGF;CBL;FER
prerank,vesicle transport along actin filament (GO:0030050),-0.324536820512533,-0.9672345130390868,0.5192307692307693,0.8198959431637001,1.0,5/19,13.52%,MYO1B;FNBP1L;MYO1D;MYO5B;MYO19
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.3597423493192033,-0.9670937483646734,0.5142857142857142,0.8184300091509225,1.0,2/14,1.20%,ATP1B3;ACTN2
prerank,regulation of focal adhesion assembly (GO:0051893),0.36796227345500515,0.966372546782157,0.5290178571428571,0.9398437043905874,1.0,16/54,21.11%,MYOC;EFNA5;EPHA3;VEGFA;S100A10;PTPRJ;SRC;SLK;SLC9A1;RHOA;BCAS3;ACTG1;RCC2;CLASP2;CORO1C;PTEN
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.44814793674734577,0.9661171094948076,0.5330634278002699,0.9399636610964415,1.0,2/15,9.12%,SMPD3;ORMDL2
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.351070567661401,0.9658421109518431,0.5711318795430945,0.9401064839602044,1.0,23/86,21.98%,DCTN1;CDC42EP2;BIN1;CLIP1;PSRC1;PFN2;TOGARAM1;PSEN1;MAPRE1;COLGALT1;GPX1;MAPT;FCHSD1;SLAIN2;FER;ARF6;CDK5RAP2;NCK1;AKAP9;NAV3;NUMA1;PYCARD;CTTN
prerank,lymphocyte chemotaxis (GO:0048247),0.39407800312118785,0.965614747332609,0.5456702253855279,0.9401554925312093,1.0,6/34,12.90%,CCL8;CXCL10;GAS6;CCL25;HSD3B7;CCL13
prerank,positive regulation of phospholipid transport (GO:2001140),0.4748510136101909,0.9653509054978536,0.5222381635581061,0.9402997207430506,1.0,4/10,23.75%,TRIAP1;TMEM30A;PRELID1;ABCB4
prerank,mitotic spindle assembly (GO:0090307),0.37507675930939527,0.9653461678109878,0.5208568207440811,0.9397721923893474,1.0,12/42,20.62%,KIFC2;TOGARAM1;KIF2A;ARHGEF10;SMC1A;PIBF1;ABRAXAS1;RHOA;KIF3B;STAG2;FLNA;CLASP2
prerank,regulation of vasoconstriction (GO:0019229),0.4023908133241839,0.9653383999030795,0.5279429250891795,0.9392525506121471,1.0,3/27,8.91%,AVPR1A;F2R;ECE1
prerank,vascular process in circulatory system (GO:0003018),0.4549746619906204,0.9652232253347849,0.5195681511470985,0.9384778684304091,1.0,1/13,0.79%,GCLC
prerank,regulation of tube diameter (GO:0035296),0.4549746619906204,0.9652232253347849,0.5195681511470985,0.9384778684304091,1.0,1/13,0.79%,GCLC
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.316796502675636,-0.9652101101567813,0.5084745762711864,0.8216798932720853,1.0,7/22,18.25%,PPM1E;PPM1D;DUSP10;PPM1F;DUSP7;DUSP6;PPP2CA
prerank,positive regulation of phosphatase activity (GO:0010922),-0.31291214735745376,-0.9650361091297703,0.4896907216494845,0.8203121747502742,1.0,6/21,13.51%,ITGA1;MEF2C;PDGFRB;PPP1R15B;BMP2;CD300A
prerank,vacuolar acidification (GO:0007035),0.4164268331097506,0.9649636419460854,0.5297029702970297,0.93860979475452,1.0,8/21,27.12%,ATP6V0A2;TMEM9;DMXL2;CCDC115;ATP6V0A1;TMEM199;DMXL1;PPT1
prerank,determination of left/right symmetry (GO:0007368),-0.2719918819134394,-0.9647554019463851,0.5405405405405406,0.819206750775777,1.0,21/36,36.25%,NOTCH1;TBX1;CITED2;BBS7;GALNT11;DNAH11;ENKUR;STIL;ZIC3;CFAP53;DLL1;ODAD2;ODAD3;FOXJ1;MEGF8;ODAD4;SHH;OFD1;CCDC40;LEFTY1;DNAAF4
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.4213185146003165,0.9644855209568965,0.5408805031446541,0.9392760648608877,1.0,6/19,21.08%,PAPSS2;BPNT2;SULT4A1;SLC26A1;ABHD14B;TPST2
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.33582476761384505,-0.9644665436253995,0.4897119341563786,0.8181337438033102,1.0,7/17,17.55%,ATP5F1C;ATP5F1D;ATP5F1E;ATP5PD;ATP5MG;ATP5MC2;STOML2
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.444538517422738,0.9644161252929178,0.5385656292286874,0.9388821227425163,1.0,2/15,1.29%,SRMS;EGFR
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.40212155552664225,0.9642612004251455,0.5177478580171359,0.9387251704384502,1.0,12/25,31.93%,PRPF4;PRPF3;MPHOSPH10;SF3B4;BCAS2;SRRM1;SF3B1;PRPF6;WDR83;LSM1;PRPF8;GEMIN2
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.28386574020276784,-0.9639375084675308,0.48717948717948717,0.8177784158537452,1.0,10/29,14.89%,THBS1;CAV1;TNFSF12;SFRP1;INHBA;WWOX;RIPK1;TNFSF10;DEDD2;GPER1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.33448308669197896,0.9636044928903303,0.5995995995995996,0.9398535474111032,1.0,27/214,13.17%,ACKR3;SYK;EPHB2;CCL8;PRKCA;EGFR;CD44;PDE8A;FGF2;CAMK2N1;F2R;MIF;SMAD4;ADCYAP1;GAS6;FLCN;PRKD2;NDRG4;TIRAP;CCL25;TLR4;SIRPA;GPNMB;TNIP1;ATP6AP1;CCL13;PIN1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.3426587112238079,0.9631249351271086,0.5739041794087666,0.9405192427452037,1.0,35/125,24.90%,GPSM2;DYNC1LI2;CLIP1;NDEL1;ZW10;AHCTF1;CENPT;NUP107;ZWINT;DYNC1LI1;NUP98;DYNC1I1;KIF2A;MAPRE1;SETD2;SBDS;KIF3B;DYNC1H1;NUP37;MAP4;CENPC;PPP1CC;RCC2;CKAP5;CENPE;EML1;PAFAH1B1;WDR62;CLASP2;DCTN2;RMDN1;TUBG2;DYNLL1;NUP133;NUP85
prerank,response to sterol (GO:0036314),0.455046662927133,0.9628057744478496,0.5124309392265194,0.9407809721186845,1.0,4/11,22.60%,TGFBR2;PMVK;TGFBR1;RORA
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.45242733597172224,0.9626864994196406,0.5455764075067024,0.9405598391286352,1.0,6/13,24.22%,CPSF6;CPSF4;CPSF2;CSTF2T;CPSF1;CPSF7
prerank,cellular response to calcium ion (GO:0071277),0.3548041399352327,0.9626235397522496,0.5641569459172853,0.9401909923872336,1.0,10/67,9.18%,SYT2;NEUROD2;CPNE8;SYT12;SYT11;SYT13;CAMK2D;PKD2;DPEP1;IQGAP1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.32706832846992073,0.9623967802583052,0.757,0.9402373071837112,1.0,291/1646,16.90%,LMX1A;EBF2;PRRX1;AR;LRP6;CD80;LHX8;ESR1;HOXA3;PAX9;COL1A1;EBF1;GCLC;ATP8B1;LOXL2;TRPS1;SP9;FOXP2;NFIX;FGF7;BNC2;IRF4;EGFR;CREB5;TGFB3;WT1;ZFHX4;ZC3H8;MEOX2;TBX15;SCRT2;ZNF367;HSF2;PRDM8;TADA1;CCNL2;SIX4;HOXA2;ELF4;HIVEP2;NEUROD2;ZMIZ1;DGKQ;VEGFA;KLF3;TSHZ2;FGF2;PBX1;KLF12;MLF2;CDK14;FOXP1;F2R;BHLHE40;TLX3;GLIS2;SFR1;RUNX1;TEF;SMAD4;NFE2L2;HDAC9;ZNF25;ATF5;WWTR1;DPF2;LMX1B;MEF2D;SMURF2;MAPK14;PAX1;CXXC1;AXIN1;SOX10;ACVR1;TSC22D4;IRX5;HOPX;RFX1;FOXK2;KLF2;MAP2K3;JUND;ZBTB12;NAB1;NFATC4;MED13L;MAFF;PSRC1;TCF7L2;MRGBP;NR1D2;ATP2B4;SPIN4;NFATC1;CBX4;RBAK;HOXA5;CAMK2D;CREB3L1;SMARCD2;MEIS2;FOXO1;NR1D1;PIAS3;NFIB;MAPRE3;EBF3;PRMT2;ZBTB7C;IGSF1;CREBZF;NFIA;RNF111;ZFHX3;DPF1;RET;MDM4;TRIP4;MLXIPL;SMAD5;DNAJC2;HDAC6;MYT1;MTF1;HOXA4;NUP107;SMARCD1;GLI2;ZFPM2;TBX6;GAS6;BRD9;MAMSTR;FOXL1;MDFIC;BRF2;PHF1;MSL3;ETV3;STAT5A;SOX8;SPTY2D1;CHUK;FZD7;ZBTB1;WDR77;VDR;NR6A1;MYBL2;ZNF260;MAGEL2;KDM3B;PSEN1;FOXC2;SIRT2;HNRNPD;ATXN7L3;SOX5;RCOR3;RYBP;ELP4;ONECUT1;CIPC;MED24;KDM5C;ING4;INPP5K;SMAD6;TLE2;RNF10;SATB2;BRD7;CALCA;MYPOP;PHC3;ZNF3;PHC1;CHD2;HDAC3;NPM1;URI1;SAMD1;MZF1;MPHOSPH8;MITF;PRDM15;ACTR5;ATF7;CAMKK2;SMARCC2;IRF2BPL;CSRNP3;BCL6;ZHX2;TOX2;CEBPB;AKT1;RBFOX2;GLI3;FBXO5;EGF;XRCC5;BACH2;LIN9;CCNC;KDM5B;QRICH1;ZNF691;ZNF112;NCOR2;ATF1;DDX17;PEG3;CDKN1A;MED13;NCOR1;BCL3;IKZF5;PROX2;CBFA2T2;TWIST1;BRIP1;RAI1;SIX1;NACC2;HDAC4;RFX5;PLAGL1;NME2;CCNH;ZNF569;FADS1;PLAGL2;DMAP1;KLF4;TASP1;HOXA7;MLLT11;HOXC4;HOXA9;SETD5;THOC1;POU3F2;IL4;GMNN;ZNF692;SMARCA4;CHD8;CCNQ;MLXIP;FZD4;NFE2L3;NR2C2;RPL6;YEATS2;SRCAP;MAP2K2;E2F3;HMGB3;RNF14;CDK5RAP2;BAHD1;ZFP28;ZBTB25;RNF187;ZBTB5;PSIP1;UBP1;USP22;PDCD4;PER1;HIVEP3;IL6;BAZ2B;OGT;STAT5B;ANXA4;CHD1;PHF5A;DDX5;SNAI2;CHD3;EFEMP1;E4F1;PITHD1;TFAP4;ZEB1;DKK3;PML;SAP18
prerank,cholesterol metabolic process (GO:0008203),0.35553724290435296,0.961975756764877,0.5506329113924051,0.9407497434750011,1.0,14/68,18.77%,CEL;ACLY;MVK;ABCA1;INSIG2;LCAT;GGPS1;TSKU;GBA2;IL4;PMVK;PIP4P1;FDX1;ANGPTL3
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.2957196503327669,-0.9618893287098513,0.5384615384615384,0.821271404953966,1.0,4/23,8.41%,CADM1;AP1G1;NECTIN2;PIK3R6
prerank,regulation of JNK cascade (GO:0046328),0.34822483154330497,0.961110509374787,0.5755102040816327,0.9423661102806928,1.0,19/101,13.20%,SH3RF3;EGFR;GADD45G;TAOK3;COPS5;AXIN1;DACT1;AIDA;ITCH;RASSF2;FZD7;SEMA3A;TIRAP;SIRPA;HDAC3;ANKRD6;CD27;TAOK2;NCOR1
prerank,cellular response to leucine starvation (GO:1990253),0.47796864227237124,0.9609269148527769,0.5414364640883977,0.9422806766358142,1.0,5/10,27.95%,MTOR;SESN3;RRAGD;SESN2;IMPACT
prerank,apoptotic DNA fragmentation (GO:0006309),-0.32840682794040416,-0.960727032132668,0.5140562248995983,0.8224800390180249,1.0,3/16,7.78%,CECR2;HMGB1;CASP3
prerank,bile acid metabolic process (GO:0008206),0.4060387990236394,0.9604120231974096,0.5420219244823387,0.9430062793931511,1.0,6/27,11.50%,OSBPL3;OSBPL2;SCP2;HSD3B7;OSBPL6;GBA2
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.30771081122907407,-0.9601279423847201,0.49230769230769234,0.8223487423678114,1.0,8/21,23.14%,HK2;DERA;PGLS;TALDO1;RBKS;RPE;GPI;RPIA
prerank,regulation of transport (GO:0051049),-0.2711896113122737,-0.959976045026558,0.45384615384615384,0.8209531777752657,1.0,9/36,11.64%,EPB41;SNCA;ICA1;ACTB;WWC1;NRP1;PINK1;RAB11A;CDK5
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.3371653643789855,0.9598914217750982,0.5813008130081301,0.9437687489273897,1.0,30/145,17.82%,DCTN1;FHL1;PSMC4;ODF2;CDK4;RAD51B;VPS4B;PSMC6;YWHAG;SSNA1;YWHAE;PSMD8;DTL;AVEN;ALMS1;MAPRE1;HAUS3;FBXO5;SFI1;CCND1;HSP90AA1;TUBB4A;TUBA4A;DYNC1H1;CDK5RAP2;CCP110;RCC2;AKAP9;CEP164;CKAP5
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.37831088160039117,0.9597675474533214,0.5559322033898305,0.9435397169620923,1.0,11/39,22.85%,GTF2H3;ERCC3;UBA52;ERCC4;FAN1;DDB1;RFC4;ERCC5;POLD1;OGG1;ERCC1
prerank,nuclear body organization (GO:0030575),0.46165890985616925,0.9596400302162384,0.538866930171278,0.9433070705072517,1.0,4/12,16.87%,AFF2;ZPR1;USP50;PML
prerank,mesenchyme development (GO:0060485),-0.34156756205601485,-0.9596348651831956,0.4859437751004016,0.8200635339093592,1.0,4/15,10.58%,BMP7;FGFR2;BMPR2;BMP2
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.2759218866359179,-0.9594527005506414,0.4846153846153846,0.8187505217563641,1.0,8/32,13.51%,CDH5;ITGA1;PPP1R16B;PDGFRB;PPP1R15B;PPP2R5A;TGFB1;CD300A
prerank,regulation of acrosome reaction (GO:0060046),-0.385713003707984,-0.9593367816153631,0.49834983498349833,0.8172263187398743,1.0,1/10,4.85%,PLCB1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.35212671263509815,0.9592384407943665,0.5464135021097046,0.9437786286939569,1.0,10/70,9.97%,NCF4;PSMC4;ITGB5;SEC22B;PSMC6;LNPEP;CHUK;PSMD8;SNAP23;ITGAV
prerank,regulation of angiogenesis (GO:0045765),0.3344234132897937,0.9590917144935257,0.6078234704112337,0.9436263102287462,1.0,32/192,14.32%,CD34;DCN;TNMD;FGF18;PRKCA;ANGPT4;ISM1;SPARC;VEGFA;FGF2;TGFB2;ECM1;RUNX1;SMOC2;CD160;ATP2B4;HOXA5;CXCL10;THBS4;SULF1;PRKD2;SERPINF1;AGO2;RHOJ;EMC10;GPNMB;JUP;HSPG2;TWIST1;PDE3B;ZC3H12A;KLF4
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.33936262042428156,-0.9586987349350969,0.4879032258064516,0.8171765508556049,1.0,7/16,17.55%,ATP5F1C;ATP5F1D;ATP5F1E;ATP5PD;ATP5MG;ATP5MC2;STOML2
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.34669528411174977,0.9584878269172938,0.5557894736842105,0.944584148057794,1.0,20/77,20.35%,AR;TRIAP1;ACVR1;TCF7L2;SRC;PELI3;NOC2L;ITGAV;HERPUD1;URI1;GPX1;AKT1;IL4;GHITM;HGF;PLAUR;QARS1;TGFBR1;MCL1;PRELID1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.41590246429606614,0.9581808594066289,0.5444162436548223,0.9448127451852785,1.0,7/20,13.33%,ANK2;TNNI3;CAMK2D;GSTM2;SLC9A1;CALM2;ATP2A2
prerank,positive regulation of reproductive process (GO:2000243),0.3905200408259381,0.9575693068467176,0.5598086124401914,0.9457842766532035,1.0,5/31,9.05%,VEGFA;SMURF2;C1QBP;AGO2;SIRT2
prerank,glycerolipid catabolic process (GO:0046503),0.42581747650961077,0.957415794255085,0.5506329113924051,0.9456604107648454,1.0,1/19,0.62%,MGLL
prerank,brain morphogenesis (GO:0048854),0.4559096108636455,0.9571603964356993,0.532033426183844,0.94578045871086,1.0,7/12,28.55%,SLC6A4;BBS4;PAFAH1B1;PTEN;FBXW11;PAX2;SPEF2
prerank,regulation of lipid kinase activity (GO:0043550),0.46728456189069467,0.9571508026996856,0.5480378890392422,0.9452675823500589,1.0,2/11,8.16%,PIK3R2;WDR91
prerank,negative regulation of cell development (GO:0010721),0.39907577814411754,0.9568694496938074,0.5401891252955082,0.9454119564870616,1.0,1/25,0.36%,FBN1
prerank,negative regulation of protein binding (GO:0032091),0.3495893525817755,0.9567454610799319,0.5659574468085107,0.945199939534503,1.0,15/71,15.09%,DACT1;GNL3L;CARD16;PTPRF;TFIP11;USP33;AKT1;SLPI;DNAJB2;ADAM15;CDKN1A;PIN1;ATP2A2;DDX11;GTF2F1
prerank,pulmonary valve morphogenesis (GO:0003184),0.4256588488925903,0.9564115121028971,0.5440613026819924,0.945481205515745,1.0,5/17,10.09%,TGFB2;SLIT2;NFATC1;JAG1;SMAD6
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.40963896400187916,0.9561227039194219,0.5705445544554455,0.9456752590123577,1.0,4/22,12.04%,PRKCA;SMAD4;CAMK2D;SLC9A1
prerank,proteasomal protein catabolic process (GO:0010498),0.33466368264302215,0.9558424059853601,0.6261306532663317,0.9458399612285727,1.0,63/201,26.34%,UCHL1;PSMC4;UBE2B;SPSB1;SPSB4;NFE2L2;SMURF2;SYVN1;TRIM71;ITCH;RAD23B;RMND5B;NR1D1;RCN3;COP1;PSMC6;SPSB2;STUB1;UBE2W;PSMD8;SIAH1;CUL3;SIRT2;HECW2;UBE2A;CDC34;DDB1;RNF216;RNF187;SOCS6;RBCK1;ZSWIM8;HACE1;PML;KCTD2;UBE2G1;SKP2;PCNP;UBE2D3;FBXL19;RNF41;KCTD10;ARRB1;UBXN11;SMURF1;DERL1;SEL1L;FBXW11;KLHL22;SPSB3;IFI27;UBXN6;PSMD3;PSMD4;MDM2;AGAP3;KAT5;DDIT3;FBXW7;RNF126;PSMB3;UBE2K;PRPF19
prerank,cellular protein catabolic process (GO:0044257),0.35472610779807234,0.9555270005072249,0.5734190782422294,0.9461000611202208,1.0,21/59,27.80%,FAP;CAPN2;AP2A2;CLTC;CLPX;MYLIP;UBE2G2;RSPRY1;CLPP;HTRA2;IDE;UBE2G1;AFG1L;RNF123;AP2M1;RAB12;CTSK;MDM2;CTSB;CTSL;CASP8
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.37302144113352553,-0.9550660282955498,0.4935064935064935,0.8247697046878459,1.0,4/10,28.62%,CAV1;KCNE4;ANK3;KCNAB1
prerank,regulation of proteolysis (GO:0030162),0.36523056863702225,0.9550193097781108,0.5722100656455142,0.9467963405558332,1.0,16/48,23.67%,CAMK2N1;ITCH;HDAC6;STUB1;AURKAIP1;CSTB;AKT1;TBC1D10A;BAK1;TRAF3;OGT;PLAUR;NEDD8;FBXW11;IST1;PARL
prerank,pore complex assembly (GO:0046931),0.4178615782412284,0.9548307532153721,0.546975546975547,0.9467099154107103,1.0,4/19,8.69%,NUP93;AHCTF1;NUP107;NUP98
prerank,cell cycle G1/S phase transition (GO:0044843),0.3605095886024441,0.9545362603356252,0.5634408602150538,0.9469268548723897,1.0,14/61,15.63%,ACVR1;CDK4;TRIM71;USP29;BCAT1;CUL3;USP26;CDC34;CDKN1A;CCND1;CCNH;DBF4;GSPT1;E2F3
prerank,negative regulation of protein kinase activity (GO:0006469),0.34434493757861556,0.9545078710560899,0.5898234683281413,0.9464693947256589,1.0,21/88,17.85%,LRP6;TARBP2;ADARB1;CAMK2N1;WWTR1;DTNBP1;RTRAF;YWHAG;SRCIN1;GSKIP;INPP5K;NPM1;AKT1;SFN;DEPTOR;SMCR8;CDKN1A;CHP1;CEP85;PPIA;QARS1
prerank,potassium ion transmembrane transport (GO:0071805),0.33278668320933724,0.9544894775128336,0.5854398382204247,0.9459708199520422,1.0,26/135,15.88%,KCNK5;KCNT2;HPN;KCNV1;ATP1A3;ATP1A4;ATP1A1;SLC12A8;KCNJ2;SLC9A9;KCND1;ABCB8;SLC12A4;PKD2;KCNK13;KCNK9;HCN4;KCNA2;KCNA6;KCNAB3;SLC9A1;SLC12A5;KCNJ3;KCNC2;SLC9A7;SLC9A6
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.46062490957924723,0.9543768141175393,0.5399719495091164,0.9457147917276054,1.0,4/11,14.37%,STK25;GSKIP;DIABLO;STK24
prerank,cellular response to light stimulus (GO:0071482),0.3568627196950577,0.9543398648371598,0.5579399141630901,0.9452784880118197,1.0,19/66,22.61%,TRIAP1;NOC2L;ZBTB1;RHNO1;CNGB1;NPM1;BMF;SAG;BAK1;ERCC4;EIF2S1;GNB1;INO80;POLD1;SMPD1;OPN3;NSMCE3;ATF4;SDE2
prerank,autonomic nervous system development (GO:0048483),0.42527210106871355,0.9537544129129241,0.5366492146596858,0.9461770061433116,1.0,4/17,13.07%,SOX10;SOX8;SEMA3A;GDNF
prerank,cation transport (GO:0006812),0.33513788845521747,0.9531731758732924,0.5915492957746479,0.9470914542824455,1.0,24/167,13.99%,KCNK5;SCNN1B;SLC5A9;PIEZO2;KCNMA1;KCNV1;FGF13;SLC7A6;ATP1A4;SLC47A1;KCNJ2;SLC11A2;KCNK9;CNGB1;HCN4;KCNA2;SLC4A4;KCNA6;KCNAB3;NDFIP1;SLC23A1;KCNJ3;CATSPER3;SLC8A2
prerank,cellular lipid catabolic process (GO:0044242),0.3898666144166397,0.9520546890122327,0.5375302663438256,0.9493879523734265,1.0,7/27,22.29%,CEL;SIRT2;ACOX1;NUDT19;ANGPTL3;LPIN3;CYP1B1
prerank,contractile actin filament bundle assembly (GO:0030038),0.43569855168944316,0.9517525141229578,0.5554072096128171,0.949047833437252,1.0,6/15,13.49%,ITGB5;FHDC1;SRC;CUL3;PDLIM1;RHOA
prerank,stress fiber assembly (GO:0043149),0.43569855168944316,0.9517525141229578,0.5554072096128171,0.949047833437252,1.0,6/15,13.49%,ITGB5;FHDC1;SRC;CUL3;PDLIM1;RHOA
prerank,sterol homeostasis (GO:0055092),-0.23527557457348616,-0.9515389451931168,0.6268656716417911,0.8321541333128626,1.0,10/65,8.48%,CYP7B1;GRAMD1B;APOE;SCARB1;TTC39B;NR1H3;ABCG1;CAV1;LDLRAP1;EPHX2
prerank,cholesterol homeostasis (GO:0042632),-0.2364195994017021,-0.9514413633792427,0.6268656716417911,0.8306094646560638,1.0,10/64,8.48%,CYP7B1;GRAMD1B;APOE;SCARB1;TTC39B;NR1H3;ABCG1;CAV1;LDLRAP1;EPHX2
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.3878765343903729,0.9512702650044994,0.5594817432273262,0.9496952208096934,1.0,8/29,10.99%,SLIT2;SMAD4;MYADM;PFN2;PIK3CA;TWF1;KANK1;SSH1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.3874187402636985,0.9511688991905061,0.5388235294117647,0.949413724842073,1.0,12/32,26.30%,GPAT4;CHKB;SLC44A1;LCAT;LPCAT1;CEPT1;SLC44A2;LPIN3;PCTP;CSNK2A2;SLC27A1;LPCAT3
prerank,DNA repair (GO:0006281),0.3289422657733307,0.9507874864765059,0.645937813440321,0.9498019886743644,1.0,50/284,15.69%,MPG;PARP3;FANCD2;INTS3;UBE2B;GTF2H3;XRCC3;EME1;NUDT1;RAD51B;RFWD3;RAD23B;KPNA2;TENT4A;IGHMBP2;UBE2N;INIP;ZBTB1;RHNO1;PPP5C;FANCL;FAAP100;POLB;FANCE;SMC1A;EXO5;NPM1;ACTR5;ASCC3;SLC30A9;POLI;SETD2;ERCC3;UBE2A;UBA52;RAD1;ERCC4;FAN1;XRCC5;DDB1;ABRAXAS1;DNA2;BRIP1;FANCG;NBN;INO80;FAM111A;TNKS1BP1;NOP53;RFC4
prerank,response to nitric oxide (GO:0071731),0.4451513100733895,0.9507669713881444,0.5378378378378378,0.9493155100587921,1.0,4/13,14.62%,FOXO1;DPEP1;MTR;KCNC2
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.36465456706217825,0.9506649139751694,0.5752212389380531,0.9490488475290195,1.0,13/49,20.13%,SCIN;RAB7B;RUNX1;DPY30;KAT2B;WDR5;EIF6;PITHD1;AGO4;THPO;AGO3;KMT2C;KMT2A
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.36354022437682576,0.9505897135570611,0.5864745011086474,0.9481593499640246,1.0,20/50,27.66%,POLR2H;NUP93;TRIM71;NUP107;NUP98;AGO2;PUM1;POLR2D;POLR2G;NUP37;NUP50;TPR;TNRC6A;POLR2C;NUP133;NUP85;NUP188;EIF4G1;NUP88;AGO1
prerank,regulation of gene silencing by RNA (GO:0060966),0.36354022437682576,0.9505897135570611,0.5864745011086474,0.9481593499640246,1.0,20/50,27.66%,POLR2H;NUP93;TRIM71;NUP107;NUP98;AGO2;PUM1;POLR2D;POLR2G;NUP37;NUP50;TPR;TNRC6A;POLR2C;NUP133;NUP85;NUP188;EIF4G1;NUP88;AGO1
prerank,lung epithelium development (GO:0060428),0.4738127303846531,0.9500771170106485,0.5448179271708683,0.9488704211021858,1.0,2/10,6.12%,PKD1;RCN3
prerank,cellular response to glucose starvation (GO:0042149),-0.2583310877183014,-0.9498175379765458,0.5142857142857142,0.8329256213685265,1.0,5/41,4.59%,PRKAG2;SIK2;NUAK1;PRKAA2;NIM1K
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.3841488981497193,0.9497939405018186,0.5529685681024447,0.9490470489097121,1.0,8/34,10.24%,ANXA1;GAS1;VEGFA;MAPK14;MAP2K3;PRKD2;PIK3CA;ERN1
prerank,regulation of DNA binding (GO:0051101),-0.24763626766196195,-0.9491710774899982,0.5454545454545454,0.8328479153156948,1.0,5/44,3.59%,LEF1;SP100;IGF1;HMGB1;FOXC1
prerank,cellular transition metal ion homeostasis (GO:0046916),0.3434041482123767,0.9488885321523346,0.5892672858617131,0.9506916792951698,1.0,16/91,17.48%,SCARA5;SLC39A13;SMAD4;ATP6V0A2;SLC39A14;COX19;SLC11A2;ARF1;SLC39A7;SLC30A9;NDFIP1;ATP6AP1;CCDC115;SLC30A5;FLVCR1;FBXL5
prerank,intracellular protein transmembrane transport (GO:0065002),0.3655974598357685,0.9487083849754996,0.5679287305122495,0.9506192741331515,1.0,12/42,25.08%,TIMM50;PEX16;GRPEL2;PEX12;PEX1;SEC63;SEC61A1;PEX5;PEX2;TIMM17A;SEC61B;TOMM40
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.2620189876363881,-0.9486073978515791,0.5454545454545454,0.8326515896858591,1.0,6/39,4.66%,NEDD4L;DMD;OSR1;WNK4;YWHAH;PRKCE
prerank,positive regulation of ATPase activity (GO:0032781),-0.2647418461063631,-0.9485248801579897,0.5748031496062992,0.8310874409243265,1.0,12/41,18.87%,TPM1;ATP1B3;PLSCR1;SSBP1;MSH3;RYR2;PFN1;MSH2;ATP1B1;SETMAR;DYNLL2;TNNT3
prerank,protein ubiquitination (GO:0016567),0.3250706388228496,0.9484412072368085,0.6936936936936937,0.9507312182175848,1.0,168/471,28.25%,WSB1;SH3RF3;TSPAN17;MIB2;PSMC4;UBE2B;NEUROD2;SPSB1;SPSB4;HECTD2;NFE2L2;UBA6;UBE2J2;SMURF2;FBXW8;SYVN1;TRIM71;ITCH;RFWD3;RBBP6;MSL2;GAN;RNF111;PSMC6;SPSB2;RC3H1;PELI3;LNPEP;STUB1;MYCBP2;UBE2N;UBE2W;FBXO2;PSMD8;FANCL;SIAH1;FBXO17;MYLIP;CUL3;DTL;FBXL2;UBE2G2;ASB12;FBXW4;HECW2;FBXL20;RNF10;PHC1;CDC23;TRIM11;RNF7;FBXO31;RNF141;UBE2A;UBA52;CDC34;USP5;THOP1;UNKL;NPEPPS;BSPRY;FBXO28;DDB1;FBXL3;CDC27;PEX12;CUL9;CBL;AMFR;USP7;UHRF2;TRPC4AP;KLHL41;UVSSA;RNF14;TRIM68;SELENOS;RNF187;USP22;RBCK1;ZSWIM8;HACE1;RNF138;KEAP1;UBE2G1;FBXL5;FBXO11;PEX5;VPS11;ARIH2;UBE2R2;NEDD8;SKP2;PCNP;RNF19A;UBE3C;LRSAM1;BRAP;UBE2D3;FBXL19;TRIM35;TPP2;FBXW9;FBXW2;ARIH1;RNF41;CUL5;KCTD10;PEX2;PAF1;ARRB1;RC3H2;ATG3;UBE2Q2;KLHL9;SMURF1;FBXO24;DERL1;UBE3A;RNF6;UBE2Z;FBXW11;SDE2;UBR2;LZTR1;DTX2;KLHL22;RNF114;TRIM36;RNF13;TRIM24;RTF1;PSMD3;RNF157;MKRN2;FBXL12;PSMD4;TRIM44;MDM2;RNF166;VHL;FBXO22;RNF20;FBXW7;FBXO30;ZNRF2;RNF126;PSMB3;UBE2K;RNF167;PRPF19;RNF31;MUL1;KLHL12;OTULIN;CUL7;PRKDC;BCL10;VCPIP1;FBXO41;PSMB2;DTX3;EIPR1;WWP1;UBE3B;TOPORS;CRBN;PSMD5
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.3758129857027629,-0.9482489476145469,0.46691176470588236,0.8301052056847984,1.0,2/10,8.88%,RAPGEF2;CTNS
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.41761299651672945,0.9481005548184319,0.5417201540436457,0.9509919945000237,1.0,6/18,22.45%,SYVN1;EDEM2;UBA52;AMFR;UGGT1;SEL1L
prerank,regulation of cellular component organization (GO:0051128),0.33477433919372107,0.9479600825773031,0.5926680244399185,0.9507928646098982,1.0,27/135,15.74%,STON2;PLCE1;CD177;IRAK3;SGK3;SGK2;ATF5;RAP1B;MTOR;ITCH;SOCS2;CAMK2D;EGLN2;RIT2;MELTF;ABL2;ARFGAP1;HJURP;NRG3;URI1;SLC2A10;RUFY1;TAOK2;HSP90AA1;SETD5;RAPGEF1;RAB33B
prerank,prostaglandin metabolic process (GO:0006693),0.3909542209510005,0.9478437857333999,0.5430303030303031,0.9505257836191073,1.0,6/26,15.83%,CYP2S1;MIF;PTGR1;PNPLA8;DAGLB;ACOX1
prerank,vitamin D metabolic process (GO:0042359),0.4475584191663163,0.9477917447797127,0.5446071904127829,0.9501270559519094,1.0,5/13,27.48%,CYP27B1;VDR;GC;LRP2;CYP2R1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.325734453520901,0.9469821198795879,0.714,0.9516138801789932,1.0,110/497,19.65%,IGFBP5;PAX9;GCLC;ATP8B1;LOXL2;FOXP2;WT1;ZC3H8;EIF2AK3;SIX4;FOXP1;BHLHE40;GLIS2;SMAD4;HDAC9;ATF5;DPF2;SMURF2;TSC22D4;RBM4;PAIP2B;GTPBP4;FOXK2;NAB1;TCF7L2;NR1D2;TRIM71;CBX4;RBAK;SAMD4B;CREB3L1;FOXO1;NR1D1;PRMT2;CREBZF;DPF1;MLXIPL;HDAC6;ZFPM2;GAS6;MDFIC;SOX8;VDR;MAGEL2;MRPL13;SIRT2;RCOR3;CIPC;KDM5C;ING4;INPP5K;TLE2;BRD7;CALCA;PHC3;PHC1;HDAC3;SAMD1;MPHOSPH8;SMARCC2;BCL6;ZHX2;RBFOX2;GLI3;IGF2BP1;PASK;XRCC5;LARP1;NCOR2;CDKN1A;NCOR1;BCL3;CBFA2T2;TERF1;TWIST1;CNOT10;NACC2;HDAC4;DMAP1;KLF4;HOXA7;IL4;GMNN;SMARCA4;CHD8;YEATS2;SELENOS;BAHD1;PDCD4;PER1;FXR2;TFAP4;ZEB1;DKK3;PML;SAP18;SET;EPRS1;QARS1;SNX6;DAP;GCFC2;CTCF;NIPBL;PAIP2;BTAF1;SUDS3;RING1;PCGF6;PCIF1
prerank,positive regulation of cell death (GO:0010942),-0.2469391977826417,-0.9464375996926032,0.6153846153846154,0.8330589849908911,1.0,7/59,5.44%,SLC6A13;EFNB2;ACER2;SNCA;WNT5A;PRODH;AXIN2
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.45215729173833186,0.9464012071661578,0.5409836065573771,0.9525416088403185,1.0,2/12,10.58%,B3GALNT1;B3GNT8
prerank,negative regulation of lyase activity (GO:0051350),0.42650323691798164,0.9463295659244623,0.5442708333333334,0.9521818340897826,1.0,3/16,9.25%,GNAI3;PALM;LTB4R2
prerank,sterol metabolic process (GO:0016125),-0.2364312110838988,-0.9460989448394163,0.5492957746478874,0.8321633914973097,1.0,6/60,6.08%,PRKAG2;CYP7B1;APOE;CYP26B1;ABCG1;HMGCR
prerank,positive regulation of type 2 immune response (GO:0002830),0.43997831471587967,0.945669590560485,0.5502645502645502,0.953241483714315,1.0,6/14,24.85%,CD81;IL4;IL6;IL18;PRKCZ;RARA
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.46604541281457795,0.9455417047965645,0.5683355886332883,0.9530062872917049,1.0,6/11,27.31%,TOR1A;AUP1;UGGT1;DERL1;UFD1;UGGT2
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.44669389412590166,0.9454435077196088,0.5673854447439353,0.952714762278786,1.0,3/12,11.89%,WDTC1;ACADVL;PIBF1
prerank,cardiac muscle cell development (GO:0055013),-0.30721046212933617,-0.9453499921892666,0.5436893203883495,0.832378912714826,1.0,5/20,8.78%,SORBS2;PDLIM5;CXADR;PDGFRB;MYH11
prerank,regulation of T cell differentiation (GO:0045580),0.3830280387209912,0.9452184658243357,0.5675675675675675,0.9527225139200082,1.0,4/33,8.30%,ZMIZ1;RUNX1;TNFRSF18;ZBTB1
prerank,apoptotic cell clearance (GO:0043277),0.3838444946587461,0.9451525567808429,0.5542452830188679,0.952361484123881,1.0,5/30,9.97%,ANXA1;LRP1;ITGB3;GAS6;ITGAV
prerank,cortical actin cytoskeleton organization (GO:0030866),0.41208545726991047,0.9450111528806716,0.5642256902761105,0.9521767992541543,1.0,6/20,14.69%,LLGL1;FMNL1;RHOQ;FMNL3;FHOD3;ARF6
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.4265043340468857,0.9449574031447363,0.5376623376623376,0.951772376505005,1.0,8/16,31.63%,CHMP7;TMEM50A;VPS36;LEPROT;STAM;CHMP4C;CHMP4A;CHMP4B
prerank,negative regulation of anoikis (GO:2000811),0.43656515128587386,0.9446546038521851,0.5546666666666666,0.9519821805555342,1.0,6/14,19.35%,ITGA5;SRC;PIK3CA;SNAI2;PTRH2;MCL1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.41095631273872496,0.9446400912407088,0.554726368159204,0.9514891449389009,1.0,5/20,14.67%,TMBIM1;PID1;CLTC;RHOQ;PPFIA1
prerank,regulation of neuron projection development (GO:0010975),0.3308019283105392,0.9442878885701999,0.6163967611336032,0.9518277208446133,1.0,34/163,13.45%,DBN1;ARHGAP44;NPTN;EPHA3;PTPRS;S100A9;LPAR1;PPFIA2;NDEL1;TENM3;RET;RIT2;STX1B;ABL2;FRMD7;NDRG4;SEMA3A;RTN4IP1;PSEN1;MYLIP;SRCIN1;TSKU;TWF1;EPHB3;KANK1;FUT9;AVIL;AKT1;MAGI2;TANC2;KIDINS220;P3H1;CBFA2T2;RTN4RL1
prerank,translation (GO:0006412),0.32973314542157456,0.943923447853872,0.6409227683049148,0.9522147496029865,1.0,78/208,31.08%,RPSA;MRPS11;RRBP1;COPS5;EEF2K;MRPS18B;MARS2;ABCE1;IGHMBP2;GTPBP2;FTSJ1;MRPL13;MRPS17;AGO2;GSPT2;RPL10A;MRPL10;TARS1;SARS2;MRPL55;TNIP1;UBA52;RPS5;MRPL36;VARS1;MRPL3;GSPT1;MRPS34;RPL6;MRPL51;EEF1B2;HARS1;GARS1;EEF1G;ABCF1;EEF1E1;EPRS1;QARS1;AIMP1;RPL22L1;RPL23;RPL17;N6AMT1;RWDD1;QRSL1;RPS25;RSL24D1;NOA1;AIMP2;RPL22;NARS1;APEH;EIF4EBP2;EIF4G1;MRPL34;PPA1;EEF1D;RPL34;ASMT;YARS1;RPS29;HBS1L;TMA7;SARS1;RPS26;PPA2;IGF2BP3;DARS1;RPS15;RPS20;WARS2;RPL31;RPLP2;RPS28;MRPL23;AARS1;LARS2;RPS6
prerank,metal ion homeostasis (GO:0055065),0.3658974863487661,0.9435997413791105,0.562137049941928,0.9524640650717326,1.0,10/40,20.50%,SCNN1B;SLC12A8;SLC12A4;CYP27B1;COX11;SLC12A5;CNNM4;KCNH2;SELENON;SLC12A6
prerank,sphingolipid metabolic process (GO:0006665),0.34045599745079963,0.9435841464505308,0.6055612770339855,0.9519756050731595,1.0,20/108,13.63%,SMPD3;CERS6;ARSA;B3GALNT1;PLPP3;ALDH3A2;TECR;PLPP1;PRKD2;ORMDL2;AGK;SGMS2;PDXDC1;FA2H;GBA2;ELOVL5;GLA;CERK;PRKD3;GLTP
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.36247218893439065,-0.9433441111546683,0.538135593220339,0.8356521759974402,1.0,3/11,6.64%,NOVA2;PCBP3;IGF2BP2
prerank,regulation of developmental growth (GO:0048638),0.3863201078819335,0.9432953489558326,0.5663082437275986,0.9521497823160373,1.0,7/29,18.94%,GHR;SIX4;STAT5A;MUSK;SIX1;STAT5B;NIPBL
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.29751467724393466,-0.9430769749282941,0.5321637426900585,0.8346180388730826,1.0,9/22,20.73%,PSMA5;PSMA2;PSMA3;PSMB10;PSMA1;PSMB8;PSMB9;PSMB4;PSMA8
prerank,cellular macromolecule catabolic process (GO:0044265),0.3638632733010306,0.9430316459436585,0.5919037199124726,0.9522482783698779,1.0,18/49,24.95%,OGA;FBXO2;FBXO17;HNRNPD;UBE2G2;EXOSC7;SIDT2;RNASE6;DNASE1L2;NGLY1;HTRA2;IDE;UBE2G1;SUPV3L1;RAB12;DFFB;RNASEH2C;DNASE1L1
prerank,positive regulation of synapse assembly (GO:0051965),0.39024980481352134,0.9425404539763323,0.572827417380661,0.9529266992996334,1.0,13/27,31.31%,EPHB2;EPHB3;VSTM5;SYNDIG1;EPHB1;CLSTN3;IL1RAPL1;GRID2;NLGN1;NLGN3;LRRC4B;NRXN1;NLGN2
prerank,phagolysosome assembly (GO:0001845),0.44898041752478474,0.9423944219325238,0.556910569105691,0.9527535190340478,1.0,1/12,2.11%,RAB7B
prerank,positive regulation of histone modification (GO:0031058),0.37842266445164663,0.9422080946629805,0.5575826681870011,0.9526724630844553,1.0,10/33,21.51%,UBE2N;CDK9;BRD7;AKAP8;NIPBL;GLYR1;CTBP1;PAF1;AKAP8L;ARRB1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.36266665742711307,0.9421870026164711,0.583610188261351,0.9521999264610973,1.0,8/46,13.17%,EPHB2;CAMK2N1;SMAD4;FLCN;TLR4;SIRPA;TNIP1;PIN1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.43617772773689645,0.9421602471780037,0.5428571428571428,0.951738054499478,1.0,3/14,16.77%,PKD1;PKD2;KEAP1
prerank,mitotic nuclear division (GO:0140014),0.3464877160045246,0.9419054283236863,0.5989361702127659,0.9518321829913634,1.0,15/71,14.55%,NDEL1;ZW10;CHMP7;KIFC2;TOGARAM1;ZWINT;KIF2A;ARHGEF10;SMC1A;PIBF1;ABRAXAS1;RHOA;KIF3B;CTDP1;INO80
prerank,acidic amino acid transport (GO:0015800),-0.32426035704292744,-0.9418545106428333,0.54337899543379,0.8359132154275472,1.0,3/17,3.01%,SLC6A13;SLC1A3;SLC6A1
prerank,positive regulation of leukocyte migration (GO:0002687),0.39036411710214636,0.9415511326091258,0.5595667870036101,0.9521651354605546,1.0,7/27,16.30%,VEGFA;MIA3;JAM3;TNFRSF18;PLVAP;IL4;IL6
prerank,positive regulation of MAP kinase activity (GO:0043406),0.3514525796816961,0.9415018613028083,0.6023835319609967,0.9517546819537115,1.0,7/66,4.01%,FGF18;EGFR;FGFR1;VEGFA;FGF2;MST1R;TAOK3
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.41895132092083553,0.9414817461535505,0.5605670103092784,0.9512743585656408,1.0,2/17,5.71%,IGFBP5;DOCK7
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.33510246348822237,0.9412607054395177,0.6103763987792472,0.9512572546054617,1.0,40/119,25.17%,TTC7A;FGF2;PIK3C2B;PIK3R2;SOCS2;PIGZ;PI4K2B;FIG4;OCRL;INPP5F;PIK3CA;ARF1;INPP5K;PIGC;PLEKHA4;MPPE1;MBOAT7;RUFY1;INPP4A;PLEKHA1;PIGW;PI4KB;PIGM;MTMR6;PI4KA;MTMR1;SOCS6;PIP4K2C;CDIPT;PITPNM1;IP6K1;PIP4K2B;PTEN;PIK3CG;PI4K2A;TTC7B;PIGL;DPM2;MTM1;SLC27A1
prerank,regulation of cell-substrate adhesion (GO:0010810),0.36737316825778066,0.940868676679294,0.5887640449438202,0.9516307671761002,1.0,5/42,8.19%,FBLN2;CORO2B;VIT;MYADM;FZD7
prerank,regulation of protein acetylation (GO:1901983),-0.3550025124643224,-0.9402489878131518,0.5253623188405797,0.8379366952300368,1.0,3/12,15.13%,RAPGEF3;SIRT1;TAOK1
prerank,regulation of cell cycle process (GO:0010564),0.3355728483967677,0.9400411399404565,0.6230847803881512,0.9531159842574685,1.0,28/104,23.66%,TIPIN;ATF5;CCDC8;AHCTF1;FSD1;FLCN;NUDT16;KIF20B;FBXO5;SETD2;PRPF40A;CALM2;PIN1;CUL9;BBS4;DBF4;DYNC1H1;CEP85;E4F1;CCP110;TTL;YTHDF2;ENTR1;NUMA1;KLHL9;USP19;CSNK2A2;RAB11FIP3
prerank,regulation of endothelial cell migration (GO:0010594),0.3434760240498944,0.9398696758779169,0.5993723849372385,0.9530011537474267,1.0,21/85,15.37%,DCN;PRKCA;ANGPT4;SPARC;ITGB3;VEGFA;FGF2;SLIT2;FOXP1;SMOC2;PRCP;PRKD2;FOXC2;RHOJ;EMC10;AKT1;EGF;AAMP;ZC3H12A;BCAS3;STC1
prerank,plasma membrane invagination (GO:0099024),0.3742657933338235,0.9392716315242017,0.5695284159613059,0.9539261537938133,1.0,1/29,0.45%,GSN
prerank,O-glycan processing (GO:0016266),0.3551749284918051,0.9391293197969338,0.578494623655914,0.9537451633780774,1.0,7/54,11.72%,ST3GAL2;C1GALT1;GALNT10;MUC1;B3GNT8;GALNT1;ST3GAL4
prerank,regulation of DNA damage checkpoint (GO:2000001),0.4590000377938328,0.9388927793934743,0.5403111739745403,0.9538042444097088,1.0,3/10,14.71%,RFWD3;ETAA1;THOC1
prerank,T-helper cell differentiation (GO:0042093),0.4417016402136792,0.9386246250968455,0.5684210526315789,0.9539263787427564,1.0,4/14,16.30%,TMEM98;FOXP1;IL4;IL6
prerank,regulation of endopeptidase activity (GO:0052548),0.3549890142124584,0.9383800459916302,0.586767895878525,0.9539905972194563,1.0,7/59,12.89%,TIMP2;SERPINB8;SERPINE3;SERPINF1;SERPINH1;AKT1;SERPING1
prerank,peptide hormone secretion (GO:0030072),0.3891377177551934,0.9381902031470937,0.5692307692307692,0.9539270581221698,1.0,5/26,18.84%,ANXA1;ADCYAP1;CRHR1;IL6;RIMS2
prerank,positive regulation of lymphocyte activation (GO:0051251),0.38122498237646935,0.9374973865695783,0.5668257756563246,0.9550666892941838,1.0,11/28,30.49%,CD47;SIRPA;IL6;PYCARD;TNIP2;TICAM1;CCDC88B;FGF10;PRKDC;XRCC6;SH3KBP1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.33119244088874444,-0.9374231683138372,0.5381679389312977,0.8434200607004919,1.0,6/14,14.28%,STARD13;THBS1;NOTCH1;PDCD10;TBXA2R;HDAC5
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.386936904885346,0.9373103703291389,0.583030303030303,0.955025389701968,1.0,6/27,18.41%,F2R;LPAR1;GPR20;CALCA;GRM1;HTR2C
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3227297627939558,0.9372140176505102,0.73,0.9547228308816846,1.0,91/476,16.87%,AR;LRP6;CD80;ESR1;COL1A1;FGF7;IRF4;EGFR;CREB5;TGFB3;WT1;SIX4;ELF4;ZMIZ1;FGF2;F2R;GLIS2;SFR1;RUNX1;SMAD4;ATF5;CXXC1;AXIN1;SOX10;ACVR1;FOXK2;KLF2;MAP2K3;PSRC1;NR1D2;NFATC1;FOXO1;NR1D1;NFIB;MAPRE3;EBF3;PRMT2;RNF111;ZFHX3;RET;TRIP4;MLXIPL;SMAD5;DNAJC2;GLI2;MDFIC;SOX8;CHUK;FZD7;PSEN1;FOXC2;HNRNPD;ATXN7L3;RYBP;MED24;INPP5K;RNF10;BRD7;NPM1;MITF;CAMKK2;SMARCC2;CEBPB;AKT1;GLI3;EGF;QRICH1;MED13;BCL3;RAI1;SIX1;HDAC4;NME2;KLF4;TASP1;MLLT11;IL4;SMARCA4;CHD8;FZD4;MAP2K2;RNF14;CDK5RAP2;RNF187;USP22;HIVEP3;IL6;PHF5A;PITHD1;TFAP4;PML
prerank,cellular response to ATP (GO:0071318),0.43237171505743577,0.9370916817330728,0.5510996119016818,0.9545094181685644,1.0,2/14,10.99%,P2RX3;SSH1
prerank,regulation of oxidoreductase activity (GO:0051341),0.4438619247752349,0.9370688410366855,0.572987721691678,0.95404684291757,1.0,2/13,7.45%,HDAC6;ABL2
prerank,bile acid biosynthetic process (GO:0006699),0.4012442824092384,0.9369090153120427,0.5631901840490797,0.95389581759963,1.0,5/24,9.72%,OSBPL3;OSBPL2;SCP2;HSD3B7;OSBPL6
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.3617882443493025,-0.9367685029124483,0.5296296296296297,0.8434459142014386,1.0,4/11,10.43%,WNT5A;FGFR2;TBX1;STAT1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3688138534898229,0.9364249611370619,0.5633640552995391,0.9545287460501566,1.0,20/37,32.66%,DYNC2I2;KIF3A;KIF3B;IFT46;DYNC2LI1;DYNC2H1;DYNC2I1;IFT52;PCM1;IFT57;DYNLRB1;DYNLL1;TNPO1;KIFAP3;IFT81;IFT20;KIF3C;IFT172;TRAF3IP1;KIF17
prerank,regulation of cell cycle phase transition (GO:1901987),0.34009872006485803,0.9359930899459292,0.6119711042311662,0.955029106509195,1.0,16/91,17.67%,MN1;PSMC4;ATP2B4;PSMC6;PSMD8;CDC23;ANAPC5;FBXO5;ERCC3;CDKN1A;DDB1;CDC27;DBF4;TFAP4;CDC26;ANAPC4
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.4225834317820244,0.9358985452177415,0.5717981888745148,0.954746513098462,1.0,4/17,16.59%,CD44;MIF;TWIST1;SNAI2
prerank,cellular response to hydroxyurea (GO:0072711),0.46043728598572553,0.9357610512320786,0.5607344632768362,0.9545258792697846,1.0,5/10,29.29%,DDX11;SPIDR;BLM;NSMCE3;ATRX
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.3884820534624749,0.9357540700031901,0.5593635250917993,0.9540300432610396,1.0,12/27,28.72%,CCDC88C;CHUK;MAPK11;UBA52;TAOK2;MAPK1;FBXW11;MAP3K7;TNIP2;KAT7;NFKB1;CUL1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.4218099188107483,0.9352680114697804,0.5614035087719298,0.954638020445806,1.0,2/15,7.49%,LRP6;GLI2
prerank,cellular protein modification process (GO:0006464),0.31688804453389907,0.9352305568056845,0.809,0.9542168397868719,1.0,271/983,25.74%,PLOD2;COL3A1;IGFBP5;FSTL1;SYK;FBN1;LOXL2;LORICRIN;PARP3;WSB1;DCLK1;ST3GAL2;PRKCA;TNK1;ANXA1;TIMM50;FGFR1;RABGGTA;STK25;CEL;EIF2AK3;CDC14B;GPC3;PSMC4;PRSS23;B3GALNT1;CDKL2;FYN;IRAK3;SGK3;SGK2;TGFB2;SPSB1;LMTK3;SPSB4;CDK14;TGFBR2;PIGT;PTPRS;FUT2;TAOK3;GPAA1;ART4;COPS5;ACVR1;CDK4;BMP15;IGFBP4;KRT10;FBXW8;GGCX;CALU;MGAT1;VCAN;MTOR;MIA3;PTPRJ;SOCS2;CCDC8;WDTC1;CAMK2D;PHKA2;CSK;COP1;TULP4;GAN;ILKAP;RET;ARF4;PSMC6;TBCK;PTPRF;SPSB2;MELTF;PARP6;ABL2;GAS6;STRADA;OGA;PRKD2;TNNI3K;FBXO2;CHUK;PPP5C;TESK2;PSMD8;FBXO17;CTDSP2;CUL3;DTL;DUSP11;CDK9;PPM1G;SENP8;SIRT2;CDK20;FBXL2;ASB12;FBXW4;AKT3;BMP2K;NRBP2;LGALS1;WIPI2;FBXL20;LOXL1;ERN1;DYRK2;ALG1;LARGE1;WDR5;WDR45B;FUT9;B3GNT8;RAB2A;ZC3HAV1;AMHR2;CSNK1G3;PPP3CC;CAMKK2;SSH1;PARP14;AKT1;MAP3K6;RNF7;DCAF6;HS3ST5;ST3GAL4;IRAK1;PPEF2;FBXO31;PASK;STK39;UBA52;CDC34;PXK;PIGS;TAOK2;DDB1;FBXL3;P3H1;DCAF13;ASB8;CUL9;ULK1;FER;RCE1;TRIOBP;STK24;STK3;PIGK;CTDP1;PPP3CA;PPP2R1B;MTMR6;EVPL;KLHL41;MXRA8;NGLY1;SOCS6;DCAF10;B3GALNT2;IL6;PPP1CC;SDC2;KEAP1;UFL1;PPP2R5B;CHRDL1;RAB1B;FBXL5;NEK4;PDP2;FBXO11;PTPN5;ST3GAL1;ILK;ST3GAL3;STK19;ADPRH;METAP2;TGFBR1;COPS4;GMFB;LOX;STK38;SDHAF2;NEDD8;SKP2;NEK7;PPP3CB;PPP2R2A;DDOST;UBE2D3;LAMC1;KCTD6;CTBP1;OXSR1;HIPK3;STK26;FBXL19;PTPN3;FBXW9;FBXW2;QSOX1;PPM1A;CUL5;PRKCSH;ACVR2A;BMPR1A;MAPK1;SRPK1;PTEN;METAP1;PPP6C;ICMT;YES1;ATG3;METAP1D;CSF1;KLHL9;BRD2;CDKL4;SUMF2;OGFOD1;FBXW11;JMJD7;CDC25B;KLHL22;CSNK1G2;SPSB3;ATG10;FUT10;CTDSP1;PTPN18;LHPP;DCAF5;UST;PICK1;KLHL11;PSMD3;VRK2;FAM20B;LATS1;BCR;WNK2;GPS1;STK10;FBXL12;PSMD4;PRKCZ;MMP15;ACVR1B;MARK2;RARA;CDKL1;MTM1;DNAJC3;RABGGTB;SERPINC1;UBA7;NRBP1;NEK1;HSP90B1;CTH;VHL;FBXO22;PARP16;RAB1A;FBXW7;FBXO30
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.3899271406274606,0.9350697700416636,0.5764139590854392,0.9540679548892201,1.0,2/26,2.27%,AREG;BTC
prerank,cellular response to interleukin-1 (GO:0071347),0.33009397862784,0.9346845599908434,0.6424974823766365,0.9544631401223085,1.0,21/143,12.90%,HAS2;CCL8;PSMC4;IRAK3;USP10;NR1D1;PSMC6;RC3H1;PELI3;UBE2N;CHUK;PSMD8;CCL25;MAPK11;CD47;SIRPA;SQSTM1;IRAK4;IRAK1;UBA52;CCL13
prerank,regulation of sequestering of calcium ion (GO:0051282),0.4460976696992074,0.934471947824727,0.5698478561549101,0.9544434899349117,1.0,3/12,15.00%,ANK2;CASQ1;DIAPH1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.355682300065739,0.9343698475823105,0.6041666666666666,0.9541645373848412,1.0,7/53,7.05%,GLMN;DESI1;PKD1;RHBDF1;RAD23B;PSMC6;UCHL5
prerank,response to amino acid (GO:0043200),0.3826868206205226,0.9343409354098591,0.5911214953271028,0.9537122234178524,1.0,9/31,22.91%,CAPN2;MTOR;MEAK7;NSMF;RRAGD;CPEB1;IPO5;SESN2;SLC38A9
prerank,regulation of nervous system development (GO:0051960),-0.255471319696332,-0.9337472610226216,0.626984126984127,0.849430257455176,1.0,6/37,9.29%,PTN;TENM4;PTPRZ1;HEYL;CX3CL1;YAP1
prerank,regulation of cell death (GO:0010941),0.33426205311086593,0.9336520348610566,0.6130030959752322,0.9547648415498257,1.0,28/94,27.95%,SNCB;LRP1;SRSF6;CCN5;PDE8A;FGF2;VPS4B;TNFRSF1B;ZC3H12A;DCC;CHP1;NCK1;SARM1;CHRNA7;SRGAP2;EPHB1;RRAS2;DUS2;CRYAB;CCN3;NOA1;RAB29;PARP16;EIF4G1;ADNP2;TSC1;CELF1;IMPACT
prerank,potassium ion import across plasma membrane (GO:1990573),0.3587984937586979,0.933198846126814,0.5712656784492588,0.9553341539702231,1.0,10/41,13.35%,ATP1A3;ATP1A4;ATP1A1;SLC12A8;KCNJ2;SLC12A4;KCNK9;HCN4;SLC12A5;KCNJ3
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.38016994988399333,-0.9329537167584824,0.5264900662251656,0.8497625442318167,1.0,3/10,12.14%,PCGF5;IGF2;ZFP57
prerank,regulation of lamellipodium organization (GO:1902743),0.4314351842159663,0.9329214463943193,0.5783783783783784,0.9554586584754975,1.0,5/14,25.16%,CD44;TWF1;FER;DMTN;RAC1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.33978386901496566,0.9329015521341283,0.6148225469728601,0.9549851579537025,1.0,29/80,27.70%,NIBAN1;SMPD3;MTOR;LARP4;HNRNPD;NPM1;PASK;EIF6;RPS27L;BCL3;ZCCHC4;POLDIP3;RBM3;EIF3E;IL6;EIF3D;FXR2;CHRNA7;YTHDF1;PCIF1;NSMAF;YTHDF3;LRRTM3;RELA;LARP6;UPF3B;SLC2A13;PRKDC;IFNGR1
prerank,protein phosphorylation (GO:0006468),0.3203472288153038,0.9326325416693404,0.737,0.9550893097906656,1.0,80/479,14.52%,SYK;DDR2;EPHB2;SRMS;DCLK1;PRKCA;EGFR;TNK1;FGFR1;MAPK12;STK25;EIF2AK3;RPS6KA2;CDKL2;EPHA3;DYRK4;FYN;GTF2H3;DGKQ;IRAK3;SGK3;SGK2;TGFB2;LMTK3;CDK14;TGFBR2;TAOK3;MAPK14;PKD1;ACVR1;CDK4;EEF2K;MTOR;CAMK2D;CSK;RET;MAST4;TBCK;SRC;ABL2;GAS6;STRADA;PRKD2;SLK;ABI1;TNNI3K;CHUK;TESK2;CDK9;TLR4;CDK20;AKT3;BMP2K;NRBP2;ERN1;EPHB3;DYRK2;MUSK;CSNK1G1;AMHR2;CSNK1G3;CAMKK2;STK16;AKT1;MAP3K6;IRAK1;PASK;STK39;ULK2;PXK;TAOK2;FLT3;ULK1;HIPK4;PDGFRA;CCNH;FER;STK24;STK3;DDR1
prerank,positive regulation of exocytosis (GO:0045921),0.37272307224554335,0.9326095207592336,0.5679156908665105,0.9546311622840871,1.0,12/35,26.38%,SMPD3;VPS4B;RAB3D;ATP6AP1;RAB27B;RAB2B;CLASP2;PDCD6IP;SDCBP;STAM;SDC4;CFTR
prerank,reverse cholesterol transport (GO:0043691),-0.3495988277220124,-0.9325905516046237,0.5444444444444444,0.8489405978702671,1.0,3/13,5.81%,APOE;SCARB1;ABCG1
prerank,heterochromatin organization (GO:0070828),0.4321527281030107,0.9324528666230577,0.5443213296398892,0.9544719605702707,1.0,8/14,26.26%,LOXL2;SETD7;POLE3;EZH1;BAHD1;SETDB1;SETDB2;HP1BP3
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.34046486920857616,0.9317406167508507,0.6063492063492063,0.9555870666984662,1.0,18/74,19.35%,AR;SCRT2;MAPK7;TMBIM1;ACVR1;TCF7L2;SRC;PELI3;EYA2;ITGAV;GPX1;AKT1;GDNF;IL4;SNAI2;FAIM2;TGFBR1;MCL1
prerank,regulation of endocytic recycling (GO:2001135),0.45042095196093124,0.9315915224339806,0.5633802816901409,0.9554306544072069,1.0,4/11,15.33%,ATP9A;INPP5F;EHD2;PLA2G4E
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.4438978640706208,0.9312176442869595,0.5625841184387618,0.9558103389052025,1.0,6/12,28.82%,DGKQ;SREBF1;LPCAT3;KPNB1;MBTPS1;SREBF2
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.32167409254537255,0.9309133784964781,0.6906906906906907,0.955989336623107,1.0,90/259,27.68%,GSN;NME8;PMP22;CDC14B;EMP3;ABLIM1;EMP1;PKD1;RAB23;FHDC1;RAP1B;ARF4;FSCN1;NTN1;S1PR2;ACTR3;HDAC6;BBS9;ATAT1;ARL13B;FXYD5;TMEM138;OCRL;CPLANE1;CNGB1;EHD2;INPP5K;NUDCD3;DZIP1;TTC39C;AVIL;TEKT5;VSTM5;PIBF1;DYNC2I2;KIF3A;RPGR;KIF3B;IFT46;TTLL3;BBS4;ARF6;TTC8;ATP6V1D;AHI1;SRGAP2;CEP164;PPP1R9B;DYNC2H1;CEP89;SHTN1;DYNC2I1;CEP83;CCDC28B;RP2;BBS5;BBIP1;IFT52;EXOC4;STK26;CC2D2A;SPAG16;FLNA;PCM1;DNAH5;FBF1;TMEM231;CCDC88A;SDCBP;TCTN2;RAB11FIP3;PDE6D;DYNLL1;DMTN;TCTN1;RAC1;CDC14A;NEK1;CYFIP1;CEP126;RAB1A;CFAP70;SPATA13;RAP1A;GBF1;ARHGEF7;FUZ;IFT81;PTPDC1;RAB8B
prerank,pulmonary valve development (GO:0003177),0.4051866964670219,0.9307911023006326,0.562107904642409,0.9557485133548193,1.0,6/18,13.72%,TGFB2;SLIT2;NFATC1;JAG1;SMAD6;TNFRSF1B
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.34664092230527704,0.9307707882073925,0.5931477516059958,0.9552833989518671,1.0,12/60,16.31%,HNRNPA1;FGF2;SMOC2;PRKD2;ACD;POLG2;CCT7;XRCC5;KLF4;HSP90AA1;RFC4;HGF
prerank,tRNA methylation (GO:0030488),0.367608383856345,0.9302677669712036,0.5630057803468208,0.9559565524129936,1.0,7/34,15.07%,PRORP;TYW3;TRMT61A;FTSJ1;DALRD3;THADA;TRMT1
prerank,DNA double-strand break processing (GO:0000729),0.40656918803131714,0.9302618992510328,0.5565438373570522,0.9554600789260655,1.0,6/18,18.32%,UBE2N;DNA2;NBN;RNF138;RAD50;BLM
prerank,protein autophosphorylation (GO:0046777),0.3263839094129583,0.9300350685564754,0.669021190716448,0.9554780552650174,1.0,31/157,14.52%,DDR2;SRMS;EGFR;TNK1;FGFR1;STK25;EIF2AK3;TAOK3;EEF2K;MTOR;CAMK2D;SRC;PRKD2;SLK;ERN1;EPHB3;MUSK;CAMKK2;STK16;AKT1;IRAK1;PASK;STK39;ULK2;TAOK2;FLT3;ULK1;PDGFRA;FER;STK24;DDR1
prerank,Golgi to endosome transport (GO:0006895),-0.3356983159263898,-0.9298608151383063,0.5497835497835498,0.8542274327958536,1.0,4/16,13.38%,SORT1;VPS13A;DOP1B;EPS15
prerank,RNA modification (GO:0009451),0.34887430356847277,0.9298105606954848,0.572354211663067,0.9554928930456031,1.0,18/54,28.43%,ADARB1;ANKRD16;TRMT6;MEPCE;TRMT61A;FTSJ1;TRMT1;DTWD1;QTRT1;TYW5;TRUB1;METTL1;NOP2;TSR3;WDR4;FTSJ3;URM1;RBM15
prerank,negative regulation of heart contraction (GO:0045822),-0.36175019022799937,-0.9291737984720255,0.5316901408450704,0.8540712154826858,1.0,1/11,0.02%,ATP1A2
prerank,epithelial tube morphogenesis (GO:0060562),0.37789874696211423,0.9289507672345166,0.5835322195704057,0.9569553247717854,1.0,6/32,7.85%,SLIT2;PKD1;ACVR1;GLI2;PRKD2;PKD2
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.3809370793269828,0.9289495131476543,0.5823244552058111,0.9564484742180266,1.0,4/29,13.07%,PKP3;TENT5B;LARP1;GDNF
prerank,regulation of myelination (GO:0031641),0.39022639336283055,0.9283246206229696,0.5806831566548881,0.9573882262762332,1.0,6/25,13.72%,EIF2AK3;TMEM98;ZPR1;SIRT2;RNF10;TNFRSF1B
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.4175026427362188,0.9282058611318238,0.5838926174496645,0.957162339690794,1.0,5/17,24.49%,ANK2;SCN4B;AKAP9;KCNH2;CACNA2D1
prerank,negative regulation of interferon-beta production (GO:0032688),0.4636076812218415,0.9280340999563385,0.5936199722607489,0.9570492070422069,1.0,2/10,10.19%,PTPRS;SIRPA
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.32721436262821063,0.9278390438401727,0.6241062308478039,0.956972470233547,1.0,17/117,14.19%,SYK;VIPR2;FYN;MAPK14;GLP2R;SRC;ADCYAP1;DPEP1;CRHR1;CD81;GPR20;CALCA;GPR45;TSHR;ADCY8;GNB1;LHCGR
prerank,positive regulation of cyclase activity (GO:0031281),-0.3397201972723814,-0.9273111270714227,0.5606694560669456,0.8570718396431118,1.0,5/14,12.97%,NOS3;CACNA1D;NOS1;MAPK8;MAPK3
prerank,male meiosis I (GO:0007141),0.4155293125903279,0.926932947956631,0.571611253196931,0.9585744464240901,1.0,3/16,18.64%,SLC25A31;DDX4;FOXJ2
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.35968805779682933,0.926574456929513,0.5777525539160046,0.9588893632086839,1.0,6/42,12.08%,MYOC;VEGFA;S100A10;PTPRJ;CCL25;JUP
prerank,determination of bilateral symmetry (GO:0009855),-0.29883483109234593,-0.9265229642872711,0.5909090909090909,0.8573360352623614,1.0,13/24,30.03%,NOTCH1;TBX1;CITED2;BBS7;GALNT11;DNAH11;STIL;ZIC3;CFAP53;DLL1;ODAD2;ODAD3;FOXJ1
prerank,sympathetic nervous system development (GO:0048485),-0.3265024019147902,-0.9263639225282443,0.5702127659574469,0.8559493062856651,1.0,4/15,15.57%,NRP2;NRP1;CTNNB1;SOX11
prerank,neuron migration (GO:0001764),0.35540772569882123,0.9261638347159398,0.6122905027932961,0.9593079379612821,1.0,8/48,8.24%,NAV1;MAP1B;FGFR1;VEGFA;FGF13;POMGNT2;LRP12;SEMA3A
prerank,negative regulation of receptor internalization (GO:0002091),0.4445050173114923,0.9254906318949493,0.5696378830083565,0.9603347016883976,1.0,2/12,7.91%,DLG4;ATXN2
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.4374172533987512,0.9254231085463492,0.5683355886332883,0.9599664754358649,1.0,7/12,27.25%,SLIT2;MIA3;AKT1;NBL1;CCN3;DUSP1;WASL
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.31568788097437384,-0.9253103009971044,0.5538461538461539,0.8568481559961134,1.0,6/18,14.56%,DAB2IP;FTH1;SFRP1;PARP10;CD300A;TRIM32
prerank,neuromuscular junction development (GO:0007528),-0.29043071359008465,-0.9252751745076043,0.5810055865921788,0.8551844992355321,1.0,5/24,5.48%,UNC13B;PDZRN3;UNC13C;CACNB2;PPFIBP2
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.34120132708517975,0.9251657821375371,0.604012671594509,0.9600222178237553,1.0,9/67,9.97%,NCF4;PSMC4;ITGB5;SEC22B;PSMC6;CHUK;PSMD8;SNAP23;ITGAV
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.3493903459476373,-0.9251439713348766,0.5685483870967742,0.8538082276071147,1.0,3/12,8.77%,DPYD;CTPS1;CTPS2
prerank,aortic valve morphogenesis (GO:0003180),0.3773854670864912,0.9249963226844329,0.5879574970484062,0.9599178536179404,1.0,8/30,16.59%,SLIT3;SLIT2;ELN;NFATC1;JAG1;SMAD6;TWIST1;SNAI2
prerank,phosphatidylinositol metabolic process (GO:0046488),0.33096712897496827,0.9248865077477826,0.65439672801636,0.9597047230993764,1.0,30/109,21.27%,MTMR11;FGF2;PIK3C2B;PIK3R2;PI4K2B;FIG4;OCRL;INPP5F;PIK3CA;ARF1;INPP5K;PLEKHA4;MBOAT7;RUFY1;INPP4A;PLEKHA1;PIGW;PI4KB;MTMR6;PLA2G4E;PI4KA;MTMR1;PIP4P1;PIP4K2C;CDIPT;INPP5B;PITPNM1;PIP4K2B;PTEN;PIK3CG
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.3646978667760426,0.9248115749046887,0.59613196814562,0.9593546345629664,1.0,12/37,25.35%,MAPK14;IL17RA;TLR4;SIRPA;ZC3H12A;PDCD4;PER1;IL6;PYCARD;CUEDC2;CHID1;TICAM1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.3982226420121612,0.9240331532160088,0.5806861499364676,0.9606095389308089,1.0,7/21,14.04%,ANK2;SRI;CAMK2D;GSTM2;PDE4D;CALM2;CASQ1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.45415254312173964,0.9236791016458036,0.5667613636363636,0.9608852903215553,1.0,2/10,11.60%,MLXIPL;ELOVL5
prerank,"phototransduction, visible light (GO:0007603)",0.4255300881556886,0.9236690088919967,0.5937904269081501,0.9603950769339108,1.0,3/14,13.75%,CNGB1;SAG;GNB1
prerank,response to calcium ion (GO:0051592),0.3291800916561613,0.9235059411944628,0.6216494845360825,0.96023526637458,1.0,13/102,9.18%,KCNMA1;SYT2;NEUROD2;CPNE8;ADAM9;SYT12;SYT11;SEC31A;SYT13;CAMK2D;PKD2;DPEP1;IQGAP1
prerank,regulation of execution phase of apoptosis (GO:1900117),0.44817893469946724,0.9232327870903551,0.5771349862258953,0.9603518389306458,1.0,3/11,14.08%,FAP;SIRT2;ZC3H12A
prerank,dendritic cell migration (GO:0036336),-0.31634775325496245,-0.9231106805911357,0.5540540540540541,0.8570785566294798,1.0,2/16,2.72%,EPS8;HMGB1
prerank,regulation of mRNA catabolic process (GO:0061013),0.3265869225350258,0.9230429545370623,0.6346938775510204,0.9602904122314809,1.0,47/121,31.72%,PRKCA;PKP3;PSMC4;ZFP36L1;SAMD4B;PSMC6;RC3H1;CARHSP1;ZFP36L2;PSMD8;HNRNPD;EXOSC7;ZC3HAV1;AKT1;PUM1;IGF2BP1;UBA52;ZFP36;ZC3H12A;EXOSC1;FXR2;YTHDF1;YTHDF2;SET;RC3H2;YWHAB;YTHDF3;PSMD3;PSMD4;RBM24;TNPO1;PSMB3;DCP1A;EIF4G1;UPF1;PSMB2;PSMD5;IGF2BP3;SERBP1;HSPA8;EXOSC3;PSMD14;PSMC3;PSMC5;CNOT8;FXR1;PSME4
prerank,B cell differentiation (GO:0030183),0.3561121303899801,0.9229491241892559,0.6114221724524076,0.9599726549583555,1.0,8/46,14.82%,HDAC9;SYVN1;CLCF1;PTPRJ;FLT3;CR2;HDAC4;IL4
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.2949559802591524,-0.9224214848266011,0.574468085106383,0.8570276838350798,1.0,1/20,0.16%,NR2F2
prerank,thymus development (GO:0048538),0.4288337118369716,0.9222802897305181,0.5951742627345844,0.9609904560928932,1.0,6/13,27.07%,ZBTB1;EPHB3;SIX1;TGFBR1;FGF10;HES1
prerank,Golgi to lysosome transport (GO:0090160),-0.3651075442258601,-0.9221264640059536,0.5367647058823529,0.8560594592671068,1.0,5/11,23.77%,SORT1;AP1G1;CLN3;EHD3;CCDC91
prerank,positive regulation of chromatin organization (GO:1905269),0.4402681931080051,0.922050282348168,0.5568022440392707,0.9610027004742646,1.0,6/12,22.09%,UBE2N;ACD;TERF1;TINF2;MIER1;TERF2IP
prerank,regulation of chemotaxis (GO:0050920),-0.2705192221989479,-0.9214101286210414,0.5714285714285714,0.8560591537297385,1.0,9/30,14.70%,EFNB2;ZSWIM6;THBS1;USP14;PDGFRB;PTPN2;TGFB1;PPM1F;ADGRA2
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.32378848954582706,0.9212144720003465,0.6636363636363637,0.9623492537692897,1.0,15/151,9.02%,ACKR3;CCL8;PRKCA;EGFR;CD44;PDE8A;FGF2;F2R;MIF;ADCYAP1;GAS6;PRKD2;NDRG4;TIRAP;CCL25
prerank,lipid droplet formation (GO:0140042),-0.36542850639957014,-0.9211342701775214,0.5824175824175825,0.8550462348436965,1.0,4/10,21.70%,ZFYVE1;PLA2G4C;FITM2;CDS2
prerank,cellular response to decreased oxygen levels (GO:0036294),0.33748801827422914,0.9209448973861527,0.6042328042328042,0.9624263963519436,1.0,11/65,9.05%,ANGPT4;VEGFA;LMNA;ZFP36L1;MTOR;CARD16;MDM4;EGLN2;STUB1;TIGAR;SIRT2
prerank,regulation of programmed cell death (GO:0043067),0.3204793156479092,0.9206950018101333,0.6763819095477387,0.9624901333993139,1.0,28/161,15.90%,TNFSF9;RABGGTA;TRIAP1;GAS1;STEAP3;USP36;DDX42;CXCL10;TARDBP;AIFM2;HS1BP3;SLK;TIGAR;BEX2;LGALS1;ALPK2;BCL6;AKT1;ANP32B;GLS2;FLT3;BCL3;DNAJA3;NME2;HSP90AA1;RSL1D1;NOP53;MADD
prerank,negative regulation of phagocytosis (GO:0050765),-0.3185303644632094,-0.9203998492917116,0.5739910313901345,0.85509837186524,1.0,4/17,4.54%,HMGB1;PLSCR1;SNX3;DYSF
prerank,apoptotic nuclear changes (GO:0030262),-0.2892708234380993,-0.9202136162434917,0.5625,0.8538535650695983,1.0,9/24,23.65%,CECR2;HMGB1;CASP3;DEDD2;GPER1;BLCAP;ACIN1;TOP2A;FOXL2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.39574376392300686,0.9194650800514064,0.5935563816604709,0.9642391680843723,1.0,5/21,17.52%,GTF2H3;ERCC3;ERCC4;DDB1;ERCC5
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.39574376392300686,0.9194650800514064,0.5935563816604709,0.9642391680843723,1.0,5/21,17.52%,GTF2H3;ERCC3;ERCC4;DDB1;ERCC5
prerank,ATP transport (GO:0015867),0.4627809114342152,0.9190920502138774,0.5836972343522562,0.9645755802851131,1.0,3/10,14.88%,SLC25A4;CD47;SLC25A17
prerank,positive regulation of locomotion (GO:0040017),0.37906036365305873,0.919049594012306,0.5882352941176471,0.9641532611074011,1.0,5/27,13.56%,DUOX1;NTN1;STX4;CCDC25;TWIST1
prerank,organelle organization (GO:0006996),0.31465923075118035,0.9186632950082513,0.766,0.964537919404572,1.0,115/388,25.94%,SEC16B;ATP8B1;ARHGAP21;ARHGAP10;EIF2AK3;PLCE1;RAB32;ODF2;DIAPH3;PEX16;TMED1;BIN1;SEC31A;FBXW8;TOR1AIP2;ZRANB1;CLUH;ZW10;CHMP7;DST;MIA3;VPS4B;PLEKHF1;CENPT;LYSMD3;RAB30;PI4K2B;MAST4;SYNE1;MIEF2;PKD2;SURF4;LARP4;LMAN1;TOR1A;STX4;POLG2;RAB2A;SEC23IP;CAMSAP1;MICAL2;PRPF40A;LNPK;STX17;KIF3A;RAB43;CCL13;HPS6;PALLD;WDR73;FMNL3;DNAJA3;PEX12;FANCG;PTCD2;BCAS3;PEX1;GEM;DIAPH1;SEC61A1;FAM161B;ANK1;PEX3;BLZF1;HACE1;REEP5;PPIA;YTHDF1;YTHDF2;DYNC2H1;BCS1L;AUP1;VPS11;MICAL1;RANBP10;SLC25A36;ABCD3;SH3D19;ARFGEF1;TMED2;PLD2;VPS13D;CLASP2;NUMA1;PEX2;SLC25A33;ATP8B2;ZMYM3;TJAP1;PDCD6IP;GABPA;PI4K2A;YTHDF3;AFG1L;GOLPH3L;PACSIN2;PACSIN3;TRAPPC12;CNTNAP1;SYNE3;BNIP1;ESRRA;CFAP126;BAG5;RAB18;DMTN;CEP78;STX7;ATP5F1B;RAB29;ATL1;RHOT2;RAB1A;STRIP1;ZMYM6
prerank,fatty acid metabolic process (GO:0006631),0.32271367220402297,0.918613614030164,0.6486761710794298,0.9641502914392445,1.0,27/115,22.15%,CEL;ACLY;ACOT6;CPT1C;ALKBH7;CRAT;SLC27A3;PON3;NDUFAB1;GPX1;FA2H;PNPLA8;ACOT1;HSD17B8;ACAD9;ACOX1;GPAM;LIPC;LIPH;NUDT19;ANGPTL3;ABCD3;MCAT;LPIN3;CPT2;PEX2;CROT
prerank,negative regulation of protein polymerization (GO:0032272),0.37990864503017946,0.9184392865515943,0.6068883610451307,0.9640433758091899,1.0,11/27,21.53%,SLIT2;MYADM;PFN2;TWF1;KANK1;MAPRE1;SSH1;TUBB4A;CLIP3;ARFGEF1;SSH3
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.3595931690406471,0.9182463724076795,0.6053811659192825,0.963960556981353,1.0,10/40,19.35%,RFWD3;ETAA1;UBE2N;CDK9;PARG;MAPT;FBXO5;FXR2;NEK4;MCL1
prerank,regulation of protein polymerization (GO:0032271),0.3679262278685767,0.9178499060558639,0.6114942528735632,0.9643501176519281,1.0,13/35,21.98%,DBN1;MAPRE3;PFN2;CAMSAP1;MAPT;GBA2;FCHSD1;TPPP3;HSP90AA1;COTL1;RASA1;ABITRAM;CTTN
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3203136478914407,0.9177454463568016,0.6740890688259109,0.9640796304559276,1.0,24/140,10.44%,TRIP10;ARHGAP21;ARHGAP10;ARHGAP44;AKAP13;PLCE1;SLIT2;PIK3R2;RASGRF1;TRIO;SRGAP1;SRC;ARHGEF3;MYO9B;FLCN;MYO9A;OCRL;ARHGAP9;TAGAP;RHOJ;ITGAV;TIAM2;RHOQ;SQSTM1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.3455455988222896,-0.9176078025050178,0.5444839857651246,0.8585937523583845,1.0,3/12,3.43%,F3;SNCA;APOD
prerank,cellular response to glucose stimulus (GO:0071333),0.3757121702873848,0.9174613405573451,0.6004618937644342,0.9642256881525302,1.0,6/30,12.54%,RAB11FIP5;SLC39A14;MLXIPL;GAS6;ERN1;ADCY8
prerank,sprouting angiogenesis (GO:0002040),0.3512859600777529,0.9174381153423488,0.6179401993355482,0.9637671348425271,1.0,7/51,7.53%,CCBE1;LOXL2;VEGFA;FGF2;SLIT2;MIA3;ESM1
prerank,histone lysine methylation (GO:0034968),0.36892126971470707,0.9173133161533517,0.6047835990888383,0.9635274085151357,1.0,15/33,28.36%,CXXC1;DPY30;WDR5;EHMT2;PRDM9;SETD1B;KMT2A;N6AMT1;EZH2;SETDB1;SETDB2;WDR5B;MEN1;SUV39H1;PRDM5
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.43923682158025085,0.9168570561646665,0.5910987482614742,0.9640621705419872,1.0,2/13,3.68%,TGFBR2;SMAD4
prerank,regulation of phosphatase activity (GO:0010921),0.3888854342299854,0.9165802176884202,0.6029411764705882,0.9641616638823015,1.0,10/24,28.87%,PPP6R2;URI1;CHP1;SH2D4A;TIPRL;HSP90B1;PPP1R26;TSC1;PTPA;GPATCH2
prerank,apical protein localization (GO:0045176),0.45059206208933433,0.9163567163476842,0.5825958702064897,0.96414519159561,1.0,5/10,20.66%,ATP8B1;JAM3;VANGL2;GOPC;SHROOM3
prerank,second-messenger-mediated signaling (GO:0019932),0.3373634346502978,0.9162649898133252,0.6457023060796646,0.9638275533121687,1.0,8/82,10.96%,ACKR3;EIF2AK3;PLCE1;RCAN3;MCU;ACKR4;RCAN1;CAMKK2
prerank,regulation of MAPK cascade (GO:0043408),0.3224813651485885,0.916155118942034,0.6973684210526315,0.9635884229079015,1.0,27/157,16.45%,SYK;LIF;MYOC;EGFR;FGFR1;FGF2;F2R;PIK3R2;LPAR1;TAOK3;TMEM106A;PTPRJ;RET;RIT2;DHX33;IQGAP1;PRDM15;GPR37L1;PPEF2;EGF;TAOK2;FLT3;GPR37;STK3;MAP2K2;IL6;NBR1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.4523412352728273,0.916104929160791,0.5947901591895803,0.9631851561835737,1.0,2/10,13.49%,MYO9A;RHOA
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.3629565353997344,0.9160533748977578,0.6194285714285714,0.9628020882117748,1.0,9/37,17.66%,S100A8;S100A9;SIAH1;BMF;BBC3;NACC2;NUPR1;NCK1;BCAP31
prerank,negative regulation of transport (GO:0051051),0.3481915943458514,0.9160372776778196,0.6203501094091903,0.962336806531286,1.0,10/51,12.49%,EPHA3;ITGB3;SYT11;SCAMP5;ITGAV;SIRPA;YRDC;EGF;NDFIP1;PXK
prerank,mitochondrial membrane organization (GO:0007006),0.37148068788340827,0.9157929525072452,0.5932611311672683,0.9623481875584398,1.0,10/32,21.87%,TIMM50;SLC25A31;SLC25A4;BAK1;GHITM;SPG7;RCC1L;MICOS10;APOOL;IMMT
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.3143724975057218,0.9154590194390004,0.793,0.962569167481945,1.0,76/509,14.13%,DCN;LIF;AREG;MYOC;CD80;ESR1;FGF18;AXL;FGF7;EGFR;AKAP13;IRS1;FGFR1;MIB2;BTC;FYN;NEUROD2;VEGFA;FGF2;TGFB2;ECM1;MST1R;F2R;MIF;S100A8;S100A9;PIK3R2;LPAR1;MID2;TMEM106A;P2RX3;TCF7L2;PTPRJ;CARD16;C1QBP;RET;CGAS;SRC;RIT2;GAS6;DHX33;FLCN;UBE2N;TFG;PRKD2;FLT3LG;CHUK;PPP5C;PIK3CA;SIAH1;TIRAP;TLR4;IQGAP1;LGALS1;ITGAV;HDAC3;IRAK4;DDX21;BMF;GPR37L1;PUM1;IRAK1;LRRC19;IRS2;CD27;EGF;NDFIP1;BBC3;SMCR8;FLT3;TRAF3IP2;RHOA;RRAGD;GPR37;CBL;PDGFRA
prerank,sulfate transport (GO:0008272),-0.33542849837931044,-0.9151050756349934,0.5482625482625483,0.8629278458722265,1.0,2/14,1.69%,SLC13A4;SLC26A7
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.3837745509631936,0.9150656373330698,0.604679802955665,0.9629594408028938,1.0,6/23,15.06%,FYN;ANK2;CAMK2D;CASQ1;DIAPH1;CACNB1
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.28669686931420935,-0.9150080237261943,0.5771428571428572,0.8614293869186591,1.0,4/25,7.95%,CDH5;ENG;NOTCH1;BMPR2
prerank,negative regulation of cellular senescence (GO:2000773),-0.3419094551710048,-0.9149881448951033,0.5551181102362205,0.8597689640894012,1.0,8/13,23.59%,SLC30A10;CDK6;MAP3K3;SIRT1;TERT;RBL1;TERF2;HMGA2
prerank,histone exchange (GO:0043486),0.3631687023684579,0.9148531117077501,0.5959137343927355,0.962908774305925,1.0,9/37,22.37%,CENPT;SPTY2D1;HJURP;NPM1;DMAP1;SRCAP;CENPC;ZNHIT1;VPS72
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.3821207725946062,0.914850110474647,0.5941176470588235,0.9624153301063801,1.0,12/27,30.09%,BHLHE40;RBM4;FBXL3;PER1;PPP1CC;PML;PER3;FBXL12;CRY2;CRTC1;TP53;FBXL8
prerank,protein destabilization (GO:0031648),0.3714056839900696,0.9146442493918809,0.6035502958579881,0.9623422636634128,1.0,4/32,8.86%,GSN;CCDC88C;NR1D1;CUL3
prerank,response to retinoic acid (GO:0032526),0.3406029861621084,0.914589326151836,0.6222222222222222,0.9619662806920061,1.0,7/59,8.19%,WNT10B;WNT2;EPHA3;WNT9A;RET;ABL2;FZD7
prerank,monocyte differentiation (GO:0030224),0.4536707060202869,0.9145718636053263,0.5862573099415205,0.9615028670409381,1.0,1/10,2.76%,VEGFA
prerank,aortic valve development (GO:0003176),0.36548510459702716,0.9144052240410582,0.6016451233842538,0.9613537111300364,1.0,9/34,16.59%,SLIT3;SLIT2;ELN;NFATC1;JAG1;SMAD6;TWIST1;TNFRSF1B;SNAI2
prerank,sensory perception of smell (GO:0007608),0.44405077947223576,0.9143628730394154,0.5812324929971989,0.9609531145874967,1.0,4/11,36.33%,BBS4;SLC24A4;DRD2;ADCY3
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.27773245657342727,-0.9134726459102342,0.6098901098901099,0.8616974053407858,1.0,3/24,4.18%,LYN;HMGB1;CXCL12
prerank,long-term memory (GO:0007616),0.40893791810072677,0.9134289549356726,0.6102564102564103,0.9624704180290606,1.0,2/19,5.07%,RASGRF1;NFATC4
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.4568714799276544,0.9134197288247521,0.592087312414734,0.9614921113700088,1.0,1/10,3.21%,CDC42EP2
prerank,regulation of pseudopodium assembly (GO:0031272),0.4568714799276544,0.9134197288247521,0.592087312414734,0.9614921113700088,1.0,1/10,3.21%,CDC42EP2
prerank,regulation of inflammatory response (GO:0050727),0.31956132436365586,0.9131328661014455,0.7178714859437751,0.961638195901491,1.0,38/190,19.13%,MGLL;ANXA1;IL16;MAPK7;FOXP1;S100A8;S100A9;AKNA;METRNL;SPATA2;NR1D2;MVK;IL33;NR1D1;IL17RA;DAGLA;TLR4;FNDC4;CD47;SIRPA;BCL6;LRRC19;TNIP1;ABCC1;CD200R1;TNFRSF1B;KLF4;IL4;LRFN5;DAGLB;SELENOS;PDCD4;IL6;UFL1;IL18;SNX6;VAMP2;IFI35
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.3351140704720801,0.9131085267694995,0.6168623265741728,0.9611866927842738,1.0,11/75,12.39%,MGLL;PLCE1;DGKQ;GNG4;SLC39A14;ZDHHC7;ADCYAP1;CNGB1;USP33;SAG;KLK6
prerank,icosanoid secretion (GO:0032309),0.42828799198112666,0.9131083668624792,0.5961272475795297,0.9606884104137272,1.0,2/12,11.43%,ANXA1;PNPLA8
prerank,rRNA modification (GO:0000154),0.39697470899170156,0.9128399319586337,0.5848375451263538,0.9607522954168406,1.0,11/21,35.54%,DIMT1;GAR1;ZCCHC4;TSR3;FTSJ3;NHP2;NAT10;FBL;NSUN3;BUD23;THUMPD1
prerank,alcohol catabolic process (GO:0046164),0.4557603688470631,0.9127346185319393,0.5905292479108635,0.9604917505110965,1.0,1/10,1.78%,CEL
prerank,dendrite morphogenesis (GO:0048813),0.3667199335010419,0.9124799112421557,0.6007109004739336,0.9605792581761404,1.0,13/35,21.43%,EPHB2;DLG4;FARP1;EPHB3;TAOK2;MAP6;CTNND2;DIP2A;SDC2;CHRNA7;EPHB1;PTEN;ABITRAM
prerank,negative regulation of cell activation (GO:0050866),0.4335172125829143,0.9122768710252889,0.5968586387434555,0.9605217153454932,1.0,3/14,14.13%,C1QTNF1;NR1D1;PDGFRA
prerank,retina homeostasis (GO:0001895),-0.2903904582709671,-0.9121404166762207,0.6086956521739131,0.8632769873979185,1.0,7/23,16.99%,ACTB;POTEF;B2M;WHRN;PRDX1;HSPB1;SOD1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.35680758949881375,0.9120253450708173,0.6105499438832772,0.9605725197733554,1.0,14/41,26.25%,FGF2;F2R;TRPV3;ATP2B4;GRIN2D;PKD2;SLC8A2;GRIN2A;HTR2C;IBTK;HTR2A;CACNA2D1;TRPV2;SLC24A2
prerank,negative regulation of RNA splicing (GO:0033119),0.39919713425617837,0.911952477707129,0.5858585858585859,0.9602334368194606,1.0,8/19,28.31%,SRSF6;C1QBP;SAP18;U2AF2;PTBP1;PTBP2;RBMX;RPS26
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.43749571864320486,0.9118897950762255,0.6,0.959873169143839,1.0,4/12,27.81%,GNL3L;CCT7;CCT4;CCT6A
prerank,regulation of synapse assembly (GO:0051963),0.3476075850973017,0.9117676658572011,0.6031215161649944,0.9596539296130939,1.0,9/46,15.05%,EPHB2;GPC6;SLIT1;EPHB3;MUSK;SYNDIG1;SETD5;LRFN5;MDGA1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.44683328071694445,0.9116094516074934,0.6005747126436781,0.9590066124424688,1.0,1/10,9.45%,CNGB1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.44683328071694445,0.9116094516074934,0.6005747126436781,0.9590066124424688,1.0,1/10,9.45%,CNGB1
prerank,sphingoid metabolic process (GO:0046519),0.44218087354408986,0.9114673781440441,0.6348773841961853,0.9588426348230059,1.0,4/12,24.28%,PLPP3;PLPP1;PLPP2;SGPP1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.4060673646151969,0.9108669117583137,0.60498687664042,0.9596548964257808,1.0,5/18,16.30%,SMAD4;SRC;CBL;FER;IL6
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.35419941187358484,0.9105663429676036,0.6101123595505618,0.9597983023088301,1.0,5/43,5.94%,WT1;FGF2;TGFB2;NFATC4;NFIB
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.42149309133529056,0.9103286794019252,0.592741935483871,0.9598397625373695,1.0,3/13,9.48%,FGFR1;FGF2;AKT3
prerank,regulation of cellular response to stress (GO:0080135),0.3232363991568946,0.9101249806959595,0.6686991869918699,0.959788910747939,1.0,39/115,26.18%,CORO2B;NUP93;MTOR;CAMK2D;DNAJC2;NUP107;AIFM2;YWHAE;NUP98;NPM1;CEBPB;MAPT;ADCY8;HSP90AA1;AMFR;HSBP1;NUPR1;CHORDC1;MANF;RSL1D1;NUP37;BAG4;NEK4;FKBP4;NUP50;MCL1;MAPK1;DNAJB1;ATF4;BAG3;USP19;TPR;CRYAB;BAG5;NUP133;NUP85;HSPH1;NUP188;EIF4G1
prerank,activation of adenylate cyclase activity (GO:0007190),-0.24991656519767114,-0.9100767912708725,0.6370967741935484,0.8665036305511986,1.0,6/35,9.13%,ADCY5;ADCY1;EDNRA;CAP2;ADCY4;ADCY9
prerank,positive regulation of establishment of protein localization (GO:1904951),0.4056242990287122,0.9097736954654356,0.6007653061224489,0.9600267409460184,1.0,3/18,15.24%,CORO2B;CCT7;CHP1
prerank,hexose biosynthetic process (GO:0019319),0.3501515629345083,0.9093898756098583,0.6259798432250839,0.9603540100443295,1.0,3/42,4.59%,AKR1B1;CRTC2;SLC39A14
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.33166411757507885,0.9093828278060769,0.6423280423280423,0.9598781914339337,1.0,22/76,22.76%,IRAK3;ITCH;PRMT2;CHUK;IRAK1;NWD1;COMMD6;ZC3H12A;KLF4;USP7;CHP1;NLRP2B;TRAF3;RBCK1;ANXA4;UFL1;TAX1BP1;DAP;PYCARD;ARRB1;CYP1B1;CYLD
prerank,peptidyl-lysine dimethylation (GO:0018027),0.4075325570248841,0.9092645328494304,0.6086404066073697,0.9596263417462237,1.0,6/18,20.13%,SETD7;SETD2;EHMT2;PRDM9;SETD1B;KMT2A
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.33479841825249534,-0.9091527099899236,0.5450980392156862,0.8670253196705209,1.0,4/13,7.43%,IGF1;RAMP1;PLCB1;ALG10B
prerank,regulation of cell-matrix adhesion (GO:0001952),0.3381795827453037,0.9089282393630744,0.6483870967741936,0.9598916257817455,1.0,17/64,22.52%,MYOC;EFNA5;EPHA3;SLK;JAG1;CCL25;SLC9A1;JUP;ADAM15;RHOA;HOXA7;ACTG1;RASA1;CORO1C;CSF1;NF1;LDB1
prerank,striated muscle cell development (GO:0055002),-0.3261832322654624,-0.9085642982017829,0.5555555555555556,0.8667406612623798,1.0,2/14,6.57%,PGM5;TMOD3
prerank,rRNA transcription (GO:0009303),0.40009609702393106,0.9084597631728256,0.5878712871287128,0.9603982860144956,1.0,6/17,23.54%,ANG;POLR1G;GTF3C2;BRF1;SPIN1;GTF3C5
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.43269936416246796,0.9084522798065267,0.6013793103448276,0.9599229232841745,1.0,3/12,12.08%,BIN1;DSC2;JUP
prerank,positive regulation of cellular catabolic process (GO:0031331),0.31802280252323084,0.9082216396306658,0.664969450101833,0.9599154510051716,1.0,29/132,20.29%,DCN;IRS1;ADAM9;MID2;DACT1;ITCH;FOXO1;PLEKHF1;MLXIPL;RC3H1;FLCN;PSEN1;ZC3HAV1;SLC4A4;IRS2;TWIST1;TNFRSF1B;ULK1;ZC3H12A;HSP90AA1;DAGLB;TRIM68;ZSWIM8;UFL1;VPS11;SUPV3L1;GPLD1;SH3D19;ATF6
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.33802434677849774,0.9080249835486163,0.6383207750269106,0.9598503976083212,1.0,25/60,29.86%,CDK4;TCF7L2;MED24;CEBPB;CCNC;CDKN1A;MED13;CCND1;MED15;IL6;AGO4;MED23;MED6;AGO3;PTEN;MED7;TNRC6A;RELA;MED26;AGO1;ATF7IP;NFKB1;BAX;TP53;SOX9
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.43900901897011824,0.9079626550654106,0.5800561797752809,0.9595055535212729,1.0,2/11,14.82%,TMEM106A;IL4
prerank,organelle fusion (GO:0048284),0.38767895305852096,0.9076992603628679,0.6196840826245443,0.9595736901457811,1.0,9/22,30.71%,GDAP1;MIEF2;STX4;SPG7;VPS11;FIS1;CHCHD3;BAX;MFN2
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.34100975708894277,0.907626418532837,0.6438653637350705,0.9592313228999493,1.0,16/59,21.82%,OSBPL3;ACLY;OSBPL2;SCP2;HSD3B7;OSBPL6;NDUFAB1;GAMT;ALDH1A3;HSD17B8;LIPC;LIPH;ABCD3;MCAT;HSD17B4;SRR
prerank,regulation of cholesterol transport (GO:0032374),0.3926526670197074,0.9076115405527897,0.5834394904458599,0.9587753543010026,1.0,3/20,9.72%,LRP1;ABCA13;OSBPL6
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.3181607020263259,0.9074535003261265,0.6914572864321608,0.9586199348661841,1.0,24/163,16.35%,SYK;LAX1;PRAM1;PSMC4;FYN;RFTN1;PIK3R2;PTPRJ;CSK;PSMC6;RC3H1;UBE2N;PRKD2;CHUK;PIK3CA;PSMD8;FYB2;PDE4D;PLEKHA1;ZC3H12A;MOG;BTN3A3;RBCK1;NCK1
prerank,response to leucine (GO:0043201),0.4444559862692572,0.907417030017019,0.6064425770308123,0.9577174375837745,1.0,6/10,22.86%,MTOR;SESN3;RRAGD;SESN2;UBR2;KLHL22
prerank,cellular response to leucine (GO:0071233),0.4444559862692572,0.907417030017019,0.6064425770308123,0.9577174375837745,1.0,6/10,22.86%,MTOR;SESN3;RRAGD;SESN2;UBR2;KLHL22
prerank,positive regulation of neuron migration (GO:2001224),-0.3523665497018073,-0.9074128925448535,0.5488215488215489,0.867688115619119,1.0,4/11,10.67%,RAPGEF2;DAB2IP;SEMA6A;MDK
prerank,nitric oxide metabolic process (GO:0046209),-0.3417716084398476,-0.9074048712782588,0.6032388663967612,0.8660180289127903,1.0,4/14,12.22%,NOS3;GCH1;NOS1;SPR
prerank,regulation of viral release from host cell (GO:1902186),0.3889006290362449,0.9073642768625522,0.6034912718204489,0.957347224087072,1.0,7/21,23.61%,MID2;TRIM11;DDB1;PML;VPS37B;TRIM35;TRIM8
prerank,cranial nerve development (GO:0021545),-0.36405104209904443,-0.907261052677056,0.5743944636678201,0.864673845830513,1.0,2/11,6.44%,CHD7;SALL1
prerank,regulation of sprouting angiogenesis (GO:1903670),0.3591330423775361,0.90718291511065,0.5915985997666278,0.9572595633821912,1.0,6/33,5.66%,FGF18;VEGFA;FGF2;ITGA5;KLF2;CREB3L1
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.41738062669289144,0.9071694392390263,0.5922077922077922,0.956795126565875,1.0,1/15,1.09%,SRM
prerank,organic anion transport (GO:0015711),0.3370322228760917,0.9070867556646255,0.6526315789473685,0.956477290310452,1.0,11/76,13.01%,SLCO2A1;SLC4A10;LRRC8D;SLC4A8;SLC4A3;SLC35B1;SLC25A4;SLC4A4;SLC26A6;SLC2A10;SLC23A1
prerank,T cell differentiation (GO:0030217),-0.24644797869147134,-0.9070120655719989,0.624,0.8636046224912948,1.0,10/40,13.69%,CHD7;SOX13;KIT;TCF7;JAG2;PIK3CD;RHOH;PTPN2;GPR89B;GPR89A
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.294625109550507,-0.906620991485591,0.5990338164251208,0.8611721756555824,1.0,3/21,2.46%,EYA1;BCL2L1;BCL2
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.294625109550507,-0.906620991485591,0.5990338164251208,0.8611721756555824,1.0,3/21,2.46%,EYA1;BCL2L1;BCL2
prerank,positive regulation of cell cycle process (GO:0090068),0.3259464388404193,0.90633532866056,0.6670103092783505,0.9575689940050349,1.0,18/91,15.34%,GPSM2;CDC14B;BTC;XRCC3;SVIL;RHNO1;DYNC1LI1;CUL3;SIRT2;NUDT16;KIF20B;EGF;RHOA;DDX11;DBF4;INO80;GIPC1;DYNC1H1
prerank,negative regulation of interleukin-1 production (GO:0032692),0.3852966031987334,0.9061509107981053,0.610705596107056,0.9574749876130261,1.0,4/23,15.94%,CARD16;GAS6;ZC3H12A;NLRP2B
prerank,iron ion homeostasis (GO:0055072),0.337087587702234,0.9059990524624524,0.6304347826086957,0.957306645669144,1.0,12/58,19.69%,SCARA5;SMAD4;ATP6V0A2;SLC11A2;NDFIP1;ATP6AP1;CCDC115;BDH2;FLVCR1;FBXL5;NEDD8;TMEM199
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.44570661222140123,0.9058841561631086,0.6138328530259366,0.9570645741607373,1.0,2/11,9.18%,CD177;STX4
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.317145101988244,0.9054665473385294,0.6998992950654582,0.957459448557591,1.0,49/166,25.24%,AR;ESR1;POLR2H;GTF2H3;HDAC9;HDAC7;WWTR1;TAF8;NR1D2;NR1D1;POLR1G;BRF2;VDR;NR6A1;CDK9;KAT2B;HDAC3;TAF3;UBTF;ERCC3;POLR2D;POLR2G;NCOR2;NCOR1;GTF2A2;CCNH;BRF1;GTF2F1;NR2C2;E2F3;POLR3H;MED23;NR2C2AP;GTF2E2;POLR1C;RRN3;RORA;MED7;TBP;TAF13;NR3C1;ESRRA;NCOA6;POLR1B;POLR2C;RARA;GTF2E1;MED26;NRBP1
prerank,regulated exocytosis (GO:0045055),0.3167022008902972,0.9054490933615406,0.6914572864321608,0.9570059118047312,1.0,35/173,20.69%,RAB11FIP5;CD9;SCIN;TGFB3;SYT2;CLEC3B;SPARC;ITGB3;VEGFA;TGFB2;ECM1;STX1A;SYT12;SYT11;SYT13;GTPBP2;GAS6;EGF;SERPING1;SNAP25;TUBA4A;RAB27B;MANF;LGALS3BP;SNAPIN;HGF;SYT1;VAMP2;RIMS2;ALDOA;PPP3CB;APOOL;QSOX1;FLNA;RAB10
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.4150393857716448,0.9053764127409321,0.6137841352405722,0.9566694205572819,1.0,5/15,24.71%,NYNRIN;NUDT16;ZC3H12A;RPP30;KHNYN
prerank,glucose import (GO:0046323),-0.33858544325744994,-0.9053512582854443,0.5720338983050848,0.862487299996958,1.0,2/13,1.84%,SORT1;SLC2A1
prerank,Ras protein signal transduction (GO:0007265),0.31824677243104105,0.9050549712026574,0.6955193482688391,0.9568642759345671,1.0,29/137,16.49%,COL1A2;GPSM2;PLCE1;FGF2;CDC42EP2;MAPK14;RAP1B;RASSF1;WASF1;FARP2;NTN1;RIT2;ARHGEF3;MYO9B;MAPK11;RGL2;GDI1;NRAS;KRAS;USP50;SHOC2;CDKN1A;RHOA;GNB1;RAPGEF1;HACD3;EPS8L2;SOS1;HACE1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.4215469553487661,0.9048640191231165,0.593103448275862,0.9567837372315627,1.0,2/12,5.71%,IGFBP5;DOCK7
prerank,positive regulation of protein localization to membrane (GO:1905477),0.32304371068168913,0.9045632602621405,0.6694129763130793,0.9569424816119009,1.0,20/98,16.15%,EPHB2;EGFR;LRP1;EPHA3;FYN;ATP2B4;MIEF2;YWHAG;CD81;YWHAE;STX4;SQSTM1;PPP3CC;AKT1;SFN;BBC3;ARF6;CHP1;PLS1;SPTBN1
prerank,defense response to protozoan (GO:0042832),0.4321087689617883,0.9042310789716658,0.588317107093185,0.9571570306636632,1.0,1/12,1.14%,IRF4
prerank,receptor catabolic process (GO:0032801),0.3817083835087275,0.9038887841298421,0.6074074074074074,0.9573566422703453,1.0,4/24,8.76%,AP2A2;MVB12A;CLTC;MYLIP
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.31884942397756616,0.9038159478887507,0.6615541922290389,0.9570391406766717,1.0,21/116,19.04%,SYK;VIPR2;FYN;MAPK14;GLP2R;SRC;ADCYAP1;DPEP1;CRHR1;GPR20;CALCA;GPR45;TSHR;ADCY8;GNB1;LHCGR;SELENOS;IL6;RXFP1;IAPP;PRKAR2A
prerank,negative regulation of cilium assembly (GO:1902018),0.4320422641799667,0.9037002894202677,0.6039603960396039,0.9567768602989327,1.0,5/12,18.49%,CEP97;MAP4;EVI5L;CCP110;ODF2L
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.39932358909432947,0.9035621321017108,0.5927367055771725,0.9565907845244563,1.0,4/17,5.30%,VEGFA;FGF2;SLIT2;MIA3
prerank,neuron projection fasciculation (GO:0106030),0.44657509355452485,0.9031791934867867,0.6121883656509696,0.9569239628833712,1.0,2/10,10.29%,EPHB2;EPHB3
prerank,amyloid-beta metabolic process (GO:0050435),-0.31762650199913267,-0.9031330063573529,0.5929203539823009,0.8659672749044596,1.0,3/16,3.36%,BACE2;MGAT3;DYRK1A
prerank,response to amyloid-beta (GO:1904645),0.34891290106084716,0.9027741032425242,0.6139169472502806,0.9572837239519286,1.0,11/44,17.99%,LRP1;FYN;MMP2;ATP1A3;PSEN1;TLR4;ABCC1;CACNB1;GRIN2A;CHRNA7;SNX6
prerank,regulation of microglial cell activation (GO:1903978),0.41041010237387804,0.9020836439619525,0.5992115637319316,0.9582369997949983,1.0,4/15,22.53%,SYT11;NR1D1;IL6;LDLR
prerank,cellular response to topologically incorrect protein (GO:0035967),0.3686725627801547,0.9019812257499578,0.6183294663573086,0.957991400779805,1.0,7/31,15.32%,HDAC6;STUB1;HSPA13;UBE2W;ERN1;BAK1;HSPA14
prerank,purine-containing compound salvage (GO:0043101),0.43137762200797675,0.901820843344328,0.603542234332425,0.9578374358338647,1.0,1/12,2.31%,AMPD2
prerank,regulation of protein secretion (GO:0050708),0.3242910988867333,0.9017270862792554,0.6941896024464832,0.9575580939525679,1.0,12/119,5.42%,DPP4;PRKCA;MTNR1B;TGFB3;DISP1;ANG;CACNA2D2;TGFB2;STX1A;ADAM9;LLGL1;RHBDF1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.3993307772753722,0.9015094754731489,0.6030927835051546,0.9575499875250427,1.0,4/18,12.54%,VEGFA;CRTC2;PRKD2;ADCY8
prerank,negative regulation of apoptotic process (GO:0043066),0.3095806374978418,0.9014982051551272,0.812,0.9570934540512921,1.0,91/444,20.74%,COMP;FSTL1;AXL;GCLC;ARHGAP10;PRKCA;EGFR;ANXA1;TGFB3;WT1;HPN;ANGPT4;TRIAP1;SIX4;CD44;VEGFA;F2R;MIF;ATF5;COPS5;ITGA5;CLCF1;NFATC4;ITCH;SOCS2;CBX4;FOXO1;CARD16;ARF4;SRC;GAS6;DPEP1;SOX8;YWHAE;PIK3CA;PSEN1;AVEN;NRBP2;SMAD6;SON;SQSTM1;HDAC3;NPM1;GPX1;AKT1;IRAK1;NAT8;UBA52;CD27;SFN;GDNF;BCL3;WDR73;SIX1;NME2;CBL;ZC3H12A;KLF4;IL4;NUPR1;VDAC1;BAG4;AHI1;IL6;HGF;ANXA4;SNAI2;TAX1BP1;PTRH2;ERCC5;FAIM2;SET;TMBIM4;PLAUR;QARS1;SNX6;NAA15;VTCN1;UFM1;SUPV3L1;PRDM9;DSTYK;MCL1;IL31RA;HIPK3;RASA1;FLNA;PRELID1;DDAH2;OPN3;TYRO3
prerank,regulation of cellular respiration (GO:0043457),-0.31195329901676,-0.9014884384093801,0.6045454545454545,0.8681577926825572,1.0,4/17,7.69%,IFNAR1;CBFA2T3;IL10RB;PRDM16
prerank,positive regulation of viral genome replication (GO:0045070),0.3717911066619851,0.9013130669822023,0.6226415094339622,0.9569953623170668,1.0,8/29,21.08%,TARBP2;ADARB1;LARP1;DDB1;HACD3;PPIA;TOP2B;SRPK1
prerank,zinc ion transport (GO:0006829),0.390194443803986,0.9010397881112493,0.6161369193154034,0.9570835824912227,1.0,6/21,19.98%,SLC39A13;SLC39A14;SLC39A7;SLC30A9;SLC30A5;SLC39A3
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.27784714667331156,-0.9010267598621647,0.5812807881773399,0.8675591341444864,1.0,2/23,1.98%,UACA;BMP7
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.31883148229494096,0.9008827749065269,0.693089430894309,0.956933948521707,1.0,33/124,25.16%,SFRP4;CCDC88C;PSMC4;SMURF2;TCF7L2;NFATC1;AP2A2;PSMC6;CLTC;FZD7;PARD6A;PSMD8;AGO2;VANGL2;RHOA;GNB1;PPP3CA;FZD4;AGO4;DAAM1;SFRP5;PPP3CB;AGO3;TIAM1;GNAO1;SMURF1;MAP3K7;AP2M1;TNRC6A;PSMD3;DVL1;PSMD4;RAC1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.3355702191152427,0.9006902517407702,0.6520307354555434,0.9568545899294574,1.0,9/54,13.75%,KCNMA1;FHL1;BIN1;KCNJ2;YWHAE;KCNAB3;STK39;KCNJ3;GNB1
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.3079421229032046,-0.9006847700988626,0.5726872246696035,0.8667516487311518,1.0,6/16,22.37%,SSBP1;PURA;WRN;MCMDC2;TWNK;RAD51
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.3304557000662482,0.900582571943736,0.6493236212278877,0.9565986261501361,1.0,22/72,23.18%,FGF13;SLIT2;SMAD4;MYADM;PFN2;CHADL;PIK3CA;TWF1;KANK1;MAPRE1;SSH1;CAMSAP1;TUBB4A;PFDN6;IAPP;NAV3;CLIP3;ARFGEF1;CLASP2;SSH3;LDLR;CRYAB
prerank,photoperiodism (GO:0009648),0.375343243131716,0.9005448028324389,0.62,0.9561955124784295,1.0,12/28,30.09%,BHLHE40;RBM4;FBXL3;PER1;PPP1CC;PML;PER3;FBXL12;CRY2;CRTC1;TP53;FBXL8
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.34284403074019043,0.9004031644082059,0.6203904555314533,0.9560106417731568,1.0,23/52,29.44%,UBE2J2;USP36;YWHAG;YWHAE;HPS4;PPP3CC;SFN;NPEPPS;BBC3;HTRA2;VPS11;ARIH2;ATG13;UBE2D3;SAE1;YWHAB;CSNK2A2;LEPROT;FBXW7;RNF31;CASP8;SREBF2;TP53
prerank,protein localization to plasma membrane (GO:0072659),0.316255876750041,0.899508255459702,0.7007150153217568,0.9573758207055373,1.0,22/129,13.74%,LRP6;TTC7A;TSPAN17;PKP3;PRAM1;ANK2;FGF13;S100A10;NECTIN3;PLEKHF1;MYADM;MYO5A;GAS6;PACS2;CD81;EHD2;INPP5K;FYB2;RAB3D;JUP;ZDHHC2;PIGW
prerank,organic substance transport (GO:0071702),0.32224407993766696,0.8993566705257959,0.6836734693877551,0.9571963730215739,1.0,20/121,13.57%,SLCO2A1;DISP1;SLC50A1;ARRDC2;SLC47A1;MIA3;TOM1;SCAMP3;RCN3;ABCG4;ABCA1;SCAMP5;TCN1;ABCA13;SLC6A4;LRP1B;RUFY1;KIF3A;SLC23A1;CMTM6
prerank,histone deubiquitination (GO:0016578),0.4013291971037252,0.8992860975061087,0.6152866242038216,0.9568860156005033,1.0,5/18,20.88%,USP36;ATXN7L3;USP7;USP22;TRRAP
prerank,negative regulation of DNA recombination (GO:0045910),0.34465590324512413,0.8991559403606354,0.6171171171171171,0.9566686560853355,1.0,14/43,26.85%,PARP3;POLR2H;CGAS;ACD;POLR2D;POLR2G;TERF1;BLM;TINF2;TERF2IP;UBQLN4;POLR2C;H1-0;MSH6
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.41670190977654453,0.8991153699130447,0.5987261146496815,0.9562667173271332,1.0,6/15,29.43%,CUL3;NPM1;PAF1;EZH2;STXBP4;GLI1
prerank,histone deacetylation (GO:0016575),0.34943982673805374,0.8985022089277626,0.625139043381535,0.9570660009358324,1.0,12/43,20.07%,HDAC9;HDAC6;SIN3B;MSL3;SIRT2;RCOR3;HDAC3;HDAC4;PER1;MORF4L1;SUDS3;MIER1
prerank,defense response to symbiont (GO:0140546),-0.21275776668104204,-0.8980254040473664,0.7647058823529411,0.8713667258822524,1.0,14/92,10.43%,BCL2L1;SERINC3;BCL2;TRIM56;PLSCR1;IFITM3;ABCC9;MAVS;CNOT7;IFIT1;IFIT2;TLR3;OAS2;STAT1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.3329027913634625,-0.8980110053666713,0.6115702479338843,0.8697334948453983,1.0,2/14,2.54%,AUTS2;KMT2E
prerank,sister chromatid segregation (GO:0000819),0.36931872853424064,0.8972596060780005,0.6412395709177592,0.959212492493079,1.0,9/31,24.04%,CHAMP1;ZW10;ZWINT;SMC1A;INO80;TOP2B;KLHL22;TUBG2;LATS1
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.3765522042657885,0.8970778516743578,0.6072727272727273,0.959123714332657,1.0,9/24,19.04%,UBE2B;PDE11A;CGAS;PDE4D;CDC34;PDE3B;PEX5L;TCP11;PRKAR2A
prerank,regulation of neutrophil migration (GO:1902622),0.43740405476183153,0.8970202876763739,0.6203059805285118,0.9587547528443233,1.0,2/10,11.70%,JAM3;MPP1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.4069719297530411,0.8966692334624548,0.6202185792349727,0.9590117395932236,1.0,5/15,15.67%,VEGFA;FGF2;ITGA5;KLF4;PKM
prerank,phagosome maturation (GO:0090382),0.3558190127781376,0.8966551110147889,0.6396807297605474,0.9585605099380478,1.0,7/35,16.13%,RAB32;ATP6V0A2;ATP6V1E1;RAB43;ATP6V0A1;ATP6V1D;ATP6V1B2
prerank,negative regulation of programmed cell death (GO:0043069),0.30917281478142405,0.8965031718156905,0.799,0.9583794328831091,1.0,72/355,20.68%,COMP;FSTL1;AXL;GCLC;ARHGAP10;EGFR;ANXA1;WT1;HPN;ANGPT4;TRIAP1;SIX4;CD44;VEGFA;MIF;ATF5;COPS5;ITCH;SOCS2;CBX4;FOXO1;ARF4;SRC;AIFM2;GAS6;DPEP1;SOX8;TIGAR;PSEN1;AVEN;SMAD6;SON;SQSTM1;HDAC3;NPM1;AKT1;IRAK1;NAT8;UBA52;CD27;GDNF;BCL3;WDR73;NME2;CBL;IL4;NUPR1;VDAC1;BAG4;AHI1;IL6;HGF;ANXA4;TAX1BP1;ERCC5;FAIM2;TMBIM4;PLAUR;NAA15;VTCN1;UFM1;SUPV3L1;PRDM9;DSTYK;MCL1;IL31RA;HIPK3;RASA1;FLNA;PRELID1;DDAH2;OPN3
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.27440655228405203,-0.8964957920526967,0.6276595744680851,0.8716072884391864,1.0,7/26,12.38%,APOE;SCARB1;PIK3CB;NPR3;GCH1;TERT;S100A1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.41237326206374625,0.8964026926326532,0.6045883940620783,0.9581086801606009,1.0,5/14,22.09%,ACD;TPP1;XRCC5;TINF2;TERF2IP
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.309721791667224,-0.8963250603707168,0.59765625,0.8703268325866319,1.0,1/16,0.39%,PDS5B
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.40457154185230704,0.8959946871900886,0.6176084099868594,0.9584861909319825,1.0,4/18,13.86%,TMEM119;FZD7;HDAC3;HDAC4
prerank,Golgi ribbon formation (GO:0090161),-0.32911409449912304,-0.8957113269188005,0.5992217898832685,0.8700750527380241,1.0,6/13,18.05%,STX6;MYO18A;OPTN;GCC2;GOLGA2;TRIP11
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.39325924280150587,0.895146085001432,0.6163522012578616,0.9597778840544238,1.0,10/19,29.17%,PARD3B;DLG2;FSCN1;SYNJ2BP;MARK2;MTCL1;CRB1;LRRC7;PRKCI;PARD3
prerank,dicarboxylic acid metabolic process (GO:0043648),0.3343075924691108,0.8950833421066933,0.6564551422319475,0.9594325537370602,1.0,13/52,25.28%,GCLC;ALDH18A1;ACLY;IDH1;NIT2;ALDH5A1;MDH2;GOT1;D2HGDH;MTHFD2L;MTHFD2;MTRR;ME3
prerank,RNA methylation (GO:0001510),0.33289130448384424,0.8950324822753001,0.6555793991416309,0.9590649064468877,1.0,9/60,13.28%,DIMT1;TRMT6;TYW3;MEPCE;TRMT61A;FTSJ1;TGS1;THADA;ZCCHC4
prerank,fatty acid transport (GO:0015908),-0.3143545604297321,-0.8949447334211494,0.6096256684491979,0.8703264640113404,1.0,2/17,2.45%,ACSL1;APOE
prerank,negative regulation of protein processing (GO:0010955),0.42022710420389797,0.8945868023912636,0.6258692628650904,0.9595187768298022,1.0,1/12,2.62%,GAS1
prerank,cellular response to copper ion (GO:0071280),-0.3132409558419244,-0.8945784184900354,0.620253164556962,0.8695135924303746,1.0,1/16,3.22%,SNCA
prerank,positive regulation of positive chemotaxis (GO:0050927),0.4092757343538499,0.8944178892001569,0.6051948051948052,0.9594192535214288,1.0,2/15,2.76%,IL16;VEGFA
prerank,nitric oxide biosynthetic process (GO:0006809),-0.3472430108223922,-0.8943447520779463,0.6072874493927125,0.8684178873511387,1.0,4/13,12.22%,NOS3;GCH1;NOS1;SPR
prerank,ncRNA transcription (GO:0098781),0.4211732633157777,0.8939551190747292,0.6114058355437666,0.9598720158287297,1.0,4/13,21.73%,ANG;POLR1G;BRF1;SPIN1
prerank,primary alcohol metabolic process (GO:0034308),0.37203444164485794,0.8939224119431444,0.6263871763255241,0.959458205864525,1.0,2/25,5.79%,DHRS9;ALDH3A2
prerank,mitotic sister chromatid segregation (GO:0000070),0.3205307622523458,0.8934923763411325,0.7070914696813977,0.9598816432394317,1.0,24/98,23.10%,DIS3L2;ZW10;CHMP7;PSRC1;VPS4B;TENT4A;ZWINT;CUL3;SMC1A;CDC23;PIBF1;NCAPG;INO80;SMC2;SET;NAA50;CENPE;NIPBL;AKAP8L;PDCD6IP;DCTN2;KLHL22;CSNK2A2;TUBG2
prerank,melanosome localization (GO:0032400),-0.28478962849879663,-0.8934640042121281,0.64,0.8688634090023896,1.0,8/21,17.84%,SHROOM2;BLOC1S5;RAB11A;BBS7;MREG;RAB27A;BLOC1S6;MLPH
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.41886359281323593,0.8934003379659857,0.618403247631935,0.9595816845562037,1.0,3/13,12.96%,AGO2;ZFP36;POLR2G
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.3898816033305821,0.8933763312902988,0.6099378881987577,0.9591566220399769,1.0,4/21,13.56%,MED24;MITF;MED13;TWIST1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.34740600780019254,-0.893072876342194,0.6220472440944882,0.8681010412404354,1.0,9/11,42.47%,STAT1;IL12RB2;STAT4;CANX;IL27RA;STAT3;IL12A;JAK1;EBI3
prerank,phosphate-containing compound metabolic process (GO:0006796),0.3109149509038507,0.8928687940224889,0.7452357071213641,0.9597236474314484,1.0,45/198,21.27%,GFPT2;EPHB2;PFKP;PLCE1;GFPT1;PLPP3;PLCB4;ACP2;MTOR;PLPP1;GK5;TIGAR;OCRL;PIK3CA;LCAT;AGK;INPP5K;AKT1;PGM2L1;CERK;PLPPR3;INPP4A;PPP3CA;PLA2G4E;PI4KA;NUDT5;G6PC3;SLC20A1;IPPK;PIP4P1;PLCD4;PLPP2;ANGPTL3;ALDOA;PPP3CB;PANK3;TOLLIP;INPP5B;ACYP1;ACP3;IP6K1;PPM1A;PIP4K2B;PTEN;PIK3CG
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.33367832276602344,0.8927287585633699,0.6630316248636859,0.9595456494970568,1.0,14/62,15.56%,POLR2H;GTF2H3;ADRM1;CDK9;ELP4;SETD2;ERCC3;POLR2D;POLR2G;CCNH;EAF2;CTDP1;GTF2F1;EAF1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.37716037970050764,0.8926861950308617,0.6126674786845311,0.9591639336044251,1.0,9/21,24.32%,RASSF2;MLXIPL;INPP5K;PDE4D;NLRP2B;NCK1;PTEN;NCK2;DMTN
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.3032954254445273,-0.8925230476113761,0.6018957345971564,0.8676150652730956,1.0,6/18,13.64%,VGLL4;DAB2IP;NELL1;ATRAID;RGP1;RIC1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.4204550920711802,0.8922939443023139,0.607094133697135,0.9595339930443251,1.0,5/12,23.47%,PAICS;GART;ATIC;ADSS2;LHPP
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.44267265068008216,0.8922263132775985,0.6033755274261603,0.9591929195193091,1.0,1/10,0.47%,LRP6
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.28240317983597235,-0.8917600458734367,0.625,0.8677844232564408,1.0,4/21,8.17%,RAP1GDS1;SLC8A3;TGM2;MICU2
prerank,protein-containing complex assembly (GO:0065003),0.3081772597210824,0.8916879350569662,0.7717717717717718,0.9598375677809008,1.0,79/259,27.80%,AREG;SEC16B;SEC24D;CNIH3;WIPF1;STX5;LLGL1;DLG4;GPAA1;AXIN1;SEC31A;ZW10;TCF7L2;PREB;ZNHIT6;SEC24A;WASF1;FARP2;SEC22B;MDM4;TFG;SEC23A;USO1;MCU;LMAN1;CUL3;SCFD1;TLE2;MITF;SEC23IP;NAPA;SLC9A1;ADCY8;CNIH1;TRAPPC2L;CDC123;ZC3H12A;BCL9;SMARCA4;NSF;TFAP4;PML;SPG7;NAPG;SEC24B;RAB1B;EPRS1;BLM;PYGO2;VAMP2;TMED2;LAMC1;KMT2A;TIAM1;TRRAP;PPP6C;TRAPPC6B;AP2M1;PYGO1;DMTN;NDUFAF1;MDM2;KAT5;TRAPPC4;RAB1A;PPIH;TCF7L1;HGSNAT;GOSR2;KIFAP3;KLHL12;TRAPPC2;HES1;GORASP1;VAMP3;WASL;MEN1;PDE4DIP;CASP8
prerank,glycolipid biosynthetic process (GO:0009247),0.3571270867243876,0.8915999380597809,0.6341743119266054,0.95953881588529,1.0,8/38,14.92%,ST3GAL2;PIGZ;PIGC;LARGE1;ST3GAL4;MPPE1;PIGW;PIGM
prerank,organophosphate ester transport (GO:0015748),0.3794737075841501,0.8909801865840639,0.6240694789081885,0.9603276627994942,1.0,9/24,22.53%,TRIAP1;OSBPL2;PRELID3A;SCP2;EPG5;PITPNM1;PRELID1;PCTP;LDLR
prerank,glycoprotein metabolic process (GO:0009100),0.3400245529713489,0.8903931195981875,0.6533477321814255,0.9610554616988976,1.0,10/53,15.68%,PCSK6;ST3GAL2;OGA;FBXO2;FBXO17;LARGE1;ST3GAL4;TNIP1;MGAT4B;NGLY1
prerank,mitochondrion localization (GO:0051646),0.3924847513840364,0.890326579284276,0.6134889753566797,0.9607111321895866,1.0,6/19,26.47%,TLE6;TRAK2;ATCAY;MARK2;MTM1;MUL1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.3363530486695193,0.8900984463129217,0.652317880794702,0.9606973428395056,1.0,18/48,27.37%,MYOC;S100A10;FBXW8;MYADM;C1QBP;TRIOBP;LIMS2;RAC3;ILK;FLNA;DMTN;CALR;RAC1;IL1RAPL1;ARHGEF7;CUL7;PRKDC;CAPRIN2
prerank,peptidyl-lysine acetylation (GO:0018394),-0.35786306999050405,-0.8899324097854568,0.5970695970695971,0.8703863476082628,1.0,3/10,12.05%,CREBBP;SIRT1;EP300
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.30876770860536673,0.8890792248358197,0.7917917917917918,0.9622707111781671,1.0,59/306,18.38%,RPSA;ST3GAL2;POLR2H;MRPS11;RRBP1;TIPIN;EXT1;COPS5;EEF2K;MRPS18B;IGHMBP2;INHA;NT5M;GTPBP2;RHNO1;PPP5C;MRPL13;MRPS17;AGO2;POLE3;ING4;MCM3;LARGE1;FUT9;GSPT2;RPL10A;RMI1;MRPL10;MRPL55;ST3GAL4;TNIP1;RAD1;PCLAF;POLR2D;POLR2G;RPS5;BCL3;DNA2;BRIP1;MRPL36;ORC6;DBF4;NBN;MRPL3;FAM111A;GSPT1;RPL6;MRPL51;RFC4;EEF1B2;GRWD1;HARS1;EEF1G;ABCF1;RAD50;SET;BLM;TBRG1;POLD1
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.3144204983295139,0.8889184938304571,0.7127016129032258,0.9621401620660861,1.0,32/124,18.29%,MYOC;ODF2;RASGRF1;UNC5A;DOCK7;DTNBP1;LRP12;ADCYAP1;PKD2;TOR1A;PLP1;L1CAM;CAMSAP1;MAPT;TBC1D23;FLRT3;LGI1;GDNF;PLEKHA1;ULK1;ATCAY;BLOC1S2;MANF;MAP4;FAM161B;SNAPIN;IL6;RAB35;PPP1R9B;STX3;CNTN4;GPM6A
prerank,histone H3-K4 methylation (GO:0051568),0.366310461036058,0.8888648994914868,0.6347305389221557,0.9617935907927205,1.0,8/26,20.13%,CXXC1;DPY30;WDR5;OGT;PRDM9;KMT2C;SETD1B;KMT2A
prerank,regulation of small molecule metabolic process (GO:0062012),-0.2661253192171126,-0.8885962561272893,0.6625,0.8717792105082717,1.0,7/28,10.54%,PDK1;APOE;TTC39B;PPARA;ACADL;EPHX2;SIRT1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3599248911479594,0.8884536954405066,0.6415094339622641,0.9621670313242163,1.0,13/31,29.17%,PARD3B;DLG2;MYO9A;RHOA;ANK1;SYNJ2BP;PDCD6IP;MARK2;MTCL1;CRB1;LRRC7;PRKCI;PARD3
prerank,regulation of insulin secretion (GO:0050796),0.31838579436821707,0.8879261571174195,0.7029804727646455,0.9628037112330343,1.0,18/101,16.30%,DPP4;PRKCA;MTNR1B;IRS1;EFNA5;CACNA2D2;STX1A;MIDN;TCF7L2;NR1D1;MCU;BMP8A;IRS2;TRH;SNAP25;KCNC2;GLUD1;IL6
prerank,regulation of calcium-mediated signaling (GO:0050848),0.3759744259515673,0.8879087276483784,0.6303549571603427,0.9623682285932244,1.0,6/25,17.71%,NEUROD2;P2RX3;RIT2;MAPT;SLC8A2;TMBIM4
prerank,histone H3-K9 demethylation (GO:0033169),-0.34313608798360196,-0.8876049410110908,0.5793357933579336,0.8723203575182799,1.0,2/11,2.52%,KDM7A;KDM4A
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.35347515444943745,0.8871854830059417,0.6434285714285715,0.9633351546085038,1.0,3/34,9.18%,EPHB2;CLCF1;STX4
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.33019396836871145,0.8871535148082496,0.6680988184747583,0.9629283975988622,1.0,10/62,12.43%,COL3A1;AKAP13;F2R;LPAR1;RASGRF1;RASGEF1A;ARHGEF3;GPR20;IRS2;SHOC2
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.31719376756419393,-0.8868116612237154,0.6502057613168725,0.8725244993505487,1.0,5/16,10.54%,BMP7;SOX13;NAPEPLD;PTGS2;SIRT1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3021712670856783,0.8868091020417496,0.89,0.9631657281482041,1.0,157/572,25.90%,AR;ESR1;LOXL2;TRPS1;FOXP2;NFIX;WT1;TLE6;SCRT2;SKIL;VEGFA;KLF12;FOXP1;BHLHE40;GLIS2;RUNX1;SMAD4;HDAC9;ZNF25;DPF2;SMURF2;SKI;SOX10;DACT1;KLF2;TCF25;NFATC4;TCF7L2;NR1D2;CBX4;MEIS2;IL33;NR1D1;NFIB;ZFHX3;C1QBP;MDM4;SIN3B;GLI2;ZFPM2;TBX6;NOC2L;RNF2;FLCN;SOX8;ZBTB1;VDR;NR6A1;PSEN1;FOXC2;SIRT2;ZMYM5;MYPOP;OTUD7B;ZNF3;HDAC3;URI1;MZF1;TAF3;TCERG1;MITF;IRF2BPL;BCL6;ZHX2;CEBPB;GLI3;UBA52;ZFP36;DR1;NCOR2;PEG3;NCOR1;IKZF5;CCND1;CRYM;TWIST1;DNAJA3;NACC2;HDAC4;EZH1;EHMT2;DMAP1;KLF4;HOXA7;HSBP1;IL4;ZNF692;SMARCA4;CHD8;DDX20;NR2C2;YEATS2;NOP53;ZBTB5;PER1;DDX5;SNAI2;CHD3;E4F1;ZEB1;HIVEP1;NRIP1;CTCF;UXT;NIPBL;SUDS3;RPL23;KDM1B;UBE2D3;CTBP1;MIER1;PPM1A;DNAJB1;HSF4;PEX2;PAF1;KDM2B;NSD1;PHF21A;JUN;LARP7;EZH2;ATF4;VPS72;LDB2;LDB1;BAG3;TPR;SDCBP;ZNF431;GATAD2A;IFI27;NR3C1;PER3;SKOR2;RTF1;RELA;ZEB2;ORC2;LCOR;HEXIM1;MDM2;BCL11A;CALR;RARA;E2F7;KAT5;PHF12;PHF6;VHL;MBD2;MAFK;MYT1L;DDIT3;H1-0;RARG;CRY2
prerank,triglyceride homeostasis (GO:0070328),-0.2630914254787746,-0.8867089646324232,0.6348314606741573,0.8711412359792713,1.0,9/26,21.16%,APOE;SCARB1;NR1H3;C1QTNF3;SIRT1;LPL;NR1H4;MTLN;FITM2
prerank,nuclear transport (GO:0051169),0.39822464992903644,0.8863333665589483,0.6207349081364829,0.9636572267884794,1.0,4/16,18.49%,NUP98;NPM1;PSIP1;NXT2
prerank,neutral amino acid transport (GO:0015804),0.36416276054893426,0.8862973496997443,0.6322115384615384,0.9632585145935348,1.0,2/28,5.23%,SLC1A5;SLC43A2
prerank,apoptotic mitochondrial changes (GO:0008637),0.35503038903110595,0.8856387455843306,0.6516724336793541,0.9641323762086272,1.0,6/32,12.73%,TIMM50;AIFM2;NDUFS1;BAK1;SFN;BBC3
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.31012051697852056,0.8852954601137474,0.7429435483870968,0.9643482351184114,1.0,50/172,23.22%,GPAT4;DGKQ;FGF2;PIK3C2B;PIK3R2;PI4K2B;FAR1;CHKB;FIG4;OCRL;INPP5F;PIK3CA;SLC44A1;LCAT;AGK;ARF1;INPP5K;AGPAT3;LPCAT1;PLEKHA4;MBOAT7;RUFY1;INPP4A;PLEKHA1;PI4KB;AGPAT5;GPAT3;MTMR6;CEPT1;PI4KA;MTMR1;PIP4K2C;SLC44A2;GPAM;CDIPT;LIPH;DDHD1;PLD2;PITPNM1;LPIN3;PIP4K2B;TAMM41;PTEN;PIK3CG;CPNE1;PCTP;PI4K2A;CSNK2A2;PTDSS1;ACP6
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.4338947227345565,0.8852520433504852,0.6034985422740525,0.9639616347880777,1.0,4/10,22.09%,ACD;TFIP11;DCLRE1A;TERF2IP
prerank,potassium ion transport (GO:0006813),0.31106328828900676,0.885181014982583,0.7231237322515213,0.9636413477290892,1.0,22/120,15.88%,KCNK5;KCNMA1;HPN;KCNV1;ATP1A4;KCNJ2;SLC9A9;KCND1;ABCB8;PKD2;KCNK13;KCNK9;HCN4;KCNA2;KCNA6;KCNAB3;SLC9A1;KCNJ3;KCNC2;CHP1;SLC9A7;SLC9A6
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.26841943860070916,-0.8849985886148507,0.6143790849673203,0.8734151873413233,1.0,9/27,16.89%,PRKCH;PPARA;NR1H3;ABCG1;AGTR1;NFKBIA;MAPK9;LPL;ABCA5
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.41918270888856823,0.8847708983029693,0.6264044943820225,0.9640316064353576,1.0,4/12,15.05%,FOXP1;NCOR2;NCOR1;SMARCA4
prerank,positive regulation of endocytosis (GO:0045807),0.34244655215103703,0.8842763874462014,0.6636771300448431,0.9645195786347205,1.0,9/45,14.82%,AXL;LRP1;GPC3;BICD1;TOR1A;ABCA13;CALY;CBL;IL4
prerank,regulation of lymphocyte differentiation (GO:0045619),0.3898545947967601,0.8842470900989655,0.6299615877080665,0.9640990730661166,1.0,2/18,7.90%,ZFP36L1;ZFP36L2
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.2988675045815418,-0.8839985204269367,0.6270491803278688,0.8740957031397053,1.0,3/16,7.94%,DPYD;UPB1;NT5E
prerank,innate immune response (GO:0045087),0.3057543172788563,0.8839598825162199,0.7662988966900702,0.9642087418402887,1.0,33/217,18.94%,SYK;LBP;SRMS;TNK1;FYN;ANG;MID2;MSRB1;COLEC11;CXCL10;SRC;CHUK;CYP27B1;TLR4;MASP2;IRAK4;TRIM11;DMBT1;SLPI;IRAK1;SETD2;RNASE6;ADAM15;CR2;FER;IL4;TRIM68;RNF187;PML;AKAP1;SMPD1;MBL2;SKP2
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.29841848573871377,-0.883946623865054,0.62882096069869,0.8725922490194473,1.0,3/17,7.52%,CADM1;AP1G1;NECTIN2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.3940920259875626,0.8838626694218594,0.6257982120051085,0.963936908441266,1.0,6/15,27.01%,ADAM9;TNFRSF1B;GPLD1;SH3D19;PACSIN3;SNX33
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.3349994577212632,-0.8837495863503487,0.6081632653061224,0.8715150305020819,1.0,4/12,17.01%,HUS1;TOPBP1;SETMAR;ORC1
prerank,positive regulation of protein acetylation (GO:1901985),-0.3367853112480027,-0.883480946168158,0.5800711743772242,0.8705093033476341,1.0,2/12,4.23%,RAPGEF3;PRKAA2
prerank,regulation of cytoplasmic translation (GO:2000765),0.4073792378692387,0.8834798778715385,0.6173800259403373,0.9642522887183682,1.0,5/14,28.80%,UNK;PKM;CPEB1;RBM24;CNBP
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.30480710197872957,0.8827764252081381,0.862,0.965159696555711,1.0,90/417,19.32%,PAX9;GCLC;ATP8B1;LOXL2;FOXP2;WT1;ZC3H8;SIX4;FOXP1;BHLHE40;GLIS2;SMAD4;HDAC9;ATF5;DPF2;SMURF2;TSC22D4;FOXK2;NAB1;TCF7L2;NR1D2;CBX4;RBAK;CREB3L1;FOXO1;NR1D1;PRMT2;CREBZF;DPF1;MLXIPL;HDAC6;ZFPM2;GAS6;MDFIC;SOX8;VDR;MAGEL2;SIRT2;RCOR3;CIPC;KDM5C;ING4;INPP5K;TLE2;BRD7;CALCA;PHC3;PHC1;HDAC3;SAMD1;MPHOSPH8;SMARCC2;BCL6;ZHX2;RBFOX2;GLI3;XRCC5;NCOR2;NCOR1;BCL3;CBFA2T2;TWIST1;NACC2;HDAC4;DMAP1;KLF4;HOXA7;IL4;GMNN;SMARCA4;CHD8;YEATS2;BAHD1;PDCD4;PER1;TFAP4;ZEB1;DKK3;PML;SAP18;SET;QARS1;SNX6;DAP;GCFC2;CTCF;NIPBL;BTAF1;SUDS3;RING1
prerank,regulation of calcium ion import (GO:0090279),0.3774421225538532,0.8826901792145934,0.6261203585147247,0.9648575569446753,1.0,4/21,15.37%,FYN;PKD2;EGF;STC1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.3203550480525578,0.8824588037700771,0.6784565916398714,0.9648522991101591,1.0,23/67,25.16%,ATP8B1;GAP43;MYO10;FSCN1;TBC1D2B;TBC1D17;TWF1;TBC1D10A;FER;ARF6;EVI5;DYNC2LI1;FXR2;TBC1D13;TBC1D22B;TBC1D15;TBC1D19;ABITRAM;ATG3;CYLD;DMTN;CDKL1;RAC1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.4308865064460159,0.8823278670915115,0.6291970802919709,0.9646506764821715,1.0,5/10,20.64%,NCOA3;CYP27B1;VDR;NME2;NUMA1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.32204710601291414,0.8820159744447985,0.6934306569343066,0.9648318907120005,1.0,11/85,10.13%,COL1A1;PIEZO2;COL11A1;SLC26A5;PDZD7;TSPEAR;MYO1A;MYO3B;TIMM9;MYH14;COL2A1
prerank,positive regulation of angiogenesis (GO:0045766),0.31320961478999304,0.8815675372023457,0.6992790937178167,0.965223255071389,1.0,10/108,4.65%,CD34;FGF18;PRKCA;ANGPT4;VEGFA;FGF2;ECM1;RUNX1;SMOC2;ITGA5
prerank,granulocyte differentiation (GO:0030851),-0.2857028776817575,-0.881340295688934,0.6488888888888888,0.8736818353776061,1.0,5/18,13.71%,LEF1;CBFA2T3;CDK2;EP300;TAL1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.2604525551802465,-0.881160103294024,0.6453900709219859,0.8724803025517205,1.0,8/30,12.45%,BMP5;BCL2L1;NOS3;FAS;ICAM1;CFLAR;RIPK1;TNFSF10
prerank,negative regulation of viral transcription (GO:0032897),0.4074235486747808,0.8811412668206703,0.6348773841961853,0.9655850149250118,1.0,6/13,24.78%,MID2;TRIM11;ZFP36;UBP1;LARP7;HEXIM1
prerank,outer dynein arm assembly (GO:0036158),0.4089809227969162,0.8810512542327028,0.6396761133603239,0.9652821361448604,1.0,4/14,22.56%,DNAH8;DNAAF5;DNAH5;DNAL1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.35000746349104794,0.8809424595042513,0.6525714285714286,0.9650351173832453,1.0,8/37,18.38%,GTF2H3;ERCC3;UBA52;ERCC4;DDB1;RFC4;ERCC5;POLD1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.4326127793855088,0.8805953543991456,0.6239316239316239,0.965253829273298,1.0,3/10,12.14%,IRS1;AKT1;IRS2
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.35196868138353066,0.8802108911848449,0.6411149825783972,0.9655353678591095,1.0,7/33,14.32%,ANGPT4;MEOX2;FGF2;ATP2B4;JUP;RHOA;KLF4
prerank,negative regulation of cell adhesion (GO:0007162),0.32233632703612664,0.8799371778233032,0.6840981856990395,0.9656186742621568,1.0,18/72,16.79%,EPHB2;CORO2B;GTPBP4;DACT2;MIA3;JAM3;MUC1;TGFBI;ADAM22;FZD7;JAG1;PLXNA3;DSCAM;RHOA;PDE3B;FZD4;SNAI2;CD164
prerank,sodium ion export across plasma membrane (GO:0036376),0.4091382985275673,0.8799170688589971,0.6241610738255033,0.9651938474850132,1.0,5/13,12.04%,ATP1A3;ATP1A4;ATP1A1;SLC4A4;SLC9A1
prerank,protein monoubiquitination (GO:0006513),0.349077478844577,0.8796528722555377,0.6444954128440367,0.9652622064371408,1.0,15/36,28.11%,UBE2B;UBE2W;FANCL;CUL3;DTL;ATXN7L3;PEX12;UBE2R2;UBE2D3;PAF1;KLHL22;RNF20;RNF126;KLHL12;TOPORS
prerank,positive regulation of transferase activity (GO:0051347),0.3104517411334146,0.8795570704702979,0.7375886524822695,0.9649647364453482,1.0,25/142,14.60%,DDR2;EPHB2;AXL;EGFR;FGFR1;EPHA3;MST1R;AXIN1;RET;UBE2N;ACD;EPM2AIP1;HNRNPD;POLG2;EPHB3;MUSK;EPHA10;XRCC5;FLT3;PIN1;PDGFRA;NBN;KLF4;DDR1;HSP90AA1
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.2439691066538987,-0.879300982006279,0.6910569105691057,0.8751087762009755,1.0,13/41,20.23%,PRKAG2;SCARB2;NUP35;NDC1;RAE1;PGAM1;NUP153;EP300;NUP214;POM121;NUP155;HIF1A;NUP205
prerank,mitotic cell cycle phase transition (GO:0044772),0.3072011286964869,0.8790180384657384,0.7660642570281124,0.9655460864180045,1.0,56/203,24.70%,DCTN1;ODF2;CDK14;ACVR1;CDK4;CHMP7;TRIM71;USP29;YWHAG;BCAT1;SSNA1;YWHAE;CUL3;PPP1R12B;ALMS1;USP26;CDC23;MAPRE1;HAUS3;CDC34;SFI1;CDKN1A;FBXL3;CCND1;CDC27;CCNH;DBF4;CTDP1;HSP90AA1;TUBB4A;TUBA4A;GSPT1;DYNC1H1;E2F3;CDK5RAP2;CCP110;AKAP9;CEP164;CKAP5;SKP2;PAFAH1B1;PPP2R2A;CUL5;CLASP2;PPP6C;PCM1;CDKN2C;DCTN2;FBXW11;CDC25B;NEDD1;LATS1;DYNLL1;CEP78;FBXL12;ACVR1B
prerank,telomere organization (GO:0032200),0.3382995492385036,0.8783670775624318,0.6431718061674009,0.9663487459982689,1.0,12/43,18.66%,PARP3;CTC1;ACD;ERCC4;XRCC5;TERF1;DNA2;NBN;RAD50;BLM;POLD1;TINF2
prerank,mesoderm development (GO:0007498),0.38330130404432805,0.8782537747326941,0.62890625,0.9661196338553657,1.0,3/18,8.76%,VEGFA;TBX6;FOXC2
prerank,substrate-dependent cell migration (GO:0006929),0.407979342489755,0.8782177147524709,0.6264900662251656,0.9657257886604367,1.0,3/14,6.86%,ITGA11;ITGA2;NTN1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.3576285004522972,0.8781256160389639,0.6535714285714286,0.9654372443419585,1.0,10/29,22.09%,ACD;GAR1;TERF1;HSP90AA1;TNKS1BP1;PPIA;RAD50;TINF2;PPP6C;TERF2IP
prerank,protein localization to centrosome (GO:0071539),0.3871698601220554,0.8779833230202262,0.6411238825031929,0.9652552528684039,1.0,7/17,23.47%,NUDCD3;PIBF1;BBS4;CEP83;PCM1;DCTN2;NEDD1
prerank,mitotic cytokinetic process (GO:1902410),0.3820718634827022,0.8777545656115897,0.6403622250970246,0.9652133518100261,1.0,3/20,13.49%,CHMP7;VPS4B;RHOA
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3051249273391518,0.8777389357949571,0.7765531062124249,0.9647767383936395,1.0,57/208,23.89%,ESR1;AKAP13;MIB2;ECM1;F2R;LPAR1;MID2;TMEM106A;USP10;NR1D1;CARD16;UBE2N;TFG;CHUK;PPP5C;TIRAP;LGALS1;OTUD7B;SQSTM1;IRAK4;DDX21;IRAK1;TNIP1;NDFIP1;TRAF3IP2;RHOA;ZC3H12A;TRIM68;TRAF3;PER1;RBCK1;SLC20A1;UFL1;MAP3K14;CANT1;SLC44A2;CARD11;LURAP1;MIER1;UNC5CL;FLNA;PPM1A;GOLT1B;TSPAN6;PYCARD;TAB2;CPNE1;TRAF4;TERF2IP;RORA;ROR1;MAP3K7;FKBP1A;TRAF5;TNIP2;TRIM8;RELA
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.41204335619368326,0.8775233145398124,0.6391184573002755,0.964722486203417,1.0,5/12,20.69%,ZDHHC7;VANGL2;AHI1;ACTG1;RAB10
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.33346674969726037,0.8775042602015407,0.6758241758241759,0.9642972772933887,1.0,7/45,9.59%,TGFB3;TGFB2;SMAD4;ACVR1;BMP15;INHA;BMP8A
prerank,DNA recombination (GO:0006310),0.3475975157519764,0.8771910830776513,0.6524663677130045,0.9644427346926866,1.0,9/37,18.62%,XRCC3;RAD51B;IGHMBP2;RHNO1;HMGB3;RECQL;RAD50;BLM;SUPV3L1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.26649307432488495,-0.8770657017142908,0.6519337016574586,0.8787372777002462,1.0,10/27,20.36%,NEDD4L;YWHAH;DLG1;GPD1L;FXYD1;NOS1;UTRN;SNTA1;SLMAP;SCN3B
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.34462664959692696,-0.8768481112752305,0.6076923076923076,0.8776083684159904,1.0,4/12,8.15%,PROM1;NKD1;CEP290;SDK2
prerank,positive regulation of RNA splicing (GO:0033120),0.36231575039515657,0.8766301893228553,0.6560283687943262,0.9650847440532507,1.0,14/29,31.28%,ZPR1;NUP98;RBM22;ERN1;RBM3;SF3B4;U2AF2;THRAP3;DAZAP1;CELF3;RBMX;HABP4;CELF4;CIRBP
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.32761166225007515,-0.8758524144185349,0.6121673003802282,0.8781782599681508,1.0,5/13,9.45%,MEF2C;NOTCH1;TGFBR3;FGFR2;TBX2
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.27256429519770453,-0.8758299780715163,0.6171428571428571,0.876627403939041,1.0,4/21,6.44%,SLC30A10;PPARA;SIRT5;PINK1
prerank,mesenchymal cell development (GO:0014031),-0.30056825864523967,-0.8758189495077495,0.6447368421052632,0.8750634618407729,1.0,6/18,17.28%,NOTCH1;FOXC1;HEYL;TAPT1;SOX11;CDH2
prerank,transcription by RNA polymerase II (GO:0006366),0.30303919212965946,0.8755848881669178,0.825,0.9667031774074712,1.0,83/305,25.24%,PRRX1;AR;ESR1;NFIX;POLR2H;ZC3H8;INTS3;GTF2H3;ABT1;HDAC9;HDAC7;WWTR1;PAX1;TAF8;NR1D2;SCAF8;NR1D1;INTS10;ZBTB1;VDR;NR6A1;ADRM1;CDK9;SOX5;ELP4;KAT2B;INTS6;CPSF4;HDAC3;TAF3;DDX21;SETD2;ERCC3;POLR2D;POLR2G;NCOR2;NCOR1;GTF2A2;CCNH;EAF2;CTDP1;GTF2F1;BTF3;NFE2L3;NR2C2;EAF1;E2F3;CPSF2;DDX5;SNRPG;INTS2;SNRPD3;MED23;INTS12;SLBP;NR2C2AP;GTF2E2;MBD1;PAF1;ICE1;LHX1;TFCP2;ATF4;RORA;RNMT;ELL;MED7;TBP;TAF13;NR3C1;CSTF2T;ESRRA;TRIM24;RTF1;CPSF1;CPSF7;WDR33;PABPN1;POLR2C;RARA;GTF2E1;MED26;NRBP1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.3896586049658841,0.875440430470127,0.660574412532637,0.9665282728244458,1.0,5/16,21.00%,ACLY;HSD17B8;DIP2A;SCD5;ACAT1
prerank,negative regulation of neuron projection development (GO:0010977),0.33081180384865655,0.8752786155409411,0.6835722160970231,0.9663912939631881,1.0,20/56,25.52%,PTPRS;LPAR1;STX1B;SEMA3A;MYLIP;TSKU;GDI1;KANK1;NGEF;CBFA2T2;RTN4RL1;RHOA;DCC;FKBP4;CRMP1;PTEN;BAG5;RTN4;BCL11A;RAB29
prerank,proteasome assembly (GO:0043248),0.4143408073302053,0.874948797828416,0.6157024793388429,0.9665544982777251,1.0,2/11,8.48%,PSMG2;ADRM1
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.2903371446891499,-0.8748690742411336,0.6634146341463415,0.8755788222759497,1.0,7/18,20.57%,MSRA;ASPG;ASS1;ADI1;ASNS;NAT8L;FOLH1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.32171265131066323,0.8747404234802669,0.6751863684771033,0.966494478035982,1.0,13/63,18.39%,AR;FGFR1;ACVR1;TCF7L2;SRC;PELI3;STX4;ITGAV;DEPTOR;IL4;MADD;PML;TGFBR1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.25219454330038027,-0.8745796708017629,0.736,0.8745984369481219,1.0,11/35,15.76%,VTN;TNK2;PIK3CB;B2M;LDLRAP1;HIP1R;HNRNPK;SGIP1;HIP1;HFE;SERPINE1
prerank,cholesterol efflux (GO:0033344),0.38695028196382164,0.8745236422442884,0.6365979381443299,0.9664321880670446,1.0,4/20,10.41%,ABCG4;ABCA1;TSKU;STX12
prerank,rRNA 3'-end processing (GO:0031125),0.43196790086999665,0.8739953331092711,0.6413502109704642,0.9669975771793664,1.0,2/10,9.53%,ERI3;EXOSC7
prerank,cellular response to metal ion (GO:0071248),0.3086001374351919,0.8737832375870126,0.7494887525562373,0.9669490564066731,1.0,15/123,9.18%,EGFR;SYT2;NEUROD2;CPNE8;DLG4;SYT12;SYT11;SYT13;CAMK2D;DLG2;PKD2;DPEP1;CHUK;TIGAR;IQGAP1
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.37011108294491507,0.8732343453549091,0.64875,0.9674834435460598,1.0,9/24,15.83%,IRS1;EPM2AIP1;INPP5K;DYRK2;AKT1;PASK;IRS2;PPP1R3C;SELENOS
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.3874744189296317,0.8731879858622914,0.6373902132998746,0.9671104602990008,1.0,3/16,13.20%,WDTC1;ACADVL;NCOR1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.4040731747820958,0.8729745451787293,0.6256613756613757,0.9670661343860828,1.0,6/14,27.46%,PRKD2;CD81;CARD11;RELA;RAB29;BCL10
prerank,positive regulation of autophagy (GO:0010508),0.31707640346080157,0.8728475135404459,0.7069864442127216,0.9668403744193169,1.0,15/81,16.84%,DCN;GNAI3;MID2;FOXO1;PLEKHF1;FLCN;GPSM1;CAMKK2;SESN3;LARP1;ULK1;ZC3H12A;IL4;TRIM68;UFL1
prerank,rRNA methylation (GO:0031167),0.3769173966653326,0.872323159704899,0.6397590361445783,0.9674053368370507,1.0,4/22,14.18%,DIMT1;FDXACB1;ZCCHC4;MRM3
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.3046894590392317,-0.8722808046496122,0.6371681415929203,0.878037236868432,1.0,3/16,7.52%,CADM1;AP1G1;NECTIN2
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.37620312507773535,0.8722786529037211,0.6419902912621359,0.9670289312330739,1.0,3/22,10.94%,CD160;PTPRJ;UBASH3A
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.4131406478694726,0.8720099023246546,0.6387362637362637,0.9670876190886497,1.0,2/13,3.19%,VEGFA;TGFBR2
prerank,mitochondrial translation (GO:0032543),0.31079096090492336,0.8716868281938157,0.7226202661207779,0.967283835290473,1.0,20/104,15.98%,MRPS11;MRPL38;MRPS18B;CHCHD1;MRPL13;MRPS17;AURKAIP1;MRPS27;MRPL30;MRPL10;GFM1;DAP3;MRPL55;MRPS10;MRPL36;MRPL3;MRPL21;MRPS34;MRPL51;HARS1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.426272739962397,0.8712881167454195,0.6388101983002833,0.9675886751944756,1.0,1/11,3.49%,RUNX1
prerank,artery morphogenesis (GO:0048844),0.35176458994704574,0.8710886207698315,0.6402877697841727,0.9675234428979933,1.0,5/30,8.92%,LRP1;VEGFA;TGFB2;PKD2;JAG1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.3250949347353058,-0.8710429562835512,0.5952380952380952,0.8791699944108882,1.0,7/13,19.33%,ELOVL7;HACD1;HACD4;HACD2;ELOVL1;ELOVL4;TECRL
prerank,inner mitochondrial membrane organization (GO:0007007),0.32903806314890666,0.8707278984991521,0.6677777777777778,0.9677566396435648,1.0,21/47,29.81%,TIMM10B;TIMM9;ATP5PO;AGK;ATP5ME;TIMM22;GHITM;SPG7;TIMM8B;UQCC3;MICOS10;APOOL;IMMT;ATP5MC3;DNAJC11;ATP5F1B;NDUFA13;LETM1;CHCHD3;ATP5F1A;CHCHD6
prerank,negative regulation of lipid storage (GO:0010888),-0.2910847477505858,-0.8706959876412665,0.6616915422885572,0.8783718492855547,1.0,7/19,12.68%,TTC39B;OSBPL8;PPARA;NR1H3;ABCG1;PTPN2;NFKBIA
prerank,substantia nigra development (GO:0021762),0.34268250388011423,0.8706010808765362,0.6701149425287356,0.9675438954796189,1.0,14/37,25.79%,YWHAE;SIRT2;PLP1;RAD1;CALM2;RHOA;GLUD1;PADI2;MBP;NDRG2;SUDS3;DYNLL1;FGF9;MAPKAP1
prerank,modulation by host of symbiont process (GO:0051851),0.35334971619205147,0.8702774170183262,0.6647465437788018,0.9677126222671156,1.0,8/31,16.80%,HPN;TARDBP;INPP5K;LRRC19;CTDP1;SMARCA4;CHD1;TFAP4
prerank,cellular response to osmotic stress (GO:0071470),0.37028326853781746,0.8702275122049106,0.627700127064803,0.9673448956448134,1.0,4/21,12.02%,LRRC8D;ZFP36L1;PKD2;STK39
prerank,regulation of autophagosome maturation (GO:1901096),-0.3229345689327559,-0.8701939302211267,0.6401515151515151,0.877831647806074,1.0,6/13,25.08%,UVRAG;TBC1D25;CLN3;ADRB2;IRGM;PHF23
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.3510947258108944,0.8701856391968155,0.6584507042253521,0.966959512818634,1.0,11/32,21.11%,MYOC;SRC;JAG1;ADAM15;HOXA7;BCAS3;RCC2;RASA1;CLASP2;CORO1C;PTEN
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.32909660853003564,-0.8701722059100343,0.6007326007326007,0.8763118610099815,1.0,2/12,1.62%,UNC13B;UNC13C
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.36396799629264925,0.8700114358577195,0.6694610778443114,0.966821390422804,1.0,7/26,12.77%,SRI;PKD2;CRHR1;YWHAE;GSTM2;CALM2;THADA
prerank,hyaluronan catabolic process (GO:0030214),0.3778693306103084,0.8698962835310216,0.6344916344916345,0.9665874565826647,1.0,4/18,15.24%,CD44;FGF2;SLC9A1;CHP1
prerank,negative regulation of lymphocyte migration (GO:2000402),0.4322423933740036,0.8695719759237421,0.6581196581196581,0.9667419446327097,1.0,4/10,17.22%,MIA3;AKT1;CD200R1;PADI2
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.3040346845566229,-0.8695418523658255,0.6270491803278688,0.8762015692317875,1.0,6/16,18.03%,DCPS;CWC15;SNRNP200;SRSF12;SRSF1;WBP4
prerank,protein deacylation (GO:0035601),0.36580821701829636,0.8694401531545933,0.6613691931540342,0.9665386853928052,1.0,5/23,13.86%,HDAC7;HDAC6;SIRT2;HDAC3;HDAC4
prerank,mesenchymal cell differentiation (GO:0048762),0.3309140859901659,0.8693253160177962,0.6759776536312849,0.9663033768261895,1.0,5/51,3.94%,LRP6;LOXL2;FGFR1;TGFB2;AKNA
prerank,regulation of ion transmembrane transport (GO:0034765),-0.2558425547341373,-0.8691781292992056,0.6794871794871795,0.8753960113734467,1.0,6/33,12.81%,NEDD4L;AHCYL1;WWP2;KCNQ1;KCNJ12;AKAP6
prerank,positive regulation of neuron projection development (GO:0010976),0.31687470582297744,0.8691586427454416,0.7007299270072993,0.9661645127487991,1.0,17/85,13.39%,DBN1;NPTN;EPHA3;COBL;S100A9;TENM3;RET;RIT2;ABL2;NDRG4;TWF1;FUT9;AVIL;MAGI2;KIDINS220;P3H1;CBFA2T2
prerank,glycerolipid metabolic process (GO:0046486),-0.3398572419859429,-0.8690487776680967,0.6254545454545455,0.8741154010649069,1.0,7/11,24.64%,DGKB;DGKZ;PIP5K1A;PLA2G15;PNPLA3;GAL3ST1;DGKG
prerank,clathrin-dependent endocytosis (GO:0072583),-0.26275927039197444,-0.8689756457164959,0.7134831460674157,0.8727414867725107,1.0,4/26,7.11%,DNAJC6;FNBP1L;GPR107;FCHSD2
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.30469490111599556,0.8689361504686185,0.7766599597585513,0.9661302388856259,1.0,32/182,16.97%,CD34;ESR1;DGKQ;VEGFA;FGF2;TGFB2;FOXP1;RUNX1;MIF;DLG4;RBMS3;ATP2B4;CREB3L1;TARDBP;MYADM;FLCN;ATXN2;VDR;PSEN1;AGO2;PARP14;MAPT;SLC2A10;NDFIP1;SMCR8;ZC3H12A;KLF4;MAP2K2;DIP2A;PTRH2;AGO4;FLOT2
prerank,cellular component assembly (GO:0022607),0.3011976646084577,0.8689067044520353,0.8118118118118118,0.9657211375767154,1.0,50/253,20.33%,HAS2;GSN;HAS1;SCIN;STK25;WIPF1;LLGL1;DLG4;CHAF1B;GPAA1;ZW10;TLCD2;WASF1;MDM4;FSCN1;GAS6;NOC2L;ACD;MYO9A;TOGARAM1;SYCP2;RSPH1;RHOJ;RHOQ;MITF;RHOA;RTN3;TTLL3;SPAG17;LIMS2;PLS1;ACTG1;SPTBN1;RAC3;TFAP4;PML;SPG7;NAPG;YTHDF1;YTHDF2;EPRS1;ILK;MICAL1;VAMP2;TINF2;LAMC1;KMT2A;SPAG16;QSOX1;FLNA
prerank,defense response to virus (GO:0051607),-0.19732064138494176,-0.8688352521380901,0.7272727272727273,0.8714782812896312,1.0,27/100,21.80%,BCL2L1;SERINC3;BCL2;TRIM56;PLSCR1;IFITM3;ABCC9;MAVS;CNOT7;IFIT1;IFIT2;TLR3;OAS2;RNF135;STAT1;IFIT3;RNASEL;CLPB;PHB2;CD40;RSAD2;OPRK1;ZDHHC1;MLKL;BNIP3;TRIM5;IRF3
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.3581923439480449,0.868447562060291,0.6613691931540342,0.9661307485846234,1.0,4/28,9.40%,PARP3;CYREN;TFIP11;NUDT16L1
prerank,positive regulation of calcium ion import (GO:0090280),-0.32675781045929814,-0.8681601417441458,0.6258992805755396,0.8713369064980824,1.0,2/12,8.68%,CXCL12;PDGFRB
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3001682193593906,0.8680222013412096,0.7921686746987951,0.9664411756314578,1.0,55/190,22.76%,ESR1;UBE2B;SLIT2;HDAC7;PIK3R2;MAPK14;OTUD3;MAP2K3;ATP2B4;PTPRJ;PDE11A;USP10;NR1D1;MYADM;SRC;PDE10A;BANK1;NOC2L;FLCN;PHLPP2;INPP5K;OTUD7B;HERPUD1;URI1;PRDM15;AKT1;MAGI2;PPEF2;PDE4D;PIK3IP1;TNIP1;CDC34;DEPTOR;PLEKHA1;TMEM127;TWIST1;PDE3B;ZC3H12A;NOP53;PER1;PPP2R5B;PLAUR;SFRP5;IFI35;MCL1;CIT;PPM1A;TSPAN6;PYCARD;PTEN;CPNE1;NF1;RORA;UBR2;CYLD
prerank,carbohydrate derivative catabolic process (GO:1901136),0.3945677156617561,0.8678202010228429,0.6582597730138714,0.9663820336036685,1.0,5/18,15.68%,OGA;FBXO2;FBXO17;SAMHD1;NGLY1
prerank,axon extension (GO:0048675),0.36404150637914534,0.8676908894780718,0.6531365313653137,0.9661686967833895,1.0,9/23,15.88%,MAP1B;SLIT3;SLIT2;SLIT1;SEMA3A;ULK2;ULK1;HSP90AA1;SLC9A6
prerank,regulation of MAP kinase activity (GO:0043405),0.31373606614058924,0.8673861331388724,0.7340980187695516,0.9662974144476222,1.0,9/92,5.35%,FGF18;EGFR;FGFR1;UCHL1;VEGFA;IRAK3;FGF2;MST1R;PTPRJ
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.36889797579462114,0.8670539162622285,0.6521197007481296,0.9664714162333343,1.0,5/20,18.39%,ZMIZ1;ITCH;DNAJB2;HSP90AA1;TGFBR1
prerank,autophagy of mitochondrion (GO:0000422),0.3399572179181808,0.8668562409533535,0.6700223713646533,0.9663756974735566,1.0,14/38,24.76%,ATG2B;WIPI2;SQSTM1;WDR45B;ULK2;ATG2A;ULK1;CISD2;ATG13;ATG3;ATG14;FIS1;CTSK;MARK2
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.27191446639410144,-0.8665988922858879,0.6607142857142857,0.8730576921284223,1.0,8/21,20.76%,EPHA7;AIM2;DELE1;TTBK1;BEX3;MT3;PSMB9;BIRC2
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.42360983153917736,0.866588857774959,0.6517482517482518,0.9664262387911582,1.0,4/11,27.81%,CCT7;TERF1;CCT4;CCT6A
prerank,linoleic acid metabolic process (GO:0043651),0.3820991807774363,0.8664814515380828,0.6442786069651741,0.9661749133348211,1.0,4/17,14.27%,GSTM2;PNPLA8;ELOVL5;FADS1
prerank,regulation of cell migration (GO:0030334),0.2982099456053751,0.8661742774567416,0.867,0.9663175153545533,1.0,54/382,12.88%,IGFBP5;SEMA3C;HAS2;MYOC;EPHB2;FGF18;COL1A1;FGF7;PRKCA;EGFR;ANXA1;IGSF10;TMEFF2;ADARB1;LDLRAD4;VEGFA;FGF2;SGK3;SLIT2;F2R;MIF;ADAM9;LMNA;ACVR1;GTPBP4;MIA3;PTPRJ;MEAK7;SRGAP1;MYADM;RET;SRC;SULF1;PIP5KL1;FLCN;DPEP1;SLK;SEMA3A;SRCIN1;JAG1;KIF2A;STX4;PLXNA3;KANK1;MAPRE1;MITF;AKT1;MAGI2;GPNMB;SEMA3D;EGF;RECK;ADAM15;MGAT5
prerank,negative regulation of hydrolase activity (GO:0051346),0.3339457579170184,0.8655244589094396,0.6778149386845039,0.9670941653921532,1.0,12/49,19.93%,MAPK7;ECM1;SLC39A14;GPSM1;CSTB;URI1;BCAS3;CHP1;SH2D4A;RCC2;ARFGEF1;TMED2
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.3585576135327766,0.8654240832183052,0.6734939759036145,0.9668168117246635,1.0,9/27,26.75%,NDEL1;FRMD7;PSEN1;AKT1;NCS1;PTEN;CCDC88A;NTNG2;IL1RAPL1
prerank,histone H3 acetylation (GO:0043966),0.3372135035510503,0.865358446751447,0.6896942242355606,0.9664711498254259,1.0,14/40,22.99%,TADA1;KAT2B;POLE3;ING4;WDR5;DR1;KAT14;YEATS2;PER1;TAF6L;SGF29;KAT6B;LDB1;MAP3K7
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.2955235501646401,0.8652663666342701,0.948,0.9661966357456511,1.0,221/807,25.90%,AR;ESR1;PAX9;GCLC;ATP8B1;LOXL2;TRPS1;FOXP2;NFIX;WT1;ZC3H8;TLE6;SCRT2;SIX4;SKIL;VEGFA;KLF12;FOXP1;BHLHE40;GLIS2;RUNX1;SMAD4;HDAC9;ZNF25;ATF5;DPF2;SMURF2;SKI;SOX10;TSC22D4;DACT1;FOXK2;KLF2;TCF25;NAB1;TCF7L2;NR1D2;CBX4;RBAK;MAF1;CREB3L1;MEIS2;FOXO1;IL33;NR1D1;PRMT2;CREBZF;MUC1;ZFHX3;DPF1;C1QBP;MDM4;MLXIPL;HDAC6;SIN3B;GLI2;ZFPM2;TBX6;GAS6;NOC2L;RNF2;FLCN;MDFIC;SOX8;ZBTB1;VDR;NR6A1;MAGEL2;PSEN1;FOXC2;SIRT2;RCOR3;CIPC;KDM5C;ING4;INPP5K;TLE2;BRD7;CALCA;ZMYM5;MYPOP;OTUD7B;PHC3;ZNF3;PHC1;HDAC3;URI1;SAMD1;MZF1;MPHOSPH8;TAF3;TCERG1;MITF;SMARCC2;IRF2BPL;BCL6;ZHX2;CEBPB;RBFOX2;GLI3;UBA52;XRCC5;ZFP36;DR1;NCOR2;PEG3;NCOR1;BCL3;IKZF5;CBFA2T2;CCND1;CRYM;TWIST1;DNAJA3;NACC2;HDAC4;EZH1;EHMT2;DMAP1;KLF4;HOXA7;HSBP1;IL4;GMNN;ZNF692;SMARCA4;CHD8;DDX20;NR2C2;YEATS2;NOP53;BAHD1;ZBTB5;PDCD4;PER1;DDX5;SNAI2;CHD3;E4F1;TFAP4;ZEB1;DKK3;PML;SAP18;SET;QARS1;HIVEP1;SNX6;DAP;GCFC2;NRIP1;CTCF;UXT;NIPBL;BTAF1;SUDS3;RING1;RPL23;PCGF6;KDM1B;UBE2D3;CTBP1;MIER1;FLNA;PPM1A;DNAJB1;MBD1;HSF4;PEX2;PAF1;KDM2B;NSD1;PHF21A;LHX1;JUN;LARP7;EZH2;ATF4;KAT6B;VPS72;FBXW11;LDB2;LDB1;TPR;SDCBP;ZNF431;GATAD2A;CRYAB;IFI27;NR3C1;PER3;SKOR2;RTF1;RELA;ZEB2;ORC2;LCOR;SCMH1;L3MBTL3;SCML2;HEXIM1;MDM2;BCL11A;SETDB2;CALR;RARA;E2F7;KAT5;PHF12;KAT7;PAX2;DPF3;PHF6;VHL;MBD2;MAFK;MYT1L;DDIT3;H1-0;RARG;CRY2
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.33661930653377403,0.8648806573933169,0.6774193548387096,0.9664695081992004,1.0,12/40,20.96%,TRIAP1;GPX1;AKT1;BMF;BBC3;MLLT11;HRK;GHITM;HGF;PLAUR;PRELID1;PYCARD
prerank,negative regulation of leukocyte migration (GO:0002686),0.43178454164389024,0.8648252528184674,0.636237897648686,0.9661244980368852,1.0,3/10,14.42%,SLIT2;CD200R1;HOXA7
prerank,positive regulation of DNA binding (GO:0043388),-0.24997580840581632,-0.8647835474152514,0.7196969696969697,0.8752683676721839,1.0,4/31,3.59%,IGF1;NIBAN2;HMGB1;FOXC1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.3574799358660322,0.8645329584353372,0.672289156626506,0.9662187455504287,1.0,6/27,17.25%,CD44;MIF;TWIST1;DDX5;SNAI2;EEF1E1
prerank,regulation of adenylate cyclase activity (GO:0045761),0.3735390463821318,0.8644352876466997,0.6547911547911548,0.9659480590791747,1.0,7/22,21.96%,GNAI3;CRHR1;PALM;LTB4R2;CAP1;STIM1;NF1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.39220921671994335,0.8643798448177044,0.6519546027742749,0.9656106183227335,1.0,8/17,33.72%,ALG1;DHDDS;SRD5A3;MVD;MPDU1;NUS1;ALG8;DOLPP1
prerank,positive regulation of TOR signaling (GO:0032008),0.33860314179399065,0.8641243565118197,0.69,0.9656275176884316,1.0,10/40,22.91%,GAS6;FLCN;PIK3CA;HDAC3;SMCR8;RRAGD;PIP4P1;GPR137B;KLHL22;SLC38A9
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.3447022140317854,0.8637519638915693,0.6732788798133023,0.965872563602097,1.0,10/33,22.09%,CTC1;ACD;GAR1;TERF1;HSP90AA1;TNKS1BP1;RAD50;TINF2;PPP6C;TERF2IP
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.4071081464242393,0.8637310380334633,0.6410958904109589,0.965466898326608,1.0,3/13,14.57%,BMF;VDAC2;BLOC1S2
prerank,synapse assembly (GO:0007416),-0.2194605486411142,-0.8636591238454603,0.8269230769230769,0.8760768942617366,1.0,16/67,13.24%,SPOCK2;CDH1;WNT5A;SHANK3;PLXND1;DNM3;RYK;SDK2;PLXNB1;LRRC4;GABRB3;SDK1;CDK5;BDNF;PCDHB14;SLITRK1
prerank,cellular response to interleukin-12 (GO:0071349),0.3342241133312098,0.8635825129769857,0.7046460176991151,0.9653009367306359,1.0,11/48,23.28%,ANXA2;MIF;RAP1B;ARF1;CD47;SIRPA;PDCD4;PPIA;RALA;SNRPA1;MTAP
prerank,termination of RNA polymerase I transcription (GO:0006363),0.3480820382428298,0.863582158607647,0.6702253855278766,0.9648490784830566,1.0,6/30,14.13%,POLR2H;GTF2H3;POLR1G;UBTF;ERCC3;CCNH
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.28629630816875096,-0.8635314909487569,0.6926229508196722,0.8748189363491478,1.0,2/18,1.62%,UNC13B;UNC13C
prerank,regulation of interferon-gamma production (GO:0032649),0.3223176344448915,0.863529236221088,0.7177334732423925,0.9644908287154996,1.0,10/71,14.87%,AXL;C1QBP;INHA;GAS6;TLR4;CD47;SIRPA;PDE4D;ZC3H12A;CD14
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.32589614942763556,-0.8633391264496209,0.6566037735849056,0.8736862218289236,1.0,4/13,12.22%,NOS3;GCH1;QDPR;SPR
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.32069596443334847,0.8632374969272442,0.6908893709327549,0.9645704508396277,1.0,14/64,15.56%,POLR2H;GTF2H3;ADRM1;CDK9;ELP4;SETD2;ERCC3;POLR2D;POLR2G;CCNH;EAF2;CTDP1;GTF2F1;EAF1
prerank,regulation of protein kinase A signaling (GO:0010738),-0.2898013405483122,-0.8631433394485992,0.6208530805687204,0.8725876341905382,1.0,7/20,17.70%,ADGRV1;AKAP7;PRKAR1B;AKAP6;PRKAR2B;TCIM;ADRB2
prerank,heme biosynthetic process (GO:0006783),-0.28046954659680623,-0.862777156854601,0.6906077348066298,0.8718621167276281,1.0,3/22,6.55%,ABCG2;PGRMC1;FECH
prerank,cobalamin metabolic process (GO:0009235),0.38408358921550256,0.8627521725008142,0.6276315789473684,0.9650119433071128,1.0,6/17,24.87%,TCN1;MTR;ABCC1;MMADHC;MMAB;MTRR
prerank,regulation of gluconeogenesis (GO:0006111),0.3533650446154621,0.862700098214266,0.669833729216152,0.9646454959421813,1.0,6/27,16.37%,DGKQ;DDB1;USP7;ZNF692;SELENOS;OGT
prerank,negative regulation of inflammatory response (GO:0050728),0.29808152348688743,0.8623548933454201,0.7891566265060241,0.9648351852365175,1.0,29/182,16.30%,SYK;VIPR2;FYN;MAPK7;MAPK14;METRNL;MVK;NR1D1;GLP2R;SRC;ADCYAP1;DPEP1;CRHR1;GPR20;FNDC4;CALCA;SIRPA;GPR45;TSHR;ADCY8;CD200R1;TNFRSF1B;GNB1;LHCGR;KLF4;IL4;LRFN5;SELENOS;IL6
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.3569427499897237,0.8621730526252811,0.6654545454545454,0.9647086097220029,1.0,11/26,28.53%,EFNA5;NR1D1;STX4;ADCY8;PPP3CB;GPLD1;EPHA5;BAIAP3;STXBP4;CFTR;LRP5
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.2864915092557078,-0.8620973679533332,0.7169811320754716,0.8717040199548378,1.0,2/17,4.18%,HMGB1;CXCL12
prerank,fatty acid elongation (GO:0030497),-0.3186935274386993,-0.8619996899009523,0.6126482213438735,0.8703686878787683,1.0,6/13,17.04%,ELOVL7;HACD1;HACD4;HACD2;ELOVL1;ELOVL4
prerank,protein mannosylation (GO:0035268),-0.27971258608779115,-0.8619164571931832,0.6822916666666666,0.8690200431336876,1.0,6/22,13.39%,TMTC1;TMTC4;TMTC2;DPY19L4;FKRP;POMT2
prerank,protein import into mitochondrial matrix (GO:0030150),0.3775432906502148,0.8616483273118029,0.6597671410090556,0.9652484813913962,1.0,2/18,11.47%,TIMM50;GRPEL2
prerank,glial cell development (GO:0021782),0.3655924641853472,0.8615005628745107,0.6436498150431565,0.9650765237321586,1.0,3/25,4.37%,PRDM8;S100A9;SOX10
prerank,protein polyglutamylation (GO:0018095),-0.3385568443262973,-0.8614548659247989,0.6607773851590106,0.8684592138703615,1.0,4/11,17.94%,TTLL5;CFAP20;TTLL1;CEP41
prerank,negative regulation of ATPase activity (GO:0032780),0.3930585646229948,0.8612978035810192,0.6679841897233202,0.9650084319867043,1.0,3/16,12.77%,TNNI3;PXK;THADA
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.3431780606032021,-0.8611596328971214,0.6054421768707483,0.8675999591374932,1.0,4/10,23.18%,SIRT1;RIF1;DNMT1;BRCA1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.38847814050517215,0.8610698973243367,0.6525759577278731,0.9649757105242868,1.0,7/15,31.85%,IL17RA;TLR4;IL6;TICAM1;MYD88;IL17D;APPL1
prerank,positive regulation of nervous system development (GO:0051962),0.3320683233398822,0.8609982164048747,0.6692913385826772,0.964667484342981,1.0,7/42,19.41%,EPHB2;NUMBL;SERPINF1;EPHB3;SYNDIG1;EPHB1;CLSTN3
prerank,glucan catabolic process (GO:0009251),-0.30093927399961157,-0.8603977810438872,0.66,0.8676392678545388,1.0,3/15,5.34%,PHKB;PYGM;AGL
prerank,genitalia development (GO:0048806),0.4070007763469356,0.8601233773570147,0.6542056074766355,0.9658613942759097,1.0,2/12,4.15%,WT1;PKD1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.28381030243986605,-0.8595795378863542,0.640625,0.8677220520499993,1.0,6/20,12.99%,BCL2L1;BCL2;CASP3;FAS;CASP9;BCL2L2
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.3044344472881886,-0.8591349857129328,0.6221198156682027,0.8671000558597183,1.0,6/15,22.07%,SCARB1;NR1H3;SIK1;CTDNEP1;FITM2;C3
prerank,negative regulation of histone methylation (GO:0031061),0.42566692487482904,0.8589156380227593,0.6566951566951567,0.9676648659610209,1.0,2/10,10.42%,PHF1;WDR5
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.3578039666497275,0.8585273732914523,0.6695331695331695,0.9679327742831703,1.0,10/23,31.26%,COPS5;RAD23B;UBA52;DDB1;COPS4;GPS1;CETN2;COPS6;COPS3;COPS7B
prerank,bile acid and bile salt transport (GO:0015721),0.36550940771161844,0.8583128254789134,0.6731946144430845,0.9678825095105367,1.0,2/24,3.12%,ATP8B1;SLC51A
prerank,cellular calcium ion homeostasis (GO:0006874),0.302765019719789,0.8582534276688886,0.7540650406504065,0.9675294117464707,1.0,28/133,19.15%,CCL8;NPTN;ANK2;TNNI3;ATP2B4;CAMK2D;PACS2;YWHAE;MCU;PSEN1;CALCA;HERPUD1;SELENOK;ATP13A1;SLC35G1;MCUB;BAK1;ADCY8;CCL13;ATP2A2;SLC8A2;STC1;TMEM165;PML;CHRNA7;ATP2B1;HTR2C;STIM1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3145089823764615,0.8580041953551123,0.7210526315789474,0.9675429972162485,1.0,20/69,25.11%,POLR2H;ZC3H8;INTS3;TAF8;INTS10;CDK9;INTS6;POLR2D;POLR2G;GTF2A2;GTF2F1;INTS2;INTS12;GTF2E2;ICE1;ELL;TBP;TAF13;POLR2C;GTF2E1
prerank,positive regulation of neuron differentiation (GO:0045666),-0.2297668336285907,-0.8579004430686006,0.7307692307692307,0.8680862900589402,1.0,10/40,16.88%,TCF4;MEF2C;HEYL;BRINP3;VWC2;BMP2;MMD2;TRIM32;SOX11;HOXD3
prerank,positive regulation of isotype switching (GO:0045830),-0.3100500631496061,-0.8578613308614434,0.6174242424242424,0.8666690777238641,1.0,9/15,21.66%,KMT5B;SHLD1;KMT5C;TFRC;RIF1;TGFB1;CD40;MAD2L2;TNFSF13
prerank,sodium ion transmembrane transport (GO:0035725),0.3113068124363999,0.8577467265854514,0.726895119418484,0.9675588248773237,1.0,18/84,16.01%,SCNN1B;SLC4A8;ATP1A3;ATP1A4;ATP1A1;SLC9A9;SLC6A8;PKD2;HCN4;SLC4A4;SLC6A11;SLC6A4;SLC9A1;ASIC2;SLC8A2;SLC9A7;SLC9A6;SCN4B
prerank,phosphatidylcholine metabolic process (GO:0046470),0.3143706339265598,0.8571522250613564,0.7238095238095238,0.9682138100208932,1.0,19/70,26.88%,GPAT4;PLAAT1;CHKB;SLC44A1;LCAT;LPCAT1;PNPLA8;MBOAT7;CEPT1;PLA2G4E;SLC44A2;LIPC;GPLD1;LPIN3;PCTP;CSNK2A2;SLC27A1;LPCAT3;PLA2G7
prerank,regulation of protein localization (GO:0032880),0.32148679597291113,0.8567987184869411,0.6885593220338984,0.9684131342998897,1.0,18/58,25.84%,RABGAP1L;ITGB3;ZDHHC7;TRIM46;ADCYAP1;ATCAY;HSP90AA1;RSL1D1;TRIM68;UFL1;CTSD;TRIM67;TMEM231;TPR;FKBP1A;DVL1;FBXW7;CSNK1E
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.3469902949014106,0.8562616425406203,0.6942148760330579,0.9689648876121031,1.0,3/33,2.91%,WT1;FGF2;TGFB2
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.3292788053271428,0.8561902502643073,0.6895388076490439,0.968648281177725,1.0,7/41,20.33%,KCNMA1;ANK2;KCNJ2;KCNJ3;GNB1;KCNH2;FLNA
prerank,cellular response to ketone (GO:1901655),0.3423611741933054,0.8557920167594789,0.6775320139697323,0.9689110149283278,1.0,6/35,13.75%,AR;SRC;LARP1;ADCY8;ADAM15;GNB1
prerank,regulation of protein metabolic process (GO:0051246),0.3313315973326118,0.8557235218198972,0.6958934517203108,0.9685974254439623,1.0,15/44,24.78%,MAPK7;KLF2;ODC1;TMEM9;SSH1;ZDHHC2;KLF4;TRAF3;CHRNA7;PLAUR;NEDD8;LDLR;FKBP1A;PARL;MDM2
prerank,gland development (GO:0048732),0.31949866534144344,0.8555907823548394,0.7261904761904762,0.9683843657353901,1.0,8/59,10.29%,ANXA1;TGFB3;WT1;COBL;GLI2;PKD2;ZBTB1;EPHB3
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.34435546955655744,-0.8554454781990253,0.6092307692307692,0.8701489956276081,1.0,3/10,12.97%,LYN;FAS;MAPK3
prerank,maturation of 5.8S rRNA (GO:0000460),0.38331223720242386,0.8553470364782793,0.6728476821192053,0.9683476267340361,1.0,7/17,27.22%,C1D;URB1;EIF6;MAK16;EXOSC10;FTSJ3;PRKDC
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.27154774722928676,-0.8551937869266412,0.6842105263157895,0.8692303378802096,1.0,6/24,11.03%,H3-3A;PPM1D;EED;SUZ12;EPC1;BMI1
prerank,negative regulation of catalytic activity (GO:0043086),0.3666779098020996,0.8548340872628705,0.6819277108433734,0.9688421903790013,1.0,3/24,7.10%,APBA3;TMBIM1;HDAC6
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.2674929349680349,-0.8546908577921741,0.6446700507614214,0.868764118302738,1.0,4/23,9.89%,CECR2;HMGB1;CASP3;REXO4
prerank,prostanoid biosynthetic process (GO:0046457),-0.3073129741929664,-0.8545008335598445,0.676595744680851,0.8676864444675056,1.0,6/15,15.79%,PTGDS;PTGS2;PTGIS;PTGES3;EDN1;CD74
prerank,ubiquinone biosynthetic process (GO:0006744),0.3846445218526138,0.8539858797156903,0.6600790513833992,0.9699701118083197,1.0,6/15,25.82%,COQ10B;COQ7;COQ3;COQ5;COQ2;COQ10A
prerank,regulation of smooth muscle contraction (GO:0006940),0.3703450959052482,0.8539668732939297,0.6586599241466498,0.9695517689515437,1.0,6/20,22.46%,PLCE1;F2R;ZDHHC21;ATP2B1;CTTN;NMU
prerank,neurotransmitter transport (GO:0006836),0.31570654373132606,0.8539025316994218,0.720855614973262,0.9692096032941464,1.0,17/73,18.55%,SLC1A7;STX1A;APBA1;PPFIA2;SLC1A6;SLC18A3;SLC6A4;GLS2;GLS;SNAP25;PPFIA1;GAD2;SNAPIN;SLC38A1;SNPH;SYT1;VAMP2
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.32566386618305804,-0.853888767298656,0.6321428571428571,0.8673730518414209,1.0,3/12,7.21%,MAVS;CAV1;IFIT1
prerank,regulation of receptor recycling (GO:0001919),0.3810276944596498,0.8537862516257342,0.6461731493099122,0.968980714380004,1.0,4/16,15.86%,ANXA2;INPP5F;ECE1;NSF
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.3503832098016395,0.8537825593573467,0.6973365617433414,0.9685392140823429,1.0,15/29,32.25%,LSM4;EDC4;EXOSC7;EXOSC1;LSM7;EDC3;DCP1A;DCP1B;LSM5;HBS1L;LSM1;PATL1;EXOSC3;CNOT8;LSM6
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.3573860010516738,0.8536658913985254,0.6646191646191646,0.9683103984202069,1.0,6/25,14.60%,KLF2;PKD2;TLR4;AKT1;KLF4;HSP90AA1
prerank,hexose metabolic process (GO:0019318),0.3348624344464262,0.8536566884316753,0.6904487917146145,0.9678830442951819,1.0,9/39,23.16%,CHST1;GALK1;IRS2;GAA;ALDOA;GALM;SLC37A4;SLC35A2;KCNJ11
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.3895567178762619,0.8534232676326282,0.6657929226736566,0.9678578749216995,1.0,3/15,7.85%,FGF2;SMOC2;PRKD2
prerank,cellular response to lectin (GO:1990858),0.3044571711270701,0.8531058331645579,0.7374872318692544,0.9675411846092827,1.0,10/104,11.26%,SYK;PSMC4;FYN;MUC1;PSMC6;SRC;CHUK;PSMD8;NRAS;KRAS
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.3044571711270701,0.8531058331645579,0.7374872318692544,0.9675411846092827,1.0,10/104,11.26%,SYK;PSMC4;FYN;MUC1;PSMC6;SRC;CHUK;PSMD8;NRAS;KRAS
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.30373978147742414,0.8530804414187355,0.746177370030581,0.9671359727530431,1.0,10/105,11.26%,SYK;PSMC4;FYN;MUC1;PSMC6;SRC;CHUK;PSMD8;NRAS;KRAS
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.30652351353048285,-0.852992862426326,0.7090163934426229,0.8677243889831228,1.0,15/15,69.38%,QDPR;KYNU;FAH;HGD;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD;TAT;KYAT1;GSTZ1;KMO
prerank,regulation of autophagy (GO:0010506),0.2974901254888626,0.8528234414123386,0.8368368368368369,0.9671634464901995,1.0,70/216,27.00%,DCN;UCHL1;PIK3R2;MID2;USP36;ATP6V0A2;FOXK2;MTOR;USP10;PRKAB2;FOXO1;PLEKHF1;HDAC6;ABL2;FLCN;IL10RA;CAPN1;SIRT2;FBXL2;USP33;ERN1;AKT1;MAPT;BMF;ATP6V1E1;SMCR8;DRAM1;RRAGD;ULK1;ZC3H12A;CISD2;NUPR1;VDAC1;ATP6V0A1;ATP6V1D;TRIM68;ATP6V1B2;HGF;HTRA2;KEAP1;UFL1;PIP4K2C;GPR137B;SNX6;DAP;ATG13;SREBF1;MCL1;EXOC4;ATF6;PIP4K2B;TAB2;USP13;KLHL22;CSNK2A2;SLC38A9;ATP6V0B;TRIM8;EIF4G3;LEPR;DCAF12;RAB39B;KAT5;TICAM1;DDIT3;FBXW7;EIF4G1;CAPNS1;CTSA;TPCN1
prerank,RNA biosynthetic process (GO:0032774),-0.24791617765680932,-0.8527616477616841,0.7484662576687117,0.8667260809444733,1.0,8/31,16.43%,PRIM2;TAF6;POLR2A;HELB;TERT;TAF7;TAF5;GTF2B
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.4177112597443227,0.8524246556764035,0.6467153284671533,0.9674493593685406,1.0,5/10,35.91%,TSKU;LAPTM4B;CDH3;HSP90AB1;FN1
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.3404775469651785,0.8523710404338624,0.6877880184331797,0.967099630882593,1.0,13/36,22.55%,NECTIN3;GGA1;ARFRP1;GGA2;GOLGA4;NSF;SPTBN1;BLZF1;PREPL;VAMP2;RAB10;VAMP4;GOLPH3L
prerank,signal transduction in response to DNA damage (GO:0042770),0.33135314041751823,0.8519408076472853,0.7266739846322722,0.9674236649956126,1.0,18/49,29.44%,TRIAP1;MAPK14;USP10;MDM4;RHNO1;RAD1;BCL3;BRIP1;NBN;DONSON;CLSPN;SESN2;TIPRL;E2F7;PRPF19;RAD17;ATRX;TP53
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.4227505839373198,0.8518645339177342,0.6521739130434783,0.9671143903172367,1.0,1/10,2.76%,VEGFA
prerank,positive regulation of sodium ion transport (GO:0010765),-0.3206226150521164,-0.8516355927605577,0.6608996539792388,0.8675422547609252,1.0,5/12,21.08%,AHCYL1;GPD1L;NOS1;SCN3B;ANK3
prerank,snRNA transcription (GO:0009301),0.3118997935953008,0.8512219691827024,0.7300420168067226,0.9678623095170008,1.0,20/70,25.11%,POLR2H;ZC3H8;INTS3;TAF8;INTS10;CDK9;INTS6;POLR2D;POLR2G;GTF2A2;GTF2F1;INTS2;INTS12;GTF2E2;ICE1;ELL;TBP;TAF13;POLR2C;GTF2E1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.338907373327302,0.850358456756461,0.6814988290398126,0.9689373359403394,1.0,7/33,15.11%,MAPK7;NFE2L2;TCF7L2;GAS6;CAST;IL4;NUPR1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.4008584118904692,0.8498025043492321,0.6591230551626591,0.9695061092328936,1.0,1/11,2.47%,FYN
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.39653258258685936,0.8496937609543903,0.6561264822134387,0.9692667509073929,1.0,5/13,12.14%,IRS1;EPM2AIP1;DYRK2;AKT1;IRS2
prerank,regulation of DNA recombination (GO:0000018),0.3398862129716308,0.8496863731419135,0.6697674418604651,0.9688332521276857,1.0,12/32,26.85%,KPNA2;SETD2;THOC1;IL4;SPIDR;RAD50;BLM;KPNA1;TERF2IP;ALYREF;H1-0;MSH6
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.3989429536954579,0.8495198773124489,0.6565096952908587,0.9686913349938145,1.0,5/13,26.30%,EIF2AK3;NUPR1;MANF;USP19;LPCAT3
prerank,membrane protein proteolysis (GO:0033619),0.3357218354254433,0.8495007177373233,0.6834285714285714,0.968285158395694,1.0,17/37,30.76%,ADAM9;ADAM19;RET;PSEN1;SPPL2B;NAPSA;CLPP;BACE1;PARL;RELA;RBMX;MBTPS1;NFKB1;HM13;ADAM17;TRAF6;PSENEN
prerank,membrane lipid biosynthetic process (GO:0046467),0.3195304262078913,0.8486377225897487,0.7318132464712269,0.969354371504285,1.0,11/58,12.42%,CERS6;ST3GAL2;PLPP3;ALDH3A2;PLPP1;PRKD2;SGMS2;FA2H;ELOVL5;ST3GAL4;PRKD3
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.24862125941903557,-0.848451972066343,0.7534246575342466,0.872476632308541,1.0,8/29,15.91%,LEF1;CREBBP;TCF7;AXIN2;TERT;EP300;CTNNB1;TLE4
prerank,Golgi to plasma membrane transport (GO:0006893),0.32580235764284005,0.8483569236627836,0.7046979865771812,0.9694135179061191,1.0,15/47,22.55%,LLGL1;GGA1;ARFRP1;GGA2;GOLGA4;NSF;SPTBN1;BLZF1;GOPC;PREPL;VAMP2;EXOC4;RAB10;VAMP4;GOLPH3L
prerank,lymphocyte differentiation (GO:0030098),0.31280570015602643,0.8481129237521995,0.74,0.9694153674409901,1.0,10/68,16.01%,AXL;PBX1;HDAC9;CLCF1;PTPRJ;FLT3;CR2;HDAC4;IL4;LMBR1L
prerank,cell cycle G2/M phase transition (GO:0044839),0.29857729398527,0.8479747059794964,0.7821681864235056,0.9692198403896499,1.0,37/129,24.45%,DCTN1;ODF2;CDK14;YWHAG;SSNA1;YWHAE;PPP1R12B;ALMS1;MAPRE1;HAUS3;SFI1;CDKN1A;FBXL3;AKAP8;CCNH;HSP90AA1;TUBB4A;TUBA4A;DYNC1H1;CDK5RAP2;CCP110;AKAP9;CEP164;CKAP5;SKP2;PAFAH1B1;PPP2R2A;PCM1;AKAP8L;DCTN2;FBXW11;CDC25B;NEDD1;LATS1;DYNLL1;CEP78;FBXL12
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.4091417309204821,0.847160376211224,0.6829268292682927,0.9701993332905344,1.0,5/12,20.83%,SCP2;ELOVL5;FADS1;ACOX1;HSD17B4
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.3782626325874214,0.8465513609928914,0.6862996158770807,0.9707959496456716,1.0,5/18,17.98%,DACT1;CD81;HSP90AA1;RNF128;VPS11
prerank,regulation of interleukin-1 beta production (GO:0032651),0.3167934243315402,0.846346932323552,0.727176220806794,0.9707342680315316,1.0,10/66,16.30%,FOXP1;F2R;TMEM106A;CARD16;TLR4;SIRPA;USP50;ZC3H12A;NLRP2B;IL6
prerank,regulation of organelle organization (GO:0033043),0.3074680533634153,0.8458607987001611,0.7405857740585774,0.9711755828583395,1.0,28/80,27.62%,CAPN2;S100A8;S100A9;STX5;SYT11;PREB;MIEF2;MYO5A;SURF4;LMAN1;SQSTM1;MAPT;DIAPH1;RAB33B;AKAP9;ARMH3;VPS11;MAPK1;TMEM33;PARL;ZEB2;FIS1;MARK2;MTM1;RHOT2;MUL1;RBSN;PDE4DIP
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.3087795077835574,0.8458592800682567,0.7460815047021944,0.9707358663036649,1.0,16/83,15.63%,CDK14;ACVR1;CDK4;TRIM71;USP29;BCAT1;CUL3;USP26;FBXO5;CDC34;CDKN1A;CCND1;CCNH;DBF4;GSPT1;E2F3
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.3166846973327444,0.8457514929940264,0.7124183006535948,0.9704863083841934,1.0,6/55,9.40%,FHL1;PSMC4;ATF5;PSMC6;PSMD8;AVEN
prerank,protein localization to cell periphery (GO:1990778),0.29665891369657665,0.8453445023712133,0.7886178861788617,0.9707940534458286,1.0,25/133,16.97%,LRP6;TTC7A;TSPAN17;PKP3;PRAM1;ANK2;FGF13;S100A10;PLEKHF1;MYADM;MYO5A;GAS6;PACS2;CD81;EHD2;INPP5K;FYB2;RAB3D;JUP;ZDHHC2;PIGW;ANK1;SPTBN1;AP4M1;FLOT2
prerank,sensory perception of sound (GO:0007605),0.3090382633503772,0.8451257657983249,0.7444794952681388,0.9707448870754232,1.0,11/88,10.13%,COL1A1;HPN;COL11A1;SLC26A5;PDZD7;TSPEAR;MYO1A;MYO3B;TIMM9;MYH14;COL2A1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.37608394235687603,0.8448232736175586,0.6908150064683053,0.9708667113279207,1.0,7/18,29.34%,TMEM259;ERN1;BAK1;NCK1;USP13;DDIT3;BAX
prerank,regulation of Notch signaling pathway (GO:0008593),0.3100881842627647,0.8448140232228197,0.737064413938754,0.9704404991424568,1.0,14/76,12.37%,EGFR;ZMIZ1;TGFB2;LLGL1;TSPEAR;BEND6;SRC;JAG1;RFNG;KAT2B;BMP2K;ENHO;AKT1;EGF
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.31397580119097923,0.8446754936442118,0.7136752136752137,0.9702344514969964,1.0,11/57,17.66%,SYK;FYN;F2R;TBC1D10A;USP50;BAK1;GRAMD4;HTRA2;GRIN2A;CTSD;BCAP31
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.3596684291481878,0.8446673666556008,0.6831683168316832,0.9698106792523811,1.0,3/22,11.15%,RUNX1;TNFRSF18;BCL6
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.34692398080682113,0.8441510309315988,0.7043269230769231,0.9702532533852429,1.0,12/30,22.55%,GGA1;ARFRP1;GGA2;GOLGA4;NSF;SPTBN1;BLZF1;PREPL;VAMP2;RAB10;VAMP4;GOLPH3L
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.24472707619532752,-0.8437997971374658,0.7284768211920529,0.8801298677866556,1.0,10/30,19.61%,ACSL1;ELOVL7;HACD1;HACD4;HACD2;ACSL6;ELOVL1;ELOVL4;TECRL;SLC27A2
prerank,excitatory postsynaptic potential (GO:0060079),0.36475579079885867,0.843550172385332,0.6733921815889029,0.9708532017087124,1.0,9/19,32.91%,MPP2;GRIN2D;AKT1;GRIN2A;GRID2;NPAS4;DRD2;GSK3A;RAB3GAP1
prerank,transcription preinitiation complex assembly (GO:0070897),0.4069696453419277,0.8434376053464803,0.6781115879828327,0.9706050514504473,1.0,5/12,23.45%,DR1;GTF2A2;TAF7L;TBP;BDP1
prerank,carnitine metabolic process (GO:0009437),0.39879910601243174,0.843406763668026,0.6840659340659341,0.9702237107459672,1.0,5/12,22.34%,CPT1C;CRAT;CPT2;CROT;ALDH9A1
prerank,sodium ion transport (GO:0006814),0.30811634967432416,0.8432443727611751,0.7429760665972945,0.9700570529332354,1.0,15/85,13.99%,SCNN1B;SLC5A9;SLC4A8;FGF13;ATP1A4;SLC6A8;PKD2;HCN4;SLC4A4;SLC6A11;SLC6A4;SLC23A1;ASIC2;CATSPER3;SLC8A2
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.29959789707885315,-0.843212317983313,0.7117903930131004,0.8796689562545859,1.0,5/16,12.12%,PDGFD;NRP1;PTPN1;PDGFRB;ABL1
prerank,mitochondrion organization (GO:0007005),0.2942137230746213,0.842801545383875,0.8254288597376388,0.9703709354083696,1.0,45/165,25.60%,TIMM50;DNM1;RAB32;CLUH;GDAP1;WASF1;TIMM10B;TRAK2;MIEF2;PID1;AIFM2;TIMM9;SLC25A4;TMEM70;MYH14;AKT3;POLG2;NDUFS1;DNAJA3;FANCG;ATCAY;PTCD2;TIMM22;MTFR1L;SPG7;TIMM8B;BCAP31;BCS1L;SUPV3L1;SLC25A36;VPS13D;TOMM5;TIMM17A;SLC25A33;GABPA;MGME1;AFG1L;ESRRA;FIS1;RAB5IF;MTM1;TOMM40;ATP5F1B;RAB29;RHOT2
prerank,chemical homeostasis (GO:0048878),0.31367500682442423,0.8423250275843864,0.7165775401069518,0.9707368595307155,1.0,16/61,24.17%,SLC4A10;SLC4A8;SLC4A3;NR1D2;TLCD2;SLC4A4;PNPLA8;IRS2;THADA;ACOX1;TENT4B;ANGPTL3;EIF5A2;SLC4A2;ABCB4;WNK2
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.4189093649117194,0.8420556277083283,0.6637298091042585,0.9707569908449669,1.0,3/10,15.81%,PDZD7;TSKU;PLS1
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.3561955032635702,0.8416488741951992,0.6810344827586207,0.9710424524313728,1.0,11/24,29.34%,TGFB2;NUPR1;MCL1;ITGAM;BACE1;NF1;ATF4;DDIT3;FBXW7;PRNP;BAX
prerank,erythrocyte development (GO:0048821),0.4145394611754367,0.8416077214682717,0.6760168302945302,0.9706830276293587,1.0,5/10,36.14%,ABCB10;DMTN;ZBTB7A;NCKAP1L;MED1
prerank,cellular response to purine-containing compound (GO:0071415),-0.3302082177803579,-0.8415463954555524,0.6413043478260869,0.8814953884531214,1.0,4/10,20.92%,RYR2;P2RY1;P2RY6;CASQ2
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.3585993546942511,0.841470925365471,0.686641697877653,0.9704907182184783,1.0,7/22,16.74%,WASF1;AKT1;MAPT;MAGI2;KIDINS220;RAPGEF1;RAB35
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.42086724968793066,0.8413683654123141,0.6753782668500687,0.9702349680990814,1.0,2/10,7.57%,AXL;GAS6
prerank,histone methylation (GO:0016571),0.3499032328530162,0.8411941148588705,0.6924910607866508,0.9701061827436281,1.0,11/26,31.65%,PRMT2;NTMT1;EHMT2;N6AMT1;NSD1;CARM1;EZH2;SUV39H1;PRMT8;SIRT7;PRMT7
prerank,sulfation (GO:0051923),0.4167218993548678,0.8411395646418116,0.6853146853146853,0.9697548443756234,1.0,3/11,23.52%,HS3ST5;SULT4A1;UST
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.3688074110714171,0.8410479741930318,0.6727989487516426,0.9694743620783428,1.0,2/16,2.88%,VEGFA;FGF2
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.403481713117657,0.8405006793092981,0.6763925729442971,0.9699994859456742,1.0,2/12,7.01%,RUNX1;RC3H1
prerank,negative regulation of type I interferon production (GO:0032480),0.3320162184673225,0.840062552133939,0.7144495412844036,0.9703122733581478,1.0,16/40,32.40%,PTPRS;ITCH;SIRPA;PIN1;RNF216;ILRUN;TAX1BP1;PYCARD;CYLD;UBA7;UFD1;HAVCR2;NPLOC4;CACTIN;TRAF3IP1;TBK1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.34858179424447544,0.8399037283901691,0.6796116504854369,0.9701531162835211,1.0,11/25,31.63%,CHMP7;VPS4B;MVB12A;TMEM50A;LYST;UBXN6;LEPROT;CHMP4C;LAPTM4B;CHMP4A;CHMP4B
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.2742102980466409,-0.8398799582498179,0.6963350785340314,0.8832655184968023,1.0,9/21,21.16%,NUDT4;NT5E;HPRT1;PDE2A;NUDT3;NT5C2;NT5C1A;AMPD3;FITM2
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2883530745190419,0.8397236054640597,0.902,0.9700308391076753,1.0,107/366,26.26%,ESR1;BNC2;WT1;PKP3;SCRT2;PRDM8;MLF2;BHLHE40;ATF5;WWTR1;LMX1B;CXXC1;FOXK2;NAB1;NR1D2;SPIN4;RBAK;RBBP6;IGSF1;NFIA;ZFHX3;TRIP4;MLXIPL;MYT1;NUP107;ATXN2;PHF1;MSL3;SPTY2D1;FZD7;MYBL2;HNRNPD;RYBP;ONECUT1;MZF1;MITF;ACTR5;ATF7;CEBPB;FBXO5;SIX1;NOLC1;RBM3;EHMT2;FADS1;GMNN;NR2C2;RPL6;RNF14;SNAI2;CHD3;EFEMP1;PML;GON4L;MED23;GCFC2;TGFBR1;ZSCAN26;PCIF1;ELAVL2;JMJD1C;TAF6L;ASCC1;OGG1;FOXO4;TRRAP;METAP1;NSD1;USP13;SPIN1;BTG1;EIF2A;CARM1;TERF2IP;EZH2;ATF4;KAT6B;RNF6;LDB1;CCDC88A;RORA;BAZ2A;NCOA2;ZNF431;NFXL1;NR3C1;RABL3;ESRRA;TGFBRAP1;SAP30L;SKOR2;RELA;SERTAD3;DVL1;ACVR1B;CALR;PHF12;APBB2;KAT7;GRM5;VHL;CYFIP1;RNF20;DDIT3;TCF7L1;ZNF2;HP1BP3
prerank,carboxylic acid catabolic process (GO:0046395),0.40052833336671106,0.8395881304785235,0.6643835616438356,0.9698194956376028,1.0,2/12,9.36%,NAGK;PON3
prerank,"DNA-templated transcription, termination (GO:0006353)",0.30937356642300645,0.8395426758596697,0.7473233404710921,0.9694523540133094,1.0,21/68,24.63%,POLR2H;GTF2H3;SCAF8;POLR1G;CPSF4;UBTF;ERCC3;CCNH;CPSF2;SNRPG;SNRPD3;SLBP;POLR1C;SMN1;TBP;CSTF2T;POLR1B;CPSF1;CPSF7;WDR33;PABPN1
prerank,extracellular transport (GO:0006858),-0.31449109374674566,-0.8391598610367698,0.6374045801526718,0.8830885905396144,1.0,9/12,36.25%,WWP2;ARRDC1;CABYR;ROPN1L;ADCY10;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.36212301880022474,0.8386884617264282,0.6967005076142132,0.9705202542393561,1.0,6/21,24.49%,ANK2;SCN4B;AKAP9;KCNH2;FLNA;CACNA2D1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.3915378349311102,0.8377175935257137,0.6812169312169312,0.9717609395284296,1.0,5/15,23.37%,EDEM1;SPCS1;SEC61A1;RAB10;SRPRB
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.2690799688714531,-0.8376863973524611,0.680628272251309,0.8844079389879541,1.0,7/21,16.62%,NES;CX3CL1;MDK;SMARCD3;CTNNB1;TOX;DISC1
prerank,striated muscle cell differentiation (GO:0051146),0.37484510505374413,0.8376852863681951,0.6644993498049415,0.9713768384424085,1.0,2/16,4.06%,AKAP13;SKI
prerank,positive regulation of innate immune response (GO:0045089),0.34297410230957986,0.8372233956115427,0.7070828331332533,0.9717314962969805,1.0,4/30,14.58%,LBP;POLR3D;AKIRIN2;SLC15A4
prerank,activin receptor signaling pathway (GO:0032924),0.3805997653329124,0.8372026986137784,0.6846254927726675,0.9713342390848728,1.0,7/15,32.24%,ACVR1;AMHR2;TGFBR1;ACVR2A;ACVR1B;ACVR1C;INHBB
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.32738975396131825,0.8371961409615238,0.7221597300337458,0.9709081427233514,1.0,17/45,25.59%,PKP3;TRIM71;RC3H1;ATXN2;LARP4;TDRD7;PUM1;LARP1;NOLC1;RBM3;PER1;PCIF1;METAP1;EIF2A;ATG14;GRM5;CYFIP1
prerank,synaptic vesicle cycle (GO:0099504),0.33841957019557783,0.8370649310490033,0.7056737588652482,0.9707067471984508,1.0,6/30,20.02%,STX1A;SNAP25;SYNDIG1;SNAPIN;VAMP2;PLD2
prerank,homeostasis of number of cells (GO:0048872),0.4012186833445611,0.8370289035550398,0.6716216216216216,0.9703392199217535,1.0,3/12,11.92%,F2R;UBAP2L;LRRC19
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.3552777840254825,0.8369581160938911,0.6927784577723378,0.9700386047863322,1.0,8/24,22.99%,ITCH;UBE2N;IRAK1;UBA52;AAMP;TAB2;CYLD;MAP3K7
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.3384261598777528,0.8368316975225263,0.710801393728223,0.969820906095494,1.0,7/34,14.13%,IRS1;FGF2;PIK3R2;WDR91;PIK3IP1;FLT3;PDGFRA
prerank,termination of RNA polymerase II transcription (GO:0006369),0.336261526391214,0.8367390219709623,0.7261072261072261,0.969544271530553,1.0,11/33,24.63%,SCAF8;CPSF4;CPSF2;SNRPG;SNRPD3;SLBP;CSTF2T;CPSF1;CPSF7;WDR33;PABPN1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.2345154262632747,-0.8365077977017708,0.7777777777777778,0.8850952723985348,1.0,13/41,20.23%,PRKAG2;LACC1;NUP35;NDC1;RAE1;PGAM1;NUP153;EP300;NUP214;POM121;NUP155;HIF1A;NUP205
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.2871468834722579,0.8364514121074953,0.895,0.9696312045038604,1.0,94/327,26.26%,ESR1;BNC2;WT1;SCRT2;PRDM8;ZMIZ1;MLF2;BHLHE40;ATF5;WWTR1;LMX1B;CXXC1;FOXK2;NAB1;NR1D2;SPIN4;RBAK;IGSF1;NFIA;ZFHX3;TRIP4;MLXIPL;MYT1;NUP107;PHF1;MSL3;SPTY2D1;FZD7;MYBL2;HNRNPD;RYBP;ONECUT1;MZF1;MITF;ACTR5;ATF7;CEBPB;SIX1;FADS1;NR2C2;RPL6;RNF14;SNAI2;CHD3;EFEMP1;PML;GON4L;MED23;GCFC2;TGFBR1;ZSCAN26;ELAVL2;JMJD1C;TAF6L;ASCC1;OGG1;FOXO4;TRRAP;NSD1;USP13;SPIN1;BTG1;CARM1;TERF2IP;EZH2;ATF4;KAT6B;RNF6;LDB1;RORA;BAZ2A;NCOA2;ZNF431;NFXL1;NR3C1;ESRRA;TGFBRAP1;SAP30L;SKOR2;RELA;SERTAD3;RALY;DVL1;ACVR1B;CALR;PHF12;APBB2;KAT7;VHL;RNF20;DDIT3;TCF7L1;ZNF2;HP1BP3
prerank,embryonic heart tube morphogenesis (GO:0003143),0.32035981735222296,0.8364359592159577,0.7354910714285714,0.9692258865904939,1.0,9/43,15.86%,TGFBR2;ACVR1;TBX6;PKD2;NDRG4;MICAL2;VANGL2;BBS4;AHI1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.29561847079191744,-0.8364284360118796,0.6586345381526104,0.8837837916350444,1.0,4/16,14.48%,AUTS2;CTR9;CTNNB1;BCOR
prerank,endothelial cell development (GO:0001885),0.3496932998865368,0.8363406305000679,0.7,0.9689616136409747,1.0,7/25,15.37%,TNMD;RAP1B;MYADM;COL15A1;PDE4D;RAPGEF1;STC1
prerank,type I interferon signaling pathway (GO:0060337),-0.21818755047591387,-0.8352838715486535,0.7583333333333333,0.8830129425317096,1.0,12/41,18.30%,SP100;IFNAR1;IFITM3;IFIT1;IFIT2;OAS2;STAT1;IFIT3;RNASEL;ADAR;RSAD2;PSMB8
prerank,cellular response to type I interferon (GO:0071357),-0.21818755047591387,-0.8352838715486535,0.7583333333333333,0.8830129425317096,1.0,12/41,18.30%,SP100;IFNAR1;IFITM3;IFIT1;IFIT2;OAS2;STAT1;IFIT3;RNASEL;ADAR;RSAD2;PSMB8
prerank,response to zinc ion (GO:0010043),0.3527724933138871,0.8349356025684969,0.694478527607362,0.9709283843250249,1.0,7/25,31.87%,CRIP1;SLC30A5;D2HGDH;PAM;P2RX4;GLRA2;SLC30A4
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.34502566906697285,0.8348753354649543,0.7055288461538461,0.9705920066482595,1.0,2/26,1.34%,EGFR;ANXA1
prerank,regulation of calcium ion transport (GO:0051924),0.3154237363639941,0.834699743609548,0.7320261437908496,0.9704549618623634,1.0,11/54,19.15%,IL16;ANK2;F2R;SRI;PKD2;INPP5K;EGF;CASQ1;STC1;ATP2B1;STIM1
prerank,regulation of JUN kinase activity (GO:0043506),-0.23794196486687583,-0.8346373588371095,0.7687074829931972,0.8828286687827951,1.0,10/33,20.41%,SASH1;DAB2IP;DUSP10;DVL3;TNFRSF11A;EDN1;MAP3K5;ARHGEF5;DUSP19;MAP3K10
prerank,regulation of mRNA stability (GO:0043488),0.29422897535199516,0.8343611300812401,0.8142131979695432,0.9705889315459381,1.0,51/145,31.72%,PRKCA;PSMC4;TENT5B;ZFP36L1;SAMD4B;PSMC6;RC3H1;CARHSP1;ZFP36L2;PSMD8;HNRNPD;EXOSC7;NPM1;AKT1;PUM1;IGF2BP1;UBA52;LARP1;ZFP36;GDNF;EXOSC1;FXR2;YTHDF1;YTHDF2;SET;THRAP3;RC3H2;YWHAB;YTHDF3;PSMD3;PSMD4;RBM24;TNPO1;PSMB3;DCP1A;EIF4G1;PSMB2;CELF1;PSMD5;PDE12;IGF2BP3;TBRG4;SERBP1;HSPA8;EXOSC3;PSMD14;PSMC3;PSMC5;CIRBP;FXR1;PSME4
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.3328387778195121,-0.8339126887661269,0.6441947565543071,0.8828239184238674,1.0,4/11,12.22%,NOS3;GCH1;QDPR;SPR
prerank,cell chemotaxis (GO:0060326),0.30911011428285345,0.8338713661143201,0.7330462863293864,0.9709957185760265,1.0,11/60,18.12%,ACKR3;VEGFA;LPAR1;CCL25;ACKR4;ABCC1;PDGFRA;HGF;CXCR4;CXCR2;EPHB1
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.3306760404243299,-0.8335436966823309,0.6654411764705882,0.8820211191092274,1.0,11/11,66.96%,PKD1L3;LPO;RTP3;TAS1R2;GNAT3;GNAT2;PIGR;TAS1R3;RTP4;RTP2;PKD2L1
prerank,neuropeptide signaling pathway (GO:0007218),-0.21924238587950134,-0.8333143963492602,0.8072289156626506,0.880993337095529,1.0,3/58,1.64%,RAPGEF2;SORT1;CPE
prerank,acylglycerol metabolic process (GO:0006639),0.33534336552503835,0.8332139199601082,0.7357630979498861,0.9716654305301861,1.0,3/37,7.63%,MGLL;DGKQ;GK5
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.2047439286788032,-0.8331946189016736,0.8974358974358975,0.8797776715783641,1.0,32/87,20.77%,RPL13;SEC61A2;RPS7;RPL37;RPS27;RPS13;RPL19;RPL36;RPL30;RPL36A;SRP14;RPS14;RPL18A;RPS18;RPS21;RPL5;RPL7A;RPS24;RPS11;RPL39;RPL29;SRP72;RPL26;RPS23;RPL35;RPL14;SRP68;RPL37A;RPL24;RPL18;ZFAND2B;RPL9
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.39790006832805236,0.8331324641701664,0.6805929919137467,0.9713770877870005,1.0,5/12,12.14%,IRS1;EPM2AIP1;DYRK2;AKT1;IRS2
prerank,alanine transport (GO:0032328),-0.33509311560578925,-0.8329279964844446,0.6579804560260586,0.8788723192328103,1.0,2/10,12.51%,SLC6A17;SLC6A6
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.37740455608407675,0.8323644015114399,0.6802096985583224,0.9722653871864567,1.0,2/17,4.97%,CHAMP1;ZW10
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.316512634385176,-0.8323295765555211,0.6746031746031746,0.8785475654610388,1.0,3/13,12.16%,NOTCH1;TBX3;TGFB1
prerank,regulation of ATP metabolic process (GO:1903578),-0.221303738489505,-0.8321619971878538,0.8850574712643678,0.8773683043334899,1.0,16/54,20.23%,PRKAG2;NUP35;NDC1;RAE1;PINK1;PGAM1;UQCC2;NUP153;EP300;NUP214;AK4;POM121;NUP155;SPHK2;HIF1A;NUP205
prerank,tetrapyrrole metabolic process (GO:0033013),0.36715034921832856,0.8319580954701588,0.6602067183462532,0.9725240965988409,1.0,6/18,24.87%,TCN1;MTR;ABCC1;MMADHC;MMAB;MTRR
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.3457334317636229,0.8317694989349159,0.7148014440433214,0.9724294126206513,1.0,6/26,15.24%,ATP2B4;STIMATE;DYRK2;RCAN1;SLC9A1;CHP1
prerank,prostaglandin biosynthetic process (GO:0001516),-0.2758009850246681,-0.83170271313014,0.6777251184834123,0.8767517016881828,1.0,9/18,23.96%,PTGDS;PTGS2;PTGIS;PTGES3;EDN1;CD74;TBXAS1;CBR1;PTGS1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.40955625997583694,0.8316014097957961,0.6783216783216783,0.9722795074227168,1.0,2/11,8.07%,RFTN1;SCARA3
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.3905852252021857,0.8315905899661075,0.6854838709677419,0.9718641279692004,1.0,6/13,26.59%,KPNA2;IPO5;KPNA1;CBLB;KPNA6;KPNB1
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.3275574767182717,0.831255326360784,0.7178051511758119,0.9719917531244543,1.0,11/42,24.07%,USP10;ZBTB1;DTL;POLI;UBA52;PCLAF;RFC4;POLD1;FAAP20;REV1;POLH
prerank,response to unfolded protein (GO:0006986),0.3205525010316697,0.8310884312919014,0.728740581270183,0.9718556192860702,1.0,24/48,34.59%,HSPA13;ERN1;HERPUD1;SERPINH1;DNAJB2;BAK1;HSP90AA1;HSPA14;DNAJB1;ERP44;DERL1;BAG3;TM7SF3;HSPH1;DDIT3;DNAJA1;BAX;HSPA8;HSF1;DNAJB5;HSPB8;HSPA5;HSP90AB1;HSPA4
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.35426622005452046,0.8310779106450384,0.6881313131313131,0.9714470210143771,1.0,4/21,20.62%,FGF13;CAMSAP1;NAV3;CLASP2
prerank,cellular respiration (GO:0045333),0.32416221191760775,0.8303632970551132,0.708803611738149,0.9721937417710901,1.0,14/41,27.02%,COQ10B;ETFA;NDUFS1;SURF1;MDH2;ETFDH;ETFB;MTFR1L;UQCRH;UQCR10;ME3;SDHC;COQ10A;COX15
prerank,ERK1 and ERK2 cascade (GO:0070371),0.35666631035249396,0.829951401032769,0.6853503184713375,0.9724524250159221,1.0,5/21,15.60%,ZFP36L1;ZFP36L2;ITGAV;EGF;MAP2K2
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.3254770428686849,0.8299468954068668,0.7116912599318955,0.9720273076450279,1.0,9/39,18.98%,TCF7L2;GRP;ADCYAP1;MCU;IRS2;TRH;GLUD1;CAPN10;AIMP1
prerank,programmed necrotic cell death (GO:0097300),0.36214663713093476,0.8299424123746839,0.6950444726810674,0.971601276200157,1.0,6/18,25.35%,ALKBH7;TLR4;PGAM5;CD14;CYLD;TICAM1
prerank,cardiac muscle cell action potential (GO:0086001),0.3362186267622863,0.8296424182753959,0.6997607655502392,0.9716739671641387,1.0,6/30,10.04%,ANK2;ATP1A1;SLC4A3;KCNJ2;YWHAE;HCN4
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.4019901925982361,0.8294069264768176,0.6848920863309352,0.9716493778891306,1.0,6/11,37.62%,TENT4B;LARP7;EXOSC10;EXOSC3;FBL;PARN
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.33525370475737604,0.8293831196318029,0.718931475029036,0.9712494488985364,1.0,6/36,14.60%,CYGB;EGFR;ATP2B4;AKT1;GLA;HSP90AA1
prerank,positive regulation of axonogenesis (GO:0050772),0.32076373479437026,0.8280658227310187,0.7331081081081081,0.9729862948947031,1.0,10/43,13.49%,DBN1;SLIT2;NTN1;ISLR2;PLXNA3;TIAM2;L1CAM;MAPT;MAP6;RHOA
prerank,regulation of intracellular protein transport (GO:0033157),-0.24153667716069546,-0.8278678784366663,0.7692307692307693,0.8825216290375792,1.0,8/32,13.91%,PTPN14;CEP290;PRR5L;PTPN1;GCC2;TGFB1;PDCD10;RIPOR1
prerank,regulation of cytokinesis (GO:0032465),0.29850082116732246,0.827373560936077,0.7523510971786834,0.9737155105284006,1.0,22/78,25.22%,CDC14B;SVIL;AHCTF1;FSD1;FLCN;CUL3;KIF20B;SETD2;PRPF40A;CALM2;PIN1;RHOA;BBS4;GIPC1;CCP110;CIT;ENTR1;KLHL9;CDC25B;RAB11FIP3;E2F7;CDC14A
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.3188863354629364,0.8271145200205351,0.7293729372937293,0.9737205477996231,1.0,16/48,26.82%,POLR2H;ZMIZ1;SMARCD1;POLR1G;KAT2B;ATAD2B;DDX21;PADI2;POLR1C;SF3B1;TBP;POLR1B;H1-0;ELOF1;SERTAD2;ARID1A
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.2883417264154889,-0.8265565949436517,0.7288135593220338,0.8834925940709678,1.0,3/16,5.34%,PHKB;PYGM;AGL
prerank,cardiac muscle contraction (GO:0060048),0.32539844362297876,0.8263507416926074,0.7220259128386337,0.9745625323903674,1.0,4/34,8.49%,GSN;TNNI3;CAMK2D;PIK3CA
prerank,cellular amide metabolic process (GO:0043603),0.29449074517439844,0.8261797633469016,0.7971014492753623,0.9744007321583243,1.0,24/102,22.18%,SMPD3;GPAT4;PLPP3;PLAAT1;ACOT6;PLPP1;ORMDL2;ACOT9;THOP1;CERK;ACOT1;PLA2G4E;ABCB9;PLPP2;ST3GAL1;BTD;DNPEP;SMPD1;GNE;NIT1;MTHFD2L;NSMAF;CPZ;ATF4
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.4083819706201794,0.8261278957977849,0.6981132075471698,0.9740598256220409,1.0,3/10,8.26%,SESTD1;BIN1;YWHAE
prerank,nitrogen compound transport (GO:0071705),0.2950082574420415,0.8260496971590882,0.8220424671385238,0.9737642273704095,1.0,28/141,17.46%,SLC1A5;LRRC8D;SLC7A6;ARRDC2;SLC43A2;MIA3;TOM1;SCAMP3;RCN3;SLC6A8;SCAMP5;TCN1;SLC44A1;SLC16A10;SLC6A4;TMEM30A;SLC7A3;LRP1B;RUFY1;KIF3A;ABCC1;SLC23A1;CMTM6;SLC15A4;SEC14L1;SLC38A1;FLVCR1;SLC44A2
prerank,pyruvate metabolic process (GO:0006090),-0.21472095377022976,-0.8258813959483325,0.872093023255814,0.8833707594278186,1.0,17/52,21.73%,BSG;ENO1;HK2;PGAM1;PGAM4;PGK1;PFKM;ALDOC;GAPDH;PFKL;DLD;TPI1;GAPDHS;ENO3;GPI;LDHB;NR4A3
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.4029873799203151,0.8253157031169354,0.6941015089163237,0.974537009709111,1.0,7/10,29.44%,MUC1;ING4;RPS27L;TFAP4;KAT5;FOXM1;TP53
prerank,negative regulation of endocytosis (GO:0045806),0.3478322918481944,0.8250480640258758,0.7268292682926829,0.9745425272939747,1.0,8/24,27.01%,EPHA3;SYT11;SCAMP5;ARF6;LRSAM1;PACSIN3;RAC1;SNX33
prerank,cellular response to radiation (GO:0071478),0.3248738296547151,0.8249035306331189,0.7334826427771557,0.9743335774022278,1.0,10/40,22.08%,MAPK14;RHNO1;RAD1;CDKN1A;INO80;TNKS1BP1;SPIDR;BLM;OPN3;NSMCE3
prerank,positive regulation of cellular senescence (GO:2000774),0.4048391572349491,0.8248833832152419,0.683982683982684,0.9739305543389816,1.0,3/10,17.25%,CGAS;YPEL3;EEF1E1
prerank,lipid phosphorylation (GO:0046834),-0.34267155091461177,-0.8246762423567623,0.6811594202898551,0.8841110034135319,1.0,3/10,4.74%,DGKB;DGKE;DGKZ
prerank,mitochondrion disassembly (GO:0061726),0.3297170195785996,0.8241727090616687,0.7258064516129032,0.9746634075482403,1.0,12/34,24.76%,ATG2B;WIPI2;SQSTM1;WDR45B;ULK2;ATG2A;ULK1;CISD2;ATG3;FIS1;CTSK;MARK2
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.3877982740874817,0.8237549372080128,0.6963064295485636,0.9749193763363977,1.0,6/13,28.93%,STX4;STX3;MAP1A;SNX33;RANGRF;TM9SF4
prerank,glycerophospholipid metabolic process (GO:0006650),-0.19960965158141214,-0.8236821684272774,0.851063829787234,0.8845129359802509,1.0,23/75,21.53%,GPCPD1;PLCG1;PLA1A;HDHD5;PIGN;PLCB1;PIGG;PIP5K1A;PIGP;PDGFRB;ABCA3;PIGB;PNPLA6;PLA2G15;CLN3;CPNE3;PNPLA3;DGKH;PLA2G4C;PIGF;CPNE7;PIGA;ABHD3
prerank,protein-containing complex disassembly (GO:0032984),0.31459848445725797,0.823311758867687,0.7453954496208017,0.9752063134555239,1.0,7/54,13.15%,LRP6;AXIN1;LIX1L;WIPI2;VPS33A;STX17;EPG5
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.20589406618974287,-0.8228966308365683,0.8591549295774648,0.8845185889348497,1.0,12/68,12.88%,PCCA;SLC2A1;ENPP1;PDXK;MTHFS;TCN2;RFK;CUBN;ALDH1L1;MMAA;MCCC2;SLC19A3
prerank,mRNA methylation (GO:0080009),0.3731964061925721,0.8228682694828223,0.6842105263157895,0.9754968419023038,1.0,2/15,8.09%,TRMT6;TRMT61A
prerank,regulation of DNA biosynthetic process (GO:2000278),0.3419263370366882,0.8227086002140991,0.7251184834123223,0.9753213250125453,1.0,6/27,16.31%,FGF2;SMOC2;PRKD2;CDKN1A;SMG6;HGF
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3372986572251869,0.8224910589719387,0.7442977190876351,0.9752411279208487,1.0,2/29,2.30%,HPN;LDLRAD4
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.3598163368848912,0.8222146187112362,0.7182926829268292,0.9752535654454852,1.0,3/21,8.08%,FOXP1;RUNX1;CD81
prerank,nucleotide metabolic process (GO:0009117),0.3429417653135578,0.8219138796413626,0.6804374240583232,0.9753244053879,1.0,6/23,17.56%,REXO2;FHIT;NME2;NUDT5;CMPK2;AK8
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.31198599407858413,-0.8216870725134139,0.6906474820143885,0.8854207692844938,1.0,2/11,5.24%,SCARB1;NR1H3
prerank,regulation of mitotic spindle assembly (GO:1901673),0.36589979004383555,0.8213445719306259,0.7096370463078848,0.9758315990009218,1.0,5/19,22.68%,VPS4B;CCSAP;CEP97;PDCD6IP;TPR
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.30042769414831627,-0.8211590831459101,0.6970802919708029,0.8849012476215301,1.0,7/13,26.60%,ATM;SPRED3;SPRED2;RPL26;PLA2R1;MSX1;ATR
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.4032537785441613,0.8208059093953405,0.7001375515818432,0.9762991549073349,1.0,2/11,8.89%,NECAB3;AGO2
prerank,chromosome organization (GO:0051276),0.29474137559735253,0.8203174975418724,0.8051546391752578,0.9766679373087869,1.0,31/99,28.06%,COPS5;TCF7L2;RFWD3;RAD23B;CENPT;PHF1;SETD7;POLE3;HDAC3;UBA52;DDB1;EZH1;GATAD1;GEM;SMARCA4;BAHD1;PADI2;COPS4;TOP2B;EZH2;LDB1;LATS1;GPS1;NUP133;TCF7L1;SAFB;CETN2;MSH6;COPS6;HDAC8;SUV39H1
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.3231174752013003,0.8203012447663837,0.7334096109839817,0.9762689919241945,1.0,8/39,14.76%,PPFIA2;NDEL1;MYO1A;TRAK2;MYO5A;DYNC1I1;TANC2;CCDC186
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.31452995832150155,-0.8201425671751267,0.6773049645390071,0.8852863217338398,1.0,4/11,27.46%,PINK1;HIF1A;NR4A3;PARK7
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.25707489010704754,-0.8200184847443815,0.7621951219512195,0.8840727053338483,1.0,3/24,6.55%,ABCG2;PGRMC1;FECH
prerank,positive regulation of cell migration (GO:0030335),0.2831595380450658,0.8199397477280777,0.897,0.9764217661379113,1.0,37/253,14.82%,SEMA3C;DDR2;HAS2;MYOC;EPHB2;COL1A1;PRKCA;EGFR;VEGFA;TGFB2;F2R;ADAM9;SMURF2;ACVR1;MTOR;MIA3;MYADM;C1QBP;RET;SRC;HDAC6;TNFRSF18;SEMA3A;AGO2;STX4;MAPRE1;KIF20B;GPNMB;FBXO5;SEMA3D;EGF;MGAT5;NSMF;PDGFRA;FER;PPP3CA;IL4
prerank,peptide biosynthetic process (GO:0043043),0.28802760790990034,0.8197696600214152,0.8431771894093686,0.976263971775368,1.0,23/153,15.98%,RPSA;PCSK5;MRPS11;RRBP1;COPS5;MRPS18B;IGHMBP2;MRPL13;MRPS17;AGO2;GSPT2;RPL10A;MRPL10;MRPL55;TNIP1;RPS5;MRPL36;GGT7;MRPL3;GSPT1;RPL6;MRPL51;HARS1
prerank,lysine catabolic process (GO:0006554),0.38998652106446147,0.8196944842481039,0.6835106382978723,0.9755328402920521,1.0,1/12,0.85%,SLC25A21
prerank,lysine metabolic process (GO:0006553),0.38998652106446147,0.8196944842481039,0.6835106382978723,0.9755328402920521,1.0,1/12,0.85%,SLC25A21
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.32877979219768766,0.8193774920756782,0.7473560517038778,0.9756189923212681,1.0,10/32,23.85%,POLR2H;GTF2H3;POLR1G;UBTF;ERCC3;CCNH;POLR1C;RRN3;TBP;POLR1B
prerank,negative regulation of mitochondrion organization (GO:0010823),0.32432983106551977,0.8193540219418138,0.7088757396449704,0.9752334404383298,1.0,9/33,20.35%,TRIAP1;FLCN;GPX1;AKT1;MAPT;GHITM;HGF;IAPP;PRELID1
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.3223269391383768,-0.8192173870184007,0.725925925925926,0.8840679344310768,1.0,1/11,1.76%,H3-3A
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.28653887315047527,0.8190792930551021,0.8543983822042467,0.9752640618685929,1.0,22/159,13.94%,CDH26;CADM3;GPC6;NPTN;CD177;TGFB2;TGFBR2;NECTIN3;PTPRS;PKD1;ACVR1;TENM3;PTPRF;CDH22;CLDN10;DSCAM;UNC5D;L1CAM;FLRT3;IGSF9;PALLD;CLDN12
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.210982381877599,-0.8190564995376817,0.8651685393258427,0.8829284564492306,1.0,14/50,18.17%,NR3C2;SASH1;APP;NFAT5;TLR3;LIMS1;EP300;SPHK1;NOD1;CD86;NMI;PHB2;TCIM;ACTN4
prerank,Notch signaling involved in heart development (GO:0061314),-0.32906636470737466,-0.8189010256787981,0.7358490566037735,0.8818018529376408,1.0,6/11,23.86%,NOTCH1;HEYL;GALNT11;HEY1;HEY2;DLL4
prerank,sodium ion import across plasma membrane (GO:0098719),0.36999611781260056,0.8187190157797306,0.7146562905317769,0.9754418319357057,1.0,5/17,15.88%,SLC9A9;HCN4;SLC9A1;SLC9A7;SLC9A6
prerank,negative regulation of cell projection organization (GO:0031345),0.3114041050877963,0.8186866579333202,0.7397107897664071,0.9750568632692229,1.0,11/48,14.33%,FYN;PTPRS;LPAR1;STX1B;SEMA3A;MYLIP;TSKU;KANK1;CBFA2T2;RTN4RL1;DCC
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.31145514974935645,0.8180467563710533,0.7526881720430108,0.9755960408392842,1.0,12/57,17.31%,CNIH3;DLG4;DLGAP4;DLG2;NEFL;CAPN1;GRIA2;DLGAP3;CACNG2;DLGAP1;GRIN2A;AKAP9
prerank,blood vessel diameter maintenance (GO:0097746),0.33237920901697515,0.8176342446449777,0.7353951890034365,0.9758479831061747,1.0,3/34,8.91%,GCLC;KLF2;ECE1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.3386635490916728,0.8173881902740048,0.7278177458033573,0.9757762309236603,1.0,6/26,12.34%,WDTC1;PRKAB2;MLXIPL;ACADVL;ELOVL5;EIF6
prerank,regulation of TOR signaling (GO:0032006),0.3009305429496956,0.8172402149744125,0.7776595744680851,0.975595776147427,1.0,11/67,15.12%,DGKQ;TBCK;GAS6;FLCN;PIK3CA;HDAC3;DEPTOR;SMCR8;TMEM127;RRAGD;GPAT3
prerank,regulation of AMPA receptor activity (GO:2000311),-0.2504360534956345,-0.8168461905782073,0.7627118644067796,0.8841732586245269,1.0,8/25,17.70%,MEF2C;SHANK3;CACNG4;CACNG8;GSG1L;SHISA9;MINK1;ADRB2
prerank,positive regulation of cellular component movement (GO:0051272),0.3434270517130083,0.8166776573097108,0.7071078431372549,0.9760694776080108,1.0,5/24,13.56%,DUOX1;VEGFA;NTN1;CCDC25;TWIST1
prerank,vitamin transport (GO:0051180),-0.24053321799957833,-0.8166160946316646,0.8209876543209876,0.8831694607807598,1.0,5/29,9.01%,ABCG2;PDPN;SLC35F3;TCN2;CUBN
prerank,amyloid precursor protein metabolic process (GO:0042982),0.35670943260851756,0.8162804729224564,0.717391304347826,0.97627722119206,1.0,5/18,13.64%,ADAM19;TMCC2;PSEN1;KLK6;NSG1
prerank,positive regulation of JNK cascade (GO:0046330),0.3058232935556113,0.8162447924111467,0.7775445960125918,0.9759010935647577,1.0,11/70,12.80%,SH3RF3;GADD45G;TAOK3;AXIN1;RASSF2;FZD7;SEMA3A;TIRAP;ANKRD6;CD27;TAOK2
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.31202735497673306,0.8161641243756199,0.7628635346756152,0.9756068310831184,1.0,7/45,11.15%,GAS1;ZFP36L1;ZW10;ZFP36L2;ZWINT;AURKAIP1;BCL6
prerank,zymogen activation (GO:0031638),0.32149164904006944,0.8160876432739955,0.7417840375586855,0.9753069128761841,1.0,6/39,16.79%,KLKB1;PRSS12;TBC1D10A;BAK1;KLK1;GRIN2A
prerank,carbohydrate homeostasis (GO:0033500),0.30501262888273095,0.8158940553497978,0.7756202804746494,0.9751798969778054,1.0,8/67,12.54%,MTNR1B;IRS1;CRTC2;TCF7L2;MLXIPL;MCU;INPP5K;ADCY8
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.2887032157488867,0.8157711169762875,0.81855249745158,0.9749686072511559,1.0,16/114,17.93%,TNFSF9;PSMC4;TNFRSF11B;PSMC6;TNFRSF18;CHUK;PSMD8;TNFSF13B;PLVAP;CD27;TNFRSF1B;EDA;BAG4;TRAF3;MAP3K14;ILK
prerank,histone monoubiquitination (GO:0010390),0.3458810068377873,0.8157073465709559,0.7278325123152709,0.9746491145809998,1.0,7/24,21.48%,RNF2;ATXN7L3;RYBP;DDB1;RING1;PAF1;KDM2B
prerank,protein autoubiquitination (GO:0051865),0.3026980597798773,0.8157051481663452,0.760043431053203,0.9742266187613287,1.0,20/61,24.78%,SH3RF3;UBE2B;TRIM71;ITCH;STUB1;CUL3;RNF10;RNF141;UBE2A;AMFR;UHRF2;TRIM68;RNF187;LRSAM1;UBE2D3;RNF41;UBE3A;RNF13;RNF157;MDM2
prerank,small GTPase mediated signal transduction (GO:0007264),0.2923305703545086,0.8156870604507988,0.8053553038105047,0.9738335648218839,1.0,36/103,25.61%,PLCE1;CCDC88C;FGF2;MAPK14;RASSF1;NTN1;RIT2;RGL1;MAPK11;RGL2;TIAM2;NRAS;KRAS;USP50;RRAD;SHOC2;CDKN1A;GNB1;CHP1;HACD3;SOS1;SHTN1;RRAS2;BRAP;PLD2;TIAM1;RALA;JUN;NF1;CCDC88A;SETDB1;BCR;RAB18;G3BP1;RAC1;RGS19
prerank,eye photoreceptor cell development (GO:0042462),0.3809179726546415,0.8153664490462441,0.7109375,0.9739340643689419,1.0,3/15,17.44%,VEGFA;BBS4;RPGRIP1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.32672061639572036,0.8152033957779075,0.7184579439252337,0.9737759790541566,1.0,4/31,7.56%,TGFB2;TNNI3;SMAD4;ZFPM2
prerank,establishment of apical/basal cell polarity (GO:0035089),0.37776994289187904,0.8151016987944212,0.7196765498652291,0.9735334455210642,1.0,3/14,13.49%,FSCN1;MYO9A;RHOA
prerank,telomere maintenance via telomerase (GO:0007004),0.33487160167956503,0.8146653716615335,0.7373493975903614,0.9738139786210374,1.0,9/28,22.09%,ACD;GAR1;TERF1;HSP90AA1;TNKS1BP1;RAD50;TINF2;PPP6C;TERF2IP
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.3810206232317077,0.8146026610719175,0.7192982456140351,0.9734959564961202,1.0,5/14,24.32%,CD177;SLC2A10;LIMS2;FLNA;DMTN
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3241691478888808,0.8143184285126093,0.753393665158371,0.9735308215330106,1.0,18/42,30.13%,SMARCD2;SPTY2D1;ACTR5;SMARCC2;DMAP1;INO80;SMARCA4;CHD8;SRCAP;CHD3;ZNHIT1;VPS72;MBD2;ARID1A;ARID1B;HNRNPC;PBRM1;MBD3
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.29844359631040435,0.8142835213256806,0.7691489361702127,0.9731632065156698,1.0,6/65,9.40%,FHL1;PSMC4;INTS3;PSMC6;PSMD8;AVEN
prerank,negative regulation of protein depolymerization (GO:1901880),0.34054920034323827,0.8138904974952741,0.7369727047146402,0.9733648904650313,1.0,5/24,20.62%,FGF13;PIK3CA;CAMSAP1;NAV3;CLASP2
prerank,regulation of innate immune response (GO:0045088),-0.209589457623795,-0.8136145959197194,0.8783783783783784,0.887038036628412,1.0,17/57,17.35%,XIAP;PLSCR1;POLR3C;ERAP1;USP18;PTPN1;POLR3B;APPL2;RNF135;GBP5;RNASEL;TRIM21;N4BP1;NMI;LRP8;DHX58;PARP9
prerank,positive regulation of transporter activity (GO:0032411),0.384723708269495,0.813101598717512,0.7261410788381742,0.9741573797251332,1.0,3/13,20.13%,SGK2;STK39;KMT2A
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.3828599261578467,0.8126991217290244,0.6995768688293371,0.9743769190715121,1.0,4/12,27.33%,GAS2L1;BRD8;CTSB;CTSL
prerank,cellular response to peptide (GO:1901653),0.30926007880377765,0.8125330939580837,0.7613762486126526,0.9742133864569383,1.0,13/56,19.50%,LRP1;FYN;ATP1A3;ZFP36L1;SRC;PSEN1;TLR4;ABCC1;DDX11;CACNB1;GRIN2A;SNX6;RPL23
prerank,lipoxygenase pathway (GO:0019372),0.3687088546613486,0.812004516560428,0.7081081081081081,0.974613799966382,1.0,2/14,10.96%,PON3;GPX1
prerank,positive regulation of TORC1 signaling (GO:1904263),0.3733007545631278,0.8118411741648993,0.7297650130548303,0.9744448592664747,1.0,5/16,22.86%,FLCN;RRAGD;PIP4P1;GPR137B;KLHL22
prerank,positive regulation of histone methylation (GO:0031062),-0.2562618804460373,-0.8118097785106267,0.7733990147783252,0.8888003437260635,1.0,6/24,14.28%,AUTS2;TET1;CTR9;SIRT1;RIF1;CTNNB1
prerank,zinc ion transmembrane transport (GO:0071577),0.3480462994759321,0.8116995123801125,0.7314702308626975,0.9742408833440844,1.0,5/22,19.98%,SLC39A13;SLC39A14;SLC39A7;SLC30A5;SLC39A3
prerank,negative regulation of JUN kinase activity (GO:0043508),0.40958577623903913,0.8113611969513808,0.7136929460580913,0.9743719977103372,1.0,3/10,20.08%,AIDA;PDCD4;HIPK3
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.28325431011540103,0.8108353786341352,0.8496468213925328,0.9747461253205637,1.0,43/158,23.89%,AKAP13;MIB2;ECM1;F2R;LPAR1;MID2;TMEM106A;CARD16;UBE2N;TFG;CHUK;PPP5C;TIRAP;LGALS1;IRAK4;DDX21;IRAK1;NDFIP1;TRAF3IP2;RHOA;TRIM68;RBCK1;SLC20A1;MAP3K14;CANT1;SLC44A2;CARD11;LURAP1;MIER1;UNC5CL;FLNA;PPM1A;GOLT1B;TSPAN6;TAB2;TERF2IP;ROR1;MAP3K7;FKBP1A;TRAF5;TNIP2;TRIM8;RELA
prerank,protein tetramerization (GO:0051262),0.29862247129393393,0.8104895188779079,0.768409818569904,0.9748869473503157,1.0,12/67,15.10%,PKD1;KRT10;TK1;KCNJ2;OSBPL2;PKD2;CPSF6;SAMHD1;ALDH1A3;GLS;CRYZ;HSD17B8
prerank,regulation of macromolecule metabolic process (GO:0060255),0.28609618607357495,0.8103638202903648,0.8685540950455005,0.9746710076929865,1.0,33/170,20.31%,AFF3;C1D;AFF2;FOXP1;CRIP1;ZFP36L1;CDK4;COQ7;TARDBP;STX1B;PSEN1;HNRNPD;ARF1;TSKU;SIRPA;TRIM11;ALPK2;ZNF462;IGF2BP1;GDNF;PEG3;PIN1;SLC8A2;ZC3H12A;MTMR1;TRIM68;RNF187;CTCF;PRDM9;MKLN1;NOVA1;RASA1;CIAO3
prerank,peptide metabolic process (GO:0006518),0.2998382381020735,0.8098550145046042,0.8012684989429175,0.9750587319438787,1.0,13/75,12.52%,PCSK5;ANPEP;SPCS1;LNPEP;DPEP1;TPP1;PSEN1;SEC11C;GPX1;GSTM2;NAT8;THOP1;NPEPPS
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.2850328585564786,0.8095878080675226,0.8255578093306288,0.9750718263180137,1.0,45/128,30.09%,DCTN1;ODF2;CDK14;YWHAG;SSNA1;YWHAE;PPP1R12B;ALMS1;MAPRE1;HAUS3;SFI1;CDKN1A;FBXL3;CCNH;HSP90AA1;TUBB4A;TUBA4A;DYNC1H1;CDK5RAP2;CCP110;AKAP9;CEP164;CKAP5;SKP2;PAFAH1B1;PPP2R2A;PCM1;DCTN2;FBXW11;CDC25B;NEDD1;LATS1;DYNLL1;CEP78;FBXL12;CSNK1E;ACTR1A;CETN2;WEE1;CEP152;CUL1;FOXM1;PLK4;SDCCAG8;FBXL8
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.288360304580874,-0.8091916070056788,0.7301587301587301,0.892062824254839,1.0,3/14,5.81%,ADAM10;DYRK1A;ABCG1
prerank,ncRNA processing (GO:0034470),0.27807604543335407,0.8091895809898461,0.8655967903711134,0.9752765698738375,1.0,48/200,23.67%,C1D;TARBP2;INTS3;DDX49;RPP21;DGCR8;FCF1;INTS10;AGO2;ESF1;HELQ;EXOSC7;INTS6;RRP36;RPL10A;WDR46;UBA52;SBDS;MPHOSPH10;RCL1;SNU13;NOLC1;DCAF13;RRP7A;EXOSC1;ZCCHC8;RPL6;NOP53;DDX52;POP4;INTS2;AGO4;PWP2;TRPT1;EBNA1BP2;INTS12;AGO3;TBL3;RPL23;RPL17;PDCD11;KRR1;RPS25;RPP30;WDR18;NOC4L;TEX10;RRP1B
prerank,regulation of telomere capping (GO:1904353),0.34431408657317664,0.809021923736077,0.742014742014742,0.9751109200613659,1.0,7/23,21.04%,HNRNPD;NBN;USP7;SMG6;RAD50;NEK7;MAPK1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.28500306882572474,-0.8086683008449269,0.6899563318777293,0.8915016867309906,1.0,2/16,3.32%,ETS1;NFAT5
prerank,filopodium assembly (GO:0046847),-0.2886444670796391,-0.8081811662968427,0.762114537444934,0.8908712906247386,1.0,3/16,4.29%,FGD4;FGD5;DNM3
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.3861244871123509,0.8079744901372128,0.7170868347338936,0.9764039494890827,1.0,1/12,2.03%,CDC14B
prerank,regulation of gene silencing by miRNA (GO:0060964),0.300838730309703,0.807856698915106,0.8042780748663102,0.9761432932537334,1.0,21/62,27.66%,POLR2H;NUP93;TRIM71;NUP107;NUP98;AGO2;PUM1;ZFP36;POLR2D;POLR2G;NUP37;NUP50;TPR;TNRC6A;POLR2C;NUP133;NUP85;NUP188;EIF4G1;NUP88;AGO1
prerank,negative regulation of synaptic transmission (GO:0050805),0.34184714403147887,0.8077144393900292,0.7300380228136882,0.9759608107534821,1.0,8/23,31.19%,SYT11;ARF1;ATAD1;PTEN;PICK1;SLC24A2;DRD2;CBLN1
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.2681330223720271,-0.8074083169693993,0.7828054298642534,0.890850347888658,1.0,4/20,9.13%,RAPGEF2;ADRA1B;ADRA2A;ADCY9
prerank,regulation of amyloid-beta clearance (GO:1900221),0.3668733483881128,0.8072007601495669,0.7329032258064516,0.9763247312121761,1.0,1/16,1.37%,LRP1
prerank,regulation of defense response (GO:0031347),0.2998806005963422,0.8070523670577749,0.7855648535564853,0.9761506572411168,1.0,13/76,16.84%,MGLL;ANXA1;FOXP1;AKNA;SPATA2;NR1D2;TIRAP;SAMHD1;BCL6;LRRC19;DAGLB;TRAF3;UFL1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.2997484915387897,0.8067450509164471,0.7815845824411135,0.9761890487639638,1.0,14/63,16.87%,TRIAP1;RFWD3;MUC1;MDM4;FBXO31;SFN;RPS27L;CDKN1A;CCND1;CNOT3;CNOT10;PLAGL1;TNKS1BP1;PML
prerank,protein sumoylation (GO:0016925),0.31139914675275826,0.8063234117713595,0.7564534231200898,0.9763967711153094,1.0,19/49,29.16%,STX1A;RNF212B;NUP93;PIAS3;NUP107;UBA2;NUP98;NUP37;NUP50;SAE1;TPR;NSMCE2;NUP133;BCL11A;NUP85;NUP188;NUP88;TOPORS;SUMO1
prerank,negative regulation of reproductive process (GO:2000242),0.3575514419066494,0.806225764901002,0.7252604166666666,0.9761159914537461,1.0,9/17,33.44%,SULF1;WDR77;PAEP;CALR;DUSP1;NPPC;ACVR1C;ARHGDIB;TIMP1
prerank,nucleotide catabolic process (GO:0009166),0.3638232146625646,0.8061739103678148,0.717391304347826,0.9757805709124551,1.0,3/16,10.96%,SAMHD1;GDA;GPX1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.36000414815129234,0.8061736498999429,0.7369077306733167,0.9753627350811362,1.0,6/18,21.15%,COX19;SURF1;BCS1L;COX16;COX14;COX18
prerank,negative regulation of cellular metabolic process (GO:0031324),0.3193407153767257,0.8061106586385128,0.734321550741163,0.9750503570529255,1.0,6/37,13.20%,ITGB3;DLG4;ATXN2;SIRT2;ITGAV;NCOR1
prerank,positive regulation of protein modification process (GO:0031401),0.2799908051979229,0.8060612436006752,0.8836509528585758,0.9747203914310901,1.0,37/203,19.33%,FGF18;NIBAN1;FGF7;EGFR;EFNA5;TMEM119;NPTN;ITGB3;VEGFA;PDE8A;FGF2;AXIN1;GAS6;FLCN;UBE2N;MUSK;HDAC3;CAMKK2;KRAS;AKT1;GPNMB;CALM2;PIN1;CCND1;NSMF;WDFY2;HSP90AA1;CHP1;HGF;FXR2;CHRNA7;PPIA;PLAUR;ILK;SMPD1;THPO;CLIP3
prerank,ceramide metabolic process (GO:0006672),0.30719063157858256,0.8057725899470581,0.7699890470974808,0.9747733921681101,1.0,8/49,12.38%,CERS6;PLPP3;PLPP1;ORMDL2;AGK;SGMS2;FA2H;CERK
prerank,regulation of transferase activity (GO:0051338),-0.2806698342206483,-0.8049979784340655,0.7339055793991416,0.8936440182929724,1.0,6/17,21.31%,EMP2;FEM1A;ATM;SPTSSB;PARP4;HMBOX1
prerank,Rac protein signal transduction (GO:0016601),0.3589414986134073,0.804902521113463,0.727509778357236,0.9757349365143998,1.0,7/18,25.59%,WASF1;FARP2;HACD3;HACE1;TIAM1;RAC1;CYFIP1
prerank,actin filament organization (GO:0007015),0.2818721604350966,0.8046758212980715,0.8617886178861789,0.9756692675193346,1.0,32/151,20.71%,DBN1;GSN;SCIN;TLE6;CDC42EP2;COBL;SVIL;SPTA1;MARCKS;MYO1A;GAS2L1;MYO5A;ABI1;MCU;EFS;AVIL;RHOA;FHOD3;TRIOBP;TMOD2;RND3;PLS1;RAC3;CORO7;PPP1R9B;TPM4;ALDOA;RFLNA;FLNA;SAMD14;SHROOM3;CORO1C
prerank,regulation of interleukin-13 production (GO:0032656),0.37651151104093156,0.8041278222801621,0.7440318302387268,0.9761325899235223,1.0,5/13,24.85%,IRF4;IL4;IL18;PRKCZ;RARA
prerank,positive regulation of insulin secretion (GO:0032024),0.31618483399274083,0.8039965158668051,0.7479861910241657,0.9759317293742882,1.0,13/36,26.38%,TCF7L2;MCU;STX4;IRS2;ADCY8;TRH;GLUD1;CAPN10;PPP3CB;GPLD1;TM7SF3;BAIAP3;CFTR
prerank,maintenance of protein location in nucleus (GO:0051457),0.3468282310749633,0.8038176112533996,0.7316176470588235,0.9757944087299276,1.0,6/20,16.87%,TAF8;SYNE1;TAF3;BCL3;BBS4;PML
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.36487827537848294,0.8038115976308579,0.7412868632707775,0.975386038584832,1.0,4/16,13.22%,INPP5F;PARP14;PIBF1;BCL3
prerank,mesenchyme morphogenesis (GO:0072132),0.3598854548554049,0.8035728739366683,0.7335058214747736,0.975336383737375,1.0,3/17,6.76%,TGFB2;ACVR1;MDM4
prerank,transcription by RNA polymerase I (GO:0006360),0.3198214949806561,0.803460225740024,0.7526132404181185,0.9750964960164622,1.0,10/34,23.85%,POLR2H;GTF2H3;POLR1G;UBTF;ERCC3;CCNH;POLR1C;RRN3;TBP;POLR1B
prerank,T cell receptor signaling pathway (GO:0050852),0.2836735122545509,0.8034049391158602,0.8575757575757575,0.9747720524763807,1.0,40/138,28.72%,PRAM1;PSMC4;FYN;RFTN1;PIK3R2;PTPRJ;CSK;PSMC6;RC3H1;UBE2N;PRKD2;CHUK;PIK3CA;PSMD8;FYB2;PDE4D;ZC3H12A;MOG;BTN3A3;RBCK1;NCK1;VTCN1;CARD11;EIF2B1;TAB2;RC3H2;FBXW11;MAP3K7;RELA;PSMD3;PSMD4;EIF2B2;PSMB3;RNF31;PAK3;BCL10;PSMB2;NFKB1;PSMD5;CUL1
prerank,myeloid dendritic cell activation (GO:0001773),0.3850521453639575,0.8030760051636268,0.713125845737483,0.9748624145894254,1.0,3/12,20.96%,TGFBR2;IL4;PYCARD
prerank,lamellipodium assembly (GO:0030032),-0.2539992665406859,-0.8028809182270589,0.825503355704698,0.8958033755742122,1.0,6/26,12.39%,PARVB;KIT;S1PR1;PTPRO;CDH13;ARHGEF4
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.3450929740284653,0.8027495143363851,0.7253433208489388,0.9749159326343388,1.0,4/21,11.08%,ADAM9;ADAM19;PSEN1;SPPL2B
prerank,negative regulation of cellular catabolic process (GO:0031330),0.30311920451207586,0.8021990223124839,0.7796976241900648,0.975366650638701,1.0,17/63,23.84%,TIMP2;FOXK2;MTOR;IL10RA;SIRT2;AKT1;BMF;NUPR1;HGF;DAP;MCL1;GPLD1;PTPN3;TAB2;KLHL22;EIF4G3;LEPR
prerank,ion transport (GO:0006811),0.2875419665567143,0.8020676627322513,0.8307692307692308,0.9751644091722906,1.0,22/111,17.16%,PIEZO2;SLC1A7;ATP1A4;SLC26A11;SLC1A6;SLC9A9;SLC12A4;SLC17A5;CNGB1;HCN4;SLC26A6;VDAC2;SLC9A1;SLC12A5;SLC8A2;SLC15A4;VDAC1;SLC9A7;SLC9A6;SLC20A1;SLC26A1;CHRNA7
prerank,response to muramyl dipeptide (GO:0032495),-0.3087443230287401,-0.801940719392688,0.6964285714285714,0.8959774716199043,1.0,4/12,24.87%,NOD1;NOD2;ERBIN;RIPK2
prerank,kinetochore organization (GO:0051383),0.3740178473088149,0.8018144786590047,0.7150610583446404,0.9751599683869354,1.0,3/13,18.82%,CENPT;CENPC;CENPE
prerank,protein localization to membrane (GO:0072657),0.27870637435146506,0.8015930669195392,0.874749498997996,0.9750899581531265,1.0,50/187,24.39%,LRP6;TTC7A;TSPAN17;PKP3;PRAM1;RAB32;ANK2;FGF13;S100A10;RFTN1;DLG4;PLEKHF1;DLG2;MYADM;AP3D1;MYO5A;GAS6;PACS2;CD81;EHD2;INPP5K;FYB2;RAB3D;MAGI2;JUP;ZDHHC2;HPS6;PIGW;FRMPD1;ANK1;SPTBN1;AP4M1;FLOT2;SYNJ2BP;RAB40C;TMED2;FLNA;CLASP2;RAB10;ABHD17A;SMURF1;SPTBN4;KCNIP4;FLOT1;SYNE3;PICK1;TTC7B;DVL1;RAB12;MRAP2
prerank,sensory organ development (GO:0007423),0.30273176636892146,0.8015361760072389,0.7680525164113785,0.9747594750055047,1.0,7/51,9.83%,SIX4;ZDHHC16;TGFB2;PBX1;MEIS2;ECE1;ADAMTS18
prerank,regulation of myoblast differentiation (GO:0045661),0.3234559327456855,0.8015094632162699,0.7604290822407628,0.9743909512105535,1.0,6/32,8.12%,MAPK14;ZFP36L1;AKIRIN1;TRIP4;BOC;SOX8
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.2873921972170544,0.801441247775006,0.8376156217882836,0.9740812281390078,1.0,20/107,19.15%,CCL8;NPTN;ANK2;TNNI3;SLC39A13;SLC39A14;ATP2B4;SLC39A7;ATP13A1;SLC30A9;CCL13;ATP2A2;SLC8A2;STC1;TMEM165;SLC30A5;CHRNA7;ATP2B1;HTR2C;STIM1
prerank,central nervous system myelination (GO:0022010),0.3872083176392803,0.8013994934935696,0.7136871508379888,0.9737223629327039,1.0,6/11,28.07%,SOX10;PLP1;PTEN;CNTNAP1;B4GALT5;MYRF
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.3569986181055101,0.8007468054181688,0.7459893048128342,0.9742876984272787,1.0,5/17,25.59%,WASF1;ARF1;GMFB;PICK1;CYFIP1
prerank,cellular response to alcohol (GO:0097306),0.31331184838017584,0.8004515234508209,0.7677345537757437,0.9743276583529732,1.0,10/42,19.54%,LRP6;GRAMD1A;JUP;LARP1;ADCY8;ADAM15;GNB1;SPIDR;BLM;GPLD1
prerank,regulation of heart contraction (GO:0008016),0.2914106171261464,0.800425081116237,0.7863157894736842,0.9739514642146231,1.0,17/90,14.04%,ANK2;TGFB2;SRI;ATP1A3;ATP1A4;ATP1A1;ATP2B4;CAMK2D;TNNI3K;HCN4;CELF2;PDE4D;CALM2;TMEM65;ATP2A2;SLC8A2;CASQ1
prerank,photoreceptor cell development (GO:0042461),0.3725177936248061,0.8002237707063519,0.750332005312085,0.9738735724550325,1.0,6/14,31.50%,VEGFA;AHI1;DCX;TOPORS;TULP1;RORB
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.3492628361889776,0.8001700520493051,0.7324120603015075,0.9735365082573947,1.0,3/19,15.94%,CARD16;ZC3H12A;NLRP2B
prerank,secondary alcohol biosynthetic process (GO:1902653),0.328452550376927,0.8000748202093664,0.7409144196951934,0.9732637930872636,1.0,4/30,9.30%,ACLY;MVK;INSIG2;GGPS1
prerank,regulation of T cell chemotaxis (GO:0010819),-0.3184370861876693,-0.7999629402031946,0.7306122448979592,0.8978986237368017,1.0,2/11,3.31%,ADAM10;WNT5A
prerank,plasma membrane tubulation (GO:0097320),-0.2920199117470996,-0.7996281263761804,0.7297297297297297,0.8969916460725161,1.0,2/13,3.88%,FNBP1L;CAVIN2
prerank,positive regulation of blood coagulation (GO:0030194),-0.27890298270352903,-0.799292255573003,0.75,0.8960911236615998,1.0,5/17,15.76%,F3;THBS1;ENPP4;USF1;SERPINE1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.313088034969438,-0.7984952381842679,0.7312925170068028,0.8961179773874315,1.0,4/11,17.70%,GRK3;GTF2H2;ADM;ADRB2
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.28195135585627906,0.7984605308916213,0.8498985801217038,0.9752760939746062,1.0,45/149,29.06%,AR;RAB7B;IRAK3;S100A8;S100A9;MID2;CARD16;DHX33;UBE2N;PRKD2;CHUK;TIRAP;TLR4;NPM1;IRAK1;UBA52;FER;EDA;TRIM68;RBCK1;IL6;FLOT2;PPIA;IL18;CARD11;PYCARD;TAB2;TERF2IP;ROR1;FLOT1;MAP3K7;TRAF5;TRIM8;RELA;PRKCZ;TICAM1;RNF31;RHEBL1;BCL10;NFKB1;EDA2R;PRKCI;RPS6KA5;ZBTB7A;MYD88
prerank,regulation of nervous system process (GO:0031644),0.35349313391426346,0.7980025855706716,0.7277167277167277,0.9755625443214941,1.0,9/18,25.88%,DLGAP4;DLGAP3;SLC8A2;DLGAP1;CHRNA7;AKAP9;HTR2C;NPTX1;BEGAIN
prerank,regulation of aerobic respiration (GO:1903715),-0.28861992531757547,-0.7978499913934982,0.7829787234042553,0.8958286661303256,1.0,4/15,15.35%,CBFA2T3;PINK1;UQCC2;AK4
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.38006967287521154,0.7976384455119074,0.7298772169167803,0.9757146357857781,1.0,7/12,34.09%,SGTA;SEC63;SEC61A1;SEC61B;CHMP4A;CHMP4B;HSPA5
prerank,piRNA metabolic process (GO:0034587),-0.2637801360895437,-0.7975741058463531,0.805,0.8948660536047027,1.0,17/19,50.43%,TDRKH;EXD1;MYBL1;PIWIL2;TDRD9;TDRD12;PIWIL4;FKBP6;MAEL;MOV10L1;HENMT1;ASZ1;GPAT2;BTBD18;TDRD1;PIWIL1;PLD6
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.23415967754264497,-0.7971011567092504,0.7866666666666666,0.8942215422926946,1.0,7/29,13.17%,WNT5A;MAVS;CNOT7;USP18;PTPN1;PTPN2;RNASEL
prerank,cellular response to nutrient levels (GO:0031669),0.29636067962059864,0.7970670166188288,0.7956989247311828,0.9761531668917944,1.0,12/62,14.37%,MTOR;FOXO1;GAS2L1;FLCN;WIPI2;USP33;WDR45B;RRAGD;ULK1;EHMT2;FADS1;STK24
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.32837300630043875,0.7970339371453649,0.7378277153558053,0.9757836201292919,1.0,3/25,6.20%,ANK2;F2R;CXCL10
prerank,steroid metabolic process (GO:0008202),0.296646800039741,0.7970135850402412,0.7970557308096741,0.9754033258084825,1.0,7/72,11.50%,DHRS9;DHRS4;CYP27B1;VDR;SCP2;SRD5A1;GBA2
prerank,regulation of protein autophosphorylation (GO:0031952),0.3175030600925552,0.7970065979141829,0.7744533947065593,0.9750008329590085,1.0,10/36,17.41%,VEGFA;RASSF2;GPNMB;CALM2;TAOK2;NBN;TNKS1BP1;CHP1;PPP2R5B;RAD50
prerank,response to UV-B (GO:0010224),0.3814982459407563,0.7961936250003241,0.7374830852503383,0.9757778060133314,1.0,2/12,13.16%,CRIP1;CDKN1A
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.3077641075122303,0.7961285881494399,0.7776497695852534,0.9754593611287884,1.0,9/43,17.38%,IRS1;GRB10;TNS2;PID1;INPP5K;KANK1;NCK1;OGT;PIP4K2C
prerank,embryonic heart tube development (GO:0035050),0.3674309308026511,0.7957404593734133,0.7223719676549866,0.9756139096061738,1.0,2/14,8.17%,ACVR1;NDRG4
prerank,nuclear migration (GO:0007097),0.377053223651378,0.7955833791128231,0.7391891891891892,0.9754331453590548,1.0,8/13,23.24%,DCTN1;DOCK7;DYNC1H1;PAFAH1B1;PCM1;TMEM201;FBXW11;SYNE3
prerank,intracellular sterol transport (GO:0032366),0.376099584099546,0.7955533147064403,0.7317744154057771,0.975071120929278,1.0,2/13,7.00%,OSBPL2;ABCA1
prerank,oligosaccharide metabolic process (GO:0009311),0.3072775520183292,0.7954881397471876,0.7880133185349611,0.9747571860079338,1.0,7/46,12.06%,ST3GAL2;B4GALT1;FUT2;GAL3ST3;FUT9;ST3GAL4;GLA
prerank,positive regulation of cytokinesis (GO:0032467),0.3211770466388383,0.7952953901533886,0.7434679334916865,0.9746394719555725,1.0,6/32,15.08%,CDC14B;SVIL;CUL3;KIF20B;RHOA;GIPC1
prerank,cellular component maintenance (GO:0043954),-0.31589675009579277,-0.7944873057145257,0.7480314960629921,0.8970789834531785,1.0,3/12,4.00%,INSR;IGF1R;ITGA3
prerank,neuromuscular synaptic transmission (GO:0007274),-0.2679738559985973,-0.7943321069941403,0.7836538461538461,0.89590475468362,1.0,4/18,13.17%,DTNA;TBC1D24;FCHSD2;SLC5A7
prerank,positive regulation of myelination (GO:0031643),-0.30794891526376755,-0.7941267498794885,0.7272727272727273,0.8948268395823538,1.0,2/11,7.91%,TENM4;TPPP
prerank,response to amino acid starvation (GO:1990928),0.2931637232431865,0.7940020238350091,0.8151260504201681,0.9761884185230844,1.0,19/72,23.20%,EIF2AK3;MTOR;FLCN;CEBPB;ATP6V1E1;SESN3;LARP1;CDKN1A;RRAGD;EIF2S1;ATP6V1D;ATP6V1B2;DAP;CASTOR2;MAPK1;SESN2;ATF4;SLC38A9;ATP6V0B
prerank,regulation of G0 to G1 transition (GO:0070316),0.3141524709315354,0.7937335843087452,0.7680995475113123,0.9761668735128974,1.0,12/38,22.14%,RNF2;RHNO1;RYBP;PHC3;PHC1;EHMT2;UXT;APAF1;RING1;PCGF6;FOXO4;EZH2
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.3617194046583616,0.7937321964062466,0.7463087248322148,0.97575718986251,1.0,3/15,12.14%,IRS1;AKT1;IRS2
prerank,regulation of protein targeting to membrane (GO:0090313),0.3243451313377341,0.7935663701051014,0.7565947242206235,0.9756070564377803,1.0,12/28,30.42%,FYN;MIEF2;INPP5K;GDI1;CHP1;ITGAM;FIS1;DMTN;MTCL1;PRNP;MYO1C;AKT2
prerank,lymphocyte proliferation (GO:0046651),0.3403590918577726,0.7928388399053888,0.7290400972053463,0.9762966697868644,1.0,6/22,21.27%,ELF4;FLT3;CR2;LMBR1L;PPP3CB;PIK3CG
prerank,cellular metal ion homeostasis (GO:0006875),0.28486257439117535,0.7923631201729616,0.8343815513626834,0.9765854125467274,1.0,10/102,5.51%,CCL8;KCNMA1;NPTN;ANK2;TNNI3;ATP1A3;ATP1A4;ATP1A1;ATP2B4;KCNJ2
prerank,regulation of TORC1 signaling (GO:1903432),0.3203295364234524,0.7923553467881398,0.7741935483870968,0.9761847890562602,1.0,10/33,22.86%,DGKQ;FLCN;SESN3;SMCR8;RRAGD;PIP4P1;GPR137B;CASTOR2;SESN2;KLHL22
prerank,histone H2A monoubiquitination (GO:0035518),0.3545548624499775,0.7916479604461857,0.7434895833333334,0.9768057510152178,1.0,7/17,24.89%,RNF2;RYBP;DDB1;RING1;PCGF6;KDM2B;PCGF3
prerank,phosphorylation (GO:0016310),0.27085438155100694,0.7913845234329813,0.947,0.976776282989137,1.0,52/385,12.80%,SYK;EPHB2;DCLK1;PRKCA;TNK1;FGFR1;STK25;EIF2AK3;CDKL2;FYN;DGKQ;IRAK3;SGK3;SGK2;TGFB2;LMTK3;CDK14;TGFBR2;TAOK3;ACVR1;CDK4;MTOR;CAMK2D;CSK;RET;TBCK;GAS6;GK5;STRADA;PRKD2;TNNI3K;CHUK;PIK3CA;TESK2;CDK9;CDK20;AGK;AKT3;BMP2K;NRBP2;ERN1;DYRK2;AMHR2;CAMKK2;AKT1;MAP3K6;IRAK1;PASK;STK39;CERK;PXK;TAOK2
prerank,protein kinase A signaling (GO:0010737),-0.2975429922547441,-0.7911462813163241,0.7170542635658915,0.8982731723185524,1.0,4/12,26.26%,MYOM1;PRKACB;LCP1;TTN
prerank,regulation of type I interferon production (GO:0032479),0.28470615767075885,0.7907438858861866,0.7896373056994819,0.9772932173442841,1.0,28/84,29.06%,POLR2H;ITCH;CGAS;DHX33;POLR3E;TIRAP;POLR3D;IRAK1;XRCC5;PIN1;CD14;RNF216;ILRUN;TRAF3;TAX1BP1;POLR3H;POLR1C;POLR3A;CYLD;RELA;G3BP1;UBA7;UFD1;PRKDC;NPLOC4;NFKB1;XRCC6;MYD88
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.3563040973747247,0.7905039251284978,0.7455012853470437,0.977248940733825,1.0,6/16,23.07%,SIRPA;ZC3H12A;PDCD4;PYCARD;CUEDC2;CHID1
prerank,negative regulation of viral process (GO:0048525),0.2944027205706534,0.7904695540728406,0.7731733914940022,0.976895184149134,1.0,17/57,24.78%,MID2;TRIM11;ZC3HAV1;SLPI;TNIP1;ZFP36;FAM111A;UBP1;PML;PPIA;MBL2;TRIM35;BTBD17;SRPK1;LARP7;TRIM8;HEXIM1
prerank,cellular response to amyloid-beta (GO:1904646),0.31696304027554534,0.7898466668570271,0.7549361207897793,0.977458517651471,1.0,9/35,17.99%,LRP1;FYN;ATP1A3;PSEN1;TLR4;ABCC1;CACNB1;GRIN2A;SNX6
prerank,ribosomal large subunit biogenesis (GO:0042273),0.2964420579654435,0.789802635192763,0.7962347729789591,0.9771236386108402,1.0,16/54,24.19%,SDAD1;NOC2L;NPM1;RPL10A;EIF6;SNU13;RSL1D1;RPL6;NOP53;RPF2;EBNA1BP2;MAK16;NOP2;RSL24D1;BRIX1;LTO1
prerank,regulation of inclusion body assembly (GO:0090083),-0.30729855545489326,-0.7897978069084132,0.778169014084507,0.898971350736263,1.0,1/11,0.83%,SNCAIP
prerank,adherens junction organization (GO:0034332),0.30195457810401405,0.7888203956530888,0.77,0.9781330593706572,1.0,7/48,12.08%,CADM3;ANG;NECTIN3;CSK;JAM3;CDH22;JUP
prerank,protein kinase B signaling (GO:0043491),0.33335594109302324,0.7881493878731396,0.7566585956416465,0.9787065226365885,1.0,8/23,25.32%,ZFP36L1;GAS6;SIRT2;AKT1;TYRO3;PTEN;TSC2;PAX2
prerank,regulation of ATP biosynthetic process (GO:2001169),0.3587125356046467,0.7876661776689703,0.7638326585695007,0.9789900927132036,1.0,4/16,14.82%,PID1;FLCN;ANTKMT;IL4
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.2915537029197001,0.7875092782570011,0.8181818181818182,0.9788050470307227,1.0,6/69,5.07%,TGFB3;SIX4;F2R;ZPR1;CLCF1;NFATC4
prerank,heart looping (GO:0001947),0.30324048852693836,0.7874006365563758,0.7806524184476941,0.9785529254925022,1.0,9/39,18.90%,TGFBR2;TBX6;PKD2;NDRG4;MICAL2;VANGL2;BBS4;AHI1;BBS5
prerank,"phagocytosis, engulfment (GO:0006911)",0.3096793717281743,0.7873518239724153,0.7720329024676851,0.9782095221030593,1.0,1/36,0.45%,GSN
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.28768452599497785,0.7869881567044414,0.832810867293626,0.9783609055348041,1.0,11/76,18.41%,ESR1;PLCE1;F2R;LPAR1;GPR20;CALCA;LHCGR;GRM1;CXCR2;TRHR;HTR2C
prerank,negative regulation of ion transport (GO:0043271),-0.25253748382443153,-0.7869235466182778,0.79,0.9021717942129391,1.0,9/24,21.36%,ACTN2;WNK4;SNCA;ADRA2A;NOS1;GPM6B;HTR1B;CASQ2;PLN
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.29044585768525627,-0.7863679637115266,0.7538461538461538,0.9017000574438878,1.0,3/13,9.43%,PTPN1;DNAJB9;PPP1R15B
prerank,positive regulation of cell motility (GO:2000147),0.2741294593098195,0.7862099590681735,0.9067201604814443,0.9790655129177436,1.0,28/205,14.82%,SEMA3C;HAS2;MYOC;EPHB2;DUOX1;COL1A1;PRKCA;EGFR;VEGFA;F2R;ADAM9;ACVR1;MYADM;RET;NTN1;SEMA3A;STX4;MAPRE1;GPNMB;SEMA3D;CCDC25;EGF;MGAT5;TWIST1;PDGFRA;FER;PPP3CA;IL4
prerank,amyloid fibril formation (GO:1990000),0.2995587819652862,0.786102831594087,0.7893569844789357,0.9787951042668283,1.0,10/51,14.77%,GSN;TGFBI;SIAH1;GGA1;CALCA;MAPT;NAT8;UBA52;HSPG2;GGA2
prerank,positive regulation of interferon-alpha production (GO:0032727),0.3381830462136437,0.7859737009892815,0.7414448669201521,0.978571803446266,1.0,3/19,11.81%,CHUK;TLR4;SETD2
prerank,mismatch repair (GO:0006298),-0.2404081332637835,-0.7857591632070091,0.7967032967032966,0.9012545314375503,1.0,12/27,25.85%,MCM9;MSH3;XPC;PCNA;ABL1;TDG;MSH2;POLD2;RPA2;MLH3;MUTYH;POLD4
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.27893394269612903,0.7851510297873482,0.8639593908629442,0.979353412301698,1.0,20/118,13.54%,PHLDB1;ARHGAP44;EFNA5;SPARC;FGF2;PPFIA2;ZRANB1;RC3H1;PID1;LARP4;SRCIN1;HECW2;EPHB3;CAMSAP1;BCL6;MAPT;GPNMB;TANC2;GDNF;NSMF
prerank,establishment of vesicle localization (GO:0051650),0.34740821535587807,0.785013845436712,0.7845953002610966,0.979151871340228,1.0,4/18,16.18%,SYT11;TOR1A;CCDC186;SNAPIN
prerank,regulation of anoikis (GO:2000209),0.342962294825622,0.7847988830362346,0.7411616161616161,0.9790598883715718,1.0,6/19,19.35%,ITGA5;SRC;PIK3CA;SNAI2;PTRH2;MCL1
prerank,stem cell differentiation (GO:0048863),0.3101527372975519,0.7847653373911369,0.7740112994350282,0.9787061196570158,1.0,8/39,18.29%,LRP6;TGFB2;EEF1AKMT4-ECE2;PUM1;SETD2;LMBR1L;UFL1;GPM6A
prerank,lipid catabolic process (GO:0016042),0.3490394885682748,0.7845781590594566,0.7503152585119798,0.9785772933791274,1.0,4/18,18.64%,CEL;SIRT2;LIPC;LIPH
prerank,myotube cell development (GO:0014904),0.3855303245288502,0.7844065056770159,0.7503526093088858,0.97843002931997,1.0,4/10,23.89%,SKI;SIX1;SELENON;MYORG
prerank,pharyngeal system development (GO:0060037),0.35416085438657496,0.7843549159526981,0.7530529172320217,0.9780930828094988,1.0,2/15,2.91%,SIX4;TGFB2
prerank,negative regulation of stem cell differentiation (GO:2000737),0.37428048520186225,0.7838566814976166,0.7604456824512534,0.9783968926105643,1.0,3/12,17.49%,ZFP36L2;JAG1;YTHDF2
prerank,visual system development (GO:0150063),0.30906305257716277,0.7838419031015335,0.7740440324449595,0.9780099087138817,1.0,5/37,9.83%,ZDHHC16;TGFB2;PBX1;MEIS2;ADAMTS18
prerank,UV-damage excision repair (GO:0070914),0.36882665413071103,0.7835712417403627,0.7372764786795049,0.9780096277461229,1.0,4/12,22.85%,ACTR5;DDB1;INO80;ERCC1
prerank,DNA conformation change (GO:0071103),-0.27007790222273986,-0.7832629343676837,0.7866666666666666,0.9036828052955918,1.0,7/17,25.52%,HMGB1;ABL1;HHEX;TOP1MT;NAA10;TOP2A;TOP3B
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.3097890604550323,0.7831192097342093,0.7951945080091534,0.9782768857403571,1.0,11/40,21.65%,PID1;PIP5KL1;AKT1;MAPT;NDUFS1;BAK1;TUSC2;SLC25A36;PYCR1;PRELID1;SLC25A33
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.3447466784742592,0.7829317679822303,0.7686375321336761,0.9781566544632061,1.0,12/20,33.75%,ADAM9;PSEN1;SPPL2B;RELA;MBTPS1;NFKB1;HM13;ADAM17;TRAF6;PSENEN;SPPL2A;NCSTN
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.2840699965518032,0.7828802591867235,0.8371848739495799,0.9778194535267739,1.0,9/86,8.57%,PSMC4;MAPK7;VEGFA;NFE2L2;KLF2;MUC1;PSMC6;EGLN2;PSMD8
prerank,heterocycle biosynthetic process (GO:0018130),0.36888148459857995,0.7824972365420317,0.7352537722908093,0.9780012735573627,1.0,8/14,35.05%,NFS1;PYCR1;MOCS1;NOXRED1;PYCR3;MOCS2;LIAS;MOCS3
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.35960025124963835,0.7823054267281221,0.7154255319148937,0.9778652399803699,1.0,6/14,27.78%,PPP5C;PPP3CA;NCK1;PPP2R2A;DUSP1;PPP2R2D
prerank,positive regulation of chromosome organization (GO:2001252),0.35924844917489895,0.7818688536938079,0.7715803452855245,0.9780850311645146,1.0,4/15,17.41%,DDX11;NBN;PML;RAD50
prerank,lipid homeostasis (GO:0055088),0.2952463433024406,0.7818517529753235,0.7966850828729282,0.9777046748449907,1.0,12/57,18.77%,NR1D2;TLCD2;RCN3;MLXIPL;ABCA1;ORMDL2;PNPLA8;IRS2;THADA;ACOX1;POLD1;ANGPTL3
prerank,tryptophan metabolic process (GO:0006568),-0.3064465507501098,-0.7816203129053568,0.7448275862068966,0.9048855415435224,1.0,11/11,69.38%,KYNU;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD;ATP7A;KYAT1;KMO
prerank,DNA methylation (GO:0006306),0.32955477064549316,0.781373306150233,0.7597087378640777,0.9779752964765439,1.0,11/23,29.85%,SPOCD1;EHMT2;DMAP1;N6AMT1;BAZ2A;GATAD2A;PICK1;MTRR;ATF7IP;ATRX;FOS
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.28139390794976554,0.7797303800735446,0.8391752577319588,0.9799474653342263,1.0,12/86,9.59%,TGFB3;TGFB2;SMAD4;ACVR1;BMP15;NUP93;SH2B1;RNF111;INHA;SULF1;FLCN;BMP8A
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.28613882836781124,-0.7794360396768688,0.7142857142857143,0.9068695652939153,1.0,9/13,46.22%,NECTIN2;CYRIB;FADD;IL12A;IL12RB1;IL23A;IL23R;IL12B;XCL1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.33931982404555894,0.7792875827152769,0.755,0.9801964943934399,1.0,9/19,29.02%,PTPRJ;STIMATE;BCAP31;FIS1;DMTN;GRM5;PTGFR;FKBP1B;PRNP
prerank,positive regulation of calcium ion transport (GO:0051928),0.3102717930490824,0.7791675230006675,0.7822120866590649,0.979962933329149,1.0,3/36,4.28%,ANK2;F2R;P2RX3
prerank,sarcomere organization (GO:0045214),0.31924067475438633,0.7782667660343571,0.7577565632458234,0.9808272971554449,1.0,4/27,14.04%,SIX4;CSRP2;FHOD3;CASQ1
prerank,determination of heart left/right asymmetry (GO:0061371),0.29582457078140534,0.777931318878025,0.7947019867549668,0.9809103220895055,1.0,9/42,18.90%,TGFBR2;TBX6;PKD2;NDRG4;MICAL2;VANGL2;BBS4;AHI1;BBS5
prerank,response to hexose (GO:0009746),0.32750810868767966,0.777677538288828,0.7832929782082324,0.9808668293980001,1.0,6/25,19.82%,TCF7L2;IRS2;SELENOS;VAMP2;GPLD1;EIF2B1
prerank,ear morphogenesis (GO:0042471),0.3389693011277305,0.7775732931581346,0.7842639593908629,0.9806029779456605,1.0,1/20,0.46%,EPHB2
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.33474303927771604,0.7773221741130968,0.7560355781448539,0.9805500520561459,1.0,6/20,23.47%,AMPD2;PAICS;GART;ATIC;ADSS2;LHPP
prerank,cellular response to zinc ion (GO:0071294),-0.2736861932567339,-0.7773108458464641,0.7763713080168776,0.9087121870483679,1.0,15/15,72.66%,MT3;HVCN1;MT2A;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;ATP13A2;GLRA1;GLRA2;P2RX4
prerank,cholesterol biosynthetic process (GO:0006695),0.3173814276210816,0.7769366856854169,0.7834691501746216,0.9806778163584233,1.0,4/31,9.30%,ACLY;MVK;INSIG2;GGPS1
prerank,regulation of response to interferon-gamma (GO:0060330),-0.2771848317428428,-0.7764724835401633,0.7725321888412017,0.9086243033469599,1.0,14/14,72.31%,STAT1;PTPN2;PIAS1;PARP9;SOCS1;IFNGR2;JAK1;IFNG;HSP90AB1;CDC37;SUMO1;SOCS3;JAK2;IFNGR1
prerank,protein localization to mitochondrion (GO:0070585),0.37507428367141593,0.7763186122495663,0.7635327635327636,0.9811442478619565,1.0,5/11,27.79%,AKT1;MTCH2;RALA;COX18;DNAJA1
prerank,response to ethanol (GO:0045471),0.36467643335989786,0.7762627036596313,0.7733516483516484,0.9808196191407272,1.0,4/14,30.12%,GRIN3A;GRIN2A;GOT2;GLRA2
prerank,chloride transport (GO:0006821),0.28707452729645955,0.7759440021871845,0.8275499474237644,0.9808724704519143,1.0,12/74,17.36%,SLC4A10;ANO3;SLC4A8;SLC12A8;GABRR3;SLC12A4;SLC26A6;SLC12A5;GABRG3;TTYH3;SLC26A1;ANO5
prerank,positive regulation of hemostasis (GO:1900048),0.3849988176193213,0.7759170998810582,0.7528571428571429,0.9800974071753867,1.0,2/10,11.72%,F2R;ST3GAL4
prerank,positive regulation of coagulation (GO:0050820),0.3849988176193213,0.7759170998810582,0.7528571428571429,0.9800974071753867,1.0,2/10,11.72%,F2R;ST3GAL4
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.2745702466591845,0.7755358175653655,0.9076142131979695,0.9801951418007032,1.0,28/151,17.79%,CERS6;ST3GAL2;PCSK5;GPAT4;PLPP3;ALDH3A2;INHA;PLPP1;CHKB;PRKD2;SLC44A1;LCAT;SGMS2;LPCAT1;LARGE1;GSTM2;FA2H;ELOVL5;ST3GAL4;TNIP1;PRKD3;NFS1;CEPT1;HACD3;SLC44A2;SLC25A15;GSTO2;PLPP2
prerank,fatty acid biosynthetic process (GO:0006633),0.28897109425501616,0.7750383689156715,0.8399570354457573,0.9804844797146293,1.0,13/63,19.72%,ACLY;TECR;NDUFAB1;ELOVL5;FADS1;HSD17B8;HACD3;FADS3;LIPC;LIPH;ABCD3;MCAT;SCD5
prerank,cognition (GO:0050890),0.29969262536197655,0.7748241582684017,0.7860310421286031,0.9803883783931683,1.0,11/42,18.94%,DGCR2;GPR155;ST3GAL4;SLC8A2;BBS4;LHCGR;SETD5;TTC8;TUSC3;CHRNA7;NIPBL
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.3875729218053001,0.7747742293078514,0.7557980900409277,0.9800574278313011,1.0,1/10,3.40%,SRI
prerank,histone mRNA metabolic process (GO:0008334),-0.23574885671610793,-0.77468996195463,0.8360655737704918,0.9098787027255166,1.0,11/27,21.25%,SSB;TUT1;TUT4;TUT7;SNRPB;ATM;MTPAP;LSM11;SNRPE;SNRPF;LSM10
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.311922961201091,0.7744886987185543,0.7759626604434072,0.9800391945974675,1.0,4/34,6.77%,TNS2;PTPRS;PTPRJ;PTPRF
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.3097713492258818,0.7743431237174933,0.7821100917431193,0.9798319944595325,1.0,2/33,1.34%,EGFR;ANXA1
prerank,regulation of adaptive immune response (GO:0002819),-0.2678986534441995,-0.7742072827231452,0.8157894736842105,0.9092277804417016,1.0,8/18,35.11%,AHR;SIRT1;FCGR2B;IRF7;SKAP1;FADD;IL4I1;SASH3
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.33470272019883335,0.7741367406736503,0.7657430730478589,0.9797200130134868,1.0,7/22,27.44%,SCAF8;TCERG1;THOC1;ELL;KAT7;ALYREF;THOC5
prerank,positive regulation of cell division (GO:0051781),0.3037953914030813,0.7736373817893876,0.776255707762557,0.9800020759383701,1.0,7/38,15.08%,CDC14B;SVIL;CUL3;SIRT2;KIF20B;RHOA;GIPC1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.3090935150552112,0.7733777058627862,0.7794994040524433,0.9799552848277864,1.0,6/32,14.04%,F2R;CXCL10;PKD2;GSTM2;CALM2;CASQ1
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.2550000106059989,-0.7733489038653473,0.8603351955307262,0.9090888602515785,1.0,3/22,9.01%,ALDH1A2;RBP1;CUBN
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.3716616471453498,0.7733476124880929,0.7419354838709677,0.9795883851415751,1.0,7/11,29.44%,MUC1;ING4;RPS27L;TFAP4;KAT5;FOXM1;TP53
prerank,neuromuscular process controlling balance (GO:0050885),0.3743980755849331,0.7732097333046795,0.7647867950481431,0.9793857642725196,1.0,5/12,33.82%,TPP1;PAFAH1B1;NRXN1;PCDH15;SHANK1
prerank,mitochondrial fusion (GO:0008053),0.34078203739545093,0.7731547408545862,0.7756892230576441,0.9790586891413895,1.0,7/18,30.71%,GDAP1;MIEF2;SPG7;FIS1;CHCHD3;BAX;MFN2
prerank,protein K63-linked ubiquitination (GO:0070534),0.30152845022232966,0.7727130421943446,0.7988571428571428,0.9792793511810813,1.0,10/41,18.12%,UBE2B;ITCH;PELI3;STUB1;UBE2N;MAGEL2;TRAF3IP2;TRAF3;UBE2G1;ARIH2
prerank,iron-sulfur cluster assembly (GO:0016226),-0.23704808723057802,-0.772075526961329,0.8369565217391305,0.9096531856961142,1.0,7/24,16.28%,NUBPL;HSPA9;CIAO1;NFU1;ISCU;GLRX3;NDOR1
prerank,detection of calcium ion (GO:0005513),0.3613232301705799,0.7717400638380869,0.7400820793433652,0.9802445626036621,1.0,7/13,31.13%,CALM2;SYT1;STIM1;KCNIP2;KCNMB2;KCNMB3;CALM1
prerank,negative regulation of transmembrane transport (GO:0034763),0.38297447681288344,0.7710512350214886,0.765625,0.9807943580879072,1.0,3/10,12.14%,INPP5K;AKT1;IRS2
prerank,AMP metabolic process (GO:0046033),0.35973755028747517,0.7708606094878951,0.7557046979865771,0.9806431683873662,1.0,1/13,2.31%,AMPD2
prerank,ncRNA export from nucleus (GO:0097064),0.3112450959430626,0.7707261719024,0.7981220657276995,0.980428731198292,1.0,19/36,34.13%,NUP93;NUP107;NUP98;NPM1;NUP37;NUP50;XPOT;TPR;NUP133;NUP85;NUP188;NUP88;TSC1;SEC13;AAAS;NUP160;NCBP2;NUP54;RANBP2
prerank,regulation of mitotic cell cycle (GO:0007346),0.2699398829546028,0.7705756079618712,0.8956870611835507,0.9802409949060115,1.0,53/171,30.16%,PRKCA;PSMC4;GAS1;CKS1B;SMOC2;CCDC8;TTC28;MEIS2;PSMC6;PSMD8;CDK9;IQGAP1;CDC23;ANAPC5;KIF20B;FBXO5;ERCC3;PIN1;DDB1;CDC27;CUL9;USP22;TFAP4;TTL;CDC26;ANAPC4;NEK7;TRIM35;PTPN3;ANAPC10;BTG1;ANAPC15;SDCBP;CYLD;CDC25B;PSMD3;PSMD4;MDM2;BTG3;CKS2;RNF20;PSMB3;ANAPC2;GBF1;CUL7;PSMB2;PSMD5;THAP1;CUL1;BRINP2;SRA1;HSF1;PSMD14
prerank,neuron maturation (GO:0042551),-0.2638768404447441,-0.7699542426551743,0.8146551724137931,0.9114260178573605,1.0,9/18,23.13%,APP;EPHA8;ANKS1A;CX3CL1;C1QA;C3;CLN5;SCARF1;ACTL6B
prerank,purine ribonucleotide transport (GO:0015868),0.35124110373354067,0.7696393595457222,0.7547945205479452,0.9810898693011502,1.0,3/16,14.88%,LRRC8D;SLC25A4;SLC25A17
prerank,negative regulation of GTPase activity (GO:0034260),-0.2515714762288043,-0.7691573964308632,0.8186528497409327,0.9112530980478529,1.0,5/22,10.29%,F11R;DAB2IP;LRCH1;CPEB2;ARL2
prerank,SNARE complex assembly (GO:0035493),-0.31401688732255884,-0.7683975059143419,0.7574850299401198,0.9110859103873463,1.0,2/10,3.47%,SNCA;UVRAG
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.25623722509091046,-0.7679289303332756,0.7655502392344498,0.9104217360565863,1.0,10/18,37.76%,PLCB1;AGRN;OPRM1;RGS10;CDK5R1;CHRM1;GNA15;GNA11;HRH3;CHRM5
prerank,histone H4-K8 acetylation (GO:0043982),0.3483870557740437,0.7671308398012345,0.76953125,0.9837523493979733,1.0,4/15,16.37%,ING4;WDR5;KANSL3;OGT
prerank,histone H4-K5 acetylation (GO:0043981),0.3483870557740437,0.7671308398012345,0.76953125,0.9837523493979733,1.0,4/15,16.37%,ING4;WDR5;KANSL3;OGT
prerank,protein localization to synapse (GO:0035418),0.368715824700843,0.7667529327552721,0.7456724367509987,0.9838351089659639,1.0,7/12,33.82%,DLG4;NLGN1;ZDHHC15;NRXN1;NLGN2;NRXN2;SHANK1
prerank,epithelial to mesenchymal transition (GO:0001837),0.2930004574584846,0.7666999840678473,0.8115942028985508,0.9835017603364891,1.0,4/47,3.94%,LOXL2;FGFR1;TGFB2;AKNA
prerank,axoneme assembly (GO:0035082),0.31128860368515576,0.7664490514614197,0.8028004667444574,0.9834467206744738,1.0,7/30,22.27%,TOGARAM1;RSPH1;TTLL3;DNAAF3;SPAG17;SPAG16;DCX
prerank,Rho protein signal transduction (GO:0007266),0.2884433800595974,0.7664193461394935,0.832408435072142,0.983085377574906,1.0,6/53,9.72%,COL1A2;CDC42EP2;NTN1;ARHGEF3;MYO9B;RHOJ
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.38151582012961066,0.7662195118339101,0.7667597765363129,0.9829741218080205,1.0,5/10,33.73%,CPEB1;PAF1;HSF1;CPEB3;NCBP2
prerank,membrane lipid metabolic process (GO:0006643),0.3276456159029651,0.7661069998358118,0.7879901960784313,0.9827351523483318,1.0,4/22,12.38%,FUT2;TECR;AGK;CERK
prerank,diol metabolic process (GO:0034311),0.33306351365541176,0.7659232398928171,0.7806691449814126,0.9825965287024522,1.0,5/19,17.79%,PLPP3;PLPP1;AKT1;HSP90AA1;PLPP2
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.31145287188140236,0.765691983991919,0.7864768683274022,0.982522262051678,1.0,3/30,5.51%,ANK2;ATP1A1;KCNJ2
prerank,regulation of cellular catabolic process (GO:0031329),0.286268199734639,0.7655119629046859,0.83881230116649,0.9823724122459689,1.0,16/62,17.44%,PIK3R2;USP10;HDAC6;ABL2;WDR91;FBXL2;USP33;MAPT;SMCR8;DRAM1;RRAGD;CISD2;NUPR1;KEAP1;PIP4K2C;GPR137B
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.330301649403028,0.7650277282974233,0.7803680981595092,0.9826476122715546,1.0,3/21,8.08%,FOXP1;PRKD2;CD81
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.3175097532434736,0.764815145829581,0.7705128205128206,0.982546253027042,1.0,4/24,15.83%,SYVN1;CREB3L1;HERPUD1;SELENOS
prerank,acyl-CoA metabolic process (GO:0006637),0.30749144285769814,0.764717730216387,0.8125,0.98227892034842,1.0,4/35,14.25%,GPAT4;ACOT6;ACOT9;ACOT1
prerank,lipid modification (GO:0030258),0.3025745034758703,0.7646886259723695,0.8154897494305239,0.9819240903545609,1.0,6/37,12.78%,DGKQ;PLPP3;PLPP5;PLPP1;MBOAT7;PLPPR3
prerank,macroautophagy (GO:0016236),0.27211034106391685,0.7644417696758775,0.884928716904277,0.9818549952186296,1.0,35/118,25.12%,VPS4B;PRKAB2;MVB12A;VPS37D;SRC;LIX1L;WIPI2;SQSTM1;TMEM74;VPS33A;PGAM5;STX17;EPG5;VPS37C;ULK1;VDAC1;ILRUN;NBR1;VPS37B;ATG13;VPS33B;TOMM5;PIP4K2B;VPS36;ATG16L1;ATG3;VPS39;CSNK2A2;ATG10;UBXN6;ATG14;STAM;DYNLL1;TOMM40;TECPR1
prerank,cellular senescence (GO:0090398),0.3117871702902361,0.7644188905240583,0.7889022919179735,0.981482938895243,1.0,8/27,24.80%,MAPK14;SMC5;CDKN1A;SMC6;PML;ECRG4;NSMCE2;CALR
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.2783557574699865,0.7639925607733012,0.8472958642629904,0.9816545083162691,1.0,18/78,24.78%,EGFR;PKD1;GTPBP4;PSRC1;MAPRE3;PKD2;AKT1;CDKN1A;CCND1;CCNH;TFAP4;IPO5;BLM;PTEN;CDKN2C;LATS1;CCNYL1;HEXIM1
prerank,negative regulation of chemotaxis (GO:0050922),0.31042246496822684,0.7639252855859436,0.8035087719298246,0.9813476300864866,1.0,4/31,12.28%,SEMA3C;SLIT2;SEMA3A;SEMA3D
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.2895930428065238,-0.7637027113950404,0.7587548638132295,0.9152098732263506,1.0,2/12,3.96%,APOE;PFDN5
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.3068418887983055,-0.7634763092584059,0.737410071942446,0.9141388129807361,1.0,3/10,16.20%,ABCA3;PHB2;MTMR3
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.20230989724941914,-0.7633997721294215,0.926829268292683,0.9128828893218826,1.0,14/55,14.89%,BCL2L1;BCL2;DAB2IP;TPD52L1;CAV1;ING5;TNFSF12;FAS;WWOX;BCL2L11;RIPK1;TNFSF10;DEDD2;GPER1
prerank,intracellular pH reduction (GO:0051452),0.30432424013351167,0.7630926218496719,0.7940841865756542,0.982112637465424,1.0,7/33,16.13%,ATP6V0A2;TMEM9;DMXL2;ATP6V1E1;ATP6V0A1;ATP6V1D;ATP6V1B2
prerank,regulation of monocyte differentiation (GO:0045655),0.3536409301615089,0.7628141995960392,0.7706666666666667,0.9820695030636055,1.0,2/14,4.40%,FOXP1;ZFP36L1
prerank,mucosal immune response (GO:0002385),0.3460064540999831,0.7621529618423006,0.7728494623655914,0.9825880675854167,1.0,2/15,14.82%,OTUD7B;IL4
prerank,megakaryocyte differentiation (GO:0030219),-0.294454778427201,-0.7619903445571243,0.7588652482269503,0.913470903515928,1.0,3/11,20.80%,KIT;TAL1;UBA5
prerank,endocardial cushion development (GO:0003197),0.3234692878642712,0.7618416046320259,0.7553058676654182,0.9826039776162718,1.0,3/21,6.76%,TGFB2;ACVR1;MDM4
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.27412212490953286,0.7618339766085233,0.867827868852459,0.9822177788138737,1.0,18/108,18.05%,SYK;GSN;EIF2AK3;F2R;S100A8;S100A9;MTCH1;PDCD2;MAPT;ANP32B;BBC3;DIABLO;RPS27L;GRAMD4;HTRA2;CTSD;BCAP31;DAP
prerank,regulation of T cell mediated immunity (GO:0002709),0.38242546375932096,0.7609830394286049,0.7586206896551724,0.9829370133655166,1.0,2/10,13.72%,ZBTB1;TNFRSF1B
prerank,protein autoprocessing (GO:0016540),0.33734927919057445,0.7607300199698416,0.7654639175257731,0.9828877592744503,1.0,6/17,30.30%,KLK6;FAM111A;HTRA2;CTSL;MYRF;SPRTN
prerank,histone H2B ubiquitination (GO:0033523),-0.3009326931865657,-0.7607007440984599,0.778169014084507,0.9138833905147594,1.0,2/10,8.80%,DTX3L;CTR9
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.2895145827197183,0.7606519105862299,0.802863436123348,0.9826040773340249,1.0,10/46,20.02%,GPAT4;DGKQ;AGPAT3;LPCAT1;AGPAT5;GPAT3;GPAM;LIPH;DDHD1;PLD2
prerank,synaptic vesicle localization (GO:0097479),0.35625407504413303,0.7602544203700361,0.7727891156462585,0.9827361571164961,1.0,3/13,16.18%,TOR1A;SYNDIG1;SNAPIN
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.2548069637996423,-0.7601290060391519,0.7649572649572649,0.9133086059952782,1.0,7/17,25.86%,OSR1;CAV1;CEACAM1;APOLD1;MAFG;DSPP;DLL1
prerank,macrophage chemotaxis (GO:0048246),-0.3140577355363535,-0.759366912710743,0.7804878048780488,0.9130305669085403,1.0,5/10,35.46%,EDNRB;TAFA4;CCL2;CXCL17;CCL5
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.3079990752100209,0.7588604190906854,0.8050749711649365,0.9841854088674804,1.0,4/29,14.82%,CXCL10;C1QBP;GAS6;IL4
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.3522450765370495,0.7586699604969968,0.7647831800262812,0.9840188343181732,1.0,2/14,7.14%,UMPS;NT5M
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.3484459132809191,0.7584611441958007,0.7561643835616438,0.9838930373180249,1.0,3/13,14.08%,RC3H1;ZC3HAV1;ZC3H12A
prerank,negative regulation of neuron differentiation (GO:0045665),-0.24521423908635134,-0.7579735292330951,0.8904109589041096,0.9135566129513051,1.0,2/22,6.86%,BMP7;B2M
prerank,mammary gland epithelium development (GO:0061180),0.3503762845691909,0.757846122227368,0.7842105263157895,0.9843247895451854,1.0,2/14,11.30%,WNT2;AKT1
prerank,respiratory chain complex IV assembly (GO:0008535),0.3330246054981044,0.757504187535966,0.8079306071871127,0.9843887467904824,1.0,8/21,27.02%,COX19;SURF1;BCS1L;COX16;COX14;COX18;SCO1;COX15
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.3151195471477306,0.757336839826365,0.7741545893719807,0.9842168940165507,1.0,8/26,22.99%,ITCH;UBE2N;IRAK1;UBA52;AAMP;TAB2;CYLD;MAP3K7
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.3277239188982072,0.7571792582044444,0.7817073170731708,0.9840159166841128,1.0,4/20,17.81%,HOPX;PSMG2;HSP90AA1;PFDN6
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.3700263341850691,0.7571716770831878,0.7592067988668555,0.9836263339433441,1.0,1/10,3.19%,TGFBR2
prerank,activation of GTPase activity (GO:0090630),0.27267273573150763,0.756907523869947,0.8556593977154725,0.9835742915287162,1.0,27/89,24.04%,SGSM2;RABGAP1L;RAP1GAP2;RASGRF1;ARHGAP42;DOCK7;TBCK;TBC1D2B;TBC1D17;ARHGEF10;TIAM2;TBC1D10A;NGEF;BCAS3;EVI5;SGSM1;EVI5L;TBC1D13;ADPRH;TBC1D22B;TBC1D15;TIAM1;CORO1C;RUNDC1;TBC1D8B;TBC1D12;BCR
prerank,cellular response to amino acid starvation (GO:0034198),0.2794348894579747,0.7568140880397678,0.8551941238195173,0.9832993818945637,1.0,18/71,23.20%,EIF2AK3;MTOR;FLCN;CEBPB;ATP6V1E1;SESN3;CDKN1A;RRAGD;EIF2S1;ATP6V1D;ATP6V1B2;DAP;CASTOR2;MAPK1;SESN2;ATF4;SLC38A9;ATP6V0B
prerank,lipid oxidation (GO:0034440),-0.2892347433399045,-0.7566461937071032,0.7431906614785992,0.9139562485846534,1.0,4/12,23.67%,ADIPOR2;ALOX12;ADIPOR1;PPARGC1A
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.31480792286372633,0.7565418652334541,0.7874692874692875,0.9832969848176204,1.0,11/25,33.72%,TCERG1;EAF2;EAF1;LARP7;LDB1;ELL;HEXIM1;NELFA;WDR43;NELFB;HNRNPU
prerank,mitochondrial gene expression (GO:0140053),0.29411471395327554,0.7563247289844571,0.8002232142857143,0.983183614048748,1.0,16/42,34.40%,MRPS11;MRPS18B;MRPS17;MRPS34;MRPL51;HARS1;QRSL1;SLC25A33;NOA1;MRPL12;MRPL23;LARS2;FOXO3;IARS2;MRPL16;GFM2
prerank,positive regulation of transmembrane transport (GO:0034764),-0.2800631613869482,-0.7549868970212605,0.7896825396825397,0.9149711330529086,1.0,1/13,0.82%,ACSL1
prerank,regulation of neuron projection arborization (GO:0150011),0.3449480647738034,0.7546740070669554,0.7705345501955672,0.984960054755578,1.0,6/15,26.64%,DLG4;MYO9A;FZD4;NTNG2;DVL1;GRIP1
prerank,cellular response to heat (GO:0034605),0.3010194802963302,0.7544570886360918,0.8052995391705069,0.984849609291526,1.0,9/35,22.68%,STUB1;YWHAE;MAPT;POLR2D;HSP90AA1;HSBP1;HTRA2;BAG3;TPR
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.2779792056341193,0.754270795240554,0.8562300319488818,0.9847116391436691,1.0,16/72,16.87%,TRIAP1;USP10;MUC1;MDM4;ING4;SFN;RPS27L;CDKN1A;BCL3;CNOT3;CNOT10;PLAGL1;NBN;TNKS1BP1;TFAP4;PML
prerank,regulation of synapse maturation (GO:0090128),0.3782595475463532,0.7541723474724488,0.7810734463276836,0.9844458764094538,1.0,1/10,2.53%,NEUROD2
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.2979241477894651,0.7540720480462505,0.8025114155251142,0.9841857672206134,1.0,12/36,23.77%,TCF7L2;NFATC1;AGO2;GNB1;PPP3CA;FZD4;AGO4;PPP3CB;AGO3;GNAO1;MAP3K7;TNRC6A
prerank,ribosome biogenesis (GO:0042254),0.26034765219546513,0.7539461118582598,0.9168336673346693,0.983953835003919,1.0,65/187,31.08%,C1D;SDAD1;DDX49;RIOK1;ABCE1;FCF1;NOC2L;ESF1;HELQ;EXOSC7;RRP36;NPM1;RPL10A;WDR46;UBA52;EIF6;SBDS;MPHOSPH10;RCL1;SNU13;MRPL36;NOLC1;DCAF13;RRP7A;EXOSC1;RPL6;NOP53;DDX52;POP4;PWP2;DDX31;RPF2;EBNA1BP2;TBL3;RPL23;RPL17;PDCD11;RIOK2;KRR1;RPS25;EIF2A;RBIS;WDR18;NOC4L;TEX10;RRP1B;LTO1;RPL22;EXOSC10;NOP16;DHX29;TSC1;RPL34;NOP56;WDR43;UTP18;NOP58;RPS15;EXOSC3;NIP7;RPL31;RPLP2;DDX27;RPS28;RPS6
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.31314777032918595,0.7534474159468172,0.7961630695443646,0.9842004698860146,1.0,1/26,0.56%,UCP1
prerank,histone acetylation (GO:0016573),0.2757362757063655,0.7534269231377344,0.8440463645943098,0.9838351969425014,1.0,21/69,25.20%,TADA1;MRGBP;MSL3;KAT2B;POLE3;ING4;WDR5;DR1;KAT14;DMAP1;YEATS2;PER1;MORF4L1;NAA50;TAF6L;TRRAP;SGF29;KAT6B;MAP3K7;KAT5;KAT7
prerank,protein localization to microtubule organizing center (GO:1905508),0.33992926234368304,0.7527544963049658,0.7802340702210663,0.9842733468836329,1.0,6/15,23.47%,PIBF1;BBS4;CEP83;PCM1;DCTN2;NEDD1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.2743452908591353,0.7527230168530508,0.8726899383983573,0.9839246258919654,1.0,24/87,21.65%,NDUFS5;COX19;TMEM126A;NDUFAF8;NDUFAB1;NDUFAF6;SDHAF1;NDUFS1;NDUFB7;NDUFV2;SURF1;TTC19;NDUFA2;ACAD9;DMAC2;BCS1L;UQCC3;COX16;COX14;SDHAF2;NDUFB2;DMAC1;COX18;SLC25A33
prerank,neuron projection regeneration (GO:0031102),0.3691592125582234,0.7523034185976731,0.7708628005657708,0.9840770605220401,1.0,3/10,13.45%,GAP43;MTR;RTN4RL1
prerank,regulation of cilium assembly (GO:1902017),0.27626109151380246,0.7521760807750084,0.8458197611292074,0.9838465029867567,1.0,29/62,31.25%,SAXO1;TBC1D2B;TBC1D17;TBC1D10A;CEP97;BBS4;EVI5;DYNC2LI1;EVI5L;CCP110;TBC1D13;ODF2L;TBC1D22B;TBC1D15;TBC1D19;ENTR1;ATG3;CROCC;CCDC88A;CYLD;CDKL1;FUZ;KCTD17;TBC1D5;TCHP;SDCCAG8;RABGAP1;TBC1D9B;IFT20
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.3058064921790249,0.7518506586250953,0.8028503562945368,0.9838768268190741,1.0,8/30,24.18%,MGAT1;LMAN1;MGAT5;MGAT2;TUSC3;DDOST;UGGT1;DPM2
prerank,regulation of actin filament bundle assembly (GO:0032231),0.31285550261768313,0.7515002809124828,0.7892215568862275,0.9839644336650959,1.0,5/26,15.98%,ASAP3;PFN2;ALMS1;SLC9A1;ACTG1
prerank,actin filament network formation (GO:0051639),0.3664470801388339,0.7512957840120144,0.7928669410150891,0.983835606001376,1.0,3/11,15.81%,COBL;FHOD3;PLS1
prerank,oligodendrocyte differentiation (GO:0048709),0.3270234917271226,0.7512652128809943,0.7807351077313055,0.9834832517892306,1.0,3/19,8.12%,PRDM8;SOX10;SOX8
prerank,positive regulation of binding (GO:0051099),0.27089645195321693,0.7511778789316034,0.8740818467995802,0.9832093017057167,1.0,18/84,17.83%,LRP1;SKI;PKD1;DACT1;TCF7L2;GPSM1;PSEN1;SIRT2;USP33;EGF;PIN1;DDX11;STK3;AMFR;GMNN;IDE;NME1;PLAUR
prerank,pancreas development (GO:0031016),0.35731087019228946,0.7508068918908712,0.7596685082872928,0.9833105657580117,1.0,1/12,5.14%,TCF7L2
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.24738080437446375,-0.7501745741958586,0.8355555555555556,0.9201416114670814,1.0,5/19,13.28%,IL34;THBS1;MDK;MAPK3;PTK2
prerank,regulation of embryonic development (GO:0045995),0.3004120878907912,0.7500167520546875,0.8331388564760793,0.9839473540932068,1.0,2/34,1.66%,PHLDB1;TLE6
prerank,monocarboxylic acid catabolic process (GO:0072329),0.3177650985131225,0.7499000943875582,0.779467680608365,0.9837083122280474,1.0,4/21,20.27%,CEL;ACOX1;NUDT19;LPIN3
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.27020245886247324,-0.7498346427261185,0.8360655737704918,0.919268117160414,1.0,5/17,12.26%,IGF1;APOE;GGA3;SORL1;NTRK2
prerank,actin crosslink formation (GO:0051764),-0.28793735066932913,-0.7495162261907304,0.7653846153846153,0.9183275152564458,1.0,4/12,16.75%,EPS8;GAS2L3;LCP1;BAIAP2L1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.3490776846074615,0.7493508102844966,0.7785234899328859,0.9840386187359919,1.0,5/13,28.27%,EGF;MGAT5;IL6;HES1;JAK2
prerank,indolalkylamine catabolic process (GO:0046218),-0.30642731609339696,-0.749233957800992,0.7972508591065293,0.9172827596497461,1.0,10/10,69.38%,KYNU;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD;KYAT1;KMO
prerank,microtubule depolymerization (GO:0007019),0.3381557959460581,0.7491043222557304,0.7871794871794872,0.9839761227525305,1.0,4/17,20.38%,KIF2A;CCSAP;CKAP5;STMN4
prerank,synapse organization (GO:0050808),0.26421485749790347,0.7490935001418751,0.8911495422177009,0.983598072236355,1.0,21/125,15.06%,SNCB;GPC6;DCTN1;F2R;PTPRS;PPFIA2;PTPRF;FARP1;CAST;PSEN1;MUSK;DSCAM;L1CAM;MAPT;FLRT3;PIN1;SLC8A2;CTNND2;PPFIA1;LRFN5;CACNB1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.31281798657460197,0.7489462560442159,0.804583835946924,0.9833927173336688,1.0,7/26,25.79%,IRAK3;TLR5;NLRP2B;FLOT2;TYRO3;FLOT1;OTUD4
prerank,glucose catabolic process to pyruvate (GO:0061718),0.31252942286394597,0.7488278000901962,0.791871921182266,0.9827593713467737,1.0,2/24,4.84%,PFKP;FOXK2
prerank,canonical glycolysis (GO:0061621),0.31252942286394597,0.7488278000901962,0.791871921182266,0.9827593713467737,1.0,2/24,4.84%,PFKP;FOXK2
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.3197681425651758,0.748668021027116,0.8159509202453987,0.9825730845549325,1.0,4/23,11.60%,GPC3;GLIS2;GPR161;GLI3
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.30759797611469875,0.7485744834331844,0.795774647887324,0.981913815334955,1.0,4/29,15.93%,CENPT;HJURP;NPM1;CENPC
prerank,CENP-A containing chromatin organization (GO:0061641),0.30759797611469875,0.7485744834331844,0.795774647887324,0.981913815334955,1.0,4/29,15.93%,CENPT;HJURP;NPM1;CENPC
prerank,negative regulation of cell aging (GO:0090344),0.33728037608653294,0.7483921399342486,0.7872611464968153,0.9817523252623496,1.0,4/16,13.56%,MIF;AKT3;FBXO5;TWIST1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.336121666413486,0.7479863558584909,0.7795484727755644,0.9818894128581687,1.0,4/16,18.66%,ERCC4;TERF1;SMG6;TINF2
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.2805289234497625,0.7475175128792896,0.8434782608695652,0.9821078945980486,1.0,22/52,29.91%,SAMD4B;RC3H1;LSM4;EDC4;EXOSC7;ZFP36;POLR2D;CNOT3;CNOT10;EXOSC1;TNKS1BP1;LSM7;RC3H2;EDC3;DCP1A;DCP1B;LSM5;HBS1L;LSM1;PDE12;PATL1;EXOSC3
prerank,ruffle organization (GO:0031529),-0.27293561315376114,-0.7470799294187148,0.8264840182648402,0.918878452674368,1.0,2/16,5.87%,TPM1;PIP5K1A
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.3087835034562749,0.7464993123277979,0.815914489311164,0.9830079425889782,1.0,11/28,27.80%,ITCH;UBE2N;IRAK1;UBA52;AAMP;TAB2;CYLD;MAP3K7;RELA;OTULIN;CASP8
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.36447047055775805,0.7463872827290924,0.7827926657263752,0.9827556172516434,1.0,2/10,17.29%,SIRT2;RCC2
prerank,regulation of ERAD pathway (GO:1904292),0.3547773468642566,0.7455006254642463,0.7777777777777778,0.9835060914195368,1.0,4/11,22.66%,TMEM259;HERPUD1;USP13;USP19
prerank,positive regulation of intracellular transport (GO:0032388),0.29485230799604467,0.7453886276807485,0.812989921612542,0.9832411019805127,1.0,15/38,27.71%,B3GAT3;EHD2;KIF20B;BCAS3;PLA2G4E;DYNC1H1;VAMP2;CAPN10;NUMA1;PCM1;ICE1;TPR;RAB29;OAZ1;EIPR1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.3724789038715156,0.745198570801619,0.7886297376093294,0.9830902772361009,1.0,2/10,9.07%,IL33;TLR4
prerank,phosphatidic acid metabolic process (GO:0046473),0.28139815443766175,0.7448716749480773,0.8386388583973655,0.983118682653748,1.0,10/48,20.02%,GPAT4;DGKQ;AGPAT3;LPCAT1;AGPAT5;GPAT3;GPAM;LIPH;DDHD1;PLD2
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.33810959509432853,0.7447491721353539,0.7777777777777778,0.9828832978754454,1.0,7/16,26.19%,PIGZ;PIGC;PIGW;PIGM;PIGL;DPM2;PIGH
prerank,regulation of neurotransmitter secretion (GO:0046928),0.29692349225338416,0.7441245005849825,0.8126436781609195,0.9832727670007938,1.0,7/32,18.84%,SYT11;DTNBP1;STX1B;HCRT;SNAPIN;PREPL;RIMS2
prerank,smoothened signaling pathway (GO:0007224),0.308945127310446,0.7440432070918694,0.8472385428907168,0.9829704682782762,1.0,5/32,11.60%,DISP2;GLI2;ARL13B;DYRK2;GLI3
prerank,phospholipid biosynthetic process (GO:0008654),0.3015635657505162,0.7436111513457496,0.8327566320645905,0.9831382623268728,1.0,13/36,27.23%,FAR1;AGK;SGMS2;AGPAT3;LPCAT1;DHDDS;AGPAT5;FADS1;GPAM;CPNE1;SRD5A3;MVD;NUS1
prerank,adenine nucleotide transport (GO:0051503),0.3361470893313388,0.7420771279781544,0.7899045020463847,0.9846785654740088,1.0,3/17,14.88%,LRRC8D;SLC25A4;SLC25A17
prerank,protein export from nucleus (GO:0006611),0.3112396790987115,0.7417699185370006,0.8098086124401914,0.9846530917098436,1.0,8/27,24.80%,DESI1;PKD1;STRADA;CHP1;SMURF1;TPR;XPO7;CALR
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.27344923551254224,0.7409382951959226,0.8507936507936508,0.9853199194503947,1.0,10/73,10.96%,POLR2H;GLMN;CREBZF;HDAC6;POLR1G;PHF1;KAT2B;MPHOSPH8;DDX21;GPX1
prerank,organophosphate catabolic process (GO:0046434),0.3572908166467894,0.7401592724551934,0.7769886363636364,0.985906315356302,1.0,11/11,64.30%,ANGPTL3;ENPP2;PNLIPRP2;APOA2;LIPG;PLBD2;PON1;PDXP;ABHD12;NUDT15;PLBD1
prerank,transcription by RNA polymerase III (GO:0006383),0.30349936621717094,0.739825557072508,0.8251497005988024,0.9859304526232019,1.0,8/27,23.54%,ZC3H8;GTF3C2;BRF1;POLR3H;ICE1;ELL;TBP;GTF3C5
prerank,platelet degranulation (GO:0002576),0.2638587810264384,0.7395927451456019,0.907520325203252,0.9858449300341195,1.0,8/118,3.05%,CD9;TGFB3;CLEC3B;SPARC;ITGB3;VEGFA;TGFB2;ECM1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.2861049345075248,0.7392816631893548,0.8353591160220994,0.9858599075042841,1.0,9/46,23.28%,ANXA2;MIF;RAP1B;ARF1;PDCD4;PPIA;RALA;SNRPA1;MTAP
prerank,regulation of protein modification process (GO:0031399),0.2809738498377955,0.7392047393151135,0.8349726775956284,0.9855687313270137,1.0,16/50,23.64%,CCDC88C;FLCN;CDK9;KAT2B;PARG;PIN1;FER;NOP53;PML;CORO1C;SESN2;CCDC88A;STAT2;ATG10;ATG14;RABL3
prerank,cell junction organization (GO:0034330),0.27228774965807795,0.738695119249198,0.8680257510729614,0.9858177098223857,1.0,17/71,17.93%,SNCB;TGFB3;TGFB2;PPFIA2;MYO9A;PSEN1;L1CAM;MAPT;PIN1;RHOA;SLC8A2;CTNND2;PPFIA1;LIMS2;ACTG1;CHRNA7;ILK
prerank,regulation of viral genome replication (GO:0045069),0.27916303822326005,0.7384083424585646,0.8485838779956427,0.9857827139539976,1.0,12/56,21.08%,TARBP2;ADARB1;ZC3HAV1;SLPI;TNIP1;LARP1;DDB1;FAM111A;HACD3;PPIA;BTBD17;SRPK1
prerank,regulation of smoothened signaling pathway (GO:0008589),0.28312877265677633,0.7382961585476135,0.8541436464088398,0.9855292763586274,1.0,7/50,12.43%,GPC3;GAS1;GLIS2;TEDC1;UCHL5;GLI3;TUBD1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.3338601116481212,0.7380804339178517,0.8129205921938089,0.9853896126060416,1.0,1/16,0.89%,PARP3
prerank,positive regulation of immune response (GO:0050778),0.27417120188582284,0.7373456280624026,0.8494623655913979,0.985941905691612,1.0,10/64,20.96%,CD177;TGFB2;CD81;STX4;POLR3D;AKIRIN2;SLC15A4;IFI35;ITGAM;PYCARD
prerank,purine nucleotide catabolic process (GO:0006195),0.3444792883182003,0.7372805174740398,0.7779255319148937,0.9856376738610921,1.0,2/13,10.96%,GDA;GPX1
prerank,cortical cytoskeleton organization (GO:0030865),0.28646482455350575,0.7372697694274821,0.8243847874720358,0.9852636369255982,1.0,9/41,16.20%,LLGL1;FMNL1;RHOQ;RHOA;FMNL3;FHOD3;ARF6;RND3;RAC3
prerank,negative regulation of hippo signaling (GO:0035331),0.3485659393750036,0.7370482748940715,0.8053691275167785,0.9851589244096735,1.0,2/12,4.92%,MAPK14;MAP2K3
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.3155564074415238,0.7366379264596946,0.8223039215686274,0.9852657826779411,1.0,11/20,34.78%,AGO2;EIF6;AGO4;AGO3;TNRC6A;AGO1;CELF1;CNOT8;LIMD1;TNRC6C;NRDE2
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.3076149971260444,0.7360708529948216,0.815136476426799,0.9855588679038216,1.0,3/24,7.57%,MAPK7;NFE2L2;GAS6
prerank,peptidyl-asparagine modification (GO:0018196),0.2983132142440089,0.7360344754267137,0.8242924528301887,0.98521395413067,1.0,8/31,24.18%,MGAT1;LMAN1;MGAT5;MGAT2;TUSC3;DDOST;UGGT1;DPM2
prerank,regulation of chemokine production (GO:0032642),0.2990007955960908,0.7357990232260736,0.8410138248847926,0.9851158839863903,1.0,8/36,20.96%,FOXP1;IL33;TLR4;ACKR1;IL6;SNAI2;IL18;PYCARD
prerank,regulation of astrocyte differentiation (GO:0048710),0.3485901259552966,0.7354960220087196,0.8008241758241759,0.9851208108484187,1.0,2/12,5.01%,BIN1;CLCF1
prerank,regulation of protein kinase C signaling (GO:0090036),0.34118447707144434,0.7353565696305666,0.7997382198952879,0.984896816625658,1.0,2/14,6.59%,VEGFA;MYADM
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.2922295254710978,0.7352251658160421,0.8254335260115607,0.9846665465472678,1.0,15/34,32.99%,MPP2;GRIN2D;AKT1;GABRG3;GRIN2A;GABRG2;GABRA3;GRID2;NPAS4;NLGN3;GABRA1;DRD2;GSK3A;RAB3GAP1;GABRA5
prerank,protein localization to Golgi apparatus (GO:0034067),-0.22228037052753577,-0.7351527912980126,0.8471337579617835,0.9327262001268961,1.0,7/27,13.91%,OPTN;PAQR3;VPS13A;GBP5;SORL1;GCC2;RIPOR1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.27738901238155417,0.7350396988090097,0.8527808069792803,0.9844982880106715,1.0,9/59,13.54%,CADM3;NPTN;NECTIN3;PKD1;TENM3;DSCAM;L1CAM;IGSF9;PALLD
prerank,positive regulation of defense response to virus by host (GO:0002230),0.30692805699546905,0.7342804474056659,0.8088942307692307,0.985034687101529,1.0,5/24,14.82%,CGAS;TRAF3IP2;ZC3H12A;HSP90AA1;IL4
prerank,regulation of cellular component size (GO:0032535),-0.2224432207957438,-0.7341582368272704,0.8601398601398601,0.932668666598087,1.0,5/30,8.04%,EPS8;RAB22A;RPTOR;RIN3;LAMTOR5
prerank,phospholipid catabolic process (GO:0009395),-0.2308892234457419,-0.7338494603871184,0.8771929824561403,0.9316612562803526,1.0,1/24,0.63%,GPCPD1
prerank,cellular response to hypoxia (GO:0071456),0.2589789995047273,0.7335946278550374,0.9204081632653062,0.985474770461748,1.0,14/126,9.05%,ANGPT4;PSMC4;VEGFA;LMNA;ZFP36L1;MTOR;CARD16;PSMC6;MDM4;EGLN2;STUB1;TIGAR;PSMD8;SIRT2
prerank,regulation of dendrite extension (GO:1903859),0.31803906331978227,0.7330663065183106,0.8042394014962594,0.9857231710271809,1.0,5/18,24.12%,SYT2;SYT1;RIMS2;SMURF1;RNF157
prerank,mRNA modification (GO:0016556),0.3096278598744899,0.7329096850971477,0.8140703517587939,0.985519918497089,1.0,4/22,20.09%,TRMT6;TRMT61A;PCIF1;TRUB1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.3359829977091531,0.731843133889216,0.8095238095238095,0.9864204230324458,1.0,5/14,23.47%,PAICS;GART;ATIC;ADSS2;LHPP
prerank,L-glutamate transmembrane transport (GO:0015813),0.3597445344930969,0.7318029607186239,0.8147100424328148,0.9860800598777127,1.0,2/10,9.92%,SLC1A6;PRAF2
prerank,apoptotic process (GO:0006915),0.2544483641143355,0.7318020959719673,0.9547738693467337,0.9856979712999692,1.0,42/203,19.41%,EFNA5;FAP;MAGI3;TGFBR2;DPF2;KREMEN1;MTOR;FOXO1;DPF1;AIFM2;PIK3CA;SIAH1;PAEP;ING4;AKT1;BMF;ERCC3;NDUFS1;BAK1;BBC3;TAOK2;ADAM15;DIABLO;NSG1;PLAGL1;DCC;STK3;ATCAY;THOC1;CD14;VDAC1;PDCD4;PRUNE2;OGT;CXCR4;PPIA;IAPP;DAP;AKAP1;SFRP5;APAF1;CIT
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.2806643230930136,0.731693654374846,0.8433598183881952,0.985445508042672,1.0,8/44,20.33%,KCNMA1;ANK2;KCNJ2;KCNJ3;GNB1;AKAP9;KCNH2;FLNA
prerank,regulation of double-strand break repair (GO:2000779),-0.2002890837581189,-0.7315659049889354,0.9193548387096774,0.9329989444355666,1.0,6/39,9.46%,TRIP12;SPIRE1;UBR5;SLF2;MGMT;MRNIP
prerank,myelin maintenance (GO:0043217),0.35829408347135483,0.7307409102094972,0.7681159420289855,0.9862191404580686,1.0,7/10,37.95%,CXCR4;PTEN;MYRF;EPB41L3;DEGS1;CLU;ABCD1
prerank,DNA methylation or demethylation (GO:0044728),0.31829571557235714,0.7301135984247974,0.8210262828535669,0.986212217136623,1.0,9/19,29.85%,SPOCD1;EHMT2;DMAP1;BAZ2A;GATAD2A;MTRR;ATF7IP;ATRX;FOS
prerank,DNA alkylation (GO:0006305),0.31829571557235714,0.7301135984247974,0.8210262828535669,0.986212217136623,1.0,9/19,29.85%,SPOCD1;EHMT2;DMAP1;BAZ2A;GATAD2A;MTRR;ATF7IP;ATRX;FOS
prerank,regulation of neuron apoptotic process (GO:0043523),0.26465208822701525,0.7300109802116942,0.9038262668045501,0.9859459771186938,1.0,21/96,22.18%,TGFB3;SIX4;TGFB2;F2R;CLCF1;NFATC4;EGLN2;NRBP2;GDNF;NSMF;SIX1;NUPR1;FAIM2;SET;SNX6;RASA1;BACE1;TYRO3;KDM2B;NF1;ATF4
prerank,positive regulation of dendrite extension (GO:1903861),0.32207945589447234,0.7294119840051173,0.8065739570164349,0.9862785229018937,1.0,5/17,24.12%,SYT2;SYT1;RIMS2;SMURF1;RNF157
prerank,tRNA modification (GO:0006400),0.268152981377992,0.7291018466556618,0.8586723768736617,0.9862795693812053,1.0,13/62,20.75%,ANKRD16;TRMT6;TYW3;TRMT61A;FTSJ1;THADA;TRMT1;DTWD1;QTRT1;TYW5;DUS2;TRUB1;METTL1
prerank,chloride transmembrane transport (GO:1902476),0.28187172696264784,0.7288030448499322,0.8440265486725663,0.9862447886122433,1.0,10/48,20.50%,ANO3;SLC4A8;SLC12A8;GABRR3;SLC12A4;SLC12A5;GABRG3;ANO5;GABRG2;SLC12A6
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.33632535805355174,0.7283941939373756,0.8146666666666667,0.9863480072759044,1.0,6/13,22.68%,RAB23;MDFIC;CABP1;CHP1;UFM1;TPR
prerank,negative regulation of centrosome duplication (GO:0010826),0.3547177722082073,0.728100764951068,0.7933884297520661,0.9863053135719565,1.0,4/11,19.74%,KAT2B;NPM1;CDK5RAP2;MDM1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.2740022099701336,0.7270551821918722,0.8733624454148472,0.9871956914467556,1.0,7/57,13.71%,GNAI3;LPAR1;HTR1F;AKAP12;GPR37L1;ADCY8;GPR37
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.2983456464124248,0.7266378014290948,0.8243080625752106,0.9873131054201493,1.0,4/28,12.37%,EGFR;BEND6;AKT1;EGF
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.27042589899283903,0.7265658892697548,0.8925531914893617,0.9870036038199783,1.0,11/76,16.35%,GPSM2;CDC42EP2;BIN1;SORBS3;PFN2;FCHSD1;FER;BCAS3;ARF6;DYNC1H1;NCK1
prerank,phosphatidylcholine catabolic process (GO:0034638),0.35811011170320933,0.726389557088177,0.8071135430916553,0.9868440868642139,1.0,3/10,26.88%,PNPLA8;LIPC;PLA2G7
prerank,endocrine system development (GO:0035270),0.3128044238338935,0.7263073224524538,0.8215613382899628,0.9865568208946145,1.0,6/21,21.96%,WT1;GLI2;SIX1;DKK3;TGFBR1;NF1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.29249592710012556,-0.7260470614574257,0.8339100346020761,0.9382950274807663,1.0,6/10,24.43%,RAPGEF3;SMARCB1;HDAC5;SPHK2;BRCA1;CHEK1
prerank,positive regulation of type I interferon production (GO:0032481),0.26697655122338415,0.7257473369767475,0.8729989327641409,0.9868573883940924,1.0,12/73,14.87%,POLR2H;CGAS;DHX33;POLR3E;CHUK;TLR4;POLR3D;IRAK1;SETD2;XRCC5;HSP90AA1;CD14
prerank,sphingosine metabolic process (GO:0006670),0.3258828384016902,0.7255459206813843,0.8229299363057325,0.9867285537865467,1.0,2/17,7.04%,PLPP3;PLPP1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.3168487824564278,0.7254790883232591,0.8216482164821648,0.9864270157710735,1.0,1/20,1.05%,PSTPIP1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.3025442721448335,0.7251836425407969,0.8380952380952381,0.9863994608326845,1.0,9/28,24.04%,DBN1;PFN2;GBA2;FCHSD1;COTL1;RASA1;ABITRAM;CTTN;LATS1
prerank,amide biosynthetic process (GO:0043604),0.27336498207087245,0.7249671833232669,0.8484513274336283,0.9862687009338917,1.0,5/47,11.28%,CERS6;PCSK5;AGK;SGMS2;FA2H
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.35658642866225276,0.7249571409371302,0.8002873563218391,0.9858978994694934,1.0,4/10,32.40%,RC3H1;PRNP;LGALS9;CD274
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.3041674847946174,0.7249056874559492,0.813810110974106,0.985575394866988,1.0,10/25,32.91%,MPP2;GRIN2D;AKT1;GRIN2A;GRID2;NPAS4;NLGN3;DRD2;GSK3A;RAB3GAP1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.26561977285031474,0.7246084883454765,0.8897058823529411,0.9855272156284025,1.0,21/78,25.84%,NFE2L2;COP1;STUB1;SIRT2;HERPUD1;DNAJB2;USP5;SGTA;NOP53;RNF14;ZER1;KEAP1;BCAP31;ARIH2;RNF19A;ARIH1;ZYG11B;DVL1;MDM2;FBXO22;CSNK1E
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.2885690235121739,0.7244527676757311,0.8360091743119266,0.9853422760325515,1.0,9/37,14.95%,DGKQ;AXIN1;S1PR2;SIRT2;INPP5K;PPEF2;EGF;CALM2;TNKS1BP1
prerank,regulation of response to oxidative stress (GO:1902882),0.35351529928956205,0.7242651630724302,0.8116343490304709,0.9851720904400153,1.0,3/11,19.01%,AIFM2;GGT7;SELENON
prerank,regulation of protein binding (GO:0043393),0.2572355345863435,0.7241713044308986,0.9207003089598352,0.984900547240051,1.0,21/114,16.88%,LRP1;PKD1;DACT1;GNL3L;TCF7L2;CARD16;TFIP11;PSEN1;USP33;AKT1;SLPI;DNAJB2;CDKN1A;PIN1;DDX11;HDAC4;STK3;AMFR;GTF2F1;SNAPIN;IDE
prerank,response to interferon-beta (GO:0035456),-0.2334027930389161,-0.724119960595529,0.8882978723404256,0.9391990537968251,1.0,4/22,10.43%,AIM2;PLSCR1;IFITM3;STAT1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.252430204439692,0.7240432369157337,0.9415322580645161,0.9846647773407634,1.0,31/168,19.51%,RPSA;DIS3L2;ZFP36L1;CTIF;SAMD4B;RC3H1;EXOSC7;HELZ2;PNRC2;GSPT2;RPL10A;UBA52;ZFP36;POLR2D;POLR2G;RPS5;CNOT3;CNOT10;ZC3H12A;SMG7;EIF3E;GSPT1;TNKS1BP1;SMG6;RPL6;DDX5;TENT2;TENT4B;PPP2R2A;RPL23;RPL17
prerank,response to cytokine (GO:0034097),0.2558660254554575,0.724018149387817,0.9313131313131313,0.98432104292853,1.0,17/141,14.50%,COL3A1;TIMP2;AFF3;PRKCA;ANXA1;IRAK3;ADAM9;SRC;PID1;CYP27B1;CDK9;IRAK1;SETD2;FLT3;RHOA;HDAC4;GGT7
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.2892403143617605,0.7237811449211694,0.8444948921679909,0.9842192197249471,1.0,11/36,22.14%,RNF2;RYBP;PHC3;PHC1;EHMT2;UXT;APAF1;RING1;PCGF6;FOXO4;EZH2
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.24763757152747612,-0.7231024318440615,0.8264840182648402,0.938991546929468,1.0,5/17,21.26%,COX4I1;COX6C;NDUFA4;CYCS;COX5A
prerank,microglial cell activation (GO:0001774),-0.23691350442919273,-0.7230216155018047,0.9137055837563451,0.9377058593333327,1.0,3/21,9.16%,APP;SNCA;CX3CL1
prerank,regulation of protein ubiquitination (GO:0031396),0.2602031701299508,0.7222251449341982,0.9088114754098361,0.9856486804365296,1.0,36/108,30.45%,AXIN1;GTPBP4;GNL3L;USP4;STUB1;MYCBP2;UBE2N;CUL3;SQSTM1;HDAC3;AKT1;DNAJB2;NDFIP1;HSP90AA1;CHP1;OGT;UFL1;TGFBR1;U2AF2;ARRB1;NSMCE3;DERL1;UBE3A;FKBP1A;BAG5;FBXW7;PRKCG;DCUN1D1;BCL10;DNAJA1;HDAC8;LAPTM5;SENP2;SPRTN;SIRT7;TRAF6
prerank,positive regulation by host of viral transcription (GO:0043923),0.3331869594776548,0.7217813926967793,0.8335517693315858,0.9857654570040135,1.0,7/15,23.67%,HPN;CTDP1;SMARCA4;CHD1;TFAP4;JUN;RRP1B
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.3014728907487197,0.7211534634050266,0.8362282878411911,0.9861268728851292,1.0,2/25,4.84%,PFKP;FOXK2
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.29410804454642736,0.720950821596779,0.8418549346016647,0.9859692346387408,1.0,9/29,28.30%,CHUK;TLR4;UBA52;CD14;TRAF3;UBE2D3;TICAM1;CASP8;CD300LF
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.2514120419950354,-0.7208446862820633,0.8136882129277566,0.9388811077311076,1.0,4/14,17.41%,ENPP1;ENPP3;AK4;AK1
prerank,rRNA processing (GO:0006364),0.24978893185363263,0.7207390637981199,0.9463562753036437,0.9858475588934272,1.0,60/172,31.08%,C1D;DDX49;RIOK1;FCF1;ESF1;HELQ;EXOSC7;RRP36;RPL10A;WDR46;UBA52;EIF6;SBDS;MPHOSPH10;RCL1;SNU13;NOLC1;DCAF13;RRP7A;EXOSC1;RSL1D1;RPL6;NOP53;DDX52;POP4;PWP2;EBNA1BP2;SRFBP1;TBL3;RPL23;RPL17;PDCD11;RIOK2;KRR1;RPS25;MAK16;NOP2;WDR18;NOC4L;TSR3;TEX10;RRP1B;RPL22;EXOSC10;RIOK3;PRKDC;RPL34;NOP56;NHP2;WDR43;UTP18;NOP58;RPS15;EXOSC3;NAT10;RPL31;RPLP2;DDX27;RPS28;RPS6
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.2885707572877506,0.7206835665432797,0.8281990521327014,0.9855326586494828,1.0,10/31,28.11%,CDC14B;AXIN1;UBE2N;PIN1;PTEN;RAB1A;FBXW7;GORASP1;DCUN1D1;TOPORS
prerank,regulation of DNA repair (GO:0006282),0.27592497201994626,0.7205951477710812,0.8587570621468926,0.9852601562273413,1.0,7/44,13.30%,EGFR;EYA2;UBE2N;TIGAR;CDK9;PARG;ABRAXAS1
prerank,regulation of stem cell population maintenance (GO:2000036),0.31985981820880416,0.720426994377132,0.8114649681528663,0.9850747523885531,1.0,2/18,6.23%,LOXL2;NCOA3
prerank,sphingolipid biosynthetic process (GO:0030148),0.26586389977393965,0.720288453143467,0.8973544973544973,0.9848537051314182,1.0,11/71,12.42%,CERS6;PLPP3;ALDH3A2;PLPP1;PRKD2;AGK;SGMS2;LARGE1;FA2H;ELOVL5;PRKD3
prerank,mitotic chromosome condensation (GO:0007076),0.2997226726013366,0.7199000868683608,0.8301204819277108,0.9849313023122589,1.0,7/26,26.78%,TENT4A;NCAPG;SMC2;SET;AKAP8L;CSNK2A2;KMT5A
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.2267728273874785,-0.7198123044520974,0.875,0.9387067065953889,1.0,5/22,13.91%,RPS7;RPL37;ATM;SPRED3;SPRED2
prerank,regulation of establishment of planar polarity (GO:0090175),0.25960731260173486,0.7196246156451623,0.9224318658280922,0.9848844301395597,1.0,21/88,25.96%,PSMC4;SMURF2;DACT1;AP2A2;PSMC6;CLTC;FZD7;PARD6A;PSMD8;VANGL2;RHOA;FZD4;DAAM1;TIAM1;SMURF1;AP2M1;PSMD3;DVL1;PSMD4;RAC1;PSMB3
prerank,regulation of cellular senescence (GO:2000772),0.2960106592484832,0.7194461244797491,0.8429073856975381,0.9846983383637923,1.0,8/28,17.49%,CGAS;YPEL3;AKT3;FBXO5;TWIST1;RSL1D1;EEF1E1;NEK4
prerank,cytoskeleton organization (GO:0007010),0.25282442773892677,0.7189451479143281,0.9152196118488254,0.9848797491352695,1.0,35/114,26.31%,ARHGAP10;PLCE1;DIAPH3;BIN1;ZRANB1;DST;MAST4;LARP4;CAMSAP1;MICAL2;PRPF40A;CCL13;RHOA;PALLD;FMNL3;DIAPH1;RND3;ANK1;RAC3;MICAL1;RANBP10;SH3D19;PLD2;ZMYM3;PACSIN2;PACSIN3;CNTNAP1;SYNE3;DMTN;RAC1;RHOBTB2;STRIP1;ZMYM6;MAST2;RND2
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.2873532540545005,0.7186675025032371,0.8511904761904762,0.98481248765527,1.0,4/29,15.33%,LPCAT1;PNPLA8;MBOAT7;PLA2G4E
prerank,regulation of RNA export from nucleus (GO:0046831),0.3515037636268099,0.7185835722832493,0.8025210084033614,0.9845288245763041,1.0,4/11,22.68%,CPSF6;SETD2;AKAP8L;TPR
prerank,I-kappaB phosphorylation (GO:0007252),0.35766716717695257,0.7184942217185272,0.8132022471910112,0.9842483531912513,1.0,2/10,9.07%,CHUK;TLR4
prerank,cytosolic calcium ion transport (GO:0060401),0.29972864711231073,0.7184616809466625,0.856453558504222,0.9839112377841822,1.0,8/28,24.49%,MCU;SLC35G1;MCUB;ATP2A2;SLC8A2;ATP2B1;JPH4;CACNA2D1
prerank,copper ion homeostasis (GO:0055070),-0.2514186868178341,-0.7179083904006238,0.8584905660377359,0.9395368413146765,1.0,3/17,9.42%,APP;XIAP;CUTC
prerank,inorganic anion transmembrane transport (GO:0098661),0.2699862551906605,0.7177679205618169,0.8737967914438503,0.9843299816574212,1.0,14/63,21.28%,ANO3;SLC4A8;SLC12A8;GABRR3;SLC37A3;SLC12A4;SLC12A5;GABRG3;SLC25A3;SLC20A1;ANO5;GABRG2;SLC12A6;SLC37A4
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.26400929547586,0.7175986673020359,0.8823529411764706,0.9841687384300608,1.0,25/75,26.99%,MAP1B;LLGL1;DOCK7;FARP1;S100A6;UNK;TAOK2;MAP6;DCC;SDC2;SHTN1;CNTN4;SLITRK4;RAB10;MAP1A;ABITRAM;SPTBN4;MAP1S;NTNG2;DVL1;PAX2;ATL1;NRCAM;SLITRK5;PAK3
prerank,calcium ion homeostasis (GO:0055074),0.25701904624644034,0.7173870432487353,0.8983402489626556,0.9840254363037163,1.0,27/95,27.55%,CCL8;NPTN;ANK2;TNNI3;ATP2B4;CYP27B1;ATP13A1;CCL13;ATP2A2;SLC8A2;STC1;TMEM165;CHRNA7;ATP2B1;HTR2C;SELENON;STIM1;SLC8B1;HTR2A;RMDN3;CALR;TMCO1;SLC24A4;SLC24A2;TMEM203;SLC10A7;FAM20A
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.2493113391406661,-0.7172248837950145,0.8414096916299559,0.9389389833043447,1.0,5/16,20.58%,SCARB1;NR1H3;CTDNEP1;PNPLA2;ABHD5
prerank,estrogen metabolic process (GO:0008210),0.3323195736643343,0.7163667413890332,0.8104138851802403,0.984848480778657,1.0,4/15,22.29%,HSD17B8;HSD17B4;HSD17B11;CYP1B1
prerank,aerobic respiration (GO:0009060),0.30853496689675847,0.7158909414963901,0.82625,0.9849861831694635,1.0,7/20,25.53%,SURF1;MDH2;MTFR1L;UQCRH;UQCR10;ME3;SDHC
prerank,regulation of Rac protein signal transduction (GO:0035020),0.3221707868369674,0.7154471033719157,0.8295904887714664,0.9850696471029582,1.0,7/16,24.31%,ARHGAP44;RASGRF1;ARF6;OGT;PIK3CG;ARHGAP17;ALS2
prerank,regulation of intracellular signal transduction (GO:1902531),0.2465361826195261,0.7150582754688409,0.994,0.9851645368552424,1.0,80/420,18.32%,MYOC;TRIP10;ARHGAP21;ARHGAP10;EGFR;ARHGAP44;AKAP13;VEGFA;PIK3R2;TAOK3;MAPK14;TRIO;MTOR;PRKAB2;RCN3;SRGAP1;RASSF2;TBCK;MDM4;RIT2;ARHGEF3;MYO9B;NOC2L;FLCN;PRKD2;MYO9A;RHNO1;OCRL;ARHGAP9;FBXL2;TAGAP;RHOJ;MAPK11;ITGAV;TIAM2;RHOQ;BRD7;DYRK2;SQSTM1;AKAP12;TAF3;RMI1;AKT1;MAPT;NGEF;RAD1;TAOK2;PIN1;BCL3;RHOA;DNA2;TMEM127;BRIP1;EHMT2;NBN;STK3;SLC15A4;USP7;GPAT3;NOP53;RFC4;TRAF3;RAC3;SOS1;PEX5L;CHD3;UFL1;PML;PIP4P1;PPP2R5B;SRGAP2;SRGAP3;PIP4K2C;ARAP1;RAD50;TCP11;TMBIM4;RPF2;DIPK2A;BLM
prerank,GPI anchor metabolic process (GO:0006505),0.30059785172018044,0.7150482743990465,0.827460510328068,0.9847992035562433,1.0,9/26,26.19%,PIGZ;PIGC;MPPE1;PIGW;PIGM;GPLD1;PIGL;DPM2;PIGH
prerank,peptidyl-lysine methylation (GO:0018022),0.299691267439809,0.7147034776427325,0.8304093567251462,0.9848033883562038,1.0,9/26,28.06%,SETD7;SETD2;ANTKMT;EHMT2;EEF2KMT;N6AMT1;EEF1AKMT3;KMT5A;SUV39H1
prerank,tRNA wobble uridine modification (GO:0002098),0.3287689454075089,0.7142715480475232,0.8187830687830688,0.9849175219285233,1.0,3/14,13.76%,ELP4;TRMU;ELP1
prerank,protein homotetramerization (GO:0051289),0.2709342388005863,0.7140338890771804,0.8727876106194691,0.9848176694501456,1.0,10/49,19.05%,TK1;KCNJ2;OSBPL2;PKD2;SAMHD1;ALDH1A3;GLS;CRYZ;ALDOA;HCN1
prerank,cardiolipin metabolic process (GO:0032048),0.3343478140895674,0.7139337107804248,0.8184210526315789,0.9845547557326804,1.0,8/13,35.64%,PNPLA8;TAMM41;SLC27A1;PGS1;PLSCR3;CRLS1;PTPMT1;HADHB
prerank,epithelial cell development (GO:0002064),0.3094686946334507,0.713841999094955,0.811704834605598,0.9842816885777447,1.0,2/20,5.33%,DACT2;PDZD7
prerank,C-terminal protein amino acid modification (GO:0018410),0.3475805047078739,0.7137420440601707,0.8147632311977716,0.9840184403789283,1.0,4/11,25.31%,TTL;GPLD1;ICMT;AGBL1
prerank,regulation of interferon-beta production (GO:0032648),0.2717396222211461,0.7135730596430809,0.8648351648351649,0.9838126658255002,1.0,11/46,22.92%,PTPRS;TIRAP;TLR4;SIRPA;POLR3D;HSP90AA1;RNF216;TRAF3;PYCARD;POLR3A;FLOT1
prerank,cilium-dependent cell motility (GO:0060285),-0.2226196676718856,-0.7135033151942117,0.8868778280542986,0.9418583994910853,1.0,12/22,34.88%,CFAP44;EFHC2;DNAH2;GAS8;RSPH9;DNAH3;DRC1;CCDC65;DNAAF2;TEKT2;DNAH17;CFAP54
prerank,positive regulation of catalytic activity (GO:0043085),0.2834324645311486,0.7134928829129318,0.8647727272727272,0.9835250495875524,1.0,7/37,14.55%,MAPK14;ABL2;B3GAT3;PSEN1;STX4;XRCC5;BCAS3
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.2680738281408898,0.7134247417903964,0.8815217391304347,0.9832262065265488,1.0,22/58,30.16%,CYREN;UBE2N;POLB;SMC5;ERCC4;XRCC5;ABRAXAS1;NBN;IFFO1;RAD50;DCLRE1A;SMARCAL1;ERCC1;NSMCE2;KAT5;PRPF19;PRKDC;XRCC6;KDM2A;ZBTB7A;SUMO1;PSMD14
prerank,respiratory electron transport chain (GO:0022904),0.33023176048739866,0.7133850872543844,0.8337765957446809,0.982897326319586,1.0,3/14,15.90%,ETFA;ETFDH;ETFB
prerank,regulation of mitochondrial translation (GO:0070129),0.30415860019753105,0.7122794848836064,0.8324808184143222,0.9837825116632889,1.0,5/21,21.41%,C1QBP;MRPS27;RCC1L;RMND1;MPV17L2
prerank,positive regulation of neuron death (GO:1901216),0.2717778503252848,0.7121909458856965,0.8622222222222222,0.9835034581111235,1.0,11/46,22.18%,FYN;TGFB2;TLR4;MAPT;EIF2S1;NUPR1;SARM1;ITGAM;BACE1;NF1;ATF4
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.285434826936296,0.7120117507771023,0.8581157775255391,0.9833274729754932,1.0,10/36,23.83%,UCHL5;RYBP;FHIT;USP7;GIPC1;NOP53;OGT;MAP1A;SDCBP;BAG5
prerank,purine-containing compound catabolic process (GO:0072523),-0.27102561080674725,-0.711775360437123,0.8446969696969697,0.9424395746906721,1.0,4/13,17.95%,DPYD;NT5E;NT5C2;NT5C1A
prerank,brain development (GO:0007420),0.2525129530987587,0.7109894251037638,0.9369277721261444,0.9841027720576216,1.0,36/136,24.29%,AFF2;UGP2;PBX1;TGFBR2;MEIS2;NFIB;GRIN2D;ZFHX3;NDRG4;EEF1AKMT4-ECE2;SLC6A4;TBC1D23;HSPG2;SLC23A1;BBS4;MDGA1;UFC1;CHD8;CDK5RAP2;GRIN2A;CXCR4;QARS1;CNTN4;UFM1;EML1;NIPBL;PAFAH1B1;PITPNM1;PTEN;NF1;UBE3A;FBXW11;MAP1S;NCOA6;NKX2-2;RAB18
prerank,presynapse assembly (GO:0099054),0.31910666067116616,0.7108461864803347,0.84,0.9838802770527479,1.0,8/16,31.31%,CEL;PTEN;LRRTM3;DVL1;IL1RAPL1;NLGN1;NLGN3;NLGN2
prerank,dephosphorylation (GO:0016311),0.25093675266284904,0.7107769403037991,0.9402834008097166,0.98357804292948,1.0,41/147,23.47%,TIMM50;CDC14B;PTPRS;PLPP3;ACP2;PTPRJ;PLPP5;ILKAP;PTPRF;PLPP1;PPP5C;CTDSP2;DUSP11;PPM1G;INPP5K;PPP3CC;SSH1;PPEF2;PLPPR3;CTDP1;PPP3CA;PPP2R1B;MTMR6;PPP1CC;PPP2R5B;PDP2;PTPN5;PLPP2;SDHAF2;PPP3CB;PPP2R2A;ACP3;PTPN3;PPM1A;PTEN;PPP6C;FBXW11;ACP6;CTDSP1;PTPN18;LHPP
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.2420879155040881,-0.7106739373328816,0.8716814159292036,0.9422314387740417,1.0,7/18,28.99%,SHANK3;CACNG4;CACNG8;CACNG3;TSHZ3;CCR2;CCL2
prerank,positive regulation of hydrolase activity (GO:0051345),0.24749995773473102,0.7102747614960406,0.9362348178137652,0.9837472068012354,1.0,22/137,17.39%,CCL8;SGSM2;MAPK12;S100A10;F2R;RASGRF1;NDEL1;RCN3;ASAP3;ADCYAP1;FLCN;CCL25;CALM2;CCL13;PIN1;RHOA;BCAS3;RAPGEF1;EVI5;EVI5L;SRGAP2;ARAP1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.2879109592548554,0.7101235896028774,0.8542654028436019,0.9835387145966528,1.0,9/30,28.30%,CHUK;TLR4;UBA52;CD14;TRAF3;UBE2D3;TICAM1;CASP8;CD300LF
prerank,retinoic acid metabolic process (GO:0042573),0.33064694459843746,0.7091959052863436,0.8344459279038718,0.9841954958309808,1.0,3/14,19.31%,CYP2S1;ALDH1A3;SCPEP1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.3069038403240906,0.7089441563106654,0.8525402726146221,0.9840818536144147,1.0,12/22,37.15%,PPP1R1B;MGAT5;FKBP1A;TIPRL;CRY2;PTPA;FKBP1B;BOD1;PPP4R4;NCKAP1L;ROCK2;GSK3B
prerank,negative regulation of cholesterol transport (GO:0032375),-0.2823248807431584,-0.7085150717964706,0.8350877192982457,0.9432193704163878,1.0,10/10,71.79%,ABCA2;APOC1;SHH;ABCG5;APOA2;PLA2G10;ABCG8;APOC3;SREBF2;NFKB1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.2546045520245611,0.7080393681391866,0.9264248704663213,0.984717716195973,1.0,37/94,29.97%,CRIP1;C1QBP;CUL3;GSKIP;ERN1;SELENOK;CEBPB;BAK1;SFN;BBC3;QRICH1;DIABLO;CDKN1A;FHIT;TNFRSF1B;STK24;MLLT11;DDX5;HTRA2;PML;APAF1;MCL1;CUL5;PYCARD;ATF4;CYP1B1;DDIT3;SCN2A;LGALS12;MSH6;PRKDC;HIC1;TOPORS;CUL1;BAX;TP53;AIFM1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.313693576393688,0.7079170876355151,0.823915900131406,0.9844937413270095,1.0,4/18,17.60%,ABL2;POR;GDNF;PDP2
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.3331514273942857,0.7075938434290234,0.8214765100671141,0.9844873563086752,1.0,7/13,32.05%,IRAK4;IRAK1;EPG5;TNIP2;MYD88;TRAF6;PIK3R4
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.2944764463835599,0.7073744174073178,0.833130328867235,0.9843546852141106,1.0,3/24,7.85%,FGF2;F2R;PKD2
prerank,T cell activation (GO:0042110),0.26472210475712477,0.7071206141051872,0.8940677966101694,0.9842591801162218,1.0,15/69,25.66%,IRF4;DPP4;CD44;PPP3CA;IL4;LMBR1L;NCK1;PPP3CB;DDOST;PIK3CG;FKBP1A;LEPR;NCK2;RAB29;KIF13B
prerank,carboxylic acid transmembrane transport (GO:1905039),0.2746647333959865,0.7070444848248986,0.8584579976985041,0.9839597803934073,1.0,5/40,13.02%,SLC25A21;SLC7A6;ABCC1;SLC23A1;SLC23A2
prerank,regulation of cellular amide metabolic process (GO:0034248),0.286850093065953,0.7068071185589807,0.8551564310544612,0.9838399274487507,1.0,11/32,27.19%,PKP3;ATXN2;TIGAR;NOLC1;RBM3;PCIF1;METAP1;EIF2A;GRM5;CYFIP1;TSC1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.2780223173409193,0.7056546044397038,0.8553240740740741,0.9846941404104923,1.0,3/32,6.20%,F2R;P2RX3;CXCL10
prerank,regulation of chromosome segregation (GO:0051983),0.3217575186642473,0.7045715965379421,0.8308921438082557,0.9854755208001441,1.0,5/16,22.88%,SMC5;PUM1;SMC6;NUMA1;CSNK2A2
prerank,negative regulation of bone mineralization (GO:0030502),0.325747255904053,0.7044498511668602,0.8494475138121547,0.9852321567609024,1.0,1/13,3.05%,ECM1
prerank,regulation of receptor binding (GO:1900120),0.34765054817359675,0.7039379327228226,0.8242245199409158,0.9854111523780446,1.0,3/10,13.33%,PTPRF;ADAM15;ATP2A2
prerank,oxoacid metabolic process (GO:0043436),0.2916391337093092,0.7033649342748275,0.8624849215922799,0.985644549240635,1.0,6/27,21.08%,LIPT2;MIF;BPNT2;SULT4A1;ABHD14B;TPST2
prerank,sulfur amino acid catabolic process (GO:0000098),0.3474406337964073,0.7027013998605499,0.8412921348314607,0.9859674100411498,1.0,4/10,25.42%,MPST;TXN2;MTRR;CTH
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.3233756863841348,0.7023048827718028,0.8601108033240997,0.9860190140072811,1.0,10/14,38.29%,NME2;CMPK2;AK8;AK5;AK3;ME1;NMNAT2;CMPK1;AK7;PNP
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.2896231231833117,0.7021832248847603,0.8454106280193237,0.9857715166383406,1.0,7/26,22.79%,FGF2;F2R;PKD2;HTR2C;IBTK;SLC8B1;HTR2A
prerank,regulation of cellular biosynthetic process (GO:0031326),0.29015266414996976,0.7018929466224229,0.8599033816425121,0.9857182673234776,1.0,7/28,13.72%,PRKAB2;CD47;SIRPA;MITF;AVIL;EIF6;TNFRSF1B
prerank,microtubule nucleation (GO:0007020),0.30692308658974743,0.7010899014096292,0.8430379746835444,0.9862017227175568,1.0,6/19,23.10%,NDEL1;SLAIN2;AKAP9;CLASP2;TUBGCP5;TUBG2
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.21780604151145025,-0.7008576645258163,0.9180327868852459,0.949882160615653,1.0,8/23,27.14%,NR1H3;STAT1;PTPN2;PIAS1;PARP9;IRGM;TXK;SOCS1
prerank,myofibril assembly (GO:0030239),0.27168603586431683,0.7006697571047696,0.864804469273743,0.9862655771057659,1.0,7/42,15.36%,SIX4;CSRP2;FHOD3;CASQ1;PDGFRA;TMOD2;KLHL41
prerank,cristae formation (GO:0042407),0.28808401488706786,0.7003099822272768,0.856453558504222,0.9862746257049506,1.0,13/27,29.81%,ATP5PO;ATP5ME;SPG7;UQCC3;APOOL;IMMT;ATP5MC3;DNAJC11;ATP5F1B;LETM1;CHCHD3;ATP5F1A;CHCHD6
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.2190847547792198,-0.6999535921131018,0.8961748633879781,0.9494908454001346,1.0,6/22,16.28%,NUBPL;HSPA9;CIAO1;NFU1;ISCU;NDOR1
prerank,cilium movement (GO:0003341),0.26702590400915766,0.6993466281913998,0.8932146829810901,0.9869135090230968,1.0,1/47,0.51%,CFAP251
prerank,lamellipodium organization (GO:0097581),0.2900616637470794,0.69931816778819,0.8568075117370892,0.9865739453066795,1.0,10/29,26.99%,ABLIM1;WASF1;SNX1;CTTN;CCDC88A;DMTN;RAC1;CYFIP1;SPATA13;ARHGEF7
prerank,steroid biosynthetic process (GO:0006694),0.26721733520715546,0.698111175291598,0.8857453754080522,0.9875021239193671,1.0,7/56,9.72%,OSBPL3;OSBPL2;INSIG2;SCP2;SRD5A1;HSD3B7;OSBPL6
prerank,cardiac conduction system development (GO:0003161),0.29110941635597465,0.6978643084555463,0.8530510585305106,0.9873838472011255,1.0,3/24,10.04%,SMAD4;SMAD5;HCN4
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.2520770590709951,0.6975418805466557,0.9203354297693921,0.9873585725674834,1.0,29/85,31.72%,PSMC4;SMURF2;AP2A2;PSMC6;CLTC;FZD7;PARD6A;PSMD8;MAGI2;VANGL2;RHOA;FZD4;DAAM1;TIAM1;SMURF1;AP2M1;PSMD3;DVL1;PSMD4;RAC1;PSMB3;PSMB2;PSMD5;PSMD14;WNT11;PSMC3;PSMC5;AP2A1;PSME4
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.33787018225318544,0.6972813772102172,0.8146611341632088,0.9872604712096128,1.0,1/11,2.47%,FYN
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.2811089288000272,0.6971849566350901,0.8965116279069767,0.9869847667338895,1.0,8/30,18.16%,RASGRF1;RASGEF1A;SRC;ITGAV;IRS2;SHOC2;RAPGEF1;STK19
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.27963649547381336,0.6968185623607703,0.8615023474178404,0.9870026170720847,1.0,8/32,20.62%,FGF13;MAPRE1;CAMSAP1;TUBB4A;FKBP4;NAV3;CLIP3;CLASP2
prerank,cellular protein-containing complex assembly (GO:0034622),0.2421436926630648,0.6966406213599103,0.9577039274924471,0.9868199899910224,1.0,40/159,25.43%,BIN1;SMAD4;AXIN1;HOPX;NUP93;PSMG2;AHCTF1;CENPT;VAMP1;SRC;SRP19;NUP107;CLTC;ADRM1;NUP98;MAPT;TBCEL;CALY;NSG1;CASQ1;DNAAF3;HSP90AA1;CENPC;NCK1;PFDN6;VAMP2;CENPE;TIAM1;VAMP4;TPR;FKBP1A;AP2M1;NCK2;EIF4H;RAB5IF;RTN4;PSMD4;NDUFAF1;VBP1;FCHO2
prerank,peptidyl-lysine monomethylation (GO:0018026),0.34365094294838217,0.6963398291956003,0.8342391304347826,0.9867793359287262,1.0,2/10,11.81%,SETD7;SETD2
prerank,cellular response to interleukin-6 (GO:0071354),0.290174493405623,0.6962078324150011,0.8536585365853658,0.986548577939532,1.0,6/26,16.30%,SMAD4;SRC;PID1;CBL;FER;IL6
prerank,cellular copper ion homeostasis (GO:0006878),0.32866082894835236,0.6962063874145206,0.8237597911227154,0.9861806241555325,1.0,2/14,9.95%,COX19;ARF1
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.23146260237615102,-0.696070776879642,0.9253731343283582,0.9522346883816892,1.0,9/19,32.20%,MTHFS;ALDH1L1;SLC19A1;SHMT2;MTHFR;FPGS;SHMT1;ALDH1L2;MTHFD1L
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.2804016649777588,0.6958727774703275,0.8581477139507621,0.9861555128203802,1.0,7/32,23.74%,HNRNPA1;ACD;CCT7;XRCC5;NEK7;MAPK1;CCT4
prerank,regulation of cellular protein metabolic process (GO:0032268),0.2719660496926356,0.695586647117155,0.8987898789878987,0.986061424218548,1.0,17/47,28.22%,PKP3;ATXN2;WDR91;SSH1;AKT1;NOLC1;RBM3;KLF4;PCIF1;METAP1;EIF2A;CSF1;GRM5;CYFIP1;EIF4G1;TSC1;NFKB1
prerank,regulation of protein localization to cell surface (GO:2000008),0.27615510129163406,0.6954296580585095,0.8602272727272727,0.9858497936506954,1.0,12/33,28.93%,RAB11FIP5;TOR1A;STX4;EGF;GOPC;STX3;MAP1A;LEPROT;GBF1;SNX33;RANGRF;TM9SF4
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.29783208259876437,0.6946956709340065,0.8605830164765526,0.9862355979971202,1.0,5/20,20.83%,ACLY;FAR1;HSD17B8;SCD5;HSD17B4
prerank,ganglioside biosynthetic process (GO:0001574),0.3172292228185448,0.6935697937458403,0.8315926892950392,0.9870473210547837,1.0,1/15,1.20%,ST3GAL2
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.325562644237966,0.6929895376752546,0.8410958904109589,0.9872851758226376,1.0,2/13,13.35%,ANK2;KCNJ3
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.33679733086393804,0.692338480488257,0.8286099865047234,0.9875844706975022,1.0,4/11,21.20%,UQCRQ;UQCC3;UQCRH;UQCR10
prerank,positive regulation of dephosphorylation (GO:0035306),0.2863523846923261,0.6922850171730447,0.8838862559241706,0.9872701289832349,1.0,8/27,22.96%,SRC;CALM2;PIN1;NSMF;PPIA;SMPD1;PTBP1;ANKLE2
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.2812377237840251,-0.6922684683637997,0.8615916955017301,0.9547105385970134,1.0,5/10,29.91%,TBX1;ACTN4;RXRG;RXRB;RXRA
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.261796140464567,0.692104418371742,0.8926247288503254,0.9871077787572851,1.0,12/48,23.65%,PAPSS2;AMPD2;SLC25A16;ADCY8;PANK1;SLC26A1;PANK3;DCAKD;ACAT1;NPR2;ADSS2;ADCY2
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.3044347159417837,0.6918485072648756,0.8578680203045685,0.9870016679075686,1.0,1/19,2.31%,AMPD2
prerank,aspartate family amino acid catabolic process (GO:0009068),0.3039193204420795,0.6912174854156786,0.8589580686149937,0.9872886784620537,1.0,1/19,0.85%,SLC25A21
prerank,regulation of potassium ion transport (GO:0043266),0.2779104300091184,0.6912042799168823,0.8726190476190476,0.9869380144946592,1.0,2/31,2.71%,FHL1;ANK2
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.2620218154420742,0.690576534909017,0.898471615720524,0.9868303514945993,1.0,14/56,20.51%,NDUFS5;TMEM126A;NDUFAF8;NDUFAB1;NDUFAF6;NDUFS1;NDUFB7;NDUFV2;NDUFA2;ACAD9;DMAC2;BCS1L;NDUFB2;DMAC1
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.2620218154420742,0.690576534909017,0.898471615720524,0.9868303514945993,1.0,14/56,20.51%,NDUFS5;TMEM126A;NDUFAF8;NDUFAB1;NDUFAF6;NDUFS1;NDUFB7;NDUFV2;NDUFA2;ACAD9;DMAC2;BCS1L;NDUFB2;DMAC1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.25280372568056014,-0.6901150763755246,0.8996282527881041,0.9555452555983348,1.0,2/14,4.55%,CHKA;ETNK2
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.2895653130922067,0.6897026145493567,0.8524788391777509,0.9869746353778233,1.0,5/23,15.08%,SMAD4;RNF111;FLCN;SLC2A10;GIPC1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.2895653130922067,0.6897026145493567,0.8524788391777509,0.9869746353778233,1.0,5/23,15.08%,SMAD4;RNF111;FLCN;SLC2A10;GIPC1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.3208883402733195,0.6896518912109203,0.8613728129205922,0.9866543522787633,1.0,5/13,17.32%,FUT9;IRAK1;RHOA;IL6;ZDHHC21
prerank,positive regulation of ion transport (GO:0043270),0.2620481290146751,0.688634241647282,0.9008908685968819,0.9873064109275742,1.0,3/48,3.19%,FHL1;ANK2;F2R
prerank,sensory perception of taste (GO:0050909),0.3404086606419729,0.6885020653009679,0.8166666666666667,0.9870782568885559,1.0,2/10,20.32%,ASIC2;ASIC1
prerank,protein alkylation (GO:0008213),0.2973766359864834,0.6878272036138625,0.8622448979591837,0.9873711313822148,1.0,9/22,35.23%,PRMT2;GSPT1;SNRPD3;EEF2KMT;CAMKMT;PRMT8;ETF1;EEF1AKMT1;FAM98A
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.25252362351322893,0.6873641614287967,0.9231578947368421,0.9874279743606073,1.0,26/76,31.82%,AXIN1;PIAS3;STUB1;UBA2;MYCBP2;CUL3;HDAC3;TNIP1;NDFIP1;HDAC4;ZC3H12A;SAE1;NSMCE3;DERL1;UBE3A;FKBP1A;FBXW7;MUL1;DCUN1D1;BCL10;LAPTM5;SENP2;SPRTN;TRAF6;GSK3A;CDK5RAP3
prerank,regulation of amyloid fibril formation (GO:1905906),0.3143994883814757,0.6873001273856659,0.8529032258064516,0.9871246981734507,1.0,8/15,26.38%,PSEN1;CHRNA7;PFDN6;IAPP;LDLR;CRYAB;VBP1;PFDN2
prerank,sterol transport (GO:0015918),0.29645815492138944,0.6872612100435289,0.8305519897304237,0.9867895803841747,1.0,2/19,8.68%,OSBPL2;LCAT
prerank,cellular amino acid catabolic process (GO:0009063),0.24802546049097188,0.6863685739329335,0.9375650364203955,0.9872989490081869,1.0,11/87,15.42%,AMDHD1;SLC25A21;HAL;BCAT1;AUH;HIBADH;GLS2;GLS;CRYM;ALDH5A1;GLUD1
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.32000251130085344,0.6861813152350676,0.8674698795180723,0.9871091098273059,1.0,14/14,68.03%,ATP6AP1;CSF1;TRAF6;IFNG;POU4F2;IL12B;IL23R;TNF;IL23A;OCSTAMP;TNFSF11;CCR1;POU4F1;TYROBP
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.24259841701847543,0.6857085230752095,0.9443298969072165,0.9872141714584092,1.0,14/104,15.60%,LRP6;GTPBP4;ETAA1;SRC;SYAP1;AKT1;PPEF2;CALM2;CDKN1A;CCND1;RHOA;SLC8A2;CCNH;MAP2K2
prerank,tRNA export from nucleus (GO:0006409),0.2798204326738128,0.6854143383952125,0.8787158145065398,0.986769524875967,1.0,16/32,34.13%,NUP93;NUP107;NUP98;NUP37;NUP50;XPOT;TPR;NUP133;NUP85;NUP188;NUP88;SEC13;AAAS;NUP160;NUP54;RANBP2
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.2798204326738128,0.6854143383952125,0.8787158145065398,0.986769524875967,1.0,16/32,34.13%,NUP93;NUP107;NUP98;NUP37;NUP50;XPOT;TPR;NUP133;NUP85;NUP188;NUP88;SEC13;AAAS;NUP160;NUP54;RANBP2
prerank,regulation of primary metabolic process (GO:0080090),0.24293324065871322,0.6851223222888861,0.9706774519716885,0.9866865760950925,1.0,21/126,16.32%,PSMC4;NR1D2;MVK;PRKAB2;NR1D1;PSMC6;PLPP1;SIN3B;CHD9;PSMD8;GGPS1;ODC1;HELZ2;HDAC3;IRS2;TGS1;NCOR2;NCOR1;BBS4;PMVK;OPA3
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.2970390051715503,0.6850584621656277,0.8598014888337469,0.9863884270201179,1.0,5/21,22.86%,ZW10;ZWINT;FBXO5;TPR;KLHL22
prerank,DNA integrity checkpoint signaling (GO:0031570),0.27381580731093724,0.6846225551497864,0.8930602957906713,0.9864400349588258,1.0,9/36,23.62%,TIPIN;RHNO1;RAD1;DNA2;BRIP1;NBN;DONSON;CLSPN;TIPRL
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.3047891123183671,0.6842876748061603,0.865211810012837,0.9863906968985885,1.0,4/18,16.43%,C1QBP;PUM1;NOP53;SEC14L1
prerank,clathrin coat assembly (GO:0048268),0.3137370775797486,0.6831524403004937,0.8651832460732984,0.9871167693526361,1.0,3/15,13.64%,CLTC;CALY;NSG1
prerank,stem cell development (GO:0048864),0.31514526200111226,0.6827403906515761,0.8456549935149157,0.9871357551424647,1.0,3/16,16.59%,SOX8;NOLC1;SNAI2
prerank,cellular response to catecholamine stimulus (GO:0071870),0.2860375459843266,0.6826458574288838,0.8760951188986232,0.9868605897457785,1.0,7/23,22.18%,ATP2B4;SIRT2;SLC9A1;GNB1;MAPK1;GABPA;ATF4
prerank,peptidyl-lysine trimethylation (GO:0018023),0.28473143939473666,0.6810069562698774,0.8844765342960289,0.9880833796541838,1.0,8/26,20.13%,SETD2;ANTKMT;SETD5;OGT;EEF2KMT;PRDM9;SETD1B;KMT2A
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.2753843705009543,-0.6803291870482979,0.8614457831325302,0.9635281165389683,1.0,2/10,9.08%,ALDH7A1;SARDH
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.32643106589053195,0.6803163228626038,0.8671328671328671,0.9884052261114761,1.0,3/13,15.83%,IL33;TLR4;SELENOS
prerank,rRNA catabolic process (GO:0016075),-0.24090674247040403,-0.6802933121965992,0.8893280632411067,0.9621922975104239,1.0,6/16,24.23%,EXOSC9;DIS3L;DEDD2;DIS3;PELO;EXOSC4
prerank,histone H3-K4 trimethylation (GO:0080182),0.3281010437220746,0.6800065295751457,0.8474341192787794,0.9883445220290046,1.0,6/11,31.06%,OGT;PRDM9;SETD1B;KMT2A;SETD1A;TET3
prerank,regulation of lipid metabolic process (GO:0019216),0.24600672601554113,0.6795539184127012,0.9398340248962656,0.9884382356991419,1.0,17/88,16.32%,NR1D2;MVK;NR1D1;PLPP1;SIN3B;CHD9;GGPS1;HELZ2;HDAC3;IRS2;MBOAT7;TGS1;NCOR2;NCOR1;BBS4;PMVK;OPA3
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.3297508635431237,0.6789460767297577,0.8728323699421965,0.988683331721288,1.0,6/10,33.35%,DBF4;INO80;E2F7;ATRX;WIZ;CDC7
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.3068749332347549,0.6786954416188912,0.8556149732620321,0.9885474312390442,1.0,2/16,13.94%,CLDN10;CLDN12
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.25371801151866835,0.6784119695219469,0.9026258205689278,0.988457784322289,1.0,9/53,17.25%,EGFR;EYA2;UBE2N;TIGAR;ABRAXAS1;NACC2;DDX5;FXR2;EEF1E1
prerank,modulation of chemical synaptic transmission (GO:0050804),0.24559422762052682,0.6782304005656916,0.9514963880288958,0.9882641287548887,1.0,33/107,26.07%,CEL;SLC4A8;DLG4;DLGAP4;STX1B;NRG3;DLGAP3;HCRT;LGI1;PXK;BTBD9;SLC8A2;DLGAP1;CNTNAP4;GRID1;GRM1;CHRNA7;SYT1;AKAP9;RIMS2;CLSTN3;PTEN;NMU;GRIK5;GRIK2;NPTX1;DGKI;BCR;GRIK4;BAIAP3;GRM5;BEGAIN;EIF4EBP2
prerank,negative regulation of MAP kinase activity (GO:0043407),0.2657375344779328,0.6776444335420808,0.8922222222222222,0.9884620932167301,1.0,4/44,5.35%,UCHL1;IRAK3;AIDA;PTPRJ
prerank,positive regulation of defense response (GO:0031349),0.24489757112908286,0.6775302448262496,0.9414784394250514,0.9882013910700549,1.0,16/89,19.46%,IL16;S100A8;S100A9;IL33;IL17RA;TLR4;CD47;POLR3D;TNIP1;AKIRIN2;ABCC1;SLC15A4;PDCD4;IL18;IFI35;LRSAM1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.2628605059843431,-0.6774134999206256,0.8962264150943396,0.9633483025632495,1.0,4/11,17.98%,CAV1;PTPRT;NF2;ADIPOR1
prerank,phagosome acidification (GO:0090383),0.2783855945227209,0.67726080470075,0.8735083532219571,0.9880869962817556,1.0,5/26,16.13%,ATP6V0A2;ATP6V1E1;ATP6V0A1;ATP6V1D;ATP6V1B2
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.28545731689961634,0.6772358240950768,0.8701923076923077,0.9877519865932948,1.0,4/24,10.96%,PKD1;RHBDF1;UCHL5;GPX1
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.25841285686083887,-0.677184909758765,0.9119718309859155,0.9621750988899528,1.0,3/12,14.28%,AXIN2;WAPL;CTNNB1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.24865956067379708,0.6770184296438939,0.9337539432176656,0.9875832225111233,1.0,21/76,25.84%,AXIN1;COP1;STUB1;SIRT2;DNAJB2;USP5;NOP53;RNF14;ZER1;KEAP1;ARIH2;RNF19A;ARIH1;PTEN;SMURF1;ZYG11B;DVL1;MDM2;FBXO22;FBXW7;CSNK1E
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.2708266593042125,0.6770153927964814,0.894374282433984,0.9872218806768075,1.0,6/34,13.53%,BTC;CUL3;CDC23;ANAPC5;EGF;CDC27
prerank,phosphate ion transmembrane transport (GO:0035435),0.3275306003495967,0.6767997779136583,0.8583333333333333,0.9870627106423447,1.0,4/12,21.28%,SLC37A3;SLC25A3;SLC20A1;SLC37A4
prerank,stress-activated MAPK cascade (GO:0051403),0.2552654786543028,0.676637973922644,0.9234088457389428,0.9868537346636577,1.0,17/61,24.27%,MAPK14;ZFP36L1;MAP2K3;UBE2N;CHUK;MAPK11;IRAK1;UBA52;ZFP36;TAOK2;MAP2K4;MAPK1;TAB2;FBXW11;MAP3K7;TNIP2;GPS1
prerank,"transcription, DNA-templated (GO:0006351)",0.2360362065653339,0.6759820831110814,0.97997997997998,0.9871546529016895,1.0,48/207,23.87%,NFIX;POLR2H;GTF2H3;ABT1;PAX1;BRF2;PPP5C;CDK9;SOX5;TAF3;DDX21;UBTF;ERCC3;GTF3C2;POLR2D;POLR2G;BCL3;GTF2A2;CCNH;EAF2;CTDP1;BRF1;GTF2F1;BTF3;NFE2L3;EAF1;DDX5;POLR3H;TCEA2;HIPK3;GTF2E2;POLR1C;MBD1;PAF1;SLC25A33;LHX1;ATF4;RNMT;POLR3A;BAZ2A;SMN1;ELL;TBP;TAF13;GTF3C5;NCOA6;TRIM24;RTF1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.24551496655479754,0.675425517605986,0.9270833333333334,0.9873007023363546,1.0,23/85,25.84%,TMEM259;COP1;PSMC6;STUB1;SIRT2;DNAJB2;USP5;NUPR1;NOP53;RNF14;ZER1;KEAP1;ARIH2;RNF19A;ARIH1;TMTC3;USP13;ZYG11B;DVL1;MDM2;FBXO22;FBXW7;CSNK1E
prerank,phosphate ion transport (GO:0006817),0.30517639643808075,0.6751635461578246,0.8771241830065359,0.9872147582496766,1.0,4/16,21.28%,SLC37A3;SLC25A3;SLC20A1;SLC37A4
prerank,acylglycerol homeostasis (GO:0055090),0.2970430498172518,0.6746883709913797,0.8573232323232324,0.9873264956964551,1.0,6/20,22.60%,MLXIPL;PNPLA8;IL18;LIPC;ANGPTL3;RORA
prerank,response to interferon-gamma (GO:0034341),0.2495967585880141,0.6739545850761203,0.9249183895538629,0.9876413919815843,1.0,8/67,12.90%,CCL8;CYP27B1;CCL25;TLR4;CD47;SIRPA;SLC26A6;CCL13
prerank,regulation of transposition (GO:0010528),0.3147041414015628,0.6730867087321771,0.8555858310626703,0.9880873502542128,1.0,3/13,22.64%,SPOCD1;DDX4;UBR2
prerank,calcium ion transmembrane transport (GO:0070588),0.24558145037063242,0.672252326481259,0.9411764705882353,0.9885255121138158,1.0,26/86,26.25%,PKD1;TRPV3;ATP2B4;GRIN2D;GAS6;PKD2;MCU;ITGAV;SLC35G1;MCUB;ATP2A2;SLC8A2;TRPC4AP;TMEM165;GRIN2A;SPG7;ATP2B1;SLC8B1;FKBP1A;PARL;TRPC1;CACNA2D1;TRPV2;TMCO1;SLC24A4;SLC24A2
prerank,inner dynein arm assembly (GO:0036159),0.3300903841325634,0.6718534892449418,0.8593530239099859,0.9885327853046978,1.0,10/10,67.01%,DNAAF5;CCDC39;CFAP73;ZMYND10;DNAI3;DNAAF1;DNAH1;DNAAF4;CCDC40;CFAP100
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.29775821785790174,0.6718010916804987,0.8698979591836735,0.9882230215688752,1.0,5/19,20.96%,DYRK2;RPS27L;BCL3;PML;PYCARD
prerank,negative regulation of binding (GO:0051100),0.2423017322486728,0.6707736534872711,0.9304531085353003,0.9888354529244285,1.0,15/81,16.80%,DACT1;GTPBP4;GNL3L;CARD16;TFIP11;USP33;AKT1;SLPI;DNAJB2;CDKN1A;PIN1;DDX11;GTF2F1;ILRUN;TFAP4
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.24776307654079938,0.6703823162436203,0.918834547346514,0.9888525489651637,1.0,11/73,12.87%,EIF2AK3;F2R;S100A8;S100A9;MTCH1;PDCD2;MAPT;ANP32B;BBC3;DIABLO;RPS27L
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.3341415527049584,0.6702377054330492,0.8674188998589563,0.9886395755335554,1.0,3/10,27.81%,CCT7;CCT4;CCT6A
prerank,positive regulation of phagocytosis (GO:0050766),0.25859404741874414,0.6697256590667054,0.9222462203023758,0.9887490037709312,1.0,5/47,10.21%,PTPRJ;GAS6;CD47;SIRPA;C4B
prerank,regulation of cation transmembrane transport (GO:1904062),-0.2026578795759627,-0.6696285891771165,0.9404761904761905,0.9674311446224736,1.0,3/29,4.69%,KCNIP3;DLG1;CACNA1D
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.26991075923062097,0.6680629139825324,0.8950471698113207,0.9899084603373011,1.0,11/28,31.82%,AXIN1;PSMC6;NUPR1;PTEN;TMTC3;SMURF1;FBXW7;LAPTM5;PSMC3;PSMC5;CDK5RAP3
prerank,negative regulation of histone modification (GO:0031057),0.30469838425669393,0.6678002975472441,0.8651535380507344,0.9897960511776512,1.0,4/14,20.02%,NOC2L;TWIST1;SET;CTBP1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.23522014568414887,0.6674969559967014,0.9574036511156186,0.989711021251876,1.0,22/117,20.06%,CYP2S1;ACOT6;CPT1C;ALKBH7;SLC6A8;SCP2;HAGH;PTGR1;PDHX;FA2H;PNPLA8;GBA2;GAMT;ALDH1A3;ACOT1;VDAC1;PDHA1;BTD;GPAM;ANGPTL3;SCPEP1;LDHA
prerank,response to glucose (GO:0009749),0.2590975971456476,0.666942361607397,0.9161147902869757,0.9898712826127807,1.0,10/46,19.82%,SLC39A14;TCF7L2;GAS6;ERN1;IRS2;ADCY8;SELENOS;VAMP2;GPLD1;EIF2B1
prerank,folic acid metabolic process (GO:0046655),-0.22330665599386212,-0.6664455241262172,0.9348837209302325,0.9686220303752102,1.0,9/18,32.20%,MTHFS;ALDH1L1;SLC19A1;SHMT2;MTHFR;FPGS;SHMT1;ALDH1L2;MTHFD1L
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.2592341811228818,0.6662839412069078,0.8988505747126436,0.9901065274167952,1.0,5/39,12.02%,FHL1;ANK2;FXYD5;YWHAE;STK39
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.24600762985723745,-0.6662328978689909,0.9076305220883534,0.9673861158292466,1.0,5/13,19.99%,PHYH;OGDH;ADHFE1;DLST;IDH2
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.245509553172519,0.6660545779654908,0.9327024185068349,0.9899680053691134,1.0,5/75,5.35%,LRP6;UCHL1;HEG1;IRAK3;PTPRJ
prerank,liver development (GO:0001889),0.2668033798787441,0.6659438791987327,0.8995271867612293,0.9896993164401009,1.0,4/32,11.23%,ANXA1;COBL;PKD2;CEBPB
prerank,macrophage migration (GO:1905517),-0.24926227462686104,-0.6657602053661215,0.868,0.966403994101434,1.0,6/13,35.46%,EDNRB;TAFA4;CCR2;CCL2;CXCL17;CCL5
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.26656381493534415,0.6651173057892855,0.9018691588785047,0.9900943111657466,1.0,7/35,23.74%,HNRNPA1;ACD;CCT7;XRCC5;NEK7;MAPK1;CCT4
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.2917818815441422,0.664159163291136,0.8788659793814433,0.990620251849782,1.0,10/18,38.06%,CCT7;CCT4;EXOSC10;CCT6A;NHP2;RUVBL1;RUVBL2;TCP1;PARN;CCT8
prerank,ceramide catabolic process (GO:0046514),-0.23571238562561717,-0.6632201919773355,0.8864628820960698,0.9671514586295519,1.0,1/14,2.35%,ACER2
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.27864170735582494,0.6629555386906966,0.8955042527339003,0.9913604452767943,1.0,5/23,24.99%,CNGB1;SAG;METAP2;METAP1;CAMKMT
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.24172091306874469,0.6629342736437164,0.9448491155046826,0.9910244806609803,1.0,22/84,28.25%,PSMC4;PSMC6;PSMD8;CUL3;CDC23;ANAPC5;FBXO5;FBXO31;UBA52;CDC27;CDC26;ANAPC4;SKP2;ANAPC10;ANAPC15;ECRG4;PSMD3;PSMD4;PSMB3;ANAPC2;PSMB2;PSMD5
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.23873204770002412,0.6627401650566385,0.9355509355509356,0.9908396388846687,1.0,30/88,31.72%,PSMC4;PSMC6;FBXO2;PSMD8;FBXO17;FBXL2;FBXW4;FBXL20;FBXO31;FBXL3;DMAC2;FBXL5;SKP2;CUL5;FBXW11;FBXO38;PSMD3;FBXL12;PSMD4;FBXW7;PSMB3;PSMB2;PSMD5;CUL1;FBXL8;PSMD14;PSMC3;PSMC5;FBXL13;PSME4
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.24930880654354806,0.6619178240036079,0.9221491228070176,0.9912165443697054,1.0,10/54,16.87%,TRIAP1;MUC1;MDM4;SFN;CDKN1A;CNOT3;CNOT10;PLAGL1;TNKS1BP1;PML
prerank,rRNA metabolic process (GO:0016072),0.22924388671180274,0.6609269262386962,0.9685916919959473,0.9917467681151061,1.0,35/160,23.67%,C1D;DDX49;FCF1;ESF1;HELQ;EXOSC7;RRP36;RPL10A;WDR46;MAPT;UBA52;SBDS;MPHOSPH10;RCL1;SNU13;NOLC1;DCAF13;RRP7A;EXOSC1;RPL6;NOP53;DDX52;POP4;PWP2;EBNA1BP2;TBL3;RPL23;RPL17;PDCD11;KRR1;RPS25;WDR18;NOC4L;TEX10;RRP1B
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.23588567919715464,0.6607595437877702,0.9611848825331971,0.9915399818532592,1.0,37/109,31.13%,SYK;PSMC4;PIK3R2;NFATC1;PSMC6;CHUK;PIK3CA;PSMD8;FER;PPP3CA;SOS1;MAP2K4;CARD11;PPP3CB;MAPK1;GAB2;TAB2;JUN;FBXW11;MAP3K7;VAV2;RELA;PSMD3;PSMD4;RAC1;PSMB3;BCL10;PSMB2;NFKB1;PSMD5;CUL1;FOS;PSMD14;TRAF6;PSMC3;PSMC5;CALM1
prerank,negative regulation of DNA metabolic process (GO:0051053),0.28036362875773846,0.660584649867107,0.8922888616891065,0.9913414611775758,1.0,10/24,27.51%,ERCC4;XRCC5;CDKN1A;BLM;KMT2A;TERF2IP;ERCC1;H1-0;MSH6;DFFA
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.31859920060328917,0.6604356749926726,0.8783216783216783,0.9911152215139448,1.0,2/11,15.11%,SLC25A4;NUPR1
prerank,response to light stimulus (GO:0009416),0.25206300806992255,0.6601089298116267,0.9230769230769231,0.9910421631800634,1.0,19/55,31.28%,UBE2B;DTL;ERCC3;UBE2A;ERCC4;PCLAF;UVSSA;ERCC5;TYR;POLD1;OPN3;REV1;CRY2;MSH6;MEN1;SPRTN;DRD2;COPS3;CIRBP
prerank,negative regulation of dephosphorylation (GO:0035305),0.2966997715114161,0.6600756158788297,0.8942675159235669,0.9907136352691015,1.0,8/18,28.87%,INPP5K;URI1;CHP1;SH2D4A;YWHAB;PPP1R26;PTPA;GPATCH2
prerank,steroid catabolic process (GO:0006706),-0.26195627032232716,-0.6599108873010656,0.8741258741258742,0.9685126521190124,1.0,2/10,10.30%,YWHAH;SPP1
prerank,cellular response to unfolded protein (GO:0034620),0.2753720593074537,0.659308485483638,0.8945497630331753,0.9909966161478606,1.0,10/26,29.96%,HSPA13;ERN1;BAK1;HSPA14;ABCB10;BAG3;TM7SF3;BAX;HSPA8;HSF1
prerank,organic cation transport (GO:0015695),0.287372279517972,0.6589065483156998,0.8768656716417911,0.9909874267268236,1.0,4/20,17.46%,SLC47A1;SLC44A1;SEC14L1;SLC44A2
prerank,regulation of mitotic nuclear division (GO:0007088),0.24620534079378542,0.6581645070264264,0.933911159263272,0.9912553161154088,1.0,9/55,15.78%,BTC;CCDC8;AURKAIP1;KIF20B;FBXO5;EGF;PIN1;CUL9;CDK5RAP2
prerank,regulation of feeding behavior (GO:0060259),-0.257674736528378,-0.6574111568876639,0.8906752411575563,0.969115848600392,1.0,3/11,21.73%,SGIP1;CFAP20;NR4A3
prerank,glycogen catabolic process (GO:0005980),0.2978148994939849,0.6568194262346707,0.8616600790513834,0.9920758983597472,1.0,8/15,31.13%,PHKA2;PGM2L1;GAA;PYGB;PHKA1;RB1CC1;PHKG1;CALM1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.26588705899390924,0.6565613148279089,0.9049295774647887,0.9919329929782917,1.0,6/31,12.73%,YWHAG;YWHAE;PPP3CC;BAK1;SFN;BBC3
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.31470067716615674,0.6563815286361137,0.8677248677248677,0.9917103603416904,1.0,1/12,8.30%,ZBTB1
prerank,negative regulation of secretion (GO:0051048),0.3217391921445772,0.6562026409081086,0.8663853727144867,0.9915177709477169,1.0,2/10,12.37%,SPX;EGF
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.29932708092785176,0.6558803608179575,0.8735332464146024,0.9914493735306048,1.0,7/15,33.06%,CNTNAP4;BAIAP3;NPAS4;NLGN1;DRD2;NLGN2;ZDHHC3
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.3087459335266509,0.6558098225999118,0.8792401628222524,0.9911481165523546,1.0,4/13,21.08%,BPNT2;SULT4A1;ABHD14B;TPST2
prerank,regulation of telomerase activity (GO:0051972),0.2511921893394218,0.6555583842701667,0.9363128491620112,0.9909777125084759,1.0,10/45,21.04%,SRC;ACD;ERCC4;XRCC5;TERF1;KLF4;HSP90AA1;SMG6;NEK7;MAPK1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.2885683172350966,0.6540472371980924,0.9010554089709762,0.99191742487653,1.0,5/19,17.16%,BIN1;PIN1;RTN3;FLOT2;CHRNA7
prerank,negative regulation of nuclear division (GO:0051784),0.31468678495857993,0.6540242597102924,0.8786610878661087,0.9915766722707775,1.0,2/11,11.79%,AURKAIP1;FBXO5
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.27617658616470103,0.6535315749244197,0.885954381752701,0.9916434304315966,1.0,12/26,31.31%,DLG4;STX1B;SLC8A2;CHRNA7;RIMS2;PTEN;PRKCZ;NLGN1;NLGN3;NRXN1;CBLN1;NLGN2
prerank,negative regulation of cell cycle process (GO:0010948),0.2448501151662665,0.6533537019093326,0.9414316702819957,0.9914436382795256,1.0,15/61,22.14%,RNF2;AURKAIP1;RYBP;PHC3;PHC1;FBXO5;TERF1;EHMT2;CCP110;UXT;APAF1;RING1;PCGF6;FOXO4;EZH2
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.2441144050130296,-0.6525779118797633,0.9128787878787878,0.9714756265909971,1.0,4/13,14.84%,YAE1;CIAO1;NFU1;GLRX3
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.2274760617705662,-0.6519341790501829,0.8981818181818182,0.9692312158985796,1.0,2/13,5.54%,PLCB1;SHC1
prerank,cellular response to interleukin-15 (GO:0071350),-0.2274760617705662,-0.6519341790501829,0.8981818181818182,0.9692312158985796,1.0,2/13,5.54%,PLCB1;SHC1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.3189213852288544,0.6517886808976777,0.8855507868383404,0.9924266915766548,1.0,3/10,16.53%,FLCN;SETD5;DIP2A
prerank,regulation of p38MAPK cascade (GO:1900744),0.26350732445518615,0.6517150387045203,0.9111880046136102,0.9921335524743023,1.0,5/35,16.19%,GADD45G;VEGFA;EMC10;ZC3H12A;PER1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.2684087977389782,0.6512183937888861,0.8987654320987655,0.9922171767236324,1.0,5/27,15.33%,PLAAT1;CHKB;PNPLA8;CEPT1;PLA2G4E
prerank,protein acetylation (GO:0006473),0.2687023179489579,0.6511463702796516,0.9043683589138135,0.9919145207027444,1.0,6/30,18.79%,FOXO1;KAT2B;ING4;MAPT;NAA15;NAA50
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.3203536803843516,0.6508182712129841,0.8831908831908832,0.9918392511170104,1.0,2/10,17.22%,ZNHIT6;NUFIP1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.24563411942328528,0.6504302323159364,0.9253567508232712,0.9917902784539062,1.0,10/54,19.21%,GTPBP4;GNL3L;PIAS3;USP4;SQSTM1;AKT1;CHP1;OGT;UFL1;U2AF2
prerank,negative regulation of chemokine production (GO:0032682),0.30042283739747755,0.6504224064588319,0.875,0.9914394852542174,1.0,3/14,16.30%,SIRPA;KLF4;IL6
prerank,nucleic acid-templated transcription (GO:0097659),0.2538521235964291,0.649886380812204,0.9064261555806088,0.9915179642815086,1.0,5/42,13.22%,POLR2H;PPP5C;POLR2D;POLR2G;BCL3
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.2424897849137723,0.6497053514349725,0.9362850971922246,0.9913174674754127,1.0,19/56,29.88%,SON;RHOA;BBS4;TTC19;SPTBN1;RAB35;CIT;RASA1;PDCD6IP;SEPTIN9;TRIM36;IST1;BIN3;SNX18;SNX33;CUL7;MYH10;INCENP;CKAP2
prerank,regulation of neurogenesis (GO:0050767),0.2434458170471787,0.6490750072354594,0.9438444924406048,0.9914748976149484,1.0,4/55,8.12%,NUMBL;BHLHE40;DOCK7;SERPINF1
prerank,negative regulation of blood pressure (GO:0045776),0.30557409464106433,0.64889100909942,0.8661311914323963,0.9912899286993047,1.0,3/13,19.31%,PRCP;GPR37L1;SCPEP1
prerank,meiosis I (GO:0007127),0.2752320415142125,0.6486988294817937,0.8916967509025271,0.9911005541099249,1.0,3/23,18.64%,SLC25A31;DDX4;FOXJ2
prerank,chromatin remodeling at centromere (GO:0031055),0.26416829732064817,0.6481282716919521,0.9044289044289044,0.9912296217335629,1.0,4/31,15.93%,CENPT;HJURP;NPM1;CENPC
prerank,negative regulation of lipid catabolic process (GO:0050995),0.2858159266594058,0.6481156455076696,0.8946684005201561,0.9908816583616348,1.0,3/17,19.54%,AKT1;PDE3B;GPLD1
prerank,protein-DNA complex assembly (GO:0065004),0.23087633342920327,0.6479127990012682,0.9723926380368099,0.9906950763726962,1.0,19/116,17.52%,PSMC4;GTF2H3;CHAF1B;RAD23B;PSMC6;SPTY2D1;PSMD8;MCM3;NPM1;ERCC3;UBA52;ANP32B;DDB1;CCNH;ORC6;GMNN;GRWD1;NAP1L2;ERCC5
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.27612867605888836,0.6477510487694044,0.9100985221674877,0.9904716723991195,1.0,6/22,24.13%,INHA;INPP5K;CDKN1A;CDKN2C;ANKLE2;DYNLL1
prerank,cellular response to dsRNA (GO:0071359),0.292988938603023,0.647481929864503,0.8887399463806971,0.9903373010645184,1.0,6/15,28.67%,CGAS;NPM1;FLOT1;RIOK3;MUL1;PDE12
prerank,positive regulation of protein ubiquitination (GO:0031398),0.23747181743190132,0.6470775123332412,0.953732912723449,0.9903012729927235,1.0,9/80,13.17%,SPSB4;AXIN1;STUB1;MYCBP2;UBE2N;CUL3;HDAC3;NDFIP1;PIN1
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.2719303882089139,0.6469217187302899,0.9095354523227384,0.9900740719997327,1.0,5/24,25.86%,LPCAT1;PNPLA8;GPAM;SLC27A1;PGS1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.2531152413721104,0.6467655833910496,0.9234234234234234,0.9898432046013853,1.0,8/44,15.71%,OSBPL3;OSBPL2;INSIG2;SCP2;HSD3B7;OSBPL6;PSAT1;PMVK
prerank,regulation of histone acetylation (GO:0035065),0.2584878526103931,0.6464066310469364,0.9212050984936269,0.9897840755097801,1.0,9/33,21.51%,NOC2L;FLCN;BRD7;SETD5;SET;GLYR1;CTBP1;KMT2A;ARRB1
prerank,histone H4 acetylation (GO:0043967),0.24919666741402963,0.6463572538305247,0.9250559284116331,0.989472070990143,1.0,12/47,20.88%,MSL2;MSL3;ING4;MSL1;WDR5;KANSL3;DMAP1;PER1;OGT;MORF4L1;KMT2A;TRRAP
prerank,leukotriene metabolic process (GO:0006691),0.2817908124745668,0.6462729779451922,0.9055627425614489,0.9891877639411871,1.0,3/19,12.70%,DPEP1;PTGR1;ABCC1
prerank,necroptotic process (GO:0070266),0.2874775433154138,0.6462082804897786,0.8884615384615384,0.9888932314783636,1.0,5/16,25.35%,TLR4;PGAM5;CD14;CYLD;TICAM1
prerank,Fc receptor signaling pathway (GO:0038093),0.23057665681965317,0.6461881837171116,0.9664292980671414,0.9885592930478347,1.0,37/110,31.13%,SYK;PSMC4;PIK3R2;NFATC1;PSMC6;CHUK;PIK3CA;PSMD8;FER;PPP3CA;SOS1;MAP2K4;CARD11;PPP3CB;MAPK1;GAB2;TAB2;JUN;FBXW11;MAP3K7;VAV2;RELA;PSMD3;PSMD4;RAC1;PSMB3;BCL10;PSMB2;NFKB1;PSMD5;CUL1;FOS;PSMD14;TRAF6;PSMC3;PSMC5;CALM1
prerank,negative regulation of double-strand break repair (GO:2000780),0.2607023711218336,0.6461539203693321,0.9297423887587822,0.9882276782774766,1.0,5/30,13.56%,CGAS;CYREN;TFIP11;NUDT16L1;TWIST1
prerank,action potential (GO:0001508),0.2492226121419506,0.6458821863403945,0.9285714285714286,0.9881067463709097,1.0,5/44,10.51%,SRI;SLC4A3;KCNJ2;MYH14;KCNA2
prerank,mitotic cytokinesis (GO:0000281),0.2456881785192529,0.6458107209785059,0.9238410596026491,0.9878189242364069,1.0,15/47,29.88%,SON;BBS4;TTC19;SPTBN1;RAB35;CIT;RASA1;PDCD6IP;TRIM36;SNX18;SNX33;CUL7;MYH10;INCENP;CKAP2
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.25928026483669986,0.6455381897386917,0.9150943396226415,0.9877082887989821,1.0,7/32,20.96%,DYRK2;RPS27L;BCL3;FHIT;DDX5;PML;PYCARD
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.2282428776047444,0.6454813847701084,0.9738430583501007,0.9874055517228784,1.0,37/148,24.94%,MAPK14;MTOR;PRKAB2;MDM4;NOC2L;RHNO1;MAPK11;BRD7;DYRK2;TAF3;RMI1;AKT1;RAD1;PIN1;DNA2;BRIP1;EHMT2;NBN;USP7;NOP53;RFC4;CHD3;PML;PIP4P1;RAD50;RPF2;BLM;TTC5;RPL23;PIP4K2B;NOP2;CSNK2A2;TBP;TAF13;HEXIM1;MDM2;KAT5
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3066723096909062,0.6450431320736595,0.8996088657105606,0.9873984815301752,1.0,3/13,26.15%,ALG1;SRD5A3;MPDU1
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.24590298581326459,-0.6443782522139753,0.894927536231884,0.9735280932099831,1.0,5/12,25.86%,MFNG;GPR183;DOCK10;FCGR2B;DLL1
prerank,peptidyl-arginine modification (GO:0018195),0.29209588275450754,0.6442935615837934,0.8936170212765957,0.9876541761162756,1.0,5/15,31.65%,ART4;PADI2;KRTCAP2;PRMT8;PRMT7
prerank,negative regulation of protein ubiquitination (GO:0031397),0.2463029613850849,0.6439630661016198,0.9352360043907794,0.9875794497795616,1.0,16/50,29.16%,GTPBP4;GNL3L;USP4;SQSTM1;AKT1;FBXO5;CHP1;OGT;UFL1;U2AF2;ARRB1;BAG5;PRKCG;DNAJA1;HDAC8;SENP2
prerank,regulation of chromosome organization (GO:0033044),0.27299761768232306,0.6437621004865756,0.8912237330037083,0.9873904645023526,1.0,8/22,27.95%,HNRNPD;MAPT;XRCC5;SMG6;TERF2IP;UPF1;SMG5;HDAC8
prerank,phasic smooth muscle contraction (GO:0014821),-0.26270404228812627,-0.6436378005202537,0.9174917491749175,0.9727090770742588,1.0,3/10,15.59%,EDNRB;EDN1;EDN3
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.23489848884866193,0.6433862009389703,0.9384941675503712,0.9873626331600929,1.0,7/74,9.05%,PSMC4;VEGFA;NFE2L2;PSMC6;EGLN2;PSMD8;SIRT2
prerank,protein targeting to ER (GO:0045047),0.2320378362955082,0.6428665175458927,0.9626943005181348,0.9874154754967194,1.0,12/99,15.51%,RPSA;EDEM1;SPCS1;SRP19;SRP9;RPL10A;UBA52;RPS5;SGTA;SEC63;SEC61A1;RPL6
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.2553167653629715,0.6426858990518781,0.9255079006772009,0.9872104876631794,1.0,12/36,30.32%,AXL;GAS6;PARP14;CXCR4;CPNE1;CSF1;TRIM44;UBE2K;LAPTM5;CD300LF;AGPAT2;ADAM17
prerank,inositol phosphate biosynthetic process (GO:0032958),0.31597839498496855,0.6415872987660627,0.8930987821380244,0.98773896827088,1.0,3/11,20.19%,FGF2;IPPK;IP6K1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.3098808336212767,0.6411335687987463,0.8901251738525731,0.987754966825275,1.0,1/11,4.40%,ZFP36L1
prerank,tRNA transport (GO:0051031),0.2566277399107632,0.6398354448986305,0.911318553092182,0.9884501759746502,1.0,11/35,27.02%,NUP93;NUP107;NUP98;NUP37;NUP50;XPOT;TPR;NUP133;NUP85;NUP188;NUP88
prerank,receptor clustering (GO:0043113),0.2674203410473569,0.6397247928024087,0.9194711538461539,0.988180150678189,1.0,11/27,28.16%,DLG4;DLG2;MUSK;MAGI2;DNAJA3;SYNJ2BP;FLNA;PICK1;DVL1;LRRC7;NLGN1
prerank,regulation of blood circulation (GO:1903522),0.25726975775477356,0.6391049113952153,0.9225512528473804,0.988307198194993,1.0,4/34,11.25%,SRI;CAMK2D;ECE1;CELF2
prerank,regulation of lipid catabolic process (GO:0050994),-0.20957606903048454,-0.6368253846272285,0.9469026548672567,0.9761289003043697,1.0,2/19,8.98%,LONP2;ADRA2A
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.30242364978591185,0.63512275818686,0.8827493261455526,0.9910521497421192,1.0,2/12,12.25%,TLR4;DUOXA1
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.19436446732896334,-0.63493839255667,0.9477124183006536,0.9760104359427972,1.0,10/25,29.31%,HSPA9;ERO1A;PTGES3;DNAJC18;HSPE1;HSPA1A;ST13;HSPA1B;HSPA2;SDF2L1
prerank,DNA damage checkpoint signaling (GO:0000077),0.2629930961133637,0.634838165911098,0.9372822299651568,0.9909178278270104,1.0,13/28,33.83%,RHNO1;RAD1;BRIP1;NBN;DONSON;CLSPN;TIPRL;PRPF19;RAD17;RAD9A;USP28;CHEK2;E2F1
prerank,regulation of vacuole organization (GO:0044088),0.27017960954975323,0.6344500281425886,0.9120734908136483,0.9908633069093444,1.0,8/20,31.25%,ANXA2;RAB1B;ADPRH;TBC1D12;MTM1;PIKFYVE;LAPTM4B;IFT20
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.2564095604406952,-0.6336261457036823,0.9166666666666666,0.9755418434835325,1.0,2/10,9.97%,ERLEC1;SVIP
prerank,embryonic hemopoiesis (GO:0035162),0.3050873342651509,0.6332521814651644,0.8842975206611571,0.9914231313107227,1.0,2/12,7.86%,TGFBR2;FLT3LG
prerank,membrane lipid catabolic process (GO:0046466),0.3161095892790229,0.6330780940182098,0.8963068181818182,0.991211240862139,1.0,3/10,27.12%,PDXDC1;CYP1B1;PPT1
prerank,chromosome condensation (GO:0030261),0.25265056871186875,0.6327691635804468,0.9158986175115207,0.991110831740571,1.0,11/36,29.97%,TENT4A;NCAPG;SMC2;SET;AKAP8L;CSNK2A2;DFFB;H1-0;KMT5A;INCENP;AIFM1
prerank,regulation of steroid metabolic process (GO:0019218),0.270919687140554,0.6327607262845723,0.9021329987452948,0.9907644820489713,1.0,3/23,9.89%,DGKQ;STUB1;ACADVL
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.2690230451511868,0.6323816259623192,0.908150064683053,0.9906856577645958,1.0,6/21,27.10%,CDC14B;FBXO5;RPL23;PTEN;RAB1A;GORASP1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.23750499740328185,0.6310109310979974,0.9431693989071038,0.9913550746966009,1.0,13/57,22.19%,SDAD1;RIOK1;NOC2L;RRP36;NPM1;TGS1;MRPL36;DDX31;RPF2;EBNA1BP2;RIOK2;RPS25;RBIS
prerank,axonemal dynein complex assembly (GO:0070286),0.25902523978645875,0.6304851412403911,0.9307048984468339,0.991396906567143,1.0,5/27,22.56%,DNAH8;DNAAF3;DNAAF5;DNAH5;DNAL1
prerank,early endosome to late endosome transport (GO:0045022),0.27723838434038456,0.6303577876882455,0.9064837905236908,0.9911390277393007,1.0,6/20,28.35%,HOOK2;WDR91;ANKRD27;SNX16;STX8;PTPN23
prerank,negative regulation of innate immune response (GO:0045824),0.2567264213840063,0.6301056042630406,0.9213872832369943,0.9909776360212437,1.0,7/34,22.59%,IRAK3;SAMHD1;SERPING1;YTHDF2;TYRO3;YTHDF3;STAT2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.24067315204423834,0.6295661028771995,0.9349240780911063,0.9910539393767663,1.0,17/48,29.44%,CRIP1;DYRK2;BAK1;SFN;RPS27L;BCL3;TNFRSF1B;HTRA2;PML;MCL1;PYCARD;MSH6;PRKDC;HIC1;TOPORS;BAX;TP53
prerank,cellular response to mechanical stimulus (GO:0071260),0.2432301367748877,0.6291545230733606,0.9331872946330778,0.9910030198001152,1.0,5/46,12.13%,PIEZO2;TLR5;TLR4;SLC9A1;BAK1
prerank,positive regulation of cell development (GO:0010720),0.25429530301868836,0.6290713367430992,0.9254079254079254,0.9907136933438596,1.0,3/31,12.57%,NUMBL;SERPINF1;ATP6AP1
prerank,mRNA polyadenylation (GO:0006378),0.2587732608864851,0.6289809570685669,0.9148936170212766,0.9900906783365664,1.0,8/26,24.47%,SCAF8;CPSF2;PAPOLB;TENT2;TENT4B;PAF1;CPSF1;WDR33
prerank,RNA polyadenylation (GO:0043631),0.2587732608864851,0.6289809570685669,0.9148936170212766,0.9900906783365664,1.0,8/26,24.47%,SCAF8;CPSF2;PAPOLB;TENT2;TENT4B;PAF1;CPSF1;WDR33
prerank,polyol biosynthetic process (GO:0046173),0.28738285283369025,0.6288177844971696,0.8940731399747793,0.9898716543013136,1.0,4/16,20.19%,FGF2;CYP27B1;IPPK;IP6K1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.28586505786560346,0.6287155392913473,0.9130434782608695,0.9896013215545245,1.0,3/17,12.62%,MTOR;MAGI2;CALM2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.24900092874681728,0.6284009760970856,0.9225512528473804,0.9894735126459057,1.0,5/38,15.93%,CENPT;HJURP;NPM1;UBN1;CENPC
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.2990602857790616,0.628072259149006,0.8765603328710125,0.9893787076116203,1.0,4/12,25.00%,KLF2;EZH2;CALR;ASXL1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.2936836698045037,0.6279483767571585,0.8903924221921515,0.9891290567153909,1.0,5/13,30.99%,NT5M;OGG1;DUT;SMUG1;UPP2
prerank,cellular response to ionizing radiation (GO:0071479),0.2412691240980876,0.6271870349512718,0.9585605234460196,0.9893492957870081,1.0,18/47,30.64%,MAPK14;RHNO1;RAD1;XRCC5;CDKN1A;INO80;TNKS1BP1;SPIDR;BLM;NIPBL;CRYAB;MDM2;EEF1D;XRCC6;TP53;HSF1;TLK2;RAD9A
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.272018711437362,0.6258954151307579,0.9231754161331626,0.9899262491568936,1.0,3/21,12.43%,TEDC1;UCHL5;TUBD1
prerank,heterochromatin assembly (GO:0031507),0.27133035223505847,0.6255174722428312,0.9024390243902439,0.9898396349129778,1.0,7/20,28.06%,SIRT2;POLE3;EZH1;BAHD1;BAZ2A;MBD2;SUV39H1
prerank,regulation of mRNA processing (GO:0050684),0.25493120994358676,0.6253022257945513,0.9264531435349941,0.9896504087010924,1.0,10/32,26.61%,ZFP36L1;SRSF3;SON;CPSF4;PTCD2;RBM39;SRPK1;LARP7;PABPN1;SAFB
prerank,regulation of histone methylation (GO:0031060),-0.23238662623026185,-0.6251588244465347,0.9102040816326531,0.9797168571334088,1.0,2/13,8.80%,TET1;CTR9
prerank,regulation of ruffle assembly (GO:1900027),0.26492996289094867,0.624823140464437,0.92,0.9896686425381093,1.0,4/23,16.27%,NDEL1;PFN2;KANK1;EPS8L2
prerank,L-serine metabolic process (GO:0006563),-0.24990002161013292,-0.624667895260142,0.9025974025974026,0.978666723909982,1.0,1/10,2.06%,SERINC3
prerank,neurotransmitter secretion (GO:0007269),0.24385483369211386,0.6242417262562521,0.9298642533936652,0.9897391898596184,1.0,8/44,18.84%,STX1A;SNAP25;GAD2;SNAPIN;SNPH;SYT1;VAMP2;RIMS2
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.27817896389324936,0.6242258596238123,0.9115734720416124,0.9894011388216799,1.0,17/17,72.21%,LPCAT1;CRLS1;PLA2G12A;LPGAT1;PLA2G1B;PLA2G4D;PLA2G2F;PLA2G2E;PLA2G10;PLA2G2D;PLA2G3;SERAC1;LPCAT4;PLA2G5;PLA2G4B;PLA2G4A;PLA2G4F
prerank,tyrosine metabolic process (GO:0006570),0.30374741070868116,0.6235376169247561,0.9028571428571428,0.9895503357701227,1.0,11/11,69.65%,TYR;GSTZ1;THAP4;PAH;TH;TAT;IYD;DCT;IL4I1;HGD;FAH
prerank,magnesium ion transport (GO:0015693),0.29655376185977445,0.6231177987142672,0.8990450204638472,0.9895019592232948,1.0,3/12,16.08%,NIPAL2;CNNM4;TUSC3
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.2002492122513485,-0.6230109198783074,0.9701492537313433,0.9783509706738138,1.0,11/20,37.76%,PLCB1;AGRN;LYPD1;RGS10;CDK5R1;CHRM1;LY6H;LY6G6D;CHRNB2;GNA11;CHRM5
prerank,pseudouridine synthesis (GO:0001522),0.2915271189358214,0.6230018440619925,0.8920377867746289,0.9892480214692503,1.0,4/13,29.71%,GAR1;TRUB1;NHP2;PUS10
prerank,covalent chromatin modification (GO:0016569),0.2890367599211693,0.622901204940899,0.9009126466753585,0.9889754855359764,1.0,5/14,30.38%,SETD5;CHD1;UFL1;MBD2;SIRT7
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.306331393296398,0.6228512153956764,0.8947368421052632,0.9886594576234001,1.0,1/10,7.10%,HDAC6
prerank,branched-chain amino acid catabolic process (GO:0009083),0.2701673049674735,0.6222940159774775,0.9103362391033624,0.9883738832205242,1.0,5/20,21.00%,BCAT1;AUH;HIBADH;BCKDHA;ACAT1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.2701673049674735,0.6222940159774775,0.9103362391033624,0.9883738832205242,1.0,5/20,21.00%,BCAT1;AUH;HIBADH;BCKDHA;ACAT1
prerank,regulation of protein dephosphorylation (GO:0035304),0.24641053891929582,0.6217826515201229,0.9405162738496072,0.9883873879929924,1.0,13/37,28.87%,PPP6R2;CALM2;PIN1;NSMF;PPIA;SMPD1;PTBP1;YWHAB;ANKLE2;TIPRL;HSP90B1;TSC1;PTPA
prerank,autophagosome maturation (GO:0097352),0.2539158269592879,0.6211807893384088,0.9457900807381776,0.9884799489081262,1.0,6/32,13.33%,LIX1L;WIPI2;VPS33A;STX17;EPG5;ATP2A2
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.21218436949828934,-0.6205010795452824,0.9156118143459916,0.97851350824129,1.0,9/17,40.02%,AKAP6;KCNE4;ANK3;NOS1AP;KCNAB1;KCNS2;RNF207;KCNG1;KCNE5
prerank,regulation of neuron differentiation (GO:0045664),0.22565155525318176,0.61954436796704,0.9708333333333333,0.9893164907915778,1.0,27/76,31.82%,FGFR1;NEUROD2;BIN1;BEND6;ZFHX3;YWHAG;RHOA;SIX1;CDK5RAP2;ZEB1;CNTN4;NBL1;KCTD11;TIAM1;CPNE1;PCP4;CALR;NRCAM;HES1;IMPACT;NLGN1;BRINP2;MMD;DISP3;ALK;NGF;CDK5RAP3
prerank,regulation of erythrocyte differentiation (GO:0045646),0.24847153164553076,0.6194849096181874,0.9418472063854048,0.989009182582872,1.0,10/35,24.70%,MAPK14;ZFP36L1;HOXA5;MAPK11;ZFP36;STAT5B;ABCB10;ACVR2A;LDB1;ACVR1B
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.28411127891876137,0.6189514576112366,0.9143239625167336,0.9890530850244661,1.0,2/15,11.60%,MLXIPL;ELOVL5
prerank,retinal metabolic process (GO:0042574),0.2903675200051491,0.6185258575420897,0.9205921938088829,0.988998944004748,1.0,3/12,22.29%,ALDH1A3;RDH13;CYP1B1
prerank,cellular response to interferon-beta (GO:0035458),0.28817936673858324,0.6179680218755879,0.912568306010929,0.9890455408481882,1.0,5/14,27.22%,UBE2G2;CDC34;HTRA2;UBE2K;NDUFA13
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.232514931573598,0.6178286212416204,0.9578833693304536,0.9887826295333051,1.0,17/59,27.46%,CHUK;TLR4;AKT1;UBA52;NKIRAS1;BCL3;CD14;RBCK1;MAP3K14;CARD11;TAB2;AZI2;MAP3K7;RELA;TICAM1;RNF31;BCL10
prerank,regulation of interleukin-17 production (GO:0032660),0.25080484021569227,0.6178100144753164,0.9245939675174014,0.9884491901405469,1.0,4/31,17.74%,RFTN1;TLR4;IL6;IL18
prerank,protein localization to cilium (GO:0061512),0.24997435510516006,0.6176995336703068,0.9344827586206896,0.988183953400417,1.0,10/32,32.00%,BBS9;BBS4;ATP6V1D;TCTN2;TCTN1;RAB29;TULP1;ZNF423;IFT20;ARL6
prerank,synaptic vesicle transport (GO:0048489),0.3013646374138293,0.6168250142275641,0.9326647564469914,0.9884471756114871,1.0,2/11,16.18%,TOR1A;SNAPIN
prerank,regulation of macrophage chemotaxis (GO:0010758),0.2638771890682462,0.6168098209490009,0.92,0.9881111476317193,1.0,2/21,5.85%,MIF;AKIRIN1
prerank,sensory perception (GO:0007600),0.23672480580143276,0.616732378001077,0.9537767756482526,0.9878242411730149,1.0,5/45,17.16%,GNAS;KCNA2;BBS4;TTC8;CHRNA7
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.27334120417054525,0.616055661744065,0.9161372299872935,0.9879532622463519,1.0,3/18,15.69%,POLE3;MCM3;RFC4
prerank,RNA destabilization (GO:0050779),0.2720722936073089,0.6157404668562464,0.8966836734693877,0.9878226667965272,1.0,6/18,27.88%,PUM1;YTHDF1;YTHDF2;YTHDF3;RBM24;CELF1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.2647650386165654,0.6153369126344861,0.928030303030303,0.9877643976754393,1.0,9/20,28.82%,DGKQ;ACADVL;SREBF1;FMO5;ARV1;LPCAT3;KPNB1;MBTPS1;SREBF2
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.2540055389748165,0.6149078803138703,0.9490291262135923,0.9876959989196898,1.0,7/25,24.48%,DOK1;AKT1;CBL;ARAP1;PLAUR;CCDC88A;RTN4
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.26223817450935677,0.6148032077703302,0.9239263803680982,0.9874287170544742,1.0,9/24,34.63%,POLB;UBA52;RFC4;POLD1;XRCC1;RFC3;RPA3;LIG1;POLD3
prerank,sphingolipid catabolic process (GO:0030149),0.27650464743541603,0.6146565351742367,0.902088772845953,0.9871765281058715,1.0,3/15,18.57%,PDXDC1;GLA;SMPD1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.2904667176515054,0.6142644152997578,0.9068493150684932,0.9870860549597668,1.0,6/12,33.72%,TCERG1;LARP7;HEXIM1;NELFA;NELFB;HNRNPU
prerank,DNA biosynthetic process (GO:0071897),-0.21230002803530057,-0.6142173428224038,0.9598214285714286,0.9808511712106858,1.0,7/16,29.02%,SIRT1;TERT;WRN;POLD2;POLE;POLD4;POLL
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.2622882098873883,0.6139383802097698,0.9284848484848485,0.9869739784804776,1.0,8/22,27.43%,CAMK2N1;CDKN1A;TFAP4;IPO5;PTEN;LATS1;HEXIM1;MEN1
prerank,positive regulation of protein deacetylation (GO:0090312),0.27993695557072656,0.6138458163595699,0.9069148936170213,0.9866829554787179,1.0,6/14,29.82%,AKAP8;NIPBL;CTBP1;AKAP8L;NNMT;BRMS1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.207901337807044,-0.6131809073336663,0.9615384615384616,0.9801369617219063,1.0,8/18,28.20%,MPV17L;HIP1R;SLC35F6;CHCHD10;HSPA1A;ZNF205;BOK;BID
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.2842073104002085,0.6129908873072136,0.9177545691906005,0.9869131222091846,1.0,6/15,30.17%,SAMHD1;YTHDF2;YTHDF3;STAT2;MUL1;CACTIN
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.2454830460744736,0.6124216686747136,0.9462616822429907,0.9869348064059631,1.0,2/32,3.64%,CDK14;ZPR1
prerank,icosanoid biosynthetic process (GO:0046456),-0.24113853664861296,-0.6121501865923835,0.9111842105263158,0.9793993715034766,1.0,6/10,33.14%,MGST3;PLA2G4A;PLA2G5;ALOX5AP;MGST2;ALOX5
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.2214711680165139,0.61181797824723,0.9710743801652892,0.9869747311047222,1.0,11/94,12.07%,PSMC4;IRAK3;PSMC6;PELI3;UBE2N;CHUK;PSMD8;SQSTM1;IRAK4;IRAK1;UBA52
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.29019659996754643,0.611662049920487,0.9071729957805907,0.9867283849429014,1.0,3/13,16.79%,TBC1D10A;BAK1;GRIN2A
prerank,nerve growth factor signaling pathway (GO:0038180),0.3040448204286579,0.6113725869302408,0.9396551724137931,0.9865866003887743,1.0,3/10,14.99%,MAGI2;KIDINS220;RAPGEF1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.2891326965091325,0.6112775725354219,0.9123783031988874,0.9863179341994962,1.0,5/12,27.89%,MPHOSPH8;SETDB1;SETDB2;TASOR;ATF7IP
prerank,RNA stabilization (GO:0043489),0.24607694482742778,0.610882420165085,0.9296600234466589,0.9862351330441934,1.0,7/33,24.83%,TENT5B;LARP1;GDNF;TENT2;ZCCHC17;THRAP3;RBM24
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.3050337691929602,0.6105909876354076,0.9152542372881356,0.9860717321087865,1.0,3/10,18.67%,NAGK;ST3GAL1;GNE
prerank,regulation of chromatin binding (GO:0035561),0.3017584482953035,0.6101311967627209,0.9111424541607899,0.986024159817355,1.0,3/10,19.09%,DDX11;GMNN;BTAF1
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.26814346528718497,0.6092162448109261,0.9184210526315789,0.9862730580791256,1.0,4/18,21.04%,SRC;MAP2K2;VPS11;MAPK1
prerank,sterol biosynthetic process (GO:0016126),0.24617257660708802,0.6078915331723515,0.9482758620689655,0.986774965420967,1.0,4/33,9.30%,ACLY;MVK;INSIG2;GGPS1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.277227584699147,0.6077413989120886,0.926860025220681,0.9865273516457655,1.0,5/16,23.22%,KAT2B;NAA15;NAA50;NAA20;NAA30
prerank,DNA-dependent DNA replication (GO:0006261),0.21713694980184806,0.6076417647917381,0.9858156028368794,0.9862472313772722,1.0,20/128,19.01%,REV3L;PSMC4;PSMC6;PSMD8;POLG2;POLB;POLE3;MCM3;DDX21;UBA52;CDC34;DNA2;ORC6;DBF4;GMNN;RFC4;RECQL;BLM;POLD1;NOC3L
prerank,exit from mitosis (GO:0010458),0.29104326836001926,0.607029243125976,0.907967032967033,0.9862997030478402,1.0,6/12,31.63%,CHMP7;CTDP1;CLASP2;PPP2R2D;SIRT7;CHMP4B
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.29351431426568897,0.6065605424538892,0.9274965800273598,0.9862551806351664,1.0,4/12,22.83%,ERN1;BAK1;ATF6;TMEM33
prerank,microtubule-based transport (GO:0099111),0.28837730055042005,0.6064286999222335,0.9163237311385459,0.9860016967757634,1.0,2/12,14.28%,DYNC1I1;SPAG17
prerank,lipoprotein biosynthetic process (GO:0042158),0.2903257539618671,0.6062412042833429,0.9149519890260631,0.9857739571140014,1.0,2/11,10.46%,WIPI2;WDR45B
prerank,DNA replication checkpoint signaling (GO:0000076),0.2760706912055415,0.6049808063915463,0.9102564102564102,0.9862035215987701,1.0,2/16,13.51%,TIPIN;DNA2
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.2226849021878935,0.6044984960804777,0.9738766980146291,0.9861943944003511,1.0,22/76,24.58%,EGFR;HDAC7;RASSF2;TLR4;IRAK1;LRRC19;CD27;BCL3;RHOA;ZC3H12A;CD14;PDCD4;ILK;IFI35;PPM1A;TSPAN6;CPNE1;TERF2IP;CYLD;CCN3;RELA;TRIM44
prerank,pigment granule transport (GO:0051904),0.2687766946642558,0.60367813742662,0.9223181257706535,0.986029681040524,1.0,4/18,18.90%,MYO5A;BBS4;RAB27B;BBS5
prerank,melanosome transport (GO:0032402),0.2687766946642558,0.60367813742662,0.9223181257706535,0.986029681040524,1.0,4/18,18.90%,MYO5A;BBS4;RAB27B;BBS5
prerank,cellular response to starvation (GO:0009267),0.21244257468070085,0.6023707695738802,0.9889001009081736,0.9865297603242702,1.0,32/147,23.55%,EIF2AK3;HNRNPA1;MTOR;FOXO1;GAS2L1;FLCN;WIPI2;USP33;WDR45B;CEBPB;ATP6V1E1;SESN3;CDKN1A;RRAGD;EIF2S1;ZC3H12A;EHMT2;FADS1;STK24;ATP6V1D;ATP6V1B2;DAP;SREBF1;CASTOR2;STK26;MAPK1;SESN2;ATF4;SLC38A9;ATP6V0B;ATG14;PICK1
prerank,regulation of presynapse assembly (GO:1905606),0.2656765212449055,0.6020442709488282,0.9340232858990944,0.9860572317368276,1.0,3/18,15.05%,GPC6;LRFN5;MDGA1
prerank,regulation of presynapse organization (GO:0099174),0.2656765212449055,0.6020442709488282,0.9340232858990944,0.9860572317368276,1.0,3/18,15.05%,GPC6;LRFN5;MDGA1
prerank,calcium ion transport into cytosol (GO:0060402),0.26009007045342664,0.6017338047612091,0.937192118226601,0.9859099507520335,1.0,2/21,6.14%,ATP2B4;GRIN2D
prerank,synaptonemal complex organization (GO:0070193),0.27392074120620585,0.6016306971896223,0.9225721784776902,0.9852992074273477,1.0,1/15,8.81%,SYCP2
prerank,synaptonemal complex assembly (GO:0007130),0.27392074120620585,0.6016306971896223,0.9225721784776902,0.9852992074273477,1.0,1/15,8.81%,SYCP2
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.24419179068529404,0.600996769908404,0.9469434832756632,0.9853577854914817,1.0,15/35,32.28%,PPP1R1B;MTOR;PPP6R2;MAGI2;CALM2;FKBP1A;TIPRL;HSP90B1;CRY2;TSC1;PTPA;FKBP1B;BOD1;CALM1;PPP4R4
prerank,regulation of microtubule-based movement (GO:0060632),0.2946399530882359,0.6006149237347793,0.9186991869918699,0.9852725952586622,1.0,1/11,7.10%,HDAC6
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.2481279881265519,0.6000894230276249,0.9316546762589928,0.9852531070513507,1.0,4/30,11.89%,INPP5F;SRCIN1;PARP14;PIBF1
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.2439451101243228,-0.5999901115533315,0.9283387622149837,0.9848564813212374,1.0,4/10,28.33%,SORL1;NAB2;RB1;EGR1
prerank,histone lysine demethylation (GO:0070076),0.2521735897707818,0.59990270495097,0.9356796116504854,0.9850304096153806,1.0,10/25,28.64%,KDM3B;KDM5C;KDM5B;KDM1B;JMJD1C;KDM2B;KDM4C;KDM3A;KDM4B;KDM2A
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.2433920906370497,0.5979136461659388,0.9545983701979045,0.9858775125645329,1.0,10/31,35.05%,SCP2;SRD5A1;NFS1;PYCR1;MOCS1;NOXRED1;PYCR3;MOCS2;LIAS;MOCS3
prerank,histone H2A acetylation (GO:0043968),0.2697796923271548,0.5978014707824502,0.9365918097754293,0.9855995497302877,1.0,8/16,32.78%,MSL3;DMAP1;MORF4L1;TRRAP;BRD8;YEATS4;RUVBL1;RUVBL2
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.27123234740029556,0.5970661137269242,0.9287564766839378,0.9857107463759157,1.0,2/16,7.10%,IRAK3;HDAC6
prerank,detection of visible light (GO:0009584),-0.20753769606007158,-0.5960081096459379,0.967741935483871,0.9856474080418348,1.0,2/16,10.27%,ABCA4;RP1
prerank,DNA catabolic process (GO:0006308),0.29177776671158984,0.5954953860219898,0.9184247538677919,0.9863267147594375,1.0,3/11,24.95%,DNASE1L2;DFFB;DNASE1L1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.27703341571869167,0.5951265170685288,0.9370816599732262,0.986196610413768,1.0,4/14,22.83%,COPS5;BAK1;UFL1;TMEM33
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.2624936532450487,0.5948293612334659,0.939622641509434,0.9853567698985188,1.0,2/20,8.28%,ZW10;ZWINT
prerank,spindle assembly checkpoint signaling (GO:0071173),0.2624936532450487,0.5948293612334659,0.939622641509434,0.9853567698985188,1.0,2/20,8.28%,ZW10;ZWINT
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.2624936532450487,0.5948293612334659,0.939622641509434,0.9853567698985188,1.0,2/20,8.28%,ZW10;ZWINT
prerank,nucleotide biosynthetic process (GO:0009165),0.2599608880434888,0.593830948980562,0.9364238410596026,0.985628025853596,1.0,4/18,16.62%,GART;PRPSAP1;PRPS1;PRPS1L1
prerank,receptor recycling (GO:0001881),0.2916412140452259,0.5931100348402135,0.9157303370786517,0.9857255989925222,1.0,3/10,16.29%,NSG1;REP15;PHETA2
prerank,protein localization to vacuole (GO:0072665),0.28087654607334656,0.5929750097918483,0.9291666666666667,0.9854685608799244,1.0,2/13,14.68%,CD81;RNF128
prerank,negative regulation of leukocyte activation (GO:0002695),0.2680917804537383,0.5927950697612209,0.9326287978863936,0.985224702807771,1.0,6/15,28.30%,ZC3H12A;IL4;LRFN5;IL31RA;HAVCR2;CD300LF
prerank,glial cell differentiation (GO:0010001),0.24719460579855496,0.5926662284350538,0.9383155397390273,0.9849670136958857,1.0,3/28,8.12%,SOX10;NFIB;SOX8
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.18399852267265326,-0.5914210394550723,0.9797979797979798,0.9865687269811115,1.0,13/23,39.72%,ABHD4;PLAAT3;PLA2G4C;PLA2G6;PLA2G4F;PLA2G4A;PLA2G4B;PLA2G5;MBOAT2;LPCAT4;PLBD1;MBOAT1;PLA2G3
prerank,neurotransmitter biosynthetic process (GO:0042136),0.277482170007743,0.5913420135210319,0.9242219215155616,0.9853965348965421,1.0,4/14,22.34%,DAGLA;SLC6A4;DAGLB;ALDH9A1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.24771401218661096,0.5908746689744392,0.9467162329615861,0.9853281494491566,1.0,10/24,32.22%,FYN;MIEF2;CHP1;ITGAM;FIS1;MTCL1;PRNP;MYO1C;AKT2;TCAF1
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.20980134319945523,0.5908032136010889,0.9867075664621677,0.985029403380339,1.0,13/110,15.51%,RPSA;CTIF;HELZ2;PNRC2;GSPT2;RPL10A;UBA52;RPS5;SMG7;EIF3E;GSPT1;SMG6;RPL6
prerank,DNA strand elongation (GO:0022616),0.2582219841576665,0.5903434237490349,0.9288343558282208,0.9849598595383867,1.0,4/18,17.41%,MCM3;NBN;RFC4;RAD50
prerank,ncRNA 3'-end processing (GO:0043628),0.2667826992250694,0.5872167615604024,0.9220246238030095,0.9863906448940561,1.0,4/14,19.29%,INTS6;INTS2;INTS12;PTCD1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.2324675359873032,0.5869523945745283,0.964367816091954,0.9862016051613897,1.0,11/38,27.22%,NDUFS5;NDUFAB1;NDUFS1;NDUFB7;NDUFV2;NDUFA2;NDUFB2;NDUFB3;NDUFAF1;NDUFB9;NDUFA13
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.1523206105920389,-0.5860839259972673,1.0,0.9878200592154843,1.0,16/48,31.75%,IL1R1;SLC7A5;TLR3;SCRIB;CYRIB;TXK;SLC11A1;IL27;CD276;FZD5;CCR2;IL12RB2;TLR7;RASGRP1;LILRB1;FADD
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.25232891054575074,0.5849208441431816,0.9334975369458128,0.98698193902921,1.0,7/20,30.79%,MCU;MCUB;SPG7;SLC8B1;PARL;LETM1;MICU1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.2581928285941508,0.5821437952351327,0.9496774193548387,0.9881283620818092,1.0,4/17,21.01%,ACVR1;JAG1;SNAI2;BMPR1A
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.21206258057509594,0.5820146344207621,0.9747368421052631,0.9878555203320456,1.0,6/73,9.29%,PSMC4;RUNX1;ITCH;PSMC6;PSMD8;PDCD2
prerank,protein neddylation (GO:0045116),0.2728738919975642,0.5818610105079024,0.9274193548387096,0.9875974805854048,1.0,5/13,29.05%,RNF7;NEDD8;UBE2F;DCUN1D1;UBE2M
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.2529900091910873,0.581086640370734,0.9467162329615861,0.9876464287550062,1.0,10/21,32.28%,PPP1R1B;YWHAE;YWHAB;FKBP1A;TIPRL;CRY2;PTPA;FKBP1B;BOD1;PPP4R4
prerank,pinocytosis (GO:0006907),0.2875947757363828,0.5804801283990594,0.9473684210526315,0.9876355954605248,1.0,5/10,31.86%,PYCARD;SNX33;PPT1;MAPKAPK3;SNX5
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.23395271099910486,0.5803580925222538,0.9507803121248499,0.9873682731427625,1.0,4/29,13.17%,AXIN1;UBE2N;FBXO5;PIN1
prerank,centromere complex assembly (GO:0034508),0.2295668008779574,0.5797908471567547,0.9670079635949943,0.9873150840621493,1.0,5/36,18.82%,CENPT;HJURP;NPM1;CENPC;CENPE
prerank,glutamate receptor signaling pathway (GO:0007215),0.22936791560852018,0.5778148661336359,0.9630484988452656,0.987966233815009,1.0,11/37,27.38%,GRIN3A;DAGLA;GRIA2;DAGLB;GRIN2A;GRM1;GRIA3;GRIK2;GRIK4;GRM5;GRID2
prerank,ribosomal large subunit assembly (GO:0000027),0.24384987152676363,0.5768549049702442,0.95875,0.9881276751461489,1.0,6/24,24.02%,RPL6;NOP53;RPF2;NOP2;RSL24D1;BRIX1
prerank,regulation of membrane repolarization (GO:0060306),0.26996290703854336,0.5767284625140753,0.943758573388203,0.9878651892193047,1.0,4/13,18.73%,KCNJ2;YWHAE;AKAP9;KCNH2
prerank,neuron fate commitment (GO:0048663),0.26622764097553453,0.5761815470107123,0.94579945799458,0.9878109092985509,1.0,3/14,25.68%,POU3F2;TGFBR1;MYT1L
prerank,protein-containing complex subunit organization (GO:0043933),0.20692734156089174,0.5760685217709993,0.9887063655030801,0.9875314915966108,1.0,27/109,27.25%,WIPF1;LLGL1;DLG4;GPAA1;ZW10;WASF1;MDM4;NUP98;MITF;TFAP4;PML;SPG7;NAPG;EPRS1;VAMP2;LAMC1;KMT2A;TPR;DMTN;NDUFAF1;NUP133;MDM2;PPIH;KIFAP3;HES1;VAMP3;WASL
prerank,aerobic electron transport chain (GO:0019646),0.21349266044586315,0.5754710783723221,0.9766454352441614,0.9875002034929363,1.0,20/68,27.22%,NDUFS5;NDUFAB1;NDUFS1;NDUFB7;NDUFV2;NDUFA2;UQCRQ;UQCC3;UQCRH;SDHAF2;COX7B;NDUFB2;UQCR10;AFG1L;NDUFB3;NDUFAF1;SDHC;NDUFB9;COX15;NDUFA13
prerank,cytoplasmic translation (GO:0002181),0.20685115362084203,0.5746857850241198,0.9864864864864865,0.9875404140542801,1.0,14/91,20.91%,RPSA;EIF4A1;FTSJ1;GSPT2;RPL10A;UBA52;RPS5;GSPT1;RPL6;RPL22L1;RPL23;RPL17;RWDD1;RPS25
prerank,regulation of store-operated calcium entry (GO:2001256),0.2803760995195469,0.5746412288211435,0.9439775910364145,0.9872246557733105,1.0,3/10,21.65%,CASQ1;STIM1;SLC8B1
prerank,regulation of mitochondrial fusion (GO:0010635),0.2801368927392654,0.5743613981671991,0.9322766570605188,0.9870324594060009,1.0,3/11,27.42%,PID1;MUL1;VAT1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.24691164732363186,0.5727948525207387,0.942998760842627,0.987483362452209,1.0,9/20,32.78%,BRD7;DIP2A;GLYR1;ARRB1;RPS6KA5;TADA2A;PRKAA1;TADA2B;RUVBL2
prerank,regulation of mRNA polyadenylation (GO:1900363),0.2572094790592654,0.5727398301301652,0.9449423815620999,0.9871752166484898,1.0,9/17,33.73%,CPSF6;CDK9;CPEB1;CPSF7;RNF20;HSF1;VIRMA;CPEB3;NCBP2
prerank,glucose metabolic process (GO:0006006),0.21209741682080496,0.5718034069626046,0.9706521739130435,0.9873049942118283,1.0,12/58,23.16%,CRTC2;SLC39A14;IRS2;GAA;MDH2;G6PC3;ALDOA;GALM;GOT1;SLC37A4;ATF4;KCNJ11
prerank,signal release from synapse (GO:0099643),0.2235421533563148,0.5700968842617674,0.9622857142857143,0.9877943116915042,1.0,7/43,18.55%,STX1A;SNAP25;GAD2;SNAPIN;SNPH;SYT1;VAMP2
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.15321629775701,-0.5699644873325455,1.0,0.9936290908736437,1.0,19/45,32.25%,APP;WNT5A;AIM2;GBP5;HSPB1;LPL;CCL19;NOD2;GSDMD;RIPK2;CASP1;FZD5;AGER;EGR1;MALT1;NLRC4;TYROBP;CD36;TLR6
prerank,natural killer cell mediated immunity (GO:0002228),-0.21102530294468513,-0.5678743096063388,0.9958677685950413,0.9931289690837452,1.0,15/15,78.92%,ULBP1;RAET1E;KIF5B;TUBB4B;SLAMF7;KLRD1;KLRK1;TUBB;KLRC2;KIR3DL1;GZMB;CEBPG;ARL8B;PLEKHM2;LYST
prerank,endothelial tube morphogenesis (GO:0061154),0.2771640063401518,0.5669575845602685,0.9450704225352112,0.988942885250098,1.0,2/10,13.49%,PRKD2;RHOA
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.263092354010561,0.5646785426495847,0.9551630434782609,0.9896421900758866,1.0,6/13,33.72%,TCERG1;LARP7;HEXIM1;NELFA;NELFB;HNRNPU
prerank,positive regulation of interleukin-1 production (GO:0032732),0.2175526233428629,0.5646688233891849,0.9802197802197802,0.9893097512544233,1.0,4/51,11.69%,IL16;TMEM106A;TLR4;USP50
prerank,motile cilium assembly (GO:0044458),-0.21834457640331117,-0.5621400859963864,0.9731543624161074,0.9940302822483363,1.0,2/12,8.50%,BBOF1;SPATA6
prerank,establishment of epithelial cell polarity (GO:0090162),0.24416335528750627,0.5621174518933836,0.9553571428571429,0.990117945163326,1.0,8/19,35.18%,MYO9A;RHOA;FBF1;SIPA1L3;PARD3;GOLPH3;CYTH1;CLASP1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.20814168808033892,0.5616200492050013,0.9872611464968153,0.9900074424420293,1.0,20/69,27.22%,NDUFS5;NDUFAB1;NDUFS1;NDUFB7;NDUFV2;NDUFA2;UQCRQ;UQCC3;UQCRH;SDHAF2;COX7B;NDUFB2;UQCR10;AFG1L;NDUFB3;NDUFAF1;SDHC;NDUFB9;COX15;NDUFA13
prerank,positive regulation of interleukin-17 production (GO:0032740),0.23905026660398748,0.5612329639962668,0.9550970873786407,0.9898485689756299,1.0,3/22,17.74%,RFTN1;IL6;IL18
prerank,snRNA 3'-end processing (GO:0034472),0.24255069509948032,0.5606762960947198,0.9521410579345088,0.9897655773744939,1.0,4/19,18.59%,EXOSC7;INTS6;INTS2;INTS12
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.27350382698855014,0.5606232863163845,0.9410919540229885,0.9894524336156055,1.0,3/10,20.02%,NOC2L;SET;CTBP1
prerank,cell differentiation in hindbrain (GO:0021533),-0.21942116273500784,-0.5604448129777756,0.9655172413793104,0.9933021348602954,1.0,2/11,9.17%,OPHN1;KNDC1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.2334418122676923,0.5594953239336413,0.9661016949152542,0.9896112862351121,1.0,6/25,20.96%,BMF;BBC3;MLLT11;HRK;PLAUR;PYCARD
prerank,negative regulation of cellular protein localization (GO:1903828),0.22223049696983307,0.5589770767093365,0.9705882352941176,0.9895110165300778,1.0,10/34,27.79%,FLCN;OTUD7B;MAPT;ILRUN;GOPC;MAP1A;LEPROT;LATS1;SNX33;DNAJA1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.20917407046272302,-0.5583412275795321,0.9686274509803922,0.9927325060316716,1.0,6/13,28.95%,SOX11;MAD2L2;TAF1;HEY1;HEY2;SIN3A
prerank,cotranslational protein targeting to membrane (GO:0006613),0.20176099156600846,0.5577227044420234,0.9885057471264368,0.9897158021031847,1.0,10/91,15.51%,RPSA;SRP19;SRP9;RPL10A;UBA52;RPS5;TRAM1;SEC63;SEC61A1;RPL6
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.20564927120338403,0.5570755449099917,0.9872068230277186,0.9896477964806579,1.0,5/70,8.57%,PSMC4;RUNX1;ITCH;PSMC6;PSMD8
prerank,lipid droplet organization (GO:0034389),-0.1722989949748744,-0.5565889367864226,0.9739583333333334,0.9920346895446057,1.0,22/22,82.80%,ZFYVE1;PNPLA3;PLA2G4C;FITM2;CDS2;HILPDA;PPID;PLIN5;CIDEA;SMIM22;FAF2;HSD17B13;TSPO2;SQLE;CIDEC;FITM1;BSCL2;CDS1;RAB3GAP1;RAB18;AUP1;PPIA
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.25292808882743323,0.555424356064566,0.9697766097240473,0.9900296099795696,1.0,8/15,38.06%,CCT7;CCT4;CCT6A;NHP2;RUVBL1;RUVBL2;TCP1;CCT8
prerank,autophagy of peroxisome (GO:0030242),0.2687569822525569,0.555328086456338,0.9546079779917469,0.9897360764795983,1.0,3/12,17.80%,SQSTM1;NBR1;PEX5
prerank,ether lipid biosynthetic process (GO:0008611),0.27748807360428157,0.555063368753143,0.9376731301939059,0.9895229102177765,1.0,2/10,20.92%,FAR1;PEDS1
prerank,endocytic recycling (GO:0032456),0.2116690597000872,0.5542197868414713,0.9779005524861878,0.989546041990191,1.0,17/50,31.07%,VPS52;EHD2;CMTM6;DENND1A;ARF6;ANKRD27;RAB35;ENTR1;VPS39;RAB11FIP3;MICALL1;EIPR1;PTPN23;ACAP2;SNX27;CCDC93;RAB14
prerank,presynapse organization (GO:0099172),0.27161430264973524,0.5526355666766771,0.941908713692946,0.98986433223238,1.0,5/10,31.31%,LRRTM3;DVL1;NLGN1;NLGN3;NLGN2
prerank,negative regulation of viral genome replication (GO:0045071),0.21473949447497853,0.5524191424337896,0.9807909604519774,0.9896181883205939,1.0,9/40,23.06%,INPP5K;MPHOSPH8;ZC3HAV1;SLPI;TNIP1;FAM111A;BTBD17;SRPK1;SETDB1
prerank,endoderm development (GO:0007492),-0.1996986628162471,-0.5519409199221418,0.9851851851851852,0.9921895335035656,1.0,13/13,80.05%,SOX17;SOX7;DUSP4;TBX20;DUSP5;DUSP2;GATA4;KIF16B;EOMES;APELA;DUSP1;LHX1;LAMC1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.23396343256053287,0.5503120390810654,0.9652605459057072,0.9901334351506409,1.0,5/23,26.30%,GSTM2;FADS1;GSTM1;ELOVL6;ACOT7
prerank,positive regulation of ruffle assembly (GO:1900029),0.2596264852830923,0.5501774434685889,0.9484126984126984,0.9898539104497589,1.0,2/13,16.27%,NDEL1;EPS8L2
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.2615189654967599,0.5499089174089768,0.9499304589707928,0.9892898557567932,1.0,3/12,19.98%,STIMATE;SLC9A1;PTBP1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.2615189654967599,0.5499089174089768,0.9499304589707928,0.9892898557567932,1.0,3/12,19.98%,STIMATE;SLC9A1;PTBP1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.21004394224733208,-0.5495520767892423,0.9337979094076655,0.9916455680607147,1.0,12/12,79.02%,ACSL3;APOC1;MTTP;P4HB;APOC4;DGAT1;APOB;APOC3;MFSD2A;SOAT2;LPCAT3;SOAT1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.25701388633100813,0.5470720451818457,0.9438502673796791,0.9900650149287353,1.0,2/14,11.73%,TIRAP;IRAK1
prerank,establishment of skin barrier (GO:0061436),0.2441561497986937,0.5461482471398185,0.9613848202396804,0.9897473033178125,1.0,2/15,12.48%,FA2H;SFN
prerank,regulation of water loss via skin (GO:0033561),0.2441561497986937,0.5461482471398185,0.9613848202396804,0.9897473033178125,1.0,2/15,12.48%,FA2H;SFN
prerank,NIK/NF-kappaB signaling (GO:0038061),0.1989394118333739,0.5450812769343835,0.990546218487395,0.98983738561709,1.0,22/72,31.72%,PSMC4;PSMC6;CHUK;PSMD8;TIRAP;AKT1;IRAK1;MAP3K14;FBXW11;MAP3K7;RELA;PSMD3;PSMD4;PSMB3;PSMB2;PSMD5;CUL1;PSMD14;TRAF6;PSMC3;PSMC5;PSME4
prerank,primary miRNA processing (GO:0031053),0.2673160063349006,0.5450041521659441,0.9536903039073806,0.9895373513831203,1.0,1/10,6.56%,DGCR8
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.25236953271264245,0.5448911930518698,0.9646133682830931,0.9892420992472306,1.0,2/14,11.70%,TLR5;PUM1
prerank,negative regulation of histone acetylation (GO:0035067),0.26032579630250374,0.5431875519773212,0.9410919540229885,0.9895229060069074,1.0,3/11,20.02%,NOC2L;SET;CTBP1
prerank,regulation of oxidative phosphorylation (GO:0002082),0.24423862781442496,0.542353146274229,0.9553450608930988,0.9894795685078777,1.0,3/16,21.65%,MLXIPL;NUPR1;SLC25A33
prerank,regulation of cellular amine metabolic process (GO:0033238),0.20511837463538116,0.5387806517660094,0.9845644983461963,0.9904747886831998,1.0,4/50,9.78%,PSMC4;PSMC6;PSMD8;ODC1
prerank,gluconeogenesis (GO:0006094),0.21048425330843376,0.5380668170601273,0.9875141884222475,0.9904060055662435,1.0,8/39,22.18%,CRTC2;SLC39A14;MDH2;G6PC3;ALDOA;GOT1;SLC37A4;ATF4
prerank,positive regulation of DNA repair (GO:0045739),0.20583705432964033,0.5369356296047849,0.9887387387387387,0.9904767127519473,1.0,7/46,16.65%,EGFR;EYA2;UBE2N;TIGAR;ABRAXAS1;DDX11;SPIDR
prerank,hydrogen peroxide catabolic process (GO:0042744),0.26378728097814186,0.536449362352702,0.9572039942938659,0.9903129764014666,1.0,2/11,17.98%,GPX1;PXDN
prerank,glycerophospholipid catabolic process (GO:0046475),0.2238272070896255,0.5360889530031461,0.9739644970414201,0.9901056197981961,1.0,5/27,20.37%,INPP5F;PNPLA8;PLA2G4E;LIPC;GDPD3
prerank,negative regulation of cell division (GO:0051782),0.26334405415237516,0.535885634149498,0.9680555555555556,0.9898452260995484,1.0,4/11,29.73%,ORC6;BLM;E2F7;CHMP4C
prerank,regulation of cell projection organization (GO:0031344),0.24959797991698396,0.5358480301392916,0.9529569892473119,0.9895240217692255,1.0,1/13,8.00%,MYO9A
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.2276181247844404,0.5356787638091094,0.9820574162679426,0.9892551962687582,1.0,7/25,27.22%,MAPK14;MAPK11;STAT5B;ABCB10;ACVR2A;ACVR1B;PRKDC
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.2115003245568507,-0.5355958324210455,0.9771986970684039,0.9947023650258366,1.0,1/10,4.21%,MTHFS
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.20277278277807875,0.5345164375145363,0.9831838565022422,0.9893297326669281,1.0,5/50,14.13%,CAMK2N1;GTPBP4;CDKN1A;CCND1;CCNH
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.23430042702838472,0.5342304515749168,0.9459459459459459,0.9890898233853237,1.0,18/18,76.60%,SPAG17;SPEF2;NPHP3;CCDC39;NEK10;RFX3;DNAAF1;DNAAF4;CCDC40;OFD1;AQP4;ODAD4;DNAAF2;SPA17;ADCY10;ROPN1L;CFAP53;CABYR
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.2116169774644635,-0.5339089244745013,0.9814126394052045,0.9937677983246007,1.0,1/12,2.06%,SERINC3
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.2554952838829522,0.5334634693699335,0.9659400544959128,0.9890467914943258,1.0,2/12,18.71%,TLR4;STRAP
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.2423725328317785,0.5333010507025083,0.9683377308707124,0.9887664408776001,1.0,3/15,16.84%,DAGLA;DAGLB;GRM1
prerank,ether lipid metabolic process (GO:0046485),-0.19873351918443372,-0.5325385544954923,0.9753086419753086,0.9928357643244522,1.0,5/14,18.91%,AGPS;LIPE;PLAAT3;DHRS7B;TMEM86B
prerank,positive regulation of telomere maintenance (GO:0032206),0.21345688142522556,0.5296458633946971,0.9685681024447031,0.9896719672979142,1.0,7/31,22.85%,HNRNPD;NBN;PML;RAD50;NEK7;MAPK1;ERCC1
prerank,tRNA metabolic process (GO:0006399),0.23769038380993646,0.5288349937843633,0.9766839378238342,0.9895972233386331,1.0,5/17,31.03%,RPP21;TRPT1;RPP30;SARS1;AARS1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.24062466230555804,0.5281478665611767,0.966931216931217,0.9894942325954316,1.0,6/16,32.88%,VAMP2;LYST;VAMP7;PLEKHM2;ARL8B;CEBPG
prerank,response to histamine (GO:0034776),0.2589861397305797,0.5204210627616931,0.9664233576642336,0.9915340033409673,1.0,2/10,19.26%,DIAPH1;GABRG2
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.19535559751789935,0.5173659104775125,0.9901531728665208,0.9921139788957998,1.0,4/53,9.78%,PSMC4;PSMC6;PSMD8;ODC1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.19758551312321485,-0.5170319526536172,0.978021978021978,0.9954831732266674,1.0,1/12,2.45%,APOE
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.22562299454391618,0.5169722975394876,0.967866323907455,0.991897824200326,1.0,2/17,15.33%,MBOAT7;PLA2G4E
prerank,pre-replicative complex assembly (GO:0036388),0.193082467936411,0.516114608958349,0.9904255319148936,0.991821810127143,1.0,7/64,14.84%,PSMC4;PSMC6;PSMD8;MCM3;UBA52;ORC6;GMNN
prerank,response to gamma radiation (GO:0010332),0.21721553953367048,0.5138879842170512,0.9877899877899878,0.9921156887532001,1.0,10/24,30.05%,FANCD2;XRCC5;CRYAB;MDM2;MEN1;XRCC6;TP53;HSF1;PRKAA1;TLK2
prerank,regulation of mRNA metabolic process (GO:1903311),0.2483461265736034,0.5116375979609734,0.973463687150838,0.9923889208866765,1.0,4/11,29.70%,PTCD2;SRPK1;SAFB;SLTM
prerank,DNA replication initiation (GO:0006270),0.2034643817356037,0.5096063969772143,0.9865016872890888,0.9926019394636794,1.0,6/37,14.84%,POLE3;MCM3;CDC34;ORC6;DBF4;GMNN
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.19759655533007803,0.5081936484114637,0.9943883277216611,0.992633810602101,1.0,14/48,27.02%,NUP93;NUP107;TIGAR;NUP98;EIF6;NUP37;OGT;NUP50;TPR;NOA1;NUP133;NUP85;NUP188;NUP88
prerank,regulation of stem cell differentiation (GO:2000736),0.1828877720729873,0.5076493592474621,0.995846313603323,0.992444181922874,1.0,7/89,8.92%,PSMC4;RUNX1;ITCH;PSMC6;ZFP36L2;PSMD8;JAG1
prerank,neuronal action potential (GO:0019228),0.215049425940782,0.5074855244260785,0.9741379310344828,0.9921603481321879,1.0,11/22,35.52%,MYH14;KCNA2;SCN9A;SCN2A;CACNA1H;KCNMB2;KCNMB3;CACNA1I;CACNA1G;SCN8A;SCN1A
prerank,regulation of stem cell proliferation (GO:0072091),0.22671971346345035,0.5061299168957112,0.9725848563968669,0.9921725674707169,1.0,1/17,4.40%,ZFP36L1
prerank,glycine metabolic process (GO:0006544),-0.19378531073446328,-0.5043032600306914,0.9853479853479854,0.996694282573309,1.0,12/12,80.64%,DLD;GCSH;SHMT2;SHMT1;AMT;GLYAT;RIDA;BAAT;SDS;SDSL;GCAT;GLDC
prerank,peptidyl-glutamic acid modification (GO:0018200),0.21140483755508838,0.5039010518509366,0.9780487804878049,0.9923924293294901,1.0,5/24,25.85%,GGCX;TTLL3;TTLL11;VKORC1;TPGS1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.19811087518705794,0.5006766856664825,0.9906868451688009,0.9928375368404246,1.0,11/35,28.60%,ACLY;FAR1;GGT7;HSD17B8;BDH2;SCD5;ACAT1;BDH1;PPT1;PAM;HMGCL
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.2081618447978811,0.496482214217868,0.9853836784409257,0.9934765861384935,1.0,5/27,17.91%,AK2;NME2;NME1;AK8;AK9
prerank,B cell mediated immunity (GO:0019724),0.24598264286381627,0.48933859477921676,0.975886524822695,0.9947242685381746,1.0,1/10,12.21%,CD27
prerank,tryptophan catabolic process (GO:0006569),0.233130374741071,0.47977886696289374,0.9844632768361582,0.996244165537612,1.0,11/11,76.70%,AFMID;KMO;KYAT1;ACMSD;IDO1;TDO2;IDO2;AADAT;HAAO;IL4I1;KYNU
prerank,mitotic DNA replication (GO:1902969),0.23734009598226719,0.47961828864411116,0.983402489626556,0.9959416161271641,1.0,1/10,10.20%,MCM3
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.22725483767320792,0.47269805560070116,0.9892761394101877,0.9968458237672688,1.0,6/12,33.72%,CDYL;LRIF1;PCGF3;RBM15;RLIM;HNRNPU
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.1625229379441384,-0.4683239464578085,0.9959016393442623,1.0,1.0,6/17,27.12%,GJA1;TERT;SOX11;HMGA2;PTPRC;N4BP2L2
prerank,fibrinolysis (GO:0042730),-0.17841672421369828,-0.4678651069077949,0.9919354838709677,0.9990943543672159,1.0,13/13,82.18%,SERPINE1;PLAT;HRG;PLG;SERPINB2;CPB2;GP1BA;F2;KRT1;FGG;SERPINF2;PLAU;PLAUR
prerank,positive regulation of telomerase activity (GO:0051973),0.1846165242355785,0.463146622595513,0.9918414918414918,0.9979769558748983,1.0,7/33,23.74%,ACD;XRCC5;KLF4;HSP90AA1;NEK7;MAPK1;CCT4
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.20210773756338668,0.4567086984677192,0.9920212765957447,0.998539028591523,1.0,3/19,17.91%,CHRNA7;CHRFAM7A;CHRNA5
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.1630462079357107,-0.45197295436114665,1.0,0.99909440424701,1.0,14/14,83.72%,PTGS2;ADAM8;PARK7;TNF;CREB3L3;OSM;FFAR2;IL1B;C2CD4B;C2CD4A;IL6ST;PTGER3;OSMR;IL6
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.2217415563272276,0.4514503693287196,0.9915492957746479,0.9988759349684667,1.0,5/10,32.99%,GABRG3;GABRG2;GABRA3;GABRA1;GABRA5
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.2142304175444049,0.4447967407827057,0.9844632768361582,0.9993314328603312,1.0,3/11,28.35%,VPS11;EIPR1;PTPN23
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.18447150389153905,-0.44330590776510576,1.0,0.9982997911700024,1.0,10/10,81.57%,QDPR;KYNU;IL4I1;PCBD1;IYD;PAH;ATP7A;KYAT1;THAP4;ASRGL1
prerank,'de novo' posttranslational protein folding (GO:0051084),0.17894083617647083,0.4416033776750922,0.9976958525345622,0.9993667143900816,1.0,5/30,21.23%,HSPA13;HSPA14;SELENOF;UGGT1;DNAJB1
prerank,negative regulation of transposition (GO:0010529),0.1965112906320211,0.4409824788632878,0.9921259842519685,0.9991019038540521,1.0,3/16,22.64%,SPOCD1;DDX4;UBR2
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.18310854558537962,0.4403278409390782,1.0,0.9988401724294944,1.0,1/29,3.89%,CD160
prerank,innate immune response in mucosa (GO:0002227),0.2159013204551195,0.4370046148691584,0.9971387696709585,0.998859460142667,1.0,1/10,14.82%,IL4
prerank,negative regulation of inclusion body assembly (GO:0090084),0.21203910187202213,0.4288826738746737,0.9945205479452055,0.999270691467105,1.0,2/10,21.23%,DNAJB2;DNAJB1
prerank,sensory perception of pain (GO:0019233),0.18309151435211374,0.4280171227469758,0.9961928934010152,0.9990104537987601,1.0,21/21,81.71%,KCNA2;SCN9A;P2RX4;RETREG1;TRPA1;PTGES;NIPSNAP1;MME;P2RX7;MRGPRX2;PRDM12;PROK2;ALOXE3;CHRNB2;OPRL1;KCNK4;CCL2;CCR2;CHRNA4;OPRM1;OPRK1
prerank,double-strand break repair via break-induced replication (GO:0000727),0.2052655053639229,0.42674047963153844,0.9946236559139785,0.9987877547825915,1.0,1/12,10.20%,MCM3
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.20088992978501144,0.4237342172613806,0.9933333333333333,0.9987075327465238,1.0,5/13,32.96%,CBL;SNX6;CBLB;SOCS4;TSG101
prerank,positive regulation of telomere capping (GO:1904355),0.18565421319445402,0.4179795164324354,0.9974126778783958,0.9988182533653169,1.0,3/17,21.04%,HNRNPD;NEK7;MAPK1
prerank,glutathione derivative metabolic process (GO:1901685),0.1833904555793142,0.41562130850755447,0.9987244897959183,0.9983221034290868,1.0,8/20,33.90%,GSTM2;GSTO2;GSTM1;ESD;GSTM5;GSTT1;GSTZ1;HPGDS
prerank,glutathione derivative biosynthetic process (GO:1901687),0.1833904555793142,0.41562130850755447,0.9987244897959183,0.9983221034290868,1.0,8/20,33.90%,GSTM2;GSTO2;GSTM1;ESD;GSTM5;GSTT1;GSTZ1;HPGDS
prerank,dendritic cell chemotaxis (GO:0002407),0.19071906941173972,0.4098973025212476,0.9947712418300654,0.998385568833925,1.0,3/14,21.27%,CXCR4;CXCR2;PIK3CG
prerank,positive regulation of lipid storage (GO:0010884),0.166702190044791,0.38852405546681557,1.0,0.9991112360118308,1.0,2/21,14.08%,PLIN2;ZC3H12A
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.16174371751793168,0.3811723909884096,1.0,0.9990435997670702,1.0,4/23,23.60%,SRCIN1;CBL;SNX6;CBLB
